Citrus Sinensis ID: 025350
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 254 | 2.2.26 [Sep-21-2011] | |||||||
| Q940H6 | 362 | Serine/threonine-protein | yes | no | 0.929 | 0.651 | 0.823 | 1e-109 | |
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.925 | 0.649 | 0.773 | 1e-102 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.925 | 0.650 | 0.753 | 1e-100 | |
| Q39193 | 361 | Serine/threonine-protein | no | no | 0.925 | 0.650 | 0.716 | 4e-96 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.925 | 0.649 | 0.679 | 6e-93 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.779 | 0.533 | 0.785 | 1e-92 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.795 | 0.595 | 0.679 | 2e-81 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.795 | 0.595 | 0.674 | 5e-81 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.763 | 0.567 | 0.691 | 4e-80 | |
| Q02066 | 332 | Abscisic acid-inducible p | N/A | no | 0.814 | 0.623 | 0.655 | 2e-78 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 394 bits (1012), Expect = e-109, Method: Compositional matrix adjust.
Identities = 201/244 (82%), Positives = 216/244 (88%), Gaps = 8/244 (3%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
+IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT QF+E
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEM-DEDIDTDPDLDIDSSGEI 250
DQP QSI+EIMQIIAEAT+P AGTQ+LN L GSLDIDD+M ++ DLDIDSSGEI
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEI 358
Query: 251 VYAM 254
VYAM
Sbjct: 359 VYAM 362
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (956), Expect = e-102, Method: Compositional matrix adjust.
Identities = 188/243 (77%), Positives = 210/243 (86%), Gaps = 8/243 (3%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EPKNFRKTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILGVQY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPECR LI+RIFVA+PA RISIPEIRNH WFLKNLPADL+ D+ ++Q+EEP
Sbjct: 241 SIPDYVHISPECRDLIARIFVANPATRISIPEIRNHPWFLKNLPADLMDDSKMSSQYEEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
+QPMQS+DEIMQI+AEATIPAAG+ +NQ D+ ED+D+DPDLD++SSGEIV
Sbjct: 301 EQPMQSMDEIMQILAEATIPAAGSGGINQ-FLNDGLDLDDDMEDLDSDPDLDVESSGEIV 359
Query: 252 YAM 254
YAM
Sbjct: 360 YAM 362
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (936), Expect = e-100, Method: Compositional matrix adjust.
Identities = 183/243 (75%), Positives = 208/243 (85%), Gaps = 8/243 (3%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI +IL VQY
Sbjct: 180 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGVQY 239
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPECR LI+RIFV +PA RI++PEI+NH WF+KN+PADL+ D +NQ+EEP
Sbjct: 240 SIPDYVHISPECRDLITRIFVGNPASRITMPEIKNHPWFMKNIPADLMDDGMVSNQYEEP 299
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
DQPMQ+++EIMQI+AEATIPAAGT +NQ L D+ ED+D+D DLDI+SSGEIV
Sbjct: 300 DQPMQNMNEIMQILAEATIPAAGTSGINQFLT-DSLDLDDDMEDMDSDLDLDIESSGEIV 358
Query: 252 YAM 254
YAM
Sbjct: 359 YAM 361
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 174/243 (71%), Positives = 204/243 (83%), Gaps = 8/243 (3%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +LL +CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPD + ISPEC HLISRIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+EP
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
+QPMQS+D IMQII+EATIPA + L+ + D+ +D D++ ++DIDSSGEIV
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVRNRCLDDFMT-DNLDLDDDMDDFDSESEIDIDSSGEIV 358
Query: 252 YAM 254
YA+
Sbjct: 359 YAL 361
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (872), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 165/243 (67%), Positives = 202/243 (83%), Gaps = 8/243 (3%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ +CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPE+LL++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+++RKTI RILSV Y
Sbjct: 181 TPAYIAPEILLRQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILSVTY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIP+ +H+SPECRHLISRIFVADPA RI+IPEI + +WFLKNLP DL+ +N +QF+EP
Sbjct: 241 SIPEDLHLSPECRHLISRIFVADPATRITIPEITSDKWFLKNLPGDLMDENRMGSQFQEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
+QPMQS+D IMQII+EATIP + L+ + D+ +D D++ ++D+DSSGEIV
Sbjct: 301 EQPMQSLDTIMQIISEATIPTVRNRCLDDFM-ADNLDLDDDMDDFDSESEIDVDSSGEIV 359
Query: 252 YAM 254
YA+
Sbjct: 360 YAL 362
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (869), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 161/205 (78%), Positives = 182/205 (88%), Gaps = 7/205 (3%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
YF+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 131 YFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 190
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGK ADVWSCGVTLYVM+VGAYPFEDPEEPKNFRKTI RIL+VQY
Sbjct: 191 TPAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRILNVQY 250
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIP+ V ISPECRHLISRIFV DP+ RI+IPEIR+H WFLKNLPADL+ D++ ++Q+EEP
Sbjct: 251 SIPENVDISPECRHLISRIFVGDPSLRITIPEIRSHGWFLKNLPADLMDDDSMSSQYEEP 310
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQ 216
DQPMQ++D+IMQI+ EATIP A ++
Sbjct: 311 DQPMQTMDQIMQILTEATIPPACSR 335
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 142/209 (67%), Positives = 168/209 (80%), Gaps = 7/209 (3%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ +CHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 102 FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVG 161
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVL +KEYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSVQY
Sbjct: 162 TPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQY 221
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
+PDYV +S ECRHL+SRIFVA+P +RI+IPEI+NH WFLKNLP ++ + + Q +
Sbjct: 222 MVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDI 281
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQ 220
+ P Q ++EIM II EA P G++ Q
Sbjct: 282 NTPSQGLEEIMAIIQEARKPGDGSKFSGQ 310
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 5e-81, Method: Compositional matrix adjust.
Identities = 141/209 (67%), Positives = 168/209 (80%), Gaps = 7/209 (3%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ +CHRDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVG
Sbjct: 102 FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVG 161
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVL +KEYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSVQY
Sbjct: 162 TPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQY 221
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
+PDYV +S ECRHL+SRIFVA+P +RI+IPEI+NH WFLKNLP ++ + + Q +
Sbjct: 222 MVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDI 281
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQ 220
+ P Q ++EIM II EA P G++ Q
Sbjct: 282 NTPSQGLEEIMAIIQEARKPGDGSKFSGQ 310
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (761), Expect = 4e-80, Method: Compositional matrix adjust.
Identities = 139/201 (69%), Positives = 164/201 (81%), Gaps = 7/201 (3%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGS PRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 102 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVG 161
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVL +KEYDGK+ADVWSCGVTLYVMLVGAYPFEDP++P+NFRKTI RILSVQY
Sbjct: 162 TPAYIAPEVLSRKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQY 221
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYV +S +CRHL+SRIFV +P +RI+IPEI+NH WFLKNLP ++ + + Q +
Sbjct: 222 SIPDYVRVSADCRHLLSRIFVGNPEQRITIPEIKNHPWFLKNLPIEMTDEYQRSMQLADM 281
Query: 192 DQPMQSIDEIMQIIAEATIPA 212
+ P QS++E+M II EA P
Sbjct: 282 NTPSQSLEEVMAIIQEARKPG 302
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02066|AAIP_WHEAT Abscisic acid-inducible protein kinase (Fragment) OS=Triticum aestivum PE=2 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 143/218 (65%), Positives = 169/218 (77%), Gaps = 11/218 (5%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVAPRLKICDFGYSKSSVLHSQPKSTVG 151
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVL ++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSVQY
Sbjct: 152 TPAYIAPEVLSRREYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQY 211
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
S+PDYV +S +C HL+SRIFV +P +RI+IPEI+NH WFLK LP ++ + + Q +
Sbjct: 212 SVPDYVRVSMDCIHLLSRIFVGNPQQRITIPEIKNHPWFLKRLPVEMTDEYQRSMQLADM 271
Query: 192 DQPMQSIDEIMQIIAEATIP---AAGTQSLNQCLNGSL 226
+ P QS++E M II EA P A G CL GS+
Sbjct: 272 NTPSQSLEEAMAIIQEAQKPGDNALGVAGQVACL-GSM 308
|
Involved in water-stress responses. Triticum aestivum (taxid: 4565) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 254 | ||||||
| 388491244 | 363 | unknown [Medicago truncatula] | 0.929 | 0.650 | 0.864 | 1e-120 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 0.929 | 0.650 | 0.839 | 1e-118 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 0.929 | 0.650 | 0.843 | 1e-117 | |
| 359475222 | 371 | PREDICTED: serine/threonine-protein kina | 0.929 | 0.636 | 0.843 | 1e-117 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.929 | 0.650 | 0.843 | 1e-117 | |
| 224105505 | 362 | predicted protein [Populus trichocarpa] | 0.925 | 0.649 | 0.843 | 1e-116 | |
| 147788088 | 363 | hypothetical protein VITISV_025025 [Viti | 0.929 | 0.650 | 0.835 | 1e-116 | |
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.929 | 0.648 | 0.868 | 1e-114 | |
| 404435147 | 362 | sucrose non-fermenting 1-related protein | 0.925 | 0.649 | 0.864 | 1e-112 | |
| 356521207 | 364 | PREDICTED: serine/threonine-protein kina | 0.929 | 0.648 | 0.860 | 1e-112 |
| >gi|388491244|gb|AFK33688.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1120), Expect = e-120, Method: Compositional matrix adjust.
Identities = 210/243 (86%), Positives = 224/243 (92%), Gaps = 7/243 (2%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMEVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI+RIL+V Y
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTINRILNVHY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPEC+HLISRIFVADPAKRISIPEIRNHEWFLKNLP DL+ DN TNNQFEEP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRISIPEIRNHEWFLKNLPTDLMDDNGTNNQFEEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
DQP QS++EIMQIIAEAT+PAAGTQSLN L GSLDIDD+M+ED+DTDPDLDIDSSGEIV
Sbjct: 301 DQPTQSVEEIMQIIAEATVPAAGTQSLNPYLTGSLDIDDDMEEDLDTDPDLDIDSSGEIV 360
Query: 252 YAM 254
YAM
Sbjct: 361 YAM 363
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1101), Expect = e-118, Method: Compositional matrix adjust.
Identities = 204/243 (83%), Positives = 222/243 (91%), Gaps = 7/243 (2%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP STVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP+NFR TIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRNFRSTIHRILNVQY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPEC+HLISRIFVADPAKRI+IPEIRNH+WFLKN PADL+V+N NNQFEEP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRITIPEIRNHDWFLKNFPADLMVENNMNNQFEEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
DQPMQSIDEIMQII EATIPAAGT SLN L GSLDIDDEM+ED+++DP+LD+DSSGEIV
Sbjct: 301 DQPMQSIDEIMQIITEATIPAAGTPSLNHYLTGSLDIDDEMEEDLESDPELDLDSSGEIV 360
Query: 252 YAM 254
YAM
Sbjct: 361 YAM 363
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1099), Expect = e-117, Method: Compositional matrix adjust.
Identities = 205/243 (84%), Positives = 225/243 (92%), Gaps = 7/243 (2%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPEC+HLISRIFVADPAKRISIPEI+NHEWFLKNLPADL+ D T NNQF+EP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRISIPEIKNHEWFLKNLPADLMDDKTINNQFDEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
+QP+QSIDEIMQII+EATIPAAGT + NQ L GSLDIDD+M+ED+++DP+LD+DSSGEIV
Sbjct: 301 EQPVQSIDEIMQIISEATIPAAGTGNPNQYLTGSLDIDDDMEEDLESDPELDMDSSGEIV 360
Query: 252 YAM 254
YAM
Sbjct: 361 YAM 363
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475222|ref|XP_003631617.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1096), Expect = e-117, Method: Compositional matrix adjust.
Identities = 205/243 (84%), Positives = 219/243 (90%), Gaps = 7/243 (2%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 129 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 188
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL VQY
Sbjct: 189 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 248
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPECRHLISRIFVADPA RI+I EIRNHEWFLKNLPADL+ + +NQ+EEP
Sbjct: 249 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETKMDNQYEEP 308
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLDIDSSGEIV
Sbjct: 309 EQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIV 368
Query: 252 YAM 254
YAM
Sbjct: 369 YAM 371
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-117, Method: Compositional matrix adjust.
Identities = 205/243 (84%), Positives = 219/243 (90%), Gaps = 7/243 (2%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPECRHLISRIFVADPA RI+I EIRNHEWFLKNLPADL+ + +NQ+EEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETKMDNQYEEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLDIDSSGEIV
Sbjct: 301 EQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIV 360
Query: 252 YAM 254
YAM
Sbjct: 361 YAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105505|ref|XP_002313835.1| predicted protein [Populus trichocarpa] gi|222850243|gb|EEE87790.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1091), Expect = e-116, Method: Compositional matrix adjust.
Identities = 205/243 (84%), Positives = 224/243 (92%), Gaps = 8/243 (3%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP NFR TIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPMNFRNTIHRILNVQY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPEC+HLISRIFVADPA RI+IPEIRNHEWFLKNLPADL+V+NT NN+FEEP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAMRITIPEIRNHEWFLKNLPADLMVENTMNNEFEEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
DQPMQSI+EIMQII+EATIPAAGT SLNQ L GSLDIDD+M ED+++DP+LD+DSSGEIV
Sbjct: 301 DQPMQSIEEIMQIISEATIPAAGTPSLNQYLTGSLDIDDDM-EDLESDPELDLDSSGEIV 359
Query: 252 YAM 254
YAM
Sbjct: 360 YAM 362
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788088|emb|CAN62745.1| hypothetical protein VITISV_025025 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1084), Expect = e-116, Method: Compositional matrix adjust.
Identities = 203/243 (83%), Positives = 218/243 (89%), Gaps = 7/243 (2%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPECRHLISRIFVADPA RI+I EIRNH+WFLKNLPADL+ + +NQ+EEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHDWFLKNLPADLMDETKMDNQYEEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLDIDSSGEIV
Sbjct: 301 EQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIV 360
Query: 252 YAM 254
YAM
Sbjct: 361 YAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1067), Expect = e-114, Method: Compositional matrix adjust.
Identities = 212/244 (86%), Positives = 225/244 (92%), Gaps = 8/244 (3%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPECRHLISRIFVADPA+RISIPEIRNHEWFL+NLPADL+V+NT NNQFEEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPAQRISIPEIRNHEWFLRNLPADLMVENTMNNQFEEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPDLDIDSSGEI 250
DQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS DD+MDED++TDPDLDIDSSGEI
Sbjct: 301 DQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPDLDIDSSGEI 360
Query: 251 VYAM 254
VYAM
Sbjct: 361 VYAM 364
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|404435147|gb|AFR68940.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 411 bits (1056), Expect = e-112, Method: Compositional matrix adjust.
Identities = 210/243 (86%), Positives = 223/243 (91%), Gaps = 8/243 (3%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI RIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIQRILNVQY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHISPECRHLISRIFVADPAKRISIPEI+NHEWFLKNLPADL +DNTTNNQFEEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIKNHEWFLKNLPADL-MDNTTNNQFEEP 299
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 251
DQ MQSIDEIMQII EATIPAAGT SLN L GSLDIDD+++ED+++DPDLDIDS GEIV
Sbjct: 300 DQRMQSIDEIMQIITEATIPAAGTNSLNHYLTGSLDIDDDIEEDLESDPDLDIDSGGEIV 359
Query: 252 YAM 254
YAM
Sbjct: 360 YAM 362
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1051), Expect = e-112, Method: Compositional matrix adjust.
Identities = 210/244 (86%), Positives = 223/244 (91%), Gaps = 8/244 (3%)
Query: 19 YFWSELL-------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 71
+F+ +L+ VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 131
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 191
SIPDYVHIS ECRHLISRIFVADPA+RISIPEIRNHEWFLKNLPADL+V+NT N QFEEP
Sbjct: 241 SIPDYVHISSECRHLISRIFVADPAQRISIPEIRNHEWFLKNLPADLMVENTMNRQFEEP 300
Query: 192 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPDLDIDSSGEI 250
DQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS DD+MDED++TDPDLDIDSSGEI
Sbjct: 301 DQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPDLDIDSSGEI 360
Query: 251 VYAM 254
VYA+
Sbjct: 361 VYAI 364
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 254 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.889 | 0.624 | 0.832 | 5.8e-98 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.885 | 0.623 | 0.734 | 1.6e-86 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.775 | 0.558 | 0.675 | 8.6e-72 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.748 | 0.527 | 0.685 | 2.1e-70 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.748 | 0.526 | 0.691 | 2.6e-70 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.744 | 0.54 | 0.694 | 1.8e-69 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.700 | 0.518 | 0.726 | 1.3e-68 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.720 | 0.539 | 0.663 | 2.9e-64 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.598 | 0.341 | 0.446 | 5.6e-29 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.590 | 0.307 | 0.432 | 1.9e-28 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
Identities = 189/227 (83%), Positives = 197/227 (86%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 148
K+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY+IPDYVHISPECRHLIS
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 149 RIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 208
RIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT QF+E DQP QSI+EIMQIIAEA
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEA 315
Query: 209 TIPAAGTQSLNQCLNGSLXXXXXXXXXXXXXXXXXXX-SSGEIVYAM 254
T+P AGTQ+LN L GSL SSGEIVYAM
Sbjct: 316 TVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEIVYAM 362
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 865 (309.6 bits), Expect = 1.6e-86, P = 1.6e-86
Identities = 166/226 (73%), Positives = 188/226 (83%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL++EYDG
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 148
KIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+YSIPD + ISPEC HLIS
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLIS 256
Query: 149 RIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 208
RIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+EP+QPMQS+D IMQII+EA
Sbjct: 257 RIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEA 316
Query: 209 TIPAAGTQSLNQCLNGSLXXXXXXXXXXXXXXXXXXXSSGEIVYAM 254
TIPA + L+ + +L SSGEIVYA+
Sbjct: 317 TIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDID-SSGEIVYAL 361
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 8.6e-72, P = 8.6e-72
Identities = 133/197 (67%), Positives = 161/197 (81%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+CHRDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDG
Sbjct: 119 ICHRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDG 178
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 148
K ADVWSCGVTLYVMLVGAYPFEDP +PKNFRKTI RI++VQY IPDYVHIS EC+HL+S
Sbjct: 179 KHADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLS 238
Query: 149 RIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 208
RIFV + AKRI++ EI+NH W+LKNLP +L+ + +QS+++IM+I+ EA
Sbjct: 239 RIFVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDTSFSLQSVEDIMKIVGEA 298
Query: 209 TIPAAGTQSLNQCLNGS 225
PA T ++ +G+
Sbjct: 299 RNPAPSTSAVKSSGSGA 315
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 713 (256.0 bits), Expect = 2.1e-70, P = 2.1e-70
Identities = 131/191 (68%), Positives = 158/191 (82%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+CHRDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDG
Sbjct: 119 ICHRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 148
K ADVWSCGVTLYVMLVG YPFEDP++P+NFRKTI RI++VQY IPDYVHIS ECRHL+S
Sbjct: 179 KHADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLS 238
Query: 149 RIFVADPAKRISIPEIRNHEWFLKNLPADLVVD-NTTNNQFEEPDQPMQSIDEIMQIIAE 207
RIFV + AKRI++ EI+ H W+LKNLP +L + E P +QS+++IM+I+ E
Sbjct: 239 RIFVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKIVGE 298
Query: 208 ATIPAAGTQSL 218
A PA + ++
Sbjct: 299 ARNPAPSSNAV 309
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 712 (255.7 bits), Expect = 2.6e-70, P = 2.6e-70
Identities = 132/191 (69%), Positives = 159/191 (83%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+CHRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL + EYDG
Sbjct: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDG 178
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 148
K+ADVWSCGVTLYVMLVGAYPFED E+PKNF+KTI RI++V+Y IPDYVHIS +C+HL+S
Sbjct: 179 KMADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLS 238
Query: 149 RIFVADPAKRISIPEIRNHEWFLKNLPADLV-VDNTTNNQFEEPDQPMQSIDEIMQIIAE 207
RIFV + KRI+I +I+ H WFLKNLP +L + + E P +QS++EIM+I+ E
Sbjct: 239 RIFVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEE 298
Query: 208 ATIPAAGTQSL 218
A PA ++S+
Sbjct: 299 AKTPARVSRSI 309
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 704 (252.9 bits), Expect = 1.8e-69, P = 1.8e-69
Identities = 134/193 (69%), Positives = 155/193 (80%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+CHRDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL +KEY+G
Sbjct: 119 ICHRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNG 178
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 148
KIADVWSCGVTLYVMLVGAYPFEDPE+P+N R TI RILSV Y+IPDYV IS EC+HL+S
Sbjct: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLS 238
Query: 149 RIFVADPAKRISIPEIRNHEWFLKNL----PADLVVDNTTNNQFEEPDQPMQSIDEIMQI 204
RIFVADP KRI++PEI H WFLK P + DN + EE ++ QS++EI++I
Sbjct: 239 RIFVADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEIVKI 298
Query: 205 IAEATIPAAGTQS 217
I EA GT +
Sbjct: 299 IEEARKGVNGTDN 311
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 696 (250.1 bits), Expect = 1.3e-68, P = 1.3e-68
Identities = 133/183 (72%), Positives = 151/183 (82%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+CHRDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL KEYDG
Sbjct: 119 ICHRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDG 178
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 148
KIADVWSCGVTLYVMLVGAYPFEDP +PK+FRKTI RIL QY+IPDYV +S ECRHL+S
Sbjct: 179 KIADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLS 238
Query: 149 RIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 208
RIFVA+P KRI+I EI+NH WFLKNLP ++ + N P Q+++EI+ II EA
Sbjct: 239 RIFVANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMMNG---PST--QTVEEIVWIIEEA 293
Query: 209 TIP 211
P
Sbjct: 294 RKP 296
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 2.9e-64, P = 2.9e-64
Identities = 124/187 (66%), Positives = 146/187 (78%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV + EYDG
Sbjct: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDG 178
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 148
K DVWSCGV LYVMLVGAYPFEDP++P+NFRKT+ +I++V Y IP YVHIS +CR L+S
Sbjct: 179 KSVDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLS 238
Query: 149 RIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTT---NNQFEEPDQPMQSIDEIMQII 205
RIFVA+P R ++ EI++H WFLKNLP +L + Q ++EIM+I+
Sbjct: 239 RIFVANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIV 298
Query: 206 AEA-TIP 211
EA TIP
Sbjct: 299 GEARTIP 305
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 322 (118.4 bits), Expect = 5.6e-29, P = 5.6e-29
Identities = 80/179 (44%), Positives = 99/179 (55%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHSQPKSTVGTPAYIAPEVL 81
V HRDLK EN LLD + LKI DFG S + +LH+Q GTPAY+APEVL
Sbjct: 131 VSHRDLKPENLLLDENGD--LKISDFGLSALPEQILQDGLLHTQ----CGTPAYVAPEVL 184
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
KK YDG AD+WSCGV LYV+L G PF+D +N +I + P + SP
Sbjct: 185 KKKGYDGAKADIWSCGVVLYVLLAGCLPFQD----ENLMNMYRKIFRADFEFPPW--FSP 238
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNL--PADLVVD------NTTNNQFEEPD 192
E R LIS++ V DP +RISIP I W KN P +D ++ NN+ EE D
Sbjct: 239 EARRLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEED 297
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 319 (117.4 bits), Expect = 1.9e-28, P = 1.9e-28
Identities = 74/171 (43%), Positives = 97/171 (56%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHSQPKSTVGTPAYIAPEVL 81
V HRDLK EN L+D + LK+ DFG S + +LH+Q GTPAY+APEVL
Sbjct: 161 VSHRDLKPENLLVDENGD--LKVSDFGLSALPEQILQDGLLHTQ----CGTPAYVAPEVL 214
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
KK YDG D+WSCG+ LYV+L G PF+D +N K +I ++ P + SP
Sbjct: 215 RKKGYDGAKGDIWSCGIILYVLLAGFLPFQD----ENLMKMYRKIFKSEFEYPPW--FSP 268
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNL--PADLVVDNTTNNQFEE 190
E + LIS++ V DP KRISIP I WF KN+ P + +D E+
Sbjct: 269 ESKRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVED 319
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q940H6 | SRK2E_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8237 | 0.9291 | 0.6519 | yes | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7736 | 0.9251 | 0.6491 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_1300020 | hypothetical protein (363 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | gw1.X.4271.1 | hypothetical protein (254 aa) | • | 0.451 | |||||||
 | gw1.57.100.1 | hypothetical protein (187 aa) | • | 0.403 | |||||||
 | gw1.66.235.1 | hypothetical protein (250 aa) | • | 0.400 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 254 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-37 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-29 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-25 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-25 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-24 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-23 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-21 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-20 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-20 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-20 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-18 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-18 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-15 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-09 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.002 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.003 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.003 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.003 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.004 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 8e-49
Identities = 54/144 (37%), Positives = 76/144 (52%), Gaps = 7/144 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL K Y
Sbjct: 117 GIVHRDLKPENILLDEDG--HVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHISPECRHL 146
+ D+WS GV LY +L G PF ++ + +I + P ISPE + L
Sbjct: 175 KAV-DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 147 ISRIFVADPAKRISIPEIRNHEWF 170
I ++ V DP KR++ E H +F
Sbjct: 231 IRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-43
Identities = 61/146 (41%), Positives = 79/146 (54%), Gaps = 6/146 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
+ HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL
Sbjct: 118 GIIHRDLKPENILLDENG--VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECR 144
G DVWS GV LY +L G PF E + + I RIL +++ P + S E +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 145 HLISRIFVADPAKRISIPEIRNHEWF 170
LI + DP+KR + EI H WF
Sbjct: 235 DLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-37
Identities = 60/149 (40%), Positives = 78/149 (52%), Gaps = 17/149 (11%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKK 84
+ +RDLK EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL K
Sbjct: 113 GIIYRDLKPENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y GK D WS GV LY ML G PF + + +IL P+++ SPE R
Sbjct: 169 GY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFPEFL--SPEAR 221
Query: 145 HLISRIFVADPAKRI---SIPEIRNHEWF 170
LIS + DP KR+ EI+ H +F
Sbjct: 222 DLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-30
Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 20/150 (13%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
++ +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE++L K
Sbjct: 121 DIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEIILSKG 174
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y GK D W+ G+ +Y ML G PF D + P + +IL + P SP+ +
Sbjct: 175 Y-GKAVDWWALGILIYEMLAGYPPFFD-DNP---IQIYEKILEGKVRFP--SFFSPDAKD 227
Query: 146 LISRIFVADPAKRI-----SIPEIRNHEWF 170
LI + D KR+ + +I+NH WF
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 62/156 (39%), Positives = 82/156 (52%), Gaps = 19/156 (12%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIA 77
+ HRDLK +N L+D + LK+ DFG SK + + K VGTP YIA
Sbjct: 112 NGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 137
PEV+L + + K D WS G LY LVG PF E P + IL+ + P+ V
Sbjct: 170 PEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDV 224
Query: 138 HISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 170
+S E LIS++ V DP KR+ SI EI+NH +F
Sbjct: 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-30
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 84
+ HRD+K N L+D +K+ DFG +K S GTP ++APEV+ +
Sbjct: 121 GIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPE 142
EY AD+WS G T+ M G P+ + P +++I S IP+ H+S E
Sbjct: 179 EYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIGSSGEPPEIPE--HLSEE 232
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170
+ + + DP KR + E+ H +
Sbjct: 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-29
Identities = 53/168 (31%), Positives = 78/168 (46%), Gaps = 34/168 (20%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVLHSQP 66
+ HRDLK EN LLD +KI DFG +K +
Sbjct: 122 GIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 67 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 126
S VGT Y++PE+L +K GK +D+W+ G +Y ML G PF E T +I
Sbjct: 180 ASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEY----LTFQKI 234
Query: 127 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISI----PEIRNHEWF 170
L ++YS P + P+ + LI ++ V DP R+ + E++ H +F
Sbjct: 235 LKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-28
Identities = 52/141 (36%), Positives = 66/141 (46%), Gaps = 39/141 (27%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL K Y
Sbjct: 112 GIIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
+ +D+WS GV LY + PE + L
Sbjct: 171 YSEKSDIWSLGVILYEL-------------------------------------PELKDL 193
Query: 147 ISRIFVADPAKRISIPEIRNH 167
I ++ DP KR S EI H
Sbjct: 194 IRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 4e-25
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 12/145 (8%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ HRD+K N LL DG +K+ DFG S + VGTP ++APEV+ K
Sbjct: 118 GIIHRDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYVHISPECR 144
YD K AD+WS G+T + G P+ + K + +I + + + S E +
Sbjct: 174 YDYK-ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFK 228
Query: 145 HLISRIFVADPAKRISIPEIRNHEW 169
+ + +P KR + ++ H +
Sbjct: 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 8e-25
Identities = 52/141 (36%), Positives = 76/141 (53%), Gaps = 15/141 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 84
+ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+ K
Sbjct: 123 KILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQNK 178
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPEC 143
Y+ K +D+WS G LY + +PFE +N + +IL QY IP S E
Sbjct: 179 PYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQYPPIPS--QYSSEL 231
Query: 144 RHLISRIFVADPAKRISIPEI 164
R+L+S + DP +R SI +I
Sbjct: 232 RNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 69/221 (31%), Positives = 99/221 (44%), Gaps = 65/221 (29%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVLHSQPK-- 67
HRD+K +N LLD +K+ DFG S+P
Sbjct: 124 HRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 68 ----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF- 110
STVGTP YIAPEV L+ Y K D WS GV +Y MLVG PF
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFC 240
Query: 111 -EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRN 166
++P+E +RK I+ ++Q PD V +SPE + LI R + +R+ + EI++
Sbjct: 241 SDNPQE--TYRKIINWKETLQ--FPDEVPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKS 295
Query: 167 HEWF-------LKNLPADLVV-----DNTTN-NQFEEPDQP 194
H +F ++ PA ++ +T+N + FEE D
Sbjct: 296 HPFFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLD 336
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 9e-25
Identities = 53/151 (35%), Positives = 81/151 (53%), Gaps = 16/151 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ +RDLK EN LLD + +K+ DFG++K + + GTP Y+APE++L K YD
Sbjct: 113 GIIYRDLKPENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 88 GKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECR 144
D WS G+ LY +L G PF ED E+P + + IL + P+Y I +
Sbjct: 171 -FSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGKLEFPNY--IDKAAK 224
Query: 145 HLISRIFVADPAKRI-----SIPEIRNHEWF 170
LI ++ +P +R+ I +I+ H+WF
Sbjct: 225 DLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 58/173 (33%), Positives = 78/173 (45%), Gaps = 41/173 (23%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSK--------------------------SSVLHS 64
HRD+K +N L+D +K+ DFG K H
Sbjct: 124 HRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 65 QPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 120
Q + STVGTP YIAPEVL Y + D WS GV LY ML G PF +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD----TLQ 236
Query: 121 KTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRI-SIPEIRNHEWF 170
+T ++I++ + S P +SPE LI R + DP R+ S EI++H +F
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-24
Identities = 56/148 (37%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D
Sbjct: 117 GIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-D 170
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--ISPECRH 145
K++D WS G ++ L G PF E P ILS + + P+ V SPE
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFH-AETPD---AVFDNILSRRINWPEEVKEFCSPEAVD 226
Query: 146 LISRIFVADPAKRIS---IPEIRNHEWF 170
LI+R+ DPAKR+ EI++H +F
Sbjct: 227 LINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 5e-24
Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLK 83
+ HRD+K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+
Sbjct: 120 IVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 84 KEYDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
+ G AD+WS G + M G P+ E F+ H + IPD + +SP
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHVGAGHKPPIPDSLQLSP 235
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEW 169
E + + R +DP KR + E+ H +
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 8e-23
Identities = 60/175 (34%), Positives = 82/175 (46%), Gaps = 18/175 (10%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 82
L FNV +RDLK EN LLD + +CDFG K ++ +T GTP Y+APE+LL
Sbjct: 109 LHKFNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
Y K D W+ GV LY ML G PF D + +RK IL PD +
Sbjct: 167 GHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPD--GFDRD 219
Query: 143 CRHLISRIFVADPAKRISI---PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 194
+ L+ + DP +R+ EI+NH +F + L + P +P
Sbjct: 220 AKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF-----SQLSWKKLLMKGIQPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-22
Identities = 55/149 (36%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
N+ +RDLK EN LLD L DFG K + HS+ ST GTP Y+APEVL K+ Y
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
D + D W G LY ML G PF + + + +++ L ++ + IS RHL
Sbjct: 174 D-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN------ISVSARHL 226
Query: 147 ISRIFVADPAKRI----SIPEIRNHEWFL 171
+ + D KR+ EI+NH +F
Sbjct: 227 LEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-22
Identities = 52/148 (35%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ +RDLK EN LLD R I D G + + K GTP Y+APEVL + YD
Sbjct: 115 RIVYRDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
D ++ G TLY M+ G PF +E + R L + PD SPE + L
Sbjct: 173 FS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLC 229
Query: 148 SRIFVADPAKRI-----SIPEIRNHEWF 170
+ DP KR+ S E+R H F
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-22
Identities = 56/146 (38%), Positives = 80/146 (54%), Gaps = 13/146 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
+ +RDLKL+N LLD +KI DFG K ++ ST GTP YIAPE+L ++Y
Sbjct: 116 GIIYRDLKLDNVLLDKDG--HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VHISPECRH 145
+ + D WS GV LY ML+G PF +E + F S+ P + IS E +
Sbjct: 174 NESV-DWWSFGVLLYEMLIGQSPFHGEDEDELFD-------SILNDRPHFPRWISKEAKD 225
Query: 146 LISRIFVADPAKRISIP-EIRNHEWF 170
+S++F DP KR+ + +IR H +F
Sbjct: 226 CLSKLFERDPTKRLGVDGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-22
Identities = 60/173 (34%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 7 QRGRGTLFLPTTYFWSELLPFNVCH------RDLKLENTLLDGSPAPRLKICDFGYSKSS 60
+GR L+ T Y + H RDLKL+N +LD +KI DFG K +
Sbjct: 89 DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG--HIKIADFGMCKEN 146
Query: 61 VLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 119
V ST GTP YIAPE+L +Y + D WS GV LY ML+G PF +E + F
Sbjct: 147 VFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DWWSFGVLLYEMLIGQSPFHGDDEDELF 205
Query: 120 RKTIHRILSVQYSIPDYVH-ISPECRHLISRIFVADPAKRISIP-EIRNHEWF 170
S++ P Y I+ E + ++ ++F DP +R+ + IR H +F
Sbjct: 206 E-------SIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 93.7 bits (231), Expect = 4e-22
Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEV 80
+ HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+APEV
Sbjct: 121 GIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 81 LL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSVQY 131
LL Y +D+WS G+TLY +L G PFE + K + L+
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
S + IS L+ ++ DP R+S +H+
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278
|
Length = 384 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-21
Identities = 54/145 (37%), Positives = 84/145 (57%), Gaps = 13/145 (8%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ +RDLKL+N LLD +KI DFG K ++L T GTP YIAPE+LL ++Y+
Sbjct: 117 IVYRDLKLDNILLDTDG--HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHL 146
+ D WS GV LY ML+G PF +E + F+ S++ P Y ++ E + +
Sbjct: 175 TSV-DWWSFGVLLYEMLIGQSPFHGHDEEELFQ-------SIRMDNPCYPRWLTREAKDI 226
Query: 147 ISRIFVADPAKRISIP-EIRNHEWF 170
+ ++FV +P +R+ + +IR H +F
Sbjct: 227 LVKLFVREPERRLGVKGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-21
Identities = 54/148 (36%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ +RDLKL+N LLD +KI DFG K +L ST GTP YIAPE+L + Y
Sbjct: 117 IIYRDLKLDNVLLDSEG--HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY- 173
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
G D W+ GV LY ML G PFE +E + F IL + P +S E + ++
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYP--RWLSKEAKSIL 227
Query: 148 SRIFVADPAKRISIP-----EIRNHEWF 170
+P KR+ +I+ H +F
Sbjct: 228 KSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-21
Identities = 47/147 (31%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRD+K +N LLD + I DF + + ST GTP Y+APEVL ++ Y
Sbjct: 120 GIIHRDIKPDNILLDEQG--HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY- 176
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDY-VHISPECRH 145
D WS GVT Y L G P+ + R +I + Q + Y S E
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATWSTEAID 231
Query: 146 LISRIFVADPAKRISIP--EIRNHEWF 170
I+++ DP KR+ +++NH +F
Sbjct: 232 AINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-21
Identities = 50/149 (33%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEY 86
+ +RD+KLEN LLD + + DFG SK + + + S GT Y+APE++ K
Sbjct: 126 IVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGG 183
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
GK D WS G+ ++ +L GA PF E + RIL P + I PE + L
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF--IGPEAQDL 241
Query: 147 ISRIFVADPAKRI-----SIPEIRNHEWF 170
+ ++ DP KR+ EI+ H +F
Sbjct: 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-21
Identities = 60/163 (36%), Positives = 87/163 (53%), Gaps = 26/163 (15%)
Query: 30 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL K YD
Sbjct: 123 IHRDLKPENFLIDASG--HIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 90 IADVWSCGVTLYVMLVGAYPF--EDPEEP----KNFRKTIHRILSVQYSIPDYV----HI 139
+ D WS G LY L G PF P E K +++T+ R P Y ++
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--------PVYDDPRFNL 229
Query: 140 SPECRHLISRIFVADPAKRI-SIPEIRNHEWFLKNLPADLVVD 181
S E LI+++ + DP++R S+ +I+NH +F K + + + +
Sbjct: 230 SDEAWDLITKL-INDPSRRFGSLEDIKNHPFF-KEVDWNELRE 270
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 49/145 (33%), Positives = 65/145 (44%), Gaps = 9/145 (6%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKK 84
++ HRD+K N L+ G KI DFG SK +T VGT Y++PE ++
Sbjct: 120 HIIHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQG 174
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
E AD+WS G+TL +G +PF P +P F I SPE R
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-ICDGPPPSLPAEEFSPEFR 233
Query: 145 HLISRIFVADPAKRISIPEIRNHEW 169
IS DP KR S E+ H +
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-20
Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 30/184 (16%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL DG
Sbjct: 125 HRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 89 KIA-----DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 141
K D WS GV Y M+ G PF + KT + I++ Q + P+ +S
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHE----GTSAKTYNNIMNFQRFLKFPEDPKVSS 238
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWF-------LKNLPADLV-----VDNTTNNQFE 189
+ LI + + +R+ + H +F ++N V D+T+N F+
Sbjct: 239 DFLDLIQSL-LCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSN--FD 295
Query: 190 EPDQ 193
EP++
Sbjct: 296 EPEK 299
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-20
Identities = 53/148 (35%), Positives = 85/148 (57%), Gaps = 15/148 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYD 87
+ +RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ ++ +
Sbjct: 119 IIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
+ AD WS GV ++ ML G+ PF+ K+ ++T+ IL + +P + +SPE + L+
Sbjct: 177 -QSADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLL 229
Query: 148 SRIFVADPAKRI-----SIPEIRNHEWF 170
+F +PA R+ + EI+ H +F
Sbjct: 230 RALFKRNPANRLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 6e-20
Identities = 53/149 (35%), Positives = 74/149 (49%), Gaps = 12/149 (8%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEY 86
+ +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV+
Sbjct: 126 IIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 87 D-GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-HRILSVQYSIPDYVHISPECR 144
K D WS GV + +L GA PF E +N + I RIL + P +S E R
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSKPPFPK--TMSAEAR 240
Query: 145 HLISRIFVADPAKRI---SIPEIRNHEWF 170
I ++ DP KR+ EI+NH +F
Sbjct: 241 DFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-20
Identities = 60/182 (32%), Positives = 101/182 (55%), Gaps = 21/182 (11%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ +RDLK EN LLD +K+ DFG K S+ T GT Y+APE+L++ +
Sbjct: 121 IIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH- 177
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
GK D WS G +Y ML GA PF +N +KTI +IL + ++P Y ++PE R L+
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPF----TAENRKKTIDKILKGKLNLPPY--LTPEARDLL 231
Query: 148 SRIFVADPAKRI-SIPE----IRNHEWFLKNLPADLVVDNTTNNQFEEPDQP-MQSIDEI 201
++ +P+ R+ + P +++H +F +++ D ++ + E P +P +QS +++
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFF-RHVNWDDLL----ARKVEPPFKPLLQSEEDV 286
Query: 202 MQ 203
Q
Sbjct: 287 SQ 288
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 9e-20
Identities = 54/174 (31%), Positives = 73/174 (41%), Gaps = 37/174 (21%)
Query: 29 VCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP----- 66
+ +RDLK EN LL S P P K G +SSV
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 67 ------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 120
S VGT YIAPEV+ + + D W+ G+ LY ML G PF+ N
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG----SNRD 238
Query: 121 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI----SIPEIRNHEWF 170
+T IL + + P +S R LI ++ V DP+KR+ EI+ H +F
Sbjct: 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-19
Identities = 52/149 (34%), Positives = 74/149 (49%), Gaps = 15/149 (10%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEVL +
Sbjct: 165 HRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEVLKSQGG 220
Query: 87 D---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
D G+ D WS GV LY MLVG PF + K + S+ + PD + IS +
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDIEISKQA 278
Query: 144 RHLISRIFVADPAK--RISIPEIRNHEWF 170
+ LI + R + EI++H +F
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 57/173 (32%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
+V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +Y
Sbjct: 115 DVVYRDLKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
G+ D W GV +Y M+ G PF + + K F IL + P +SPE + L
Sbjct: 173 -GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLSPEAKSL 225
Query: 147 ISRIFVADPAKRI-----SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 194
++ + DP +R+ EI H +F A + + + E P +P
Sbjct: 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRFF-----ASINWQDVVQKKLEPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 3e-19
Identities = 55/154 (35%), Positives = 79/154 (51%), Gaps = 20/154 (12%)
Query: 27 FNVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLK 83
NV HRD+K +N LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ +
Sbjct: 135 QNVIHRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTIHRILSVQYSIPDYVHI--- 139
K+Y K+ D+WS G+ M G P +P P I IP +
Sbjct: 191 KDYGPKV-DIWSLGIMCIEMAEGEPPYLREP--PLRALFLI-----TTKGIPPLKNPEKW 242
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173
SPE + +++ V DP KR S E+ H FLK
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHP-FLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-19
Identities = 49/148 (33%), Positives = 78/148 (52%), Gaps = 16/148 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
++ +RDLK EN LLD +K+ DFG++K + + + GTP Y+APEV+ K +
Sbjct: 138 DIIYRDLKPENLLLDNKG--HVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH- 192
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
GK D W+ GV LY + G PF D + P FR +IL+ + P++ R L+
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWF--DGRARDLV 246
Query: 148 SRIFVADPAKRI-----SIPEIRNHEWF 170
+ D KR+ + +++NH +F
Sbjct: 247 KGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 8e-19
Identities = 47/141 (33%), Positives = 66/141 (46%), Gaps = 11/141 (7%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
V HRDLK N LD + +K+ DFG +K S T VGTP Y++PE L YD
Sbjct: 131 VLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYD 188
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHL 146
K +D+WS G +Y + + PF +N + +I ++ IP S E +
Sbjct: 189 EK-SDIWSLGCLIYELCALSPPF----TARNQLQLASKIKEGKFRRIPY--RYSSELNEV 241
Query: 147 ISRIFVADPAKRISIPEIRNH 167
I + DP KR S E+
Sbjct: 242 IKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-18
Identities = 49/140 (35%), Positives = 71/140 (50%), Gaps = 7/140 (5%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ K Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
K +D+W+ G LY + F E N + +I+S ++ P SP+ R LI
Sbjct: 180 QK-SDIWALGCVLYELASLKRAF----EAANLPALVLKIMSGTFA-PISDRYSPDLRQLI 233
Query: 148 SRIFVADPAKRISIPEIRNH 167
+ DP+KR + +I
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 16/148 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ K +
Sbjct: 121 EIVYRDLKPENILLDKEG--HIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
K D W+ G+ +Y MLVG PF D N +IL+ + P H+ + LI
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPR--HLDLYAKDLI 229
Query: 148 SRIFVADPAKRI-----SIPEIRNHEWF 170
++ V D +R+ +++NH WF
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-18
Identities = 49/140 (35%), Positives = 71/140 (50%), Gaps = 6/140 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N HRD+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ ++
Sbjct: 122 NTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
G AD+WS G T+ M G P+ E K I R + IPD H+S E + I
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELP-PIPD--HLSDEAKDFI 235
Query: 148 SRIFVADPAKRISIPEIRNH 167
+ DP+ R + E+ H
Sbjct: 236 LKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 55/149 (36%), Positives = 77/149 (51%), Gaps = 15/149 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEY 86
NV +RDLKLEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y
Sbjct: 116 NVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 173
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
G+ D W GV +Y M+ G PF + + K F IL + P +SPE + L
Sbjct: 174 -GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSL 226
Query: 147 ISRIFVADPAKRI-----SIPEIRNHEWF 170
+S + DP +R+ EI H++F
Sbjct: 227 LSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-18
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 23/151 (15%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK-KE 85
V HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ + K
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-------H 138
YD K AD+WS G+T+Y M G P+ D IP
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSD-----------VDAFRAMMLIPKSKPPRLEDNG 226
Query: 139 ISPECRHLISRIFVADPAKRISIPEIRNHEW 169
S R ++ +P +R+S E+ +W
Sbjct: 227 YSKLLREFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 51/148 (34%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ +RDLKL+N +LD +KI DFG K ++ + T GTP YIAPE++ + Y
Sbjct: 122 IIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY- 178
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
GK D W+ GV LY ML G PF+ +E + F+ + +S S +S E +
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS------LSKEAVSIC 232
Query: 148 SRIFVADPAKRISI-----PEIRNHEWF 170
+ PAKR+ +IR H +F
Sbjct: 233 KGLLTKHPAKRLGCGPTGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 52/152 (34%), Positives = 80/152 (52%), Gaps = 16/152 (10%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 83
L N+ +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLN 202
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
+ GK AD W+ G+ +Y +LVG PF E ++K + I+ P + + C
Sbjct: 203 VGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----YFPKF--LDNNC 255
Query: 144 RHLISRIFVADPAKRI-----SIPEIRNHEWF 170
+HL+ ++ D KR ++ H WF
Sbjct: 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-18
Identities = 54/167 (32%), Positives = 81/167 (48%), Gaps = 31/167 (18%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKSTV 70
+ + HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 120 YGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 71 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILS 128
GTP YIAPEV+L++ Y GK D W+ G+ LY LVG PF + PEE F + I S
Sbjct: 178 GTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI----S 230
Query: 129 VQYSIPDYVH-ISPECRHLISRIFVADPAKRI---SIPEIRNHEWFL 171
P+ + + + LISR+ +P +R+ E++ H +FL
Sbjct: 231 DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 9e-18
Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 15/146 (10%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
V HRD+K N L DG +K+ DFG + K + + S VGTP ++APEV+
Sbjct: 120 VIHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECR 144
+D+WS G T+ +L G P+ D N + RI+ + +P+ ISPE +
Sbjct: 176 ASTA-SDIWSLGCTVIELLTGNPPYYD----LNPMAALFRIVQDDHPPLPE--GISPELK 228
Query: 145 HLISRIFVADPAKRISIPEIRNHEWF 170
+ + F DP R + ++ H W
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 42/112 (37%), Positives = 53/112 (47%), Gaps = 19/112 (16%)
Query: 68 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE------EPKNFRK 121
S VGTP YIAPEVLL+ Y ++ D WS GV LY MLVG PF + N+
Sbjct: 203 SLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET 261
Query: 122 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 170
T+H IP +S E LI R+ R+ EI+ H +F
Sbjct: 262 TLH--------IPSQAKLSREASDLILRL-CCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-17
Identities = 51/148 (34%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLKK 84
+ HRD+K N L D A +K+ DFG SK + S KS GTP +++PEV+ +
Sbjct: 125 IVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPE 142
Y G+ ADVWS G T+ ML P+ + E I +I + +P H+SP+
Sbjct: 183 GY-GRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPTNPQLPS--HVSPD 235
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170
R+ + R FV + KR S E+ H +
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 18 TYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 77
TY + + HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+A
Sbjct: 114 TYLHEKH---KIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLV-NSLAKTFVGTSSYMA 167
Query: 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPD 135
PE + +Y K +D+WS G++L + G +P+ +P + I +L V P
Sbjct: 168 PERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNEPPPR 223
Query: 136 Y-VHI-SPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172
SP+ + ++ + DP +R S E+ H + K
Sbjct: 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-17
Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ +
Sbjct: 136 VIHRDIKSDSILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y G D+WS G+ + M+ G P+ + E P K I L + + + +SP R
Sbjct: 192 Y-GTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK--LKNLHKVSPRLRS 247
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 181
+ R+ V DPA+R + E+ NH + K P +V
Sbjct: 248 FLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 52/152 (34%), Positives = 73/152 (48%), Gaps = 17/152 (11%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
V +RDLKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L + EY
Sbjct: 117 VIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
+ D W+ GV +Y M+ G PFE E F +H V Y V +S E ++
Sbjct: 175 PSV-DWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYP----VWLSKEAVSIL 227
Query: 148 SRIFVADPAKRISI-------PEIRNHEWFLK 172
+P KR+ I+ H +F +
Sbjct: 228 KAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 46/133 (34%), Positives = 68/133 (51%), Gaps = 10/133 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
+ +RDLKL+N LLD +KI DFG K + ST GTP ++APEVL + Y
Sbjct: 121 KIVYRDLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
+ D W GV +Y MLVG PF +E + F ++ V+Y +S E +
Sbjct: 179 -TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPR----FLSREAISI 231
Query: 147 ISRIFVADPAKRI 159
+ R+ +P +R+
Sbjct: 232 MRRLLRRNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-17
Identities = 51/150 (34%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEY 86
+V +RD+KLEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y
Sbjct: 115 DVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
G+ D W GV +Y M+ G PF + + + F IL + P +SPE + L
Sbjct: 173 -GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAKSL 225
Query: 147 ISRIFVADPAKRI-----SIPEIRNHEWFL 171
++ + DP +R+ E+ H +FL
Sbjct: 226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 54/152 (35%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 82
L N+ +RDLK EN LLD + + DFG K ++ H+ ST GTP Y+APEVL
Sbjct: 112 LHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
K+ YD + D W G LY ML G PF + + +++ L ++ P+ I+
Sbjct: 170 KQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNS 222
Query: 143 CRHLISRIFVADPAKRISIP----EIRNHEWF 170
RHL+ + D KR+ EI+NH +F
Sbjct: 223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-16
Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ +RDLK EN LLD ++I D G + + S+ K GTP ++APE+L +EY
Sbjct: 117 RIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
D + D ++ GVTLY M+ PF E ++ RIL+ + PD SP +
Sbjct: 175 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSF 231
Query: 147 ISRIFVADPAKRI-----SIPEIRNHEWF 170
+ DP KR+ + +R H F
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 56/172 (32%), Positives = 84/172 (48%), Gaps = 20/172 (11%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ + Y
Sbjct: 122 IIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY- 178
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
GK D W+ GV LY ML G PF+ +E + F+ + +S S +S E +
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS------LSKEAVSIC 232
Query: 148 SRIFVADPAKRISI-PE----IRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 194
+ P+KR+ PE IR H +F + + D N + + P +P
Sbjct: 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRR-----IDWDKLENREIQPPFKP 279
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 52/148 (35%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYD 87
+ +RDLKLEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y
Sbjct: 116 IVYRDLKLENLMLDKDG--HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY- 172
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
G+ D W GV +Y M+ G PF + + K F IL P +S + + L+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEDIKFPRT--LSADAKSLL 226
Query: 148 SRIFVADPAKRI-----SIPEIRNHEWF 170
S + + DP KR+ EI H +F
Sbjct: 227 SGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 51/148 (34%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYD 87
+ +RDLKL+N +LD +KI DFG K ++ K+ GTP YIAPE++ + Y
Sbjct: 122 IIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY- 178
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
GK D W+ GV LY ML G PFE +E + F+ + ++ S +S E +
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS------MSKEAVAIC 232
Query: 148 SRIFVADPAKRISI-PE----IRNHEWF 170
+ P KR+ PE I+ H +F
Sbjct: 233 KGLMTKHPGKRLGCGPEGERDIKEHAFF 260
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (184), Expect = 1e-15
Identities = 46/171 (26%), Positives = 64/171 (37%), Gaps = 34/171 (19%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 83
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 118 RILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLG 172
Query: 84 -KEYDGKIADVWSCGVTLYVMLVGAYPFE------------------DPEEPKNFRK--T 122
K Y + D+WS G M+ G F E K
Sbjct: 173 SKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 123 IHRILSVQYSIPDYVHIS---PECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ PE L+S++ +PAKRIS E H +F
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 27/153 (17%)
Query: 31 HRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ + YD
Sbjct: 121 HRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIPDYVHIS 140
K AD+WS G+T + G P D PKN ++ S
Sbjct: 177 EK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-----------NKFS 224
Query: 141 PECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173
+ +S DP +R S E+ H+ F+K
Sbjct: 225 KPFKDFVSLCLNKDPKERPSAKELLKHK-FIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 85
+++ +RDLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL ++
Sbjct: 115 YDIVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
K D WS GV ++ M G PF + + +R I + P V +S E R
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----IAFGKVRFPKNV-LSDEGRQ 227
Query: 146 LISRIFVADPAKRI----SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 200
+ + +P R+ E++ H +F AD+ D + Q P +P+ DE
Sbjct: 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFF-----ADIDWDLLSKKQITPPFKPIVDSDE 281
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-15
Identities = 45/141 (31%), Positives = 77/141 (54%), Gaps = 17/141 (12%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK 83
+ HRD+K +N L DG+ +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 122 ILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
+ Y+ K +D+W+ G LY M + F E N + + +I+ Y P H S +
Sbjct: 176 RPYNNK-SDIWALGCVLYEMCTLKHAF----EAGNMKNLVLKIIRGSYP-PVSSHYSYDL 229
Query: 144 RHLISRIFVADPAKRISIPEI 164
R+L+S++F +P R S+ I
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 47/134 (35%), Positives = 77/134 (57%), Gaps = 13/134 (9%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
HRD+K N LL + +K+ DFG+SK ++V ++ GTP Y+APE+ +K Y
Sbjct: 166 HRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHL 146
K AD++S GV LY +L PF+ +N + +H+ L+ +Y +P ISPE + +
Sbjct: 224 KK-ADMFSLGVLLYELLTLKRPFDG----ENMEEVMHKTLAGRYDPLPP--SISPEMQEI 276
Query: 147 ISRIFVADPAKRIS 160
++ + +DP +R S
Sbjct: 277 VTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 70/227 (30%), Positives = 106/227 (46%), Gaps = 64/227 (28%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK------------ 67
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 124 HRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 68 -------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--ED 112
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 113 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEW 169
P+E +RK ++ ++ + P V IS + + LI R F D RI + EI++H +
Sbjct: 241 PQE--TYRKVMNWKETLVF--PPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHPF 295
Query: 170 F-------LKNLPADL-----VVDNTTN-NQFEEPD--QPMQSIDEI 201
F ++ PA + +D+T+N ++F E D QP ++ E
Sbjct: 296 FEGVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEP 342
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPK 67
G LF E+ + HRDLK N L P +K+ DFG+SK SV
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 68 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 127
S GTP Y+APE+ +K Y K AD+WS GV LY +L PF+ P + R+ + ++L
Sbjct: 230 SFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVL 284
Query: 128 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 187
+Y P +S + L+ + +PA R + ++ + E FLK + A+L D +++
Sbjct: 285 YGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTE-FLKYV-ANLFQDIVRHSE 341
Query: 188 FEEPDQPMQSIDEIMQIIAEATIPAA 213
P + + ++ + A P++
Sbjct: 342 TISPHDREEILRQLQESGERAPPPSS 367
|
Length = 478 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-15
Identities = 53/148 (35%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 31 HRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVL-L 82
HRD+K N LL DGS +KI DFG S S K+ VGTP ++APEV+
Sbjct: 125 HRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
YD K AD+WS G+T + GA P+ K T+ + DY S
Sbjct: 181 VHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170
R +IS DP+KR + E+ H++F
Sbjct: 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-15
Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 18 TYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 77
TY ++ + HRD+K N L++ ++K+CDFG S +++S + VGT Y++
Sbjct: 117 TYLYNVH---RIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMS 170
Query: 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQ 130
PE + +Y K +DVWS G+++ + +G +PF P + +I VQ
Sbjct: 171 PERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI--VQ 227
Query: 131 YSIPDY--VHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 171
P + R + + DP +R + ++ F+
Sbjct: 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 47/171 (27%), Positives = 69/171 (40%), Gaps = 33/171 (19%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKK 84
+ HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL
Sbjct: 118 GILHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------------S 128
+ D+WS G +L F E K I R L +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-IFRTLGTPDPEVWPKFTSLARN 232
Query: 129 VQYSIPDYVHI---------SPECRHLISRIFVADPAKRISIPEIRNHEWF 170
++S P + SP+ L+S++ DP KRI+ + H +F
Sbjct: 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 14/153 (9%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKE- 85
+ +RD+KLEN LLD + + + DFG SK + S GT Y+AP+++ +
Sbjct: 126 IIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183
Query: 86 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+D K D WS GV +Y +L GA PF E + + RIL + P +S +
Sbjct: 184 GHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALAK 240
Query: 145 HLISRIFVADPAKRI-----SIPEIRNHEWFLK 172
+I R+ + DP KR+ EI+ H +F K
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-14
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE + +
Sbjct: 123 NIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 88 GKI-----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYVHISP 141
+DVWS G+++ M +G YP+ PE N + I+ ++P S
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYP-PETYANIFAQLSAIVDGDPPTLPS--GYSD 236
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 177
+ + +++ P +R + ++ H W +K AD
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-14
Identities = 46/139 (33%), Positives = 67/139 (48%), Gaps = 13/139 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK N LL +KI D G SK VL K+ +GTP Y+APEV + Y
Sbjct: 123 KILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRH 145
K +D+WS G LY M A PF E ++ + +++ +Y IP S + ++
Sbjct: 179 SYK-SDIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKYPPIPP--IYSQDLQN 231
Query: 146 LISRIFVADPAKRISIPEI 164
I + P R + +I
Sbjct: 232 FIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 46/132 (34%), Positives = 65/132 (49%), Gaps = 10/132 (7%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ +RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L + Y
Sbjct: 117 IIYRDLKLDNVLLDHEG--HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY- 173
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
G D W+ GV LY ML G PFE E F IL+ + P ++ + ++
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTWLS--QDAVDIL 227
Query: 148 SRIFVADPAKRI 159
+P R+
Sbjct: 228 KAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-14
Identities = 45/143 (31%), Positives = 64/143 (44%), Gaps = 14/143 (9%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLK 83
+ HRD+K N + + +K+ D G SK++ HS VGTP Y++PE + +
Sbjct: 127 IMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSPERIHE 180
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
Y+ K +D+WS G LY M PF + N +I Y H S E
Sbjct: 181 NGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237
Query: 144 RHLISRIFVADPAKRISIPEIRN 166
R L+SR DP KR I +
Sbjct: 238 RDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-14
Identities = 53/163 (32%), Positives = 79/163 (48%), Gaps = 28/163 (17%)
Query: 68 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHR 125
STVGTP YIAPE+ L++ Y G+ D WS G ++ L+G PF E+ E +RK I+
Sbjct: 207 STVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHE--TYRKIINW 263
Query: 126 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLKNLPADLVVDN 182
++ + PD +H+S E LI R+ + + R+ EI++H +F VD
Sbjct: 264 RETLYF--PDDIHLSVEAEDLIRRL-ITNAENRLGRGGAHEIKSHPFFRG-------VDW 313
Query: 183 TTNNQFEEPDQP-MQSI--------DEIMQIIAEATIPAAGTQ 216
T Q P P ++SI DE+ Q+ EA
Sbjct: 314 DTIRQIRAPFIPQLKSITDTSYFPTDELEQVP-EAPALKQAAP 355
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-14
Identities = 51/155 (32%), Positives = 83/155 (53%), Gaps = 11/155 (7%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ +
Sbjct: 137 VIHRDIKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y G D+WS G+ + M+ G P+ + E P K I L + + + +SP +
Sbjct: 193 Y-GPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPK--LKNLHKVSPSLKG 248
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 180
+ R+ V DPA+R + E+ H + K P +V
Sbjct: 249 FLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIV 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 39/101 (38%), Positives = 60/101 (59%), Gaps = 10/101 (9%)
Query: 18 TYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 77
TY WS + HRD+K N L++ ++K+CDFG S V +S K+ VGT AY+A
Sbjct: 109 TYLWS----LKILHRDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMA 161
Query: 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 118
PE + ++Y G +DVWS G++ + +G +P+ P+ KN
Sbjct: 162 PERISGEQY-GIHSDVWSLGISFMELALGRFPY--PQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 56/150 (37%), Positives = 78/150 (52%), Gaps = 17/150 (11%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLKKE- 85
HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL +
Sbjct: 165 HRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKSQGG 220
Query: 86 --YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
Y G+ D WS GV LY MLVG PF + K ++ S+ + PD IS E
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDISKEA 278
Query: 144 RHLISRIFVADPAKRI---SIPEIRNHEWF 170
++LI F+ D R+ + EI+ H +F
Sbjct: 279 KNLIC-AFLTDREVRLGRNGVEEIKRHLFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL----L 82
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 135 GVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISP 141
+YD + ADVWS G++L + G +P+++ + F + + +IL + S+P SP
Sbjct: 192 NPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQEEPPSLPPNEGFSP 247
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 180
+ + D KR E+ H + + A++ V
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 13/140 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 84
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 121 GILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQGV 176
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+Y+ K +D+W+ G LY +L F + N + +I+ Y+ V+ S E
Sbjct: 177 KYNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNYTPVVSVY-SSELI 230
Query: 145 HLISRIFVADPAKRISIPEI 164
L+ + DP KR + E+
Sbjct: 231 SLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-13
Identities = 47/147 (31%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 81
+ HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 127 IIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHIS 140
+ Y K AD+WS G + ML G +PF D + + I +I IP +IS
Sbjct: 185 KQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIFKIGENASPEIPS--NIS 237
Query: 141 PECRHLISRIFVADPAKRISIPEIRNH 167
E + + F D KR + E+ H
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKH 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 50/148 (33%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
N+ +RDLK EN LLD + + DFG K V + ST GTP Y+APEVL K+ Y
Sbjct: 116 NIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
D + D W G LY ML G PF + + + +H+ L + C L
Sbjct: 174 D-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA-----CDLL 227
Query: 147 ISRIFVADPAKRI----SIPEIRNHEWF 170
+ + D +R+ EI+NH +F
Sbjct: 228 VG-LLHKDQRRRLGAKADFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 50/151 (33%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVL 81
+ HRD+K N L+D S RL+I DFG ++ L ++ +GT A++APEVL
Sbjct: 124 IIHRDVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHI 139
++Y G+ DVWS G + M P+ + E+ N I +I S SIP+ H+
Sbjct: 181 RGEQY-GRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPE--HL 236
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNHEWF 170
SP R + R P R E+ H F
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 51/171 (29%), Positives = 71/171 (41%), Gaps = 45/171 (26%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLK 83
+ HRD+K N L++ A +KI DFG S+ P S+VGT AY++PE L
Sbjct: 189 IVHRDIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPF------------------EDPEEPKNFRKTIHR 125
YDG D+WS GV++ +G +PF + PE P
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT------- 299
Query: 126 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176
S E RH IS +PAKR S ++ H + L+ P
Sbjct: 300 -------------ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337
|
Length = 353 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 49/171 (28%), Positives = 70/171 (40%), Gaps = 32/171 (18%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-KK 84
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L +
Sbjct: 119 GIMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDY 136
+YD + D+W+ G +L G+ P E + R L S+PDY
Sbjct: 177 KYDPGV-DLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234
Query: 137 VHIS-------------PECR----HLISRIFVADPAKRISIPEIRNHEWF 170
I+ P+ L+ + V DP+KR+S E H +F
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 5/105 (4%)
Query: 68 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 127
S VGTP YIAPEVLL+K Y ++ D WS GV L+ MLVG PF P + K I+
Sbjct: 207 SLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN 265
Query: 128 SVQYSIPDYVHISPECRHLISRIFVA--DPAKRISIPEIRNHEWF 170
++ IP V +SPE LI+++ + + R +I+ H +F
Sbjct: 266 TLH--IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-13
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 62/216 (28%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK------------ 67
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 124 HRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 68 -------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--ED 112
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 113 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP---EIRNHEW 169
P+E ++K ++ ++ + P V IS + + LI R F + RI P EI+ + +
Sbjct: 241 PQE--TYKKVMNWKETLIF--PPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPF 295
Query: 170 F-------LKNLPADL-----VVDNTTN-NQFEEPD 192
F ++ PA + +D+T+N ++F + D
Sbjct: 296 FEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSD 331
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-13
Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 82
L N+ +RDLK EN LLD + + DFG K + S +T GTP Y+APEV+
Sbjct: 112 LHSINIVYRDLKPENILLDSQG--HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
K+ YD + D W G LY ML G PF + + + +H+ L ++ S
Sbjct: 170 KQPYDNTV-DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG------ASLT 222
Query: 143 CRHLISRIFVADPAKRI----SIPEIRNHEWF 170
++ + D +R+ EI+ H +F
Sbjct: 223 AWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 7e-13
Identities = 50/177 (28%), Positives = 69/177 (38%), Gaps = 41/177 (23%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 83
NV HRDLK N L++ + LKICDFG ++ K V T Y APE+LL
Sbjct: 123 NVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 84 -KEYDGKIADVWSCGVTLYVML---------------------VGAYPFEDPEEPKNFRK 121
Y I D+WS G +L +G ED + + K
Sbjct: 181 SSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS-EK 238
Query: 122 TIHRILSVQYS--------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ + S+ P SPE L+ ++ V DP KRI+ E H +
Sbjct: 239 ARNYLKSLPKKPKKPLSKLFPG---ASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 52/150 (34%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLKKE- 85
HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL +
Sbjct: 165 HRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLKSQGG 220
Query: 86 --YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
Y G+ D WS GV L+ MLVG PF + K + S+ + P+ V IS
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEISKHA 278
Query: 144 RHLISRIFVADPAKRI---SIPEIRNHEWF 170
++LI F+ D R+ + EI+ H +F
Sbjct: 279 KNLIC-AFLTDREVRLGRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-12
Identities = 38/144 (26%), Positives = 58/144 (40%), Gaps = 15/144 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLL 82
N HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 123 NFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESLK 177
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
+ ++ K +DVWS GV L+ + E N + L Y +P + PE
Sbjct: 178 EGKFTSK-SDVWSFGVLLWEIF--TLGEEPYPGMSNAE--VLEYLKKGYRLPKPPNCPPE 232
Query: 143 CRHLISRIFVADPAKRISIPEIRN 166
L+ + + DP R + E+
Sbjct: 233 LYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 49/141 (34%), Positives = 78/141 (55%), Gaps = 12/141 (8%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK--KE 85
+ HRD+K +N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+ K +
Sbjct: 129 IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN--FRKTIHRILSVQYSIPDYVHISPEC 143
Y G AD+WS G T+ M G PF + EP+ F+ + +I IP+ +S E
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---HPEIPE--SLSAEA 241
Query: 144 RHLISRIFVADPAKRISIPEI 164
++ I R F DP KR S ++
Sbjct: 242 KNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 61/205 (29%), Positives = 87/205 (42%), Gaps = 34/205 (16%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLK-KE 85
NV HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL E
Sbjct: 128 NVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185
Query: 86 YDGKIADVWSCG---------------------VTLYVMLVGAYPFEDPE--EPKNFRKT 122
Y I DVWS G + L L+G+ ED + R+
Sbjct: 186 YTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244
Query: 123 IHRILSVQYSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPAD 177
I R L + H +P L+ ++ V DP+KRI++ E H + L + +
Sbjct: 245 I-RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303
Query: 178 LVVDNTTNNQFEEPDQPMQSIDEIM 202
V + FEE + I E++
Sbjct: 304 PVCQTPFSFDFEEDALTEEDIKELI 328
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 32/165 (19%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ +
Sbjct: 138 VIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP 193
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPF--EDP--------EEPKNFRKTIHRILSVQYSIPD 135
Y ++ D+WS G+ + M+ G P+ + P + P K H+
Sbjct: 194 YGTEV-DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK---------- 242
Query: 136 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLV 179
ISP R + R+ +P +R + E+ +H + L+ LP LV
Sbjct: 243 ---ISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 2e-12
Identities = 47/177 (26%), Positives = 70/177 (39%), Gaps = 52/177 (29%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-KEYD 87
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LL+ Y
Sbjct: 122 HRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLRSTSYS 177
Query: 88 GKIADVWSCG------VTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------ 129
+ D+W+ G TL + G+ + +++I SV
Sbjct: 178 SPV-DIWALGCIMAELYTLRPLFPGSSEID----------QLYKICSVLGTPTKQDWPEG 226
Query: 130 -------QYSIPDYVHI---------SPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ P + SPE LI + DP KR + + H +F
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 16/162 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 86
+ +RDLK EN LLD ++I D G + + + + VGT Y+APEV+ + Y
Sbjct: 122 RIVYRDLKPENILLDDYG--HIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
D W G +Y M+ G PF +E + R+ Q + S R +
Sbjct: 179 -TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSI 235
Query: 147 ISRIFVADPAKRI-----SIPEIRNHEWF----LKNLPADLV 179
++ DP R+ E++ H +F K L A ++
Sbjct: 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGML 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 23/149 (15%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ + Y+ K
Sbjct: 122 HRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DYVHISP 141
AD+WS G+T M G P+ D IH + + IP D SP
Sbjct: 180 -ADIWSLGITAIEMAEGKPPYSD----------IHPM-RAIFMIPNKPPPTLSDPEKWSP 227
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWF 170
E + + V DP +R S ++ H +
Sbjct: 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-12
Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 16/141 (11%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK 83
+ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
+ Y+ K D+WS G LY + +PFE N + + +I ++ P + S +
Sbjct: 177 RPYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQGYFA-PISPNFSRDL 230
Query: 144 RHLISRIFVADPAKRISIPEI 164
R LIS++F P R SI I
Sbjct: 231 RSLISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-12
Identities = 42/133 (31%), Positives = 62/133 (46%), Gaps = 13/133 (9%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKE 85
+ HRD+K N LD +KI D G +K +L + VGTP Y++PE+ K
Sbjct: 122 ILHRDIKSLNLFLDAYD--NVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y+ K +DVW+ GV LY G +PF + N I +I+ + P S +
Sbjct: 178 YNEK-SDVWALGVVLYECCTGKHPF----DANNQGALILKIIRGVFP-PVSQMYSQQLAQ 231
Query: 146 LISRIFVADPAKR 158
LI + D +R
Sbjct: 232 LIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 49/151 (32%), Positives = 70/151 (46%), Gaps = 19/151 (12%)
Query: 29 VCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84
V +RDLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKG 170
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
AD +S G L+ +L G PF + K+ + L+V +PD SPE +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTVNVELPD--SFSPELK 227
Query: 145 HLISRIFVADPAKRISI-----PEIRNHEWF 170
L+ + D +KR+ E++ H +F
Sbjct: 228 SLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ +RDLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y
Sbjct: 117 IIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 88 GKIADVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
+ D W+ GV ++ M+ G PF+ D + IL Q IP +S +
Sbjct: 175 FSV-DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 231
Query: 143 CRHLISRIFVADPAKRI------SIPEIRNHEWF 170
++ DP +R+ +I++H +F
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-12
Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 18/150 (12%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 85
V HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K
Sbjct: 136 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH---ISPE 142
Y K+ D+WS G+ M+ G P+ + +N + ++ I + P+ + +S
Sbjct: 192 YGPKV-DIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIAT--NGTPELQNPEKLSAI 244
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWFLK 172
R ++R D KR S E+ H FLK
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 4e-12
Identities = 43/172 (25%), Positives = 68/172 (39%), Gaps = 33/172 (19%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL-KK 84
+ HRD+K N L++ LK+ DFG ++ + T V T Y PE+LL
Sbjct: 120 GILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI------------------ 126
Y ++ D+WS G L + +G F+ E + K I +
Sbjct: 178 RYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEK-IFELCGSPTDENWPGVSKLPWF 235
Query: 127 --LSVQYSIP----DYVH--ISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
L + ++ I P L+ ++ DP KRIS + HE+F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-12
Identities = 48/138 (34%), Positives = 70/138 (50%), Gaps = 12/138 (8%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L + YD
Sbjct: 127 ILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYD 183
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECRHL 146
K +D+WS G LY M A+ FE +NF + RI+ S+P+ S + +
Sbjct: 184 SK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE--TYSRQLNSI 236
Query: 147 ISRIFVADPAKRISIPEI 164
+ + DP+ R S EI
Sbjct: 237 MQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-12
Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ +RDLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +EY
Sbjct: 117 IIYRDLKLDNVLLDADG--HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY- 173
Query: 88 GKIADVWSCGVTLYVMLVGAYPFE---DPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
G D W+ GV ++ M+ G PF+ D + IL IP + +S +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKAS 231
Query: 145 HLISRIFVADPAKRI------SIPEIRNHEWF 170
H++ DP +R+ +I++H +F
Sbjct: 232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 6e-12
Identities = 40/146 (27%), Positives = 60/146 (41%), Gaps = 21/146 (14%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLL 82
N HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 122 NFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESLK 176
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGA---YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 139
+ ++ K +DVWS GV L+ + YP EE + K +R+ P
Sbjct: 177 EGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL-----PQPPNCP- 229
Query: 140 SPECRHLISRIFVADPAKRISIPEIR 165
PE L+ + + DP R + E+
Sbjct: 230 -PELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-12
Identities = 51/153 (33%), Positives = 71/153 (46%), Gaps = 23/153 (15%)
Query: 29 VCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84
V +RDLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKG 170
Query: 85 -EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ILSVQYSIPDYVHISPE 142
YD AD +S G L+ +L G PF + + I R L++ +PD SPE
Sbjct: 171 VAYDSS-ADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--SFSPE 225
Query: 143 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 170
R L+ + D +R+ E++ H +F
Sbjct: 226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-12
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 33/202 (16%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYD 87
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L ++YD
Sbjct: 129 VVHRDLKPSNILINENC--DLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 88 GKIADVWSCGVTLYVMLVGA--YPFEDP------------EEPKNFRKTI--HRILSVQY 131
++ D+WS G ML G +P +D P + TI L
Sbjct: 185 VEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 132 SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADL-VV 180
S+P + + P L+ ++ V DP KRIS E H + + P D V
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA 303
Query: 181 DNTTNNQFEEPDQPMQSIDEIM 202
+ + F + D P+ + +M
Sbjct: 304 EEKFDWSFNDADLPVDTWKVMM 325
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-12
Identities = 48/145 (33%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKK 84
+ HRD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ +
Sbjct: 127 IVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y G+ ADVWS G T+ ML P+ + E I +I + + HIS R
Sbjct: 185 GY-GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHAR 239
Query: 145 HLISRIFVADPAKRISIPEIRNHEW 169
+ IFV + R S E+ H +
Sbjct: 240 DFLGCIFV-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 46/153 (30%), Positives = 66/153 (43%), Gaps = 16/153 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRD+K N LL +K+CDFG S V S + GT Y+APE + K Y
Sbjct: 125 KIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQGKPYS 181
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIP-------DYVH 138
+DVWS G+TL + +PF PE +LS V P + +
Sbjct: 182 IT-SDVWSLGLTLLEVAQNRFPFP-PEGEPPLGPI--ELLSYIVNMPNPELKDEPGNGIK 237
Query: 139 ISPECRHLISRIFVADPAKRISIPEIRNHEWFL 171
S E + I + DP +R + ++ H W
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 16/150 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---VQYSIPDYVHISPECRH 145
D W+ G LY M+ G PF+ + K R+ + R++ +YS SP+ R
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYS----EKFSPDARS 234
Query: 146 LISRIFVADPAKRI-----SIPEIRNHEWF 170
L + DP +R+ E++ H F
Sbjct: 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 34/170 (20%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 86 YDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTIHRILSV----------QYSIP 134
Y G D+W+ G + +L +P F E K IH +L +
Sbjct: 175 YYGPKMDIWAVGCVFFEIL-SLFPLFPGTNELDQIAK-IHDVLGTPDAEVLKKFRKSRHM 232
Query: 135 DY--------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+Y + S E L+ ++ DP +RI+ + H +F
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 47/155 (30%), Positives = 67/155 (43%), Gaps = 24/155 (15%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 82
V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 83 ---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-- 137
YD K AD+WS G+TL + E P + + +L + S P +
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIELAQM-------EPPHHELNPMRVLLKILKSEPPTLDQ 230
Query: 138 --HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
S + V DP R + E+ H +
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 52/153 (33%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLKK 84
HRD+K +N LLD + RL DFG S L TV GTP YI+PE+L
Sbjct: 125 HRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 85 EYDGK-----IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 139
E DGK D WS GV +Y ML G PF + + K ++ Q+ PD +
Sbjct: 179 E-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP-PDVTDV 236
Query: 140 SPECRHLISRIFVADPAK--RISIPEIRNHEWF 170
S E + LI R+ + + R + + ++H +F
Sbjct: 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 52/147 (35%), Positives = 75/147 (51%), Gaps = 12/147 (8%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 85
V HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K
Sbjct: 136 VIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y K+ D+WS G+ M+ G P+ + E P I + + P+ +SP R
Sbjct: 192 YGPKV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSPIFRD 247
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLK 172
++R D KR S E+ H FLK
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 56/194 (28%), Positives = 79/194 (40%), Gaps = 42/194 (21%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFG----------------YSKSSVLHSQ---PKST 69
V HRDLK +N LL + I D+G + ++ +S P
Sbjct: 134 VLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI 191
Query: 70 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--HRIL 127
VGTP Y+APE LL D+++ GV LY ML ++P+ K RK IL
Sbjct: 192 VGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR----KKGRKISYRDVIL 246
Query: 128 SVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEIRNH-----EWFLKNLPAD 177
S P Y I P + + DPA+R S ++ H EW +K A
Sbjct: 247 SPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWTVK---AT 302
Query: 178 LVVDNTTNNQFEEP 191
L+ + +F EP
Sbjct: 303 LMTKKKSCWKFYEP 316
|
Length = 932 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 48/175 (27%), Positives = 68/175 (38%), Gaps = 34/175 (19%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLKK 84
+ HRDLK N L+ LK+ DFG ++S P V T Y APE+L
Sbjct: 123 ILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPELLFGA 177
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDY 136
+ G D+WS G +L+ PF + + I L S+PDY
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236
Query: 137 VHISP---------------ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176
V P + L+ R+ +P KRI+ + H +F N PA
Sbjct: 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF-SNDPA 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-11
Identities = 40/146 (27%), Positives = 57/146 (39%), Gaps = 16/146 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 84
HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 125 KFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
+ K +DVWS GV L+ + +GA P+ EE + L Y +P +
Sbjct: 183 IFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRLPKPEYCPD 234
Query: 142 ECRHLISRIFVADPAKRISIPEIRNH 167
E L+ + DP R + E+
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 47/152 (30%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LL 82
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 128 GILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS---IPDYV-- 137
+ Y K+ D+WS G + M G P+ D E K L + S IP V
Sbjct: 186 SQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-----LGNKRSAPPIPPDVSM 239
Query: 138 HISPECRHLISRIFVADPAKRISIPEIRNHEW 169
++SP ++ F +P R + E+ H +
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-11
Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 15/140 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKK 84
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y+ K +D+WS G LY + +PF + +++ I ++ Y P H S E R
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYK-PLPSHYSYELR 229
Query: 145 HLISRIFVADPAKRISIPEI 164
LI ++F +P R S I
Sbjct: 230 SLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 55/172 (31%), Positives = 73/172 (42%), Gaps = 38/172 (22%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 84
V HRDLK +N L+D A LK+ DFG +++ P T V T Y APE+LL
Sbjct: 120 VLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGS 174
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILS---------VQYSIP 134
D+WS G M+ F D E + FR I R L V S+P
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVT-SLP 231
Query: 135 DYV----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
DY ++ + L+S++ V DPAKRIS H +F
Sbjct: 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 34/84 (40%), Positives = 41/84 (48%), Gaps = 8/84 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 83
NV HRDLK N LL+ LKICDFG ++ + V T Y APE++L
Sbjct: 126 NVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183
Query: 84 -KEYDGKIADVWSCGVTLYVMLVG 106
K Y I D+WS G L ML
Sbjct: 184 SKGYTKAI-DIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-11
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 16/150 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE----VLL 82
+V HRD+K N L++ ++K+CDFG S V S K+ G Y+APE L
Sbjct: 124 SVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPERINPELN 180
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--IS 140
+K YD K +DVWS G+T+ + G +P++ + P K + V+ P S
Sbjct: 181 QKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-----VEEPSPQLPAEKFS 234
Query: 141 PECRHLISRIFVADPAKRISIPEIRNHEWF 170
PE + +++ + +R + PE+ H +F
Sbjct: 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-11
Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLLKK 84
+ HRD+K N L D +K+ DFG SK + + KS GTP +++PEV+ +
Sbjct: 127 IVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VHISPEC 143
Y G+ AD+WS G T+ ML P+ + E K ++ Q + P H+S C
Sbjct: 185 GY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----IATQPTNPVLPPHVSDHC 238
Query: 144 RHLISRIFVADPAKRISIPEIRNH 167
R + RIFV + R S E+ H
Sbjct: 239 RDFLKRIFV-EAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-11
Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 12/147 (8%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
V HRD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ +K
Sbjct: 137 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y K+ D+WS G+ M+ G P+ + E P I + + P+ +S R
Sbjct: 193 YGPKV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRD 248
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLK 172
++R D KR S E+ H+ FLK
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQ-FLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-11
Identities = 49/147 (33%), Positives = 79/147 (53%), Gaps = 12/147 (8%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ +
Sbjct: 139 VIHRDIKSDSILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y G D+WS G+ + M+ G P+ + E P + I L + + D +S R
Sbjct: 195 Y-GTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPR--VKDSHKVSSVLRG 250
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLK 172
+ + V +P++R + E+ H FLK
Sbjct: 251 FLDLMLVREPSQRATAQELLQHP-FLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 36/174 (20%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90
HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y +
Sbjct: 123 HRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYTVQ- 178
Query: 91 ADVWSCGVTLYVMLVGAYPFEDP-----------EEPKNFRKTIHRILSVQ--------- 130
+D+WS G++L M +G YP P + K HR +S
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238
Query: 131 -YSIPDYV-----------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172
+ + DY+ S E + + + +P +R + E+ H + +
Sbjct: 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-10
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 34/209 (16%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ +RDLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y
Sbjct: 117 IIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 173
Query: 88 GKIADVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
G D W+ GV ++ M+ G PF+ D + IL Q IP +S +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVK 231
Query: 143 CRHLISRIFVADPAKRISI------------PEIRNHEW-----------FLKNLPADLV 179
++ DP +R+ P RN +W F N+ +
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFG 291
Query: 180 VDNTTNNQFEEPDQPMQSIDEIMQIIAEA 208
+DN EP Q D+I++ I ++
Sbjct: 292 LDNFDAQFTNEPVQLTPDDDDIVRKIDQS 320
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-10
Identities = 41/115 (35%), Positives = 55/115 (47%), Gaps = 21/115 (18%)
Query: 29 VCHRDLKLENTLLDG---------------SPAPRLKICDFGYSKSSVLHSQPKSTVGTP 73
V HRDLK +N L + P KI DFG SK+ + S S VGTP
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTP 205
Query: 74 AYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 126
Y +PE+LL K YD K +D+W+ G +Y + G PF + NF + I +
Sbjct: 206 YYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPF---HKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 46/170 (27%), Positives = 69/170 (40%), Gaps = 38/170 (22%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK +N L+ DG ++KI DFG ++ S V T Y APEVLL+ Y
Sbjct: 128 IVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSY 183
Query: 87 DGKIADVWSCGVTLYVM---------------------LVGAYPFED-PEE----PKNFR 120
+ D+WS G + ++G E+ P +F
Sbjct: 184 ATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFP 242
Query: 121 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
S + +P+ I E L+ ++ +P KRIS E H +F
Sbjct: 243 SY--TPRSFKSFVPE---ICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 44/112 (39%), Positives = 59/112 (52%), Gaps = 19/112 (16%)
Query: 68 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPK----NFRK 121
S VGTP YIAPEVLL+ Y ++ D WS GV LY MLVG PF + P E + N++
Sbjct: 207 SLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT 265
Query: 122 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 170
++H IP +SPE LI ++ P R+ EI+ H +F
Sbjct: 266 SLH--------IPPQAKLSPEASDLIIKL-CRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 50/147 (34%), Positives = 74/147 (50%), Gaps = 12/147 (8%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 85
V HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K
Sbjct: 136 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y K+ D+WS G+ M+ G P+ + E P I + + P+ +S R
Sbjct: 192 YGPKV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--RLSAVFRD 247
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLK 172
++R D +R S E+ H FLK
Sbjct: 248 FLNRCLEMDVDRRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-10
Identities = 51/176 (28%), Positives = 70/176 (39%), Gaps = 43/176 (24%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-KKE 85
+ HRDLK N LL + LKICDFG ++ S L + V T Y APE+LL KE
Sbjct: 127 ILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAKE 183
Query: 86 YDGKIADVWSCG------VTLYVMLVGA--------------YPFED--PEEPKNFRKTI 123
Y I D+WS G +T + G P E P F +
Sbjct: 184 YSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG----FSELP 238
Query: 124 HRILSVQYSIPDYVHISPECRH---------LISRIFVADPAKRISIPEIRNHEWF 170
++ Y + + L++R+ DPAKRIS + H +F
Sbjct: 239 G-AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 47/169 (27%), Positives = 66/169 (39%), Gaps = 32/169 (18%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
V HRDLK +N L+D LKI D G ++ S+ + T Y APEVLL +
Sbjct: 131 VMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHY 189
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------------------- 127
D+WS G M F E + I ++L
Sbjct: 190 STPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTPTEQVWPGVSKLRDWHEF 248
Query: 128 ------SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ ++PD +SPE L+ ++ DPAKRIS H +F
Sbjct: 249 PQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 21/144 (14%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 84
++ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+ K
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP----DYVHIS 140
Y+ K +DVW+ G +Y M + F K+ ++RI ++ +P DY S
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDY---S 227
Query: 141 PECRHLISRIFVADPAKRISIPEI 164
PE LI+ + P KR S+ I
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 33/83 (39%), Positives = 49/83 (59%), Gaps = 8/83 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 83
N+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 120 NIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLVG 175
Query: 84 KEYDGKIADVWSCGVTLYVMLVG 106
GK DVW+ G + +L G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 25/99 (25%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAP 78
V HRD+K +N LL + +K+ DFG S +Q ST +GTP ++AP
Sbjct: 133 KVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRNTFIGTPYWMAP 182
Query: 79 EVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 112
EV+ E YD + +DVWS G+T + G P D
Sbjct: 183 EVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 32/173 (18%)
Query: 31 HRDLKLENTLLDGSPAPRL-------KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 83
HRD+K +N LLD + RL K+ G +SSV VGTP YI+PE+L
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYISPEILQA 177
Query: 84 KEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-H 138
E G D WS GV +Y ML G PF + + K ++ ++ P ++
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITD 235
Query: 139 ISPECRHLISRIFVADPAKRI---SIPEIRNHEWF-------LKNLPADLVVD 181
+S E + LI R+ + +R+ I + + H +F ++NL A + D
Sbjct: 236 VSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPD 287
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 36/160 (22%)
Query: 27 FNVCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL 81
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 120 TGKIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVA 173
Query: 82 ---LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---- 134
K YDGK D+W+ G+T + P D +H + + I
Sbjct: 174 AVERKGGYDGK-CDIWALGITAIELAELQPPMFD----------LH-PMRALFLISKSNF 221
Query: 135 ------DYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168
D SP I + DP KR + ++ H
Sbjct: 222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 64/222 (28%), Positives = 89/222 (40%), Gaps = 58/222 (26%)
Query: 28 NVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST--VGTPAYIAPEV 80
NV HRDLK N L D LKICDFG ++ S + T V T Y APE+
Sbjct: 125 NVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFE----------------DPEEPKNFRKTIH 124
+L + K DVWS G L +L F+ P+E +T+
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE-----ETLS 235
Query: 125 RILSVQ-----YSIPDYVHI---------SPECRHLISRIFVADPAKRISIPEIRNH--- 167
RI S + S+P+ +P L+ ++ DP KRIS+ E H
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295
Query: 168 -EWFLKNLPAD-LVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 207
W + P D V + FE D S++E+ +I E
Sbjct: 296 AIW---HDPDDEPVCQKPFDFSFESED----SMEELRDMIIE 330
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 7e-10
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KK 84
N+ HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L +
Sbjct: 145 NMIHRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEG 199
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+YDGK+ DVWS G+T + L P P N ++ I + S R
Sbjct: 200 QYDGKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 181
+ + P R + E+ H + L+ P +++D
Sbjct: 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-10
Identities = 31/86 (36%), Positives = 50/86 (58%), Gaps = 4/86 (4%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 125 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 181
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPE 114
+ +D+WS G++L + +G YP P+
Sbjct: 182 Q-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 32/86 (37%), Positives = 50/86 (58%), Gaps = 4/86 (4%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 125 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 181
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPE 114
+ +D+WS G++L M +G YP P+
Sbjct: 182 Q-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-10
Identities = 34/72 (47%), Positives = 45/72 (62%), Gaps = 9/72 (12%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 87
HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+L + +YD
Sbjct: 138 HRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDEGQYD 192
Query: 88 GKIADVWSCGVT 99
GK DVWS G+T
Sbjct: 193 GK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-10
Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 11/152 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N +RDLK EN LLD ++I D G + + VGT Y+APEVL + Y
Sbjct: 122 NTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY- 178
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
D W G +Y M+ G PF +E + R+L + S E + +
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSIC 236
Query: 148 SRIFVADPAKRISIP-----EIRNHEWFLKNL 174
+ DP +R+ E++ H F +N+
Sbjct: 237 KMLLTKDPKQRLGCQEEGAGEVKRHP-FFRNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 17/148 (11%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDG 88
HRD+K N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD
Sbjct: 124 HRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYV-HISPECRH 145
K AD+WS G+T + G EP N R+L + + + P S +
Sbjct: 181 K-ADIWSLGITAIELAKG--------EPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKE 231
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKN 173
I DP+ R + E+ H++ +KN
Sbjct: 232 FIDACLNKDPSFRPTAKELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 42/213 (19%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDLK N ++ LKI DFG ++++ + V T Y APEV+L Y
Sbjct: 144 IIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKE 201
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--------LSVQYSIPDYVHIS 140
+ D+WS G + ++ G+ F+ + + K I ++ +Q ++ +YV
Sbjct: 202 NV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENR 260
Query: 141 P----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW--- 169
P + R L+S++ V DP KRIS+ E H +
Sbjct: 261 PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320
Query: 170 FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIM 202
+ A+ + Q EE + ++ E++
Sbjct: 321 WYDPAEAEAPPPQIYDAQLEEREHAIEEWKELI 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEV 80
V HRD+K N +L P +K+ DFG ++ HS KS GTP ++APEV
Sbjct: 122 CVVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPF 110
+ + Y G+ +D+WS G T++ M G P
Sbjct: 180 INESGY-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 9/137 (6%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDL N +L ++ I DFG +K S+ S VGT Y PE++ + Y G
Sbjct: 135 IVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPY-G 191
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLI 147
+ ADVW+ G LY M PF N +I+ Y +P+ ++ S + +I
Sbjct: 192 EKADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYEPLPEGMY-SEDVTDVI 246
Query: 148 SRIFVADPAKRISIPEI 164
+ D R I ++
Sbjct: 247 TSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 34/87 (39%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL---K 83
+ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE + +
Sbjct: 128 KIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPF 110
YD + +DVWS G+TLY + G +P+
Sbjct: 185 DGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KK 84
N+ HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L +
Sbjct: 135 NMIHRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+YDGK+ DVWS G+T + L P P N ++ I + H S R
Sbjct: 190 QYDGKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 181
+ + P R + + H + L+ P +++D
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 43/138 (31%), Positives = 62/138 (44%), Gaps = 14/138 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLK 83
V HRD+K N + + +K+ D G SK++ HS VGTP Y++PE + +
Sbjct: 127 VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERIHE 180
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
Y+ K +D+WS G LY M PF + N +I Y H S +
Sbjct: 181 NGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 144 RHLISRIFVADPAKRISI 161
R L+S DP +R I
Sbjct: 238 RELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 44/128 (34%), Positives = 64/128 (50%), Gaps = 11/128 (8%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKK 84
+ HRD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ +
Sbjct: 127 IVHRDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y G+ ADVWS T+ ML P+ + E K + +PD +S CR
Sbjct: 185 GY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM--LPD--GVSDACR 239
Query: 145 HLISRIFV 152
+ +IFV
Sbjct: 240 DFLKQIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 51/160 (31%), Positives = 72/160 (45%), Gaps = 28/160 (17%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 89
HRD+K N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K
Sbjct: 124 HRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 90 IADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIP--DYVH-- 138
AD+WS G+T + G P D PKN T L QYS P ++V
Sbjct: 182 -ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT----LEGQYSKPFKEFVEAC 236
Query: 139 ------ISPECRHLISRIFVADPAKRIS-IPEI--RNHEW 169
P + L+ F+ K+ S + E+ R W
Sbjct: 237 LNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRW 276
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 13/124 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRD+K EN ++ ++ I D G ++ V+ GT APEVL + +Y+
Sbjct: 178 IIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNS 235
Query: 89 KIADVWSCGVTLYVMLVGAYP---FEDP-----EEPKNFRKTIHRILSVQYSIPDYVHIS 140
K AD+WS G+ L+ ML AYP FEDP E K+ + +I+S P+
Sbjct: 236 K-ADIWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292
Query: 141 PECR 144
P R
Sbjct: 293 PGSR 296
|
Length = 357 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 3e-09
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 11/148 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + YD
Sbjct: 129 NIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNYD 184
Query: 88 GKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
D W+ GV Y +L G +PF+ D +E + + R Q +P ++S
Sbjct: 185 VSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDF 240
Query: 147 ISRIFVADPAKR-ISIPEIRNHEWFLKN 173
+ + + R + EI H FLK
Sbjct: 241 VQSMLKYNINYRLTNYNEIIKHP-FLKI 267
|
Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 34/75 (45%), Positives = 48/75 (64%), Gaps = 9/75 (12%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KK 84
N+ HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L +
Sbjct: 141 NMIHRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 85 EYDGKIADVWSCGVT 99
+YDGK+ DVWS G+T
Sbjct: 196 QYDGKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 48/172 (27%), Positives = 70/172 (40%), Gaps = 38/172 (22%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KKEY 86
V HRDLK +N L++ LK+ DFG +++ + + + V T Y AP+VLL + Y
Sbjct: 121 VLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 87 DGKIADVWSCGVTLYVMLVGAYPF-----ED-----------------------PEEPKN 118
I D+WS G + M+ G F ED PE
Sbjct: 179 STSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237
Query: 119 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
F + + +Q P H P L+ R+ +P RIS + H WF
Sbjct: 238 FPRYPPQ--DLQQLFP---HADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 53/179 (29%), Positives = 70/179 (39%), Gaps = 44/179 (24%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPEVLL 82
NV HRDLK N L++ L+I DFG S S H V T Y APE+LL
Sbjct: 127 NVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 83 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPD----- 135
EY I D+WS G ML F P KN+ + ILSV S +
Sbjct: 185 SLPEYTTAI-DMWSVGCIFAEMLGRRQLF-----PGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 136 ------------------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ SPE L+S++ DP +RI++ + H +
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 45/178 (25%), Positives = 69/178 (38%), Gaps = 47/178 (26%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAPEVL 81
NV HRDLK N LL+ R+K+ DFG ++S + V T Y APE+L
Sbjct: 127 NVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL 184
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---RILSV--------- 129
L K D+WS G L ML+G F T++ +I+ V
Sbjct: 185 LGSTRYTKGVDMWSVGCILGEMLLGKPLFPG-------TSTLNQLEKIIEVIGPPSAEDI 237
Query: 130 -------------------QYSIPDYV-HISPECRHLISRIFVADPAKRISIPEIRNH 167
+ + + + S + L+ ++ V +P KR++ E H
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 54/188 (28%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL-KKEY 86
+ HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL Y
Sbjct: 129 IIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 87 DGKIADVWSCG---------------------VTLYVMLVGA-----YP----------F 110
I D+W+ G + L + L+G +P F
Sbjct: 187 TTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245
Query: 111 EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
P++P N K H+ + +S L++ + + DP KR + E +F
Sbjct: 246 TLPKQPYNNLK--HK----------FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
Query: 171 LKN-LPAD 177
+ LP +
Sbjct: 294 KEKPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 45/192 (23%), Positives = 68/192 (35%), Gaps = 54/192 (28%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGTPAYIAPEV 80
V HRDLK N L+ +G +KI D G ++ + ++ K V T Y APE+
Sbjct: 129 VLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVTIWYRAPEL 186
Query: 81 LL-KKEYDGKIADVWSCG------VTLYVMLVGA-----------------------YPF 110
LL + Y I D+W+ G +TL + G P
Sbjct: 187 LLGARHYTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPT 245
Query: 111 ED--------PEEPKNFRKTIHRILSVQYSIPDYVHI----SPECRHLISRIFVADPAKR 158
E PE K S+ ++ + L+ ++ DP KR
Sbjct: 246 EKDWPDIKKMPEYDT-LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR 304
Query: 159 ISIPEIRNHEWF 170
I+ E H +F
Sbjct: 305 ITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-09
Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 8/147 (5%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
++ +RD+K EN LLD RL D G + GT Y+APE+L ++ Y
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
+ D ++ G ++Y M+ G PF+D +E + R L + ++ + + E + +
Sbjct: 173 YPV-DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDIC 230
Query: 148 SRIFVADPAKRISIPEI----RNHEWF 170
P R+ E R HE+F
Sbjct: 231 RLFLAKKPEDRLGSREKNDDPRKHEFF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-09
Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 25/152 (16%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDG 88
HRD+K N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD
Sbjct: 124 HRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIPDYVHISP 141
K AD+WS G+T + G P + PKN T L YS P
Sbjct: 181 K-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP------- 228
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173
+ + +P+ R + E+ H++ ++
Sbjct: 229 -LKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 30/170 (17%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
N+ HRD+K EN L+ S + +K+CDFG++++ + T V T Y APE+L+
Sbjct: 120 NIIHRDIKPENILV--SQSGVVKLCDFGFART-LAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFED------------------PEEPKNFRKT----I 123
G+ D+W+ G + ML G F P + F+K
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 124 HRILSVQYSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
R+ V+ P + +S L + DP R S ++ +HE+F
Sbjct: 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-09
Identities = 44/138 (31%), Positives = 62/138 (44%), Gaps = 14/138 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLK 83
V HRD+K N + + +K+ D G SK++ HS VGTP Y++PE + +
Sbjct: 127 VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERIHE 180
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
Y+ K +D+WS G LY M PF + N +I Y H S E
Sbjct: 181 NGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 144 RHLISRIFVADPAKRISI 161
R L++ DP KR I
Sbjct: 238 RQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 52/171 (30%), Positives = 73/171 (42%), Gaps = 36/171 (21%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 84
V HRDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL
Sbjct: 121 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGC 175
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIPD 135
+Y D+WS G M+ F D E + FR I R L S+PD
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSLPD 233
Query: 136 YV----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
Y + + R L+S++ DP KRIS H +F
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 47/169 (27%), Positives = 68/169 (40%), Gaps = 32/169 (18%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL-KK 84
+ HRD+K N L++ + LKICDFG ++ T V T Y APE+L+ +
Sbjct: 123 GILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSR 180
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFE----------------DP--EEPKNFRK-TIHR 125
Y + D+WS G +L F+ P E ++ +
Sbjct: 181 HYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239
Query: 126 ILSVQYSIPD----YVHISP---ECRHLISRIFVADPAKRISIPEIRNH 167
IL + P Y S E HL+ R+ V DP KRIS + H
Sbjct: 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 1e-08
Identities = 36/145 (24%), Positives = 59/145 (40%), Gaps = 20/145 (13%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKE 85
HRDL N L+ + +KI DFG S+ ++ + APE L +
Sbjct: 125 HRDLAARNCLVTENL--VVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 86 YDGKIADVWSCGVTLY-VMLVGAYPFED--PEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
+ K +DVWS GV L+ + +G P+ EE + +R+ P+ E
Sbjct: 181 FTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLP-----RPENCP--DE 232
Query: 143 CRHLISRIFVADPAKRISIPEIRNH 167
L+ + + DP R + E+
Sbjct: 233 LYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 24/168 (14%)
Query: 3 CRAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 62
C + Q RG FL + HRDL N LL S +KICDFG ++ +
Sbjct: 178 CYSFQVARGMEFLASR---------KCIHRDLAARNILL--SENNVVKICDFGLARD--I 224
Query: 63 HSQP----KSTVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEP 116
+ P K + P ++APE + K Y + +DVWS GV L+ + +GA P+ +
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIN 283
Query: 117 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164
+ F + + + P+ +PE ++ + DP +R + +
Sbjct: 284 EEFCQRLKD--GTRMRAPENA--TPEIYRIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDG 88
HRD+K +N L+D + RL DFG + +S+V GTP YI+PE+L E DG
Sbjct: 125 HRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME-DG 181
Query: 89 K-----IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
K D WS GV +Y ML G PF + + K ++ Q+ +S +
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP-AQVTDVSEDA 240
Query: 144 RHLISRIFVADPAK--RISIPEIRNHEWF 170
+ LI R+ + + + I + + H +F
Sbjct: 241 KDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 52/172 (30%), Positives = 75/172 (43%), Gaps = 37/172 (21%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 84
V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+LL
Sbjct: 123 VLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEILLGS 178
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQY--------SIP 134
+ D+WS G ++ +V P D E + F+ I RIL S+P
Sbjct: 179 RHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGVTSLP 235
Query: 135 DYVH----------------ISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
DY + P L+S++ DP+KRI+ HE+F
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 42/174 (24%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLL 82
V HRDLK +N L+D +K+ DFG +++ H V T Y APEVLL
Sbjct: 122 VLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE-----VVTLWYRAPEVLL 174
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQ--------YS 132
D+WS G T++ + P D E + FR I RIL S
Sbjct: 175 GSPRYSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVTS 231
Query: 133 IPDYVHISPECR----------------HLISRIFVADPAKRISIPEIRNHEWF 170
+PDY + P+ + L+ ++ + DPAKRIS + NH +F
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 52/184 (28%), Positives = 72/184 (39%), Gaps = 53/184 (28%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEV 80
+ HRD+K N L+ DG LK+ DFG +++ L K V T Y PE+
Sbjct: 139 KILHRDMKAANILITKDGI----LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 81 LLKKEYDGKIADVWSCG---------------------VTLYVMLVGA-----YP----- 109
LL + G D+W G +TL L G+ +P
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL 254
Query: 110 --FEDPEEPKN-FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166
F+ E P+ RK R+ YV P LI ++ V DPAKRI N
Sbjct: 255 ELFKKMELPQGQKRKVKERLKP-------YVK-DPHALDLIDKLLVLDPAKRIDADTALN 306
Query: 167 HEWF 170
H++F
Sbjct: 307 HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 35/131 (26%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ +RDLK EN LLD ++I D G + + VGT Y+APEV+ ++Y
Sbjct: 123 IVYRDLKPENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 148
D W G +Y M+ G PF +E + R+ Q + S + + +
Sbjct: 181 S-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSICR 237
Query: 149 RIFVADPAKRI 159
+ +P +R+
Sbjct: 238 MLLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 39/116 (33%), Positives = 56/116 (48%), Gaps = 20/116 (17%)
Query: 3 CRAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 62
CR + RG + L V HRD+K +N LL + +K+ DFG S
Sbjct: 127 CREILRG-----------LAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDR 173
Query: 63 HSQPKST-VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 112
++T +GTP ++APEV+ E YD + +D+WS G+T M GA P D
Sbjct: 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-08
Identities = 36/83 (43%), Positives = 48/83 (57%), Gaps = 13/83 (15%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 82
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 83 --KKEYDGKIADVWSCGVTLYVM 103
YD K AD+WS G+TL M
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 70 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 129
+GTP Y+APE+LL K + G D W+ GV L+ L G PF D E P+ + IL+
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFND-ETPQ---QVFQNILNR 595
Query: 130 QYSIPDYVH-ISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
P+ +S ++ I + DP KR + E++ H F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-08
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 38/173 (21%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
N HRD+K N LL+ ++K+ DFG ++ T V T Y PE+LL +E
Sbjct: 136 NFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE 193
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEE---------------PKNF----------- 119
G DVWSCG L + F+ +E P +
Sbjct: 194 RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNT 253
Query: 120 ---RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169
+K R L ++S I L+ + DP+KR + E N W
Sbjct: 254 MKPKKQYRRRLREEFS-----FIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-08
Identities = 36/83 (43%), Positives = 48/83 (57%), Gaps = 13/83 (15%)
Query: 29 VCHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 82
+ HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 124 IIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 83 --KKEYDGKIADVWSCGVTLYVM 103
+ YD K ADVWS G+TL M
Sbjct: 180 SKDRPYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-08
Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVL-LKKEY 86
+ HRD+K N LL +K+ DFG S + + ++VGTP ++APEV+ +++Y
Sbjct: 149 IIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206
Query: 87 DGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
D DVWS G+T + G P D K K I R P +H C
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPP-----PTLLHPEKWC 260
Query: 144 R---HLISRIFVADPAKRISIPEIRNHEWFLK 172
R H IS+ + D R S+ + H F+K
Sbjct: 261 RSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 30/174 (17%)
Query: 3 CRAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 62
C + Q +G FL + HRDL N LL S +KICDFG ++ +
Sbjct: 183 CYSFQVAKGMEFLASR---------KCIHRDLAARNILL--SENNVVKICDFGLARD--I 229
Query: 63 HSQP----KSTVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEP 116
+ P K P ++APE + + Y + +DVWS GV L+ + +GA P+ +
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKID 288
Query: 117 KNFRKTIH---RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167
+ F + + R+ + Y+ P+ +C H +P++R + E+ H
Sbjct: 289 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 8/84 (9%)
Query: 29 VCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+CHRDLK +N L+D P LK+CDFG +K+ + + S + + Y APE++L
Sbjct: 191 ICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT 246
Query: 86 YDGKIADVWSCGVTLYVMLVGAYP 109
D+WS G + M++G YP
Sbjct: 247 NYTTHIDLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-07
Identities = 41/116 (35%), Positives = 56/116 (48%), Gaps = 20/116 (17%)
Query: 3 CRAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 62
CR + RG S L V HRD+K +N LL + +K+ DFG S
Sbjct: 117 CREILRG-----------LSHLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDR 163
Query: 63 HSQPKST-VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 112
++T +GTP ++APEV+ E YD K +D+WS G+T M GA P D
Sbjct: 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 45/169 (26%), Positives = 69/169 (40%), Gaps = 29/169 (17%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KKE 85
NV HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL K
Sbjct: 119 NVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDYV 137
Y I D+WS G + P + + K I R+L +PDY
Sbjct: 177 YSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 138 ----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
++ R L+ + V +P +RIS E H +F
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 38/184 (20%)
Query: 21 WSELLPFNVC------HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVG 71
W L N C HRD+K EN L+ + ++K+CDFG+++ +L V
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVA 162
Query: 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--YPFE-DPEEPKNFRKTI----- 123
T Y APE+L+ G DVW+ G +L G +P + D ++ RKT+
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP 222
Query: 124 -HR-ILSVQ-----YSIPD----------YVHISPECRHLISRIFVADPAKRISIPEIRN 166
H+ I S SIP+ + +IS + DP +R+S E+
Sbjct: 223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282
Query: 167 HEWF 170
H +F
Sbjct: 283 HPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 22/143 (15%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKK 84
HRDL N L+ + ++KI DFG S+ S V S+ + V ++A E L
Sbjct: 150 HRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV---KWMAIESLFDH 204
Query: 85 EYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
Y + +DVWS GV L+ ++ +G YP PE N KT +R+ P+ + S
Sbjct: 205 IYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM-----ERPE--NCSE 256
Query: 142 ECRHLISRIFVADPAKRISIPEI 164
E +L+ + +P KR + +I
Sbjct: 257 EMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-07
Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 32/195 (16%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L +
Sbjct: 139 IIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVILNWMHYT 194
Query: 89 KIADVWSCGVTLYVMLVGAYPFE--------------------------DPEEPKNFRKT 122
+ D+WS G + ML G F+ E+ KN+ K
Sbjct: 195 QTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKK 254
Query: 123 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLVVD 181
+ R + + +P +++ ++ V D RI+ E H +F + + P D
Sbjct: 255 LPRFRKKDFRSL-LPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEA 313
Query: 182 NTTNNQFEEPDQPMQ 196
++ F+E DQ ++
Sbjct: 314 PPYDDSFDEVDQSLE 328
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-07
Identities = 31/75 (41%), Positives = 43/75 (57%), Gaps = 5/75 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
++ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 86 YDGKIADVWSCGVTL 100
Y GK D+WS G L
Sbjct: 178 Y-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-07
Identities = 45/177 (25%), Positives = 72/177 (40%), Gaps = 39/177 (22%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 147 IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVHIS 140
+ D+WS G + M+ G F + + K I ++ + +Q ++ YV
Sbjct: 205 NV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263
Query: 141 P----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 169
P + R L+S++ V D +KRIS+ E H +
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 44/183 (24%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 139 IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 196
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--------HRILSVQYSIPDYVHIS 140
+ D+WS G + M+ G F + + K I + +Q ++ +YV
Sbjct: 197 NV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR 255
Query: 141 PEC-----------------------------RHLISRIFVADPAKRISIPEIRNHE--- 168
P+ R L+S++ V DP KRIS+ + H
Sbjct: 256 PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315
Query: 169 -WF 170
W+
Sbjct: 316 VWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 41/175 (23%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 86
V HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P++LL +Y
Sbjct: 125 VLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 87 DGKIADVWSCGVTLYVMLVGA--YPFEDPEEPKNFRKTIHRILS---------------- 128
+I D+W G Y M G +P EE +F I RIL
Sbjct: 183 STQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEEF 238
Query: 129 VQYSIPDYVHISPECRH------------LISRIFVADPAKRISIPEIRNHEWFL 171
Y+ P Y +C H L+S++ + KRIS E H +F
Sbjct: 239 KSYNYPKY---RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 39/177 (22%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 140 IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVHIS 140
+ D+WS G + M+ F + + K I ++ + +Q ++ +YV
Sbjct: 198 NV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 141 P----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 169
P + R L+S++ V DPAKRIS+ E H +
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 23/152 (15%)
Query: 3 CRAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 62
+ Q RG FL + HRDL N LL S +KICDFG ++ +
Sbjct: 177 SYSFQVARGMEFLASR---------KCIHRDLAARNILL--SENNVVKICDFGLARD--I 223
Query: 63 HSQP----KSTVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEP 116
+ P K P ++APE + K Y + +DVWS GV L+ + +GA P+ +
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQID 282
Query: 117 KNF-RKTIH--RILSVQYSIPDYVHISPECRH 145
+ F R+ R+ + +Y+ P+ I +C H
Sbjct: 283 EEFCRRLKEGTRMRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 49/213 (23%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
+ HRDLK N ++ LKI DFG ++ H+ + T V T Y APE++L
Sbjct: 138 GIIHRDLKPSNIAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 191
Query: 86 YDGKIADVWSCGVTLYVMLVGA--YPFEDP------------------------EEPKNF 119
+ + D+WS G + +L G +P D E +N+
Sbjct: 192 HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNY 251
Query: 120 RKTIHRILSVQYSIPDYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 174
+++ Q D+ + +P L+ ++ V DP KRI+ E H + + +
Sbjct: 252 IQSLP-----QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306
Query: 175 PADLVVDNTTNNQFEEPDQPMQ-----SIDEIM 202
P D V + FE D + EIM
Sbjct: 307 PEDEPVAPPYDQSFESRDLTVDEWKELVYKEIM 339
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 50/171 (29%), Positives = 68/171 (39%), Gaps = 32/171 (18%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 86
V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL EY
Sbjct: 124 VLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------------VQ 130
+ D+W G Y M G F + ++ I R+L
Sbjct: 182 STSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240
Query: 131 YSIPDY------VHIS-----PECRHLISRIFVADPAKRISIPEIRNHEWF 170
YS P Y H P L + +P KRIS E H +F
Sbjct: 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 12/147 (8%)
Query: 23 ELLPFNVC-HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIAP 78
L C HRDL N LL + +KICDFG ++ + S K P ++AP
Sbjct: 155 AFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 79 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 137
E + Y + +DVWS G+ L+ + +G+ P+ F K I Y +
Sbjct: 213 ESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQPE 267
Query: 138 HISPECRHLISRIFVADPAKRISIPEI 164
H E ++ + ADP KR + +I
Sbjct: 268 HAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 28/153 (18%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVL-----LK 83
HRD+K N LL + +K+ DFG S +S + ++VGTP ++APEV+ L
Sbjct: 147 HRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAPEVIACEQQLD 203
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIPDY 136
YD + DVWS G+T + G P D P+N T+H+ P+
Sbjct: 204 STYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ--------PEL 254
Query: 137 VHISPECRHLISRIFVADPAKRISIPEIRNHEW 169
S E I + D KR ++ ++ H +
Sbjct: 255 --WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLLKKEY 86
HRDL N L++ +KI DFG +K K +P + APE L ++
Sbjct: 132 HRDLAARNILVESED--LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 123
+DVWS GVTLY + P + P P F + I
Sbjct: 190 SSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 44/185 (23%), Positives = 66/185 (35%), Gaps = 56/185 (30%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--------------STVGTPAYI 76
HRD+K N L+D LKI DFG ++ P + V T Y
Sbjct: 138 HRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193
Query: 77 APEVLL-KKEYDGKIADVWSCGVTLYVM---------------------LVGAYPFED-- 112
PE+LL ++ Y + D+W G M L G P E+
Sbjct: 194 PPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT-PTEETW 251
Query: 113 PE-------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165
P E + R L ++ + PE L+S++ DP KR++ +
Sbjct: 252 PGWRSLPGCEGVHSFTNYPRTLEERFG-----KLGPEGLDLLSKLLSLDPYKRLTASDAL 306
Query: 166 NHEWF 170
H +F
Sbjct: 307 EHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 35/105 (33%), Positives = 47/105 (44%), Gaps = 12/105 (11%)
Query: 2 QCRAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 61
Q RA+ + L Y + L HRD+KLEN L+ L DFG +
Sbjct: 268 QTRAIMK---QLLCAVEYIHDKKL----IHRDIKLENIFLNCDGKIVLG--DFGTAMPFE 318
Query: 62 LHSQPKST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 104
+ VGT A +PE+L Y +I D+WSCG+ L ML
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 36/98 (36%), Positives = 47/98 (47%), Gaps = 11/98 (11%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPEVLLKKEY 86
HRDL N LLD +KI DFG +K+ + + + +P + A E L KE
Sbjct: 130 HRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL--KEN 185
Query: 87 DGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 123
A DVWS GVTLY +L + P PK F + I
Sbjct: 186 KFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 47/206 (22%), Positives = 70/206 (33%), Gaps = 45/206 (21%)
Query: 22 SELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------HSQPK--- 67
+ L + HRDL N ++ KI DFG ++ Q +
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 68 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 126
S V T Y APE+L+ E D+WS G +L G F E + I +
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR-IFEL 249
Query: 127 LSV--------QYSIPDYVHISP---------------ECRHLISRIFVADPAKRISIPE 163
L +P Y +P + L+ + +P +RIS E
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309
Query: 164 IRNHEWF----LKNLPADLVVDNTTN 185
HE+F L P+ L + T
Sbjct: 310 ALKHEYFKSDPLPCDPSQLPFNFLTK 335
|
Length = 335 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 44/172 (25%), Positives = 69/172 (40%), Gaps = 32/172 (18%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 85
++ HRDLK +N L+ S LK+ DFG +++ + SQ S+ V T Y P+VLL +
Sbjct: 123 HILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------- 129
Y + D+W G ML G F + + I +L V
Sbjct: 181 YSSAL-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239
Query: 130 ----QYSIPDYVHI-------SPECRHLISRIFVADPAKRISIPEIRNHEWF 170
P + + P+ L S++ + P RIS + H +F
Sbjct: 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 7/86 (8%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPEVLLKKEYD 87
HRDL N L+ +P +KI DFG +K V + + G P ++A E +L + Y
Sbjct: 132 HRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 88 GKIADVWSCGVTLY-VMLVGAYPFED 112
K +DVWS GVT++ +M GA P+E
Sbjct: 190 HK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 28/83 (33%), Positives = 38/83 (45%), Gaps = 5/83 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLK 83
NV HRDLK N ++ + LKI DFG ++ H K + T Y +P +LL
Sbjct: 134 NVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192
Query: 84 KEYDGKIADVWSCGVTLYVMLVG 106
K D+W+ G ML G
Sbjct: 193 PNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 39/128 (30%), Positives = 58/128 (45%), Gaps = 15/128 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 84
N HRDL N L+ +KICDFG ++ + S ST ++APE +
Sbjct: 259 NCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN--FRKTIHRILSVQYSIPDYVHISP 141
Y ++DVWS G+ L+ + +G P+ PE P N F I R Y + H S
Sbjct: 317 LYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMNEQFYNAIKR----GYRMAKPAHASD 369
Query: 142 ECRHLISR 149
E ++ +
Sbjct: 370 EIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 26/72 (36%), Positives = 44/72 (61%), Gaps = 5/72 (6%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG- 88
HRD+K N LL + +K+ DFG + K + ++ KS +GTP ++APEV ++ G
Sbjct: 129 HRDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 89 -KIADVWSCGVT 99
++ D+W+ G+T
Sbjct: 187 NQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 47/194 (24%), Positives = 85/194 (43%), Gaps = 36/194 (18%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
++ HRDLK N L + LKI DFG ++ H+ + T V T Y APE++L
Sbjct: 140 DIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 193
Query: 86 YDGKIADVWSCGVTLYVMLVGA--YPFED------------------------PEEPKNF 119
+ + D+WS G + +L G +P D E +N+
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253
Query: 120 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADL 178
+++ ++ + ++ ++ +P L+ ++ V D KRI+ + H +F + + P D
Sbjct: 254 IQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 312
Query: 179 VVDNTTNNQFEEPD 192
V + + FE D
Sbjct: 313 PVADPYDQSFESRD 326
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 9/105 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLKK 84
V H+D+ N ++D ++KI D S+ H + ++A E L+ K
Sbjct: 137 GVIHKDIAARNCVIDEEL--QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK 194
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFRKTIHRI 126
EY +DVWS GV L+ +M +G P+ DP E + K +R+
Sbjct: 195 EYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL 238
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 26/72 (36%), Positives = 42/72 (58%), Gaps = 5/72 (6%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYDG- 88
HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV + G
Sbjct: 129 HRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 89 -KIADVWSCGVT 99
++ D+W+ G+T
Sbjct: 187 NQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 3/76 (3%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
V HRDLK +N L+ S ++K+ DFG ++ S V T Y APEVLL+ Y
Sbjct: 131 VVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 188
Query: 89 KIADVWSCGVTLYVML 104
+ D+WS G M
Sbjct: 189 PV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 39/147 (26%), Positives = 67/147 (45%), Gaps = 17/147 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLK 83
HRDL N L++ ++KI DFG +K+ + K + +P + APE L++
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSV---QYSI 133
++ +DVWS GVTLY +L P P + + T+ R++ V +
Sbjct: 187 SKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245
Query: 134 PDYVHISPECRHLISRIFVADPAKRIS 160
P + E L+ + + P+KR +
Sbjct: 246 PRPPNCPEEVYQLMRKCWEFQPSKRTT 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 22/159 (13%)
Query: 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 66
Q RG FL + N HRDL N LL + +KICDFG ++ ++H
Sbjct: 245 QVARGMEFLASK---------NCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSN 292
Query: 67 KSTVGTP----AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRK 121
+ G+ ++APE + Y ++DVWS G+ L+ + +G P+ F
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351
Query: 122 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 160
I + + PD H + E ++ + + ++P KR S
Sbjct: 352 KIKS--GYRMAKPD--HATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-05
Identities = 46/181 (25%), Positives = 71/181 (39%), Gaps = 37/181 (20%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 87
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 124 ILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDYVHI 139
D+W G M+ G F ++ ++ + I +L +S+P H
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP---HF 238
Query: 140 SPE----------------------CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 177
PE L S++ P R+S +HE+F +LP
Sbjct: 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF-SDLPPR 297
Query: 178 L 178
L
Sbjct: 298 L 298
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L +
Sbjct: 138 IIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILNWMHYN 193
Query: 89 KIADVWSCGVTLYVMLVGAYPFE--------------------------DPEEPKNFRKT 122
+ D+WS G + ML G F+ + + K++ K+
Sbjct: 194 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS 253
Query: 123 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ + +S + SP+ L+ ++ D KR++ E H +F
Sbjct: 254 LPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 27/76 (35%), Positives = 38/76 (50%), Gaps = 3/76 (3%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDLK EN L+ + ++K+ DFG ++ V T Y APEVLL+ Y
Sbjct: 129 IVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYAT 186
Query: 89 KIADVWSCGVTLYVML 104
+ D+WS G M
Sbjct: 187 PV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 43/144 (29%), Positives = 65/144 (45%), Gaps = 17/144 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIAPEVLLKK 84
N HRDL N LL + KICDFG ++ S K P ++APE +
Sbjct: 234 NCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC 291
Query: 85 EYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTI---HRILSVQYSIPDYVHIS 140
Y + +DVWS G+ L+ + +G+ P+ F K I +R+LS + + + I
Sbjct: 292 VYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350
Query: 141 PECRHLISRIFVADPAKRISIPEI 164
C + ADP KR + +I
Sbjct: 351 KSC-------WDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 30/80 (37%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 86
+ HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY
Sbjct: 124 ILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 87 DGKIADVWSCGVTLYVMLVG 106
I D+W G LY M G
Sbjct: 182 STPI-DMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 20/142 (14%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG-TPA-YIAPEVLLKKE 85
HRDL N L+ + +KI DFG ++ +H K+T G P ++APE L +
Sbjct: 155 HRDLAARNVLV--TEDHVMKIADFGLARD--IHHIDYYRKTTNGRLPVKWMAPEALFDRV 210
Query: 86 YDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
Y + +DVWS GV L+ + +G YP EE K +R+ Q + H+ +
Sbjct: 211 YTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRD 269
Query: 143 CRHLISRIFVADPAKRISIPEI 164
C H P++R + ++
Sbjct: 270 CWH-------EVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-05
Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 35/171 (20%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 86
V HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 87 DGKIADVWSCGVTLYVMLVGA--YPFEDPEEPKNFRKTIHRILSV--------------- 129
+I D+W G + M G +P E+ + I R+L
Sbjct: 183 STQI-DMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSNDEF 238
Query: 130 -QYSIPDY-----VHISP----ECRHLISRIFVADPAKRISIPEIRNHEWF 170
Y+ P Y ++ +P E L+++ + KRIS E H +F
Sbjct: 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 11/79 (13%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLLKK 84
HRDL N LL + ++KI DFG ++ + + V P A+ APE L +
Sbjct: 120 HRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTR 175
Query: 85 EYDGKIADVWSCGVTLYVM 103
+ +DVW GVTL+ M
Sbjct: 176 TFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 39/140 (27%), Positives = 56/140 (40%), Gaps = 24/140 (17%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLK 83
N HRDL N L+ K+ DFG + K V L S K + APE
Sbjct: 124 NSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASH 178
Query: 84 KEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
+ K +DVWS G+ LY + G P+ N + +I + Y +P +
Sbjct: 179 GTFSTK-SDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQITA-GYRMPC----PAK 228
Query: 143 CRHLISRIFV----ADPAKR 158
C I +I + A+P R
Sbjct: 229 CPQEIYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 1e-04
Identities = 47/150 (31%), Positives = 63/150 (42%), Gaps = 26/150 (17%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPAYIA 77
N HRDL N L+ + LKI DFG Y+ S L P K T A
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT-------A 163
Query: 78 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 136
PE L Y + +DVWS G+ L+ +G P+ + ++T RI S Y +P
Sbjct: 164 PEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPG----MSNQQTRERIES-GYRMPAP 217
Query: 137 VHISPECRHLISRIFVADPAKRISIPEIRN 166
E L+ + + DP R S EI N
Sbjct: 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 25/147 (17%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEY 86
N HRDL N L+ K+ DFG +K + SQ + + P + APE L +K++
Sbjct: 122 NFVHRDLAARNVLVSEDLVA--KVSDFGLAKEA---SQGQDSGKLPVKWTAPEALREKKF 176
Query: 87 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI------PDYVHI 139
K +DVWS G+ L+ + G P+ P P K + + Y + P V+
Sbjct: 177 STK-SDVWSFGILLWEIYSFGRVPY--PRIP---LKDVVPHVEKGYRMEAPEGCPPEVY- 229
Query: 140 SPECRHLISRIFVADPAKRISIPEIRN 166
++ + DPAKR + ++R
Sbjct: 230 -----KVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 30/85 (35%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVL-- 81
NV HRDLK +N L + +LKICDFG ++ + + V T Y APE+
Sbjct: 123 NVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVG 106
+Y I D+WS G +L G
Sbjct: 181 FFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIAPEVLLK 83
N HRD+ N LL DG A KICDFG ++ + S K P ++APE +
Sbjct: 232 NCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD 288
Query: 84 KEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
Y + +DVWS G+ L+ + +G P+ F K + R Q S PD+ PE
Sbjct: 289 CVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR--GYQMSRPDFA--PPE 343
Query: 143 CRHLISRIFVADPAKRISIPEI 164
++ + +P +R + +I
Sbjct: 344 IYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 49/192 (25%), Positives = 75/192 (39%), Gaps = 53/192 (27%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAPE 79
V HRDLK N L+ +G R+KI D G+++ L + P V T Y APE
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 80 VLLKKEYDGKIADVWSCGVTLYVML-----------------------------VGAYP- 109
+LL + K D+W+ G +L V +P
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA 245
Query: 110 ---FED----PEEP---KNFRKTIHRILS-VQYSIPDYVHISPECRHLISRIFVADPAKR 158
+ED PE K+FR+ + S ++Y V + HL+ ++ DP KR
Sbjct: 246 DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 305
Query: 159 ISIPEIRNHEWF 170
I+ + +F
Sbjct: 306 ITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 50/192 (26%), Positives = 76/192 (39%), Gaps = 53/192 (27%)
Query: 29 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAPE 79
V HRDLK N L+ +G R+KI D G+++ L + P V T Y APE
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 80 VLLKKEYDGKIADVWSCGVTLYVML-----------------------------VGAYP- 109
+LL + K D+W+ G +L V +P
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPA 245
Query: 110 ---FED----PEEP---KNFRKTIHRILS-VQYSIPDYVHISPECRHLISRIFVADPAKR 158
+ED PE P K+FR+T + S ++Y V + L+ ++ DP KR
Sbjct: 246 DKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKR 305
Query: 159 ISIPEIRNHEWF 170
I+ + +F
Sbjct: 306 ITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 46/174 (26%), Positives = 70/174 (40%), Gaps = 31/174 (17%)
Query: 8 RGRGTLFLPTTYFWSELLPF--NVC------------HRDLKLENTLLDGSPAPRLKICD 53
R RG + +LL F +V HRDL N L+ S K+ D
Sbjct: 90 RTRGRALVSV----IQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV--SEDGVAKVSD 143
Query: 54 FGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 111
FG ++ + S P + APE L K++ K +DVWS GV L+ V G P+
Sbjct: 144 FGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPY- 198
Query: 112 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165
PK K + + Y + + L++ + +P KR S ++R
Sbjct: 199 ----PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLR 248
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 20/102 (19%)
Query: 19 YFWSELLPFNVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHS 64
YF +EL ++ H DLK EN L++ S P P R++ICD G HS
Sbjct: 246 YFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHS 301
Query: 65 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 106
+ + V T Y +PEV+L + D+WS G +Y + G
Sbjct: 302 R-TAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 40/148 (27%), Positives = 64/148 (43%), Gaps = 20/148 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 82
N HRDL N +L + +C DFG SK S + Q + +IA E L
Sbjct: 133 NFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 188
Query: 83 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPE--EPKNFRKTIHRILSVQYSIPDYVHI 139
+ Y K +DVW+ GVT++ + G P+ E E ++ + +R L D ++
Sbjct: 189 DRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR-LKQPEDCLDELY- 245
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNH 167
L+ + ADP R + ++R
Sbjct: 246 -----DLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 28/85 (32%), Positives = 37/85 (43%), Gaps = 6/85 (7%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLKKE 85
+ HRD+K EN LD L DFG + H P+ GT +PE+L
Sbjct: 206 IIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP 263
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPF 110
Y K D+WS G+ L+ M V
Sbjct: 264 YCAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 39/132 (29%), Positives = 54/132 (40%), Gaps = 20/132 (15%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQPKSTVGTPAYIAPEV 80
+ HRD+K EN L++G IC DFG S S+ H TV T APEV
Sbjct: 281 IIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGIAGTVDTN---APEV 333
Query: 81 LLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN--FRKTIHRILSVQYSIPDYV 137
L Y + D+WS G+ ++ V A F + + I RI+ D
Sbjct: 334 LAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392
Query: 138 HISPECRHLISR 149
R L+S+
Sbjct: 393 PQHAGSR-LVSQ 403
|
Length = 461 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 39/174 (22%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDLK N ++ L+I DFG ++ + + V T Y APE++L +
Sbjct: 139 IIHRDLKPSNVAVNEDC--ELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLNWMHYN 194
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSV------------------ 129
+ D+WS G + +L G F P N + + RI+ V
Sbjct: 195 QTVDIWSVGCIMAELLKGKALF-----PGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249
Query: 130 QY--SIPDYVH---------ISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172
+Y S+P +P L+ ++ V D KRIS E H +F +
Sbjct: 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 20/148 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 84
+ HRDL N L+ +KI DFG S+ S+ + ++ ++ PE +L
Sbjct: 144 HFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG 201
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYP---FEDPEEPKNFRKTIHRILSVQYSIPDYVH-I 139
++ + +D+WS GV L+ + G P F + E + R +L P V+ +
Sbjct: 202 KFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ--LLPCPEDCPARVYAL 258
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNH 167
EC + I PA+R +I
Sbjct: 259 MIECWNEI-------PARRPRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 29/78 (37%), Positives = 39/78 (50%), Gaps = 13/78 (16%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEVLLK 83
HRDL N L++ R+KI DFG +K + Q K V P + APE L +
Sbjct: 131 HRDLATRNILVESEN--RVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 84 KEYDGKIADVWSCGVTLY 101
++ +DVWS GV LY
Sbjct: 186 SKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLK 83
N HRDL N LL KI DFG SK+ + + +S P + APE +
Sbjct: 115 NFVHRDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 84 KEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPK 117
+++ + +DVWS G+T++ G P++ + P+
Sbjct: 173 RKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.003
Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLKKEY 86
HRDL N LL + KI DFG S++ ++T P + APE + ++
Sbjct: 118 HRDLAARNVLLVNRH--QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 87 DGKIADVWSCGVTLYVML-VGAYPFED 112
K +DVWS GVTL+ GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 28/82 (34%), Positives = 40/82 (48%), Gaps = 9/82 (10%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKIC--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKK 84
+ HRD+K EN ++ P +C DFG + V + K GT A APE+L +
Sbjct: 203 IIHRDIKAENIFIN-HPG---DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD 258
Query: 85 EYDGKIADVWSCGVTLYVMLVG 106
Y G D+WS G+ L+ M
Sbjct: 259 PY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.004
Identities = 33/136 (24%), Positives = 57/136 (41%), Gaps = 15/136 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLLK 83
N HRDL N L+ + KI DFG ++ ++ + P + APE
Sbjct: 123 NYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 84 KEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
+ K +DVWS G+ L ++ G P+ R+ + ++ Y +P + E
Sbjct: 179 GRFTIK-SDVWSFGILLTEIVTYGRVPYPG----MTNREVLEQV-ERGYRMPRPPNCPEE 232
Query: 143 CRHLISRIFVADPAKR 158
L+ + + DP +R
Sbjct: 233 LYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 254 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.98 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.98 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.93 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.91 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.88 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.85 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.85 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.84 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.83 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.83 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.75 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.61 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.53 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.52 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.49 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.45 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.3 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.3 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.25 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.1 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.08 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.06 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.92 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.35 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.18 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.12 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.71 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.16 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.11 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.02 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 95.77 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 95.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.39 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.02 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.6 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.41 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.36 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.1 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 93.97 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.89 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 93.16 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.76 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.65 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.31 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 92.17 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 92.12 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.96 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.89 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 91.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.79 | |
| PLN02236 | 344 | choline kinase | 91.63 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 90.95 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 90.39 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 90.1 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 89.59 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.12 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 88.82 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 88.74 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 88.73 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 88.5 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 87.57 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 85.08 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 81.51 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=289.87 Aligned_cols=163 Identities=36% Similarity=0.494 Sum_probs=137.9
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-CCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCC
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 85 (254)
+-....++.|++.|+.|||++||+||||||+|||+..+ ....+||+|||+|+.....+...+.||||.|.|||++.+..
T Consensus 275 ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg 354 (475)
T KOG0615|consen 275 EDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG 354 (475)
T ss_pred cchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCC
Confidence 33456789999999999999999999999999999766 22359999999999988888889999999999999998655
Q ss_pred C--CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC--CCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 86 Y--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 86 ~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
+ ++.++|+||+||++|-+++|.+||.+......+.+ ++..+.+. .+.|..++++.++||.+||..||++|||+
T Consensus 355 ~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~ 431 (475)
T KOG0615|consen 355 VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSA 431 (475)
T ss_pred eecccchheeeeccceEEEEeccCCCcccccCCccHHH---HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCH
Confidence 3 45568999999999999999999988665443333 34444443 35677899999999999999999999999
Q ss_pred hHHhcCccccc
Q 025350 162 PEIRNHEWFLK 172 (254)
Q Consensus 162 ~e~l~hp~~~~ 172 (254)
.|+|+||||+.
T Consensus 432 ~eaL~hpW~~~ 442 (475)
T KOG0615|consen 432 DEALNHPWFKD 442 (475)
T ss_pred HHHhcChhhhc
Confidence 99999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=279.20 Aligned_cols=166 Identities=28% Similarity=0.452 Sum_probs=139.6
Q ss_pred ccCcCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCC
Q 025350 7 QRGRGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 85 (254)
+...+.+..++++||.|||. ++||||||||+|||++..+. |||||||.++..... ...+.+||..|||||.+.+..
T Consensus 177 E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~ 253 (364)
T KOG0581|consen 177 EPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IANTFVGTSAYMSPERISGES 253 (364)
T ss_pred HHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hcccccccccccChhhhcCCc
Confidence 34456788999999999995 99999999999999998877 999999999876554 668889999999999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHHhc-cCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILS-VQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
|+.+ +||||||++++|+++|+.||... .........+..+.. ....+|.. .+|+++++|+..||++||.+|||+.|
T Consensus 254 Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~q 331 (364)
T KOG0581|consen 254 YSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQ 331 (364)
T ss_pred CCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 9877 99999999999999999999875 223344555555555 33344432 58999999999999999999999999
Q ss_pred HhcCccccccCCcc
Q 025350 164 IRNHEWFLKNLPAD 177 (254)
Q Consensus 164 ~l~hp~~~~~~~~~ 177 (254)
+++|||+++....+
T Consensus 332 Ll~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 332 LLQHPFIKKFEDPN 345 (364)
T ss_pred HhcCHHHhhccccc
Confidence 99999998755443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=253.20 Aligned_cols=155 Identities=33% Similarity=0.598 Sum_probs=132.6
Q ss_pred cHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcch
Q 025350 13 LFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 13 ~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
.+.|++.+|.|.|.+||||||+||+|+++.+.. ..-|||+|||+|.....+.....++|||.|||||+++..+|..+ +
T Consensus 115 ~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kp-v 193 (355)
T KOG0033|consen 115 CIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKP-V 193 (355)
T ss_pred HHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCc-c
Confidence 457899999999999999999999999995432 23599999999998776666677889999999999999998766 9
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--CCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 92 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 92 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
|||+.|++||-++.|++||.+.+....+.. +....+ ..|.|.+++++.++|+++||..||.+|+|+.|+|+|||
T Consensus 194 DiW~cGViLfiLL~G~~PF~~~~~~rlye~----I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 194 DIWACGVILYILLVGYPPFWDEDQHRLYEQ----IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred hhhhhhHHHHHHHhCCCCCCCccHHHHHHH----HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 999999999999999999998655444443 444443 44578899999999999999999999999999999999
Q ss_pred ccc
Q 025350 170 FLK 172 (254)
Q Consensus 170 ~~~ 172 (254)
+++
T Consensus 270 i~~ 272 (355)
T KOG0033|consen 270 ICN 272 (355)
T ss_pred hcc
Confidence 976
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=277.42 Aligned_cols=157 Identities=34% Similarity=0.585 Sum_probs=139.0
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..+.++.|++.|+.|||+++|+|||||..|+|++.+-. |||+|||+|...... ....+.||||.|.|||++...+++
T Consensus 119 Eary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHs 196 (592)
T KOG0575|consen 119 EARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHS 196 (592)
T ss_pred HHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccccceecCCCcccChhHhccCCCC
Confidence 34557789999999999999999999999999998876 999999999877644 567788999999999999988776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
-. +||||+||++|.|++|++||.. +.+...+.++....+..|. .+|.++++||.+||..||.+|||+++||.|
T Consensus 197 fE-vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 197 FE-VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred Cc-hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 55 9999999999999999999987 4556666777777888877 689999999999999999999999999999
Q ss_pred ccccccC
Q 025350 168 EWFLKNL 174 (254)
Q Consensus 168 p~~~~~~ 174 (254)
+||++.+
T Consensus 270 ~Ff~~g~ 276 (592)
T KOG0575|consen 270 PFFKSGF 276 (592)
T ss_pred HhhhCCC
Confidence 9996654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=272.27 Aligned_cols=159 Identities=44% Similarity=0.709 Sum_probs=140.1
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-CCCcEEEecCCCcccC-CCCCCCCCCcCCCCcccchhccCC
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-~~~~vkl~Dfg~a~~~-~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
+.....+|.|++.|++|+|++||+||||||+|||++.+ +. +||+|||++... .......+.+||+.|+|||++.+.
T Consensus 119 E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~ 196 (370)
T KOG0583|consen 119 EDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGK 196 (370)
T ss_pred hHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccccCCCCCcccCCCCCcccCCHHHhCCC
Confidence 33456789999999999999999999999999999988 54 999999999877 456677888999999999999998
Q ss_pred C-CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 E-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
. |.++++||||+||+||.|++|+.||....... ....+....+..|.+.. |++++.|+++||..||.+|+|+.+
T Consensus 197 ~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l~~ki~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~ 271 (370)
T KOG0583|consen 197 GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----LYRKIRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLE 271 (370)
T ss_pred CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----HHHHHhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHH
Confidence 8 99899999999999999999999999844433 33446677788887643 999999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
++.||||+.
T Consensus 272 i~~h~w~~~ 280 (370)
T KOG0583|consen 272 ILEHPWFQK 280 (370)
T ss_pred HhhChhhcc
Confidence 999999997
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=260.86 Aligned_cols=162 Identities=33% Similarity=0.546 Sum_probs=133.7
Q ss_pred ccccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhc
Q 025350 3 CRAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVL 81 (254)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~ 81 (254)
+++.+......+.+++.||.|||++|||||||||+|||++..|. ++|+|||+|+..... ....+.|||+.|||||++
T Consensus 120 g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil 197 (357)
T KOG0598|consen 120 GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEIL 197 (357)
T ss_pred CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccCCCccccccCCccccChHHH
Confidence 44555556677889999999999999999999999999998876 999999999854443 345567999999999999
Q ss_pred cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC--
Q 025350 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-- 159 (254)
Q Consensus 82 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-- 159 (254)
.+.+|+.. +|+||||+++|+|++|.+||.+.+..... .++.......+. ..++.+++++++++|..||.+|.
T Consensus 198 ~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~----~~I~~~k~~~~p-~~ls~~ardll~~LL~rdp~~RLg~ 271 (357)
T KOG0598|consen 198 LGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMY----DKILKGKLPLPP-GYLSEEARDLLKKLLKRDPRQRLGG 271 (357)
T ss_pred hcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHH----HHHhcCcCCCCC-ccCCHHHHHHHHHHhccCHHHhcCC
Confidence 99988765 99999999999999999999986554443 334444422221 23799999999999999999996
Q ss_pred --CHhHHhcCccccc
Q 025350 160 --SIPEIRNHEWFLK 172 (254)
Q Consensus 160 --s~~e~l~hp~~~~ 172 (254)
++.++.+||||..
T Consensus 272 ~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 272 PGDAEEIKRHPFFKG 286 (357)
T ss_pred CCChHHhhcCccccc
Confidence 6889999999965
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=275.41 Aligned_cols=163 Identities=36% Similarity=0.643 Sum_probs=148.4
Q ss_pred cccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCC
Q 025350 6 VQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 85 (254)
.++.....|.|+..++.|.|..+|+||||||+|+|++..+. +||+|||+|.....+....+.||+|+|.|||++.|.+
T Consensus 110 ~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~p 187 (786)
T KOG0588|consen 110 PEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRP 187 (786)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccccccCCCcccCCchhhcCCC
Confidence 34445667899999999999999999999999999998876 9999999999888888889999999999999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
|++.++||||+|||||.|++|+.||.+ ++...++.++..+.+.+|. .+|+++++||++||..||.+|+|.++|+
T Consensus 188 YdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml~VDp~~RiT~~eI~ 261 (786)
T KOG0588|consen 188 YDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRMLDVDPSTRITTEEIL 261 (786)
T ss_pred CCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHhccCccccccHHHHh
Confidence 999999999999999999999999986 5667777788888888885 5999999999999999999999999999
Q ss_pred cCccccccCCc
Q 025350 166 NHEWFLKNLPA 176 (254)
Q Consensus 166 ~hp~~~~~~~~ 176 (254)
+|||+...-..
T Consensus 262 kHP~l~g~~~~ 272 (786)
T KOG0588|consen 262 KHPFLSGYTSL 272 (786)
T ss_pred hCchhhcCCCC
Confidence 99999875433
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=252.69 Aligned_cols=161 Identities=32% Similarity=0.533 Sum_probs=136.2
Q ss_pred cccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC-
Q 025350 6 VQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK- 84 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~- 84 (254)
.+..-..+..|+..++.|||.++||||||||+|||++++.. +||+|||+|.....+......||||.|+|||.+...
T Consensus 121 SEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m 198 (411)
T KOG0599|consen 121 SEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSM 198 (411)
T ss_pred cHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccCCchhHHHhcCCCcccChhheeeec
Confidence 34445667899999999999999999999999999998876 999999999998888888888999999999998643
Q ss_pred ----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc--CCCCCCCCCCCHHHHHHHHHhchhCCCCC
Q 025350 85 ----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 85 ----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
+..++.+|+||+|+++|.++.|.+||....... .+..+..+ .+..|.|.++|...++||.+||+.||.+|
T Consensus 199 ~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml----MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~R 274 (411)
T KOG0599|consen 199 YENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML----MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKR 274 (411)
T ss_pred ccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH----HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhc
Confidence 233556999999999999999999998632222 22333333 45668899999999999999999999999
Q ss_pred CCHhHHhcCccccc
Q 025350 159 ISIPEIRNHEWFLK 172 (254)
Q Consensus 159 ps~~e~l~hp~~~~ 172 (254)
+|++|+|.||||.+
T Consensus 275 itake~LaHpff~q 288 (411)
T KOG0599|consen 275 ITAKEALAHPFFIQ 288 (411)
T ss_pred ccHHHHhcChHHHH
Confidence 99999999999965
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=267.26 Aligned_cols=155 Identities=32% Similarity=0.522 Sum_probs=131.0
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--------------CCCCCcCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------------QPKSTVGTPA 74 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--------------~~~~~~~~~~ 74 (254)
+.+....+++.+|.|||++|||||||||+|||++.++. +||+|||.|+.+.... ...+++||..
T Consensus 175 caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAe 252 (604)
T KOG0592|consen 175 CARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAE 252 (604)
T ss_pred HHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhccccCccCcccccCcccceeeeec
Confidence 34455678999999999999999999999999998876 9999999998543211 1145789999
Q ss_pred cccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhC
Q 025350 75 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 75 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 154 (254)
|.+||++.....+.. +|+|+|||++|.|+.|.+||.+.++...+ ++++...+.+|. .+++.+++||+++|..|
T Consensus 253 YVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliF----qkI~~l~y~fp~--~fp~~a~dLv~KLLv~d 325 (604)
T KOG0592|consen 253 YVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIF----QKIQALDYEFPE--GFPEDARDLIKKLLVRD 325 (604)
T ss_pred ccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHH----HHHHHhcccCCC--CCCHHHHHHHHHHHccC
Confidence 999999988777655 99999999999999999999997665544 445566676665 58999999999999999
Q ss_pred CCCCCCHhHHhcCccccc
Q 025350 155 PAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 155 P~~Rps~~e~l~hp~~~~ 172 (254)
|++|+|+.+|.+||||..
T Consensus 326 p~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 326 PSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred ccccccHHHHhhCccccc
Confidence 999999999999999965
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=253.34 Aligned_cols=168 Identities=28% Similarity=0.371 Sum_probs=134.8
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC---CCCCCCCcCCCCcccchhccCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~---~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
.....++.|+++||+|+|+.||+||||||.|+|++.++. +||+|||+|+.... ....+..+.|.+|.|||++...
T Consensus 125 ~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~ 202 (359)
T KOG0660|consen 125 DHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNS 202 (359)
T ss_pred HHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccccCcccchhcceeeeeecCHHHHhcc
Confidence 344567899999999999999999999999999999887 99999999997643 3344567899999999998766
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH-------------------HhccCCCCC------CCCCC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------------ILSVQYSIP------DYVHI 139 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------------------~~~~~~~~~------~~~~~ 139 (254)
...+++.||||+||++.||++|++.|.|.+...++..+..- ........| .+++.
T Consensus 203 ~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a 282 (359)
T KOG0660|consen 203 SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNA 282 (359)
T ss_pred ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCC
Confidence 65566799999999999999999999987765555433221 111111111 13467
Q ss_pred CHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCcc
Q 025350 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 177 (254)
Q Consensus 140 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~ 177 (254)
++.+.+|+.+||..||.+|+|++|+|+|||+.....+.
T Consensus 283 ~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 283 NPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 89999999999999999999999999999998876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=257.17 Aligned_cols=164 Identities=26% Similarity=0.379 Sum_probs=138.0
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....+..|++++|+++|.+|+.|||+||+|||+..+.. |||+|||+|+........+..+.|.+|+|||++....+++
T Consensus 111 ~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys 188 (538)
T KOG0661|consen 111 DIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYS 188 (538)
T ss_pred HHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCCCcchhhhcccccchHHhhhccccC
Confidence 34567899999999999999999999999999986554 9999999999877666667778999999999998887777
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cCCCCCC---------CCCCCHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIPD---------YVHISPECR 144 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~---------~~~~~~~~~ 144 (254)
.+.|+||+||+++|+.+-++.|.|.++.+++.++..-+.. ..+.+|. .+..++++.
T Consensus 189 ~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~ 268 (538)
T KOG0661|consen 189 SPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAA 268 (538)
T ss_pred CchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHH
Confidence 7799999999999999999999999988887776542211 1223332 124688999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
+||.+||.+||.+||||.++|+||||+...
T Consensus 269 ~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 269 SLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 999999999999999999999999997644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=248.30 Aligned_cols=162 Identities=23% Similarity=0.371 Sum_probs=133.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.|+|++++|||||||+||||+.++. +||||||+|+..... ...+..+.|.+|+|||++.+....++
T Consensus 104 k~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~ 181 (396)
T KOG0593|consen 104 KKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGK 181 (396)
T ss_pred HHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCC
Confidence 457799999999999999999999999999998886 999999999977633 33445679999999999998555566
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC---------------CCCCC----------CCCCCHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSIPD----------YVHISPECR 144 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~----------~~~~~~~~~ 144 (254)
++||||+||++.||++|.+.|.+.++.+++..+...+.... ..+|. ++.++.-+.
T Consensus 182 pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~l 261 (396)
T KOG0593|consen 182 PVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLL 261 (396)
T ss_pred cccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHH
Confidence 69999999999999999999999998888776654322111 12222 235677889
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
+|+++||..||.+|++.+++|.||||...+
T Consensus 262 d~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 262 DLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred HHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 999999999999999999999999995433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=264.00 Aligned_cols=162 Identities=25% Similarity=0.394 Sum_probs=137.0
Q ss_pred ccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccC
Q 025350 5 AVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 5 ~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~ 83 (254)
+.+...+.+..+++.||+|||.+||+|||||.+|||+..++. +||+|||+|....... ...+.+|||.|||||++..
T Consensus 366 ~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr 443 (550)
T KOG0578|consen 366 MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR 443 (550)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccccCCCCccchhhhhh
Confidence 344455677889999999999999999999999999998887 9999999998765544 5566789999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..|..+ +||||||++++||+-|.+||........+..+ ...+...+.....+|+.+++|+.+||+.|+.+|++|.+
T Consensus 444 k~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI---a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 444 KPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred cccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHHH---hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 998776 99999999999999999999875443333322 23455566666789999999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+|+||||+.
T Consensus 520 LL~HpFl~~ 528 (550)
T KOG0578|consen 520 LLEHPFLKM 528 (550)
T ss_pred HhcChhhhh
Confidence 999999954
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=243.93 Aligned_cols=158 Identities=33% Similarity=0.569 Sum_probs=137.7
Q ss_pred cccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC
Q 025350 4 RAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 4 ~~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~ 83 (254)
|+.+........|++.||.|||+++|++|||||+|||++.+|. +||+|||+|+..... ..+.||||.|+|||++..
T Consensus 140 rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 140 RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc--EEEecCCccccChHHhhc
Confidence 4555666778889999999999999999999999999999887 999999999976433 677899999999999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC----
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---- 159 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---- 159 (254)
.+|. +++|.|||||++|||+.|.+||...+. ..+..++......+|.. +++.+++||+++|+.|-.+|.
T Consensus 216 k~yn-kavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~vD~t~R~gnlk 288 (355)
T KOG0616|consen 216 KGYN-KAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPSY--FSSDAKDLLKKLLQVDLTKRFGNLK 288 (355)
T ss_pred CCCC-cchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCcc--cCHHHHHHHHHHHhhhhHhhhcCcC
Confidence 8885 459999999999999999999998666 34555677778877764 899999999999999999995
Q ss_pred -CHhHHhcCccccc
Q 025350 160 -SIPEIRNHEWFLK 172 (254)
Q Consensus 160 -s~~e~l~hp~~~~ 172 (254)
...+|..||||+.
T Consensus 289 nG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 289 NGVEDIKNHPWFKG 302 (355)
T ss_pred CCccccccCccccc
Confidence 5789999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=252.22 Aligned_cols=160 Identities=28% Similarity=0.363 Sum_probs=124.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC-CCCCcEEEecCCCcccCCC----CCCCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL----HSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~----~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
......|++.+|.|||++|||||||||+|||++. ++. +||+|||+++.... ........||+.|||||++..+
T Consensus 119 v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g 196 (313)
T KOG0198|consen 119 VRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNG 196 (313)
T ss_pred HHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccccccccccccCCccccCchhhcCC
Confidence 4456789999999999999999999999999998 465 99999999986542 1223456799999999999864
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
....+++|||||||++.||+||..||... ..... +..+.......+.+..+|+++++||.+||..+|++||||.+
T Consensus 197 ~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~----~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~e 272 (313)
T KOG0198|consen 197 EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA----LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEE 272 (313)
T ss_pred CcCCccchhhhcCCEEEeccCCCCcchhhcchHHH----HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 33334699999999999999999999863 21111 11122222122333458999999999999999999999999
Q ss_pred HhcCccccccCC
Q 025350 164 IRNHEWFLKNLP 175 (254)
Q Consensus 164 ~l~hp~~~~~~~ 175 (254)
+|+|||.+...+
T Consensus 273 LL~hpf~~~~~~ 284 (313)
T KOG0198|consen 273 LLEHPFLKQNSI 284 (313)
T ss_pred HhhChhhhcccc
Confidence 999999977554
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=243.14 Aligned_cols=167 Identities=31% Similarity=0.536 Sum_probs=139.9
Q ss_pred cccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC
Q 025350 6 VQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
.++..+.+..|+..|++|||+.+|.||||||+|+|..... +..+||+|||+|+.........+.+-||.|.|||++...
T Consensus 159 TErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~e 238 (400)
T KOG0604|consen 159 TEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPE 238 (400)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCch
Confidence 3455567889999999999999999999999999996543 346999999999987767778889999999999999888
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC--CCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
+|+.. +|+||+||++|-|++|.+||.+......-.....++..+.+.+ |.|..+|+..+++|+++|..+|.+|.|+.
T Consensus 239 Kydks-cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~ 317 (400)
T KOG0604|consen 239 KYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIE 317 (400)
T ss_pred hcCCC-CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHH
Confidence 87655 9999999999999999999987665333333334455555554 56788999999999999999999999999
Q ss_pred HHhcCcccccc
Q 025350 163 EIRNHEWFLKN 173 (254)
Q Consensus 163 e~l~hp~~~~~ 173 (254)
++++|||+...
T Consensus 318 ~~m~hpwi~~~ 328 (400)
T KOG0604|consen 318 EVMDHPWINQY 328 (400)
T ss_pred HhhcCchhccc
Confidence 99999999764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=251.11 Aligned_cols=163 Identities=32% Similarity=0.516 Sum_probs=138.7
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC------CCCCCCcCCCCcccchhcc
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH------SQPKSTVGTPAYIAPEVLL 82 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~------~~~~~~~~~~~y~aPE~~~ 82 (254)
....++..+..||.|||.+|||||||||+|+|++.++. |||+|||.+.....+ ......+|||.|+|||+..
T Consensus 211 ~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~ 288 (576)
T KOG0585|consen 211 QARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCS 288 (576)
T ss_pred HHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhc
Confidence 34567888999999999999999999999999988865 999999998765222 1233468999999999987
Q ss_pred C---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC
Q 025350 83 K---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 159 (254)
Q Consensus 83 ~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 159 (254)
+ ..+.+.+.||||+||+||.|+.|+.||.+.. ......++....+.+|....+.+.+++||++||.+||.+|+
T Consensus 289 ~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri 364 (576)
T KOG0585|consen 289 GGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRI 364 (576)
T ss_pred CCCCccccchhhhhhhhhhhHHHhhhccCCcccch----HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhee
Confidence 7 5567888999999999999999999999844 44556667777888888888899999999999999999999
Q ss_pred CHhHHhcCccccccCCcc
Q 025350 160 SIPEIRNHEWFLKNLPAD 177 (254)
Q Consensus 160 s~~e~l~hp~~~~~~~~~ 177 (254)
++.+|..|||........
T Consensus 365 ~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 365 TLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred ehhhheecceeccCCCCC
Confidence 999999999998875443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=243.43 Aligned_cols=168 Identities=25% Similarity=0.368 Sum_probs=139.7
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....+...|+.+|++|||+.||+||||||.|+|+|.+. +.+||||||.|+....+....+...|..|+|||++.+....
T Consensus 125 ~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Y 203 (364)
T KOG0658|consen 125 LEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 203 (364)
T ss_pred eeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCcccc
Confidence 34567889999999999999999999999999999764 46999999999988777777778899999999999987766
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc----------C---CCCC----------CCCCCCHHHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------Q---YSIP----------DYVHISPECR 144 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------~---~~~~----------~~~~~~~~~~ 144 (254)
+.+.||||.||++.||+.|++.|.+.+...++..+++-...+ . ...| .....+++..
T Consensus 204 t~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~ 283 (364)
T KOG0658|consen 204 TTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDAL 283 (364)
T ss_pred CceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHH
Confidence 666999999999999999999999988877777665422111 0 1111 1235789999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
+|+.++|.++|.+|.++.+++.||||..-..+
T Consensus 284 dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 284 DLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 99999999999999999999999999765544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=253.59 Aligned_cols=158 Identities=35% Similarity=0.579 Sum_probs=131.4
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC----------------------CC-C
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL----------------------HS-Q 65 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~----------------------~~-~ 65 (254)
+....+.+...|+..||+.|+|||||||+|+||+..|. +||+|||+|..... .. .
T Consensus 242 ~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (550)
T KOG0605|consen 242 WARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFP 319 (550)
T ss_pred HHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcccc
Confidence 34556778999999999999999999999999998876 99999999852110 00 0
Q ss_pred -------------------------CCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q 025350 66 -------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 120 (254)
Q Consensus 66 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 120 (254)
..+.+|||-|+|||++.+.+|... +|+||||||+||||.|.+||.+.+....+.
T Consensus 320 ~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG~ImyEmLvGyPPF~s~tp~~T~r 398 (550)
T KOG0605|consen 320 KFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLGCIMYEMLVGYPPFCSETPQETYR 398 (550)
T ss_pred ccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 012479999999999999998655 999999999999999999999988877777
Q ss_pred HHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC---CHhHHhcCccccc
Q 025350 121 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK 172 (254)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~ 172 (254)
+++.- ...+..|....+++++++||.+||. ||.+|. +++||.+||||+.
T Consensus 399 kI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 399 KIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 66543 3445667777789999999999998 999998 5899999999975
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=258.59 Aligned_cols=157 Identities=32% Similarity=0.541 Sum_probs=135.6
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCC-CCCCCCCCcCCCCcccchhccCCC
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~ 85 (254)
..+......+++.||+|||++||||||||.+|||+|..|. +||+|||+++... .+....+.||||.|+|||++.+..
T Consensus 467 e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~ 544 (694)
T KOG0694|consen 467 EPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS 544 (694)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCCccccccCChhhcChhhhccCc
Confidence 3444556678999999999999999999999999998876 9999999999755 455667889999999999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS----- 160 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----- 160 (254)
|+.. +|+|||||+||+|+.|..||.+.++.+.+.. +.......|.+ +|.++.++++++|.++|++|..
T Consensus 545 Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~Fds----I~~d~~~yP~~--ls~ea~~il~~ll~k~p~kRLG~~e~d 617 (694)
T KOG0694|consen 545 YTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDS----IVNDEVRYPRF--LSKEAIAIMRRLLRKNPEKRLGSGERD 617 (694)
T ss_pred ccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HhcCCCCCCCc--ccHHHHHHHHHHhccCcccccCCCCCC
Confidence 8755 9999999999999999999999777655544 55566666765 8999999999999999999994
Q ss_pred HhHHhcCccccc
Q 025350 161 IPEIRNHEWFLK 172 (254)
Q Consensus 161 ~~e~l~hp~~~~ 172 (254)
+.+|..||||+.
T Consensus 618 ~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 618 AEDIKKHPFFRS 629 (694)
T ss_pred chhhhhCCcccc
Confidence 578999999975
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=236.59 Aligned_cols=167 Identities=28% Similarity=0.360 Sum_probs=138.3
Q ss_pred cccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC-CCCcCCCCcccchhcc
Q 025350 4 RAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 82 (254)
Q Consensus 4 ~~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~y~aPE~~~ 82 (254)
++.......+.+|+++|++|||.+.|+||||||+|+|++..|. +||+|||+|+........ +..+-|.+|+|||++.
T Consensus 173 ~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLL 250 (419)
T KOG0663|consen 173 PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLL 250 (419)
T ss_pred CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCcccCcceEEEeeecCHHHhc
Confidence 4555667788999999999999999999999999999988887 999999999987655433 3446899999999999
Q ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-------CCCC-----------------C--
Q 025350 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------SIPD-----------------Y-- 136 (254)
Q Consensus 83 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~-----------------~-- 136 (254)
+....+.+.|+||+|||+.||+++++.|.+.+...++.+++.....+.. .+|. +
T Consensus 251 G~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~ 330 (419)
T KOG0663|consen 251 GAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGA 330 (419)
T ss_pred CCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccc
Confidence 8876666699999999999999999999999988888777654322110 1110 0
Q ss_pred CCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 137 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 137 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
..++....+|+..+|.+||.+|.||.++|+|.||.+
T Consensus 331 ~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 331 LSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 114588899999999999999999999999999987
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=246.16 Aligned_cols=163 Identities=27% Similarity=0.415 Sum_probs=126.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|.|||++||+||||||+|||++.++. +||+|||+++............+|+.|+|||++.+..++.+
T Consensus 126 ~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~- 202 (359)
T cd07876 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKEN- 202 (359)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcc-
Confidence 346789999999999999999999999999988776 99999999976544444445678999999999988888766
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH------------------hccCCCCC------------------
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI------------------LSVQYSIP------------------ 134 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------------------~~~~~~~~------------------ 134 (254)
+|||||||++|+|++|+.||.+.+....+....... .......+
T Consensus 203 ~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
T cd07876 203 VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESE 282 (359)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccc
Confidence 999999999999999999998765433322221110 00000000
Q ss_pred CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 135 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 135 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
.....++.+++||.+||..||.+|||+.|+|+||||..+..+
T Consensus 283 ~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 283 RDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred cccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 011236789999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=227.55 Aligned_cols=161 Identities=24% Similarity=0.330 Sum_probs=133.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCC-CCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.....++++++++|+|++.|+||||||.|+||++++. +||+|||+|+.+....... ..+-|.+|+|||++.|....+
T Consensus 103 iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg 180 (318)
T KOG0659|consen 103 IKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYG 180 (318)
T ss_pred HHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCcccccceeeeeccChHHhccchhcC
Confidence 3456788999999999999999999999999998886 9999999999776544333 337899999999999877666
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-CCCCC---------------------CCCCCHHHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPD---------------------YVHISPECRHL 146 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~---------------------~~~~~~~~~~l 146 (254)
..+|+||.||++.||+.|.+.|.+.++.+++..++.....+. ..+|. +...+.++.+|
T Consensus 181 ~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldL 260 (318)
T KOG0659|consen 181 TGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDL 260 (318)
T ss_pred CcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHH
Confidence 679999999999999999999999998888777654332211 11111 22356788999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccccc
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
+.+||.+||.+|+|+.|+|+|+||+.
T Consensus 261 l~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 261 LSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHhhhccCchhcccHHHHhcchhhhc
Confidence 99999999999999999999999986
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=256.36 Aligned_cols=161 Identities=24% Similarity=0.354 Sum_probs=125.1
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcch
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
.++.|++.||+|||++||+||||||+|||++.++ ..+||+|||+|+............+|+.|+|||++.+....+.++
T Consensus 174 ~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 252 (440)
T PTZ00036 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHI 252 (440)
T ss_pred HHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHH
Confidence 4557999999999999999999999999998654 249999999998655444445567899999999987654334459
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------------CCCCCC----------CCCCCHHHHHHHH
Q 025350 92 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------QYSIPD----------YVHISPECRHLIS 148 (254)
Q Consensus 92 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~~~~~~~li~ 148 (254)
|||||||++|+|++|.+||.+......+...+...... ...++. ....++++++||.
T Consensus 253 DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~ 332 (440)
T PTZ00036 253 DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFIS 332 (440)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHH
Confidence 99999999999999999999876655554443321100 001111 1235789999999
Q ss_pred HhchhCCCCCCCHhHHhcCcccccc
Q 025350 149 RIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 149 ~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+||.+||.+|||+.++++||||...
T Consensus 333 ~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 333 QFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHCCCChhHCcCHHHHhCChhHHhh
Confidence 9999999999999999999999764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=246.07 Aligned_cols=163 Identities=27% Similarity=0.388 Sum_probs=126.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++............+++.|+|||++.+..++.+
T Consensus 129 ~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~- 205 (364)
T cd07875 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN- 205 (364)
T ss_pred HHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCch-
Confidence 346789999999999999999999999999988765 99999999986544444445678999999999988877665
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc------------------cCCC--------------CC----
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------------VQYS--------------IP---- 134 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~~--------------~~---- 134 (254)
+|||||||++|+|++|+.||.+..........+..... .... .+
T Consensus 206 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (364)
T cd07875 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSE 285 (364)
T ss_pred hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccccc
Confidence 99999999999999999999876654444433321100 0000 00
Q ss_pred CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 135 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 135 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
.....+..+++||.+||..||.+|||+.++|+||||..+...
T Consensus 286 ~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 286 HNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred ccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 001134678999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.48 Aligned_cols=158 Identities=28% Similarity=0.355 Sum_probs=126.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|.|||++||+||||||+|||++.++. +||+|||+++............|++.|+|||++.+..++.+
T Consensus 112 ~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 189 (290)
T cd07862 112 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 189 (290)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccceEeccCCcccccccccccccChHHHhCCCCCCc
Confidence 3557889999999999999999999999999988765 99999999976544434445578999999999987777665
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-CCCC--------------------CCCCCCHHHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIP--------------------DYVHISPECRHLIS 148 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--------------------~~~~~~~~~~~li~ 148 (254)
+|||||||++|+|++|.+||.+.........+........ ..++ ....+++.+++|+.
T Consensus 190 -~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (290)
T cd07862 190 -VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 268 (290)
T ss_pred -cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHH
Confidence 9999999999999999999998766555544433211000 0000 01246788999999
Q ss_pred HhchhCCCCCCCHhHHhcCccc
Q 025350 149 RIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 149 ~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+||+.||++|||+.++++||||
T Consensus 269 ~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 269 KCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHhccCchhcCCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=236.12 Aligned_cols=162 Identities=27% Similarity=0.356 Sum_probs=130.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...+..|++.|++|||++||+||||||.||||++++. +||+|||+|+....... ..+.++|.+|+|||++.+.....
T Consensus 122 ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys 199 (323)
T KOG0594|consen 122 IKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYS 199 (323)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCC
Confidence 4567899999999999999999999999999998776 99999999986653333 45567999999999999885545
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-CCCC-------------CC----------CCCCHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIP-------------DY----------VHISPECR 144 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~-------------~~----------~~~~~~~~ 144 (254)
...||||+||+++||+++++.|.+..+..+...+...+..+. ..+| .+ ...++...
T Consensus 200 ~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~ 279 (323)
T KOG0594|consen 200 TSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGI 279 (323)
T ss_pred CCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHH
Confidence 559999999999999999999999888777666554322111 1111 11 12335889
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+++.+||.++|.+|.|+..+|.||||...
T Consensus 280 dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 280 ELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 99999999999999999999999999763
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=227.49 Aligned_cols=163 Identities=28% Similarity=0.431 Sum_probs=134.1
Q ss_pred ccCcCCcHHHHHHHHHHHh-hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC--
Q 025350 7 QRGRGTLFLPTTYFWSELL-PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-- 83 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-- 83 (254)
++..|.+...+..||.||. .+||+|||+||+|||++..|. +||||||++.+...........|.+.|||||.+.-
T Consensus 190 E~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~ 267 (391)
T KOG0983|consen 190 ERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPD 267 (391)
T ss_pred HHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecccccccccCCccccCccccCCCC
Confidence 4556777888999999998 789999999999999998887 99999999988777666666789999999999863
Q ss_pred -CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 84 -KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 84 -~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..|+-+ +||||||+++++|.||+.||.+..........+.. .....++....+|+.+++|+..||.+|+.+||...
T Consensus 268 ~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~ 344 (391)
T KOG0983|consen 268 KPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYN 344 (391)
T ss_pred CCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchH
Confidence 356666 89999999999999999999986543332222221 23345555556899999999999999999999999
Q ss_pred HHhcCccccccC
Q 025350 163 EIRNHEWFLKNL 174 (254)
Q Consensus 163 e~l~hp~~~~~~ 174 (254)
++|+|||++.+-
T Consensus 345 ~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 345 KLLEHPFIKRYE 356 (391)
T ss_pred HHhcCcceeecc
Confidence 999999997643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=240.49 Aligned_cols=158 Identities=24% Similarity=0.356 Sum_probs=126.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||++.............|++.|+|||++.+..++.+
T Consensus 104 ~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 181 (285)
T cd05631 104 AIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181 (285)
T ss_pred HHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcc
Confidence 3456779999999999999999999999999987765 99999999976543333345678999999999988887765
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e~ 164 (254)
+|||||||++|+|++|+.||...............+..... .....+++.+.+|+++||+.||.+||+ ++++
T Consensus 182 -~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 258 (285)
T cd05631 182 -PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258 (285)
T ss_pred -cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc--cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH
Confidence 89999999999999999999876543333333332222222 223457999999999999999999997 8999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||..
T Consensus 259 ~~h~~~~~ 266 (285)
T cd05631 259 KQHPIFKN 266 (285)
T ss_pred hcCHhhcC
Confidence 99999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=242.18 Aligned_cols=161 Identities=28% Similarity=0.385 Sum_probs=125.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++............+|+.|+|||++.+..++.+
T Consensus 122 ~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~- 198 (355)
T cd07874 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN- 198 (355)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCch-
Confidence 356789999999999999999999999999988765 99999999986544444455678999999999988877665
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc------------------cCC-----CCC-------------
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------------VQY-----SIP------------- 134 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~-----~~~------------- 134 (254)
+|||||||++|+|++|+.||.+..........+..... ... ..+
T Consensus 199 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (355)
T cd07874 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278 (355)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccc
Confidence 99999999999999999999876544433332221100 000 000
Q ss_pred CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 135 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 135 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
.....+..+++||.+||..||.+|||+.++++||||....
T Consensus 279 ~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 279 HNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred cccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 0112356789999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=238.26 Aligned_cols=162 Identities=23% Similarity=0.346 Sum_probs=120.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||++...... .......+++.|+|||++.+.....
T Consensus 105 ~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (303)
T cd07869 105 VKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182 (303)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCC
Confidence 3456789999999999999999999999999987765 999999998743322 2223456899999999987654434
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--------CC------------C-------CCCCCCH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------SI------------P-------DYVHISP 141 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~------------~-------~~~~~~~ 141 (254)
.++|||||||++|+|++|..||.+..+.......+........ .. + ....+++
T Consensus 183 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (303)
T cd07869 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVN 262 (303)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCCh
Confidence 5599999999999999999999876543322222211111000 00 0 0012457
Q ss_pred HHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 142 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
.+++|+.+||+.||.+|||+.++++||||++.
T Consensus 263 ~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 263 HAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred HHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 88999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=240.65 Aligned_cols=170 Identities=29% Similarity=0.411 Sum_probs=130.9
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-----CCCCcCCCCcccchhc
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVL 81 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~ 81 (254)
+.....++.++++||.|||.+|.||||||+.||||+.+|. |||+|||.+......+. ..+.+||++|||||++
T Consensus 125 E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 125 EASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCceeeEeeccccCcccccChHHh
Confidence 3445678899999999999999999999999999999887 99999998754332221 1456899999999995
Q ss_pred cC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc----CCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 82 LK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----QYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 82 ~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
.. .+|+.+ +||||||++..|+.+|..||......+.+...++..... .........++..++.++..||.+||
T Consensus 203 ~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP 281 (516)
T KOG0582|consen 203 MQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDP 281 (516)
T ss_pred hhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCc
Confidence 43 445555 999999999999999999999876655544333221110 00111123467889999999999999
Q ss_pred CCCCCHhHHhcCccccccCCcccc
Q 025350 156 AKRISIPEIRNHEWFLKNLPADLV 179 (254)
Q Consensus 156 ~~Rps~~e~l~hp~~~~~~~~~~~ 179 (254)
.+|||++++|+|+||++..+....
T Consensus 282 ~kRptAskLlkh~FFk~~k~~~~~ 305 (516)
T KOG0582|consen 282 SKRPTASKLLKHAFFKKAKSKEYL 305 (516)
T ss_pred ccCCCHHHHhccHHHhhccchhhc
Confidence 999999999999999987665543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=236.91 Aligned_cols=158 Identities=23% Similarity=0.349 Sum_probs=120.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+....+.
T Consensus 106 ~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 183 (288)
T cd07871 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183 (288)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCccccCceecccccChHHhcCCcccCc
Confidence 446789999999999999999999999999988765 9999999987543222 2234568999999999876443345
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------CCCCCC---------CCCCCHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIPD---------YVHISPECRH 145 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~---------~~~~~~~~~~ 145 (254)
++||||+||++|+|++|+.||.+................. ....+. ...++.++++
T Consensus 184 ~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 263 (288)
T cd07871 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGID 263 (288)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHH
Confidence 5999999999999999999998766544443332211100 000111 1246789999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
||++||..||.+|||++|+++||||
T Consensus 264 ll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 264 LLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHhcCcCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=240.48 Aligned_cols=158 Identities=26% Similarity=0.342 Sum_probs=129.8
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCC
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 85 (254)
+.....++.+++.|+.|||.++.+|||||+.|||+...+. |||+|||++....... ...+++||+.|||||++.+..
T Consensus 110 E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~ 187 (467)
T KOG0201|consen 110 EFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSG 187 (467)
T ss_pred cceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhccccccccccccchhhhcccc
Confidence 4456778899999999999999999999999999988866 9999999997655433 336789999999999999889
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
|+.+ +||||||++.+||++|.+|+........+. -+ ...........+|+.+++|+..||++||+.||||.++|
T Consensus 188 Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlf----lI-pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 188 YDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLF----LI-PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred ccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEE----ec-cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 9887 899999999999999999998765522111 11 11111111236899999999999999999999999999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+|+|+++
T Consensus 262 Kh~FIk~ 268 (467)
T KOG0201|consen 262 KHKFIKR 268 (467)
T ss_pred hhHHHHh
Confidence 9999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=242.86 Aligned_cols=154 Identities=34% Similarity=0.564 Sum_probs=124.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 98 ~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 175 (323)
T cd05571 98 RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175 (323)
T ss_pred HHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCcc
Confidence 346689999999999999999999999999988765 99999999875322 222344579999999999988877655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~ 164 (254)
+|||||||++|+|++|..||......... ..+.......| ..+++++++||++||..||.+|| ++.++
T Consensus 176 -~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 248 (323)
T cd05571 176 -VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEI 248 (323)
T ss_pred -ccCcccchhhhhhhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHH
Confidence 99999999999999999999875443222 22333333333 35899999999999999999999 89999
Q ss_pred hcCcccccc
Q 025350 165 RNHEWFLKN 173 (254)
Q Consensus 165 l~hp~~~~~ 173 (254)
++||||...
T Consensus 249 l~h~~f~~~ 257 (323)
T cd05571 249 MEHRFFASI 257 (323)
T ss_pred HcCCCcCCC
Confidence 999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=244.37 Aligned_cols=165 Identities=32% Similarity=0.513 Sum_probs=139.5
Q ss_pred cccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC--CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC
Q 025350 6 VQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~ 83 (254)
.+.....+..|++.+++|||+.||+||||||+|+|+..... +.+|++|||++............+||+.|+|||++..
T Consensus 133 sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~ 212 (382)
T KOG0032|consen 133 SERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG 212 (382)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC
Confidence 34445667889999999999999999999999999965532 4699999999998766556677899999999999988
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.+|... +||||+|+++|.|++|.+||.+.+......++... ...+..+.|..++..+++||++||..||.+|+|+.+
T Consensus 213 ~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~ 289 (382)
T KOG0032|consen 213 RPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQ 289 (382)
T ss_pred CCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHH
Confidence 888766 99999999999999999999998766655543322 224456778889999999999999999999999999
Q ss_pred HhcCcccccc
Q 025350 164 IRNHEWFLKN 173 (254)
Q Consensus 164 ~l~hp~~~~~ 173 (254)
+|+|||++..
T Consensus 290 ~L~HpWi~~~ 299 (382)
T KOG0032|consen 290 ALQHPWIKSI 299 (382)
T ss_pred HhcCccccCC
Confidence 9999998764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.33 Aligned_cols=158 Identities=27% Similarity=0.311 Sum_probs=124.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++.............++..|+|||++.+..++.+
T Consensus 110 ~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 187 (288)
T cd07863 110 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATP 187 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCccccccCcccCCCccccccccCchHhhCCCCCCc
Confidence 3557789999999999999999999999999988776 99999999976544333344568999999999988777665
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------CCCC--------------CCCCCCCHHHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------QYSI--------------PDYVHISPECRHLIS 148 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~~--------------~~~~~~~~~~~~li~ 148 (254)
+|||||||++|+|++|.+||.+........+........ .... .....++..+++||.
T Consensus 188 -~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 266 (288)
T cd07863 188 -VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLL 266 (288)
T ss_pred -chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHH
Confidence 999999999999999999998776555444433321100 0000 001246788999999
Q ss_pred HhchhCCCCCCCHhHHhcCccc
Q 025350 149 RIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 149 ~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+||..||.+|||+.+++.||||
T Consensus 267 ~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 267 EMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=226.60 Aligned_cols=145 Identities=29% Similarity=0.403 Sum_probs=122.8
Q ss_pred cCCcHHHHHHHHHHHhh--cC--cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLP--FN--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~--~g--ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 84 (254)
.-.+|.|++.||..+|. .. |+||||||.|||++.++. |||+|||+++.+..... ..+.+|||.||+||++.+.
T Consensus 126 Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~ 203 (375)
T KOG0591|consen 126 VWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHES 203 (375)
T ss_pred HHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcC
Confidence 34578999999999997 55 899999999999998886 99999999997654433 3556899999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
+|+.+ |||||+||++|||+.-++||.+. ++..+.+++..+.++.-....+|.++..||..|+..||..||+.
T Consensus 204 ~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 204 GYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 99877 99999999999999999999995 55666666666655422225689999999999999999999985
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=249.80 Aligned_cols=163 Identities=23% Similarity=0.361 Sum_probs=121.4
Q ss_pred CCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCC--------------CcEEEecCCCcccCCCCCCCCCCcCCCCc
Q 025350 11 GTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPA--------------PRLKICDFGYSKSSVLHSQPKSTVGTPAY 75 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~--------------~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y 75 (254)
..++.|++.+|.|||+ .|||||||||+|||++..+. ..+||+|||.+... .......+||+.|
T Consensus 234 ~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y 311 (467)
T PTZ00284 234 AQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHY 311 (467)
T ss_pred HHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccC--ccccccccCCccc
Confidence 4577899999999997 59999999999999976542 14999999987642 2223456799999
Q ss_pred ccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------------------cCCC-CCC
Q 025350 76 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------------VQYS-IPD 135 (254)
Q Consensus 76 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------------~~~~-~~~ 135 (254)
+|||++.+..++.+ +|||||||++|+|++|+.||.+......+..+...... .... .+.
T Consensus 312 ~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (467)
T PTZ00284 312 RSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPC 390 (467)
T ss_pred cCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccccccc
Confidence 99999998888765 99999999999999999999876543332221111000 0000 000
Q ss_pred ----------------CCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 136 ----------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 136 ----------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
....++.+.+||.+||.+||.+|||++|+|+||||.+..+.
T Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 447 (467)
T PTZ00284 391 TDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPE 447 (467)
T ss_pred CCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCc
Confidence 00014567899999999999999999999999999886654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=239.66 Aligned_cols=162 Identities=25% Similarity=0.312 Sum_probs=135.1
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 85 (254)
....-++.|++.+|.|+|.+||+|||||.+||||+.++. +||+|||+|+...... ..+..+-|.+|+|||++.|..
T Consensus 218 ~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t 295 (560)
T KOG0600|consen 218 PQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGAT 295 (560)
T ss_pred HHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCCcccccceEEeeccChHHhcCCc
Confidence 344567889999999999999999999999999998887 9999999999654433 355668899999999999987
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC------CCCC-----------------CCCCCHH
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------SIPD-----------------YVHISPE 142 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~-----------------~~~~~~~ 142 (254)
.++.++|+||+||||.||++|++.|.+.++..++..+++-...... .+|. +..+++.
T Consensus 296 ~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~ 375 (560)
T KOG0600|consen 296 SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPAS 375 (560)
T ss_pred ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHH
Confidence 6677799999999999999999999999998888877654322211 1111 1246788
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCcccc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWFL 171 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 171 (254)
..+|+..||..||.+|.||.++|+|+||+
T Consensus 376 ~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 376 ALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred HHHHHHHHhccCccccccHHHHhcCcccc
Confidence 99999999999999999999999999994
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=240.56 Aligned_cols=159 Identities=32% Similarity=0.502 Sum_probs=124.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+....+
T Consensus 108 ~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 185 (332)
T cd05614 108 RFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185 (332)
T ss_pred HHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCC
Confidence 446679999999999999999999999999988775 9999999987543222 223456999999999997655344
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e 163 (254)
.++|||||||++|+|++|..||...............+.......+ ..+++.+++++.+||..||++|| ++++
T Consensus 186 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 263 (332)
T cd05614 186 KAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263 (332)
T ss_pred CccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 5599999999999999999999754432222333333333333333 35799999999999999999999 7889
Q ss_pred HhcCcccccc
Q 025350 164 IRNHEWFLKN 173 (254)
Q Consensus 164 ~l~hp~~~~~ 173 (254)
+++||||+..
T Consensus 264 ~l~h~~~~~~ 273 (332)
T cd05614 264 IKEHPFFKGL 273 (332)
T ss_pred HHcCCCcCCC
Confidence 9999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=243.51 Aligned_cols=156 Identities=28% Similarity=0.525 Sum_probs=133.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC-CCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...+..++..||.|||+.+|+|||+||.|||+..++. +|+||||+|+....+... ....|||.|||||++.+.+|+.
T Consensus 102 v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~ 179 (808)
T KOG0597|consen 102 VRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDH 179 (808)
T ss_pred HHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccc
Confidence 3456678999999999999999999999999988776 999999999976655433 3446999999999999999987
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
. +|+|||||++||+++|++||.. ..+...++.+......+|. ..+..+++|+..+|.+||.+|.|..+++.||
T Consensus 180 ~-sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 180 T-SDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred h-hhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 7 9999999999999999999987 4445556666665555554 6899999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
|.+..+
T Consensus 253 F~k~~~ 258 (808)
T KOG0597|consen 253 FWKGKI 258 (808)
T ss_pred HHhhhh
Confidence 998755
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=231.36 Aligned_cols=158 Identities=24% Similarity=0.314 Sum_probs=121.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+++|||+.||+||||||+||+++.++. +||+|||++....... ......|++.|+|||++.+..++
T Consensus 102 ~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (287)
T cd07848 102 VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccccccccccccCCcHHHcCCCCC
Confidence 3457789999999999999999999999999987765 9999999997653322 22334689999999999887776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cCCCCCC-----------CCCCCH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIPD-----------YVHISP 141 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~-----------~~~~~~ 141 (254)
.+ +|+|||||++|+|++|++||.+................ .....+. ...+|.
T Consensus 180 ~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 258 (287)
T cd07848 180 KA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSG 258 (287)
T ss_pred Cc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCH
Confidence 55 99999999999999999999876543332221110000 0000111 113678
Q ss_pred HHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 142 ECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 142 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
.+++||++||..||++|||++++++||||
T Consensus 259 ~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 259 VLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 89999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=234.24 Aligned_cols=151 Identities=32% Similarity=0.535 Sum_probs=123.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||++..... ......|++.|+|||++.+..++.+
T Consensus 104 ~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~- 178 (291)
T cd05612 104 LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQSKGHNKA- 178 (291)
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--CcccccCChhhcCHHHHcCCCCCch-
Confidence 456789999999999999999999999999987765 99999999875432 2234578999999999988777655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e~l 165 (254)
+|||||||++|+|++|..||.+........ .+......++. .+++.+++||++||..||.+|++ +.+++
T Consensus 179 ~DiwSlG~il~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 179 VDWWALGILIYEMLVGYPPFFDDNPFGIYE----KILAGKLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCcCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 999999999999999999998765433332 23333333333 46899999999999999999995 99999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||..
T Consensus 253 ~h~~~~~ 259 (291)
T cd05612 253 NHRWFKS 259 (291)
T ss_pred cCccccC
Confidence 9999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=236.98 Aligned_cols=154 Identities=34% Similarity=0.571 Sum_probs=124.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 96 ~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 173 (312)
T cd05585 96 RFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173 (312)
T ss_pred HHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCc
Confidence 446789999999999999999999999999988776 999999998753222 22334579999999999988877655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC---CHhHHhc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRN 166 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~ 166 (254)
+|||||||++|+|++|..||.+....... ..+.......+ ..+++.+++||.+||..||.+|| ++.++++
T Consensus 174 -~DvwslGvil~el~tg~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 174 -VDWWTLGVLLYEMLTGLPPFYDENVNEMY----RKILQEPLRFP--DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -cceechhHHHHHHHhCCCCcCCCCHHHHH----HHHHcCCCCCC--CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 89999999999999999999875543332 33333333333 35789999999999999999997 5799999
Q ss_pred Ccccccc
Q 025350 167 HEWFLKN 173 (254)
Q Consensus 167 hp~~~~~ 173 (254)
||||.+.
T Consensus 247 hp~~~~~ 253 (312)
T cd05585 247 HPFFSQL 253 (312)
T ss_pred CCCcCCC
Confidence 9999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=237.12 Aligned_cols=153 Identities=32% Similarity=0.502 Sum_probs=124.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... ........||+.|+|||++.+..++.+
T Consensus 99 ~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (320)
T cd05590 99 RFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176 (320)
T ss_pred HHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCc
Confidence 446789999999999999999999999999988776 99999999875322 222344579999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH------hH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI------PE 163 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~------~e 163 (254)
+|||||||++|+|++|+.||.+....... ..+.......| ..++.++++||++||..||.+||++ ++
T Consensus 177 -~DiwslG~il~el~~g~~Pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~ 249 (320)
T cd05590 177 -VDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEA 249 (320)
T ss_pred -cchhhhHHHHHHHhhCCCCCCCCCHHHHH----HHHhcCCCCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHH
Confidence 89999999999999999999876543332 23333333333 3479999999999999999999998 89
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||..
T Consensus 250 ~~~h~~f~~ 258 (320)
T cd05590 250 ILRHPFFKE 258 (320)
T ss_pred HHcCCCcCC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=239.18 Aligned_cols=151 Identities=30% Similarity=0.505 Sum_probs=124.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||++..... ......|++.|+|||++.+..++.+
T Consensus 121 ~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~- 195 (329)
T PTZ00263 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKGHGKA- 195 (329)
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--CcceecCChhhcCHHHHcCCCCCCc-
Confidence 345678999999999999999999999999988776 99999999976432 2234579999999999988777655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e~l 165 (254)
+|||||||++|+|++|..||.+...... ...+.......|. .++..+++||++||..||.+|++ +++++
T Consensus 196 ~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 196 VDWWTMGVLLYEFIAGYPPFFDDTPFRI----YEKILAGRLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred ceeechHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCCcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 9999999999999999999987554332 2333344444443 47899999999999999999996 79999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||.+
T Consensus 270 ~hp~f~~ 276 (329)
T PTZ00263 270 NHPYFHG 276 (329)
T ss_pred cCCccCC
Confidence 9999976
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=237.55 Aligned_cols=161 Identities=24% Similarity=0.355 Sum_probs=120.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccC--
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLK-- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~-- 83 (254)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....|++.|+|||++.+
T Consensus 105 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 182 (338)
T cd07859 105 HQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 182 (338)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccc
Confidence 3456789999999999999999999999999988776 99999999875322211 133568999999999865
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH-----------H--------H---hccCCCC---CCCCC
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-----------R--------I---LSVQYSI---PDYVH 138 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-----------~--------~---~~~~~~~---~~~~~ 138 (254)
..++. ++|||||||++|+|++|++||.+............ . . ....... .....
T Consensus 183 ~~~~~-~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
T cd07859 183 SKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPN 261 (338)
T ss_pred cccCc-hhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCC
Confidence 44544 49999999999999999999987554322211100 0 0 0000000 11234
Q ss_pred CCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 139 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 139 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+++.+.++|.+||..||.+|||+.++++||||+..
T Consensus 262 ~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 262 ADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred CChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 67889999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=237.75 Aligned_cols=153 Identities=33% Similarity=0.544 Sum_probs=123.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 98 ~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 175 (328)
T cd05593 98 RFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175 (328)
T ss_pred HHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCcc
Confidence 446789999999999999999999999999988775 99999999875322 222334579999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~ 164 (254)
+|||||||++|+|++|+.||........ ...+......+| ..+++++.+||++||..||.+|+ ++.++
T Consensus 176 -~DiwslGvil~elltG~~Pf~~~~~~~~----~~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~i 248 (328)
T cd05593 176 -VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEDIKFP--RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEI 248 (328)
T ss_pred -CCccccchHHHHHhhCCCCCCCCCHHHH----HHHhccCCccCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHH
Confidence 9999999999999999999987544322 222333333333 35799999999999999999997 89999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||..
T Consensus 249 l~h~~~~~ 256 (328)
T cd05593 249 MRHSFFTG 256 (328)
T ss_pred hcCCCcCC
Confidence 99999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=239.26 Aligned_cols=155 Identities=30% Similarity=0.447 Sum_probs=119.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..+..|++.++.++|.+||||.||||.|+|+-.+ .+||+|||+|....... ...+.+||+.||+||.+....++
T Consensus 463 k~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG---~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~ 539 (677)
T KOG0596|consen 463 KFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG---RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS 539 (677)
T ss_pred HHHHHHHHHHHHHHHHhceeecCCCcccEEEEee---eEEeeeechhcccCccccceeeccccCcccccCHHHHhhcccc
Confidence 3456789999999999999999999999998653 39999999997654332 23456899999999998643322
Q ss_pred ----------CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--CCCCCCCCCHHHHHHHHHhchhCC
Q 025350 88 ----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 88 ----------~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
++++|||||||+||+|+.|++||... .+....+..+..... .+|..+. ..++.++++.||..||
T Consensus 540 ~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdP 615 (677)
T KOG0596|consen 540 RENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---INQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDP 615 (677)
T ss_pred ccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---HHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCc
Confidence 34599999999999999999999642 333444455555443 2333221 2349999999999999
Q ss_pred CCCCCHhHHhcCccccc
Q 025350 156 AKRISIPEIRNHEWFLK 172 (254)
Q Consensus 156 ~~Rps~~e~l~hp~~~~ 172 (254)
++|||+.++|+|||++-
T Consensus 616 kkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 616 KKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCcHHHhcCccccc
Confidence 99999999999999864
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=242.54 Aligned_cols=160 Identities=26% Similarity=0.308 Sum_probs=128.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
+.+..|++.+|..||+.||||+||||+|||+.......|||+|||.|..... ...+.+.+..|+|||++.|.+|+.+
T Consensus 292 r~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q--~vytYiQSRfYRAPEVILGlpY~~~- 368 (586)
T KOG0667|consen 292 RKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ--RVYTYIQSRFYRAPEVILGLPYDTA- 368 (586)
T ss_pred HHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC--cceeeeeccccccchhhccCCCCCc-
Confidence 4567899999999999999999999999999776666899999999986433 3447889999999999999999887
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-----------------c------------------------
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-----------------V------------------------ 129 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----------------~------------------------ 129 (254)
.||||||||++||++|.+.|.+.+..+++..++.-... .
T Consensus 369 IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~ 448 (586)
T KOG0667|consen 369 IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRK 448 (586)
T ss_pred cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhh
Confidence 99999999999999999999998877776655421000 0
Q ss_pred -------CCCCC-CCC--------CCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 130 -------QYSIP-DYV--------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 130 -------~~~~~-~~~--------~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
....| ... .-...+.+||++||.+||.+|+|+.++|+||||...
T Consensus 449 ~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 449 YYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred hhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 00001 000 012467899999999999999999999999999853
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=234.03 Aligned_cols=160 Identities=26% Similarity=0.326 Sum_probs=115.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC--CCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~--~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 84 (254)
..++.|++.|++|||++||+||||||+|||+... ..+.+||+|||+++...... ......+|+.|+|||++.+.
T Consensus 111 ~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07868 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred HHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCC
Confidence 4578899999999999999999999999999432 22359999999997543221 12345689999999999875
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCch---------HHHHHHHHHHh------------------------ccCC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRIL------------------------SVQY 131 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~~~~~~------------------------~~~~ 131 (254)
...+.++||||+||++|+|++|++||...... ........... ....
T Consensus 191 ~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (317)
T cd07868 191 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 270 (317)
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhcccc
Confidence 54455599999999999999999999754321 11111111000 0000
Q ss_pred CC--------CCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 132 SI--------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 132 ~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
.. ......+..+.+||++||..||.+|||++|+|+||||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 271 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=236.53 Aligned_cols=156 Identities=35% Similarity=0.636 Sum_probs=138.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
...|.|+..++.|.|+..+|||||||+||.+-..- +-|||+|||++..+..+....+.||+..|.|||++.|..|+.++
T Consensus 121 ~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl-GlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPA 199 (864)
T KOG4717|consen 121 KKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL-GLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPA 199 (864)
T ss_pred HHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec-CceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcc
Confidence 45789999999999999999999999999775432 35999999999988888888999999999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+|||||||+||-|++|++||...++.+.+.. ++...+..|. +++.++++||..||..||++|.|+++|..|+|+
T Consensus 200 VDiWSLGVILyMLVCGq~PFqeANDSETLTm----ImDCKYtvPs--hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 200 VDIWSLGVILYMLVCGQPPFQEANDSETLTM----IMDCKYTVPS--HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred hhhhHHHHHHHHHHhCCCccccccchhhhhh----hhcccccCch--hhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 9999999999999999999998777665544 4556666665 689999999999999999999999999999999
Q ss_pred ccc
Q 025350 171 LKN 173 (254)
Q Consensus 171 ~~~ 173 (254)
+..
T Consensus 274 q~~ 276 (864)
T KOG4717|consen 274 QAG 276 (864)
T ss_pred cCC
Confidence 753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=238.94 Aligned_cols=159 Identities=21% Similarity=0.271 Sum_probs=118.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC--CCCCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.|++.||.|||++||+||||||+|||++..+. +||+|||+|+..... .......||+.|+|||++.+..++.
T Consensus 185 ~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 262 (391)
T PHA03212 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGP 262 (391)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCc
Confidence 456789999999999999999999999999987765 999999998643221 1223457999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHHHHHH----------------------hccCCC----CCC
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRI----------------------LSVQYS----IPD 135 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~----------------------~~~~~~----~~~ 135 (254)
+ +|||||||++|+|++|..||..... ...+..++... ...... .+.
T Consensus 263 ~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (391)
T PHA03212 263 A-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPL 341 (391)
T ss_pred H-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCC
Confidence 5 9999999999999999988754321 11111111110 000000 011
Q ss_pred C---CCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 136 Y---VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 136 ~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
+ ..++.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 342 ~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 342 WTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 1 134678999999999999999999999999999976
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=230.69 Aligned_cols=158 Identities=29% Similarity=0.406 Sum_probs=125.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++....... ......|++.|+|||++.+..++.
T Consensus 99 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 176 (280)
T cd05608 99 ACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCc
Confidence 3457789999999999999999999999999987765 9999999987543322 223446899999999998887765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e 163 (254)
+ +|+|||||++|+|++|+.||...............+...... ....+++.+.+++.+||+.||.+|| ++++
T Consensus 177 ~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 253 (280)
T cd05608 177 S-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT--YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDG 253 (280)
T ss_pred c-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC--CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 5 999999999999999999998654333223333333322222 2235799999999999999999999 7899
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 254 ~l~h~~~~~ 262 (280)
T cd05608 254 LRTHPLFRD 262 (280)
T ss_pred HhcChhhhc
Confidence 999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=234.49 Aligned_cols=153 Identities=34% Similarity=0.569 Sum_probs=123.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||+++.... .......+|++.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (316)
T cd05620 99 TFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176 (316)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcc
Confidence 346679999999999999999999999999988775 99999999874322 222344578999999999988877655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH-hHHhcCc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-PEIRNHE 168 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~e~l~hp 168 (254)
+|||||||++|+|++|..||.+........ .+.......|. .++.++++||++||..||.+||++ +++++||
T Consensus 177 -~DiwslGvil~el~~g~~Pf~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 177 -VDWWSFGVLLYEMLIGQSPFHGDDEDELFE----SIRVDTPHYPR--WITKESKDILEKLFERDPTRRLGVVGNIRGHP 249 (316)
T ss_pred -cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence 999999999999999999998765433222 22223333333 478999999999999999999998 5899999
Q ss_pred cccc
Q 025350 169 WFLK 172 (254)
Q Consensus 169 ~~~~ 172 (254)
||..
T Consensus 250 ~f~~ 253 (316)
T cd05620 250 FFKT 253 (316)
T ss_pred CcCC
Confidence 9976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=236.10 Aligned_cols=162 Identities=23% Similarity=0.328 Sum_probs=123.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|.|||++||+||||||+||+++.++. +||+|||+++.... ......+++.|+|||++.+....+.
T Consensus 120 ~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 195 (343)
T cd07878 120 VQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQ 195 (343)
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCC--CcCCccccccccCchHhcCCccCCc
Confidence 4457889999999999999999999999999988776 99999999976432 2344578999999999877443345
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------------------cCCCCC------CCCCCCHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------------VQYSIP------DYVHISPECR 144 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------------~~~~~~------~~~~~~~~~~ 144 (254)
++|||||||++|+|++|..||.+................ .....+ .....++.+.
T Consensus 196 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (343)
T cd07878 196 TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAI 275 (343)
T ss_pred hhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHH
Confidence 599999999999999999999875543333322211000 000001 0123567789
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
+||.+||..||.+|||+.++++||||.+...
T Consensus 276 ~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 276 DLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 9999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=235.25 Aligned_cols=154 Identities=33% Similarity=0.569 Sum_probs=124.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++..... ........|++.|+|||++.+..++.
T Consensus 97 ~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (323)
T cd05595 97 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCc
Confidence 3456789999999999999999999999999988765 99999999875322 22233457999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e 163 (254)
+ +|||||||++|+|++|+.||.......... .+.......| ..+++.+++||.+||..||.+|+ ++.+
T Consensus 175 ~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 175 A-VDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred h-hchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCCCCC--CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 5 999999999999999999998755433222 2233333333 35799999999999999999998 8999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||.+
T Consensus 248 ~l~h~~~~~ 256 (323)
T cd05595 248 VMEHRFFLS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=227.94 Aligned_cols=160 Identities=28% Similarity=0.477 Sum_probs=132.9
Q ss_pred cccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-----------------------
Q 025350 6 VQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL----------------------- 62 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~----------------------- 62 (254)
...+......+++.||.|||-.|||+|||||+||||..+|. |.|+||.++.....
T Consensus 177 se~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~ 254 (459)
T KOG0610|consen 177 SESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQ 254 (459)
T ss_pred chhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCCCeeeccCCCCCCCCCccccccc
Confidence 34445566788999999999999999999999999988876 99999987632100
Q ss_pred ----------C-C-----------------------CCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 025350 63 ----------H-S-----------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 108 (254)
Q Consensus 63 ----------~-~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 108 (254)
. . ...+.+||-.|+|||++.|.+.... +|+|+|||++|||+.|..
T Consensus 255 ~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA-VDWWtfGIflYEmLyG~T 333 (459)
T KOG0610|consen 255 PSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA-VDWWTFGIFLYEMLYGTT 333 (459)
T ss_pred ccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch-hhHHHHHHHHHHHHhCCC
Confidence 0 0 0123468999999999999888655 999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC----HhHHhcCccccc
Q 025350 109 PFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS----IPEIRNHEWFLK 172 (254)
Q Consensus 109 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~ 172 (254)
||.+.+....+.+ ++.....+|....++..+++||+++|.+||.+|.. |.||.+||||+.
T Consensus 334 PFKG~~~~~Tl~N----Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 334 PFKGSNNKETLRN----IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred CcCCCCchhhHHH----HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 9999877665554 56667778877788999999999999999999997 999999999975
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=234.76 Aligned_cols=153 Identities=34% Similarity=0.529 Sum_probs=124.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||++..... ........|++.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (321)
T cd05591 99 RFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS 176 (321)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCccccccccCccccCHHHHcCCCCCCc
Confidence 446789999999999999999999999999988775 99999999875322 222334568999999999988777665
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-------CHh
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-------SIP 162 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-------s~~ 162 (254)
+|||||||++|+|++|+.||.......... .+.......|. .++.++.++|++||..||.+|+ ++.
T Consensus 177 -~DvwslG~il~el~tg~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~ 249 (321)
T cd05591 177 -VDWWALGVLMYEMMAGQPPFEADNEDDLFE----SILHDDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGED 249 (321)
T ss_pred -cceechhHHHHHHhcCCCCCCCCCHHHHHH----HHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHH
Confidence 999999999999999999998765543333 23333333333 4789999999999999999999 899
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++||||..
T Consensus 250 ~~~~hp~~~~ 259 (321)
T cd05591 250 AIKQHPFFKE 259 (321)
T ss_pred HHhcCCccCC
Confidence 9999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=214.42 Aligned_cols=159 Identities=34% Similarity=0.525 Sum_probs=138.1
Q ss_pred cccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC
Q 025350 4 RAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 4 ~~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~ 83 (254)
++-+......+.|++.|+.|+|.++++||||||+|+|++..+. +||+|||.+.... .+...+.|||.-|.+||...+
T Consensus 120 ~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 120 RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CCCceeeecccccCCHhhcCC
Confidence 3455666778899999999999999999999999999988776 9999999987654 555677899999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++.. +|+|++|++.|+++.|.+||.... ..+.++++.......| ..++.++++||.+||.++|.+|.+..+
T Consensus 197 ~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~----~~etYkrI~k~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~ 269 (281)
T KOG0580|consen 197 RGHDKF-VDLWSLGVLCYEFLVGLPPFESQS----HSETYKRIRKVDLKFP--STISGGAADLISRLLVKNPIERLALTE 269 (281)
T ss_pred CCccch-hhHHHHHHHHHHHHhcCCchhhhh----hHHHHHHHHHccccCC--cccChhHHHHHHHHhccCccccccHHH
Confidence 998877 999999999999999999999855 3344555666666666 468999999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
++.|||+..
T Consensus 270 v~~hpwI~a 278 (281)
T KOG0580|consen 270 VMDHPWIVA 278 (281)
T ss_pred HhhhHHHHh
Confidence 999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=231.39 Aligned_cols=160 Identities=31% Similarity=0.506 Sum_probs=132.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-CC---CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-~~---~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 85 (254)
......|++.|+++||+++||||||||.|||++.. .. +.+||+|||+|+....+....+.+|++.|||||++....
T Consensus 111 ~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~ 190 (429)
T KOG0595|consen 111 ARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQ 190 (429)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhcc
Confidence 34567889999999999999999999999999765 22 569999999999988887888899999999999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC-CCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
|+.+ +|+||+|+++|++++|+.||...+..+.+. .++ ......|. ...++..+.+|+...|..+|..|.+..+-
T Consensus 191 YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-~~~---k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 191 YDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL-YIK---KGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred ccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHh---ccccccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 9888 899999999999999999999866544433 222 22222222 22367778899999999999999999999
Q ss_pred hcCccccccC
Q 025350 165 RNHEWFLKNL 174 (254)
Q Consensus 165 l~hp~~~~~~ 174 (254)
+.|+++..+.
T Consensus 266 ~~~~~l~~~p 275 (429)
T KOG0595|consen 266 FDHPFLAANP 275 (429)
T ss_pred hhhhhcccCc
Confidence 9999986644
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=237.95 Aligned_cols=157 Identities=34% Similarity=0.552 Sum_probs=126.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-------------------------
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------------------------- 64 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~------------------------- 64 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 103 ~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (350)
T cd05573 103 ARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180 (350)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccccccccccccccccccccccccc
Confidence 3456789999999999999999999999999988776 9999999987543322
Q ss_pred -----CCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCC
Q 025350 65 -----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 139 (254)
Q Consensus 65 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (254)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........+.. .......|....+
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~ 257 (350)
T cd05573 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN--WKESLRFPPDPPV 257 (350)
T ss_pred ccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHHHHHHHhc--cCCcccCCCCCCC
Confidence 2234468999999999988877655 9999999999999999999988664433333221 1133444555557
Q ss_pred CHHHHHHHHHhchhCCCCCCC-HhHHhcCccccc
Q 025350 140 SPECRHLISRIFVADPAKRIS-IPEIRNHEWFLK 172 (254)
Q Consensus 140 ~~~~~~li~~~L~~dP~~Rps-~~e~l~hp~~~~ 172 (254)
++.+++||.+||. ||.+|++ +.++++||||+.
T Consensus 258 ~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 258 SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred CHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 9999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=236.30 Aligned_cols=160 Identities=28% Similarity=0.365 Sum_probs=117.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++..+. +||+|||+++............||+.|+|||++.+..++.+
T Consensus 159 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 236 (357)
T PHA03209 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK 236 (357)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccccccccccCCeecCCCCCCch
Confidence 3557789999999999999999999999999987766 99999999875433333345578999999999988887665
Q ss_pred chhHHHHHHHHHHHHhCCCCC-CCCCch---------HHHHHHHHHHhccCCCCC-------------------------
Q 025350 90 IADVWSCGVTLYVMLVGAYPF-EDPEEP---------KNFRKTIHRILSVQYSIP------------------------- 134 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf-~~~~~~---------~~~~~~~~~~~~~~~~~~------------------------- 134 (254)
+|||||||++|+|+++..++ ...... ..+...+.........++
T Consensus 237 -~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (357)
T PHA03209 237 -ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRY 315 (357)
T ss_pred -hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCccccc
Confidence 99999999999999865554 322111 011111111100000000
Q ss_pred ---CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 135 ---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 135 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
....++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 316 ~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 316 PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 01235677888999999999999999999999999975
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=236.63 Aligned_cols=151 Identities=32% Similarity=0.572 Sum_probs=124.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|.|||++||+||||||+|||++.++. +||+|||++..... ......||+.|+|||++.+..++.+
T Consensus 134 ~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~- 208 (340)
T PTZ00426 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDT--RTYTLCGTPEYIAPEILLNVGHGKA- 208 (340)
T ss_pred HHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecCC--CcceecCChhhcCHHHHhCCCCCcc-
Confidence 456789999999999999999999999999987765 99999999975432 2345679999999999987777655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l 165 (254)
+|+|||||++|+|++|..||.+........ .+.......|. .+++.++++|++||+.||.+|+ ++++++
T Consensus 209 ~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQ----KILEGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred ccccchhhHHHHHhcCCCCCCCCCHHHHHH----HHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence 999999999999999999998765433322 23333333333 4789999999999999999996 899999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||.+
T Consensus 283 ~hp~f~~ 289 (340)
T PTZ00426 283 EHPWFGN 289 (340)
T ss_pred cCCCcCC
Confidence 9999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=239.77 Aligned_cols=148 Identities=33% Similarity=0.463 Sum_probs=124.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEec-CCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..+..+++.++.|||++|+|||||||+|||++ +.+ +++|+|||.++..... ..+.+-|..|.|||++....|+..
T Consensus 418 ~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g--~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~a 493 (612)
T KOG0603|consen 418 SQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG--HLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEA 493 (612)
T ss_pred HHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC--cEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcc
Confidence 44778999999999999999999999999995 444 4999999999865433 445678899999999998888766
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+||||++||+|++|+.||...... ..+..++..+... ..+|..+++||++||+.||.+|+++.+++.|||
T Consensus 494 -cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 494 -CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred -hhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 99999999999999999999876654 2333334333332 458999999999999999999999999999999
Q ss_pred c
Q 025350 170 F 170 (254)
Q Consensus 170 ~ 170 (254)
|
T Consensus 566 ~ 566 (612)
T KOG0603|consen 566 F 566 (612)
T ss_pred h
Confidence 9
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=233.10 Aligned_cols=161 Identities=29% Similarity=0.442 Sum_probs=122.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccC----CC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK----KE 85 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~ 85 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......|+..|+|||++.. ..
T Consensus 171 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 248 (353)
T PLN00034 171 ADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248 (353)
T ss_pred HHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccccccccccCccccCccccccccccCc
Confidence 357789999999999999999999999999988765 9999999987543222 2234578999999998743 23
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+.++|||||||++|+|++|+.||..... ..+......... .........++.++++||.+||..||.+|||+.+++
T Consensus 249 ~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell 326 (353)
T PLN00034 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMCAICM-SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLL 326 (353)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHHHHHhc-cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 334469999999999999999999974332 112222222211 111222335789999999999999999999999999
Q ss_pred cCccccccCC
Q 025350 166 NHEWFLKNLP 175 (254)
Q Consensus 166 ~hp~~~~~~~ 175 (254)
+||||.+...
T Consensus 327 ~hp~~~~~~~ 336 (353)
T PLN00034 327 QHPFILRAQP 336 (353)
T ss_pred cCcccccCCc
Confidence 9999987543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=233.61 Aligned_cols=153 Identities=31% Similarity=0.550 Sum_probs=124.3
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
.++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... .......|++.|+|||++.+..++.+
T Consensus 104 ~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~- 180 (323)
T cd05584 104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKA- 180 (323)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCc-
Confidence 45679999999999999999999999999988765 999999998743222 22334569999999999987777655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l 165 (254)
+|||||||++|+|++|..||......... ..+.......| ..+++.+++||++||..+|.+|| ++.+++
T Consensus 181 ~DiwslG~il~ell~G~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~ 254 (323)
T cd05584 181 VDWWSLGALMYDMLTGAPPFTAENRKKTI----DKILKGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254 (323)
T ss_pred ceecccHHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence 99999999999999999999876543332 33333343333 34789999999999999999999 899999
Q ss_pred cCcccccc
Q 025350 166 NHEWFLKN 173 (254)
Q Consensus 166 ~hp~~~~~ 173 (254)
+||||...
T Consensus 255 ~h~~~~~~ 262 (323)
T cd05584 255 SHPFFRHV 262 (323)
T ss_pred cCCCcCCC
Confidence 99999763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=233.82 Aligned_cols=153 Identities=33% Similarity=0.465 Sum_probs=123.7
Q ss_pred cCcCCcHHHHHHHHHHHhhcC-cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhcc--C
Q 025350 8 RGRGTLFLPTTYFWSELLPFN-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLL--K 83 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~g-ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~--~ 83 (254)
..+..+.+++++|+.|||+++ ||||||||+|||++.+. .++||+|||+++..... .......||+.|||||++. .
T Consensus 142 ~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~ 220 (362)
T KOG0192|consen 142 KVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEK 220 (362)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccccccccCCCCCccccChhhhcCCC
Confidence 345677899999999999999 99999999999998876 24999999999865443 3334468999999999999 5
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..|+.+ +||||||+++|||+||+.||.+...... ...+.....+.+.+..+++.+..|+.+||..||.+||++.+
T Consensus 221 ~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~----~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~e 295 (362)
T KOG0192|consen 221 SPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQV----ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLE 295 (362)
T ss_pred CcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHH
Confidence 577766 9999999999999999999998765222 22233333343434458999999999999999999999999
Q ss_pred Hhc
Q 025350 164 IRN 166 (254)
Q Consensus 164 ~l~ 166 (254)
++.
T Consensus 296 i~~ 298 (362)
T KOG0192|consen 296 IVS 298 (362)
T ss_pred HHH
Confidence 874
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=227.23 Aligned_cols=157 Identities=24% Similarity=0.380 Sum_probs=124.3
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcch
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
.++.|++.+++|||++||+||||||+||+++.++. ++|+|||++.............|+..|+|||++.+..++.+ +
T Consensus 99 ~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~ 175 (277)
T cd05607 99 HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-V 175 (277)
T ss_pred HHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCc-h
Confidence 45679999999999999999999999999988765 99999999876544333344568999999999988777655 9
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH----hHHhcC
Q 025350 92 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI----PEIRNH 167 (254)
Q Consensus 92 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~----~e~l~h 167 (254)
|+|||||++|+|++|..||.......................+ ...+++++++|+.+||+.||.+||++ .+++.|
T Consensus 176 DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence 9999999999999999999865443333333333333222222 23579999999999999999999999 678899
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||+.
T Consensus 255 ~~f~~ 259 (277)
T cd05607 255 EFFKT 259 (277)
T ss_pred hhhcC
Confidence 99975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=233.31 Aligned_cols=154 Identities=32% Similarity=0.547 Sum_probs=124.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++..... .......+||+.|+|||++.+..++.
T Consensus 103 ~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 180 (324)
T cd05587 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK 180 (324)
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCc
Confidence 3446789999999999999999999999999988765 99999999864322 22233456999999999998887765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH-----hH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-----PE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e 163 (254)
+ +|+||+||++|+|++|+.||.+........ .+.......| ..+++.+.+++++||..||.+|++. ++
T Consensus 181 ~-~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 253 (324)
T cd05587 181 S-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----SIMEHNVSYP--KSLSKEAVSICKGLLTKHPAKRLGCGPTGERD 253 (324)
T ss_pred c-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH
Confidence 5 999999999999999999998765433332 2333333333 3579999999999999999999976 89
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||..
T Consensus 254 ~~~hp~~~~ 262 (324)
T cd05587 254 IREHAFFRR 262 (324)
T ss_pred HhcCCCcCC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=236.02 Aligned_cols=157 Identities=31% Similarity=0.485 Sum_probs=121.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-------------------------
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------------------------- 64 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~------------------------- 64 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 103 ~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (363)
T cd05628 103 TQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180 (363)
T ss_pred HHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccccccccccccccccccccccccc
Confidence 3457789999999999999999999999999988765 9999999986432110
Q ss_pred -----------CCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC
Q 025350 65 -----------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 133 (254)
Q Consensus 65 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 133 (254)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+........++.. .......
T Consensus 181 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~ 257 (363)
T cd05628 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN--WKETLIF 257 (363)
T ss_pred ccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CcCcccC
Confidence 0123479999999999988877765 9999999999999999999987655443333221 1122334
Q ss_pred CCCCCCCHHHHHHHHHhchhCCC---CCCCHhHHhcCccccc
Q 025350 134 PDYVHISPECRHLISRIFVADPA---KRISIPEIRNHEWFLK 172 (254)
Q Consensus 134 ~~~~~~~~~~~~li~~~L~~dP~---~Rps~~e~l~hp~~~~ 172 (254)
|....+++++++||.+|+. +|. .||+++++++||||+.
T Consensus 258 p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 258 PPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 4444578999999999775 444 4689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=221.29 Aligned_cols=196 Identities=25% Similarity=0.360 Sum_probs=144.8
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....++.|.+.++++||+.||+||||||+||++..++. +||.|||+|+.....-.....+.|..|.|||++.+.++..
T Consensus 119 tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke 196 (369)
T KOG0665|consen 119 TISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKE 196 (369)
T ss_pred HHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccCcccccCchhheeeccCchheeccCCcc
Confidence 34568899999999999999999999999999988876 9999999998765544556678999999999999988776
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC---------------------------CCCCC--C---
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------------------YSIPD--Y--- 136 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~--~--- 136 (254)
. +||||+||++.+|++|+..|.+.....++.+......... ..+|. +
T Consensus 197 ~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~ 275 (369)
T KOG0665|consen 197 N-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVV 275 (369)
T ss_pred c-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccccccc
Confidence 6 9999999999999999999998776666655543221110 00110 0
Q ss_pred ---C-CCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCccccccCCCCCCCCCCCCCCCCHHHHHHHHHH
Q 025350 137 ---V-HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 207 (254)
Q Consensus 137 ---~-~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (254)
. .-+..+++++.+||..||++|.|++++|+|||++=++..+.+........-........+.++++..+.+
T Consensus 276 ~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ 350 (369)
T KOG0665|consen 276 LEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFK 350 (369)
T ss_pred ccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHH
Confidence 0 1134678999999999999999999999999998666555544444331111122223346666655443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=230.03 Aligned_cols=157 Identities=29% Similarity=0.401 Sum_probs=135.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
.....+++-+|.+||..+||+|||||+|||+|+.|. |+|+|+|+|.....+......+||..|||||++.+..|+..
T Consensus 290 ~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s- 366 (591)
T KOG0986|consen 290 RFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFS- 366 (591)
T ss_pred HHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCC-
Confidence 345578999999999999999999999999998876 99999999998888877778899999999999999998776
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l 165 (254)
.|.|||||++|+|+.|+.||..........++-+++......++ ..+|+++++|.+.+|.+||.+|. +++++.
T Consensus 367 ~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk 444 (591)
T KOG0986|consen 367 PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVK 444 (591)
T ss_pred ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcchhh
Confidence 89999999999999999999876654444455555555555555 46899999999999999999998 567999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 445 ~HpfFk~ 451 (591)
T KOG0986|consen 445 EHPFFKD 451 (591)
T ss_pred hCccccc
Confidence 9999986
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=235.22 Aligned_cols=158 Identities=28% Similarity=0.471 Sum_probs=123.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.++.|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 98 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (329)
T cd05588 98 ARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175 (329)
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccCCccccCHHHHcCCCCCC
Confidence 3456789999999999999999999999999988765 99999999874322 22334457999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC---
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS--- 160 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps--- 160 (254)
+ +|+|||||++|+|++|+.||...... .........+.......|. .++..+.++|++||+.||.+|+|
T Consensus 176 ~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~ 252 (329)
T cd05588 176 S-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHP 252 (329)
T ss_pred c-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCC
Confidence 5 99999999999999999999632211 1111122233333444443 47899999999999999999997
Q ss_pred ---HhHHhcCccccc
Q 025350 161 ---IPEIRNHEWFLK 172 (254)
Q Consensus 161 ---~~e~l~hp~~~~ 172 (254)
++++++||||..
T Consensus 253 ~~~~~~i~~hp~~~~ 267 (329)
T cd05588 253 QTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCHHHHhcCCCCCC
Confidence 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=236.48 Aligned_cols=161 Identities=26% Similarity=0.359 Sum_probs=122.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+....+
T Consensus 106 ~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 183 (372)
T cd07853 106 KVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183 (372)
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCC
Confidence 446789999999999999999999999999988765 9999999987543221 223346789999999998755434
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH-------------------HhccCCCCC-------CCCCCCHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------------ILSVQYSIP-------DYVHISPE 142 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------------------~~~~~~~~~-------~~~~~~~~ 142 (254)
.++|||||||++|+|++|+.||.+.........+... +.......+ .....+++
T Consensus 184 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (372)
T cd07853 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHE 263 (372)
T ss_pred cHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHH
Confidence 5599999999999999999999876654433322110 111111111 12245789
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+.+||.+||..||.+|||+.++++||||...
T Consensus 264 ~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 264 AVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=230.51 Aligned_cols=160 Identities=23% Similarity=0.339 Sum_probs=121.8
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCcc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
.++.|++.+|+|||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+....+.+
T Consensus 108 ~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 185 (309)
T cd07872 108 IFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185 (309)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccccccccccccccCCHHHhCCCCCCcH
Confidence 45679999999999999999999999999987765 9999999987533222 22334678999999998765433455
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------CCCCC---------CCCCCCHHHHHH
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIP---------DYVHISPECRHL 146 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~---------~~~~~~~~~~~l 146 (254)
+|||||||++|+|++|+.||.+.+............... ....+ ....+++++++|
T Consensus 186 ~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T cd07872 186 IDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIEL 265 (309)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHH
Confidence 999999999999999999998766544433322211000 00001 113468899999
Q ss_pred HHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
|.+||..||.+|||+.++++||||+..
T Consensus 266 i~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 266 LTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred HHHhccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=238.18 Aligned_cols=156 Identities=28% Similarity=0.400 Sum_probs=127.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhcc-----CC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLL-----KK 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~-----~~ 84 (254)
.-+-.|++.+|.|||+++|||||||..|||++-+|. ++|+|||++..... .....+++|||+|||||++. ..
T Consensus 133 qvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~ 210 (1187)
T KOG0579|consen 133 QVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQ 210 (1187)
T ss_pred HHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhccccCCcccccchheeeccccCC
Confidence 345578999999999999999999999999998887 99999998754322 23345778999999999975 46
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
+|+.+ +||||||++|.+|.-+.+|....+....+.++.+ ...+.+..+.+++..+.+|+++||.+||..||++.++
T Consensus 211 PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql 286 (1187)
T KOG0579|consen 211 PYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQL 286 (1187)
T ss_pred Cchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence 77766 8999999999999999999987655444433322 2334444556789999999999999999999999999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
|+||||++
T Consensus 287 l~Hpfv~~ 294 (1187)
T KOG0579|consen 287 LKHPFVQN 294 (1187)
T ss_pred hhCccccc
Confidence 99999964
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=232.26 Aligned_cols=155 Identities=30% Similarity=0.495 Sum_probs=125.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||+++.... .......+|++.|+|||.+.+..++.
T Consensus 103 ~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 180 (324)
T cd05589 103 AVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180 (324)
T ss_pred HHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCc
Confidence 3456789999999999999999999999999988776 99999999874322 22234457999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e 163 (254)
+ +|||||||++|+|++|+.||.+........ .+.......| ..+++.+.++|.+||..||.+|| ++.+
T Consensus 181 ~-~DiwslG~il~el~~G~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 253 (324)
T cd05589 181 A-VDWWGLGVLIYEMLVGESPFPGDDEEEVFD----SIVNDEVRYP--RFLSREAISIMRRLLRRNPERRLGSGEKDAED 253 (324)
T ss_pred c-cchhhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 5 999999999999999999998765433332 2333333333 34799999999999999999999 6999
Q ss_pred HhcCcccccc
Q 025350 164 IRNHEWFLKN 173 (254)
Q Consensus 164 ~l~hp~~~~~ 173 (254)
+++||||++.
T Consensus 254 l~~~~~f~~~ 263 (324)
T cd05589 254 VKKQPFFRDI 263 (324)
T ss_pred HhhCCCcCCC
Confidence 9999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=233.85 Aligned_cols=157 Identities=28% Similarity=0.474 Sum_probs=122.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+++|||++||+||||||+||+++.++. +||+|||+++.... ........||+.|+|||++.+..++.+
T Consensus 99 ~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (329)
T cd05618 99 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176 (329)
T ss_pred HHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCc
Confidence 456789999999999999999999999999988776 99999999875322 222344579999999999988877655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC----
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEE-----PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---- 160 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---- 160 (254)
+|+|||||++|+|++|..||..... ..........+.......| ..++..+.+||++||+.||.+||+
T Consensus 177 -~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~ll~~~L~~dP~~R~~~~~~ 253 (329)
T cd05618 177 -VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQ 253 (329)
T ss_pred -cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHhcCCHHHcCCCCCC
Confidence 9999999999999999999953211 1111122223333344444 357899999999999999999998
Q ss_pred --HhHHhcCccccc
Q 025350 161 --IPEIRNHEWFLK 172 (254)
Q Consensus 161 --~~e~l~hp~~~~ 172 (254)
+.++++||||+.
T Consensus 254 ~~~~~i~~hp~f~~ 267 (329)
T cd05618 254 TGFADIQGHPFFRN 267 (329)
T ss_pred CCHHHHhcCCCCCC
Confidence 579999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=237.38 Aligned_cols=155 Identities=29% Similarity=0.499 Sum_probs=123.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||++..... .......+||+.|+|||++.+....+.
T Consensus 99 ~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (330)
T cd05586 99 KFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176 (330)
T ss_pred HHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCC
Confidence 446789999999999999999999999999988775 99999999875322 223345579999999999876543345
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC----CHhHHh
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI----SIPEIR 165 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----s~~e~l 165 (254)
++|||||||++|+|++|..||.+...... ...+.......+. ..+++.+++||++||..||.+|| ++.+++
T Consensus 177 ~~DvwslGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll 251 (330)
T cd05586 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YRNIAFGKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELK 251 (330)
T ss_pred ccceeccccEEEEeccCCCCCCCCCHHHH----HHHHHcCCCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHh
Confidence 59999999999999999999987554332 2233333334433 24789999999999999999998 689999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||..
T Consensus 252 ~h~~~~~ 258 (330)
T cd05586 252 EHPFFAD 258 (330)
T ss_pred cCccccC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=233.75 Aligned_cols=155 Identities=34% Similarity=0.493 Sum_probs=124.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||++..... ......|++.|+|||++.+..++.+
T Consensus 104 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~- 178 (333)
T cd05600 104 RFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFT- 178 (333)
T ss_pred HHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCc-
Confidence 446789999999999999999999999999988765 99999999975433 3345679999999999988877655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCC----CCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY----VHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+|||||||++|+|++|..||............... ......|.. ..++.++.+||.+||..+|.+||++.++++
T Consensus 179 ~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 99999999999999999999876554433332211 111112221 256899999999999999999999999999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
||||.+
T Consensus 257 h~~~~~ 262 (333)
T cd05600 257 HPFFKE 262 (333)
T ss_pred CcccCC
Confidence 999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=237.22 Aligned_cols=159 Identities=32% Similarity=0.523 Sum_probs=125.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCC--
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKE-- 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-- 85 (254)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||++....... .....+||+.|+|||++.+..
T Consensus 144 ~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 221 (370)
T cd05596 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD 221 (370)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCC
Confidence 3446689999999999999999999999999988776 9999999987543322 223457999999999986543
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCC--CCCHh
Q 025350 86 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK--RISIP 162 (254)
Q Consensus 86 -~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rps~~ 162 (254)
..+.++|+|||||++|+|++|..||.+......+..+... ......|....+|..+++||++||..+|.+ |+|+.
T Consensus 222 ~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ 299 (370)
T cd05596 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVD 299 (370)
T ss_pred CCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHH
Confidence 2234599999999999999999999886654433332211 122344555568999999999999999988 99999
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++||||+.
T Consensus 300 ell~h~~~~~ 309 (370)
T cd05596 300 EIKSHPFFKN 309 (370)
T ss_pred HHhcCcccCC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-33 Score=235.83 Aligned_cols=153 Identities=36% Similarity=0.573 Sum_probs=123.6
Q ss_pred CCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.|++.+|+|||+ +||+||||||+|||++.++. +||+|||+++.... ........|++.|+|||++.+..++.
T Consensus 98 ~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05594 98 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175 (325)
T ss_pred HHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCC
Confidence 4567899999999997 89999999999999988776 99999999875322 22233456999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e 163 (254)
+ +|||||||++|+|++|..||.+....... ..+.......| ..+++++.+||++||+.||.+|+ ++.+
T Consensus 176 ~-~DiwslG~il~el~tG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 248 (325)
T cd05594 176 A-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFP--RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKE 248 (325)
T ss_pred c-cccccccceeeeeccCCCCCCCCCHHHHH----HHHhcCCCCCC--CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHH
Confidence 5 99999999999999999999875543222 22333333333 35799999999999999999997 8999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||..
T Consensus 249 il~h~~~~~ 257 (325)
T cd05594 249 IMQHKFFAG 257 (325)
T ss_pred HhcCCCcCC
Confidence 999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=232.54 Aligned_cols=154 Identities=32% Similarity=0.516 Sum_probs=125.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 103 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 180 (323)
T cd05616 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCC
Confidence 4557789999999999999999999999999988775 99999999875332 22234457899999999998888765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH-----hH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-----PE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e 163 (254)
+ +|+|||||++|+|++|+.||.+........ .+.......| ..++.++++++.+||..+|.+|+++ .+
T Consensus 181 ~-~DiwSlGvil~elltg~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ 253 (323)
T cd05616 181 S-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----SIMEHNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 253 (323)
T ss_pred c-cchhchhHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHH
Confidence 5 999999999999999999998765433332 2333333333 3579999999999999999999974 89
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 254 i~~h~~~~~ 262 (323)
T cd05616 254 IKEHAFFRY 262 (323)
T ss_pred HhcCCCcCC
Confidence 999999965
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=232.70 Aligned_cols=153 Identities=35% Similarity=0.547 Sum_probs=123.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... ......+|++.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (323)
T cd05575 99 RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176 (323)
T ss_pred HHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCcc
Confidence 346789999999999999999999999999988775 999999998753222 22334568999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH----hHHh
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI----PEIR 165 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~----~e~l 165 (254)
+|||||||++|+|++|..||......... ..+.......+ ..+++.+.++|++||+.||.+||++ .+++
T Consensus 177 -~DvwslG~il~ell~g~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il 249 (323)
T cd05575 177 -VDWWCLGAVLYEMLYGLPPFYSRDTAEMY----DNILNKPLRLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIK 249 (323)
T ss_pred -ccccccchhhhhhhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence 99999999999999999999875543332 22333333332 3479999999999999999999987 5999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||..
T Consensus 250 ~~~~~~~ 256 (323)
T cd05575 250 NHVFFSS 256 (323)
T ss_pred cCCCcCC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=231.40 Aligned_cols=154 Identities=34% Similarity=0.557 Sum_probs=124.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .......+|++.|+|||++.+..++.
T Consensus 98 ~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 175 (318)
T cd05570 98 ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175 (318)
T ss_pred HHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCc
Confidence 3456789999999999999999999999999988776 99999999864322 22233456899999999998888766
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH-----hH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-----PE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e 163 (254)
+ +|+|||||++|+|++|..||.+....... ..+.......| ..++..+++||++||..||.+|||+ .+
T Consensus 176 ~-~DiwslGvil~~l~~G~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ 248 (318)
T cd05570 176 A-VDWWALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYP--RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQD 248 (318)
T ss_pred c-hhhhhHHHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCCCC--CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 5 99999999999999999999875543322 22333333333 3479999999999999999999999 99
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 249 ll~~~~~~~ 257 (318)
T cd05570 249 IKGHPFFRE 257 (318)
T ss_pred HhcCCCcCC
Confidence 999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=231.24 Aligned_cols=153 Identities=35% Similarity=0.612 Sum_probs=123.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||++..... ........||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (316)
T cd05619 99 TFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176 (316)
T ss_pred HHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCch
Confidence 446789999999999999999999999999988765 99999999874322 222334568999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh-HHhcCc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP-EIRNHE 168 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~-e~l~hp 168 (254)
+||||+||++|+|++|..||.+........ .+.......|. .++.++++||.+||..||.+||++. ++++||
T Consensus 177 -~DvwslG~il~el~~G~~pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~ 249 (316)
T cd05619 177 -VDWWSFGVLLYEMLIGQSPFHGHDEEELFQ----SIRMDNPCYPR--WLTREAKDILVKLFVREPERRLGVKGDIRQHP 249 (316)
T ss_pred -hhhhhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhcCCChHHHHcCc
Confidence 999999999999999999998765433222 22222233333 4789999999999999999999996 899999
Q ss_pred cccc
Q 025350 169 WFLK 172 (254)
Q Consensus 169 ~~~~ 172 (254)
||..
T Consensus 250 ~~~~ 253 (316)
T cd05619 250 FFRE 253 (316)
T ss_pred ccCC
Confidence 9976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=231.16 Aligned_cols=153 Identities=37% Similarity=0.589 Sum_probs=123.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (316)
T cd05592 99 RFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176 (316)
T ss_pred HHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCc
Confidence 446789999999999999999999999999988765 999999998753322 22334579999999999988877655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH-hHHhcCc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-PEIRNHE 168 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~e~l~hp 168 (254)
+|||||||++|+|++|..||.+........ .+.......| ..++.++.+||.+||..||.+||++ .++++||
T Consensus 177 -~DvwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~~--~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~ 249 (316)
T cd05592 177 -VDWWSFGVLLYEMLIGQSPFHGEDEDELFD----SILNDRPHFP--RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHP 249 (316)
T ss_pred -ccchhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCc
Confidence 999999999999999999998765433322 2333333333 3478999999999999999999986 5889999
Q ss_pred cccc
Q 025350 169 WFLK 172 (254)
Q Consensus 169 ~~~~ 172 (254)
||..
T Consensus 250 ~~~~ 253 (316)
T cd05592 250 FFRG 253 (316)
T ss_pred ccCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=226.86 Aligned_cols=158 Identities=27% Similarity=0.385 Sum_probs=126.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||+.||+||||||+||+++.++. ++|+|||++.............|++.|+|||++.+..++.+
T Consensus 104 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (285)
T cd05605 104 AVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181 (285)
T ss_pred HHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCcc
Confidence 3456789999999999999999999999999987765 99999999876543333344578999999999987777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~ 164 (254)
+||||+||++|+|++|..||.+.............+....... ...++..+++|+.+||..||.+|| +++++
T Consensus 182 -~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l 258 (285)
T cd05605 182 -PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV 258 (285)
T ss_pred -ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc--CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHH
Confidence 8999999999999999999987654333333333332222222 234789999999999999999999 89999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||..
T Consensus 259 ~~~~~~~~ 266 (285)
T cd05605 259 KAHPFFRT 266 (285)
T ss_pred hcCcCccC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=228.88 Aligned_cols=159 Identities=25% Similarity=0.476 Sum_probs=121.3
Q ss_pred CCcHHHHHHHHHHHhhc-CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPF-NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~-givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.|||++ +|+||||||+|||++.++. +||+|||++..... .......|++.|+|||++.+..++.+
T Consensus 106 ~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~ 182 (331)
T cd06649 106 GKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ 182 (331)
T ss_pred HHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-cccccCCCCcCcCCHhHhcCCCCCch
Confidence 45678899999999986 6999999999999988775 99999999875432 22344578999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH-------------------------------------------HH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------------------------------------------RI 126 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-------------------------------------------~~ 126 (254)
+|||||||++|+|++|+.||....... +...+. .+
T Consensus 183 -~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T cd06649 183 -SDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYI 260 (331)
T ss_pred -HhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHH
Confidence 999999999999999999997544321 111110 00
Q ss_pred hccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 127 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
............+++++++||.+||..||++|||+.++++||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 261 VNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred HhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 000000001123688999999999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=235.78 Aligned_cols=160 Identities=26% Similarity=0.300 Sum_probs=121.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|.|||++||+||||||+|||++.++. +||+|||++........ .....||+.|+|||++.+..+
T Consensus 187 ~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 264 (392)
T PHA03207 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264 (392)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCcccccccccccccccCccCHhHhcCCCC
Confidence 3467789999999999999999999999999988776 99999999875433221 223569999999999988877
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhccC-------------------------CCCCC---
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQ-------------------------YSIPD--- 135 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~-------------------------~~~~~--- 135 (254)
+.+ +|||||||++|+|++|+.||.+.... ..+..++....... +..+.
T Consensus 265 ~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (392)
T PHA03207 265 CAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIR 343 (392)
T ss_pred Cch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhh
Confidence 665 99999999999999999999765421 12222221111000 00110
Q ss_pred CCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 136 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 136 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
...++.++++||++||..||.+|||+.++|+||||++
T Consensus 344 ~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 344 KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0134678899999999999999999999999999976
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=231.33 Aligned_cols=158 Identities=28% Similarity=0.474 Sum_probs=123.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 98 ~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (327)
T cd05617 98 ARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175 (327)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCc
Confidence 3457789999999999999999999999999988776 99999999875322 22334457999999999998887765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS----- 160 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----- 160 (254)
+ +|||||||++|+|++|..||...... .........+.......| ..++..+.++|++||..||.+|++
T Consensus 176 ~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 252 (327)
T cd05617 176 S-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVKASHVLKGFLNKDPKERLGCQPQT 252 (327)
T ss_pred h-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHhccCHHHcCCCCCCC
Confidence 5 99999999999999999999643211 111112222333333333 347899999999999999999998
Q ss_pred -HhHHhcCccccc
Q 025350 161 -IPEIRNHEWFLK 172 (254)
Q Consensus 161 -~~e~l~hp~~~~ 172 (254)
+.++++||||..
T Consensus 253 ~~~~i~~h~~f~~ 265 (327)
T cd05617 253 GFSDIKSHTFFRS 265 (327)
T ss_pred CHHHHHcCCCCCC
Confidence 469999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=230.53 Aligned_cols=160 Identities=25% Similarity=0.311 Sum_probs=114.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC--CCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~--~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 84 (254)
..++.|++.||+|||++||+||||||+|||+... ..+++||+|||+++...... ......+|+.|+|||++.+.
T Consensus 111 ~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07867 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred HHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCC
Confidence 4567899999999999999999999999999432 12359999999997543321 12334689999999998775
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCch---------HHHHHHHHHHh------------------------ccCC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRIL------------------------SVQY 131 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~~~~~~------------------------~~~~ 131 (254)
...+.++|||||||++|+|++|.+||...... ........... ....
T Consensus 191 ~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (317)
T cd07867 191 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTY 270 (317)
T ss_pred CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhccccc
Confidence 54455599999999999999999999753321 01111000000 0000
Q ss_pred CC--------CCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 132 SI--------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 132 ~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
.. ......+..+++||.+||..||.+|||+.|+|+||||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 271 ANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=233.66 Aligned_cols=156 Identities=28% Similarity=0.469 Sum_probs=122.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccC-----
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLK----- 83 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~----- 83 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||++........ .....||+.|+|||++..
T Consensus 105 ~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (330)
T cd05601 105 QFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182 (330)
T ss_pred HHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccc
Confidence 446789999999999999999999999999987765 99999999975433222 223468999999999863
Q ss_pred -CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 84 -KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 84 -~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..++ .++|||||||++|+|++|..||........+..+... ......|....+++.+++||.+||. +|.+|||+.
T Consensus 183 ~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~ 258 (330)
T cd05601 183 KGTYG-VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYE 258 (330)
T ss_pred cCCCC-CcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHH
Confidence 3343 4499999999999999999999876554443332211 1123344445689999999999997 999999999
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++||||..
T Consensus 259 ~l~~h~~~~~ 268 (330)
T cd05601 259 GLCCHPFFSK 268 (330)
T ss_pred HHhCCCCcCC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=234.09 Aligned_cols=157 Identities=36% Similarity=0.601 Sum_probs=123.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-------------------------
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------------------------- 64 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~------------------------- 64 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 103 ~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (364)
T cd05599 103 TRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180 (364)
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccccccccccccccccccccccccc
Confidence 4457789999999999999999999999999988776 9999999986432110
Q ss_pred --------------CCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC
Q 025350 65 --------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 130 (254)
Q Consensus 65 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 130 (254)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.............. ....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~--~~~~ 257 (364)
T cd05599 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN--WKET 257 (364)
T ss_pred ccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCc
Confidence 0112468999999999988877655 9999999999999999999987664433332221 1122
Q ss_pred CCCCCCCCCCHHHHHHHHHhchhCCCCCCC---HhHHhcCccccc
Q 025350 131 YSIPDYVHISPECRHLISRIFVADPAKRIS---IPEIRNHEWFLK 172 (254)
Q Consensus 131 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~ 172 (254)
...|....+++.+++||++||. +|.+|++ +.++++||||+.
T Consensus 258 ~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 258 LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 3344444679999999999996 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=240.54 Aligned_cols=156 Identities=31% Similarity=0.487 Sum_probs=125.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++
T Consensus 146 ~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s 223 (496)
T PTZ00283 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223 (496)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCC
Confidence 446789999999999999999999999999988765 999999998754321 123345799999999999888776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
.+ +|||||||++|+|++|+.||.+....... ........ .+....+++.+.+++.+||..||.+||++.++++|
T Consensus 224 ~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~----~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 224 KK-ADMFSLGVLLYELLTLKRPFDGENMEEVM----HKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 55 99999999999999999999875443322 22222222 22334689999999999999999999999999999
Q ss_pred ccccccC
Q 025350 168 EWFLKNL 174 (254)
Q Consensus 168 p~~~~~~ 174 (254)
||++...
T Consensus 298 p~~~~~~ 304 (496)
T PTZ00283 298 PICKLFI 304 (496)
T ss_pred HHHHHhh
Confidence 9987644
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=225.91 Aligned_cols=158 Identities=28% Similarity=0.407 Sum_probs=123.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.++.|||++||+||||||+||+++.++. ++|+|||++.............|+..|+|||++.+..++.+
T Consensus 104 ~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 181 (285)
T cd05630 104 AVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181 (285)
T ss_pred HHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCc
Confidence 3456789999999999999999999999999987765 99999999875543333344578999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e~ 164 (254)
+|+||+||++|+|++|..||..................... .....+++.+++|+.+||+.||.+||| +.++
T Consensus 182 -~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~ 258 (285)
T cd05630 182 -PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE--EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREV 258 (285)
T ss_pred -cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh--hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHH
Confidence 99999999999999999999865432111111111111111 122357899999999999999999999 8999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||++
T Consensus 259 ~~h~~~~~ 266 (285)
T cd05630 259 KEHPLFKQ 266 (285)
T ss_pred HcChhhhc
Confidence 99999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=234.17 Aligned_cols=159 Identities=31% Similarity=0.498 Sum_probs=123.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCC--
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKE-- 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-- 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+|........ ..+.+||+.|+|||++.+..
T Consensus 144 ~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 221 (370)
T cd05621 144 AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221 (370)
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCceecccCCCCcccCCHHHHhccCCC
Confidence 3456789999999999999999999999999988765 99999999976432221 23557999999999987543
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCC--CCCHh
Q 025350 86 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK--RISIP 162 (254)
Q Consensus 86 -~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rps~~ 162 (254)
+.+.++|+|||||++|+|++|..||.+.........+... ......|....++..+++++.+||..++.+ |+|+.
T Consensus 222 ~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~ 299 (370)
T cd05621 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVE 299 (370)
T ss_pred CCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHH
Confidence 2234599999999999999999999876654443332221 122344554567999999999999865544 88999
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++||||+.
T Consensus 300 e~l~hp~~~~ 309 (370)
T cd05621 300 EIKQHPFFKN 309 (370)
T ss_pred HHhcCcccCC
Confidence 9999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=230.06 Aligned_cols=152 Identities=34% Similarity=0.528 Sum_probs=122.9
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
.++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 100 ~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~- 176 (325)
T cd05602 100 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT- 176 (325)
T ss_pred HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCc-
Confidence 46789999999999999999999999999987765 99999999875322 222344579999999999988777655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh----HHhc
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP----EIRN 166 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~----e~l~ 166 (254)
+|||||||++|+|++|..||.+......... +...... ....++..+.++|.+||..||.+|+++. ++++
T Consensus 177 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 177 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred cccccccHHHHHHhcCCCCCCCCCHHHHHHH----HHhCCcC--CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 9999999999999999999987654433332 2222222 2235799999999999999999999876 8999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
|+||..
T Consensus 251 ~~~~~~ 256 (325)
T cd05602 251 HIFFSP 256 (325)
T ss_pred CcccCC
Confidence 999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=234.96 Aligned_cols=156 Identities=35% Similarity=0.543 Sum_probs=122.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---------------------------
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--------------------------- 63 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--------------------------- 63 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||++......
T Consensus 104 ~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (382)
T cd05625 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181 (382)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCccccccccccccccccccccccccccccccccc
Confidence 345779999999999999999999999999988775 999999997532100
Q ss_pred ---------------------CCCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 025350 64 ---------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 122 (254)
Q Consensus 64 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 122 (254)
....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 260 (382)
T cd05625 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260 (382)
T ss_pred cccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 00123468999999999988888765 99999999999999999999876544333322
Q ss_pred HHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC---HhHHhcCccccc
Q 025350 123 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---IPEIRNHEWFLK 172 (254)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~ 172 (254)
.. .......|....+++++.++|.+|+ .+|.+|++ +.++++||||+.
T Consensus 261 ~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 261 IN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred Hc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 21 1223344555568999999999986 59999997 999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=235.67 Aligned_cols=160 Identities=22% Similarity=0.282 Sum_probs=118.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|.|||++|||||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+..+
T Consensus 262 ~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 339 (461)
T PHA03211 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY 339 (461)
T ss_pred HHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCC
Confidence 4567899999999999999999999999999987765 99999999875432211 223469999999999988877
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHHHHHHhccC--------------------------CC-
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQ--------------------------YS- 132 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~--------------------------~~- 132 (254)
+.+ +|||||||++|+|++|..|+..... .....+.+....... ..
T Consensus 340 ~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 418 (461)
T PHA03211 340 TPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTR 418 (461)
T ss_pred Cch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCC
Confidence 665 9999999999999998765533211 112222222111000 00
Q ss_pred --CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 133 --IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 133 --~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
+.....++..+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 419 ~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 419 PAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111235678999999999999999999999999999965
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=232.98 Aligned_cols=158 Identities=34% Similarity=0.529 Sum_probs=121.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC--------------------------
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------------------------- 63 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-------------------------- 63 (254)
...++.|++.+|.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 103 ~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (381)
T cd05626 103 ARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180 (381)
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccccccccccccccccCcccccccc
Confidence 3456789999999999999999999999999987765 999999987532100
Q ss_pred ----------------------CCCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q 025350 64 ----------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 121 (254)
Q Consensus 64 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 121 (254)
....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~~~~~ 259 (381)
T cd05626 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVILFEMLVGQPPFLAPTPTETQLK 259 (381)
T ss_pred cccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHHHHHHhCCCCCcCCCHHHHHHH
Confidence 00123469999999999988777655 9999999999999999999987654333322
Q ss_pred HHHHHhccCCCCCCCCCCCHHHHHHHHHhch--hCCCCCCCHhHHhcCccccc
Q 025350 122 TIHRILSVQYSIPDYVHISPECRHLISRIFV--ADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dP~~Rps~~e~l~hp~~~~ 172 (254)
... .......|....+++++++||.+|+. .+|..|+++.++++||||..
T Consensus 260 i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 260 VIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 221 12233445555689999999999654 45556999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=230.59 Aligned_cols=153 Identities=29% Similarity=0.466 Sum_probs=123.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .......+|++.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (325)
T cd05604 99 RFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176 (325)
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCc
Confidence 446789999999999999999999999999988776 99999999875322 222344569999999999988877665
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH----hHHh
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI----PEIR 165 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~----~e~l 165 (254)
+|||||||++|+|++|..||........... +.......+ ...+..+.++|++||..+|.+||++ .+++
T Consensus 177 -~DvwslG~il~el~~G~~pf~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 177 -VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN----ILHKPLVLR--PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred -CccccccceehhhhcCCCCCCCCCHHHHHHH----HHcCCccCC--CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 9999999999999999999987654433332 333222222 3478999999999999999999976 5899
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||..
T Consensus 250 ~h~~f~~ 256 (325)
T cd05604 250 EHPFFES 256 (325)
T ss_pred cCCCcCC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=238.91 Aligned_cols=160 Identities=22% Similarity=0.265 Sum_probs=118.8
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCCCc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
.++.|++.+|+|||++|||||||||+|||++.++. +||+|||+++...... ......|+..|+|||++.+..++.+
T Consensus 271 ~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 348 (501)
T PHA03210 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK--IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI 348 (501)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH
Confidence 47789999999999999999999999999987765 9999999997654322 1234579999999999988887665
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHHHHhccCCCCC--------------------------CCCCCC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPE---EPKNFRKTIHRILSVQYSIP--------------------------DYVHIS 140 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~ 140 (254)
+|||||||++|+|++|..++.... ....+.+.+..+......+| ....++
T Consensus 349 -~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 427 (501)
T PHA03210 349 -TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLP 427 (501)
T ss_pred -HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCC
Confidence 999999999999999876543222 11222222211100000000 011356
Q ss_pred HHHHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 141 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 141 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
..+.++|.+||..||.+|||+.|+|.||||....
T Consensus 428 ~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 428 ADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred hHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 7788899999999999999999999999997643
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=221.07 Aligned_cols=159 Identities=22% Similarity=0.321 Sum_probs=118.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.++.|||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+....+
T Consensus 101 ~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 178 (284)
T cd07839 101 VKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 178 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccC
Confidence 3567789999999999999999999999999988765 9999999987543322 223346788999999987755434
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhc-------------cCCCC----------CCCCCCCHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILS-------------VQYSI----------PDYVHISPECR 144 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~-------------~~~~~----------~~~~~~~~~~~ 144 (254)
.++|||||||++|+|++|..||...... ..+......... ..... .....+++.++
T Consensus 179 ~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (284)
T cd07839 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGR 258 (284)
T ss_pred cHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHH
Confidence 5599999999999999998886543332 222222111000 00000 01124688999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+||.+||..||.+|||+.++++||||
T Consensus 259 ~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 259 DLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=228.02 Aligned_cols=155 Identities=32% Similarity=0.531 Sum_probs=124.8
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.|++.|++|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++
T Consensus 102 ~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05615 102 QAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccccCccCCccccCHHHHcCCCCC
Confidence 34557789999999999999999999999999988775 9999999987532222 23345689999999999887776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----Hh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IP 162 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~ 162 (254)
.+ +|+|||||++|+|++|..||.+........ .+.......| ..++..+++++.+||..+|.+|++ ..
T Consensus 180 ~~-~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 252 (323)
T cd05615 180 KS-VDWWAYGVLLYEMLAGQPPFDGEDEDELFQ----SIMEHNVSYP--KSLSKEAVSICKGLMTKHPSKRLGCGPEGER 252 (323)
T ss_pred Cc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--ccCCHHHHHHHHHHcccCHhhCCCCCCCCHH
Confidence 55 999999999999999999998765433332 2333333333 347899999999999999999997 47
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++||||..
T Consensus 253 ~i~~h~~f~~ 262 (323)
T cd05615 253 DIREHAFFRR 262 (323)
T ss_pred HHhcCcccCC
Confidence 8999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=233.42 Aligned_cols=160 Identities=33% Similarity=0.513 Sum_probs=122.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCC--
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKE-- 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-- 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... .....+||+.|+|||++.+..
T Consensus 144 ~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 221 (371)
T cd05622 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221 (371)
T ss_pred HHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCC
Confidence 3456789999999999999999999999999988765 9999999997543322 223457999999999987543
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCC--CCCHh
Q 025350 86 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK--RISIP 162 (254)
Q Consensus 86 -~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rps~~ 162 (254)
..+.++|||||||++|+|++|..||...+.......+... ......|....++..+++||.+||..++.+ |+++.
T Consensus 222 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ 299 (371)
T cd05622 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVE 299 (371)
T ss_pred ccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHH
Confidence 2234599999999999999999999876554333332211 122344555578999999999999844433 78999
Q ss_pred HHhcCcccccc
Q 025350 163 EIRNHEWFLKN 173 (254)
Q Consensus 163 e~l~hp~~~~~ 173 (254)
++++||||++.
T Consensus 300 ei~~h~~~~~~ 310 (371)
T cd05622 300 EIKRHLFFKND 310 (371)
T ss_pred HHhcCcccCCC
Confidence 99999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-33 Score=236.53 Aligned_cols=149 Identities=30% Similarity=0.388 Sum_probs=132.0
Q ss_pred cHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcchh
Q 025350 13 LFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 92 (254)
Q Consensus 13 ~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 92 (254)
+..+++.++.|||.+.|||||||.-||||+.+.. |||+|||-++.....+....++||..|||||+++..+.+.+ +|
T Consensus 217 Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEK-VD 293 (904)
T KOG4721|consen 217 WSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEK-VD 293 (904)
T ss_pred HHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccc-cc
Confidence 3456899999999999999999999999988776 99999999988777777788899999999999999998877 99
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 93 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 93 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
||||||+||||+||..||..-.. ..++..+....+.+|.+..++..++-||+.||+..|.+||+++++|.|-
T Consensus 294 IwSfGVVLWEmLT~EiPYkdVds----sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 294 IWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred eehhHHHHHHHHhcCCCccccch----heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 99999999999999999986433 3445556666778888888999999999999999999999999999984
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=223.28 Aligned_cols=160 Identities=23% Similarity=0.341 Sum_probs=121.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++++||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+....+.
T Consensus 107 ~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 184 (301)
T cd07873 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184 (301)
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCcc
Confidence 346689999999999999999999999999988765 9999999987543222 2233457889999999876554445
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cCCCCCC---------CCCCCHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIPD---------YVHISPECRH 145 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~---------~~~~~~~~~~ 145 (254)
++|||||||++|+|++|++||...+.............. .....+. ...+++.+++
T Consensus 185 ~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (301)
T cd07873 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAE 264 (301)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHH
Confidence 599999999999999999999876543333222111000 0001111 1246889999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
||.+||..||.+|||+.++++||||+.
T Consensus 265 li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 265 LLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred HHHHHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=226.03 Aligned_cols=163 Identities=27% Similarity=0.395 Sum_probs=125.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+++|||++||+||||||+||+++.++. +||+|||+++............++..|+|||.+.+..++.+
T Consensus 121 ~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~- 197 (353)
T cd07850 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN- 197 (353)
T ss_pred HHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCc-
Confidence 346789999999999999999999999999988775 99999999986544433344568899999999988877655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc------------------cCCC--------------CCC---
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------------VQYS--------------IPD--- 135 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~~--------------~~~--- 135 (254)
+|||||||++|+|++|+.||...+.............. .... .+.
T Consensus 198 ~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
T cd07850 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSE 277 (353)
T ss_pred hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccc
Confidence 99999999999999999999876543333322211000 0000 000
Q ss_pred --CCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 136 --YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 136 --~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
....++.+++||.+||..||.+|||+.++|.||||+.++..
T Consensus 278 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 278 SHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred cccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 11245678999999999999999999999999999876653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=230.45 Aligned_cols=154 Identities=34% Similarity=0.586 Sum_probs=124.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++...... .......|++.|+|||++.+..++.
T Consensus 100 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 177 (318)
T cd05582 100 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177 (318)
T ss_pred HHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCC
Confidence 3456789999999999999999999999999988776 999999998754333 2233457899999999998777765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e 163 (254)
+ +|||||||++|+|++|+.||......... ..+.......| ..+++.+++||++||+.||.+||+ +.+
T Consensus 178 ~-~DiwslG~il~el~tg~~p~~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~ 250 (318)
T cd05582 178 S-ADWWSFGVLMFEMLTGSLPFQGKDRKETM----TMILKAKLGMP--QFLSPEAQSLLRALFKRNPANRLGAGPDGVEE 250 (318)
T ss_pred c-cceeccceEeeeeccCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 5 99999999999999999999876543332 22333333333 347899999999999999999999 677
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||..
T Consensus 251 ~~~~~~~~~ 259 (318)
T cd05582 251 IKRHPFFST 259 (318)
T ss_pred HhCCCCcCC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=221.00 Aligned_cols=158 Identities=25% Similarity=0.308 Sum_probs=119.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||++........ .....+++.|+|||++.+....+.
T Consensus 104 ~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (285)
T cd07861 104 KSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181 (285)
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCc
Confidence 346889999999999999999999999999988776 99999999875432221 223457889999999876543344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-----------------------CCCCCCCCCCCHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-----------------------QYSIPDYVHISPECRHL 146 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l 146 (254)
++|+|||||++|+|++|++||.+................. .........++++++++
T Consensus 182 ~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (285)
T cd07861 182 PVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDL 261 (285)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHH
Confidence 5999999999999999999998765433322221111000 00000123478999999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccc
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
|++||..||.+|||+.+++.||||
T Consensus 262 i~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 262 LEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHhcCChhhCCCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=232.93 Aligned_cols=155 Identities=32% Similarity=0.538 Sum_probs=120.6
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---------------------------
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------------------------- 64 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--------------------------- 64 (254)
.++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 105 ~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (377)
T cd05629 105 FYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182 (377)
T ss_pred HHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccccccccccccccccccccccccccc
Confidence 46789999999999999999999999999987765 9999999985321100
Q ss_pred ---------------------CCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 025350 65 ---------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 123 (254)
Q Consensus 65 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 123 (254)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAIMFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred cccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 0012468999999999988777655 999999999999999999998765543333222
Q ss_pred HHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCC---CCHhHHhcCccccc
Q 025350 124 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKR---ISIPEIRNHEWFLK 172 (254)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---ps~~e~l~hp~~~~ 172 (254)
. .......|....++.++++||.+||. +|.+| +|+.++++||||+.
T Consensus 262 ~--~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 262 N--WRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred c--cCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 1 11233445555689999999999997 77765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=227.41 Aligned_cols=153 Identities=32% Similarity=0.476 Sum_probs=122.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||+++.... .......+|++.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (321)
T cd05603 99 RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176 (321)
T ss_pred HHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCc
Confidence 346789999999999999999999999999988775 99999999875322 222334568999999999988777665
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH----hHHh
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI----PEIR 165 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~----~e~l 165 (254)
+|||||||++|+|++|..||...+.... ...+.......+ ...+..+.++|.+||..||.+|+++ .+++
T Consensus 177 -~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~ 249 (321)
T cd05603 177 -VDWWCLGAVLYEMLYGLPPFYSRDVSQM----YDNILHKPLQLP--GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIK 249 (321)
T ss_pred -CcccccchhhhhhhcCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHh
Confidence 9999999999999999999987653322 223333333333 3468899999999999999999975 4999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+|+||..
T Consensus 250 ~~~~~~~ 256 (321)
T cd05603 250 NHVFFSP 256 (321)
T ss_pred CCCCcCC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=220.97 Aligned_cols=160 Identities=27% Similarity=0.393 Sum_probs=127.7
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....++.|++.++.|||++||+||||||+||+++.++. +||+|||++.............|+..|+|||++.+..++.
T Consensus 103 ~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~ 180 (285)
T cd05632 103 RALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCc
Confidence 34557789999999999999999999999999987765 9999999987544333334457899999999998777766
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e 163 (254)
+ +|+|||||++|+|++|..||...............+....... ...++..+.+|+.+||..||.+||+ +.+
T Consensus 181 ~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05632 181 S-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGE 257 (285)
T ss_pred c-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc--CccCCHHHHHHHHHHccCCHhHcCCCcccChHH
Confidence 5 8999999999999999999987654433333333333322222 2357899999999999999999999 889
Q ss_pred HhcCcccccc
Q 025350 164 IRNHEWFLKN 173 (254)
Q Consensus 164 ~l~hp~~~~~ 173 (254)
++.|+||+..
T Consensus 258 l~~~~~~~~~ 267 (285)
T cd05632 258 VKRHPFFRNM 267 (285)
T ss_pred HHcChhhhcC
Confidence 9999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=236.19 Aligned_cols=155 Identities=32% Similarity=0.507 Sum_probs=124.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|.|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+..+
T Consensus 171 ~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 248 (478)
T PTZ00267 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248 (478)
T ss_pred HHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCC
Confidence 3457789999999999999999999999999988765 9999999998643322 1334569999999999988777
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|||||||++|+|++|+.||.+......... +...... +....++..++++|.+||..||++||++.+++.
T Consensus 249 ~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~----~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 249 SKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQ----VLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCC-CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 655 9999999999999999999987554333222 2222221 223457899999999999999999999999999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
|+|++.
T Consensus 323 ~~~~~~ 328 (478)
T PTZ00267 323 TEFLKY 328 (478)
T ss_pred CHHHHH
Confidence 999964
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=231.98 Aligned_cols=156 Identities=34% Similarity=0.554 Sum_probs=122.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--------------------------
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------------------- 64 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-------------------------- 64 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 104 ~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (360)
T cd05627 104 QFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181 (360)
T ss_pred HHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccccccccccCCcccccccccccccc
Confidence 446789999999999999999999999999987765 9999999986432110
Q ss_pred ----------CCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC
Q 025350 65 ----------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 134 (254)
Q Consensus 65 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 134 (254)
.....+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.........+.. .......|
T Consensus 182 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~--~~~~~~~p 258 (360)
T cd05627 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN--WKETLVFP 258 (360)
T ss_pred cccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCCCCCHHHHHHHHHc--CCCceecC
Confidence 0123469999999999988888765 9999999999999999999987665443333221 11223344
Q ss_pred CCCCCCHHHHHHHHHhchhCCCCCC---CHhHHhcCccccc
Q 025350 135 DYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK 172 (254)
Q Consensus 135 ~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~ 172 (254)
....+++.+++||.+|+ .||.+|+ ++.++++||||..
T Consensus 259 ~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 259 PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 44457899999999987 5999998 4899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=225.97 Aligned_cols=157 Identities=30% Similarity=0.523 Sum_probs=137.9
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....+...+..|+.|||++|||+|||||+|++++.+|. +||.|||+|+....+....++||||.|.|||++...+.+.
T Consensus 521 tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~ 598 (732)
T KOG0614|consen 521 TARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDR 598 (732)
T ss_pred hhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCceeeecCCcccccchhhhccCcch
Confidence 34566677999999999999999999999999998887 9999999999988888889999999999999999998876
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e 163 (254)
. +|.||||+++|||++|.+||.+.+....+..+++.+-.. .+| ..++....+||+++...+|.+|.. +.+
T Consensus 599 a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--~~P--r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~D 673 (732)
T KOG0614|consen 599 A-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--EFP--RRITKTATDLIKKLCRDNPTERLGYQKGGIND 673 (732)
T ss_pred h-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--hcc--cccchhHHHHHHHHHhcCcHhhhccccCChHH
Confidence 6 999999999999999999999988877777666554332 233 458899999999999999999985 899
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
|.+|.||..
T Consensus 674 IkkH~Wf~g 682 (732)
T KOG0614|consen 674 IKKHRWFEG 682 (732)
T ss_pred HHhhhhhhc
Confidence 999999954
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=223.55 Aligned_cols=159 Identities=27% Similarity=0.439 Sum_probs=121.9
Q ss_pred CcCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC---
Q 025350 9 GRGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK--- 84 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~--- 84 (254)
....++.+++.+++|||+ .||+||||||+||+++.++. +||+|||++.............++..|+|||.+.+.
T Consensus 108 ~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 185 (288)
T cd06616 108 ILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARD 185 (288)
T ss_pred HHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhccCCccccccCccCccCHHHhcccccc
Confidence 345677889999999997 59999999999999987765 999999998755443333445688899999998766
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-CCC--CCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSI--PDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
.++. ++|||||||++|+|++|+.||..... ............ ... .....++..+.+||.+||..+|.+|||+
T Consensus 186 ~~~~-~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 261 (288)
T cd06616 186 GYDV-RSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKY 261 (288)
T ss_pred CCcc-hhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCH
Confidence 3444 49999999999999999999976542 111122221111 111 1123478999999999999999999999
Q ss_pred hHHhcCcccccc
Q 025350 162 PEIRNHEWFLKN 173 (254)
Q Consensus 162 ~e~l~hp~~~~~ 173 (254)
.+++.||||++.
T Consensus 262 ~~i~~~~~~~~~ 273 (288)
T cd06616 262 KELLEHPFIKDY 273 (288)
T ss_pred HHHhcChhhhch
Confidence 999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=232.63 Aligned_cols=155 Identities=34% Similarity=0.526 Sum_probs=121.3
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC----------------------------
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---------------------------- 63 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---------------------------- 63 (254)
.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|......
T Consensus 105 ~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (376)
T cd05598 105 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182 (376)
T ss_pred HHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccccccccccccccccccccccccccc
Confidence 45679999999999999999999999999987765 999999997422100
Q ss_pred ----------------CCCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh
Q 025350 64 ----------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 127 (254)
Q Consensus 64 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 127 (254)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+............ .
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--~ 259 (376)
T cd05598 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFLADTPAETQLKVIN--W 259 (376)
T ss_pred ccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeehhhCCCCCCCCCHHHHHHHHhc--c
Confidence 00113469999999999988877655 9999999999999999999987664433322211 1
Q ss_pred ccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC---CHhHHhcCccccc
Q 025350 128 SVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK 172 (254)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~ 172 (254)
......+....+++.+.++|.+|+ .+|.+|+ |+.++++||||+.
T Consensus 260 ~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 260 ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 223334444568999999999976 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-33 Score=236.30 Aligned_cols=166 Identities=36% Similarity=0.583 Sum_probs=142.5
Q ss_pred ccccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-CCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhc
Q 025350 3 CRAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 81 (254)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~ 81 (254)
.|+-++.-..++.|++.||+|||-+||||+||||+|||+.+. ..+++||||||+|+.....+...+.+|||.|+|||++
T Consensus 659 gRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVL 738 (888)
T KOG4236|consen 659 GRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVL 738 (888)
T ss_pred ccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHH
Confidence 456677778899999999999999999999999999999643 4468999999999998888888889999999999999
Q ss_pred cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 82 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
+.++|... .|+||.|+++|.-++|..||....+... .++ .....+....|..+++++.+||..+|+..-.+|.|+
T Consensus 739 rnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdInd---QIQ-NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysv 813 (888)
T KOG4236|consen 739 RNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDIND---QIQ-NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSV 813 (888)
T ss_pred hhcccccc-ccceeeeEEEEEEecccccCCCccchhH---Hhh-ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcch
Confidence 99999766 8999999999999999999987654322 121 223445556788899999999999999999999999
Q ss_pred hHHhcCcccccc
Q 025350 162 PEIRNHEWFLKN 173 (254)
Q Consensus 162 ~e~l~hp~~~~~ 173 (254)
+..|.|||+++.
T Consensus 814 dk~lsh~Wlq~y 825 (888)
T KOG4236|consen 814 DKSLSHPWLQDY 825 (888)
T ss_pred Hhhccchhhhcc
Confidence 999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=223.40 Aligned_cols=164 Identities=26% Similarity=0.384 Sum_probs=121.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.+|++||++||+||||||+||+++.++. +||+|||++........ .....+++.|+|||.+.+...
T Consensus 109 ~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (336)
T cd07849 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG 186 (336)
T ss_pred HHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCC
Confidence 446789999999999999999999999999988766 99999999875432211 123468899999998765443
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH-------------------hc---cCCCCC---CCCCCCH
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------------LS---VQYSIP---DYVHISP 141 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------------------~~---~~~~~~---~~~~~~~ 141 (254)
.+.++||||+||++|+|++|+.||.+.............. .. .....+ ....+++
T Consensus 187 ~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (336)
T cd07849 187 YTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADP 266 (336)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCc
Confidence 3455999999999999999999997654322221111000 00 000000 0124578
Q ss_pred HHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 142 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
.+.++|.+||+.+|.+|||+.++++||||+.....
T Consensus 267 ~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 267 KALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 89999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=216.31 Aligned_cols=153 Identities=32% Similarity=0.406 Sum_probs=121.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC----CCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.++++||+.||+||||+|+||+++.++. ++|+|||+++........ ....++..|+|||.+.+..+
T Consensus 107 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (263)
T cd06625 107 RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184 (263)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceeccccccccccccCCCcCccccCcceeccCCC
Confidence 446688999999999999999999999999987765 999999998754322111 23457889999999988776
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +||||||+++|++++|+.||........... .............++..+.++|++||..+|.+|||+.++++
T Consensus 185 ~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 185 GRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred Cch-hhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 555 9999999999999999999987544333222 22222222233457899999999999999999999999999
Q ss_pred Cccc
Q 025350 167 HEWF 170 (254)
Q Consensus 167 hp~~ 170 (254)
||||
T Consensus 260 ~~~~ 263 (263)
T cd06625 260 HFFV 263 (263)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=219.29 Aligned_cols=158 Identities=25% Similarity=0.399 Sum_probs=120.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++|++||||+|+||+++. + .+||+|||++.............++..|+|||.+.+....+.
T Consensus 102 ~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 178 (282)
T cd07831 102 VKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D--ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP 178 (282)
T ss_pred HHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C--CeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCc
Confidence 4557789999999999999999999999999987 4 499999999976544433344568899999998765544455
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc--------------cCCCCCC---------CCCCCHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------VQYSIPD---------YVHISPECRHL 146 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~---------~~~~~~~~~~l 146 (254)
++|+|||||++|+|++|..||.+.+.............. .....+. ...++..++++
T Consensus 179 ~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (282)
T cd07831 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDL 258 (282)
T ss_pred chhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHH
Confidence 599999999999999999999876544333222211000 0011111 12468999999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccc
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
|.+||..+|.+|||+.++++||||
T Consensus 259 i~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 259 LKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHhccCcccccCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=222.04 Aligned_cols=159 Identities=30% Similarity=0.522 Sum_probs=142.0
Q ss_pred ccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC
Q 025350 5 AVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 5 ~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
+.++....+|.|+..++.|.|.++++|||||.+|||++.+++ +||+|||++..........++||+|.|.+||++.|.
T Consensus 150 LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~ 227 (668)
T KOG0611|consen 150 LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGT 227 (668)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHHHhcCCcccCCccccCCC
Confidence 455566778999999999999999999999999999999987 999999999887777778899999999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
+|.++.+|.||||++||.|+.|..||.+. ....++.++..+.+.-|. -+..+.-||+.||..||.+|.|+.+|
T Consensus 228 PY~GPEVDsWsLGvLLYtLVyGtMPFDG~----Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVNP~RRATieDi 300 (668)
T KOG0611|consen 228 PYKGPEVDSWSLGVLLYTLVYGTMPFDGR----DHKRLVRQISRGAYREPE---TPSDASGLIRWMLMVNPERRATIEDI 300 (668)
T ss_pred CCCCCccchhhHHHHHHHHhhcccccCCc----hHHHHHHHhhcccccCCC---CCchHHHHHHHHHhcCcccchhHHHH
Confidence 99999999999999999999999999984 445566667777777665 37788999999999999999999999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
-.|=|.+=
T Consensus 301 AsHWWvNw 308 (668)
T KOG0611|consen 301 ASHWWVNW 308 (668)
T ss_pred hhhheeec
Confidence 99988753
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=218.73 Aligned_cols=153 Identities=27% Similarity=0.355 Sum_probs=118.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccC-----C
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLK-----K 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~ 84 (254)
..+..|++.+++|||++||+||||||+||+++.++. +||+|||++...... .......|+..|+|||++.+ .
T Consensus 114 ~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 191 (272)
T cd06637 114 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 191 (272)
T ss_pred HHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecccccccCCcccccccccCHhHhccccCcCC
Confidence 447789999999999999999999999999988775 999999998754322 22334568899999999863 2
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.++.+ +|+||+||++|+|++|..||........... .............++..+++|+.+||..+|.+|||+.++
T Consensus 192 ~~~~~-~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 192 TYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred CCCch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 34444 9999999999999999999976543222221 111122222233578999999999999999999999999
Q ss_pred hcCccc
Q 025350 165 RNHEWF 170 (254)
Q Consensus 165 l~hp~~ 170 (254)
+.||||
T Consensus 267 l~~~~~ 272 (272)
T cd06637 267 MKHPFI 272 (272)
T ss_pred hhCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=229.64 Aligned_cols=160 Identities=29% Similarity=0.370 Sum_probs=136.3
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCC
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 85 (254)
+......|.|++.++.|||+++|+|||||+.|||++.++. |||+|||+|+...... ...+.+||+.|++||++.+.+
T Consensus 105 E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~p 182 (426)
T KOG0589|consen 105 EERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIP 182 (426)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCC
Confidence 3445668899999999999999999999999999998876 8999999999876655 556778999999999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
|..+ +|||||||++|||++-+++|.+.+-.....+ +.... ..|.+..++.+++.+|+.||..+|..||++.++|
T Consensus 183 Yn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k----i~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL 256 (426)
T KOG0589|consen 183 YNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILK----INRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELL 256 (426)
T ss_pred CCcc-CcchhhcchHHHHHhcccccCccchHHHHHH----Hhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHh
Confidence 9877 9999999999999999999998654443333 33333 3344556899999999999999999999999999
Q ss_pred cCccccccC
Q 025350 166 NHEWFLKNL 174 (254)
Q Consensus 166 ~hp~~~~~~ 174 (254)
.+|.....+
T Consensus 257 ~~P~l~~~~ 265 (426)
T KOG0589|consen 257 RRPHLLRYL 265 (426)
T ss_pred hChhhhhHH
Confidence 999987654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=222.90 Aligned_cols=160 Identities=25% Similarity=0.442 Sum_probs=119.2
Q ss_pred CCcHHHHHHHHHHHhhc-CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPF-NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~-givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++.|||++ +|+||||||+|||++.++. +||+|||++..... .......++..|+|||++.+..++.+
T Consensus 106 ~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (333)
T cd06650 106 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ 182 (333)
T ss_pred HHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hccccCCCCccccCHHHhcCCCCCcH
Confidence 35667899999999975 7999999999999987765 99999999875422 22234568999999999987777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHH----------------------------------------HHHHHHhcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFR----------------------------------------KTIHRILSV 129 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----------------------------------------~~~~~~~~~ 129 (254)
+|+|||||++|+|++|+.||.......... .....+...
T Consensus 183 -~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (333)
T cd06650 183 -SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE 261 (333)
T ss_pred -HHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcC
Confidence 999999999999999999997543211110 000001010
Q ss_pred CCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 130 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 130 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
.........++.++++||.+||.+||++|||+.+++.||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 262 PPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000001113578899999999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=215.07 Aligned_cols=153 Identities=37% Similarity=0.582 Sum_probs=128.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccC-CCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...-.++..||.|||+++||+||||.+|+|++.+|. +||+|||+|+.. ..+....+.||||.|+|||++....|..
T Consensus 271 RFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgr- 347 (516)
T KOG0690|consen 271 RFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGR- 347 (516)
T ss_pred hhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccceeccccCChhhcCchhhccccccc-
Confidence 334467899999999999999999999999998886 999999999853 3344567889999999999999888865
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~ 164 (254)
++|+|.+||++|+|++|+.||...+....+.- ++-....+|. .++++++.|+..+|.+||.+|. .+.||
T Consensus 348 aVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL----Il~ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi 421 (516)
T KOG0690|consen 348 AVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL----ILMEDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEI 421 (516)
T ss_pred eeehhhhhHHHHHHHhccCcccccchhHHHHH----HHhhhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHH
Confidence 49999999999999999999998655443332 3444555554 5899999999999999999998 58899
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
.+|+||..
T Consensus 422 ~~h~FF~~ 429 (516)
T KOG0690|consen 422 MRHRFFAS 429 (516)
T ss_pred Hhhhhhcc
Confidence 99999964
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=217.34 Aligned_cols=158 Identities=35% Similarity=0.544 Sum_probs=120.3
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccC-CCCCCCCCCcCCCCcccchhcc-CCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLL-KKEY 86 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~~~~~y~aPE~~~-~~~~ 86 (254)
....++.|++.+|.+||++||+|+||||+||+++.++. ++|+|||.+... ..........++..|+|||++. +...
T Consensus 99 ~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 176 (260)
T PF00069_consen 99 EILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKY 176 (260)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSB
T ss_pred cccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc
Confidence 34667889999999999999999999999999997665 999999998752 2233344567899999999998 4555
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--CCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
+ .++|+||||+++|+|++|..||........... ......... ........+..+.++|.+||..||++|||+.++
T Consensus 177 ~-~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 177 T-RKSDIWSLGIILYELLTGKLPFEESNSDDQLEI-IEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp S-THHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH-HHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred c-ccccccccccccccccccccccccccchhhhhh-hhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 4 459999999999999999999997632222222 211111111 111111124899999999999999999999999
Q ss_pred hcCccc
Q 025350 165 RNHEWF 170 (254)
Q Consensus 165 l~hp~~ 170 (254)
++||||
T Consensus 255 ~~~~~~ 260 (260)
T PF00069_consen 255 LKHPWF 260 (260)
T ss_dssp HTSGGG
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=216.90 Aligned_cols=158 Identities=25% Similarity=0.456 Sum_probs=122.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.++.|||++||+|+||||+||+++.++. +||+|||++...... ......++..|+|||.+.+..++.+
T Consensus 98 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~- 173 (279)
T cd06619 98 GRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIH- 173 (279)
T ss_pred HHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCc-
Confidence 457789999999999999999999999999988776 999999998754322 2344578999999999987777655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|+|||||++|+|++|..||........ .....................++++++++.+||..+|.+||+++++++|
T Consensus 174 ~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 9999999999999999999975322111 1111111111111111223468899999999999999999999999999
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||..
T Consensus 254 ~~~~~ 258 (279)
T cd06619 254 PFIVQ 258 (279)
T ss_pred ccccc
Confidence 99965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=220.45 Aligned_cols=161 Identities=26% Similarity=0.342 Sum_probs=122.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++|++||||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+....+
T Consensus 110 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 187 (309)
T cd07845 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187 (309)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCccCCCCcccccccccChhhhcCCCCcC
Confidence 3557889999999999999999999999999987765 9999999987654322 122234678899999987654444
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------CCCCCC---------CCCCCHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIPD---------YVHISPECR 144 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~---------~~~~~~~~~ 144 (254)
.++|+|||||++|+|++|++||...+............... ....+. ...+++.+.
T Consensus 188 ~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T cd07845 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGL 267 (309)
T ss_pred chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHH
Confidence 55999999999999999999998776555444433211100 000000 122578899
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
+||.+||..||++|||+.++++||||++
T Consensus 268 ~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 268 RLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=219.55 Aligned_cols=193 Identities=24% Similarity=0.321 Sum_probs=134.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~ 84 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||+++...... ......|+..|+|||.+.+.
T Consensus 107 ~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 184 (332)
T cd07857 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF 184 (332)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceecccccccccccccCcccCccccCcHHHhCC
Confidence 3457789999999999999999999999999988765 9999999997543221 12234688999999987664
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh----------------------ccC--CCC-CCCCCC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------------------SVQ--YSI-PDYVHI 139 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------------~~~--~~~-~~~~~~ 139 (254)
.....++|+||+||++|++++|.+||............+.... ... ..+ .....+
T Consensus 185 ~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (332)
T cd07857 185 QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNA 264 (332)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCC
Confidence 3334459999999999999999999987553332222111100 000 000 011235
Q ss_pred CHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCccccccCCCCCCCCCCCCCCCCHHHHHHHHH
Q 025350 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 206 (254)
Q Consensus 140 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (254)
+..+++|+.+||+.||.+|||+.+++.||||.++-.+... ..-...+..+.....++++++..+.
T Consensus 265 ~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (332)
T cd07857 265 NPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDE--PVCQKPFDFSFESEDSMEELRDMII 329 (332)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccc--ccccccccCCccccccHHHHHHHHh
Confidence 7899999999999999999999999999999866432211 1123334444444556666665543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=215.15 Aligned_cols=156 Identities=26% Similarity=0.430 Sum_probs=122.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.++.+||+.|++||||||+||+++.++ ..++|+|||++..... .....++..|+|||++.+..++.+
T Consensus 111 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 186 (267)
T PHA03390 111 VKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIGT---PSCYDGTLDYFSPEKIKGHNYDVS 186 (267)
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecCC---CccCCCCCcccChhhhcCCCCCch
Confidence 456788999999999999999999999999998776 1499999999875432 233468899999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-HhHHhcCc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-IPEIRNHE 168 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-~~e~l~hp 168 (254)
+|+||+|+++|+|++|..||................. ....+....+++.+++||.+||+.+|.+||+ ++++|+||
T Consensus 187 -~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~ 263 (267)
T PHA03390 187 -FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP 263 (267)
T ss_pred -hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence 9999999999999999999985543221111121111 1222333458999999999999999999996 69999999
Q ss_pred cccc
Q 025350 169 WFLK 172 (254)
Q Consensus 169 ~~~~ 172 (254)
||++
T Consensus 264 ~~~~ 267 (267)
T PHA03390 264 FLKI 267 (267)
T ss_pred cccC
Confidence 9963
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=215.85 Aligned_cols=155 Identities=32% Similarity=0.413 Sum_probs=121.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC-----CCCcCCCCcccchhccCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~ 85 (254)
..++.|++.++++||++|++||||+|+||+++.++. ++|+|||++......... ....++..|+|||.+....
T Consensus 105 ~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 182 (267)
T cd06610 105 ATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182 (267)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccccccccccccCChhhcChHHHcccc
Confidence 456789999999999999999999999999988765 999999998754433222 2346888999999987663
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC---CCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD---YVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..+.++|+|||||++|+|++|..||..........+.... .....+. ...+++.+++++.+||..||.+|||+.
T Consensus 183 ~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06610 183 GYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAE 259 (267)
T ss_pred CcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHH
Confidence 3344599999999999999999999876554433333222 1111111 235789999999999999999999999
Q ss_pred HHhcCccc
Q 025350 163 EIRNHEWF 170 (254)
Q Consensus 163 e~l~hp~~ 170 (254)
++++||||
T Consensus 260 ~ll~~p~~ 267 (267)
T cd06610 260 ELLKHKFF 267 (267)
T ss_pred HHhhCCCC
Confidence 99999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=216.73 Aligned_cols=160 Identities=27% Similarity=0.317 Sum_probs=121.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC-CCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|.|||++||+||||||+||+++. ++ .+||+|||++....... ......+++.|+|||.+.+....
T Consensus 112 ~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 189 (295)
T cd07837 112 IKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHY 189 (295)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC--eEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCC
Confidence 3456789999999999999999999999999987 44 49999999987543221 12233578899999988664433
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-C------------CC---------CCCCCCHHHHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S------------IP---------DYVHISPECRH 145 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------------~~---------~~~~~~~~~~~ 145 (254)
..++|+||||+++|+|++|..||.+.+................. . .+ ....++..+.+
T Consensus 190 ~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (295)
T cd07837 190 STPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD 269 (295)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHH
Confidence 45599999999999999999999876655544433322110000 0 00 01247889999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCcccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWFL 171 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~~ 171 (254)
||.+||..||.+||++.+++.||||+
T Consensus 270 ~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 270 LLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHHccCChhhcCCHHHHhcCCCcC
Confidence 99999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=216.32 Aligned_cols=156 Identities=29% Similarity=0.411 Sum_probs=119.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC-CCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 88 (254)
...++.|++.+++|||++||+||||||+||+++.++. ++|+|||++...... ......|+..|+|||.+.+ ..++.
T Consensus 99 ~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 175 (279)
T cd05633 99 MRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDS 175 (279)
T ss_pred HHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCCCcCccCHHHhcCCCCCCc
Confidence 3456789999999999999999999999999987765 999999998654322 2234468999999999864 33444
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e 163 (254)
++|+||+||++|+|++|..||........ ............. ....++.+++++|++||..||.+|| |+.+
T Consensus 176 -~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 251 (279)
T cd05633 176 -SADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVE--LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQE 251 (279)
T ss_pred -hhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcC--CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 49999999999999999999976432211 1111111112222 2235789999999999999999999 6999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 252 ~~~h~~~~~ 260 (279)
T cd05633 252 VKEHVFFKG 260 (279)
T ss_pred HHhCccccC
Confidence 999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=215.10 Aligned_cols=159 Identities=25% Similarity=0.393 Sum_probs=121.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++|++||||||+||+++.++. +||+|||++....... ......++..|+|||.+.+....+
T Consensus 102 ~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 179 (286)
T cd07847 102 IKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179 (286)
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCcccccCcccccccCCHHHHhCCCCcC
Confidence 4567889999999999999999999999999987765 9999999987654332 222345788999999987644334
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------CCCCCC----------CCCCCHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIPD----------YVHISPEC 143 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~----------~~~~~~~~ 143 (254)
.++|+||||+++|+|++|..||.+................. ....+. ...++..+
T Consensus 180 ~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd07847 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPA 259 (286)
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHH
Confidence 45999999999999999999998766544333222111000 000010 12467889
Q ss_pred HHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 144 RHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
.+|+.+||..+|.+|||+.+++.||||
T Consensus 260 ~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 260 LSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=234.76 Aligned_cols=160 Identities=29% Similarity=0.399 Sum_probs=129.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCC-CCCCCCCCcCCCCcccchhccCCC-CC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLKKE-YD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~ 87 (254)
.+....|++.+|.|||++.|||||||-+|+||+.- .+.+||+|||-+++.. ......++.||..|||||++..++ ..
T Consensus 677 m~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy-SGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGY 755 (1226)
T KOG4279|consen 677 MNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGY 755 (1226)
T ss_pred HHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec-cceEEecccccchhhccCCccccccccchhhhChHhhccCCcCC
Confidence 34556899999999999999999999999999753 2469999999998654 344566778999999999997543 34
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
++++|||||||++.||.||++||.....+.. .+.++.-.....|.+..++.+++.||.+|+..+|..||++.++|.+
T Consensus 756 G~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 756 GKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CchhhhhhccceeEeeccCCCCeeecCChhH---hhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 6779999999999999999999987765432 2223333333445555689999999999999999999999999999
Q ss_pred cccccc
Q 025350 168 EWFLKN 173 (254)
Q Consensus 168 p~~~~~ 173 (254)
||++.+
T Consensus 833 pFlq~~ 838 (1226)
T KOG4279|consen 833 PFLQHN 838 (1226)
T ss_pred cccccC
Confidence 999765
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=213.89 Aligned_cols=158 Identities=26% Similarity=0.355 Sum_probs=121.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhcc-----C
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLL-----K 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~-----~ 83 (254)
...++.|++.++.|||+.|++||||||+||+++.++. +||+|||++....... ......++..|+|||++. +
T Consensus 105 ~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (282)
T cd06643 105 IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182 (282)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEccccccccccccccccccccccccccCHhhccccCCCC
Confidence 3457789999999999999999999999999987765 9999999986543221 223446889999999984 2
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++ .++|+||+||++|+|++|.+||.............. ......+....++..+++||.+||..+|.+||++.+
T Consensus 183 ~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 183 RPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 3343 349999999999999999999987554333222211 111122233457899999999999999999999999
Q ss_pred HhcCcccccc
Q 025350 164 IRNHEWFLKN 173 (254)
Q Consensus 164 ~l~hp~~~~~ 173 (254)
+++||||+..
T Consensus 259 il~~~~~~~~ 268 (282)
T cd06643 259 LLQHPFVTVN 268 (282)
T ss_pred HhcCCCEecc
Confidence 9999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=210.60 Aligned_cols=152 Identities=26% Similarity=0.421 Sum_probs=121.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++++||++||+||||||+||+++.++. ++|+|||++....... ......+++.|+|||++.+..++.+
T Consensus 105 ~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (257)
T cd08223 105 VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182 (257)
T ss_pred HHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCccccccCCcCccChhHhcCCCCCch
Confidence 457788999999999999999999999999987765 9999999987543222 2234468899999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+||||++++++++|+.||........... ...... .+....+++.+.+++.+||+.+|.+|||+.++++|||
T Consensus 183 -~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 183 -SDVWALGCCVYEMATLKHAFNAKDMNSLVYR----IIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred -hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 8999999999999999999986543322222 222221 1222357899999999999999999999999999999
Q ss_pred c
Q 025350 170 F 170 (254)
Q Consensus 170 ~ 170 (254)
|
T Consensus 257 ~ 257 (257)
T cd08223 257 I 257 (257)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=220.34 Aligned_cols=148 Identities=24% Similarity=0.409 Sum_probs=115.0
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..++.
T Consensus 178 ~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 255 (338)
T cd05102 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255 (338)
T ss_pred HHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCc
Confidence 36789999999999999999999999999987765 99999999975422211 12234567899999998877766
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++|+|++ |..||.+............ . .........+++.+++++.+||..||.+|||+.++++
T Consensus 256 ~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 256 Q-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK---D-GTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred c-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh---c-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 5 999999999999997 9999987554333222221 1 1122223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=216.13 Aligned_cols=153 Identities=26% Similarity=0.336 Sum_probs=118.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccC-----C
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLK-----K 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~ 84 (254)
..++.|++.+++|||++||+||||||+||+++.++. ++|+|||++...... .......+++.|+|||.+.. .
T Consensus 124 ~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~ 201 (282)
T cd06636 124 AYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 201 (282)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCc
Confidence 456679999999999999999999999999987765 999999998754321 22334568999999999863 3
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.++.+ +|+|||||++|+|++|..||........... .............++..+.+||.+||..||.+|||+.++
T Consensus 202 ~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el 276 (282)
T cd06636 202 TYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276 (282)
T ss_pred CCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 34444 9999999999999999999976543322221 111111112223578999999999999999999999999
Q ss_pred hcCccc
Q 025350 165 RNHEWF 170 (254)
Q Consensus 165 l~hp~~ 170 (254)
++||||
T Consensus 277 l~~~~~ 282 (282)
T cd06636 277 LKHPFI 282 (282)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=218.56 Aligned_cols=155 Identities=34% Similarity=0.525 Sum_probs=123.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-------------------------
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ------------------------- 65 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~------------------------- 65 (254)
..++.|++.+|+|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 106 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (316)
T cd05574 106 RFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183 (316)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhcccccccccccccccccccccccccchhhhcc
Confidence 346689999999999999999999999999988765 99999998864322110
Q ss_pred -----CCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCC
Q 025350 66 -----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 140 (254)
Q Consensus 66 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (254)
.....|+..|+|||++.+..++.+ +||||||+++|+|++|..||.+......+.. +.......+....++
T Consensus 184 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~ 258 (316)
T cd05574 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSN----ILKKEVTFPGSPPVS 258 (316)
T ss_pred cccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCchHHHHHH----HhcCCccCCCccccC
Confidence 112357889999999987777554 9999999999999999999987665444333 223333444444478
Q ss_pred HHHHHHHHHhchhCCCCCCC----HhHHhcCccccc
Q 025350 141 PECRHLISRIFVADPAKRIS----IPEIRNHEWFLK 172 (254)
Q Consensus 141 ~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~ 172 (254)
..++++|.+||..+|.+||| +.++++||||+.
T Consensus 259 ~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 259 SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 99999999999999999999 999999999976
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=218.96 Aligned_cols=162 Identities=28% Similarity=0.364 Sum_probs=123.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCC-C
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKK-E 85 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~ 85 (254)
..++.+++.++++||++||+||||||.|||++.++. ++|+|||++....... ......++..|+|||.+.+. .
T Consensus 106 ~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 183 (330)
T cd07834 106 QYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR 183 (330)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccccccccccccccccCcCCceeeecccC
Confidence 447789999999999999999999999999988765 9999999998654432 12344678899999999877 4
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC--------------------C--CC---CCCCCCC
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------------Y--SI---PDYVHIS 140 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------~--~~---~~~~~~~ 140 (254)
++ .++|+||||+++|+|++|.+||.+.................. . .. .....++
T Consensus 184 ~~-~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T cd07834 184 YT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGAS 262 (330)
T ss_pred CC-cchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCC
Confidence 44 449999999999999999999987665443333222110000 0 00 0012367
Q ss_pred HHHHHHHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 141 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 141 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
..+.++|.+||+.+|.+|||+.++++||||.+...
T Consensus 263 ~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 263 PEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 89999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=212.62 Aligned_cols=157 Identities=31% Similarity=0.510 Sum_probs=124.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+++|||++|++|+||+|+||+++.++. ++|+|||++.............+++.|+|||.+.+..++.+
T Consensus 96 ~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~- 172 (262)
T cd05572 96 RFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS- 172 (262)
T ss_pred HHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCCh-
Confidence 346678999999999999999999999999988765 99999999986544433344568899999999877777655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e~l 165 (254)
+|+||+|+++|++++|..||...... .......+.......+.....++.++++|.+||..+|.+||+ +.+++
T Consensus 173 ~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~ 250 (262)
T cd05572 173 VDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIK 250 (262)
T ss_pred hhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHh
Confidence 89999999999999999999876521 112222233222222223345899999999999999999999 99999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||++
T Consensus 251 ~~~~~~~ 257 (262)
T cd05572 251 KHKWFNG 257 (262)
T ss_pred cChhhhC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=214.34 Aligned_cols=158 Identities=27% Similarity=0.358 Sum_probs=120.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.+++|||++|++||||+|+||+++.++. +||+|||++....... ......+++.|+|||.+.+....+.
T Consensus 103 ~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 180 (284)
T cd07860 103 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180 (284)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCccccccccccccccCCeEEecCCCCCc
Confidence 446678999999999999999999999999988776 9999999987543221 1223356889999999876554445
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC--------------CCCC---------CCCCCCHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------YSIP---------DYVHISPECRHL 146 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~~~---------~~~~~~~~~~~l 146 (254)
++|+|||||++|+|+||+.||.+........+......... ...+ ....+++.++++
T Consensus 181 ~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (284)
T cd07860 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDL 260 (284)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHH
Confidence 59999999999999999999987665444333222111000 0000 012467899999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccc
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
|.+||..||.+|||++++++||||
T Consensus 261 i~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 261 LSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhcCCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=215.68 Aligned_cols=160 Identities=25% Similarity=0.346 Sum_probs=122.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+++|||++|++|+||||+||+++.++. ++|+|||++........ .....++..|+|||.+.+....
T Consensus 101 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 178 (286)
T cd07832 101 VKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178 (286)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCccccccCcccccCceeeeccccC
Confidence 3456789999999999999999999999999988765 99999999876543321 2344688999999998765544
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC---------------CCCC---------CCCCCCHHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSIP---------DYVHISPEC 143 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~---------~~~~~~~~~ 143 (254)
+.++||||+||++|+|++|.+||.+.................. ...+ .....+..+
T Consensus 179 ~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (286)
T cd07832 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEA 258 (286)
T ss_pred CchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHH
Confidence 5569999999999999999888877665444433332211100 0000 112457899
Q ss_pred HHHHHHhchhCCCCCCCHhHHhcCcccc
Q 025350 144 RHLISRIFVADPAKRISIPEIRNHEWFL 171 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l~hp~~~ 171 (254)
.+||.+||..+|.+|||++++++||||.
T Consensus 259 ~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 259 LDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 9999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=218.08 Aligned_cols=159 Identities=28% Similarity=0.412 Sum_probs=122.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC------------------CCcEEEecCCCcccCCCCCCCCCCcCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP------------------APRLKICDFGYSKSSVLHSQPKSTVGT 72 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 72 (254)
..+-.|++.++++||+.+++|.||||+|||+.++. ...|+|+|||.|... .....+.+.|
T Consensus 195 r~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsT 272 (415)
T KOG0671|consen 195 RHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVST 272 (415)
T ss_pred HHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCccee--ccCcceeeec
Confidence 34557999999999999999999999999984321 124899999999753 3334667899
Q ss_pred CCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC------------------CCCC
Q 025350 73 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------------YSIP 134 (254)
Q Consensus 73 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------------~~~~ 134 (254)
..|+|||++.+-+++.+ +||||+||||+|+.+|...|...++.+.+ ..+.+++.+. ..++
T Consensus 273 RHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~ 350 (415)
T KOG0671|consen 273 RHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWP 350 (415)
T ss_pred cccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCc
Confidence 99999999999999887 99999999999999999999987755543 2233222211 1111
Q ss_pred CCC-----------------------CCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 135 DYV-----------------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 135 ~~~-----------------------~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
... .--.++.+||++||.+||.+|+|+.|+|.||||+..
T Consensus 351 e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 351 EVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred cccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 100 001357899999999999999999999999999763
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=211.36 Aligned_cols=152 Identities=31% Similarity=0.393 Sum_probs=120.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-------CCCCCcCCCCcccchhccC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------QPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-------~~~~~~~~~~y~aPE~~~~ 83 (254)
..++.|++.++++||++|++||||+|+||+++.++. +||+|||.++...... ......++..|+|||.+.+
T Consensus 109 ~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 186 (267)
T cd06628 109 RNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186 (267)
T ss_pred HHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCcccccccccCCccccccccCCCcCccChhHhcc
Confidence 356789999999999999999999999999987765 9999999987553211 1122357889999999987
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++.+ +|+|||||++|+|++|..||........... .... ........++..++++|++||+.+|.+||++.+
T Consensus 187 ~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 187 TSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----IGEN-ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred CCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----Hhcc-CCCcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence 777655 8999999999999999999987544332222 1111 111222357899999999999999999999999
Q ss_pred HhcCccc
Q 025350 164 IRNHEWF 170 (254)
Q Consensus 164 ~l~hp~~ 170 (254)
+++||||
T Consensus 261 il~~~~~ 267 (267)
T cd06628 261 LLKHPFL 267 (267)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=214.63 Aligned_cols=159 Identities=26% Similarity=0.383 Sum_probs=124.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
+..++.+++.++.+||++|++||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..++.
T Consensus 117 ~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (296)
T cd06655 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194 (296)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCc
Confidence 3456788999999999999999999999999987765 99999999875433221 23346888999999998777765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|+|||||++|++++|..||............. ............+++.++++|++||..+|.+|||+.+++.||
T Consensus 195 ~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 195 K-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 5 999999999999999999998765433322211 111222233446789999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||+...
T Consensus 271 ~~~~~~ 276 (296)
T cd06655 271 FLKLAK 276 (296)
T ss_pred Hhhhcc
Confidence 997533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=210.30 Aligned_cols=154 Identities=28% Similarity=0.415 Sum_probs=120.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++.|||+.|++||||+|+||+++.++. +||+|||++....... ......++..|+|||.+.+..++.+
T Consensus 102 ~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 179 (256)
T cd06612 102 AAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179 (256)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCccccccccCCccccCHHHHhcCCCCch
Confidence 457788999999999999999999999999988765 9999999987654332 2233457889999999987777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+||||||+++|+|++|+.||............. ............++..+.++|.+||..+|.+|||+.+++.|||
T Consensus 180 -~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 180 -ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 999999999999999999998654332221110 0111112222346789999999999999999999999999999
Q ss_pred c
Q 025350 170 F 170 (254)
Q Consensus 170 ~ 170 (254)
|
T Consensus 256 ~ 256 (256)
T cd06612 256 I 256 (256)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=214.34 Aligned_cols=157 Identities=32% Similarity=0.428 Sum_probs=123.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.++.|||++|++||||+|+||+++.++. +||+|||.+.............++..|+|||.+.+..++.+
T Consensus 98 ~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~- 174 (277)
T cd05577 98 IFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS- 174 (277)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCch-
Confidence 445679999999999999999999999999988765 99999999876543333344567889999999887776555
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l 165 (254)
+|+|||||++|+|++|+.||..................... .....+++.++++|++||..+|.+|| ++.+++
T Consensus 175 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV--EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc--cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 99999999999999999999775542222222222222222 22234789999999999999999999 888899
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||.+
T Consensus 253 ~h~~~~~ 259 (277)
T cd05577 253 EHPLFKD 259 (277)
T ss_pred hChhhhc
Confidence 9999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=218.73 Aligned_cols=165 Identities=24% Similarity=0.332 Sum_probs=122.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-----CCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 84 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+.
T Consensus 109 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (334)
T cd07855 109 IRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL 186 (334)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCcCCCcccccccccccccChHHhcCC
Confidence 3456789999999999999999999999999988776 99999999875432221 1234688899999998664
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH-------------------h---ccCCCCC---CCCCC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------------L---SVQYSIP---DYVHI 139 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------------------~---~~~~~~~---~~~~~ 139 (254)
.....++|+|||||++|+|++|+.||.+.............. . ......+ .....
T Consensus 187 ~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (334)
T cd07855 187 PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKA 266 (334)
T ss_pred cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccC
Confidence 333455999999999999999999998755433222111100 0 0000000 01346
Q ss_pred CHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 140 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
++.++++|++||+.+|.+|||+.+++.||||.+.-.+
T Consensus 267 ~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 267 SPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 8999999999999999999999999999999765433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=215.19 Aligned_cols=157 Identities=25% Similarity=0.388 Sum_probs=123.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.|||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+..++.+
T Consensus 119 ~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 196 (296)
T cd06654 119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196 (296)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccccccCcccCCccccCHHHHcCCCCCcc
Confidence 456778999999999999999999999999987765 9999999887543222 1233468899999999987766555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+|||||++|+|++|+.||............ ........+....++..+.+++.+||..+|.+|||+.++++|||
T Consensus 197 -~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 197 -VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred -chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 99999999999999999999876543322211 11222222333457899999999999999999999999999999
Q ss_pred cccc
Q 025350 170 FLKN 173 (254)
Q Consensus 170 ~~~~ 173 (254)
|...
T Consensus 273 ~~~~ 276 (296)
T cd06654 273 LKIA 276 (296)
T ss_pred hhcc
Confidence 9753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=226.53 Aligned_cols=161 Identities=26% Similarity=0.371 Sum_probs=131.8
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc---CC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KK 84 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~---~~ 84 (254)
+..+.|..+++.||+|||+.+.||||||..|||++..+. |||+|||.|... ...++++|||+|||||++. .+
T Consensus 126 vEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~---~PAnsFvGTPywMAPEVILAMDEG 200 (948)
T KOG0577|consen 126 VEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIM---APANSFVGTPYWMAPEVILAMDEG 200 (948)
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhc---CchhcccCCccccchhHheecccc
Confidence 344567788999999999999999999999999988876 999999988753 3457889999999999986 56
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.|+++ +||||||++..++.-.++|+...+....+..+. ....+.++ ...+|..++.|+..||.+-|..|||.+++
T Consensus 201 qYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIA---QNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~l 275 (948)
T KOG0577|consen 201 QYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEEL 275 (948)
T ss_pred ccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHH---hcCCCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHH
Confidence 78888 999999999999999999998765444333322 22222222 34579999999999999999999999999
Q ss_pred hcCccccccCCccc
Q 025350 165 RNHEWFLKNLPADL 178 (254)
Q Consensus 165 l~hp~~~~~~~~~~ 178 (254)
|.|+|..+.-|...
T Consensus 276 l~H~fv~R~Rp~tv 289 (948)
T KOG0577|consen 276 LKHRFVLRERPPTV 289 (948)
T ss_pred hhcchhccCCCchH
Confidence 99999987666554
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=212.62 Aligned_cols=158 Identities=28% Similarity=0.359 Sum_probs=124.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.++.+||++|++||||+|+||+++.++. ++|+|||+++..... .......+++.|+|||.+.+..++.
T Consensus 100 ~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 177 (274)
T cd06609 100 IAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177 (274)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeecccccccccccCCccccChhhhccCCCCc
Confidence 4567889999999999999999999999999988776 999999999765433 2233456888999999998877665
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|+||||+++|+|++|..||.......... .+............++..+.+++.+||..+|.+|||++++++||
T Consensus 178 ~-sDv~slG~il~~l~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 178 K-ADIWSLGITAIELAKGEPPLSDLHPMRVLF----LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred h-hhHHHHHHHHHHHHhCCCCcccCchHHHHH----HhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 5 999999999999999999997654322221 11111111111112788999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||++..
T Consensus 253 ~~~~~~ 258 (274)
T cd06609 253 FIKKAK 258 (274)
T ss_pred hhcCCC
Confidence 997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=221.47 Aligned_cols=159 Identities=28% Similarity=0.507 Sum_probs=118.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccC----
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLK---- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~---- 83 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||++......... ....||+.|+|||++..
T Consensus 104 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 181 (331)
T cd05597 104 ARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181 (331)
T ss_pred HHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCccccceeccccccCHHHHhhcccc
Confidence 3457789999999999999999999999999987765 999999998754332221 22468999999999863
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC-CCCCCCHHHHHHHHHhchhCCCC--CCC
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHISPECRHLISRIFVADPAK--RIS 160 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~--Rps 160 (254)
....+.++|||||||++|+|++|+.||............... ......+ ....++..+++||++||..++++ |++
T Consensus 182 ~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~ 259 (331)
T cd05597 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNG 259 (331)
T ss_pred ccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCC
Confidence 222234599999999999999999999876544333332211 1111222 22347999999999999764444 789
Q ss_pred HhHHhcCccccc
Q 025350 161 IPEIRNHEWFLK 172 (254)
Q Consensus 161 ~~e~l~hp~~~~ 172 (254)
+.++++||||..
T Consensus 260 ~~~~l~hp~~~~ 271 (331)
T cd05597 260 LQDFKDHPFFEG 271 (331)
T ss_pred HHHHhcCCCCCC
Confidence 999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=213.82 Aligned_cols=159 Identities=29% Similarity=0.370 Sum_probs=121.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++|++||||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+....+
T Consensus 108 ~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 185 (293)
T cd07843 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYS 185 (293)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCccccccccccccccCchhhcCCcccc
Confidence 3457789999999999999999999999999988765 9999999987654432 223345788999999987655434
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-----------------CCC-------CCCCCC--CCHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-----------------QYS-------IPDYVH--ISPE 142 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----------------~~~-------~~~~~~--~~~~ 142 (254)
.++|+||||+++|+|++|.+||..........+........ ... ...... +++.
T Consensus 186 ~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (293)
T cd07843 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDN 265 (293)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChH
Confidence 55999999999999999999998766544443332211100 000 000111 4888
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
++++|++||+.+|++|||+.|++.||||
T Consensus 266 ~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 266 GFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 9999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=213.20 Aligned_cols=158 Identities=28% Similarity=0.526 Sum_probs=122.1
Q ss_pred CCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++.+||+ .|++|+||||+||+++.++. ++|+|||.+........ ....++..|+|||.+.+..++.+
T Consensus 103 ~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~ 179 (265)
T cd06605 103 GKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSVK 179 (265)
T ss_pred HHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCCCch
Confidence 4577899999999999 99999999999999988765 99999999865432222 22668889999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHHhccCC-CCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|+||||+++|++++|..||..... ................ ..+. ..++.+++++|.+||..+|.+|||+.+++.|
T Consensus 180 -~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 180 -SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 9999999999999999999976421 1122222232222221 1111 1278899999999999999999999999999
Q ss_pred cccccc
Q 025350 168 EWFLKN 173 (254)
Q Consensus 168 p~~~~~ 173 (254)
|||++.
T Consensus 258 ~~~~~~ 263 (265)
T cd06605 258 PFIKKY 263 (265)
T ss_pred chhhcc
Confidence 999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=221.86 Aligned_cols=158 Identities=25% Similarity=0.491 Sum_probs=118.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccC----
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLK---- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~---- 83 (254)
...++.|++.++.|||++||+||||||+|||++.++. +||+|||++........ ....+||+.|+|||++.+
T Consensus 104 ~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 181 (332)
T cd05623 104 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181 (332)
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcceecccccCccccCHHHHhccccC
Confidence 3456779999999999999999999999999987765 99999999875432222 223469999999999863
Q ss_pred -CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC-CCCCCHHHHHHHHHhchhCCCC--CC
Q 025350 84 -KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLISRIFVADPAK--RI 159 (254)
Q Consensus 84 -~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~--Rp 159 (254)
..++ .++|||||||++|+|++|+.||............... ......|. ...+++.+++||++||..++.+ |+
T Consensus 182 ~~~~~-~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~ 258 (332)
T cd05623 182 KGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQN 258 (332)
T ss_pred CCCCC-CcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC--CccccCCCccccCCHHHHHHHHHHccChhhhcCCC
Confidence 2344 4499999999999999999999876544443332211 11112222 2357999999999999765544 68
Q ss_pred CHhHHhcCccccc
Q 025350 160 SIPEIRNHEWFLK 172 (254)
Q Consensus 160 s~~e~l~hp~~~~ 172 (254)
++.++++||||..
T Consensus 259 ~~~~~~~h~~f~~ 271 (332)
T cd05623 259 GIEDFKQHPFFTG 271 (332)
T ss_pred CHHHHhCCCCcCC
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=214.72 Aligned_cols=157 Identities=25% Similarity=0.320 Sum_probs=119.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCC--
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY-- 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-- 86 (254)
...++.|++.++++||++|++||||||+||+++.++. +||+|||++....... ......++..|+|||.+.....
T Consensus 130 ~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 207 (291)
T cd06639 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYD 207 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcccccccccCccCCccccChhhhcCCCCcc
Confidence 3447788999999999999999999999999987765 9999999987543322 2234468889999999764331
Q ss_pred --CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 87 --DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 87 --~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.+.++|+|||||++|+|++|+.||.............. ...........++..+.+||.+||..+|.+||++.++
T Consensus 208 ~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 284 (291)
T cd06639 208 YSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHL 284 (291)
T ss_pred cccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 23459999999999999999999987544333222111 1111222223467889999999999999999999999
Q ss_pred hcCcccc
Q 025350 165 RNHEWFL 171 (254)
Q Consensus 165 l~hp~~~ 171 (254)
++||||+
T Consensus 285 l~~~~~~ 291 (291)
T cd06639 285 LEHPFIK 291 (291)
T ss_pred hcCcccC
Confidence 9999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=215.06 Aligned_cols=160 Identities=28% Similarity=0.464 Sum_probs=124.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.++.|||++||+||||||+||+++.++. +||+|||++....... ......++..|+|||.+.+..++.
T Consensus 120 ~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 197 (292)
T cd06658 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197 (292)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCceeecCccccCHHHHccCCCCc
Confidence 4566788999999999999999999999999987765 9999999986532222 223346889999999997777765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|+||||+++|++++|..||........... +.... ....+....++..+.+++.+||..||.+|||+.++++||
T Consensus 198 ~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 198 E-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNL--PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcC--CCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 5 9999999999999999999987554333222 11111 122223334788999999999999999999999999999
Q ss_pred cccccCC
Q 025350 169 WFLKNLP 175 (254)
Q Consensus 169 ~~~~~~~ 175 (254)
||...-+
T Consensus 274 ~~~~~~~ 280 (292)
T cd06658 274 FLKLAGP 280 (292)
T ss_pred hhhccCC
Confidence 9976443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=217.15 Aligned_cols=161 Identities=27% Similarity=0.340 Sum_probs=120.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.|||++|++||||||+||+++.++. +||+|||++...... .......++..|+|||.+.+....+.
T Consensus 111 ~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 188 (337)
T cd07858 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTT 188 (337)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCCcccccccccccCccChHHHhcCCCCCC
Confidence 456789999999999999999999999999987765 999999999765333 22234467889999998865333344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH-------------------HhccCCCC------CCCCCCCHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------------ILSVQYSI------PDYVHISPECR 144 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------------------~~~~~~~~------~~~~~~~~~~~ 144 (254)
++|+|||||++|+|++|+.||.+.+........... ........ .....+++.++
T Consensus 189 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (337)
T cd07858 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAI 268 (337)
T ss_pred cccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHH
Confidence 599999999999999999999765432211111100 00000000 01235789999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+||++||+.+|.+|||+.++++||||...
T Consensus 269 ~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 269 DLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 99999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=214.58 Aligned_cols=157 Identities=27% Similarity=0.487 Sum_probs=120.6
Q ss_pred cCCcHHHHHHHHHHHhhc-CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC----C
Q 025350 10 RGTLFLPTTYFWSELLPF-NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK----K 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~-givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~----~ 84 (254)
...++.|++.+++|||++ +++||||||+||+++.++. +||+|||++.............++..|+|||.+.+ .
T Consensus 105 ~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (283)
T cd06617 105 LGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 182 (283)
T ss_pred HHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccccccccccCCccccChhhcCCccccc
Confidence 346778999999999997 9999999999999988765 99999999876543333333568889999998864 2
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.++. ++|+|||||++|+|++|+.||...... ...... ........+. ..+|.++.++|.+||..+|.+||++.+
T Consensus 183 ~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~ 257 (283)
T cd06617 183 GYDV-KSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---VEEPSPQLPA-EKFSPEFQDFVNKCLKKNYKERPNYPE 257 (283)
T ss_pred ccCc-cccchhhHHHHHHHHhCCCCCCccccCHHHHHHH---HhcCCCCCCc-cccCHHHHHHHHHHccCChhhCcCHHH
Confidence 3344 489999999999999999999753322 222221 1111222222 247899999999999999999999999
Q ss_pred HhcCcccccc
Q 025350 164 IRNHEWFLKN 173 (254)
Q Consensus 164 ~l~hp~~~~~ 173 (254)
++.||||.+.
T Consensus 258 il~~~~~~~~ 267 (283)
T cd06617 258 LLQHPFFELH 267 (283)
T ss_pred HhcCchhhhc
Confidence 9999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=219.66 Aligned_cols=159 Identities=25% Similarity=0.329 Sum_probs=120.3
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcch
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
.++.|++.+++|||++||+||||||+||+++.++. +||+|||+++.... ......++..|+|||.+.+....+.++
T Consensus 121 ~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~ 196 (342)
T cd07879 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTV 196 (342)
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchH
Confidence 46788999999999999999999999999988765 99999999875422 223446788999999987643334459
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH-------------------hccCCCCC------CCCCCCHHHHHH
Q 025350 92 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------------LSVQYSIP------DYVHISPECRHL 146 (254)
Q Consensus 92 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------------------~~~~~~~~------~~~~~~~~~~~l 146 (254)
|+|||||++|+|++|+.||.+..........+... .......+ .....++.+.+|
T Consensus 197 Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (342)
T cd07879 197 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDL 276 (342)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHH
Confidence 99999999999999999998765433332222100 00000000 012467889999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
|.+||+.||.+||++.+++.||||....
T Consensus 277 i~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 277 LEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 9999999999999999999999997754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=218.48 Aligned_cols=159 Identities=22% Similarity=0.365 Sum_probs=115.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--------CCCCCcCCCCcccchhcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLL 82 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~ 82 (254)
..++.|++.+|+|||++||+||||||+|||++.++. ++++||+.+....... ......++..|+|||++.
T Consensus 104 ~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (327)
T cd08227 104 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQ 181 (327)
T ss_pred HHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccccccccccccccceecccChHHhh
Confidence 456788999999999999999999999999987765 9999998654321111 112234677899999987
Q ss_pred CC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC------------------------------
Q 025350 83 KK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------------------------ 130 (254)
Q Consensus 83 ~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------------------------ 130 (254)
+. .++.+ +|||||||++|+|++|..||....................
T Consensus 182 ~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T cd08227 182 QNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTV 260 (327)
T ss_pred cccCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCccccc
Confidence 53 35444 9999999999999999999976543322222111000000
Q ss_pred ----------CCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 131 ----------YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 131 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
...+....+++.+++||.+||..||.+|||++++++||||++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 261 STPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred CCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000111235678999999999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=213.88 Aligned_cols=149 Identities=16% Similarity=0.158 Sum_probs=116.0
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--------CCCCCcCCCCcccchhccC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~ 83 (254)
.++.|++.+++|||++||+||||||+|||++.++. ++|+|||+|+...... ......||+.|+|||++.+
T Consensus 130 ~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~ 207 (294)
T PHA02882 130 NIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG 207 (294)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC
Confidence 47789999999999999999999999999987665 9999999997543211 1123469999999999988
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-----HHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCC
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK-----TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
..++.+ +|||||||++|+|++|..||.+......... ...++....... ...++.+.++++.|+..+|.+|
T Consensus 208 ~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r 283 (294)
T PHA02882 208 ACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEK 283 (294)
T ss_pred CCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCC
Confidence 877655 9999999999999999999987643222211 122222222222 3468899999999999999999
Q ss_pred CCHhHHhc
Q 025350 159 ISIPEIRN 166 (254)
Q Consensus 159 ps~~e~l~ 166 (254)
|++.++++
T Consensus 284 p~~~~l~~ 291 (294)
T PHA02882 284 PDYDALIK 291 (294)
T ss_pred CCHHHHHH
Confidence 99999875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=218.92 Aligned_cols=162 Identities=23% Similarity=0.334 Sum_probs=123.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.++++||+.||+||||||+||+++.++. +||+|||++...... .....++..|+|||.+.+....+.+
T Consensus 121 ~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~ 196 (343)
T cd07851 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 196 (343)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCch
Confidence 346789999999999999999999999999988765 999999998764332 3345678899999998654333455
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------------------CCCC------CCCCCCCHHHHH
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------------QYSI------PDYVHISPECRH 145 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~~------~~~~~~~~~~~~ 145 (254)
+|||||||++|++++|+.||................... .... .....+++.+.+
T Consensus 197 ~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~d 276 (343)
T cd07851 197 VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAID 276 (343)
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHH
Confidence 999999999999999999998765543333322211000 0000 001235889999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
+|.+||+.+|.+|||+.++++||||.+....
T Consensus 277 li~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 277 LLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 9999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=210.55 Aligned_cols=153 Identities=29% Similarity=0.344 Sum_probs=117.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC----CCCCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..+..|++.++++||++||+||||||+||+++.++. +||+|||++...... .......++..|+|||.+.+..+
T Consensus 109 ~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (266)
T cd06651 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186 (266)
T ss_pred HHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCC
Confidence 356789999999999999999999999999987765 999999998754221 11123457889999999987776
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.. +|+||+||++|++++|+.||........... .............+++.+++++ +||..+|.+||+++++++
T Consensus 187 ~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 187 GRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred Cch-hhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 655 9999999999999999999987544333222 1111111111234688899999 577789999999999999
Q ss_pred Ccccc
Q 025350 167 HEWFL 171 (254)
Q Consensus 167 hp~~~ 171 (254)
||||+
T Consensus 261 hp~~~ 265 (266)
T cd06651 261 HPFAQ 265 (266)
T ss_pred Ccccc
Confidence 99985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=213.63 Aligned_cols=158 Identities=25% Similarity=0.359 Sum_probs=117.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-----CCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 84 (254)
...++.|++.+++|||++|++|+||||+||+++.++. +||+|||++........ .....++..|+|||.+.+.
T Consensus 121 ~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 198 (310)
T cd07865 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198 (310)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC
Confidence 3456789999999999999999999999999987765 99999999875433221 1234577889999988765
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC----------------CCCCC-----------CC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------------YSIPD-----------YV 137 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~~~~~-----------~~ 137 (254)
.....++|+||||+++|+|++|+.||.+......... +....... ...+. ..
T Consensus 199 ~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 277 (310)
T cd07865 199 RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL-ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY 277 (310)
T ss_pred cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccc
Confidence 4334559999999999999999999987654332221 11111100 00000 00
Q ss_pred CCCHHHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 138 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 138 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
..+..+++||.+||..||.+|||++++++||||
T Consensus 278 ~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 278 VKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=215.16 Aligned_cols=161 Identities=28% Similarity=0.330 Sum_probs=121.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC------CCCCCcCCCCcccchhccCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~~~~~y~aPE~~~~~ 84 (254)
..++.|++.+++|||++||+||||||+||+++.++. +||+|||++....... ......++..|+|||.+.+.
T Consensus 110 ~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 187 (337)
T cd07852 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS 187 (337)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccccccCcchhcccccccccCceeeecc
Confidence 347889999999999999999999999999988776 9999999987543322 12234588899999988665
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH-------------------hc----cCC--CCCCCCCC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------------LS----VQY--SIPDYVHI 139 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------------------~~----~~~--~~~~~~~~ 139 (254)
.....++|+||||+++|+|++|+.||.+.............. .. ... .......+
T Consensus 188 ~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (337)
T cd07852 188 TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA 267 (337)
T ss_pred ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCC
Confidence 444455999999999999999999998755443322221110 00 000 00111236
Q ss_pred CHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 140 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+..+.++|.+||..+|.+|||+.++++||||++.
T Consensus 268 ~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 268 SDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred CHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 8899999999999999999999999999999774
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=211.09 Aligned_cols=158 Identities=28% Similarity=0.350 Sum_probs=123.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...+..|++.++++||+.|++|+||+|+||+++.++. +||+|||.+.............++..|+|||.+.+..++.+
T Consensus 109 ~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 186 (287)
T cd07838 109 IKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATP 186 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceeccCCcccccccccccccChHHhccCCCCCc
Confidence 3457789999999999999999999999999988865 99999999876544433344457889999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-CCCC--------------------CCCCCCHHHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIP--------------------DYVHISPECRHLIS 148 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--------------------~~~~~~~~~~~li~ 148 (254)
+|+|||||++|+|++|.+||..........+......... ...+ ....+++.+.++|.
T Consensus 187 -~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 265 (287)
T cd07838 187 -VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLK 265 (287)
T ss_pred -chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHH
Confidence 9999999999999999999988766555544433211100 0000 01134678899999
Q ss_pred HhchhCCCCCCCHhHHhcCccc
Q 025350 149 RIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 149 ~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+||+.||.+||++.++++||||
T Consensus 266 ~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 266 KMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHhccCCccCCCHHHHhcCcCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=211.39 Aligned_cols=158 Identities=29% Similarity=0.432 Sum_probs=123.0
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC-CCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~ 87 (254)
.+..++.|++.++.|||++||+||||||+||+++.++. +||+|||++...... ......|+..|+|||.+.+. .++
T Consensus 98 ~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 174 (278)
T cd05606 98 EMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYD 174 (278)
T ss_pred HHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCC
Confidence 34567889999999999999999999999999987765 999999998754322 23345789999999998754 455
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIP 162 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~ 162 (254)
. ++|+||+||++|+|++|+.||........ ..............+ ..++..+.+++.+||..+|.+|| ++.
T Consensus 175 ~-~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~ 250 (278)
T cd05606 175 S-SADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 250 (278)
T ss_pred c-ccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCC--CcCCHHHHHHHHHHhhcCHHhccCCCCCCHH
Confidence 4 49999999999999999999986532211 111122222222233 34689999999999999999999 999
Q ss_pred HHhcCcccccc
Q 025350 163 EIRNHEWFLKN 173 (254)
Q Consensus 163 e~l~hp~~~~~ 173 (254)
++++||||+..
T Consensus 251 ~ll~~~~~~~~ 261 (278)
T cd05606 251 EVKEHPFFRSL 261 (278)
T ss_pred HHHhCccccCC
Confidence 99999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=211.34 Aligned_cols=157 Identities=30% Similarity=0.505 Sum_probs=123.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++++||++||+||||+|+||+++.++. ++|+|||.+....... ......|++.|+|||.+.+..++.+
T Consensus 118 ~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 195 (285)
T cd06648 118 ATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195 (285)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCc
Confidence 357788999999999999999999999999988765 9999999876443221 2233468899999999987777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-CCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+|+||||+++|+|++|..||........... .... .........++..+.+++.+||..+|.+|||+.++++||
T Consensus 196 -~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 196 -VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR----IRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred -ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 9999999999999999999977543332222 2211 112222234788999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||++..
T Consensus 271 ~~~~~~ 276 (285)
T cd06648 271 FLAKAG 276 (285)
T ss_pred ccccCC
Confidence 997744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=216.07 Aligned_cols=158 Identities=25% Similarity=0.284 Sum_probs=116.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC----CCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG----SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLL 82 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~----~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~ 82 (254)
..++.|++.+++|||++||+||||||+||+++. ++. +||+|||++........ .....++..|+|||++.
T Consensus 111 ~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (316)
T cd07842 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLL 188 (316)
T ss_pred HHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCccccccCCCcccccccCCccccccccCHHHHh
Confidence 457789999999999999999999999999987 544 99999999875433221 22345788999999887
Q ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchH---------HHHHHHHHHh----------------------ccCC
Q 025350 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---------NFRKTIHRIL----------------------SVQY 131 (254)
Q Consensus 83 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~~~~~~~----------------------~~~~ 131 (254)
+......++|+|||||++|+|++|+.||.+..... ........+. ....
T Consensus 189 ~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (316)
T cd07842 189 GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTK 268 (316)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCC
Confidence 65433455999999999999999999997654321 0111110000 0000
Q ss_pred CCC---------CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 132 SIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 132 ~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
..+ .....+..+.+++.+||..||++|||+.++++||||
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 269 TYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 001457789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=207.10 Aligned_cols=168 Identities=32% Similarity=0.528 Sum_probs=131.2
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-CCCcEEEecCCCcccCCCC--------CCCCCCcCCCCcccch
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLH--------SQPKSTVGTPAYIAPE 79 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~--------~~~~~~~~~~~y~aPE 79 (254)
....++..++.+|.+||.+||.||||||+|||.... ...-||||||.++...... ....+.+|+..|||||
T Consensus 177 EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPE 256 (463)
T KOG0607|consen 177 EASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPE 256 (463)
T ss_pred HHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchh
Confidence 344566779999999999999999999999998543 2234899999887532211 1234568999999999
Q ss_pred hcc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----------chHHHHHHHHHHhccCCCCCC--CCCCCHH
Q 025350 80 VLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-----------EPKNFRKTIHRILSVQYSIPD--YVHISPE 142 (254)
Q Consensus 80 ~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 142 (254)
++. ...++.+.+|.||||+++|-|++|.+||.+.- -..-...+...+..+.+.+|. |.++|.+
T Consensus 257 VVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~e 336 (463)
T KOG0607|consen 257 VVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSE 336 (463)
T ss_pred HHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHH
Confidence 864 22334455999999999999999999997632 122344556677788887774 7789999
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
.++|+..+|..|+.+|.++.++++|||++.-.+.
T Consensus 337 akdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 337 AKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 9999999999999999999999999999875443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=211.29 Aligned_cols=157 Identities=27% Similarity=0.355 Sum_probs=119.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccC-----
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK----- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~----- 83 (254)
...++.|++.++.+||++|++||||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+
T Consensus 112 ~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 189 (292)
T cd06644 112 IQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189 (292)
T ss_pred HHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccccceecCCccccCceeeccccccC
Confidence 3557889999999999999999999999999987665 9999999886532221 2233468889999999853
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++. ++|+|||||++|+|++|..||..........+.. .......+....++..+.++|.+||..+|.+||++.+
T Consensus 190 ~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 265 (292)
T cd06644 190 TPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQ 265 (292)
T ss_pred CCCCc-hhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh---cCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 23333 4999999999999999999997654322222211 1111122233457889999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||..
T Consensus 266 il~~~~~~~ 274 (292)
T cd06644 266 LLEHPFVSS 274 (292)
T ss_pred HhcCccccc
Confidence 999999954
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=227.71 Aligned_cols=162 Identities=34% Similarity=0.576 Sum_probs=144.8
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCC
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
....+..|.|+.++++|+|+++|||||||.+|||++.+.. +||+|||++..+.......+.+|++.|.|||++.+..|
T Consensus 154 e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y 231 (596)
T KOG0586|consen 154 EKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKY 231 (596)
T ss_pred hhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccccCCCCCccChHhhcCccc
Confidence 3456778999999999999999999999999999988776 99999999998888888889999999999999999999
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+..+|+||+|+++|.|+.|..||.+.. +.....+++...+.+|.+ ++.++.++|+++|..+|.+|+++++++.
T Consensus 232 ~gpe~D~Wslgvvly~LV~GsLPFDG~~----lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 232 DGPEVDIWSLGVVLYALVEGSLPFDGQN----LKELRPRVLRGKYRIPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred CCcceehhhhhhhheeeeecccccCCcc----cccccchheeeeecccce--eechhHHHHHHhhccCccccCCHHHhhh
Confidence 9999999999999999999999999843 344445566777777775 7899999999999999999999999999
Q ss_pred CccccccCCc
Q 025350 167 HEWFLKNLPA 176 (254)
Q Consensus 167 hp~~~~~~~~ 176 (254)
|.|....+..
T Consensus 306 ~~W~n~~~~~ 315 (596)
T KOG0586|consen 306 DRWRNDLLEA 315 (596)
T ss_pred hcccchhhhh
Confidence 9999876655
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=211.96 Aligned_cols=158 Identities=30% Similarity=0.480 Sum_probs=121.7
Q ss_pred CCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCC----
Q 025350 11 GTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE---- 85 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~---- 85 (254)
..++.+++.+++|||+ .||+||||+|+||+++.++. +||+|||++.............++..|+|||.+.+..
T Consensus 117 ~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 194 (296)
T cd06618 117 GKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPK 194 (296)
T ss_pred HHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccc
Confidence 4588899999999997 69999999999999987765 9999999987654333333445788999999987543
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-cCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|+||||+++|+|++|+.||....... ........ .....+....++.++.+|+.+||..||.+||++.++
T Consensus 195 ~~~~-~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 270 (296)
T cd06618 195 YDIR-ADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270 (296)
T ss_pred cccc-hhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 4444 999999999999999999997543221 11222222 222233333578999999999999999999999999
Q ss_pred hcCccccccC
Q 025350 165 RNHEWFLKNL 174 (254)
Q Consensus 165 l~hp~~~~~~ 174 (254)
++||||....
T Consensus 271 l~~~~~~~~~ 280 (296)
T cd06618 271 LQHPFIRRYE 280 (296)
T ss_pred hcChhhhccc
Confidence 9999997643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=212.59 Aligned_cols=163 Identities=25% Similarity=0.311 Sum_probs=122.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+|+||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+....+
T Consensus 104 ~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (298)
T cd07841 104 IKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYG 181 (298)
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCC
Confidence 3457789999999999999999999999999988765 9999999987654332 222335678899999986544444
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-------CCC---------------CCCCCCCHHHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------YSI---------------PDYVHISPECRHL 146 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~---------------~~~~~~~~~~~~l 146 (254)
.++|+|||||++|+|++|.+||.+........+......... ... ......+..+.++
T Consensus 182 ~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (298)
T cd07841 182 VGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDL 261 (298)
T ss_pred cHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHH
Confidence 559999999999999999888877665444333322110000 000 0112357889999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
|.+||..+|.+|||+.+++.||||.+..
T Consensus 262 i~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 262 LQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred HHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 9999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=211.73 Aligned_cols=148 Identities=23% Similarity=0.250 Sum_probs=116.7
Q ss_pred cCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC--CCC
Q 025350 10 RGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~ 86 (254)
...++.+++.+++|||+ .+++||||||+|||++.++. +||+|||+++..... .....++..|+|||++.+ ..+
T Consensus 124 ~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 199 (283)
T PHA02988 124 KLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEY 199 (283)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhccc--cccccCcccccCHHHhhhccccc
Confidence 34567899999999998 59999999999999998775 999999998754322 234568899999999875 455
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|||||||++|+|++|..||.+......... +.......+....+++.+++|+.+||+.||.+|||+.++++
T Consensus 200 ~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 200 TIK-DDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred cch-hhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 554 9999999999999999999987654333322 22222233333357999999999999999999999999985
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=206.20 Aligned_cols=152 Identities=27% Similarity=0.402 Sum_probs=120.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++.|||++|++|+||||+||+++.++. ++|+|||++........ .....+++.|+|||++.+..++.+
T Consensus 104 ~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (256)
T cd08529 104 WRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEK 181 (256)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCc
Confidence 356779999999999999999999999999988765 99999999875443322 223468889999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+|||||++|+|++|+.||.......... ....... .+....++..+.+++.+||+.+|++||++.++++|||
T Consensus 182 -~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 182 -SDVWALGVVLYECCTGKHPFDANNQGALIL----KIIRGVF-PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred -cchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCC-CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 999999999999999999998765322222 2222221 1122257899999999999999999999999999999
Q ss_pred c
Q 025350 170 F 170 (254)
Q Consensus 170 ~ 170 (254)
+
T Consensus 256 ~ 256 (256)
T cd08529 256 L 256 (256)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=208.91 Aligned_cols=155 Identities=33% Similarity=0.533 Sum_probs=120.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.++.|||+.|++||||+|+||+++.++. +||+|||++..... .....++..|+|||.+.+..++.+
T Consensus 99 ~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~ 173 (260)
T cd05611 99 AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKM 173 (260)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCCcCccChhhhcCCCCcch
Confidence 3456789999999999999999999999999987765 99999998875332 234468889999999987775544
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC---HhHHhc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---IPEIRN 166 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~ 166 (254)
+|+||||+++|+|++|..||............... ...........+++.+.+++.+||..+|.+||+ +.+++.
T Consensus 174 -~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 174 -SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR--RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc--ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 99999999999999999999876543332222111 111111122347899999999999999999995 579999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
||||++
T Consensus 251 ~~~~~~ 256 (260)
T cd05611 251 HPFFKS 256 (260)
T ss_pred ChHhhc
Confidence 999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=214.01 Aligned_cols=159 Identities=23% Similarity=0.329 Sum_probs=118.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC------------CCCCcCCCCccc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ------------PKSTVGTPAYIA 77 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~------------~~~~~~~~~y~a 77 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||++........ .....+++.|+|
T Consensus 117 ~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a 194 (311)
T cd07866 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRP 194 (311)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCcccccCCcccccccccceeccCcCC
Confidence 4457789999999999999999999999999988776 99999999875432211 112246788999
Q ss_pred chhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-------------------CCCC----
Q 025350 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------------------YSIP---- 134 (254)
Q Consensus 78 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~---- 134 (254)
||.+.+......++|||||||++|+|++|++||.+.................. ...+
T Consensus 195 PE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (311)
T cd07866 195 PELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE 274 (311)
T ss_pred hHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHH
Confidence 99886654334459999999999999999999987665544433322111000 0000
Q ss_pred -CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 135 -DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 135 -~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
....+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 275 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 275 ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 012345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=210.20 Aligned_cols=158 Identities=26% Similarity=0.368 Sum_probs=115.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|.|||++||+||||||+||+++.++. +||+|||+++...... ......+++.|+|||.+.+......
T Consensus 106 ~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 183 (291)
T cd07870 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183 (291)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCc
Confidence 446789999999999999999999999999987765 9999999987533222 2233457889999999876443334
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC------------------CC--CC-------CCCCCCHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------------YS--IP-------DYVHISPE 142 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------------~~--~~-------~~~~~~~~ 142 (254)
++|+|||||++|+|++|..||.................... .. .+ .....+..
T Consensus 184 ~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (291)
T cd07870 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPK 263 (291)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChH
Confidence 49999999999999999999986543222111111000000 00 00 00112578
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+.+++.+||..||.+|||+.+++.||||
T Consensus 264 ~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 264 AEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 8999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=210.94 Aligned_cols=160 Identities=27% Similarity=0.334 Sum_probs=119.7
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCcc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
.++.|++.+++|||++|++||||+|+||+++..+ ..+||+|||++....... ......+++.|+|||.+.+......+
T Consensus 106 ~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 184 (294)
T PLN00009 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTP 184 (294)
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcH
Confidence 4567999999999999999999999999998543 248999999987543222 12334578899999998765443445
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-----------------CCCC------CCCCCCHHHHHHH
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-----------------YSIP------DYVHISPECRHLI 147 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------~~~~------~~~~~~~~~~~li 147 (254)
+|+|||||++|+|++|..||..........+......... ...+ ....+++.+++++
T Consensus 185 ~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 264 (294)
T PLN00009 185 VDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLL 264 (294)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHH
Confidence 9999999999999999999987655444333221110000 0000 0124688999999
Q ss_pred HHhchhCCCCCCCHhHHhcCccccc
Q 025350 148 SRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 148 ~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
.+||+.+|.+||++.++++||||.+
T Consensus 265 ~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 265 SKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred HHHccCChhhCcCHHHHhcCchHhH
Confidence 9999999999999999999999965
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=209.90 Aligned_cols=159 Identities=26% Similarity=0.326 Sum_probs=119.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++|++||||+|+||+++.++. ++|+|||++....... ......++..|+|||++.+.....
T Consensus 101 ~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 178 (283)
T cd07835 101 IKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYS 178 (283)
T ss_pred HHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccCccccccCCCCCceeecCcccC
Confidence 3457788999999999999999999999999988665 9999999987543222 122335688999999887654334
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc--------------CCCC---------CCCCCCCHHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYSI---------PDYVHISPECRH 145 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~---------~~~~~~~~~~~~ 145 (254)
.++|+||||+++|+|++|..||..........+........ .... .....++..+.+
T Consensus 179 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (283)
T cd07835 179 TPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLD 258 (283)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHH
Confidence 45999999999999999999998766544333322210000 0000 112346789999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+|.+||+.+|.+|||+.+++.||||
T Consensus 259 li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 259 LLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHhcCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-31 Score=242.25 Aligned_cols=154 Identities=26% Similarity=0.394 Sum_probs=123.7
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcccchhccCCC-
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKE- 85 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~- 85 (254)
....|++.+++|||++|||||||||.|||++.+|. +|++|||.|....... ......||+.|||||++.+..
T Consensus 1338 vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~ 1415 (1509)
T KOG4645|consen 1338 VYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKG 1415 (1509)
T ss_pred HHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhccccc
Confidence 35678999999999999999999999999998886 9999999998654432 223457999999999998644
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-ccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 86 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 86 -~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
....+.|||||||++.||+||+.||...+... +++..+. ...+..|. .+|++.++||.+||..||++|+++.|
T Consensus 1416 kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~~gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1416 KGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVAAGHKPQIPE--RLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred CCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHhccCCCCCch--hhhHhHHHHHHHHHhcCchhhhHHHH
Confidence 23456899999999999999999998765432 2333332 22333443 49999999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
++.|.|-+.
T Consensus 1491 lle~~f~~~ 1499 (1509)
T KOG4645|consen 1491 LLEHAFGKS 1499 (1509)
T ss_pred HHHhhcccc
Confidence 999998643
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=206.43 Aligned_cols=155 Identities=29% Similarity=0.461 Sum_probs=121.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC-----CCCcCCCCcccchhccCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~ 85 (254)
..++.+++.++++||++||+|+||+|+||+++.++. +||+|||++......... ....++..|+|||.+.+..
T Consensus 102 ~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 179 (264)
T cd06626 102 RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179 (264)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCC
Confidence 346789999999999999999999999999988765 999999998765433221 1245788999999987655
Q ss_pred ---CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 86 ---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 86 ---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
+. .++||||||+++|++++|+.||........... ..........|....+++.+.++|++||..+|.+|||+.
T Consensus 180 ~~~~~-~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 180 GKGHG-RAADIWSLGCVVLEMATGKRPWSELDNEFQIMF--HVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCC-cccchHHHHHHHHHHHhCCCCccCCcchHHHHH--HHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHH
Confidence 44 449999999999999999999976543222211 111123334455555689999999999999999999999
Q ss_pred HHhcCccc
Q 025350 163 EIRNHEWF 170 (254)
Q Consensus 163 e~l~hp~~ 170 (254)
+++.|||+
T Consensus 257 ~i~~~~~~ 264 (264)
T cd06626 257 ELLQHPFV 264 (264)
T ss_pred HHhcCCCC
Confidence 99999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=205.99 Aligned_cols=153 Identities=33% Similarity=0.448 Sum_probs=121.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.+++.++++||++|++|+||+|+||+++.++. .+||+|||++.............++..|+|||.+.+..++.+
T Consensus 104 ~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~- 181 (256)
T cd08220 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK- 181 (256)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcc-
Confidence 446678999999999999999999999999975542 489999999986654444445568899999999987766555
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+|+||||+++|+|++|..||............ .... ..+....++..+++++.+||..+|.+|||+.++++||||
T Consensus 182 ~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 182 SDIWALGCVLYELASLKRAFEAANLPALVLKI----MSGT-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cchHHHHHHHHHHHhCCCCcccCchHHHHHHH----HhcC-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999875543332222 1111 112223478999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=234.45 Aligned_cols=159 Identities=32% Similarity=0.492 Sum_probs=129.6
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccC---
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLK--- 83 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~--- 83 (254)
...+.+.++..||.-||+.|+|||||||+|||++..|. +||+|||.|......+. ....+|||-|.+||++..
T Consensus 176 ~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~ 253 (1317)
T KOG0612|consen 176 WARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGD 253 (1317)
T ss_pred HHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcC
Confidence 34566788999999999999999999999999998876 99999999976654443 345689999999999862
Q ss_pred C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC--
Q 025350 84 K-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-- 160 (254)
Q Consensus 84 ~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-- 160 (254)
. ..+++.+|+||+||++|||+.|..||...+-...+.+++.. ...+.+|....+|+++++||.+++ .+|..|.+
T Consensus 254 ~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--k~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrn 330 (1317)
T KOG0612|consen 254 GKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--KESLSFPDETDVSEEAKDLIEALL-CDREVRLGRN 330 (1317)
T ss_pred CccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--hhhcCCCcccccCHHHHHHHHHHh-cChhhhcccc
Confidence 1 33356699999999999999999999985555555554432 235666766679999999999987 67899997
Q ss_pred -HhHHhcCccccc
Q 025350 161 -IPEIRNHEWFLK 172 (254)
Q Consensus 161 -~~e~l~hp~~~~ 172 (254)
++++.+||||..
T Consensus 331 giedik~HpFF~g 343 (1317)
T KOG0612|consen 331 GIEDIKNHPFFEG 343 (1317)
T ss_pred cHHHHHhCccccC
Confidence 999999999964
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=210.37 Aligned_cols=161 Identities=25% Similarity=0.415 Sum_probs=121.8
Q ss_pred CcCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCC-
Q 025350 9 GRGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY- 86 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 86 (254)
....++.+++.++.|||+ .||+||||||+||+++.++. +||+|||++..... .......+++.|+|||.+.+...
T Consensus 103 ~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 179 (286)
T cd06622 103 VLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA-SLAKTNIGCQSYMAPERIKSGGPN 179 (286)
T ss_pred HHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccC-CccccCCCccCccCcchhcCCCCC
Confidence 445677889999999996 69999999999999988665 99999999875432 22334568889999999865432
Q ss_pred ----CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 87 ----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 87 ----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
.+.++|+|||||++|+|++|..||.......... ....+.... .......++..+.+||.+||..+|.+||++.
T Consensus 180 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 257 (286)
T cd06622 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-QLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYA 257 (286)
T ss_pred ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-HHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHH
Confidence 1345999999999999999999997654322222 222222211 1122234789999999999999999999999
Q ss_pred HHhcCccccccC
Q 025350 163 EIRNHEWFLKNL 174 (254)
Q Consensus 163 e~l~hp~~~~~~ 174 (254)
++++||||...-
T Consensus 258 ~l~~~~~~~~~~ 269 (286)
T cd06622 258 QLLEHPWLVKYK 269 (286)
T ss_pred HHhcChhhhhcc
Confidence 999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=208.87 Aligned_cols=156 Identities=24% Similarity=0.309 Sum_probs=116.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhcc---CCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLL---KKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~---~~~ 85 (254)
...++.|++.+++|||++|++|+||||+||+++.++. +||+|||++....... ......|+..|+|||++. ...
T Consensus 108 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 185 (267)
T cd06645 108 IAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185 (267)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccccccCcccccChhhhccccCCC
Confidence 3456788999999999999999999999999987765 9999999986543221 223446899999999874 333
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
++. ++|+|||||++|+|++|..||................ ...........++..+.++|.+||..+|++|||+++++
T Consensus 186 ~~~-~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll 263 (267)
T cd06645 186 YNQ-LCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN-FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263 (267)
T ss_pred CCc-hhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-CCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 444 4999999999999999999997654332222111110 00111111224688999999999999999999999999
Q ss_pred cCcc
Q 025350 166 NHEW 169 (254)
Q Consensus 166 ~hp~ 169 (254)
+|||
T Consensus 264 ~~~~ 267 (267)
T cd06645 264 QHPF 267 (267)
T ss_pred cCCC
Confidence 9998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=212.97 Aligned_cols=158 Identities=25% Similarity=0.377 Sum_probs=122.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++.+||+.|++||||||+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.+
T Consensus 118 ~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 195 (297)
T cd06656 118 AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195 (297)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcH
Confidence 456778999999999999999999999999987765 9999999987543222 1223468889999999987776555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+|||||++|++++|..||............ .............++..+++|+.+||..+|.+||++.++++|||
T Consensus 196 -~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 196 -VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred -HHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 99999999999999999999765432221111 11112222233457889999999999999999999999999999
Q ss_pred ccccC
Q 025350 170 FLKNL 174 (254)
Q Consensus 170 ~~~~~ 174 (254)
|+...
T Consensus 272 ~~~~~ 276 (297)
T cd06656 272 LKLAK 276 (297)
T ss_pred hcccc
Confidence 97633
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=210.24 Aligned_cols=159 Identities=27% Similarity=0.355 Sum_probs=121.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.+++.++.+||++||+|+||||+||+++.++. +||+|||.+....... ......++..|+|||.+.+....+
T Consensus 100 ~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~ 177 (283)
T cd05118 100 IKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177 (283)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCC
Confidence 3457789999999999999999999999999987765 9999999987554332 222345788899999987763344
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC---------------CCCC---------CCCCCCHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSIP---------DYVHISPECR 144 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~---------~~~~~~~~~~ 144 (254)
.++|+||||+++|+|++|+.||...+................ ...+ ....++..++
T Consensus 178 ~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (283)
T cd05118 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQAL 257 (283)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHH
Confidence 559999999999999999999987665444333322111100 0000 1123678999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
++|.+||..||.+||++.+++.||||
T Consensus 258 ~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 258 DLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHhccCcccCcCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=235.43 Aligned_cols=160 Identities=28% Similarity=0.365 Sum_probs=122.9
Q ss_pred cCCcHHHHHHHHHHHhhc-------CcccCCCCCCcEEecCC---------------CCCcEEEecCCCcccCCCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPF-------NVCHRDLKLENTLLDGS---------------PAPRLKICDFGYSKSSVLHSQPK 67 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~-------givHrdlkp~NIll~~~---------------~~~~vkl~Dfg~a~~~~~~~~~~ 67 (254)
...++.|++.+|.|||+. +||||||||+||||+.. +...+||+|||++..........
T Consensus 120 Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~ 199 (1021)
T PTZ00266 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH 199 (1021)
T ss_pred HHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccccc
Confidence 345778999999999984 59999999999999642 22348999999998654444444
Q ss_pred CCcCCCCcccchhccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHH
Q 025350 68 STVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145 (254)
Q Consensus 68 ~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (254)
...||+.|+|||++.+. .++. ++|||||||++|+|++|..||........+...+. .....+ ....+..+.+
T Consensus 200 s~vGTp~YmAPEvL~ge~~~~s~-KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk----~~p~lp-i~~~S~eL~d 273 (1021)
T PTZ00266 200 SCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHKANNFSQLISELK----RGPDLP-IKGKSKELNI 273 (1021)
T ss_pred ccCCCccccCHHHHhccCCCCCc-hhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHh----cCCCCC-cCCCCHHHHH
Confidence 56799999999998643 3444 49999999999999999999986554433332221 112222 2346899999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
||.+||..+|.+||++.++|.|||++...+
T Consensus 274 LI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 274 LIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 999999999999999999999999986543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=210.46 Aligned_cols=158 Identities=27% Similarity=0.402 Sum_probs=115.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.|||++||+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+....+.
T Consensus 106 ~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 183 (291)
T cd07844 106 RLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYST 183 (291)
T ss_pred HHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccccccccccccCCcHHhhcCcccCc
Confidence 345679999999999999999999999999988776 99999999875332211 122346788999999876443344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC----------------CCC---------CCCCCCC--HH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------------YSI---------PDYVHIS--PE 142 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~~~---------~~~~~~~--~~ 142 (254)
++||||+|+++|+|++|+.||............+....... ... .....++ ..
T Consensus 184 ~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (291)
T cd07844 184 SLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPH 263 (291)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchh
Confidence 59999999999999999999976553222211111110000 000 0001234 78
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+.+++.+||..+|.+|||+.++++||||
T Consensus 264 ~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 264 GEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 8999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=207.19 Aligned_cols=154 Identities=23% Similarity=0.285 Sum_probs=119.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-------CCCCCCcCCCCcccchhccC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------SQPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-------~~~~~~~~~~~y~aPE~~~~ 83 (254)
..++.|++.++++||+.||+|+||+|+||+++.++. ++|+|||++...... .......++..|+|||.+.+
T Consensus 105 ~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 105 CKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccccccccccccccCCCccccChhhhcC
Confidence 456789999999999999999999999999987765 999999988643211 11223458889999999987
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++.+ +|+|||||++|++++|..||.............. ......+....++..+.++|++||..+|.+||++.+
T Consensus 183 ~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 258 (265)
T cd06631 183 SGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQ 258 (265)
T ss_pred CCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh---ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 777655 9999999999999999999986543332221111 111111223357899999999999999999999999
Q ss_pred HhcCccc
Q 025350 164 IRNHEWF 170 (254)
Q Consensus 164 ~l~hp~~ 170 (254)
+++||||
T Consensus 259 ~l~~~~~ 265 (265)
T cd06631 259 LLRHDFL 265 (265)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=207.68 Aligned_cols=155 Identities=27% Similarity=0.356 Sum_probs=119.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCC---CC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKK---EY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~ 86 (254)
..++.|++.+++|||++||+|+||+|+||+++.++. +||+|||++....... ......++..|+|||.+.+. .+
T Consensus 104 ~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~ 181 (262)
T cd06613 104 AYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181 (262)
T ss_pred HHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccccccCCccccCchhhcccccCCc
Confidence 457889999999999999999999999999998766 9999999987543322 22344688899999998766 56
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.. +|+||||+++|+|++|..||................. ..........++.++++++++||..+|..|||+.+++.
T Consensus 182 ~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 182 DGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Cch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 544 9999999999999999999987654333322211100 11111122345788999999999999999999999999
Q ss_pred Ccc
Q 025350 167 HEW 169 (254)
Q Consensus 167 hp~ 169 (254)
|+|
T Consensus 260 ~~~ 262 (262)
T cd06613 260 HPF 262 (262)
T ss_pred CCC
Confidence 998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=209.62 Aligned_cols=151 Identities=34% Similarity=0.586 Sum_probs=122.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|.+||++||+||||+|.||+++.++. +||+|||++...... .....+++.|+|||.+.+...+.+
T Consensus 104 ~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~- 178 (290)
T cd05580 104 RFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKA- 178 (290)
T ss_pred HHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCcc-
Confidence 346688999999999999999999999999988765 999999998765333 334568899999999877766544
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l 165 (254)
+|+||||+++|+|++|..||........ ...+.......| ..++..++++|.+||..||.+|+ ++++++
T Consensus 179 ~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 179 VDWWALGILIYEMLAGYPPFFDDNPIQI----YEKILEGKVRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCccCC--ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 9999999999999999999987553222 222233333333 34689999999999999999999 899999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||..
T Consensus 253 ~~~~~~~ 259 (290)
T cd05580 253 NHPWFAG 259 (290)
T ss_pred cCccccc
Confidence 9999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=209.48 Aligned_cols=159 Identities=25% Similarity=0.373 Sum_probs=120.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.+++.+++|||++|++||||+|+||+++.++. +||+|||++....... ......++..|+|||++.+....
T Consensus 102 ~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 179 (288)
T cd07833 102 VRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179 (288)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCc
Confidence 3456789999999999999999999999999988765 9999999987654433 22344678899999999877333
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------CCCCC-----------CCCCCCH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIP-----------DYVHISP 141 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~-----------~~~~~~~ 141 (254)
+.++|+||||+++|+|++|..||.+................. ....+ ....++.
T Consensus 180 ~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (288)
T cd07833 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSS 259 (288)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccch
Confidence 445999999999999999999998765443332221110000 00000 0112488
Q ss_pred HHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 142 ECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 142 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
++++||++||..+|.+|||++++++||||
T Consensus 260 ~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 260 PALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=205.72 Aligned_cols=163 Identities=27% Similarity=0.357 Sum_probs=123.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC--CCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~--~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~ 83 (254)
..++++|++.++.|||++=|+||||||.|||+..++ .++|||+|||+++.+...-. ....+.|.+|+|||++.|
T Consensus 134 vKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 134 VKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred HHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 457899999999999999999999999999997652 24699999999987544322 223468999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch---------HHHHHHHHHHhcc--CCCCC------CC----------
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRILSV--QYSIP------DY---------- 136 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~~~~~~~~--~~~~~------~~---------- 136 (254)
....+++.|+||+||++.||+|-.+.|.+.... .++.+++. ++.. ...+| .+
T Consensus 214 a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~-vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~ 292 (438)
T KOG0666|consen 214 ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE-VLGTPTDKDWPDLKKMPEYQTLLSDFRRH 292 (438)
T ss_pred cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH-HcCCCccccchhhhhCcchHHHHHHhHHh
Confidence 998888899999999999999999888764311 11222211 1110 00111 10
Q ss_pred --------------CCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 137 --------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 137 --------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
..-++...+|+.+||.+||.+|+|+.++|+|+||+..
T Consensus 293 ~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 293 YYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred hcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 0124557899999999999999999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=215.68 Aligned_cols=163 Identities=23% Similarity=0.343 Sum_probs=122.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.|++|||++||+||||||+||+++.++. +||+|||++..... ......++..|+|||.+.+......
T Consensus 122 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (345)
T cd07877 122 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQ 197 (345)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccccc--cccccccCCCccCHHHHhCccCCCc
Confidence 3447789999999999999999999999999988775 99999999875422 2234567889999999876433344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-------------------ccCCCCC------CCCCCCHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------------------SVQYSIP------DYVHISPECR 144 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------------------~~~~~~~------~~~~~~~~~~ 144 (254)
++|+|||||++|+|++|+.||................. ......+ .....++.++
T Consensus 198 ~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (345)
T cd07877 198 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 277 (345)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHH
Confidence 59999999999999999999976554333322211100 0000000 0123578899
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
+||.+||..||.+|||+.++++||||++...+
T Consensus 278 ~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 278 DLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred HHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 99999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=216.18 Aligned_cols=162 Identities=23% Similarity=0.304 Sum_probs=119.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.|+.|||++||+||||||+||+++..+ ..+||+|||.+....... ......++..|+|||.+.+..
T Consensus 116 ~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 194 (342)
T cd07854 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN 194 (342)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCcccceecCCccccccccccccccccccCHHHHhCcc
Confidence 345678999999999999999999999999997543 248999999987542211 112235788999999876544
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh------------------c---cCCCCC---CCCCCCH
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------------------S---VQYSIP---DYVHISP 141 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------------------~---~~~~~~---~~~~~~~ 141 (254)
....++|||||||++|+|++|+.||................. . .....+ ....++.
T Consensus 195 ~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (342)
T cd07854 195 NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP 274 (342)
T ss_pred ccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCH
Confidence 444559999999999999999999987654443333221100 0 000000 0124678
Q ss_pred HHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 142 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
++++||.+||..||.+|||+.+++.||||+.
T Consensus 275 ~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 275 EALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 9999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=209.47 Aligned_cols=154 Identities=26% Similarity=0.351 Sum_probs=118.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCC-----
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKK----- 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~----- 84 (254)
..++.|++.+++|||++|++|+||+|+||+++.++. +||+|||++....... ......++..|+|||.+...
T Consensus 116 ~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 193 (275)
T cd06608 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDA 193 (275)
T ss_pred HHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccceecccchhhhcCccccccccCHhHhcccccccC
Confidence 347789999999999999999999999999988765 9999999986543222 22345688999999987542
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.++ .++|||||||++|+|++|..||.............. ...........++..+++||.+||..||++|||+.++
T Consensus 194 ~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 194 SYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred Ccc-ccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 233 348999999999999999999976543333322211 1111222223467899999999999999999999999
Q ss_pred hcCccc
Q 025350 165 RNHEWF 170 (254)
Q Consensus 165 l~hp~~ 170 (254)
++|||+
T Consensus 270 l~~~~~ 275 (275)
T cd06608 270 LEHPFI 275 (275)
T ss_pred hcCCCC
Confidence 999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=211.77 Aligned_cols=158 Identities=27% Similarity=0.461 Sum_probs=123.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.++.+||++|++||||||+||+++.++. +||+|||++....... ......++..|+|||.+.+..++.
T Consensus 119 ~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (297)
T cd06659 119 IATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196 (297)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccceecCccccCHHHHccCCCCc
Confidence 3457789999999999999999999999999988765 9999999986443222 223456889999999998777765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|+|||||++|+|++|..||............ .. ...........++..+.++|.+||..+|.+||++.++++||
T Consensus 197 ~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 197 E-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RD--SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hc--cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 5 99999999999999999999865543332221 11 11111222335788999999999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
||.+.
T Consensus 273 ~~~~~ 277 (297)
T cd06659 273 FLLQT 277 (297)
T ss_pred hhccC
Confidence 99753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=208.43 Aligned_cols=157 Identities=27% Similarity=0.361 Sum_probs=121.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccC-----
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK----- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~----- 83 (254)
...++.|++.+++|||++||+|+||||+||+++.++. ++|+|||++....... ......+++.|+|||.+..
T Consensus 105 ~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 182 (280)
T cd06611 105 IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccceeecchhhcCHHHHhhcccCC
Confidence 3457889999999999999999999999999987765 9999999876543222 2233468899999999753
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-CCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..++. ++|+||||+++|+|++|..||........... +.... ........++..+.++|.+||..+|.+||++.
T Consensus 183 ~~~~~-~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 257 (280)
T cd06611 183 NPYDY-KADIWSLGITLIELAQMEPPHHELNPMRVLLK----ILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAA 257 (280)
T ss_pred CCCCc-cccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----HhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHH
Confidence 23333 49999999999999999999987544332222 22221 12222345789999999999999999999999
Q ss_pred HHhcCcccccc
Q 025350 163 EIRNHEWFLKN 173 (254)
Q Consensus 163 e~l~hp~~~~~ 173 (254)
++++||||.+.
T Consensus 258 ~il~~~~~~~~ 268 (280)
T cd06611 258 ELLKHPFVSDQ 268 (280)
T ss_pred HHhcChhhccc
Confidence 99999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=213.00 Aligned_cols=163 Identities=25% Similarity=0.332 Sum_probs=123.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---------------CCCCCCcCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---------------SQPKSTVGTPA 74 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---------------~~~~~~~~~~~ 74 (254)
...++.|++.++++||++||+||||+|+||+++.++. +||+|||++...... .......+++.
T Consensus 121 ~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (335)
T PTZ00024 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLW 198 (335)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCccceeecccccccccccccccccccccccccccccC
Confidence 3457789999999999999999999999999987765 999999998754311 11122346788
Q ss_pred cccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC-CC-------------------
Q 025350 75 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IP------------------- 134 (254)
Q Consensus 75 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~------------------- 134 (254)
|+|||.+.+....+.++|+|||||++|+|++|..||.+.................... ++
T Consensus 199 y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
T PTZ00024 199 YRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL 278 (335)
T ss_pred CCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH
Confidence 9999998765543455999999999999999999998876655444333221111000 00
Q ss_pred --CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 135 --DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 135 --~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
.....+..+.++|.+||..+|.+|||+++++.||||+...
T Consensus 279 ~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 279 KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 0123578899999999999999999999999999998653
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=207.14 Aligned_cols=157 Identities=27% Similarity=0.348 Sum_probs=118.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCC--
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKE-- 85 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-- 85 (254)
..++.|++.++++||++|++||||+|+||+++.++. ++|+|||++....... ......++..|+|||.+....
T Consensus 111 ~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 188 (272)
T cd06629 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188 (272)
T ss_pred HHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeeccccccccccccccccccccCCccccCHHHhccccCC
Confidence 446788999999999999999999999999987765 9999999987543221 122345788999999987654
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
++ .++|+||||+++|++++|..||............................++..++++|.+||..+|.+|||+.+++
T Consensus 189 ~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (272)
T cd06629 189 YS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267 (272)
T ss_pred CC-ccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 44 44999999999999999999997544332222211111111111111234689999999999999999999999999
Q ss_pred cCccc
Q 025350 166 NHEWF 170 (254)
Q Consensus 166 ~hp~~ 170 (254)
+||||
T Consensus 268 ~~~~~ 272 (272)
T cd06629 268 QHPFI 272 (272)
T ss_pred hCCCC
Confidence 99996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=208.77 Aligned_cols=159 Identities=25% Similarity=0.405 Sum_probs=119.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||+.|++||||+|+||+++.++. ++|+|||++........ .....++..|+|||.+.+....+
T Consensus 102 ~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 179 (286)
T cd07846 102 VRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179 (286)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccC
Confidence 3456789999999999999999999999999988765 99999999875433222 22345788999999987654444
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cCCCCC----------CCCCCCHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIP----------DYVHISPEC 143 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~----------~~~~~~~~~ 143 (254)
.++||||||+++|+|++|++||.................. .....+ ....++..+
T Consensus 180 ~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd07846 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV 259 (286)
T ss_pred chHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHH
Confidence 5599999999999999999999765543332222210000 000001 123468899
Q ss_pred HHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 144 RHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
.+|+.+||..+|.+||++.++++||||
T Consensus 260 ~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 260 LDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=203.37 Aligned_cols=154 Identities=27% Similarity=0.372 Sum_probs=121.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.+++.++++||.+|++||||+|+||+++.++. ++|+|||.+.............++..|+|||.+.+..++.+
T Consensus 100 ~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 177 (253)
T cd05122 100 IAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177 (253)
T ss_pred HHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeeccccccccccccccceecCCcccCHHHHcCCCCCcc
Confidence 3457789999999999999999999999999988765 99999999876544332344568889999999987766555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+||||+++|+|++|..||...+......... .......+....++..+.++|.+||..||++|||+.++++|||
T Consensus 178 -~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 178 -ADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999998754333222211 1222223333335899999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=212.52 Aligned_cols=161 Identities=22% Similarity=0.368 Sum_probs=117.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCcccchhc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVL 81 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~ 81 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||.+........ .....++..|+|||++
T Consensus 103 ~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeeccccccccccccccccccccccccCHHHh
Confidence 3456789999999999999999999999999987765 99999998864322111 1223467789999998
Q ss_pred cCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC----------------------------C
Q 025350 82 LKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------------------------Y 131 (254)
Q Consensus 82 ~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------~ 131 (254)
.+. .++. ++|+||+||++|+|++|..||.................... .
T Consensus 181 ~~~~~~~~~-~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (314)
T cd08216 181 QQNLQGYNE-KSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSV 259 (314)
T ss_pred cCCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhh
Confidence 653 3444 49999999999999999999987554333222111000000 0
Q ss_pred CCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 132 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 132 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
..+....++..+.+|+.+||..||.+|||+.++++||||+..
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 260 DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000011234678899999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=210.64 Aligned_cols=157 Identities=27% Similarity=0.360 Sum_probs=120.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC---CCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK---KEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~ 86 (254)
...++.|++.++.|||+.||+||||+|+||+++.++. +||+|||++..... .....+++.|+|||++.+ ..+
T Consensus 117 ~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 191 (307)
T cd06607 117 IAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQY 191 (307)
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC---CCCccCCccccCceeeeccCCCCC
Confidence 3456789999999999999999999999999988775 99999998865322 234567889999998742 334
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+. ++||||||+++|+|++|..||........... .............++..++++|.+||..+|.+||++.+++.
T Consensus 192 ~~-~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 192 DG-KVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred Cc-ccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 44 49999999999999999999987543332221 11111111112246889999999999999999999999999
Q ss_pred CccccccCCc
Q 025350 167 HEWFLKNLPA 176 (254)
Q Consensus 167 hp~~~~~~~~ 176 (254)
||||....++
T Consensus 267 ~~~~~~~~~~ 276 (307)
T cd06607 267 HRFVLRERPP 276 (307)
T ss_pred ChhhcccCCc
Confidence 9999875443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=209.84 Aligned_cols=159 Identities=25% Similarity=0.332 Sum_probs=120.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+++|||+.||+||||||+||+++.++. +||+|||.+........ .....++..|+|||.+.+....
T Consensus 118 ~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 195 (302)
T cd07864 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 195 (302)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccccccccCCcccccccceeccCccChHHhcCCCCC
Confidence 3456789999999999999999999999999988776 99999999875433321 1123467789999988654433
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-C------C-----------------CCCCCCCHHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S------I-----------------PDYVHISPEC 143 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------~-----------------~~~~~~~~~~ 143 (254)
+.++|||||||++|+|++|++||..................... . . ..+..++..+
T Consensus 196 ~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (302)
T cd07864 196 GPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPA 275 (302)
T ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHH
Confidence 45599999999999999999999876654444333322111100 0 0 0122468999
Q ss_pred HHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 144 RHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
.+++.+||..+|.+|||+.+++.||||
T Consensus 276 ~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 276 LDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=210.07 Aligned_cols=158 Identities=27% Similarity=0.498 Sum_probs=119.8
Q ss_pred cCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.++.|||+ .|++||||||+|||++.++. +||+|||++..... .......++..|+|||++.+..++.
T Consensus 101 ~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ 177 (308)
T cd06615 101 LGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYTV 177 (308)
T ss_pred HHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-cccccCCCCcCccChhHhcCCCCCc
Confidence 45677899999999997 69999999999999987765 99999999865432 2234457889999999987776665
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH---------------------------------HHhcc-CCCCC
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---------------------------------RILSV-QYSIP 134 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---------------------------------~~~~~-~~~~~ 134 (254)
+ +|+|||||++|+|++|+.||...... ....... ..... ....|
T Consensus 178 ~-~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (308)
T cd06615 178 Q-SDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP 255 (308)
T ss_pred c-chHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc
Confidence 5 99999999999999999999754321 1111110 00000 00111
Q ss_pred CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 135 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 135 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
...++.++++|+.+||..+|++|||+.++++||||.+.
T Consensus 256 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 256 -SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred -CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 11367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=216.08 Aligned_cols=146 Identities=25% Similarity=0.368 Sum_probs=121.2
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCCCc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
.+..|++.|++||.++++|||||...||||+.+.. +||+|||+|+........ ....-...|.|||.+....++.+
T Consensus 307 ~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k 384 (468)
T KOG0197|consen 307 DFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSK 384 (468)
T ss_pred HHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccc
Confidence 34578999999999999999999999999998875 999999999943332221 11223567999999999999877
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 90 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 90 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
||||||||+|||++| |+.||.+.+..+.+. .+...+++|.+..+|+++.+++..||..+|++|||++.+.
T Consensus 385 -SDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 385 -SDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -cceeehhhhHHHHhccCCCCCCCCCHHHHHH-----HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999999998 899998876644433 3456778888889999999999999999999999998654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=217.12 Aligned_cols=158 Identities=27% Similarity=0.495 Sum_probs=118.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccC----
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLK---- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~---- 83 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++........ .....|++.|+|||++.+
T Consensus 104 ~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 181 (331)
T cd05624 104 ARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181 (331)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccC
Confidence 3456789999999999999999999999999987765 99999999875433222 123469999999999865
Q ss_pred -CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC-CCCCCHHHHHHHHHhchhCCCC--CC
Q 025350 84 -KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLISRIFVADPAK--RI 159 (254)
Q Consensus 84 -~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~--Rp 159 (254)
..++ .++|+|||||++|+|++|+.||............... ......|. ...+++.++++|.+||..++.+ |+
T Consensus 182 ~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~ 258 (331)
T cd05624 182 MGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQN 258 (331)
T ss_pred CCCCC-CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCccccCCHHHHHHHHHHccCchhhcCCC
Confidence 3344 4489999999999999999999876544333322211 11122222 2357899999999999876654 46
Q ss_pred CHhHHhcCccccc
Q 025350 160 SIPEIRNHEWFLK 172 (254)
Q Consensus 160 s~~e~l~hp~~~~ 172 (254)
+++++++||||..
T Consensus 259 ~~~~~~~h~~f~~ 271 (331)
T cd05624 259 GIEDFKKHAFFEG 271 (331)
T ss_pred CHHHHhcCCCcCC
Confidence 8999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=214.50 Aligned_cols=154 Identities=23% Similarity=0.366 Sum_probs=118.8
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccC
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~ 83 (254)
......++.|++.+++|||++||+||||||+||+++.++. +||+|||++........ .....++..|+|||++.+
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 249 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD 249 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccccCcHHhcC
Confidence 3345567889999999999999999999999999987665 99999999976432211 122345678999999988
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 84 KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..++.+ +|||||||++|+|++ |..||.+..........+.. .........+++++.+++.+||+.+|.+||++.
T Consensus 250 ~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 250 KVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE----GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred CCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc----cCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 888766 999999999999997 99999875443333322221 111122234688999999999999999999999
Q ss_pred HHhcC
Q 025350 163 EIRNH 167 (254)
Q Consensus 163 e~l~h 167 (254)
++++|
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=229.98 Aligned_cols=161 Identities=19% Similarity=0.258 Sum_probs=111.1
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC--CCCCCCcCCCCcccchhccCCCCC--
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLKKEYD-- 87 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-- 87 (254)
.++.|++.+|.|||++||+||||||+|||++... ..+||+|||+|+..... .......+++.|+|||.+......
T Consensus 259 ~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~ 337 (566)
T PLN03225 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 337 (566)
T ss_pred HHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCC
Confidence 5788999999999999999999999999998532 24999999999754322 223456789999999976432211
Q ss_pred -------------------CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH----------HhccCCC------
Q 025350 88 -------------------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR----------ILSVQYS------ 132 (254)
Q Consensus 88 -------------------~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~------ 132 (254)
..++|||||||++|+|+++..++.. ....+...+.. .......
T Consensus 338 ~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (566)
T PLN03225 338 APSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRG 415 (566)
T ss_pred CccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhh
Confidence 1236999999999999987766542 11222211111 0000000
Q ss_pred CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 133 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 133 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
+......+...++||.+||.+||.+|||+.++|+||||+..-.
T Consensus 416 ~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 416 FEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 0000112345668999999999999999999999999987443
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=207.73 Aligned_cols=157 Identities=26% Similarity=0.444 Sum_probs=119.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++.+||+.||+|+||+|+||+++.++. ++|+|||++....... ......|+..|+|||.+.+....+.
T Consensus 104 ~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (277)
T cd06917 104 SVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181 (277)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCccccccccCCcceeCHHHhccCCcccc
Confidence 346678999999999999999999999999988665 9999999987654332 2233468889999999875444344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|+|||||++|+|++|..||.......... ..............++.++.+++.+||..||.+||++.+++.|+|
T Consensus 182 ~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMM----LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred chhHHHHHHHHHHHHhCCCCCCCCChhhhhh----ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 5999999999999999999998654322211 111111111111236889999999999999999999999999999
Q ss_pred cccc
Q 025350 170 FLKN 173 (254)
Q Consensus 170 ~~~~ 173 (254)
|++.
T Consensus 258 ~~~~ 261 (277)
T cd06917 258 IKAH 261 (277)
T ss_pred hhcc
Confidence 9763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=205.37 Aligned_cols=156 Identities=38% Similarity=0.599 Sum_probs=123.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---------CCCCCcCCCCcccchh
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QPKSTVGTPAYIAPEV 80 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---------~~~~~~~~~~y~aPE~ 80 (254)
+..++.|++.+|++||++|++||||+|+||+++.++. ++|+|||++....... ......++..|+|||.
T Consensus 95 ~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~ 172 (265)
T cd05579 95 ARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172 (265)
T ss_pred HHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccccCcccCccccCHHH
Confidence 3457889999999999999999999999999988776 9999999987543221 1123357889999999
Q ss_pred ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC
Q 025350 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 160 (254)
Q Consensus 81 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 160 (254)
......+.+ +|+||||+++|++++|..||......... ..........+....++..+.+++.+||+.+|.+|||
T Consensus 173 ~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt 247 (265)
T cd05579 173 ILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIF----QNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLG 247 (265)
T ss_pred hcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCC
Confidence 877765544 99999999999999999999875543322 2233333444443345899999999999999999999
Q ss_pred H---hHHhcCccccc
Q 025350 161 I---PEIRNHEWFLK 172 (254)
Q Consensus 161 ~---~e~l~hp~~~~ 172 (254)
+ .++++||||++
T Consensus 248 ~~~~~~~l~~~~~~~ 262 (265)
T cd05579 248 AKSIEEIKNHPFFKG 262 (265)
T ss_pred CccHHHHhcCccccC
Confidence 9 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=207.67 Aligned_cols=149 Identities=21% Similarity=0.324 Sum_probs=117.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+++|||++|++||||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+..++
T Consensus 127 ~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05048 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT--VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT 204 (283)
T ss_pred HHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc
Confidence 357889999999999999999999999999987765 9999999987542221 12233567889999998877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+......... +... ...+....+++++.+|+.+||+.||.+||++.++++
T Consensus 205 ~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~~~----i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 205 TE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM----IRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred hh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 55 999999999999998 9999987654332222 2222 122233468999999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 279 ~ 279 (283)
T cd05048 279 R 279 (283)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=208.16 Aligned_cols=153 Identities=26% Similarity=0.362 Sum_probs=117.3
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccC-----CC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK-----KE 85 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~ 85 (254)
.++.|++.++.|||+++|+||||||+||+++.++. +||+|||++....... ......|++.|+|||++.. ..
T Consensus 128 ~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 205 (286)
T cd06638 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST 205 (286)
T ss_pred HHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeecccCCCccccccCCCcccChhhhchhhhcccc
Confidence 36788999999999999999999999999988765 9999999987543322 2234468999999998753 22
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
++ .++|+||+||++|+|++|..||.............. ...........++..+.+||.+||..||.+|||+.+++
T Consensus 206 ~~-~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 206 YD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred cc-chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 43 449999999999999999999987543332221111 11111222234678999999999999999999999999
Q ss_pred cCccc
Q 025350 166 NHEWF 170 (254)
Q Consensus 166 ~hp~~ 170 (254)
+|+||
T Consensus 282 ~~~~~ 286 (286)
T cd06638 282 QHVFI 286 (286)
T ss_pred hcccC
Confidence 99997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=204.07 Aligned_cols=153 Identities=29% Similarity=0.394 Sum_probs=121.8
Q ss_pred cCCcHHHHHHHHHHHh-----hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELL-----PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh-----~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~ 83 (254)
...++.+++.++.+|| +.+++|+||||+||+++.++. +||+|||++........ .....+++.|+|||.+.+
T Consensus 107 ~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~ 184 (265)
T cd08217 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH 184 (265)
T ss_pred HHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccccccCCcccccccccCCCccChhhhcC
Confidence 3456789999999999 999999999999999987765 99999999886544332 334568999999999987
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++.+ +|+||||+++|+|++|..||...... .. ...+..... .+....++..+.+++.+||..+|.+||++.+
T Consensus 185 ~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~-~~---~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 185 MSYDEK-SDIWSLGCLIYELCALSPPFTARNQL-QL---ASKIKEGKF-RRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred CCCCch-hHHHHHHHHHHHHHHCCCcccCcCHH-HH---HHHHhcCCC-CCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 776555 99999999999999999999876522 22 222222221 1222357899999999999999999999999
Q ss_pred HhcCccc
Q 025350 164 IRNHEWF 170 (254)
Q Consensus 164 ~l~hp~~ 170 (254)
+++|||+
T Consensus 259 il~~~~~ 265 (265)
T cd08217 259 LLQLPLI 265 (265)
T ss_pred HhhCCCC
Confidence 9999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=199.92 Aligned_cols=154 Identities=29% Similarity=0.366 Sum_probs=118.5
Q ss_pred cCCcHHHHHHHHHHHhhcC--cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC----------CCCcCCCCccc
Q 025350 10 RGTLFLPTTYFWSELLPFN--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----------KSTVGTPAYIA 77 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~~~~~y~a 77 (254)
...+++++++||++||+.. ++||||||.|||+.+++. ++|.|||.+......-.. .....|..|+|
T Consensus 129 iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRA 206 (302)
T KOG2345|consen 129 ILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRA 206 (302)
T ss_pred HHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccC
Confidence 4568899999999999999 999999999999988665 999999998754322111 11246889999
Q ss_pred chhccCCCCC--CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 78 PEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 78 PE~~~~~~~~--~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
||++.-..+. +.++|||||||++|.|+.|..||...... -..+.-.+......+|....+|+.+.++|+.||+.||
T Consensus 207 PELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP 284 (302)
T KOG2345|consen 207 PELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDP 284 (302)
T ss_pred chheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCc
Confidence 9998644332 34499999999999999999999632110 0001112345567777777899999999999999999
Q ss_pred CCCCCHhHHhcC
Q 025350 156 AKRISIPEIRNH 167 (254)
Q Consensus 156 ~~Rps~~e~l~h 167 (254)
.+||++.+++.+
T Consensus 285 ~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 285 NQRPTIPELLSK 296 (302)
T ss_pred ccCCCHHHHHHH
Confidence 999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=204.68 Aligned_cols=163 Identities=26% Similarity=0.426 Sum_probs=129.2
Q ss_pred cccCcCCcHHHHHHHHHHHh-hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC-
Q 025350 6 VQRGRGTLFLPTTYFWSELL-PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 83 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~- 83 (254)
-+...|.+......||.||. ..+|||||+||+|||++..|. |||||||.+.....+-......|...|||||.+..
T Consensus 165 pE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~ 242 (361)
T KOG1006|consen 165 PENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPS 242 (361)
T ss_pred cHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHHHHHhhhccCCccccChhccCCc
Confidence 34445666667788999998 678999999999999998887 99999999977655555556679999999999863
Q ss_pred -CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC----CCCCCCHHHHHHHHHhchhCCCCC
Q 025350 84 -KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP----DYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 84 -~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
.+|+-+ ||+||||++|||+.||..||.+... ....+..+..+.+..- ...+++..++.+|.-||.+|-+.|
T Consensus 243 ~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~R 318 (361)
T KOG1006|consen 243 DKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDR 318 (361)
T ss_pred cCCcchh-hhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccC
Confidence 346666 9999999999999999999987543 2333333443332221 123578999999999999999999
Q ss_pred CCHhHHhcCccccccC
Q 025350 159 ISIPEIRNHEWFLKNL 174 (254)
Q Consensus 159 ps~~e~l~hp~~~~~~ 174 (254)
|+..+++.+||++...
T Consensus 319 pky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 319 PKYDDLKKFPFYRMYA 334 (361)
T ss_pred cchhhhhcCchhhhhh
Confidence 9999999999997654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=207.67 Aligned_cols=159 Identities=26% Similarity=0.366 Sum_probs=120.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||+.|++||||||+||+++.++. ++|+|||++....... ......++..|++||.+.+.....
T Consensus 102 ~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 179 (284)
T cd07836 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCccccccccccccccChHHhcCCCCCC
Confidence 3457889999999999999999999999999987765 9999999987543221 122345788999999987655444
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc--------------CCCCCC---------CCCCCHHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYSIPD---------YVHISPECRH 145 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~~---------~~~~~~~~~~ 145 (254)
.++|+|||||++|++++|..||.+................. ....+. ...++..+++
T Consensus 180 ~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (284)
T cd07836 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGID 259 (284)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHH
Confidence 55999999999999999999998776554444333211000 000000 1235788999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
++.+||+.||.+||++.++++||||
T Consensus 260 ~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 260 LLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=205.60 Aligned_cols=155 Identities=30% Similarity=0.370 Sum_probs=115.7
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCC-CCCc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKE-YDGK 89 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~ 89 (254)
.+..|++.+++|||++||+||||||+||+++... ..+||+|||.+....... ......+++.|+|||.+.+.. ..+.
T Consensus 112 ~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 190 (268)
T cd06624 112 FYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190 (268)
T ss_pred HHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCc
Confidence 4567999999999999999999999999997533 249999999986543222 122345788999999986543 1234
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|+||+|+++|+|++|..||........... ........... ...+++++++|+.+||..+|.+|||+.+++.|||
T Consensus 191 ~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 191 PADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEI--PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhccCCCC--CcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 59999999999999999999976443221111 11111111222 2347899999999999999999999999999999
Q ss_pred c
Q 025350 170 F 170 (254)
Q Consensus 170 ~ 170 (254)
|
T Consensus 268 ~ 268 (268)
T cd06624 268 L 268 (268)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=202.85 Aligned_cols=152 Identities=31% Similarity=0.407 Sum_probs=119.6
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCC-CCCcc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-YDGKI 90 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~ 90 (254)
.++.+++.++++||+.||+|+||+|+||+++.++. +||+|||++.............++..|+|||.+.... ++ .+
T Consensus 106 ~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~ 182 (258)
T cd06632 106 LYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG-LA 182 (258)
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccccccCCCcceeCHHHhcCCCCCC-ch
Confidence 45778999999999999999999999999987765 9999999987654433334556889999999987655 44 44
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+|+||||+++|++++|..||........... .............+++.+++++++||..+|.+||++.+++.|||+
T Consensus 183 ~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 183 ADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999977553222222 111111112223578999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=207.04 Aligned_cols=159 Identities=28% Similarity=0.400 Sum_probs=120.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.++++||++|++|+||||+||+++.++. +||+|||++....... ......++..|+|||.+.+....
T Consensus 102 ~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 179 (287)
T cd07840 102 IKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY 179 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCcccccccccccccCCceeeEccccC
Confidence 3567789999999999999999999999999998776 9999999987654332 12234567889999987654433
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-CCCCC-----------------------CCC-CCHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPD-----------------------YVH-ISPE 142 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~-----------------------~~~-~~~~ 142 (254)
+.++||||||+++|+|++|..||.................... ...+. ... +++.
T Consensus 180 ~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (287)
T cd07840 180 GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPS 259 (287)
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHH
Confidence 4559999999999999999999987665444443332111000 00000 011 3889
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+.+++++||..+|.+||++.+++.||||
T Consensus 260 ~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 260 ALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=206.48 Aligned_cols=159 Identities=25% Similarity=0.361 Sum_probs=121.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.++.|||++|++|+||+|+||+++.++. ++|+|||++.............++..|+|||.+.+....+.
T Consensus 101 ~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 178 (283)
T cd07830 101 IRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSS 178 (283)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCC
Confidence 3456789999999999999999999999999988766 99999999976544333344568889999998865443344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cCCCCC---------CCCCCCHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIP---------DYVHISPECRH 145 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~---------~~~~~~~~~~~ 145 (254)
++|+||||+++++|++|++||..........+....... .....+ .....+..+++
T Consensus 179 ~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (283)
T cd07830 179 PVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAID 258 (283)
T ss_pred ccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHH
Confidence 599999999999999999999876654443332211000 000000 01123688999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+|++||..+|.+|||+.+++.||||
T Consensus 259 li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 259 LIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHhcccCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=205.05 Aligned_cols=159 Identities=31% Similarity=0.498 Sum_probs=132.6
Q ss_pred ccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccC
Q 025350 5 AVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 5 ~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~ 83 (254)
+.+........+++-+|-+||++|||+||||.+||+++..+. +||+|||+++.... .....+.+|||-|+|||++.-
T Consensus 447 FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y 524 (683)
T KOG0696|consen 447 FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY 524 (683)
T ss_pred cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeecccccccccCCcceeeecCCCcccccceEEe
Confidence 444555666778999999999999999999999999998876 99999999986433 334567799999999999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH--
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-- 161 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-- 161 (254)
.+|.. ++|+||+|++||||+.|++||.+.+....+..+. ......|. .+|.++.++.+.+|.+.|.+|...
T Consensus 525 qPYgk-svDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~----ehnvsyPK--slSkEAv~ickg~ltK~P~kRLGcg~ 597 (683)
T KOG0696|consen 525 QPYGK-SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM----EHNVSYPK--SLSKEAVAICKGLLTKHPGKRLGCGP 597 (683)
T ss_pred ccccc-chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----HccCcCcc--cccHHHHHHHHHHhhcCCccccCCCC
Confidence 88864 4999999999999999999999987766665544 33444444 489999999999999999999853
Q ss_pred ---hHHhcCccccc
Q 025350 162 ---PEIRNHEWFLK 172 (254)
Q Consensus 162 ---~e~l~hp~~~~ 172 (254)
++|..||||+.
T Consensus 598 ~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 598 EGERDIREHPFFRR 611 (683)
T ss_pred ccccchhhCcchhh
Confidence 68999999965
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=204.93 Aligned_cols=159 Identities=28% Similarity=0.367 Sum_probs=121.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-----CCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 84 (254)
...++.|++.++.+||++|++|+||+|+||+++.++. .+||+|||.+........ .....++..|+|||.+.+.
T Consensus 105 ~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 183 (268)
T cd06630 105 IINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183 (268)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccccCCccccccccccceeCHhHhccC
Confidence 3456789999999999999999999999999976542 489999999875433211 1223578899999999877
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.++.+ +|+||+|+++|++++|..||.......... .................+++.+.+++.+||..+|.+||++.++
T Consensus 184 ~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 184 QYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred CCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 76655 899999999999999999997544322222 2222222222222223578999999999999999999999999
Q ss_pred hcCcccc
Q 025350 165 RNHEWFL 171 (254)
Q Consensus 165 l~hp~~~ 171 (254)
++||||+
T Consensus 262 l~~~~~~ 268 (268)
T cd06630 262 LKHPVFR 268 (268)
T ss_pred hcCcccC
Confidence 9999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=205.38 Aligned_cols=159 Identities=27% Similarity=0.382 Sum_probs=119.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
+..++.+++.++++||++||+||||+|+||+++.++. +||+|||.+....... ......++..|+|||.+.+....+
T Consensus 100 ~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 177 (282)
T cd07829 100 IKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYS 177 (282)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCC
Confidence 4556789999999999999999999999999988765 9999999987543322 222335677899999987663334
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc--------------cCCCCC---------CCCCCCHHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------VQYSIP---------DYVHISPECRH 145 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~---------~~~~~~~~~~~ 145 (254)
.++|+|||||++|++++|..||..........+....... .....+ ....++..+.+
T Consensus 178 ~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (282)
T cd07829 178 TAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGID 257 (282)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHH
Confidence 4599999999999999999999876544443332221100 000001 11234788999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+|++||..+|.+||++.+++.||||
T Consensus 258 ~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 258 LLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHhhccCcccCCCHHHHhhCcCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=207.48 Aligned_cols=159 Identities=28% Similarity=0.431 Sum_probs=120.1
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcch
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
.++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||++....... .....++..|+|||.+.+..++.+ +
T Consensus 109 ~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~-~ 184 (287)
T cd06621 109 KIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSIT-S 184 (287)
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeeccccccccccc-cccccCCccccCHHHhcCCCCCch-h
Confidence 47788999999999999999999999999987765 9999999987543222 223457889999999987777665 9
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhcc-CCCCCC----CCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 92 DVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-QYSIPD----YVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 92 DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
|+|||||++|+|++|..||...... ............. ....+. ...+++.++++|.+||..+|.+|||+.+++
T Consensus 185 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil 264 (287)
T cd06621 185 DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264 (287)
T ss_pred hHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 9999999999999999999865210 0011111111111 111111 123567899999999999999999999999
Q ss_pred cCccccccC
Q 025350 166 NHEWFLKNL 174 (254)
Q Consensus 166 ~hp~~~~~~ 174 (254)
.||||++..
T Consensus 265 ~~~~~~~~~ 273 (287)
T cd06621 265 EHPWIKAQM 273 (287)
T ss_pred hCccccccc
Confidence 999996644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=202.90 Aligned_cols=155 Identities=28% Similarity=0.395 Sum_probs=122.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+..++.+++.+++|||+.|++|+||+|+||+++.++. ++|+|||.+........ .....++..|+|||.+.+...
T Consensus 103 ~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 180 (260)
T cd06606 103 IRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180 (260)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccccccCCCCCccccCHhhhcCCCC
Confidence 3457789999999999999999999999999988665 99999999876554432 344568899999999987766
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|+||||+++|++++|..||........ .................++..++++|.+||..+|.+||++.++++
T Consensus 181 ~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 181 GRA-ADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 555 9999999999999999999987652221 122222112222233356899999999999999999999999999
Q ss_pred Cccc
Q 025350 167 HEWF 170 (254)
Q Consensus 167 hp~~ 170 (254)
||||
T Consensus 257 ~~~~ 260 (260)
T cd06606 257 HPFL 260 (260)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=204.58 Aligned_cols=153 Identities=31% Similarity=0.391 Sum_probs=118.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC----CCCCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.++++||++|++|+||||+||+++.++. ++|+|||++...... .......++..|+|||.+.+..+
T Consensus 109 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (265)
T cd06652 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186 (265)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccccccccccccCCCCccccChhhhcCCCC
Confidence 456788999999999999999999999999987765 999999998754321 11233458889999999987766
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|+|||||++|+|++|+.||..........+ .............++..+.++|.+|| .+|++||+++++++
T Consensus 187 ~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 187 GRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred Ccc-hhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 555 9999999999999999999986543333222 22211111222346788999999999 49999999999999
Q ss_pred Ccccc
Q 025350 167 HEWFL 171 (254)
Q Consensus 167 hp~~~ 171 (254)
|||+.
T Consensus 261 ~~~~~ 265 (265)
T cd06652 261 HTFVH 265 (265)
T ss_pred CcccC
Confidence 99973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=204.52 Aligned_cols=158 Identities=30% Similarity=0.419 Sum_probs=123.4
Q ss_pred cCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCC-CCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.++++||+ .|++||||+|+||+++.++. ++|+|||++.......... ...++..|+|||.+.+..++
T Consensus 101 ~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~ 178 (264)
T cd06623 101 LAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS 178 (264)
T ss_pred HHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCcccceeecccccCHhhhCCCCCC
Confidence 45677899999999999 99999999999999988765 9999999987654333222 44678899999998877665
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCC-CCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+||||+++|+|++|..||..... .........+.... ..+.... ++..+.++|.+||..+|++|||+.++++
T Consensus 179 ~~-~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 179 YA-ADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGP-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhcCC-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 55 9999999999999999999987642 11122222222221 1222223 7899999999999999999999999999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
||||+.
T Consensus 256 ~~~~~~ 261 (264)
T cd06623 256 HPFIKK 261 (264)
T ss_pred CHHHHh
Confidence 999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=207.72 Aligned_cols=159 Identities=29% Similarity=0.500 Sum_probs=124.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+++|||++|++||||+|+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.+
T Consensus 119 ~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~ 196 (292)
T cd06657 119 AAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196 (292)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccccCccccCHHHhcCCCCCch
Confidence 456788999999999999999999999999988765 9999999886543222 2233468899999999877666554
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+||+|+++|+|++|..||.+......... ..... .........+++.+.+++.+||..+|.+||++.++++|||
T Consensus 197 -~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 197 -VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDNL--PPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhhC--CcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 9999999999999999999987544333222 21111 1122233457899999999999999999999999999999
Q ss_pred ccccCC
Q 025350 170 FLKNLP 175 (254)
Q Consensus 170 ~~~~~~ 175 (254)
|.+..+
T Consensus 273 ~~~~~~ 278 (292)
T cd06657 273 LAKAGP 278 (292)
T ss_pred HhccCC
Confidence 987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=208.20 Aligned_cols=156 Identities=33% Similarity=0.594 Sum_probs=119.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----------------CCCCCcCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKSTVGTP 73 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----------------~~~~~~~~~ 73 (254)
...++.+++.+++|||++|++||||||+||+++.++. +||+|||+++...... ......++.
T Consensus 103 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (305)
T cd05609 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180 (305)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCccccccccccccchhhccccCCccCc
Confidence 3456778999999999999999999999999987765 9999999886311100 011234678
Q ss_pred CcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC-CCCCCHHHHHHHHHhch
Q 025350 74 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLISRIFV 152 (254)
Q Consensus 74 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~ 152 (254)
.|+|||.+.+..++.+ +|+|||||++|++++|..||.+........ .........+. ...++..++++|.+||.
T Consensus 181 ~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 255 (305)
T cd05609 181 EYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFG----QVISDDIEWPEGDEALPADAQDLISRLLR 255 (305)
T ss_pred cccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCCCCccccCCHHHHHHHHHHhc
Confidence 8999999887777655 999999999999999999998754432222 22222222222 12478999999999999
Q ss_pred hCCCCCCC---HhHHhcCccccc
Q 025350 153 ADPAKRIS---IPEIRNHEWFLK 172 (254)
Q Consensus 153 ~dP~~Rps---~~e~l~hp~~~~ 172 (254)
.+|.+||+ +.++++||||+.
T Consensus 256 ~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 256 QNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cChhhccCccCHHHHHhCccccC
Confidence 99999997 789999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=215.45 Aligned_cols=149 Identities=23% Similarity=0.377 Sum_probs=115.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..++
T Consensus 215 ~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 292 (374)
T cd05106 215 LRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYT 292 (374)
T ss_pred HHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCC
Confidence 457789999999999999999999999999987665 99999999875433221 1122345679999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||............. ......+....+++++++++.+||+.||.+|||+.++++
T Consensus 293 ~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 293 VQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred cc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----HcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 65 999999999999997 999998754433332222 222222223346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=203.44 Aligned_cols=152 Identities=27% Similarity=0.472 Sum_probs=120.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.+||++|++|+||+|+||+++.++. ++|+|||++........ .....+++.|+|||++.+...+.+
T Consensus 104 ~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 181 (256)
T cd08218 104 LDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181 (256)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCc
Confidence 456789999999999999999999999999987765 99999999875433221 123457889999999987776555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+|||||++|++++|..||........... ...... .+....++..+.++|.+||+.+|.+||++.++++|||
T Consensus 182 -~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 182 -SDIWALGCVLYEMCTLKHAFEAGNMKNLVLK----IIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred -cchhHHHHHHHHHHcCCCCccCCCHHHHHHH----HhcCCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 8999999999999999999986544333222 222221 1223457899999999999999999999999999999
Q ss_pred c
Q 025350 170 F 170 (254)
Q Consensus 170 ~ 170 (254)
|
T Consensus 256 ~ 256 (256)
T cd08218 256 I 256 (256)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=204.08 Aligned_cols=155 Identities=28% Similarity=0.413 Sum_probs=122.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.+++.++.|||++|++|+||+|+||+++.++. ++|+|||.+.............++..|+|||.+.+..++.+
T Consensus 102 ~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 179 (258)
T cd05578 102 VKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVA 179 (258)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCc
Confidence 3456789999999999999999999999999988765 99999999876544433344568889999999987776555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH--hHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI--PEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~--~e~l~h 167 (254)
+|+||||+++|+|++|..||...... .............. .....++..+.++|.+||..||.+||++ .++++|
T Consensus 180 -~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 180 -VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADV--LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred -ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccc--cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 99999999999999999999876542 11111111111222 2233578999999999999999999999 999999
Q ss_pred ccc
Q 025350 168 EWF 170 (254)
Q Consensus 168 p~~ 170 (254)
|||
T Consensus 256 ~~~ 258 (258)
T cd05578 256 PYF 258 (258)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-31 Score=210.86 Aligned_cols=161 Identities=24% Similarity=0.343 Sum_probs=128.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++...+++|+|||...-+|||||..|||++..+. .||+|||+|...... ...++..|||.|||||++..-+|+.
T Consensus 131 Is~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~ 208 (502)
T KOG0574|consen 131 ISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDT 208 (502)
T ss_pred HHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccch
Confidence 3455667889999999999999999999999988776 999999999765433 2345678999999999999999988
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
. +||||||++..+|..|++||..-.... .+.--.......+..+..+|.++-+|+++||.++|++|.|+.++++||
T Consensus 209 ~-ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 209 K-ADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred h-hhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 7 899999999999999999998643322 111111222233333445789999999999999999999999999999
Q ss_pred cccccCCc
Q 025350 169 WFLKNLPA 176 (254)
Q Consensus 169 ~~~~~~~~ 176 (254)
|+++.-+.
T Consensus 285 FiknA~g~ 292 (502)
T KOG0574|consen 285 FIKNAPGC 292 (502)
T ss_pred hhcCCCcc
Confidence 99774443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=213.73 Aligned_cols=159 Identities=21% Similarity=0.345 Sum_probs=113.8
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCcccchhccC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~ 83 (254)
.++.|++.+|+|||++||+||||||+||+++.++. ++++||+.+........ .....++..|+|||++.+
T Consensus 105 ~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 105 NILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCccccccccccccccCccCccChhhhcC
Confidence 57789999999999999999999999999987765 99999985532211111 111234567999999876
Q ss_pred CCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH------------------------------------
Q 025350 84 KEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI------------------------------------ 126 (254)
Q Consensus 84 ~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------------------------------------ 126 (254)
... .+.++|||||||++|+|++|..||................
T Consensus 183 ~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (328)
T cd08226 183 DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAG 262 (328)
T ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccc
Confidence 421 2345999999999999999999998754333222211100
Q ss_pred -----hccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 127 -----LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 127 -----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
.......+....+++.+++||++||..||.+|||+.++++||||..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 263 MTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred cccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0000011112235678999999999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=236.68 Aligned_cols=157 Identities=15% Similarity=0.190 Sum_probs=113.0
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-----------------CCcEEEecCCCcccCCCCC-------
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-----------------APRLKICDFGYSKSSVLHS------- 64 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-----------------~~~vkl~Dfg~a~~~~~~~------- 64 (254)
....++.|++.||.|||++||+||||||+||||+..+ ...+|++|||+++......
T Consensus 81 ~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~ 160 (793)
T PLN00181 81 ECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKL 160 (793)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhh
Confidence 3456788999999999999999999999999995422 2347777888775321100
Q ss_pred ----------CCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC
Q 025350 65 ----------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 134 (254)
Q Consensus 65 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 134 (254)
......||+.|+|||++.+..++.+ +|||||||++|||++|.+|+.... ........... .+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-----~~ 232 (793)
T PLN00181 161 EEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCA-SDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-----PP 232 (793)
T ss_pred hccccCCCcccccccCCCcceEChhhhccCCCCch-hhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-----Ch
Confidence 0011357889999999988888655 999999999999999988875321 11111111111 11
Q ss_pred CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 135 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 135 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
......+....++.+||..+|.+||++.++++||||.+.
T Consensus 233 ~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 233 QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 111124567789999999999999999999999999763
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=206.79 Aligned_cols=149 Identities=23% Similarity=0.291 Sum_probs=114.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||++..............+..|+|||.+.+..++.+
T Consensus 122 ~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~- 198 (297)
T cd05089 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK- 198 (297)
T ss_pred HHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-
Confidence 457789999999999999999999999999987765 99999999864322111122233557999999987777655
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 91 ADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 91 ~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|||||||++|+|++ |..||........... ... ....+....++..+++|+.+||..+|.+|||++++++.
T Consensus 199 ~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 199 SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----LPQ-GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999997 9999987654333222 221 22223334578999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=212.38 Aligned_cols=160 Identities=23% Similarity=0.282 Sum_probs=121.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+++|||+.||+||||||+||+++.++. +||+|||++..... ......+++.|+|||.+.+....+.+
T Consensus 121 ~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 196 (343)
T cd07880 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQT 196 (343)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccccccccc--CccccccCCcccCHHHHhCCCCCCcH
Confidence 457789999999999999999999999999987765 99999999875432 22334678899999998764333455
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------------------cCCCC------CCCCCCCHHHHH
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------------VQYSI------PDYVHISPECRH 145 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------------~~~~~------~~~~~~~~~~~~ 145 (254)
+|+|||||++|++++|..||.+................ ..... .....+++.+.+
T Consensus 197 ~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (343)
T cd07880 197 VDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVN 276 (343)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHH
Confidence 99999999999999999999876543333222211000 00000 011346888999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
+|.+||..||.+|||+.+++.||||+...
T Consensus 277 li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 277 VLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 99999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=206.23 Aligned_cols=152 Identities=23% Similarity=0.340 Sum_probs=115.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccC---CCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK---KEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~---~~~ 86 (254)
..+..|++.+++|||++||+||||||+||+++.++. +||+|||++....... ......++..|+|||.+.. ..+
T Consensus 109 ~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 186 (267)
T cd06646 109 AYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186 (267)
T ss_pred HHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCccccCccccCHhHcccccCCCC
Confidence 446778999999999999999999999999987765 9999999987543222 2234468889999998742 334
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC---CCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS---IPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
+ .++|+||+||++|+|++|..||........... ....... .+....++..+.+||++||..+|.+|||+++
T Consensus 187 ~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 187 N-QLCDIWAVGITAIELAELQPPMFDLHPMRALFL----MSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred c-chhhHHHHHHHHHHHHhCCCCccccchhhhhee----eecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 3 459999999999999999999965432221111 1111111 1122346899999999999999999999999
Q ss_pred HhcCcc
Q 025350 164 IRNHEW 169 (254)
Q Consensus 164 ~l~hp~ 169 (254)
+++|+|
T Consensus 262 il~~l~ 267 (267)
T cd06646 262 LLTHLF 267 (267)
T ss_pred HhcCCC
Confidence 999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=201.76 Aligned_cols=152 Identities=27% Similarity=0.386 Sum_probs=121.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.|||+.|++||||+|+||+++.++. +||+|||++....... ......+++.|+|||.+.+..++.+
T Consensus 104 ~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~ 181 (256)
T cd08221 104 LWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFK 181 (256)
T ss_pred HHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCc
Confidence 456788999999999999999999999999988765 9999999987543332 2334568999999999987776555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+||||+++|+|++|..||........... +...... +....++..+.+++.+||..+|.+||++.++++|||
T Consensus 182 -~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 182 -SDIWALGCVLYELLTLKRTFDATNPLNLVVK----IVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred -chhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 8999999999999999999987554333322 2222222 222457899999999999999999999999999998
Q ss_pred c
Q 025350 170 F 170 (254)
Q Consensus 170 ~ 170 (254)
+
T Consensus 256 l 256 (256)
T cd08221 256 L 256 (256)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=204.86 Aligned_cols=160 Identities=23% Similarity=0.427 Sum_probs=121.7
Q ss_pred CCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..+..+++.++.|||+ .|++||||||+||+++.++. ++|+|||++...... ......++..|+|||++.+..++.+
T Consensus 106 ~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~ 182 (284)
T cd06620 106 GKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVK 182 (284)
T ss_pred HHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCcc
Confidence 4567789999999996 69999999999999987765 999999988653222 2234578999999999877766655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
+|+|||||++|++++|+.||...... ......................++..+.+|+.+||..||.+|||+.
T Consensus 183 -~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~ 261 (284)
T cd06620 183 -SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQ 261 (284)
T ss_pred -chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHH
Confidence 99999999999999999999865432 1111222222222211111123678999999999999999999999
Q ss_pred HHhcCccccccC
Q 025350 163 EIRNHEWFLKNL 174 (254)
Q Consensus 163 e~l~hp~~~~~~ 174 (254)
++++|+||.+..
T Consensus 262 e~~~~~~~~~~~ 273 (284)
T cd06620 262 QLCAMPPFIQAL 273 (284)
T ss_pred HHhcCccccccc
Confidence 999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=219.89 Aligned_cols=157 Identities=24% Similarity=0.405 Sum_probs=126.4
Q ss_pred CcCCcHHHHHHHHHHHhhc--CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPF--NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~--givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+...+-.|++++|.|||++ -|||||||-+||||+.+. +.|||+|+|+|.... .+...+.+|||.|||||++. ..|
T Consensus 144 aik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDLGLAtl~r-~s~aksvIGTPEFMAPEmYE-E~Y 220 (632)
T KOG0584|consen 144 AIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDLGLATLLR-KSHAKSVIGTPEFMAPEMYE-ENY 220 (632)
T ss_pred HHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc-CceeecchhHHHHhh-ccccceeccCccccChHHHh-hhc
Confidence 3455678999999999966 599999999999998654 579999999998653 33445578999999999996 667
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.. +||||||++++||+|+..||.....+.+. ++++..+..+.....--.+++++||.+||.. .+.|+|+.|+|.
T Consensus 221 nE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQI---YKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 221 NEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQI---YKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred chh-hhhhhhhHHHHHHHhccCChhhhCCHHHH---HHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 766 99999999999999999999988766544 3444444332222222368999999999999 999999999999
Q ss_pred Ccccccc
Q 025350 167 HEWFLKN 173 (254)
Q Consensus 167 hp~~~~~ 173 (254)
||||...
T Consensus 296 d~Ff~~d 302 (632)
T KOG0584|consen 296 DPFFDED 302 (632)
T ss_pred Chhhccc
Confidence 9999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=202.29 Aligned_cols=146 Identities=23% Similarity=0.299 Sum_probs=114.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.++.|||++||+||||||+||+++.++. ++|+|||.+...... .....++..|+|||.+.+..++.+
T Consensus 87 ~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 162 (237)
T cd05576 87 VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEA 162 (237)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccCCCCCCch
Confidence 3456788999999999999999999999999988776 999999987654322 233456778999999877766555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH-----hHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-----PEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~ 164 (254)
+|+||+|+++|+|++|..||....... . .......| ..+++.++++|.+||+.||.+||++ +++
T Consensus 163 -~DvwslG~il~el~~g~~~~~~~~~~~------~--~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 231 (237)
T cd05576 163 -CDWWSLGAILFELLTGKTLVECHPSGI------N--THTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231 (237)
T ss_pred -hhHHHHHHHHHHHHHCcchhhcCchhc------c--cccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccchHHH
Confidence 899999999999999998876432110 0 01111222 3478999999999999999999986 999
Q ss_pred hcCccc
Q 025350 165 RNHEWF 170 (254)
Q Consensus 165 l~hp~~ 170 (254)
++||||
T Consensus 232 ~~h~~~ 237 (237)
T cd05576 232 KSHPFF 237 (237)
T ss_pred HcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=207.32 Aligned_cols=153 Identities=25% Similarity=0.363 Sum_probs=119.4
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC---CCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK---KEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~ 88 (254)
.++.|++.+++|||++|++|+||+|+||+++.++. +||+|||++.... ......++..|+|||.+.. ..++.
T Consensus 125 ~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (313)
T cd06633 125 AITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDG 199 (313)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCc
Confidence 36788999999999999999999999999987765 9999999886432 2234568889999999842 33444
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
++|+|||||++|+|++|..||............. ...........++..+++|+.+||+.+|.+||++.++++||
T Consensus 200 -~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 200 -KVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred -hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 4999999999999999999998765433333222 11111112234678899999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||....
T Consensus 275 ~~~~~~ 280 (313)
T cd06633 275 FVRRDR 280 (313)
T ss_pred ccCCCc
Confidence 997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=208.85 Aligned_cols=149 Identities=21% Similarity=0.324 Sum_probs=117.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC---CCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++........ ....++..|+|||.+.+..++
T Consensus 112 ~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~ 189 (316)
T cd05108 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189 (316)
T ss_pred HHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCCCcceeccCCccceeecChHHhccCCCC
Confidence 346679999999999999999999999999987765 999999999865432221 122345679999999887776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|++++ |..||.+..... ... ........+....++..+.+++.+||..+|.+||++.+++.
T Consensus 190 ~~-~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 190 HQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 263 (316)
T ss_pred ch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 55 999999999999997 999998654322 222 22233344444567899999999999999999999999998
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 264 ~ 264 (316)
T cd05108 264 E 264 (316)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=204.53 Aligned_cols=149 Identities=19% Similarity=0.268 Sum_probs=115.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+++|||++||+||||||+||+++.++. +||+|||+++....... .....+++.|+|||.+.+..++
T Consensus 127 ~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05091 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS 204 (283)
T ss_pred HHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--eEecccccccccccchheeeccCccCCccccCHHHHhcCCCC
Confidence 346789999999999999999999999999987765 99999999875432221 1233457789999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+....... ..+.... ..+....++..+.+|+.+||+.+|.+||++.+++.
T Consensus 205 ~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 205 ID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVI----EMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred cc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 55 999999999999998 88898775443322 2222222 22233468899999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
.
T Consensus 279 ~ 279 (283)
T cd05091 279 R 279 (283)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=207.58 Aligned_cols=157 Identities=25% Similarity=0.384 Sum_probs=122.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++++||++|++||||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+..++.+
T Consensus 118 ~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 195 (293)
T cd06647 118 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195 (293)
T ss_pred HHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceecccccccccccccCChhhcCchhhccCCCCch
Confidence 456788999999999999999999999999987765 9999999886543322 2233468889999999887766555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+||||+++|++++|..||............ ........+....++..++++|.+||..+|.+||++.+++.|+|
T Consensus 196 -~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 196 -VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 99999999999999999999865433221111 11112223333456889999999999999999999999999999
Q ss_pred cccc
Q 025350 170 FLKN 173 (254)
Q Consensus 170 ~~~~ 173 (254)
|+..
T Consensus 272 ~~~~ 275 (293)
T cd06647 272 LKIA 275 (293)
T ss_pred HhcC
Confidence 9753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=204.80 Aligned_cols=154 Identities=26% Similarity=0.333 Sum_probs=120.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++.|||++|++|+||+|+||+++.++. ++|+|||++........ .....++..|+|||.+.+..++.+
T Consensus 104 ~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (277)
T cd06642 104 ATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181 (277)
T ss_pred HHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchh
Confidence 456788999999999999999999999999987765 99999999875433221 223457889999999987776655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+|||||++|+|++|..||........... ... .........++..+.+++.+||..+|.+||++.++++|||
T Consensus 182 -~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 182 -ADIWSLGITAIELAKGEPPNSDLHPMRVLFL----IPK-NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred -hhHHHHHHHHHHHHhCCCCCcccchhhHHhh----hhc-CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 9999999999999999999975443222111 111 1111112346889999999999999999999999999999
Q ss_pred ccc
Q 025350 170 FLK 172 (254)
Q Consensus 170 ~~~ 172 (254)
|.+
T Consensus 256 ~~~ 258 (277)
T cd06642 256 ITR 258 (277)
T ss_pred HHH
Confidence 975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=200.45 Aligned_cols=154 Identities=28% Similarity=0.418 Sum_probs=120.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.+++.++.|||+.|++|+||||+||+++.++. .+||+|||.+........ .....|++.|+|||.+.+..++.
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~ 181 (257)
T cd08225 103 ILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181 (257)
T ss_pred HHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCc
Confidence 4456788999999999999999999999999987643 479999999875533222 12345888999999987777665
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|+||||+++|++++|..||........... ..... ..+....++..+++++.+||..+|.+|||+.++++||
T Consensus 182 ~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 182 K-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----ICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 5 9999999999999999999986543332222 22211 1122235688999999999999999999999999999
Q ss_pred cc
Q 025350 169 WF 170 (254)
Q Consensus 169 ~~ 170 (254)
||
T Consensus 256 ~~ 257 (257)
T cd08225 256 FL 257 (257)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=204.02 Aligned_cols=155 Identities=28% Similarity=0.381 Sum_probs=120.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++++||++|++|+||+|+||+++.++. ++|+|||++....... ......++..|+|||.+.+..++.+
T Consensus 104 ~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 181 (277)
T cd06640 104 ATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181 (277)
T ss_pred HHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCccccccccCcccccCHhHhccCCCccH
Confidence 346678999999999999999999999999987765 9999999987543322 1223457889999999987776655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+|||||++|+|++|..||........... . ...........++..+.+++.+||..+|.+||++.++++|||
T Consensus 182 -~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 182 -ADIWSLGITAIELAKGEPPNSDMHPMRVLFL----I-PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred -HHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----h-hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 9999999999999999999986543322211 1 111111122346789999999999999999999999999999
Q ss_pred cccc
Q 025350 170 FLKN 173 (254)
Q Consensus 170 ~~~~ 173 (254)
|.+.
T Consensus 256 ~~~~ 259 (277)
T cd06640 256 IVKN 259 (277)
T ss_pred hhhc
Confidence 9653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=205.23 Aligned_cols=151 Identities=23% Similarity=0.288 Sum_probs=113.1
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.++.|++.+++|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..++.
T Consensus 142 ~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 219 (304)
T cd05096 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219 (304)
T ss_pred HHHHHHHHHHHHHHHCCccccCcchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCc
Confidence 57889999999999999999999999999987765 99999999875432211 12234577899999988777765
Q ss_pred cchhHHHHHHHHHHHHh--CCCCCCCCCchHHHHHHHHHHhcc--CCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 89 KIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
+ +|||||||++|+|++ +..||................... .........++..+.+|+.+||..+|.+|||+.+|
T Consensus 220 ~-~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 220 A-SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred h-hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 5 999999999999986 567887655433332221111111 11111223578999999999999999999999999
Q ss_pred h
Q 025350 165 R 165 (254)
Q Consensus 165 l 165 (254)
.
T Consensus 299 ~ 299 (304)
T cd05096 299 H 299 (304)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=201.99 Aligned_cols=149 Identities=23% Similarity=0.304 Sum_probs=115.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||.+.+..++
T Consensus 115 ~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 192 (272)
T cd05075 115 VKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT 192 (272)
T ss_pred HHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcC
Confidence 455678999999999999999999999999987765 99999999876433221 1222456789999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+|||||++|+|++ |..||.+........ .+.... ..+....++..++++|.+||+.||.+|||+.++++
T Consensus 193 ~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 193 TK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYD----YLRQGN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred hH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 55 999999999999999 889997754432222 222221 22233457899999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 267 ~ 267 (272)
T cd05075 267 E 267 (272)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=199.56 Aligned_cols=152 Identities=24% Similarity=0.351 Sum_probs=120.1
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 84 (254)
.....++.|++.++.+||++|++||||||+||+++.++. +||+|||.+....... ......++..|+|||.+.+.
T Consensus 105 ~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 105 KDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred HHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccccccccccCCCcCccccCHHHhccC
Confidence 334567889999999999999999999999999988765 9999999998654332 12334578899999999877
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.++.+ +|+||||+++|+|++ |..||........... +.. ....+....++..+.+++.+||..+|.+|||+.+
T Consensus 183 ~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 256 (262)
T cd00192 183 IFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSE 256 (262)
T ss_pred Ccchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHH
Confidence 66555 999999999999999 6999987654333222 221 2233334457899999999999999999999999
Q ss_pred HhcC
Q 025350 164 IRNH 167 (254)
Q Consensus 164 ~l~h 167 (254)
++++
T Consensus 257 l~~~ 260 (262)
T cd00192 257 LVER 260 (262)
T ss_pred HHHh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=211.20 Aligned_cols=150 Identities=27% Similarity=0.373 Sum_probs=115.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..++
T Consensus 217 ~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 294 (375)
T cd05104 217 LSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYT 294 (375)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCC
Confidence 346789999999999999999999999999987665 99999999875433221 1122345679999999887776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||..........+.+.. ......+...+.++++|+.+||..||++|||+.++++
T Consensus 295 ~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 295 FE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred CC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 55 999999999999998 88999775544333333222 1122222346889999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
.
T Consensus 370 ~ 370 (375)
T cd05104 370 L 370 (375)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=199.64 Aligned_cols=153 Identities=32% Similarity=0.440 Sum_probs=121.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.+++.++.+||++|++|+||+|+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.
T Consensus 105 ~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~ 182 (258)
T cd08215 105 ILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNY 182 (258)
T ss_pred HHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcceecceeeeecccChhHhccCCCCc
Confidence 3456789999999999999999999999999987665 9999999987644332 223346888999999988777665
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|+||+|+++++|++|..||......... ....... ..+....++..+.+++.+||..+|.+|||+.++++||
T Consensus 183 ~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 256 (258)
T cd08215 183 K-SDIWSLGCVLYELCTLKHPFEGENLLELA----LKILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256 (258)
T ss_pred c-ccHHHHHHHHHHHHcCCCCCCCCcHHHHH----HHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCC
Confidence 5 99999999999999999999765532222 2222221 1222235789999999999999999999999999999
Q ss_pred cc
Q 025350 169 WF 170 (254)
Q Consensus 169 ~~ 170 (254)
||
T Consensus 257 ~~ 258 (258)
T cd08215 257 FI 258 (258)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=205.33 Aligned_cols=153 Identities=25% Similarity=0.348 Sum_probs=118.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC---CCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK---KEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~ 87 (254)
..++.+++.++.|||++|++||||+|+||+++.++. +||+|||++..... .....+++.|+|||.+.+ ..++
T Consensus 118 ~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 192 (308)
T cd06634 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYD 192 (308)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC---cccccCCccccCHHHHhhcccCCCC
Confidence 445678999999999999999999999999987765 99999998865322 234468889999999752 3344
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
. ++|||||||++|+|++|..||............ ............++..+++||++||..+|.+||++.++++|
T Consensus 193 ~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 193 G-KVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred c-ccchHHHHHHHHHHHcCCCCCccccHHHHHHHH----hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 4 499999999999999999999765432222221 11111111223578899999999999999999999999999
Q ss_pred cccccc
Q 025350 168 EWFLKN 173 (254)
Q Consensus 168 p~~~~~ 173 (254)
||+...
T Consensus 268 ~~~~~~ 273 (308)
T cd06634 268 RFVLRE 273 (308)
T ss_pred cccccc
Confidence 999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=199.12 Aligned_cols=149 Identities=23% Similarity=0.254 Sum_probs=114.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
...+..|++.++++||++||+||||||.||+++.++. +||+|||++........ .....++..|+|||.+....
T Consensus 97 ~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05116 97 ITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174 (257)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCC
Confidence 4556789999999999999999999999999987765 99999999875433221 11223457899999987666
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|+|||||++|+|++ |..||........... +... ...+.+..++++++++|.+||+.||.+||++++|
T Consensus 175 ~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----i~~~-~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i 248 (257)
T cd05116 175 FSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM----IESG-ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248 (257)
T ss_pred cCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHCC-CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence 6555 999999999999998 9999987544322222 2221 2223334589999999999999999999999988
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
..
T Consensus 249 ~~ 250 (257)
T cd05116 249 EL 250 (257)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=203.58 Aligned_cols=158 Identities=31% Similarity=0.460 Sum_probs=120.8
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCC-CCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKE-YDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~ 88 (254)
.++.|++.++.+||+.|++||||+|+|||++.++. +||+|||++....... ......++..|+|||.+.+.. ...
T Consensus 109 ~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 186 (290)
T cd05613 109 IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186 (290)
T ss_pred HHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccccccccccccCCcccCChhhccCCCCCCC
Confidence 34558999999999999999999999999987765 9999999987543321 122346889999999986532 223
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e 163 (254)
.++||||||+++|+|++|..||....................... ...+++.+.+++.+||..+|.+|| ++.+
T Consensus 187 ~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~ 264 (290)
T cd05613 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADE 264 (290)
T ss_pred ccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC--CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 449999999999999999999975433333333333333333222 234789999999999999999997 8999
Q ss_pred HhcCcccccc
Q 025350 164 IRNHEWFLKN 173 (254)
Q Consensus 164 ~l~hp~~~~~ 173 (254)
++.||||.+.
T Consensus 265 l~~~~~~~~~ 274 (290)
T cd05613 265 IKKHPFFQKI 274 (290)
T ss_pred HHcCcccccC
Confidence 9999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=203.66 Aligned_cols=158 Identities=28% Similarity=0.430 Sum_probs=123.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
+..++.+++.++++||+.||+|+||+|+||+++.++. ++|+|||++....... ......++..|+|||.+.+..++.
T Consensus 118 ~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 195 (286)
T cd06614 118 IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195 (286)
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCC
Confidence 3457889999999999999999999999999987765 9999999876433221 122335788999999998777765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|+||||+++|+|++|..||............. .......+....++..++++|.+||+.+|.+|||+.++++|+
T Consensus 196 ~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 196 K-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred c-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 5 999999999999999999998654433222211 111222223334789999999999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
||++.
T Consensus 272 ~~~~~ 276 (286)
T cd06614 272 FLKKA 276 (286)
T ss_pred Hhhcc
Confidence 99873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=201.88 Aligned_cols=148 Identities=20% Similarity=0.333 Sum_probs=114.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC---CCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..+..|++.+++|||++||+||||||+|||++.++. +||+|||+++........ ....+++.|+|||.+.+..++
T Consensus 112 ~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (279)
T cd05109 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189 (279)
T ss_pred HHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCC
Confidence 456789999999999999999999999999987665 999999998765332211 122346789999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|++++ |..||....... ....+ ......+....++..+.+++.+||..||++||++.+++.
T Consensus 190 ~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 190 HQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLL----EKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH----HCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55 999999999999998 899997644322 22222 222233334467899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=197.66 Aligned_cols=152 Identities=38% Similarity=0.558 Sum_probs=121.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++...... .......++..|+|||.+.+...+.
T Consensus 95 ~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~ 172 (250)
T cd05123 95 ARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172 (250)
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCc
Confidence 3456778999999999999999999999999988765 999999998765433 1233456788999999997776655
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH---hHHh
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI---PEIR 165 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~---~e~l 165 (254)
. +|+||||+++|++++|..||....... ....+...... ....++..+.+++++||..||.+||++ .+++
T Consensus 173 ~-~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~ 245 (250)
T cd05123 173 A-VDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILKDPLR--FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIK 245 (250)
T ss_pred h-hhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCCCC--CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence 5 999999999999999999997654422 22223233333 333468999999999999999999999 9999
Q ss_pred cCccc
Q 025350 166 NHEWF 170 (254)
Q Consensus 166 ~hp~~ 170 (254)
+||||
T Consensus 246 ~~~~f 250 (250)
T cd05123 246 AHPFF 250 (250)
T ss_pred hCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=201.01 Aligned_cols=148 Identities=22% Similarity=0.329 Sum_probs=115.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.++++||++|++||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+..++
T Consensus 125 ~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05049 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT 202 (280)
T ss_pred HHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--EEECCcccceecccCcceecCCCCcccceecChhhhccCCcc
Confidence 346788999999999999999999999999988765 9999999987432211 11233457789999999888776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||........... +...... +....++..+++++.+||..||.+||++.++++
T Consensus 203 ~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 203 TE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC----ITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred hh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 65 999999999999998 9999987654332222 2222222 222357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=216.32 Aligned_cols=149 Identities=22% Similarity=0.289 Sum_probs=114.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCC---CCCCCCCCcCCCCcccchhccC---C
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLK---K 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~---~~~~~~~~~~~~~y~aPE~~~~---~ 84 (254)
..|..|++.|+.|||.++|||||||..|||+.+++. |||+|||++.... .........|...|||||+++. .
T Consensus 491 idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~n 568 (678)
T KOG0193|consen 491 IDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDN 568 (678)
T ss_pred HHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccC
Confidence 346778999999999999999999999999987765 9999999986422 2223445568899999999873 4
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC---CCCCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---YSIPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
+|+.. +|||||||++|||++|..||....... ++..+..+- -......+++.++++|+..||.+++++||.+
T Consensus 569 PfS~q-SDVYaFGiV~YELltg~lPysi~~~dq----IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F 643 (678)
T KOG0193|consen 569 PFSFQ-SDVYAFGIVWYELLTGELPYSIQNRDQ----IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLF 643 (678)
T ss_pred CCCcc-cchhhhhHHHHHHHhCcCCcCCCChhh----eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccH
Confidence 45544 999999999999999999998433322 222222221 1112234567899999999999999999999
Q ss_pred hHHhc
Q 025350 162 PEIRN 166 (254)
Q Consensus 162 ~e~l~ 166 (254)
.+||.
T Consensus 644 ~~il~ 648 (678)
T KOG0193|consen 644 PQLLS 648 (678)
T ss_pred HHHHH
Confidence 99886
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=204.51 Aligned_cols=155 Identities=26% Similarity=0.373 Sum_probs=120.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc---CCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~ 87 (254)
..++.+++.++.|||++||+||||+|+||+++.++. +||+|||++..... .....+++.|+|||.+. ...++
T Consensus 128 ~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 202 (317)
T cd06635 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYD 202 (317)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCC
Confidence 346788999999999999999999999999987765 99999998864322 23456888999999974 23444
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
. ++|+|||||++|+|++|..||............ ............+++.+++++.+||..+|.+||++.++++|
T Consensus 203 ~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 203 G-KVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred c-cccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 4 499999999999999999999875433333222 22222222233578899999999999999999999999999
Q ss_pred ccccccCC
Q 025350 168 EWFLKNLP 175 (254)
Q Consensus 168 p~~~~~~~ 175 (254)
+|+....+
T Consensus 278 ~~~~~~~~ 285 (317)
T cd06635 278 MFVLRERP 285 (317)
T ss_pred hhhhccCc
Confidence 99966443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=206.13 Aligned_cols=150 Identities=23% Similarity=0.286 Sum_probs=114.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||++.............++..|+|||.+.+..++.+
T Consensus 126 ~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (303)
T cd05088 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 203 (303)
T ss_pred HHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc
Confidence 3457789999999999999999999999999987765 99999999864322111222234567999999877766555
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|||||||++|+|++ |..||........... . ......+....+++.+.+|+.+||..+|.+||++.+++.+
T Consensus 204 -~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 204 -SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----L-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -ccchhhhhHHHHHHhcCCCCcccCChHHHHHH----H-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999998 9999976544322221 1 2222223334578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=199.11 Aligned_cols=149 Identities=23% Similarity=0.320 Sum_probs=115.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~ 87 (254)
+..+..|++.++++||++|++||||||+||+++.++. +||+|||++......... ....++..|+|||.+.+..++
T Consensus 106 ~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 183 (263)
T cd05052 106 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183 (263)
T ss_pred HHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCC
Confidence 3456789999999999999999999999999987765 999999998765432211 112245679999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.. +|||||||++|+|++ |..||.+......... . ......+....++..+.+++.+||..+|++|||+.++++
T Consensus 184 ~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 184 IK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----L-EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H-HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 55 999999999999998 9999987543322222 1 112223334457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=191.80 Aligned_cols=161 Identities=22% Similarity=0.311 Sum_probs=124.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~ 84 (254)
......++..+|.|||...|+|||+|+.|+||+.++. +||+|||+++.++... ....++.|.+|++||.+.|.
T Consensus 126 Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~ 203 (376)
T KOG0669|consen 126 IKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD 203 (376)
T ss_pred HHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcc
Confidence 4455667999999999999999999999999998876 9999999997554322 12334579999999999987
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC--CCCCCCC-------------------------
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYV------------------------- 137 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~------------------------- 137 (254)
...+++.|+|+.||++.+|++|.+.+.+.++...+..+.. ..... -.+|...
T Consensus 204 r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~-LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~ 282 (376)
T KOG0669|consen 204 REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ-LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRL 282 (376)
T ss_pred cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH-HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhc
Confidence 7777779999999999999999999998877665543321 11100 0011100
Q ss_pred ---CCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 138 ---HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 138 ---~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
.-.++..+|+.++|..||.+|++++++++|.||.+.
T Consensus 283 kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 283 KPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 013577899999999999999999999999999764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=183.69 Aligned_cols=161 Identities=23% Similarity=0.339 Sum_probs=129.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
.+..+|+++++.+.|++++.||||||.|+||+.++. +||+|||+++.++..- .....+.|.+|.+|.++.+....+.
T Consensus 104 rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcysaevvtlwyrppdvlfgakly~t 181 (292)
T KOG0662|consen 104 RSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181 (292)
T ss_pred HHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhcc
Confidence 456789999999999999999999999999998887 9999999998765543 3344578999999999998887666
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccC-CCCCCC----------------------CCCCHHHHH
Q 025350 90 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDY----------------------VHISPECRH 145 (254)
Q Consensus 90 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~----------------------~~~~~~~~~ 145 (254)
..|+||.||++.|+.. |++.|.+.+-..++.++........ -.+|.. ++++...++
T Consensus 182 sidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grd 261 (292)
T KOG0662|consen 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRD 261 (292)
T ss_pred chHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHH
Confidence 6999999999999985 8888888877777776665432211 111211 123456789
Q ss_pred HHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
|++++|.-+|.+|++++++++||||.+.
T Consensus 262 llqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 262 LLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred HHHHHhccCcccccCHHHHhcCcccccc
Confidence 9999999999999999999999999764
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=202.10 Aligned_cols=149 Identities=23% Similarity=0.289 Sum_probs=113.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++|++||||||+||+++.++. +||+|||++..............+..|+|||++....++.+
T Consensus 114 ~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 191 (270)
T cd05047 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 191 (270)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCCccccchhhhccCCCCccccCChHHHccCCCCch
Confidence 3567788999999999999999999999999987765 99999999863322111122234567999999877776555
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 90 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 90 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+|+|||||++|+|++ |..||.+......... . ......+....++..+.+++.+||..+|.+|||+.+++.
T Consensus 192 -~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 192 -SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----L-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -hhHHHHHHHHHHHHcCCCCCccccCHHHHHHH----H-hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 999999999999997 9999976543322221 2 122222333457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=222.36 Aligned_cols=155 Identities=26% Similarity=0.463 Sum_probs=126.3
Q ss_pred ccccCcCCcHHHHHHHHHHHhhcC--cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCC----------CCcCC
Q 025350 5 AVQRGRGTLFLPTTYFWSELLPFN--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----------STVGT 72 (254)
Q Consensus 5 ~~~~~~~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~----------~~~~~ 72 (254)
+..-....||.+++.|+++||..+ |||||||.+||||+.++. .||||||.|.......... ...-|
T Consensus 141 lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TT 218 (738)
T KOG1989|consen 141 LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTT 218 (738)
T ss_pred CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccCCCccHHHHHHHHHHHHhhCC
Confidence 344456789999999999999887 999999999999988876 9999999986432222110 12468
Q ss_pred CCcccchhcc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHH
Q 025350 73 PAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 149 (254)
Q Consensus 73 ~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 149 (254)
+.|+|||.+. +.+.+.+ +|||+|||+||.|+....||...... .++...+.+|.+..++..+++||+.
T Consensus 219 p~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~l--------aIlng~Y~~P~~p~ys~~l~~LI~~ 289 (738)
T KOG1989|consen 219 PQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGKL--------AILNGNYSFPPFPNYSDRLKDLIRT 289 (738)
T ss_pred ccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcce--------eEEeccccCCCCccHHHHHHHHHHH
Confidence 9999999874 5555555 99999999999999999999875322 2567888999988999999999999
Q ss_pred hchhCCCCCCCHhHHhcCccc
Q 025350 150 IFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 150 ~L~~dP~~Rps~~e~l~hp~~ 170 (254)
||+.||.+||++-+++.+-+-
T Consensus 290 mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 290 MLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred HhccCcccCCCHHHHHHHHHH
Confidence 999999999999998876544
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=201.66 Aligned_cols=149 Identities=22% Similarity=0.312 Sum_probs=115.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+++|||++|++||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..+
T Consensus 122 ~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 199 (288)
T cd05093 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 199 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCC
Confidence 3457789999999999999999999999999987765 99999999875432211 122345778999999987776
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|+|||||++|+|++ |..||........... +..... .+....++..+.+|+.+||+.||.+|||+.+++
T Consensus 200 ~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~----i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 200 TTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC----ITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 655 999999999999998 9999987654332222 222221 122335789999999999999999999999986
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
.
T Consensus 274 ~ 274 (288)
T cd05093 274 S 274 (288)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=201.87 Aligned_cols=159 Identities=32% Similarity=0.460 Sum_probs=120.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCC-CC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKE-YD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~ 87 (254)
..++.|++.++.+||+.|++||||||.||+++.++. ++|+|||++........ .....++..|+|||.+.+.. ..
T Consensus 108 ~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 185 (288)
T cd05583 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185 (288)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccccccccccccCCccccCHHHhcCCCCCC
Confidence 345679999999999999999999999999987765 99999999875433221 12345788999999986654 22
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC---HhHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---IPEI 164 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~ 164 (254)
..++|+||||+++|+|++|..||.............+........ ....++..+++++.+||+.+|++||| +.++
T Consensus 186 ~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~ 263 (288)
T cd05583 186 DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANGADEI 263 (288)
T ss_pred cchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC--CCcccCHHHHHHHHHHhcCCHhhccCcchHHHH
Confidence 344999999999999999999997543322223333333333332 23347899999999999999999998 5677
Q ss_pred hcCcccccc
Q 025350 165 RNHEWFLKN 173 (254)
Q Consensus 165 l~hp~~~~~ 173 (254)
++||||+..
T Consensus 264 l~~~~~~~~ 272 (288)
T cd05583 264 KNHPFFQGI 272 (288)
T ss_pred hcCcccccC
Confidence 999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=202.51 Aligned_cols=149 Identities=18% Similarity=0.332 Sum_probs=115.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.+++.+++|||++||+||||||+|||++.++. +||+|||+++...... ......++..|+|||.+.+..++
T Consensus 127 ~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05090 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH--VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS 204 (283)
T ss_pred HHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--EEeccccccccccCCcceecccCCCccceecChHHhccCCCC
Confidence 347789999999999999999999999999987765 9999999997543221 12233456789999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+|||||++|+|++ |..||.+....... .. +.. ....+....+++.+++++.+||+.||.+||++.++++
T Consensus 205 ~~-~Dv~slG~il~el~~~g~~p~~~~~~~~~~-~~---~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 205 SD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVI-EM---VRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred ch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HH---HHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 55 999999999999998 99999775432222 21 111 2222334457899999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 279 ~ 279 (283)
T cd05090 279 R 279 (283)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=204.60 Aligned_cols=161 Identities=28% Similarity=0.414 Sum_probs=119.7
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcch
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
.+..|++.+++|||++||+||||+|.||+++.++. +||+|||.+..... ......++..|+|||.+.+....+.++
T Consensus 112 ~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~ 187 (328)
T cd07856 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEV 187 (328)
T ss_pred HHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHH
Confidence 45688999999999999999999999999987765 99999999875322 223446788999999886633334559
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH--------------------H--hccCCCCC---CCCCCCHHHHHH
Q 025350 92 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR--------------------I--LSVQYSIP---DYVHISPECRHL 146 (254)
Q Consensus 92 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--------------------~--~~~~~~~~---~~~~~~~~~~~l 146 (254)
|+|||||++|+|++|..||............... . .......+ ....++..++++
T Consensus 188 Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (328)
T cd07856 188 DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDL 267 (328)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHH
Confidence 9999999999999999999765432221111100 0 00000111 112467899999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
|++||+.+|.+|||+.+++.||||.....+
T Consensus 268 i~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 268 LEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=196.60 Aligned_cols=152 Identities=28% Similarity=0.405 Sum_probs=120.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.+||+.||+||||+|+||+++.++. ++|+|||.+........ .....++..|+|||.+.+..++.
T Consensus 102 ~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~- 178 (254)
T cd06627 102 AVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST- 178 (254)
T ss_pred HHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCc-
Confidence 456788999999999999999999999999987655 99999999976543322 23346888999999987766554
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|+||+|+++|+|++|..||............ ..... .+....++..+++++.+||..+|++|||+.+++.|||
T Consensus 179 ~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 253 (254)
T cd06627 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI---VQDDH--PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPW 253 (254)
T ss_pred chhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---hccCC--CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence 499999999999999999999865533222221 11112 2223457899999999999999999999999999999
Q ss_pred c
Q 025350 170 F 170 (254)
Q Consensus 170 ~ 170 (254)
|
T Consensus 254 ~ 254 (254)
T cd06627 254 I 254 (254)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=200.63 Aligned_cols=151 Identities=19% Similarity=0.244 Sum_probs=115.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.+++|||++|++||||||+||+++.++ ...+||+|||+++....... ......+..|+|||++.+..+
T Consensus 119 ~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05036 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF 198 (277)
T ss_pred HHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCc
Confidence 34788999999999999999999999999997654 23589999999875422211 112233567999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+........ . +.. .........++..+.+++.+||+.+|.+|||+.+++
T Consensus 199 ~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~-~---~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl 272 (277)
T cd05036 199 TSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-F---VTG-GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272 (277)
T ss_pred Cch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-H---HHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 655 999999999999997 999998755433222 1 211 112222345789999999999999999999999999
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
+|
T Consensus 273 ~~ 274 (277)
T cd05036 273 ER 274 (277)
T ss_pred HH
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=200.35 Aligned_cols=153 Identities=35% Similarity=0.582 Sum_probs=121.4
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---------------------CC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---------------------PK 67 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---------------------~~ 67 (254)
....++.|++.++.+||++|++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 103 ~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (280)
T cd05581 103 CTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180 (280)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCccccccCCCCCccccccccccccccc
Confidence 34567789999999999999999999999999987765 99999999875433221 12
Q ss_pred CCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHH
Q 025350 68 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147 (254)
Q Consensus 68 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 147 (254)
...++..|+|||++.+..++.. +|+||||++++++++|+.||.......... .........+ ..+++.+.+||
T Consensus 181 ~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li 253 (280)
T cd05581 181 SFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQ----KILKLEYSFP--PNFPPDAKDLI 253 (280)
T ss_pred cccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHHhcCCCCC--CccCHHHHHHH
Confidence 2357889999999877665544 999999999999999999998765433322 2222333333 35789999999
Q ss_pred HHhchhCCCCCCCH----hHHhcCccc
Q 025350 148 SRIFVADPAKRISI----PEIRNHEWF 170 (254)
Q Consensus 148 ~~~L~~dP~~Rps~----~e~l~hp~~ 170 (254)
.+||..+|.+|||+ .++++||||
T Consensus 254 ~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 254 EKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 99999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=201.30 Aligned_cols=149 Identities=21% Similarity=0.312 Sum_probs=115.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+..++.|++.+++|||++||+||||||+||+++.++. +||+|||++....... ......++..|+|||.+.+..+
T Consensus 125 ~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 202 (291)
T cd05094 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 202 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC
Confidence 4567789999999999999999999999999987765 9999999987543222 1223446788999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.......... ...... .......++..+.+++.+||..+|++|||+.+++
T Consensus 203 ~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~ 276 (291)
T cd05094 203 TTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIE----CITQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276 (291)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHhCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 655 999999999999998 999997755433222 122221 1122234688999999999999999999999987
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 277 ~ 277 (291)
T cd05094 277 K 277 (291)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=189.10 Aligned_cols=151 Identities=21% Similarity=0.215 Sum_probs=112.5
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCC
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
......++.|++.||+|||+++ ||+|||++.++. +|+ ||++...... ...|++.|+|||++.+..+
T Consensus 16 ~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g~~~y~aPE~~~~~~~ 81 (176)
T smart00750 16 EEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRVDPYFMAPEVIQGQSY 81 (176)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCCcccccChHHhcCCCC
Confidence 3345678899999999999998 999999988765 888 9998754322 2368899999999998888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHHhccCCC-CCCCCCCCH--HHHHHHHHhchhCCCCCCCHh
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYS-IPDYVHISP--ECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~--~~~~li~~~L~~dP~~Rps~~ 162 (254)
+.+ +|||||||++|+|++|+.||........ .............. .+....++. .+++++.+||..+|.+||++.
T Consensus 82 ~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~ 160 (176)
T smart00750 82 TEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAAN 160 (176)
T ss_pred cch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHH
Confidence 765 9999999999999999999976543222 22222221111100 011112333 699999999999999999999
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++|+|+..
T Consensus 161 ~ll~~~~~~~ 170 (176)
T smart00750 161 HYLAHCRALF 170 (176)
T ss_pred HHHHHHHHHH
Confidence 9999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=200.03 Aligned_cols=148 Identities=20% Similarity=0.246 Sum_probs=113.5
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.++.+++.++.|||++|++||||||+||+++.++. +||+|||+++....... .....+++.|+|||.+.+..++.
T Consensus 123 ~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 200 (277)
T cd05062 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 200 (277)
T ss_pred HHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCc
Confidence 45678999999999999999999999999987765 99999999875432211 11234567899999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|+|||||++|+|++ |..||.+........ .+..... .+....++..+++++.+||+.+|.+|||+.+++++
T Consensus 201 ~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 201 Y-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLR----FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred h-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5 999999999999998 788997754432222 1222211 12234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=199.38 Aligned_cols=149 Identities=23% Similarity=0.316 Sum_probs=115.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|.|||++|++||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..++
T Consensus 116 ~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 193 (273)
T cd05035 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 193 (273)
T ss_pred HHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCccceeeccccccccccccccCCccccCHhhcccCCCC
Confidence 346789999999999999999999999999987765 99999999875433221 1112346689999998777666
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+......... .... ...+....++..+.+++.+||+.||.+|||+.++++
T Consensus 194 ~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 194 SK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDY----LRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred cc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55 999999999999999 8899977554333222 2211 122233457899999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 268 ~ 268 (273)
T cd05035 268 V 268 (273)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=196.07 Aligned_cols=151 Identities=30% Similarity=0.384 Sum_probs=120.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.+++.++++||+.|++|+||+|.||+++.++. +||+|||++...... ......+++.|+|||.+.+..++.+
T Consensus 106 ~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~- 181 (256)
T cd08530 106 WRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYK- 181 (256)
T ss_pred HHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCch-
Confidence 356678999999999999999999999999988665 999999998765443 3334568889999999987777655
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccc
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 170 (254)
+|+||||+++|++++|+.||.......... ........ +....++.++++++.+||..+|.+|||+.++++||++
T Consensus 182 ~D~~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 182 SDIWSLGCLLYEMATFAPPFEARSMQDLRY----KVQRGKYP-PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCCC-CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 999999999999999999998765432222 12222211 1223578999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=222.19 Aligned_cols=154 Identities=31% Similarity=0.425 Sum_probs=118.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC---CCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~---~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~ 83 (254)
..++.|++.|+++||+.+||||||||.||||+. ++..+++|+|||+++....+.. .....||.+|+|||++..
T Consensus 609 ~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~ 688 (903)
T KOG1027|consen 609 ISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE 688 (903)
T ss_pred HHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc
Confidence 456789999999999999999999999999976 4555799999999987654432 234469999999999987
Q ss_pred CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhccCCCCCCCCC-CCHHHHHHHHHhchhCCCCCCCH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
..... ++||+||||++|+.++| .+||...... ...+....+.+-.... ...++++||.+|++.+|..||+|
T Consensus 689 ~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~R------~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa 761 (903)
T KOG1027|consen 689 DRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLER------QANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSA 761 (903)
T ss_pred cccCc-ccchhhcCceEEEEecCCccCCCchHHh------hhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCH
Confidence 66544 59999999999999986 8999753221 1112333332221110 11289999999999999999999
Q ss_pred hHHhcCcccc
Q 025350 162 PEIRNHEWFL 171 (254)
Q Consensus 162 ~e~l~hp~~~ 171 (254)
.++|.||+|-
T Consensus 762 ~~VL~HPlFW 771 (903)
T KOG1027|consen 762 TDVLNHPLFW 771 (903)
T ss_pred HHHhCCCccC
Confidence 9999999994
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=201.63 Aligned_cols=155 Identities=22% Similarity=0.243 Sum_probs=114.4
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~ 84 (254)
.+..++.|++.++.|||++||+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+.
T Consensus 108 ~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 185 (283)
T cd05080 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc
Confidence 34567789999999999999999999999999987765 99999999875433221 1122356679999999877
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHH-HH---------HHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FR---------KTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 154 (254)
.++.+ +||||||+++|+|++|..||........ .. .............+....++..+++++.+||+.+
T Consensus 186 ~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 264 (283)
T cd05080 186 KFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE 264 (283)
T ss_pred CCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 76655 9999999999999999999865332100 00 0001111111222333457899999999999999
Q ss_pred CCCCCCHhHHhc
Q 025350 155 PAKRISIPEIRN 166 (254)
Q Consensus 155 P~~Rps~~e~l~ 166 (254)
|++|||++++++
T Consensus 265 p~~Rps~~~i~~ 276 (283)
T cd05080 265 AKFRPTFRSLIP 276 (283)
T ss_pred hhhCCCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=201.04 Aligned_cols=150 Identities=21% Similarity=0.333 Sum_probs=115.5
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 85 (254)
....++.|++.+++|||++|++||||||+|||++.++. +||+|||++........ .....+++.|+|||.+.+..
T Consensus 123 ~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (280)
T cd05092 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 200 (280)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC
Confidence 34556789999999999999999999999999987665 99999999864422211 12233567899999998877
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |.+||............ ... ........+++.+.+++.+||..||.+||++.++
T Consensus 201 ~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 201 FTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI----TQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred cCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH----HcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 7665 999999999999998 99999765543333222 111 1122234578999999999999999999999998
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
+.
T Consensus 275 ~~ 276 (280)
T cd05092 275 HS 276 (280)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=199.62 Aligned_cols=153 Identities=20% Similarity=0.272 Sum_probs=116.9
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.+..|++.++.|||++||+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..++.
T Consensus 123 ~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 200 (288)
T cd05061 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200 (288)
T ss_pred HHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEECcCCccccccccccccccCCCcccccccCHHHhccCCCCh
Confidence 46778999999999999999999999999987765 99999999875432211 11223567899999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc-
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN- 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~- 166 (254)
+ +|+|||||++|+|++ |..||.+....... ..+.... ..+....+++.+++++.+||+.+|.+|||+.++++
T Consensus 201 ~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 274 (288)
T cd05061 201 S-SDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 274 (288)
T ss_pred H-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5 999999999999998 78899775443322 2222211 11222346899999999999999999999999986
Q ss_pred -----Cccccc
Q 025350 167 -----HEWFLK 172 (254)
Q Consensus 167 -----hp~~~~ 172 (254)
||||..
T Consensus 275 l~~~~~~~~~~ 285 (288)
T cd05061 275 LKDDLHPSFPE 285 (288)
T ss_pred HHhhcCCCCCC
Confidence 888853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=223.36 Aligned_cols=150 Identities=32% Similarity=0.449 Sum_probs=114.5
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCC-------------------CCCCCCCCcCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGT 72 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~~~ 72 (254)
.+|.+++.||.|+|++|||||||||.|||++..+. |||+|||+|.... .....+..+||
T Consensus 701 rLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGT 778 (1351)
T KOG1035|consen 701 RLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGT 778 (1351)
T ss_pred HHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccce
Confidence 47899999999999999999999999999998776 9999999997411 11123455799
Q ss_pred CCcccchhccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC---CCCCCCHHHHHH
Q 025350 73 PAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---DYVHISPECRHL 146 (254)
Q Consensus 73 ~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 146 (254)
..|+|||++.+.. |+.+ +|+||||++++||+ .||...-+ ....+..+..+..+.+ ... --+.-..+
T Consensus 779 alYvAPEll~~~~~~~Yn~K-iDmYSLGIVlFEM~---yPF~TsME---Ra~iL~~LR~g~iP~~~~f~~~-~~~~e~sl 850 (1351)
T KOG1035|consen 779 ALYVAPELLSDTSSNKYNSK-IDMYSLGIVLFEML---YPFGTSME---RASILTNLRKGSIPEPADFFDP-EHPEEASL 850 (1351)
T ss_pred eeeecHHHhcccccccccch-hhhHHHHHHHHHHh---ccCCchHH---HHHHHHhcccCCCCCCcccccc-cchHHHHH
Confidence 9999999997655 6555 99999999999997 45654322 2233333333433333 111 12456789
Q ss_pred HHHhchhCCCCCCCHhHHhcCcccc
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFL 171 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~ 171 (254)
|+.||+.||++||||.|+|++.||-
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhhccCCC
Confidence 9999999999999999999999985
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=196.33 Aligned_cols=151 Identities=29% Similarity=0.397 Sum_probs=117.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.|||++|++|+||+|+||+++.+ .+||+|||++........ .....+++.|+|||.+.+..++.+
T Consensus 109 ~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 185 (260)
T cd08222 109 CEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185 (260)
T ss_pred HHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCch
Confidence 4567889999999999999999999999999753 399999999875433222 233457889999999877776655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|+||||+++|+|++|..||........ .......... .....++..+.++|.+||..+|.+||++.++++|||
T Consensus 186 -~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 186 -SDIWSLGCILYEMCCLAHAFEGQNFLSV----VLRIVEGPTP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHcCCCC-CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 9999999999999999999976443222 2222222111 112357889999999999999999999999999999
Q ss_pred c
Q 025350 170 F 170 (254)
Q Consensus 170 ~ 170 (254)
|
T Consensus 260 ~ 260 (260)
T cd08222 260 I 260 (260)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=197.57 Aligned_cols=149 Identities=28% Similarity=0.408 Sum_probs=117.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.++.+||++||+|+||||+||+++.++. ++|+|||.+........ .....+++.|+|||++.+..++.+
T Consensus 103 ~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 180 (255)
T cd08219 103 LQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNK 180 (255)
T ss_pred HHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccccccCCccccCHHHHccCCcCch
Confidence 345789999999999999999999999999987765 99999999875433222 233468889999999987776555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|+||||+++|+|++|..||.......... .+..... .+....++..+++||.+||+.||.+|||+.++++-
T Consensus 181 -~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 181 -SDIWSLGCILYELCTLKHPFQANSWKNLIL----KVCQGSY-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -hhhhhhchhheehhhccCCCCCCCHHHHHH----HHhcCCC-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999998754322222 2222222 22234578999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=197.95 Aligned_cols=148 Identities=20% Similarity=0.286 Sum_probs=114.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..+..|++.+++|||++|++||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..++
T Consensus 112 ~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~ 189 (279)
T cd05111 112 LNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189 (279)
T ss_pred HHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcC
Confidence 457789999999999999999999999999987765 99999999975432221 1223466789999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|++++ |..||.+..... ....+ ......+....++..+..++.+||..+|.+|||+.++++
T Consensus 190 ~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 190 HQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLL----EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH----HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 55 999999999999998 999998754322 12221 222222333346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=197.98 Aligned_cols=153 Identities=18% Similarity=0.253 Sum_probs=109.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCC---
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKK--- 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~--- 84 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||++....... ......++..|+|||++...
T Consensus 103 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (269)
T cd05042 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180 (269)
T ss_pred HHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheeccCCCCCcccccCHHHHhhcccc
Confidence 356688999999999999999999999999988765 9999999986432221 11223456779999997532
Q ss_pred ---CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC
Q 025350 85 ---EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 160 (254)
Q Consensus 85 ---~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 160 (254)
...+.++|||||||++|+|++ |..||............................++..+.+++..|+ .||.+|||
T Consensus 181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt 259 (269)
T cd05042 181 LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPT 259 (269)
T ss_pred ccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccC
Confidence 122445999999999999998 7888877654443333222111111111112357888999999998 59999999
Q ss_pred HhHHhc
Q 025350 161 IPEIRN 166 (254)
Q Consensus 161 ~~e~l~ 166 (254)
++++++
T Consensus 260 ~~~v~~ 265 (269)
T cd05042 260 AEEVHE 265 (269)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=196.87 Aligned_cols=152 Identities=30% Similarity=0.361 Sum_probs=118.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC----CCCCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..+..+++.++.+||++|++|+||||+||+++.++. ++|+|||+++..... .......++..|+|||.+.+...
T Consensus 109 ~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (264)
T cd06653 109 RRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186 (264)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccccccCccccccCCcccccCHhhhcCCCC
Confidence 346678999999999999999999999999987765 999999998754321 11123458889999999987766
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|+|||||++|++++|+.||..........+ ..........+..+++.+.+++.+||. +|.+||++.+++.
T Consensus 187 ~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 187 GRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFK----IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred Ccc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHHH----HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 555 8999999999999999999987544333222 222222222234578999999999998 5799999999999
Q ss_pred Cccc
Q 025350 167 HEWF 170 (254)
Q Consensus 167 hp~~ 170 (254)
|||.
T Consensus 261 ~~~~ 264 (264)
T cd06653 261 HPFV 264 (264)
T ss_pred CCCC
Confidence 9984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=196.24 Aligned_cols=146 Identities=25% Similarity=0.352 Sum_probs=113.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.+++.++++||++|++||||||+||+++.++. +||+|||++...... .....++..|+|||++.+..++.+
T Consensus 105 ~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~- 179 (256)
T cd05082 105 LKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTK- 179 (256)
T ss_pred HHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceecccc--CCCCccceeecCHHHHccCCCCch-
Confidence 456789999999999999999999999999988775 999999998754322 123345668999999987777655
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 91 ADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 91 ~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+|||||||++|+|++ |+.||......... ..+.. .........+++.+++++.+||..+|.+|||+.++++
T Consensus 180 ~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVEK-GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999997 99999764432222 11211 2222223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=195.44 Aligned_cols=159 Identities=30% Similarity=0.491 Sum_probs=126.7
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
......-.+++.+|.|||++|||+||||.+|+|++..+. +||+|+|+++.... +....+.+|||.|.|||++.+..|
T Consensus 351 eharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeey 428 (593)
T KOG0695|consen 351 EHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 428 (593)
T ss_pred HHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCCCCCcccccccCCCcccchhhhccccc
Confidence 334455567889999999999999999999999998876 99999999986443 344567799999999999999988
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCC--CC-chHHHHH-HHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC---
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFED--PE-EPKNFRK-TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI--- 159 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~--~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp--- 159 (254)
.-. +|+|+||+++++|+.|+.||.- .. ...+-.. +.+-++..+.+.|. .+|-.+..+++..|++||.+|.
T Consensus 429 gfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--slsvkas~vlkgflnkdp~erlgc~ 505 (593)
T KOG0695|consen 429 GFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLSVKASHVLKGFLNKDPKERLGCR 505 (593)
T ss_pred Cce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eeehhhHHHHHHhhcCCcHHhcCCC
Confidence 655 9999999999999999999962 11 1111111 22334555556665 3677888999999999999997
Q ss_pred ---CHhHHhcCcccc
Q 025350 160 ---SIPEIRNHEWFL 171 (254)
Q Consensus 160 ---s~~e~l~hp~~~ 171 (254)
.++++..|+||+
T Consensus 506 ~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 506 PQTGFSDIKSHAFFR 520 (593)
T ss_pred cccchhhhhcchhhh
Confidence 478999999997
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=196.65 Aligned_cols=148 Identities=20% Similarity=0.296 Sum_probs=115.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.+++.+++|||++|++||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..++.
T Consensus 106 ~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 183 (261)
T cd05072 106 IDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183 (261)
T ss_pred HHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCceeccCCCccceecCCHHHhccCCCCh
Confidence 346679999999999999999999999999988765 99999999976433221 12223566899999998777665
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|+|||||++|+|++ |..||........... + ......+....++..+.+++.+||..+|++||+++++++
T Consensus 184 ~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 184 K-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----L-QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred h-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 5 999999999999998 9999987544332222 1 122334444568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=197.81 Aligned_cols=148 Identities=20% Similarity=0.273 Sum_probs=114.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.++.|||++||+||||||+||+++.++. +||+|||+++...... ......++..|+|||.+.+..++
T Consensus 122 ~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 199 (277)
T cd05032 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT 199 (277)
T ss_pred HHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCC
Confidence 346789999999999999999999999999988776 9999999987543222 11233467789999998777766
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|++++ |..||.......... .. .. ....+....++..+.+++.+||+.+|++|||+.++++
T Consensus 200 ~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~---~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 200 TK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLK-FV---ID-GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred cc-cchHHHHHHHHHhhccCCCCCccCCHHHHHH-HH---hc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 55 999999999999998 999998755433222 21 11 1122223447899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=199.39 Aligned_cols=148 Identities=23% Similarity=0.349 Sum_probs=114.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..++
T Consensus 130 ~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~ 207 (290)
T cd05045 130 ISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207 (290)
T ss_pred HHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc
Confidence 466789999999999999999999999999987765 99999999875422211 1222456789999998777666
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +||||||+++|+|++ |..||.+...... .... ......+....++..+++++.+||+.+|.+||++.++++
T Consensus 208 ~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 208 TQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERL-FNLL----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred hH-hHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHH----hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 55 999999999999998 9999976543322 2221 222233334567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=196.61 Aligned_cols=151 Identities=27% Similarity=0.404 Sum_probs=115.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.+++|||++|++|+||||+||+++.++. ++|+|||++........ .....++..|+|||.+.+..++.+
T Consensus 109 ~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~ 186 (267)
T cd08229 109 WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186 (267)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccch
Confidence 345778999999999999999999999999987765 99999998875433222 223468889999999987777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+|+||||+++|+|++|..||.+.... .......+............+++.+++++.+||..+|.+|||+.+|++
T Consensus 187 -~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 187 -SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999999764321 122222222222222222357889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=201.06 Aligned_cols=148 Identities=22% Similarity=0.370 Sum_probs=114.5
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.++.|++.+++|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..++.
T Consensus 136 ~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 213 (293)
T cd05053 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH 213 (293)
T ss_pred HHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence 47889999999999999999999999999987765 99999999875433211 11223456799999987777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|||||||++|++++ |..||........... . ...........++..+.+|+.+||..+|++|||+.+++++
T Consensus 214 ~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 214 Q-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL----L-KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred c-cceeehhhHHHHHhcCCCCCCCCCCHHHHHHH----H-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5 999999999999997 9999987544332222 1 1122222334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=195.49 Aligned_cols=149 Identities=21% Similarity=0.290 Sum_probs=115.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.+++.++.|||+.|++|+||||+||+++.++. ++|+|||++........ .....++..|+|||...+..++
T Consensus 104 ~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 181 (260)
T cd05069 104 LVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181 (260)
T ss_pred HHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcC
Confidence 3456789999999999999999999999999988765 99999999875433221 1123456789999998877765
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+||||+++|+|++ |..||.+......... .. .....+....++..+++++++||..||.+||+++++++
T Consensus 182 ~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 182 IK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----VE-RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred hH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 55 999999999999999 8999987654333222 11 12223333457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=197.26 Aligned_cols=152 Identities=26% Similarity=0.385 Sum_probs=115.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++.|||++|++|+||||+||+++.++. ++|+|||++........ .....+++.|+|||.+.+..++.+
T Consensus 109 ~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 186 (267)
T cd08228 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186 (267)
T ss_pred HHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccchhHHHhcCCCCccccChhhhccCCCCch
Confidence 456778999999999999999999999999988765 99999999875433221 223468889999999987776655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|+||+|+++|+|++|+.||...... .......+............++..+++++.+||..+|.+||++.++++.
T Consensus 187 -~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 187 -SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999754321 1122222222222111123467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=198.08 Aligned_cols=156 Identities=25% Similarity=0.343 Sum_probs=121.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.+++.++.+||++|++|+||+|+||+++.++. ++|+|||++....... ......++..|+|||.+.+...+.
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 180 (277)
T cd06641 103 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180 (277)
T ss_pred HHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhccccCCccccChhhhccCCCCc
Confidence 3456788999999999999999999999999987765 9999999986543322 122345788999999987776655
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|+|||||++|+|++|..||.......... .+.... .......++.++.+++.+||..+|.+||++.++++||
T Consensus 181 ~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 181 K-ADIWSLGITAIELAKGEPPHSELHPMKVLF----LIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred h-hhHHHHHHHHHHHHcCCCCCCccchHHHHH----HHhcCC-CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 5 999999999999999999997644322221 111111 1112234688999999999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
||.+.
T Consensus 255 ~~~~~ 259 (277)
T cd06641 255 FIVRF 259 (277)
T ss_pred HHhhh
Confidence 99764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=195.29 Aligned_cols=150 Identities=19% Similarity=0.297 Sum_probs=115.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.++++||++|++||||||+||+++.++. +||+|||+++........ ....++..|+|||.+.+..++
T Consensus 102 ~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 179 (256)
T cd05059 102 LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCCCCCCccccCHHHhccCCCC
Confidence 3457788999999999999999999999999988765 999999998754322111 111234579999999887776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+||||+++|++++ |..||........... +. .....+....++..+.+++.+||..+|.+|||+.++++
T Consensus 180 ~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 180 SK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVES----VS-AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred ch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH----HH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 55 999999999999998 8999976554333222 11 12222333457999999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
.
T Consensus 254 ~ 254 (256)
T cd05059 254 Q 254 (256)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=194.23 Aligned_cols=149 Identities=22% Similarity=0.310 Sum_probs=116.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.+++|||++|++||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..+
T Consensus 100 ~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 177 (257)
T cd05040 100 CDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177 (257)
T ss_pred HHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecccCCCCCceecCHHHhcccCc
Confidence 445679999999999999999999999999988765 99999999876533221 112346778999999887777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||............. ......+....++..+.+++.+||..+|.+|||+.+++
T Consensus 178 ~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 252 (257)
T cd05040 178 SHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID----KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALR 252 (257)
T ss_pred Cch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----hcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHH
Confidence 655 999999999999998 999997655443333222 12223333345789999999999999999999999987
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 253 ~ 253 (257)
T cd05040 253 E 253 (257)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=199.48 Aligned_cols=150 Identities=27% Similarity=0.404 Sum_probs=116.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...+..+++.+++|||++||+|+||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..+
T Consensus 143 ~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 220 (302)
T cd05055 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY 220 (302)
T ss_pred HHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCC
Confidence 3456788999999999999999999999999987665 99999999875433221 122345678999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +||||+||++|+|++ |..||..........+... .....+.....++.+.+++.+||..+|.+|||+.+++
T Consensus 221 ~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell 295 (302)
T cd05055 221 TFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295 (302)
T ss_pred CcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 655 999999999999998 9999987655443333222 2222223335689999999999999999999999998
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 296 ~ 296 (302)
T cd05055 296 Q 296 (302)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=195.93 Aligned_cols=148 Identities=22% Similarity=0.246 Sum_probs=110.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC-----CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA-----PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~-----~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
...+..|++.+++|||++||+||||||+|||++.++. ..+|++|||++..... .....++..|+|||.+...
T Consensus 107 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~ 183 (262)
T cd05077 107 KFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS---RQECVERIPWIAPECVEDS 183 (262)
T ss_pred HHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC---cccccccccccChhhhcCC
Confidence 3457789999999999999999999999999975442 2389999998865322 2334578889999998744
Q ss_pred CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
...+.++|||||||++|+|+ +|..||........ .. ....... .....+.++++||.+||..||.+||++.+
T Consensus 184 ~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~----~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~ 256 (262)
T cd05077 184 KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ER----FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRA 256 (262)
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HH----HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHH
Confidence 43344599999999999998 58888876432211 11 1111111 11224688999999999999999999999
Q ss_pred HhcC
Q 025350 164 IRNH 167 (254)
Q Consensus 164 ~l~h 167 (254)
|+++
T Consensus 257 il~~ 260 (262)
T cd05077 257 IMRD 260 (262)
T ss_pred HHHh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=199.58 Aligned_cols=148 Identities=20% Similarity=0.325 Sum_probs=114.3
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.++.|++.+++|||++||+||||||+||+++.++. +||+|||+++....... .....+++.|+|||++.+..++.
T Consensus 141 ~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 218 (304)
T cd05101 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218 (304)
T ss_pred HHHHHHHHHHHHHHHCCeeecccccceEEEcCCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence 35679999999999999999999999999987765 99999999875433221 11223567899999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +||||||+++|++++ |..||.+........ .+.. .........++..+++|+.+||..+|.+|||+.++++.
T Consensus 219 ~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 219 Q-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKE-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred h-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHHc-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 5 999999999999998 788887654333222 1211 22222334678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=194.39 Aligned_cols=149 Identities=21% Similarity=0.265 Sum_probs=114.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.+++.++.|||++||+||||||+||+++.++. +||+|||.++........ ....++..|+|||.+.+..++
T Consensus 102 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (256)
T cd05114 102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccc
Confidence 3456778999999999999999999999999987765 999999998754322211 122345679999999877766
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+||||+++|+|++ |+.||........... +.... ........+..+.+++.+||..+|.+|||+.++++
T Consensus 180 ~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~----i~~~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 180 SK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM----ISRGF-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred hh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHCCC-CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 55 999999999999999 8999987654433332 22221 12222346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=196.14 Aligned_cols=149 Identities=15% Similarity=0.247 Sum_probs=115.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+++|||++|++||||||+|||++.++. +|++|||.+......... ....++..|+|||.+.+..++
T Consensus 109 ~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (266)
T cd05064 109 LMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186 (266)
T ss_pred HHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccccchhcccCCCCceeecCHHHHhhCCcc
Confidence 4567788999999999999999999999999987765 999999987643222111 122346789999999887776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|++++ |..||........... + ......+....++..+.+++.+||..+|.+||++.++++
T Consensus 187 ~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 187 SA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA----V-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----H-HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 55 999999999999775 9999987654332222 2 222233445568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=194.92 Aligned_cols=148 Identities=21% Similarity=0.299 Sum_probs=114.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~ 87 (254)
+..++.+++.+++|||++||+||||||+||+++.++. ++|+|||++......... ....++..|+|||.+.+..++
T Consensus 104 ~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 181 (260)
T cd05070 104 LVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181 (260)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCc
Confidence 4567789999999999999999999999999987765 999999998754332211 122345679999998777766
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|+||||+++|+|++ |..||.+......... +. .....+.....+..+++|+.+||..+|.+|||++++.
T Consensus 182 ~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 182 IK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQ----VE-RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred ch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 55 999999999999999 8999977544332222 21 1223333446789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=194.49 Aligned_cols=150 Identities=25% Similarity=0.309 Sum_probs=115.9
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCC----CCcCCCCcccchhccCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLKK 84 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~----~~~~~~~y~aPE~~~~~ 84 (254)
.+..+..|++.++++||.+|++||||||+||+++.++. +||+|||+++......... ...++..|+|||.+.+.
T Consensus 96 ~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05060 96 DLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173 (257)
T ss_pred HHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccCccccccccCHHHhcCC
Confidence 34667889999999999999999999999999988775 9999999987543332211 11234679999999877
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.++.+ +|+|||||++|++++ |..||......... ..+ .. ....+....++..++++|.+||..+|.+||++.+
T Consensus 174 ~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-~~~---~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~ 247 (257)
T cd05060 174 KFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AML---ES-GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSE 247 (257)
T ss_pred CCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHH---Hc-CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 77655 999999999999998 99999775543222 221 11 2223344567899999999999999999999999
Q ss_pred Hhc
Q 025350 164 IRN 166 (254)
Q Consensus 164 ~l~ 166 (254)
+++
T Consensus 248 l~~ 250 (257)
T cd05060 248 LES 250 (257)
T ss_pred HHH
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=194.69 Aligned_cols=149 Identities=19% Similarity=0.288 Sum_probs=115.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.+++.+++|||++|++||||||+||+++.++. +||+|||.+......... ....++..|+|||...+..++
T Consensus 104 ~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 181 (262)
T cd05071 104 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181 (262)
T ss_pred HHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccccccccCCcccceecCHhHhccCCCC
Confidence 3557789999999999999999999999999987765 999999998754332211 123456789999998877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+|||||++|++++ |..||.+......... +.. ....+....++..+.+++.+||+.+|.+||++.++++
T Consensus 182 ~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 182 IK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH----Hhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 55 999999999999999 8889977554332222 211 2222333457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=194.04 Aligned_cols=149 Identities=23% Similarity=0.307 Sum_probs=113.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC----CCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~ 85 (254)
...+..|++.++.|||++|++||||||+||+++.++. +||+|||++......... ....++..|+|||.+.+..
T Consensus 97 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05115 97 VVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174 (257)
T ss_pred HHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC
Confidence 3456789999999999999999999999999987765 999999998754322211 1112356899999988777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|+|||||++|++++ |..||.......... .+.. ....+.....++++.++|.+||..+|++||++.++
T Consensus 175 ~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i 248 (257)
T cd05115 175 FSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMS----FIEQ-GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248 (257)
T ss_pred CCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHHC-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 6555 999999999999996 999998765433221 1211 11222334578999999999999999999999998
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
.+
T Consensus 249 ~~ 250 (257)
T cd05115 249 EE 250 (257)
T ss_pred HH
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=194.24 Aligned_cols=148 Identities=23% Similarity=0.341 Sum_probs=115.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.+++|||++||+||||||+||+++.++. +||+|||.+........ .....++..|+|||.+.+..++.+
T Consensus 107 ~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 184 (261)
T cd05148 107 IDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTK 184 (261)
T ss_pred HHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCch
Confidence 447789999999999999999999999999988765 99999999875433221 122335667999999987777655
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 90 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 90 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+|+||||+++|+|++ |..||............ . .....+....+++.+.+++.+||..||.+|||+.++++
T Consensus 185 -~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 185 -SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI----T-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----H-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999998 89999875543333322 2 22233444568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=199.43 Aligned_cols=147 Identities=20% Similarity=0.321 Sum_probs=112.6
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.++.|++.++.|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..++.
T Consensus 138 ~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (314)
T cd05099 138 SCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH 215 (314)
T ss_pred HHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence 35679999999999999999999999999987765 99999999975432211 11123446799999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++|++++ |..||........... ... .........++..+++++.+||..+|.+|||+.++++
T Consensus 216 ~-~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 216 Q-SDVWSFGILMWEIFTLGGSPYPGIPVEELFKL----LRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred c-chhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5 999999999999999 8899976543332222 111 1122223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=193.38 Aligned_cols=148 Identities=25% Similarity=0.344 Sum_probs=112.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCC---CCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.++.|||++||+||||||+||+++.++. +||+|||++.......... ....+..|+|||.+.+..++
T Consensus 97 ~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 174 (252)
T cd05084 97 IQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174 (252)
T ss_pred HHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCCceeecCchhhcCCCCC
Confidence 457789999999999999999999999999987765 9999999987543221111 11224569999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+|||||++|+|++ |..||........ ..... .....+....++..+.+|+.+||..+|.+|||+.++++
T Consensus 175 ~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 175 SE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIE----QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred hH-HHHHHHHHHHHHHHhCCCCCccccCHHHH-HHHHH----cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55 999999999999997 8889876543222 11111 12222333457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=197.88 Aligned_cols=154 Identities=23% Similarity=0.286 Sum_probs=115.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+++|||++||+||||||+||+++.++. ++|+|||+++...... ......++..|+|||.+.+..+
T Consensus 132 ~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (296)
T cd05051 132 LLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF 209 (296)
T ss_pred HHHHHHHHHHHHHHHHHcCccccccchhceeecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC
Confidence 3457789999999999999999999999999988765 9999999987543221 1223346778999999887776
Q ss_pred CCcchhHHHHHHHHHHHHh--CCCCCCCCCchHHHHHHHHHHh--ccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 87 DGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRIL--SVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
+.+ +|||||||++|+|++ |..||........+........ ......+....++.++.+++.+||..||.+|||+.
T Consensus 210 ~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 210 TTK-SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred Ccc-chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence 655 999999999999998 7788876554333332221100 11112223345689999999999999999999999
Q ss_pred HHhc
Q 025350 163 EIRN 166 (254)
Q Consensus 163 e~l~ 166 (254)
++++
T Consensus 289 el~~ 292 (296)
T cd05051 289 EIHL 292 (296)
T ss_pred HHHH
Confidence 9964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=193.66 Aligned_cols=150 Identities=20% Similarity=0.280 Sum_probs=115.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+++|||++|++|+||||+||+++.++. +||+|||.++........ ....++..|+|||.+.+..++
T Consensus 102 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~ 179 (256)
T cd05113 102 LLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeecCCCccChhhCCHHHHhcCccc
Confidence 3557889999999999999999999999999987765 999999998754332211 112345679999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+|||||++|+|++ |..||........... +.... ..+.....+..+++++.+||..+|.+||++.+++.
T Consensus 180 ~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 180 SK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEK----VSQGL-RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred ch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----HhcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 55 999999999999998 9999976554332222 22211 12222346899999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 254 ~ 254 (256)
T cd05113 254 S 254 (256)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=196.88 Aligned_cols=154 Identities=22% Similarity=0.270 Sum_probs=115.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+++|||++|++||||||+|||++.++. ++|+|||+++....... .....++..|++||...+..+
T Consensus 132 ~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 209 (296)
T cd05095 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF 209 (296)
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc
Confidence 4556789999999999999999999999999987665 99999999875432221 112234678999998877777
Q ss_pred CCcchhHHHHHHHHHHHHh--CCCCCCCCCchHHHHHHHHHH--hccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 87 DGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRI--LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
+.+ +|+|||||++|+|++ |..||................ .......+....+++.+.+|+.+||..||.+||++.
T Consensus 210 ~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 210 TTA-SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred cch-hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 655 999999999999998 778987655443332221111 111122333445789999999999999999999999
Q ss_pred HHhc
Q 025350 163 EIRN 166 (254)
Q Consensus 163 e~l~ 166 (254)
++++
T Consensus 289 ~i~~ 292 (296)
T cd05095 289 EIHA 292 (296)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=209.20 Aligned_cols=159 Identities=20% Similarity=0.239 Sum_probs=115.7
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCC--CcCCCCcccchhccCCCC---
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVLLKKEY--- 86 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~--- 86 (254)
.++.|++.++.|||++||+||||||+|||++.++. +||+|||++........... ..+++.|+|||.+.....
T Consensus 313 ~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~ 390 (507)
T PLN03224 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPR 390 (507)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCc
Confidence 46788999999999999999999999999987765 99999999865433222222 235789999998754321
Q ss_pred -----------------C-CcchhHHHHHHHHHHHHhCCC-CCCCCCchHH-------HHHHHHHHhccCCCCCCCCCCC
Q 025350 87 -----------------D-GKIADVWSCGVTLYVMLVGAY-PFEDPEEPKN-------FRKTIHRILSVQYSIPDYVHIS 140 (254)
Q Consensus 87 -----------------~-~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 140 (254)
. ....|+||+||++|+|++|.. ||........ ............+.++.+...+
T Consensus 391 ~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s 470 (507)
T PLN03224 391 APAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNK 470 (507)
T ss_pred cchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccC
Confidence 1 123699999999999999875 6653221111 0011112223344455566789
Q ss_pred HHHHHHHHHhchhCC---CCCCCHhHHhcCccccc
Q 025350 141 PECRHLISRIFVADP---AKRISIPEIRNHEWFLK 172 (254)
Q Consensus 141 ~~~~~li~~~L~~dP---~~Rps~~e~l~hp~~~~ 172 (254)
+..++|+.+||..+| .+|+|+.|+|+||||..
T Consensus 471 ~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 471 EAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 999999999999876 68999999999999965
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=194.64 Aligned_cols=149 Identities=21% Similarity=0.283 Sum_probs=114.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.+++.++.+||++||+||||||+||+++.++. +||+|||++......... .....+..|+|||.+.+..++
T Consensus 105 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 182 (261)
T cd05068 105 LIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS 182 (261)
T ss_pred HHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccccCCCcCceeccCccccccCCCC
Confidence 3567788999999999999999999999999988776 999999998765422211 111234579999998877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+||||+++|+|++ |+.||.+......... +. .....+....++..+.+++.+||+.+|.+||++.++++
T Consensus 183 ~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 183 IK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ----VD-QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 55 999999999999999 9999987554332222 21 12223334457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=199.42 Aligned_cols=148 Identities=21% Similarity=0.323 Sum_probs=113.3
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.++.|++.+|+|||++|++||||||+||+++.++. +||+|||.+........ .....++..|+|||.+.+..++.
T Consensus 144 ~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 221 (307)
T cd05098 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221 (307)
T ss_pred HHHHHHHHHHHHHHHCCcccccccHHheEEcCCCc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence 46789999999999999999999999999987765 99999999875432211 11122456899999998777665
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|+|||||++|+|++ |..||.+... ......+ ......+....++.++++|+.+||..+|.+|||+.+++++
T Consensus 222 ~-~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 222 Q-SDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLL----KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred H-HHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHH----HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5 999999999999998 8889876443 2222222 1222223334578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=193.15 Aligned_cols=148 Identities=22% Similarity=0.286 Sum_probs=110.6
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcccchhccCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
.+..+++.+++|||+.|++||||||+|||++.++. +||+|||+++...... ......++..|+|||.+.+..+
T Consensus 102 ~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 179 (262)
T cd05058 102 GFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179 (262)
T ss_pred HHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecccccCcCCccccChhHhccCcc
Confidence 34568999999999999999999999999987765 9999999987542211 1112245678999999887777
Q ss_pred CCcchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++| .+||........ ...+.... ..+....++..+.+++.+||..+|++||++.+++
T Consensus 180 ~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il 253 (262)
T cd05058 180 TTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDI----TVYLLQGR-RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELV 253 (262)
T ss_pred chH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHhcCC-CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 655 9999999999999995 566665433222 22222221 2222334688999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
..
T Consensus 254 ~~ 255 (262)
T cd05058 254 SR 255 (262)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=194.17 Aligned_cols=149 Identities=24% Similarity=0.353 Sum_probs=108.9
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC--
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY-- 86 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-- 86 (254)
.+..|++.+++|||++|++||||||+||+++.++. +||+|||++........ .....++..|+|||++.+...
T Consensus 104 ~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (269)
T cd05087 104 RMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL 181 (269)
T ss_pred HHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeecCCCcCCcccccCHhHhccccccc
Confidence 45679999999999999999999999999987665 99999999864322211 122356788999999864321
Q ss_pred ----CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCC---CCCCCHHHHHHHHHhchhCCCCC
Q 025350 87 ----DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD---YVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 87 ----~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~R 158 (254)
.+.++|+||||+++|+|++ |..||............. .......+. ....+..+.+++.+|+ .+|.+|
T Consensus 182 ~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~R 257 (269)
T cd05087 182 LVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---REQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQR 257 (269)
T ss_pred cccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---hcccCCCCCCccCCCCChHHHHHHHHHh-cCcccC
Confidence 1345999999999999996 999997755433322211 111111111 1235788999999998 689999
Q ss_pred CCHhHHhc
Q 025350 159 ISIPEIRN 166 (254)
Q Consensus 159 ps~~e~l~ 166 (254)
||+++|+.
T Consensus 258 pt~~~l~~ 265 (269)
T cd05087 258 PSAEEVHL 265 (269)
T ss_pred CCHHHHHH
Confidence 99999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=194.23 Aligned_cols=150 Identities=21% Similarity=0.327 Sum_probs=116.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-C--CCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P--KSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~--~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.+++.+++|||++||+||||||+||+++.++. +||+|||++........ . ....++..|+|||.+.+..+
T Consensus 108 ~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~ 185 (266)
T cd05033 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185 (266)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhcccccccceeccCCCCCccccChhhhccCCC
Confidence 3456789999999999999999999999999987765 99999999986542111 1 11234568999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|+||||+++|++++ |..||.......... .+.. ....+....++..+.+++.+||..+|.+||++.+++
T Consensus 186 ~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~ 259 (266)
T cd05033 186 TSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIK----AVED-GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIV 259 (266)
T ss_pred ccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 655 999999999999998 999997655433222 2221 223333446799999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
++
T Consensus 260 ~~ 261 (266)
T cd05033 260 ST 261 (266)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=209.52 Aligned_cols=159 Identities=26% Similarity=0.429 Sum_probs=121.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
....-|+..||..|...||+|.||||+|||++.+.. .+||||||.|...... ....+..+..|.|||++.|.+|+..
T Consensus 539 RsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~- 615 (752)
T KOG0670|consen 539 RSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYP- 615 (752)
T ss_pred HHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccccc-cccHHHHHHhccCcceeecCcccCC-
Confidence 345567888899999999999999999999987664 6899999999765443 3344566788999999999999887
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH-------HHh-ccCCCCCC---------------------------
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------RIL-SVQYSIPD--------------------------- 135 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-------~~~-~~~~~~~~--------------------------- 135 (254)
.|+||+||+||||.||+..|.+.+....+.-.+. +++ ...+....
T Consensus 616 iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~v 695 (752)
T KOG0670|consen 616 IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNV 695 (752)
T ss_pred ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEeccc
Confidence 8999999999999999999999876555432221 000 00000000
Q ss_pred ------------CCCCC-------HHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 136 ------------YVHIS-------PECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 136 ------------~~~~~-------~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
...++ ..+++|+.+||..||.+|.|+.++|.||||+.
T Consensus 696 kPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 696 KPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred CcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00011 46889999999999999999999999999964
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=195.72 Aligned_cols=149 Identities=21% Similarity=0.325 Sum_probs=115.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.+++.+++|||++|++||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..+
T Consensus 119 ~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 196 (280)
T cd05043 119 LVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY 196 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC
Confidence 3457789999999999999999999999999987765 99999999975432211 112345667999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|++++ |+.||....... ..... ......+....+++.+.+++.+||..+|++|||+.+++
T Consensus 197 ~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 270 (280)
T cd05043 197 SSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYL----KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLV 270 (280)
T ss_pred Cch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHH----HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 655 999999999999998 999998654322 22211 12233334445789999999999999999999999998
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 271 ~ 271 (280)
T cd05043 271 Q 271 (280)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=192.74 Aligned_cols=147 Identities=20% Similarity=0.246 Sum_probs=110.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC------CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~------~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
..++.|++.+++|||++||+||||||+||+++.++. +.++++|||++..... .....++..|+|||++.+.
T Consensus 103 ~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~ 179 (258)
T cd05078 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---KEILLERIPWVPPECIENP 179 (258)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC---chhccccCCccCchhccCC
Confidence 446789999999999999999999999999976553 2379999998864322 2334678899999999765
Q ss_pred CCCCcchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
...+.++|+|||||++|+|++|. .||........ ... .......|. ..+.++.+|+.+||+.+|.+|||+++
T Consensus 180 ~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~----~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ 252 (258)
T cd05078 180 QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQF----YEDRHQLPA--PKWTELANLINQCMDYEPDFRPSFRA 252 (258)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHH----HHccccCCC--CCcHHHHHHHHHHhccChhhCCCHHH
Confidence 43344599999999999999985 66654333221 111 112222222 35688999999999999999999999
Q ss_pred HhcC
Q 025350 164 IRNH 167 (254)
Q Consensus 164 ~l~h 167 (254)
+++.
T Consensus 253 il~~ 256 (258)
T cd05078 253 IIRD 256 (258)
T ss_pred HHHh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=196.98 Aligned_cols=149 Identities=19% Similarity=0.302 Sum_probs=115.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.++.|||++||+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..++
T Consensus 112 ~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (303)
T cd05110 112 LNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189 (303)
T ss_pred HHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccCcccccccCCCccccccCCHHHhccCCCC
Confidence 456679999999999999999999999999987665 99999999975433221 1123356789999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|++++ |..||.+... ...... .......+....++..+.+++.+||..+|.+||++.++++
T Consensus 190 ~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 190 HQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDL----LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred hH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH----HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55 999999999999997 8999976542 222222 2222333444457889999999999999999999999887
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
.
T Consensus 264 ~ 264 (303)
T cd05110 264 E 264 (303)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=192.83 Aligned_cols=148 Identities=22% Similarity=0.300 Sum_probs=115.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.+++.+++|||+.|++||||||+||+++.++. ++|+|||++........ .....++..|+|||.+.+..++.
T Consensus 105 ~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~ 182 (260)
T cd05067 105 IDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182 (260)
T ss_pred HHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCc
Confidence 446779999999999999999999999999988765 99999999875432221 12234567899999998777655
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|+||||+++|++++ |+.||.+.......... ......+.....+.++.+++.+||+.+|++|||++++++
T Consensus 183 ~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 183 K-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-----ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred c-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5 999999999999998 99999876543332221 122233444457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=209.01 Aligned_cols=156 Identities=31% Similarity=0.466 Sum_probs=123.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCC---------CCCC----------------
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---------LHSQ---------------- 65 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~---------~~~~---------------- 65 (254)
.+.+.++..++.+.|..|+|||||||+|||||.+|. +||+|||+|..+. .+..
T Consensus 732 RFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~ 809 (1034)
T KOG0608|consen 732 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADIS 809 (1034)
T ss_pred HHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccccccCCCccccccCCCchhhcccc
Confidence 455678999999999999999999999999998876 9999999986321 0000
Q ss_pred ------------------CCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh
Q 025350 66 ------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 127 (254)
Q Consensus 66 ------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 127 (254)
....+||+.|+|||++...+|+.. +|+||.||+||+|+.|++||..........+++ .+
T Consensus 810 ~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~--nw 886 (1034)
T KOG0608|consen 810 KCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLVGQPPFLADTPGETQYKVI--NW 886 (1034)
T ss_pred ccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhhCCCCccCCCCCcceeeee--eh
Confidence 001269999999999998888766 999999999999999999998766544433322 12
Q ss_pred ccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC---CHhHHhcCccccc
Q 025350 128 SVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK 172 (254)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~ 172 (254)
...+.++...++|.++.+||.++ ...++.|. .++++..||||+.
T Consensus 887 ~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 887 RNFLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccc
Confidence 34456677778999999999986 47788998 4778999999974
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=200.02 Aligned_cols=149 Identities=21% Similarity=0.324 Sum_probs=114.9
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.++.|++.++.|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..++.
T Consensus 138 ~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (334)
T cd05100 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215 (334)
T ss_pred HHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence 36779999999999999999999999999987765 99999999875433221 11123456799999998877766
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|||||||++|+|++ |..||.+......... +.. ....+....++..+.+++.+||..+|.+|||+.+++++
T Consensus 216 ~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 216 Q-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL----LKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred h-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5 999999999999998 8899977543332221 211 22223334578899999999999999999999999986
Q ss_pred c
Q 025350 168 E 168 (254)
Q Consensus 168 p 168 (254)
-
T Consensus 290 l 290 (334)
T cd05100 290 L 290 (334)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=192.55 Aligned_cols=152 Identities=28% Similarity=0.406 Sum_probs=115.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.+++.++.+||+.||+||||+|+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.
T Consensus 108 ~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 185 (267)
T cd08224 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185 (267)
T ss_pred HHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCc
Confidence 3456788999999999999999999999999987765 9999999987543322 223346888999999998777765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|+|||||++|+|++|..||...... ....................++..++++|.+||..+|.+|||+.++++
T Consensus 186 ~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 186 K-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred h-hcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5 99999999999999999999654321 112222222221111111257889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=195.22 Aligned_cols=153 Identities=22% Similarity=0.271 Sum_probs=113.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.+++.+++|||++|++||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..++
T Consensus 132 ~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 209 (295)
T cd05097 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT 209 (295)
T ss_pred HHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcC
Confidence 346789999999999999999999999999987765 99999999875432221 1222356789999998877776
Q ss_pred CcchhHHHHHHHHHHHHh--CCCCCCCCCchHHHHHHHHHHhc--cCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 88 GKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.+ +|+|||||++|+|++ |..||.................. ..........+++.+.+|+.+||..+|.+|||+++
T Consensus 210 ~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 210 TA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred ch-hhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 55 999999999999988 66788765543333222211111 11111223346899999999999999999999999
Q ss_pred Hhc
Q 025350 164 IRN 166 (254)
Q Consensus 164 ~l~ 166 (254)
+++
T Consensus 289 i~~ 291 (295)
T cd05097 289 IHH 291 (295)
T ss_pred HHH
Confidence 964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=191.23 Aligned_cols=147 Identities=26% Similarity=0.366 Sum_probs=114.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.++.|||++|++||||||+||+++.++. +||+|||.++...... .....+..|+|||.+.+..++.+
T Consensus 104 ~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~ 179 (256)
T cd05039 104 QLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREKKFSTK 179 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEccccccccccccc--ccCCCcccccCchhhcCCcCCcH
Confidence 4567789999999999999999999999999987765 9999999997653221 23345667999999887776655
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 90 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 90 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+|+||||+++|++++ |..||......... ... .. .........+++.+.++|.+||..+|.+|||+.+++.
T Consensus 180 -~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~---~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 180 -SDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PHV---EK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -HHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHH---hc-CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999997 99999765433222 111 11 1122223357899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=217.88 Aligned_cols=149 Identities=28% Similarity=0.401 Sum_probs=112.9
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-------------------CCCCCCcCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------------------SQPKSTVGT 72 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-------------------~~~~~~~~~ 72 (254)
.++.|++.+|+|||++||+||||||+||+++.++. +||+|||+++..... ......+||
T Consensus 117 ~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT 194 (932)
T PRK13184 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGT 194 (932)
T ss_pred HHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCcceecccccccccccccccccccccccccCCCCCCC
Confidence 46779999999999999999999999999988776 999999999754110 011224689
Q ss_pred CCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhch
Q 025350 73 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 152 (254)
Q Consensus 73 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 152 (254)
+.|+|||++.+..++.+ +|||||||++|+|++|..||........... ..............+++.+.+++.+||.
T Consensus 195 ~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~ki~~~---~~i~~P~~~~p~~~iP~~L~~LI~rcL~ 270 (932)
T PRK13184 195 PDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRKISYR---DVILSPIEVAPYREIPPFLSQIAMKALA 270 (932)
T ss_pred CCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhhhhhh---hhccChhhccccccCCHHHHHHHHHHcc
Confidence 99999999988877655 9999999999999999999987443222111 1111111222234678999999999999
Q ss_pred hCCCCCCCHhHHhc
Q 025350 153 ADPAKRISIPEIRN 166 (254)
Q Consensus 153 ~dP~~Rps~~e~l~ 166 (254)
.||++|++..+.+.
T Consensus 271 ~DP~kR~ss~eeLl 284 (932)
T PRK13184 271 VDPAERYSSVQELK 284 (932)
T ss_pred CChhhCcCHHHHHH
Confidence 99999987655543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=204.57 Aligned_cols=149 Identities=26% Similarity=0.427 Sum_probs=115.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+++|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..++
T Consensus 240 ~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 317 (400)
T cd05105 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT 317 (400)
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC
Confidence 347789999999999999999999999999987765 99999999875432221 2233467789999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||............+ ......+....++..+++++.+||..+|++|||+.++.+
T Consensus 318 ~~-~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 318 TL-SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI----KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ch-hhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH----hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 55 999999999999997 999997654332222221 222233334567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=199.94 Aligned_cols=149 Identities=23% Similarity=0.400 Sum_probs=114.1
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.+..|++.+++|||++||+||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..++.
T Consensus 183 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 260 (343)
T cd05103 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260 (343)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCc
Confidence 46789999999999999999999999999987765 99999999875422211 11223566799999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|+||||+++|++++ |..||.............. . ....+....+++.+.+++.+||..+|.+|||+.++++|
T Consensus 261 ~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 261 Q-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---E-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred h-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh---c-cCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5 999999999999996 9999976543333222221 1 11222223468899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=190.78 Aligned_cols=148 Identities=28% Similarity=0.358 Sum_probs=112.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC---CCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..+..+++.++++||++|++||||||+||+++.++. +||+|||++......... .....+..|+|||.+.+..++
T Consensus 96 ~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 173 (251)
T cd05041 96 LQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173 (251)
T ss_pred HHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcceeccCChHhhccCCCC
Confidence 345678899999999999999999999999987765 999999998754321111 112235579999998877765
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+||||+++|+|++ |..||........... + ......+....++..+.+++.+||..+|.+|||+.++++
T Consensus 174 ~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 174 SE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRER----I-ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred cc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHH----H-hcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 55 999999999999998 8889876554322221 1 112233333457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=191.42 Aligned_cols=152 Identities=19% Similarity=0.281 Sum_probs=109.7
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCC---
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKE--- 85 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--- 85 (254)
.+..|++.+++|||++|++||||||+|||++.++. +||+|||++....... ......++..|+|||++....
T Consensus 103 ~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (268)
T cd05086 103 RMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180 (268)
T ss_pred HHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc
Confidence 45678999999999999999999999999987765 9999999886422211 122346788999999975321
Q ss_pred ---CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 86 ---YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 86 ---~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
..+.++|||||||++|+|++ |..||............................+++.+.+++..|| .+|.+||++
T Consensus 181 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~ 259 (268)
T cd05086 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATA 259 (268)
T ss_pred ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCH
Confidence 11345899999999999996 5778876655444444333221111111122346889999999999 789999999
Q ss_pred hHHhc
Q 025350 162 PEIRN 166 (254)
Q Consensus 162 ~e~l~ 166 (254)
+++++
T Consensus 260 ~~i~~ 264 (268)
T cd05086 260 EEVHR 264 (268)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=191.15 Aligned_cols=146 Identities=23% Similarity=0.352 Sum_probs=113.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.++.|||++|++||||||+||+++.++. +||+|||++...... ......+..|+|||.+.+..++.+
T Consensus 103 ~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~- 177 (254)
T cd05083 103 LQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSK- 177 (254)
T ss_pred HHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CCCCCCCceecCHHHhccCCcCch-
Confidence 446779999999999999999999999999987765 999999998753221 122334568999999887777655
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 91 ADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 91 ~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+|+|||||++|+|++ |+.||......... .. ... ....+....++..+.+++.+||+.+|.+||++.+++.
T Consensus 178 ~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~---~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-EC---VEK-GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred hhHHHHHHHHHHHHhCCCCCCccCCHHHHH-HH---HhC-CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999997 99999875543222 11 111 2222333457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=192.09 Aligned_cols=150 Identities=21% Similarity=0.352 Sum_probs=114.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC---CCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~---~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~ 84 (254)
..++.|++.+++|||++|++|+||||+||+++.+. ...++|+|||++........ .....++..|+|||.+.+.
T Consensus 109 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (269)
T cd05044 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG 188 (269)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC
Confidence 44678999999999999999999999999998765 12499999999875432211 1223456789999999877
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.++.+ +|||||||++|+|++ |..||........... +. ..........++..+.++|.+||..+|.+||++.+
T Consensus 189 ~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 189 KFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQH----VT-AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred Ccccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH----Hh-cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 77655 999999999999998 9999976544332221 11 11222333457899999999999999999999999
Q ss_pred Hhc
Q 025350 164 IRN 166 (254)
Q Consensus 164 ~l~ 166 (254)
+++
T Consensus 263 i~~ 265 (269)
T cd05044 263 IQE 265 (269)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=188.27 Aligned_cols=155 Identities=37% Similarity=0.539 Sum_probs=122.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.+++.++.+||+.|++|+||+|.||+++.++. ++|+|||.+.............++..|++||.+.+..++.
T Consensus 89 ~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~- 165 (244)
T smart00220 89 ARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGK- 165 (244)
T ss_pred HHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHHccCCCCc-
Confidence 3457788999999999999999999999999988765 9999999998655443445567888999999998777766
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCC-CCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-HISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
++|+||||++++++++|..||............ ............ .++..+.+++.+||..+|++||++.++++||
T Consensus 166 ~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~ 242 (244)
T smart00220 166 AVDVWSLGVILYELLTGKPPFPGDDQLLELFKK---IGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHP 242 (244)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCC
Confidence 499999999999999999999774333332222 222222222111 1788999999999999999999999999999
Q ss_pred cc
Q 025350 169 WF 170 (254)
Q Consensus 169 ~~ 170 (254)
||
T Consensus 243 ~~ 244 (244)
T smart00220 243 FF 244 (244)
T ss_pred CC
Confidence 97
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=193.02 Aligned_cols=149 Identities=21% Similarity=0.340 Sum_probs=113.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+++|||++||+||||||+||+++.++. +||+|||+++....... .....+++.|++||.+.+..++
T Consensus 116 ~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 193 (273)
T cd05074 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT 193 (273)
T ss_pred HHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccc
Confidence 457789999999999999999999999999987665 99999999875432221 1223456789999998877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |.+||.+......... +.... ........+..+.+++.+||..+|.+|||+.+++.
T Consensus 194 ~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 194 TH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY----LIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred hh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH----HHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55 999999999999999 8899976544322221 11111 12222346899999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 268 ~ 268 (273)
T cd05074 268 Q 268 (273)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=195.42 Aligned_cols=154 Identities=23% Similarity=0.322 Sum_probs=114.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
+..++.+++.+++|||++|++||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..
T Consensus 111 ~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 188 (284)
T cd05079 111 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccccCccceeecCCCCCCccccCHHHhccCC
Confidence 3456789999999999999999999999999987765 99999999875433221 12334667899999988777
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCc-----------hHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhC
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 154 (254)
++.+ +|||||||++|++++++.|+..... ......... ........+....++..+.+|+.+||+.+
T Consensus 189 ~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 266 (284)
T cd05079 189 FYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VLEEGKRLPRPPNCPEEVYQLMRKCWEFQ 266 (284)
T ss_pred CCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HHHcCccCCCCCCCCHHHHHHHHHHccCC
Confidence 6655 9999999999999998776532111 001111111 11222233444568999999999999999
Q ss_pred CCCCCCHhHHhcC
Q 025350 155 PAKRISIPEIRNH 167 (254)
Q Consensus 155 P~~Rps~~e~l~h 167 (254)
|.+|||+.+++++
T Consensus 267 p~~Rpt~~~il~~ 279 (284)
T cd05079 267 PSKRTTFQNLIEG 279 (284)
T ss_pred cccCcCHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=189.46 Aligned_cols=148 Identities=23% Similarity=0.319 Sum_probs=113.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.+++.++.+||++|++||||||+||+++.++. +||+|||++......... ....++..|+|||++.+..++.
T Consensus 96 ~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 173 (250)
T cd05085 96 VKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173 (250)
T ss_pred HHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCc
Confidence 456788999999999999999999999999987765 999999998653322211 1123456799999998777665
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|+||||+++|++++ |..||........... +. ..........++..+.+++.+||..+|.+||++.++++
T Consensus 174 ~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 174 E-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQ----VE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred h-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5 999999999999998 9999987644322221 11 12222333457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=192.63 Aligned_cols=150 Identities=27% Similarity=0.369 Sum_probs=116.8
Q ss_pred CCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.+++.++.+||+ .|++|+||+|+||+++.++. +||+|||.+.............++..|+|||.+.+..++.+
T Consensus 116 ~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~ 193 (269)
T cd08528 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK 193 (269)
T ss_pred HHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecccceeecccccccccccCcccCcChhhhcCCCCchH
Confidence 4456789999999995 78999999999999987765 99999999976544433345568899999999987776555
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|+||||+++|+|++|..||.......... .+............+++.+.++|.+||..||.+||++.++..+
T Consensus 194 -~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 194 -ADVWAFGCILYQMCTLQPPFYSTNMLSLAT----KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -HHHHHHHHHHHHHHhCCCcccccCHHHHHH----HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999997654332222 2222222222223578999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=180.66 Aligned_cols=159 Identities=21% Similarity=0.337 Sum_probs=124.6
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcch
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
-.+.+++.||.|.|+.||+|||+||.|++|+.... +++|+|+|+|.....+..-..++.+..|--||++...+....+.
T Consensus 136 yY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSL 214 (338)
T KOG0668|consen 136 YYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSL 214 (338)
T ss_pred HHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccH
Confidence 34678999999999999999999999999987653 69999999998877776667778889999999998766544558
Q ss_pred hHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHHHHhc----------cCCCCC-------------CC---------CC
Q 025350 92 DVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILS----------VQYSIP-------------DY---------VH 138 (254)
Q Consensus 92 DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~----------~~~~~~-------------~~---------~~ 138 (254)
|+|||||++..|+..+.||. +.++.+++.++.+ ++. -...++ .| .-
T Consensus 215 D~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak-VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl 293 (338)
T KOG0668|consen 215 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK-VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHL 293 (338)
T ss_pred HHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH-HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccccc
Confidence 99999999999999988875 4445555444322 111 000000 00 11
Q ss_pred CCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 139 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 139 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
+++++.+|+.++|.+|-.+|+|+.|++.||||..
T Consensus 294 ~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 294 VSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 4699999999999999999999999999999965
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-28 Score=197.96 Aligned_cols=152 Identities=32% Similarity=0.448 Sum_probs=113.6
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccC
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~ 83 (254)
...+..++.|++.|++|||+++++|++|+++|||++.++. +||+|||++........ .........|+|||.+.+
T Consensus 102 ~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 179 (259)
T PF07714_consen 102 EQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD 179 (259)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc
Confidence 3445677899999999999999999999999999998775 99999999876522111 223346778999999987
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 84 KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..++.+ +||||||+++|++++ |+.||........... + ......+....++..+.++|.+||..+|.+|||+.
T Consensus 180 ~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~ 253 (259)
T PF07714_consen 180 GEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK----L-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQ 253 (259)
T ss_dssp SEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH----H-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HH
T ss_pred cccccc-cccccccccccccccccccccccccccccccc----c-cccccceeccchhHHHHHHHHHHcCCChhhCcCHH
Confidence 776545 999999999999999 7899987644332222 2 12222334446899999999999999999999999
Q ss_pred HHhc
Q 025350 163 EIRN 166 (254)
Q Consensus 163 e~l~ 166 (254)
++++
T Consensus 254 ~i~~ 257 (259)
T PF07714_consen 254 EILQ 257 (259)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 9874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=190.83 Aligned_cols=149 Identities=21% Similarity=0.344 Sum_probs=114.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCC----CCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~----~~~~~~~y~aPE~~~~~~ 85 (254)
...++.+++.+++|||+.|++||||||+||+++.++. +||+|||++.......... ....+..|+|||.+.+..
T Consensus 109 ~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (268)
T cd05063 109 LVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186 (268)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccccccceeccCCCcCceecCHHHhhcCC
Confidence 3556788999999999999999999999999987665 9999999987543222111 112345799999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|+|||||++|++++ |..||........... +.. ....+....++..+.+++.+||..+|.+||++.++
T Consensus 187 ~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 187 FTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA----IND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred cChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH----Hhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 7655 999999999999997 9999977554332222 222 23344445678999999999999999999999999
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 261 ~~ 262 (268)
T cd05063 261 VN 262 (268)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=191.42 Aligned_cols=150 Identities=22% Similarity=0.330 Sum_probs=115.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~ 87 (254)
+..++.+++.++.|||++|++||||||+||+++.++. +||+|||+++........ ....++..|+|||.+....++
T Consensus 109 ~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (270)
T cd05056 109 LILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186 (270)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccccceecCCCCccccccChhhhccCCCC
Confidence 3456789999999999999999999999999987765 999999998754332211 122345679999998777766
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+||||+++|++++ |..||........... +. .....+....++..+.+++.+||..+|.+|||+.+++.
T Consensus 187 ~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 187 SA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IE-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55 999999999999986 9999987654333222 11 12222334567899999999999999999999999886
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
.
T Consensus 261 ~ 261 (270)
T cd05056 261 Q 261 (270)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=192.98 Aligned_cols=153 Identities=22% Similarity=0.247 Sum_probs=112.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC----CCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||++......... ....++..|+|||.+.+..+
T Consensus 111 ~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 188 (284)
T cd05081 111 LLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188 (284)
T ss_pred HHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCc
Confidence 456789999999999999999999999999987765 999999998864332211 11123456999999987776
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHH-----------HHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-----------FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
+.+ +|+|||||++|+|++|..++........ ...............+....++..+.+|+.+||..+|
T Consensus 189 ~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 267 (284)
T cd05081 189 SVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDP 267 (284)
T ss_pred ChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCCh
Confidence 554 9999999999999998877643321100 0000111222223334445678999999999999999
Q ss_pred CCCCCHhHHhc
Q 025350 156 AKRISIPEIRN 166 (254)
Q Consensus 156 ~~Rps~~e~l~ 166 (254)
++|||+.++++
T Consensus 268 ~~Rpt~~ei~~ 278 (284)
T cd05081 268 SQRPSFSELAL 278 (284)
T ss_pred hhCCCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=194.00 Aligned_cols=148 Identities=20% Similarity=0.277 Sum_probs=113.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.+++.++.+||++|++||||||+||+++.++. +||+|||++........ ......+..|+|||.+.+..++
T Consensus 133 ~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 210 (288)
T cd05050 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT 210 (288)
T ss_pred HHHHHHHHHHHHHHHhCCeecccccHhheEecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC
Confidence 468889999999999999999999999999987765 99999999875322211 1222346679999998877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+....... ..+.... ..+....++..+.+|+.+||+.+|.+|||+.|+++
T Consensus 211 ~~-~Dv~slG~il~el~~~~~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 211 TE-SDVWAYGVVLWEIFSYGMQPYYGMAHEEVI----YYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55 999999999999997 88899765443322 2222222 12223357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=188.70 Aligned_cols=161 Identities=26% Similarity=0.377 Sum_probs=124.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....+.|++++|+|||+.||.||||||.|+|++++.. +||||||+|+...... .....+.|..|+|||++.|....
T Consensus 158 vKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhY 235 (449)
T KOG0664|consen 158 VKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRY 235 (449)
T ss_pred hhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhh
Confidence 3456789999999999999999999999999999887 9999999998543322 23344678899999999998777
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH-------------------HHhccCCCCCCC---------CCC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------------------RILSVQYSIPDY---------VHI 139 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~---------~~~ 139 (254)
+.+.||||.||++.|++..+..|...+...++.-+.. .++......|.. ..-
T Consensus 236 s~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~ 315 (449)
T KOG0664|consen 236 TGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDK 315 (449)
T ss_pred cCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCccc
Confidence 7779999999999999999999987665555433221 112222222221 122
Q ss_pred CHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 140 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
..+...++.++|..||.+|.+..+++.|++..+
T Consensus 316 ~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 316 NHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred chHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 356778999999999999999999999999854
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=188.20 Aligned_cols=149 Identities=26% Similarity=0.382 Sum_probs=114.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCC--CCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.++++||++|++||||||+||+++.++. ++|+|||++.......... ...+++.|+|||.+.+..++
T Consensus 105 ~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 182 (258)
T smart00219 105 LLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFT 182 (258)
T ss_pred HHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccccccccCCCcccccChHHhccCCCC
Confidence 3557789999999999999999999999999988765 9999999987554332111 12367889999998666665
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+||||+++|+|++ |.+||........... +... ...+....++..+.+++.+||..+|.+|||+.++++
T Consensus 183 ~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 183 SK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKG-YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred cc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcC-CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 54 999999999999998 7888876443332222 2221 122333447899999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=189.15 Aligned_cols=148 Identities=23% Similarity=0.328 Sum_probs=114.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.+++.++.+||++|++||||||+||+++..+. +||+|||.+........ .....++..|+|||.+....++.
T Consensus 105 ~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 182 (260)
T cd05073 105 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182 (260)
T ss_pred HHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCc
Confidence 446678999999999999999999999999987765 99999999875433221 11223556799999998776655
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|+|||||++|++++ |..||........... + ......+.....+.++.+++.+||..+|.+||++.++++
T Consensus 183 ~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 183 K-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-L----ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred c-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-H----hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 5 999999999999998 9999987554332221 1 222333444567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=190.87 Aligned_cols=149 Identities=21% Similarity=0.275 Sum_probs=115.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.+++.++.|||++|++|+||||+||+++.++. +||+|||++........ ......+..|+|||.+.+..++
T Consensus 105 ~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 182 (261)
T cd05034 105 LVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182 (261)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhhhhccCCCccccCHHHhccCCcC
Confidence 3567788999999999999999999999999988765 99999999875432211 1122345689999999877765
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|+||||+++|++++ |+.||.+......... +. .....+.....+..+++++.+||..+|.+||++.++++
T Consensus 183 ~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 183 IK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ----VE-RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55 999999999999998 9999987654333322 21 12233334456899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=190.67 Aligned_cols=149 Identities=21% Similarity=0.339 Sum_probs=114.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCC---Cc---CCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TV---GTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~---~~---~~~~y~aPE~~~~ 83 (254)
...++.|++.+++|||++|++||||||+||+++.++. +||+|||++........... .. .+..|+|||.+.+
T Consensus 108 ~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (269)
T cd05065 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185 (269)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccCccccccccccCCCcceeecCHhHhcc
Confidence 3456688999999999999999999999999987665 99999999865432221111 11 2347999999987
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 84 KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..++.+ +|||||||++|++++ |..||........... + ......+....++..+.+++.+||..+|.+||++.
T Consensus 186 ~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (269)
T cd05065 186 RKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINA----I-EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFG 259 (269)
T ss_pred Ccccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH----H-HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 777655 999999999999886 9999987554322222 2 12233444456789999999999999999999999
Q ss_pred HHhc
Q 025350 163 EIRN 166 (254)
Q Consensus 163 e~l~ 166 (254)
+++.
T Consensus 260 ~i~~ 263 (269)
T cd05065 260 QIVS 263 (269)
T ss_pred HHHH
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=191.00 Aligned_cols=152 Identities=21% Similarity=0.360 Sum_probs=117.1
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
.+..++.|++.+|+|||++||+||||||+||+++..+. ++|+|||++....... ......++..|+|||.+.+...
T Consensus 118 ~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 195 (275)
T cd05046 118 QKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF 195 (275)
T ss_pred HHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccccccccCcccccccCCceeEEeecChhhhccCCC
Confidence 34567889999999999999999999999999988765 9999999986432211 1223346778999999877666
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
..+ +||||||+++|++++ |..||........ ...........+....++..+.+++.+||..+|.+|||+.+++
T Consensus 196 ~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l 270 (275)
T cd05046 196 STK-SDVWSFGVLMWEVFTQGELPFYGLSDEEV----LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270 (275)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCccccchHHH----HHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 544 999999999999998 8889976543322 2223223333334446789999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
.+
T Consensus 271 ~~ 272 (275)
T cd05046 271 SA 272 (275)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=201.22 Aligned_cols=149 Identities=24% Similarity=0.391 Sum_probs=115.8
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.+..|++.++.|||++||+||||||+|||++.++. +||+|||+++...... ......++..|+|||.+.+..++.
T Consensus 243 ~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 320 (401)
T cd05107 243 GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320 (401)
T ss_pred HHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc
Confidence 35679999999999999999999999999987665 9999999987542221 112335678899999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|+|||||++|+|++ |..||............+ ......+.+..++..+.+|+.+||..+|.+||+++++++.
T Consensus 321 ~-~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 321 L-SDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI----KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred H-hHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH----HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5 999999999999998 889997654433322222 2222333344578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=190.24 Aligned_cols=148 Identities=24% Similarity=0.299 Sum_probs=110.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-----CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-----~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
+..++.|++.+++|||++||+||||||+|||++..+ .+.+|++|||++..... .....++..|+|||.+.+.
T Consensus 119 ~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~ 195 (274)
T cd05076 119 KITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGG 195 (274)
T ss_pred HHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccccc---ccccccCCcccCchhhcCC
Confidence 345788999999999999999999999999997543 22489999998764322 2234577889999988764
Q ss_pred CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
...+.++|+|||||++|+++ +|..||........ .... ......+. ..++.+.++|.+||+.+|.+|||+.+
T Consensus 196 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~----~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~ 268 (274)
T cd05076 196 NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFY----EKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRT 268 (274)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHH----HhccCCCC--CCChHHHHHHHHHcccChhhCcCHHH
Confidence 43345599999999999985 79999986543322 1111 11222222 24678999999999999999999999
Q ss_pred HhcC
Q 025350 164 IRNH 167 (254)
Q Consensus 164 ~l~h 167 (254)
++++
T Consensus 269 il~~ 272 (274)
T cd05076 269 ILRD 272 (274)
T ss_pred HHHh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=188.09 Aligned_cols=149 Identities=23% Similarity=0.336 Sum_probs=112.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..+..+++.++.+||++|++||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..++.
T Consensus 103 ~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~ 180 (256)
T cd05112 103 LGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180 (256)
T ss_pred HHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcCh
Confidence 446678999999999999999999999999987665 99999999875432211 11223456899999998777665
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|+||||+++|+|++ |..||........... +... .........+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 181 ~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 181 K-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVET----INAG-FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred H-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH----HhCC-CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 5 999999999999998 9999976543322222 2111 1212223368999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=189.80 Aligned_cols=149 Identities=23% Similarity=0.315 Sum_probs=114.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCC---CcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~ 86 (254)
...+..|++.+++|||++||+||||||+||+++.++. +||+|||+++.......... ..++..|+|||.+....+
T Consensus 111 ~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (279)
T cd05057 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188 (279)
T ss_pred HHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCc
Confidence 3556789999999999999999999999999987765 99999999976543222111 123567999999877776
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|+||||+++|++++ |..||.+...... ... +.. ....+.....+..+.+++.+||..+|++||++.+++
T Consensus 189 ~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~---~~~-~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 189 THK-SDVWSYGVTVWELMTFGAKPYEGIPAVEI-PDL---LEK-GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred Cch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHH-HHH---HhC-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 655 999999999999998 9999987543322 221 222 222333345788999999999999999999999886
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 263 ~ 263 (279)
T cd05057 263 N 263 (279)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=187.63 Aligned_cols=146 Identities=22% Similarity=0.236 Sum_probs=109.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCC-----cEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~-----~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
+..++.|++.+++|||++||+||||||+||+++..+.. .+||+|||++..... .....++..|+|||.+.+.
T Consensus 103 ~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 103 KLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNG 179 (259)
T ss_pred HHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCC
Confidence 34566799999999999999999999999999876521 499999999875432 2234567789999998766
Q ss_pred --CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 85 --EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 85 --~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
.++ .++|+|||||++|++++ |..||....... ...... .....+. .....+.+++.+||..+|.+|||+
T Consensus 180 ~~~~~-~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~~----~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~ 251 (259)
T cd05037 180 QASLT-IAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQ----DQHRLPM--PDCAELANLINQCWTYDPTKRPSF 251 (259)
T ss_pred CCCcc-hhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHHh----cCCCCCC--CCchHHHHHHHHHhccChhhCCCH
Confidence 444 44999999999999999 577886654221 111111 1111222 124789999999999999999999
Q ss_pred hHHhc
Q 025350 162 PEIRN 166 (254)
Q Consensus 162 ~e~l~ 166 (254)
.++++
T Consensus 252 ~~il~ 256 (259)
T cd05037 252 RAILR 256 (259)
T ss_pred HHHHH
Confidence 99985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=188.41 Aligned_cols=148 Identities=20% Similarity=0.338 Sum_probs=114.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC----CCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.++++||++|++||||||+||+++.++. ++|+|||++......... ....++..|+|||.+.+..+
T Consensus 109 ~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 186 (267)
T cd05066 109 VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186 (267)
T ss_pred HHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccccceeeecCCCccceeecCHhHhccCcc
Confidence 456678999999999999999999999999987765 999999998754332211 11123467999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|+|||||++|++++ |..||........... +.. ....+....+++.+.+++.+||+.+|.+||++.+++
T Consensus 187 ~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 260 (267)
T cd05066 187 TSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA----IEE-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260 (267)
T ss_pred Cch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH----HhC-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHH
Confidence 655 999999999999886 9999987554332222 222 223344456789999999999999999999999987
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 261 ~ 261 (267)
T cd05066 261 S 261 (267)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=190.39 Aligned_cols=153 Identities=24% Similarity=0.284 Sum_probs=115.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC----CCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.+++.+|++||++|++||||||+||+++.++. ++|+|||.+......... ....++..|+|||.+.+..+
T Consensus 112 ~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 189 (284)
T cd05038 112 LLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189 (284)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCC
Confidence 457789999999999999999999999999988765 999999999765422111 11234567999999887776
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHH----------HHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCC
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN----------FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 156 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 156 (254)
+.+ +|+||||+++|+|++|..|+........ ...............+....++..+.+++.+||..+|.
T Consensus 190 ~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 268 (284)
T cd05038 190 SSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQ 268 (284)
T ss_pred Ccc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChh
Confidence 655 8999999999999999999865432110 01112222223333444455788999999999999999
Q ss_pred CCCCHhHHhc
Q 025350 157 KRISIPEIRN 166 (254)
Q Consensus 157 ~Rps~~e~l~ 166 (254)
+|||+.++++
T Consensus 269 ~Rpt~~ei~~ 278 (284)
T cd05038 269 DRPSFADLIL 278 (284)
T ss_pred hCCCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=204.21 Aligned_cols=147 Identities=24% Similarity=0.329 Sum_probs=121.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC---CCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~ 87 (254)
.-+..|++.|+.||-++.+|||||-.+|+||..+.. |||+|||+++..-..... ....-..+|||||.+..++++
T Consensus 606 L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT 683 (774)
T KOG1026|consen 606 LHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT 683 (774)
T ss_pred HHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc
Confidence 346789999999999999999999999999988776 999999999854322211 122346789999999999998
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+. |||||+||+|||+++ |..||.+.++.+.. ..+..... ++.+..+|.++.+||..||+.+|.+||++.+|-
T Consensus 684 te-SDVWs~GVvLWEIFsyG~QPy~glSn~EVI----e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 684 TE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVI----ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ch-hhhhhhhhhhhhhhccccCcccccchHHHH----HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 87 999999999999997 99999997765443 33444444 666678999999999999999999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=206.77 Aligned_cols=98 Identities=33% Similarity=0.609 Sum_probs=77.5
Q ss_pred cCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC-CCCCCHHHHHHHH
Q 025350 70 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLIS 148 (254)
Q Consensus 70 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~ 148 (254)
+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+..+ ......++. ...++..+.+++.
T Consensus 541 vGT~~Y~APE~l~~~~~~~~-~DiwSlG~il~ElltG~~pf~~~~~~~~~~~i----l~~~~~~p~~~~~~~~~~~~~l~ 615 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQQVFQNI----LNRDIPWPEGEEKLSVNAQNAIE 615 (669)
T ss_pred eeCccccCHHHcCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhcCCCCCcccccCCHHHHHHHH
Confidence 35888999999998887655 99999999999999999999876544433332 222222222 2256888999999
Q ss_pred HhchhCCCCCCCHhHHhcCccccc
Q 025350 149 RIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 149 ~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
+||..||.+||++.++++||||..
T Consensus 616 ~lL~~dP~~R~ta~e~l~h~~~~~ 639 (669)
T cd05610 616 ILLTMDPTKRAGLKELKQHPLFHG 639 (669)
T ss_pred HHcccChhHCcCHHHHHhCHhhcC
Confidence 999999999999999999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=207.87 Aligned_cols=147 Identities=24% Similarity=0.338 Sum_probs=118.8
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.+-.+++++.+||+++++|||||..+|+|++.... |||+|||+|+-...... .....-...|||||.+..+.+++
T Consensus 806 ~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFts 883 (1025)
T KOG1095|consen 806 AFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTS 883 (1025)
T ss_pred HHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEcccchhHhhhhchheeccCccccceecCCHHHHhhccccc
Confidence 34578999999999999999999999999988765 99999999983322211 11113346899999999988887
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++||+++ |..||......+.+. .+.... +++.+..++..+.++|..||+.+|++||++..|++
T Consensus 884 k-SDvWsFGVllWEifslG~~PY~~~~n~~v~~----~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 884 K-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLL----DVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred c-cchhhhHHHHHHHHhCCCCCCCCcchHHHHH----HHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 7 999999999999998 889998865544332 233333 66777789999999999999999999999999987
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-26 Score=203.55 Aligned_cols=159 Identities=26% Similarity=0.333 Sum_probs=128.6
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCC-
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKK- 84 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~- 84 (254)
+.+..=|+..++.++.+||.+.++|||||-.|||++.++. |||+|||++..... .....+.+|||.|||||++...
T Consensus 122 E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e 199 (953)
T KOG0587|consen 122 EEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDE 199 (953)
T ss_pred hHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecccccccCcCCCcccccceeeeccc
Confidence 3344556788999999999999999999999999999887 99999999875433 3345677899999999998643
Q ss_pred ----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC
Q 025350 85 ----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 160 (254)
Q Consensus 85 ----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 160 (254)
.|+.. +|+||||++..||.-|.+|+........+ +.....+.+.+..+.+++.++-+||..||.+|-.+||+
T Consensus 200 ~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraL---F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~ 275 (953)
T KOG0587|consen 200 SPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS 275 (953)
T ss_pred CCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhh---ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc
Confidence 35555 89999999999999999999876543322 22222333344445678999999999999999999999
Q ss_pred HhHHhcCcccc
Q 025350 161 IPEIRNHEWFL 171 (254)
Q Consensus 161 ~~e~l~hp~~~ 171 (254)
..++|+|||++
T Consensus 276 ~~~ll~hpFi~ 286 (953)
T KOG0587|consen 276 TEELLKHPFIT 286 (953)
T ss_pred hhhhccCCccc
Confidence 99999999986
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-26 Score=196.56 Aligned_cols=150 Identities=25% Similarity=0.355 Sum_probs=120.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCC-CCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~ 88 (254)
+....++++.|++|||+++++||||-.+|+|++.++. +||+|||+++......... ...-...|+|||.+....|+.
T Consensus 264 k~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~ 341 (474)
T KOG0194|consen 264 KLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSF 341 (474)
T ss_pred HHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcceeeccccccCcceecChhhhccCcccc
Confidence 4456788999999999999999999999999988765 8999999987543111111 123457899999999887776
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++||+++ |..||.+..... ...++....++.+.+...+..+..++.+||..+|++|||+.++.+
T Consensus 342 k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~----v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 342 K-TDVWSFGVLLWEIFENGAEPYPGMKNYE----VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred c-cchhheeeeEEeeeccCCCCCCCCCHHH----HHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 6 999999999999998 788999866543 334444556666666678899999999999999999999998864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=196.44 Aligned_cols=154 Identities=29% Similarity=0.391 Sum_probs=116.6
Q ss_pred ccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC--CCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc
Q 025350 5 AVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 82 (254)
Q Consensus 5 ~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~ 82 (254)
+.+.....++..++.|++|||++|||||||||.||++-.. +..-.||+|||.|+....++...+.+||..|.+||++.
T Consensus 117 LpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 117 LPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYE 196 (732)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHh
Confidence 3344445567789999999999999999999999988433 33346999999999998888888899999999999998
Q ss_pred C-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------------------cCCCCCCCCCCCHH
Q 025350 83 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------------VQYSIPDYVHISPE 142 (254)
Q Consensus 83 ~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~ 142 (254)
. +.|+.. +|.|||||++|+++||..||.....+++....+..+.. ....+|.+.++++.
T Consensus 197 ~q~~y~~t-VDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~ 275 (732)
T KOG4250|consen 197 RQKKYTAT-VDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRG 275 (732)
T ss_pred hccCcCce-eehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHH
Confidence 5 556555 99999999999999999999876655543333322211 11233444445544
Q ss_pred H----HHHHHHhchhCCCCCC
Q 025350 143 C----RHLISRIFVADPAKRI 159 (254)
Q Consensus 143 ~----~~li~~~L~~dP~~Rp 159 (254)
+ -.++..+|..+|.+|.
T Consensus 276 l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 276 LATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred HHhhhhHHHHHHHhhhHHHhC
Confidence 3 4677788999999998
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=185.05 Aligned_cols=170 Identities=24% Similarity=0.349 Sum_probs=130.5
Q ss_pred ccCcCCcHHHHHHHHHHHhh--cCcccCCCCCCcEEecC-CCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCc
Q 025350 7 QRGRGTLFLPTTYFWSELLP--FNVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAY 75 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~--~givHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y 75 (254)
+.....|++|+..+|.||.+ -.|||-||||.|||+.+ +..+.+||+|||+++.....+. .....||.+|
T Consensus 567 EKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWY 646 (775)
T KOG1151|consen 567 EKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWY 646 (775)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeee
Confidence 44456789999999999994 56999999999999843 3334699999999987644332 1234699999
Q ss_pred ccchhccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhch
Q 025350 76 IAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 152 (254)
Q Consensus 76 ~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 152 (254)
++||++.-+ +--+.++||||+||++|.++.|+.||............-.-+......+|..+.++.++++||++||+
T Consensus 647 LPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLa 726 (775)
T KOG1151|consen 647 LPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLA 726 (775)
T ss_pred cCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHH
Confidence 999998643 22234599999999999999999999876544333322222233445667777899999999999999
Q ss_pred hCCCCCCCHhHHhcCccccccCCc
Q 025350 153 ADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 153 ~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
+.-+.|..+.++-.||||....-.
T Consensus 727 YRKeDR~DV~qLA~dpyllPh~rr 750 (775)
T KOG1151|consen 727 YRKEDRIDVQQLACDPYLLPHIRR 750 (775)
T ss_pred hhhhhhhhHHHHccCccccchhhh
Confidence 999999999999999999875533
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=189.64 Aligned_cols=158 Identities=25% Similarity=0.295 Sum_probs=113.6
Q ss_pred cccCcCCcHHHHHHHHHHHhhcC---cccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCC-cCCCCcccchh
Q 025350 6 VQRGRGTLFLPTTYFWSELLPFN---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKST-VGTPAYIAPEV 80 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~Lh~~g---ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~-~~~~~y~aPE~ 80 (254)
-+..|..|.+.+++||+|||... ||||||||+|||+|.+.. .||+|||+|+.... .....+. .||..|+|||.
T Consensus 172 ~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy 249 (361)
T KOG1187|consen 172 DWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEY 249 (361)
T ss_pred CHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccccceeeecCCCCccCChhh
Confidence 34557789999999999999643 999999999999998877 99999999976544 3333333 79999999999
Q ss_pred ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHHHHhccC----CCCCCC--CCCC--HH---HHHHH
Q 025350 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKTIHRILSVQ----YSIPDY--VHIS--PE---CRHLI 147 (254)
Q Consensus 81 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~----~~~~~~--~~~~--~~---~~~li 147 (254)
+..+..+.+ +||||||+++.|+++|+.+..... ....+........... .-.|.. ...+ .. +..+.
T Consensus 250 ~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a 328 (361)
T KOG1187|consen 250 ASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELA 328 (361)
T ss_pred hccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHH
Confidence 987777666 999999999999999998877532 1111222211111111 011111 1223 23 45667
Q ss_pred HHhchhCCCCCCCHhHHhc
Q 025350 148 SRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 148 ~~~L~~dP~~Rps~~e~l~ 166 (254)
.+|+..+|..||++.++++
T Consensus 329 ~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 329 LRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHcCcCCCcCcCHHHHHH
Confidence 8999999999999999754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=190.96 Aligned_cols=145 Identities=23% Similarity=0.363 Sum_probs=118.8
Q ss_pred cHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCc--CCCCcccchhccCCCCCCcc
Q 025350 13 LFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 13 ~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~ 90 (254)
.-.|++.+++|||+..+|||||...|||+.+... |||+|||+++............ -...|||||.+.-..+++.
T Consensus 496 y~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtA- 572 (974)
T KOG4257|consen 496 YCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTA- 572 (974)
T ss_pred HHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhhccccccceeecCccccchhcccch-
Confidence 3468999999999999999999999999987766 9999999999765554333223 4567999999988888665
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 91 ADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+|||.|||++||++. |..||.+-.+.+... ......++|.++++|+.+..|+.+||+++|.+||++.++.
T Consensus 573 SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-----~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 573 SDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-----HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred hhHHHHHHHHHHHHHhcCCccccccccceEE-----EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 999999999999885 999999865543322 2344557777888999999999999999999999987754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=180.60 Aligned_cols=125 Identities=26% Similarity=0.434 Sum_probs=85.6
Q ss_pred cEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHH
Q 025350 48 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----PKNFRKT 122 (254)
Q Consensus 48 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~ 122 (254)
+|||+|||.|.... ...+..+.|..|+|||++.+.+|.+. +||||++|++|||+||...|...+. .+.-...
T Consensus 392 ~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 392 RVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred eEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 36777887776532 22344568899999999999999888 8999999999999999998864321 1111111
Q ss_pred HHHHhc---------cCC---------------CCCCCC---------CCC----HHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 123 IHRILS---------VQY---------------SIPDYV---------HIS----PECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 123 ~~~~~~---------~~~---------------~~~~~~---------~~~----~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+-.++. +.+ .+..|+ .+| .++.+|+.-||+.+|.+||||.++|
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 111110 000 011110 122 4678999999999999999999999
Q ss_pred cCccccccCC
Q 025350 166 NHEWFLKNLP 175 (254)
Q Consensus 166 ~hp~~~~~~~ 175 (254)
+|||++....
T Consensus 549 ~hPwLn~~~~ 558 (590)
T KOG1290|consen 549 KHPWLNPVAG 558 (590)
T ss_pred cCccccCCCC
Confidence 9999976443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=189.04 Aligned_cols=152 Identities=24% Similarity=0.352 Sum_probs=124.8
Q ss_pred cHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCC----cCCCCcccchhccCCCCCC
Q 025350 13 LFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 13 ~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~----~~~~~y~aPE~~~~~~~~~ 88 (254)
...|++.+++||.++++|||||-..|+|+..... |||+|||+.+....+...+.. .-...|+|||.+....++.
T Consensus 217 ya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSh 294 (1039)
T KOG0199|consen 217 YAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSH 294 (1039)
T ss_pred HHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccc
Confidence 4578999999999999999999999999987554 999999999977666554432 2345799999999999876
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
. +|+|++||++|||++ |..||.+......+.+ +- ....++....+++.+.++++.||..+|.+|||+..|...
T Consensus 295 a-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~----iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 295 A-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN----ID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred c-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----cc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 6 999999999999997 7899999776554443 32 344566666799999999999999999999999998765
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
-+..+
T Consensus 369 ~~l~e 373 (1039)
T KOG0199|consen 369 LVLAE 373 (1039)
T ss_pred HHHHh
Confidence 55543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=164.55 Aligned_cols=106 Identities=33% Similarity=0.482 Sum_probs=87.7
Q ss_pred CcCCcHHHHHHHHHHHh-hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC----
Q 025350 9 GRGTLFLPTTYFWSELL-PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK---- 83 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---- 83 (254)
..|.+...+..|+.+|| +..++|||+||+||||+..|. ||+||||.+.....+-......|...|||||.+..
T Consensus 149 vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~ 226 (282)
T KOG0984|consen 149 VLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQ 226 (282)
T ss_pred HhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCc
Confidence 35678888999999999 568999999999999988776 99999999876655444444678899999999853
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 117 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 117 (254)
..|+-+ +||||||++++||.+++.||.....+.
T Consensus 227 ~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 227 KGYSVK-SDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred ccceee-hhhhhhhhhhhhhhhccccccccCCHH
Confidence 356666 999999999999999999998765443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=179.68 Aligned_cols=160 Identities=24% Similarity=0.371 Sum_probs=113.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccC-----------------CC--CC-------
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-----------------VL--HS------- 64 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~-----------------~~--~~------- 64 (254)
+..+..+..+++++|.+|||||||||.|+|.+... .+-.|.|||+|... .. +.
T Consensus 135 ~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t-~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~ 213 (418)
T KOG1167|consen 135 RWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT-QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSV 213 (418)
T ss_pred HHHHHHHHHHhhhhhccCccccCCCcccccccccc-CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccccc
Confidence 34567789999999999999999999999997654 35789999998610 00 00
Q ss_pred -------------------CCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHH-
Q 025350 65 -------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTI- 123 (254)
Q Consensus 65 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~- 123 (254)
......||++|.|||++..-+..+.++||||.|+++..+++++.||....+ ...+.++.
T Consensus 214 ~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~t 293 (418)
T KOG1167|consen 214 ATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIAT 293 (418)
T ss_pred ccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHH
Confidence 001125999999999998766656669999999999999999999864332 11111111
Q ss_pred -------HHH--hccC---------------------------CC-------C-CCCCCCCHHHHHHHHHhchhCCCCCC
Q 025350 124 -------HRI--LSVQ---------------------------YS-------I-PDYVHISPECRHLISRIFVADPAKRI 159 (254)
Q Consensus 124 -------~~~--~~~~---------------------------~~-------~-~~~~~~~~~~~~li~~~L~~dP~~Rp 159 (254)
.+. .... .. . ......+..+.+|+.+||..||.+|+
T Consensus 294 ifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRi 373 (418)
T KOG1167|consen 294 IFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRI 373 (418)
T ss_pred HhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcc
Confidence 000 0000 00 0 00112345889999999999999999
Q ss_pred CHhHHhcCcccc
Q 025350 160 SIPEIRNHEWFL 171 (254)
Q Consensus 160 s~~e~l~hp~~~ 171 (254)
|++++|+||||.
T Consensus 374 tAEeALkHpFF~ 385 (418)
T KOG1167|consen 374 TAEDALKHPFFD 385 (418)
T ss_pred cHHHHhcCcCCc
Confidence 999999999996
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=191.61 Aligned_cols=149 Identities=25% Similarity=0.388 Sum_probs=118.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC--CCCc--CCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTV--GTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~--~~~~y~aPE~~~~~~~ 86 (254)
..+..|++.+++||+++++|||||-.+|||+..+.. +||+|||+|+........ .... -...|||||.+....|
T Consensus 421 lsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f 498 (609)
T KOG0200|consen 421 LSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF 498 (609)
T ss_pred HHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc
Confidence 345689999999999999999999999999988765 999999999854332221 1112 2445999999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +||||+|+++||+++ |..||.+......+.+ .+....+...+..+++++.++++.||+.+|.+||++.++.
T Consensus 499 t~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~----~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 499 TSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEELLE----FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred ccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 776 899999999999998 8899987442333322 3344556666667899999999999999999999999987
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
.
T Consensus 574 ~ 574 (609)
T KOG0200|consen 574 E 574 (609)
T ss_pred H
Confidence 3
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=191.27 Aligned_cols=148 Identities=22% Similarity=0.389 Sum_probs=123.1
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcC---CCCcccchhccCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVG---TPAYIAPEVLLKKEYD 87 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~---~~~y~aPE~~~~~~~~ 87 (254)
.++..++.+++||-+.|+|||||...|||++.+-. .|++|||+++....... .++..| ..+|.|||.+.-.+++
T Consensus 735 gMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFT 812 (996)
T KOG0196|consen 735 GMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFT 812 (996)
T ss_pred HHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCCccccccCCccceeecChhHhhhcccC
Confidence 34567899999999999999999999999988765 99999999997654442 222222 4689999999988887
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+. +||||+|++|||+++ |..||...++.+.+.. ....+++|.+-.+|..+.+|+..||++|-.+||++.+|+.
T Consensus 813 sA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-----Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 813 SA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-----IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ch-hhccccceEEEEecccCCCcccccchHHHHHH-----HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 66 999999999999875 9999998776554443 3557788888899999999999999999999999999876
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 887 ~ 887 (996)
T KOG0196|consen 887 T 887 (996)
T ss_pred H
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=195.56 Aligned_cols=163 Identities=34% Similarity=0.490 Sum_probs=127.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-----CCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 84 (254)
.--.|.|++.+++|||+.||.||||||+|+++..++. +||+|||.+..+..... ....+|+..|+|||++.+.
T Consensus 422 ~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~ 499 (601)
T KOG0590|consen 422 ADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGK 499 (601)
T ss_pred hhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccc
Confidence 3456889999999999999999999999999998876 99999999875443322 2345799999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH---HhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR---ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
.|++...||||.|+++..|.+|+.||......++....... ........+....++...+.+|.+||+.+|.+|.|+
T Consensus 500 ~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti 579 (601)
T KOG0590|consen 500 EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITI 579 (601)
T ss_pred ccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecH
Confidence 99999999999999999999999999765433221100000 000000111223467889999999999999999999
Q ss_pred hHHhcCccccccC
Q 025350 162 PEIRNHEWFLKNL 174 (254)
Q Consensus 162 ~e~l~hp~~~~~~ 174 (254)
++|++.+||+..-
T Consensus 580 ~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 580 EQILNDEWIRSIE 592 (601)
T ss_pred HHHhhChHhhhcc
Confidence 9999999998643
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=178.89 Aligned_cols=145 Identities=24% Similarity=0.340 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCC--CcCCCCcccchhccCCCCCCcch
Q 025350 14 FLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 14 ~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
..|+..++.||..+++|||||...|+|+..+.. ||++|||+++.......... ..-...|.|||.+.-..++.+ +
T Consensus 371 AtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiK-S 447 (1157)
T KOG4278|consen 371 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIK-S 447 (1157)
T ss_pred HHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecccCccCcccccCcccccccccccc-h
Confidence 457899999999999999999999999987765 99999999987654432211 123567999999988888777 9
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 92 DVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 92 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
|||+|||+|||+.| |-.||.+-+... +..++...++...+..+++.+.+|++.||++.|..||+++++-+
T Consensus 448 DVWAFGVLLWEIATYGMsPYPGidlSq-----VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 448 DVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCccHHH-----HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 99999999999997 888998855322 33355667777777789999999999999999999999998743
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=166.01 Aligned_cols=147 Identities=18% Similarity=0.297 Sum_probs=117.7
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.+..|++.+++|||++|+||.||..+|++|++.-. |||+|=.+++-.-... ..........||+||.+....|+.
T Consensus 400 ~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yss 477 (563)
T KOG1024|consen 400 LMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSS 477 (563)
T ss_pred HHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcc
Confidence 45578999999999999999999999999987754 9999999887432221 112223456899999999888876
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
. +|+||||+++|||+| |+.|+..-++.+. .. .+...+++..+-++|.++..++.-||+..|++||+++|+..
T Consensus 478 a-sDvWsfGVllWELmtlg~~PyaeIDPfEm-~~----ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 478 A-SDVWSFGVLLWELMTLGKLPYAEIDPFEM-EH----YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred h-hhhHHHHHHHHHHHhcCCCCccccCHHHH-HH----HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 6 999999999999997 8899987554332 22 33455666666789999999999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=172.71 Aligned_cols=152 Identities=22% Similarity=0.289 Sum_probs=117.8
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC---CCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.+..|++.+++||.+.++|||||.+.|+|++.+.. +||+|||+++..-.+... ...+-..+|||||.+.-+++++
T Consensus 641 si~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFtt 718 (807)
T KOG1094|consen 641 SICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTT 718 (807)
T ss_pred HHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccc
Confidence 36789999999999999999999999999988876 999999999854333221 1234568999999999999977
Q ss_pred cchhHHHHHHHHHHHH--hCCCCCCCCCchHHHHHHHHHH--hccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 89 KIADVWSCGVTLYVML--VGAYPFEDPEEPKNFRKTIHRI--LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 89 ~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
. +|+|+||+++||++ +...||....+.....+...-. .....-++.+.-++..+.++|.+||..+-.+|||++++
T Consensus 719 a-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 719 A-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred h-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 6 99999999999986 5788998766544433322111 11112233445689999999999999999999999998
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
..
T Consensus 798 h~ 799 (807)
T KOG1094|consen 798 HL 799 (807)
T ss_pred HH
Confidence 54
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-23 Score=161.00 Aligned_cols=165 Identities=21% Similarity=0.318 Sum_probs=115.9
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCC--
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-- 85 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~-- 85 (254)
.+...++.|+++|+.|+|++++||||||.+||||-.....+|||||||.++..+. .....-.+..|.+||+.....
T Consensus 121 ~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--tV~~~~~~~~y~~pe~~~~~~ne 198 (378)
T KOG1345|consen 121 ANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--TVKYLEYVNNYHAPELCDTVVNE 198 (378)
T ss_pred HHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--eehhhhhhcccCCcHHHhhcccc
Confidence 3456788999999999999999999999999999655545899999998875322 222223456788998864322
Q ss_pred -C-CCcchhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHHhccCCCCC-CCCCCCHHHHHHHHHhchhCCCCC---
Q 025350 86 -Y-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRILSVQYSIP-DYVHISPECRHLISRIFVADPAKR--- 158 (254)
Q Consensus 86 -~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R--- 158 (254)
+ ..+.+|+|.||+++|.++||++||....... .+.+..+-........| .+..+++.+..+.++-|..+|++|
T Consensus 199 ~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki 278 (378)
T KOG1345|consen 199 KLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKI 278 (378)
T ss_pred ceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchh
Confidence 1 1344899999999999999999998543222 22222221122222333 345579999999999999999999
Q ss_pred CCHhHHhcCccccccC
Q 025350 159 ISIPEIRNHEWFLKNL 174 (254)
Q Consensus 159 ps~~e~l~hp~~~~~~ 174 (254)
.++.......|....+
T Consensus 279 ~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 279 WTAKKMRKCLWKEKLI 294 (378)
T ss_pred HHHHHHHHHHHHHhhh
Confidence 5566666667765433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=190.79 Aligned_cols=152 Identities=18% Similarity=0.178 Sum_probs=104.6
Q ss_pred CcCCcHHHHHHHHHHHh---hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCC
Q 025350 9 GRGTLFLPTTYFWSELL---PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh---~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 85 (254)
.+..++.+++.|++||| +.+|+||||||+||+++.+.. .++. ||.+.... ......+++.|+|||++.+..
T Consensus 781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~ 854 (968)
T PLN00113 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKCFISSAYVAPETRETKD 854 (968)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCccccccccCcccccCCC
Confidence 34567889999999999 779999999999999987765 4544 55443221 122346789999999998887
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhcc-------CCCCCCC----CCCCHHHHHHHHHhchh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------QYSIPDY----VHISPECRHLISRIFVA 153 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~~~~~----~~~~~~~~~li~~~L~~ 153 (254)
++.+ +|||||||++|||++|+.||...... ............. ....... .....++.+++.+||..
T Consensus 855 ~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~ 933 (968)
T PLN00113 855 ITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT 933 (968)
T ss_pred CCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcC
Confidence 7665 99999999999999999998543211 1111111110000 0000000 01123567899999999
Q ss_pred CCCCCCCHhHHhcC
Q 025350 154 DPAKRISIPEIRNH 167 (254)
Q Consensus 154 dP~~Rps~~e~l~h 167 (254)
+|.+|||+.++++.
T Consensus 934 ~P~~RPt~~evl~~ 947 (968)
T PLN00113 934 DPTARPCANDVLKT 947 (968)
T ss_pred CchhCcCHHHHHHH
Confidence 99999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-22 Score=181.67 Aligned_cols=164 Identities=31% Similarity=0.557 Sum_probs=131.5
Q ss_pred ccccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----------------CC
Q 025350 3 CRAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QP 66 (254)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----------------~~ 66 (254)
|+......+.+-.+++.+++|||+.||+|||+||+|.+|+.-+. +|++|||+++...... ..
T Consensus 138 c~tllk~~g~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~d 215 (1205)
T KOG0606|consen 138 CATLLKNIGPLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQD 215 (1205)
T ss_pred hhhhcccCCCCcchhhHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhcchHHHHHHhhh
Confidence 77777777777788899999999999999999999999987765 9999999986422110 11
Q ss_pred CCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHH
Q 025350 67 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146 (254)
Q Consensus 67 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 146 (254)
...+||+.|.|||++...+|..+ +|+|++|+++|+.+.|+.||.+....+.+...+......... ...++++++++
T Consensus 216 KqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~---dea~p~Ea~dl 291 (1205)
T KOG0606|consen 216 KQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE---DEALPPEAQDL 291 (1205)
T ss_pred ccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc---CcCCCHHHHHH
Confidence 23489999999999998888544 999999999999999999999977766665555443222211 23478999999
Q ss_pred HHHhchhCCCCCC---CHhHHhcCccccc
Q 025350 147 ISRIFVADPAKRI---SIPEIRNHEWFLK 172 (254)
Q Consensus 147 i~~~L~~dP~~Rp---s~~e~l~hp~~~~ 172 (254)
|.++|..+|..|. .+-++.+|+||+.
T Consensus 292 i~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 292 IEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred HHHHHHhChHhhcccchhhhhhhccceee
Confidence 9999999999997 5678999999964
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=174.51 Aligned_cols=147 Identities=22% Similarity=0.331 Sum_probs=119.4
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCc---CCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~---~~~~y~aPE~~~~~~~~~ 88 (254)
.+..|++++++|||++++|||||-.+|||+..-.. ||+.|||+++.........+.. -.+.|||=|.+....|+.
T Consensus 802 nw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~th 879 (1177)
T KOG1025|consen 802 NWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTH 879 (1177)
T ss_pred HHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCc
Confidence 45679999999999999999999999999976654 9999999998765544433332 356799999998888876
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
. +|||||||++||++| |..|+.+....+ +...+....+++.++.++-++.-++.+||..|+..||+++++..
T Consensus 880 q-SDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 880 Q-SDVWSFGVTIWELMTFGAKPYDGIPAEE-----IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred h-hhhhhhhhhHHHHHhcCCCccCCCCHHH-----hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 6 999999999999998 899998765432 23334444556777779999999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-21 Score=163.36 Aligned_cols=150 Identities=23% Similarity=0.252 Sum_probs=103.2
Q ss_pred CcHHHHHHHHHHHh---------hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccch
Q 025350 12 TLFLPTTYFWSELL---------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPE 79 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh---------~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE 79 (254)
.+...++++|+||| +..|+|||||..||||.++.. .-|+|||+|..+..... ....+||.+|||||
T Consensus 311 ria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPE 388 (534)
T KOG3653|consen 311 RIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPE 388 (534)
T ss_pred HHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccceeEEecCCCCCcchhhhhhhhhhcCHH
Confidence 35677999999999 668999999999999988876 99999999987653322 22358999999999
Q ss_pred hccCCCCC-----CcchhHHHHHHHHHHHHhCCCCCC-CCC---------------chHHHHHHHHHHhccCCCCCC-CC
Q 025350 80 VLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFE-DPE---------------EPKNFRKTIHRILSVQYSIPD-YV 137 (254)
Q Consensus 80 ~~~~~~~~-----~~~~DiwslG~il~~ll~g~~pf~-~~~---------------~~~~~~~~~~~~~~~~~~~~~-~~ 137 (254)
++.+.-.- -+..||||+|.++||+++...-+. +.. ..+.++..+-+ .+..+.+|. |.
T Consensus 389 vLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~-kK~RP~~p~~W~ 467 (534)
T KOG3653|consen 389 VLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVR-KKQRPKIPDAWR 467 (534)
T ss_pred HHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHh-hccCCCChhhhh
Confidence 99764322 245899999999999998654332 100 11111111111 011112221 10
Q ss_pred --CCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 138 --HISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 138 --~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.-...+++.+..||..||+.|.|+.=+
T Consensus 468 ~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 468 KHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred cCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 123568899999999999999998644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-21 Score=168.34 Aligned_cols=161 Identities=24% Similarity=0.296 Sum_probs=121.7
Q ss_pred cHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhcc---CCCCCC
Q 025350 13 LFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLL---KKEYDG 88 (254)
Q Consensus 13 ~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~ 88 (254)
.-.+..++++|||+.|-+|||||-.|||++..+. |||+|||.+..... -.....+.||+.|||||+.. .+.|..
T Consensus 117 vcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynq 194 (829)
T KOG0576|consen 117 VCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 194 (829)
T ss_pred HHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccc
Confidence 3456788999999999999999999999998887 99999998865432 23446678999999999863 445544
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
. +|+|++|++..++---++|.........+. .+.+-......+.....+++.+-+|++.+|.++|++||+++.+|.||
T Consensus 195 l-cdiwa~gitAiel~eLqpplfdlhpmr~l~-LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~ 272 (829)
T KOG0576|consen 195 L-CDIWALGITAIELGELQPPLFDLHPMRALF-LMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHP 272 (829)
T ss_pred c-ccccccccchhhhhhcCCcccccchHHHHH-HhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheece
Confidence 4 999999999999988887765533322221 11111112223334456899999999999999999999999999999
Q ss_pred cccccCCcc
Q 025350 169 WFLKNLPAD 177 (254)
Q Consensus 169 ~~~~~~~~~ 177 (254)
|....++..
T Consensus 273 fvs~~l~~r 281 (829)
T KOG0576|consen 273 FVSQTLSRR 281 (829)
T ss_pred eeccchhhH
Confidence 998765433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=157.71 Aligned_cols=152 Identities=25% Similarity=0.375 Sum_probs=107.2
Q ss_pred CcHHHHHHHHHHHh--------hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-----CCCCCCcCCCCcccc
Q 025350 12 TLFLPTTYFWSELL--------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAP 78 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh--------~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~~~~~y~aP 78 (254)
.+.+.++.+|++|| +-.|.|||||+.|||+.+++. .-|+|+|+|...... ...+..+||.+||||
T Consensus 312 ~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAP 389 (513)
T KOG2052|consen 312 KLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAP 389 (513)
T ss_pred HHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccCh
Confidence 45678999999999 556999999999999998876 999999999754433 234567899999999
Q ss_pred hhccCCC----C-CCcchhHHHHHHHHHHHHhC----------CCCCCCCCchHHHHHHHHHHhc---cCCCCCCCCCCC
Q 025350 79 EVLLKKE----Y-DGKIADVWSCGVTLYVMLVG----------AYPFEDPEEPKNFRKTIHRILS---VQYSIPDYVHIS 140 (254)
Q Consensus 79 E~~~~~~----~-~~~~~DiwslG~il~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 140 (254)
|++...- + +.+.+||||||.++||++.. ++||.+..+.+.-.+.+.++.- ..+..|..=.-.
T Consensus 390 EvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~ 469 (513)
T KOG2052|consen 390 EVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSD 469 (513)
T ss_pred HHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccC
Confidence 9986422 1 13448999999999999852 4788765443333333333322 222222211112
Q ss_pred ---HHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 141 ---PECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 141 ---~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
..+..+++.||..||..|.|+-.+.
T Consensus 470 ~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 470 PALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 3456789999999999999886654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=146.25 Aligned_cols=120 Identities=43% Similarity=0.609 Sum_probs=99.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC-CCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
+..++.+++.++++||++|++|+||+|.||+++. .+. ++|+|||.+....... ......+...|++||........
T Consensus 94 ~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 171 (215)
T cd00180 94 ILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171 (215)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCC
Confidence 3456789999999999999999999999999987 554 9999999987543322 12334578899999998766233
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+.+.|+|++|++++++ ..+.+++.+|+..+|.+||++.++++|
T Consensus 172 ~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 172 SEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred CchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 4458999999999998 577899999999999999999999987
Q ss_pred c
Q 025350 168 E 168 (254)
Q Consensus 168 p 168 (254)
+
T Consensus 215 ~ 215 (215)
T cd00180 215 L 215 (215)
T ss_pred C
Confidence 5
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-21 Score=166.93 Aligned_cols=106 Identities=30% Similarity=0.461 Sum_probs=94.4
Q ss_pred cccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC
Q 025350 4 RAVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 4 ~~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~ 83 (254)
+..+.....+|.|++.++++||+.||||||||-+|+.++.+|. +||+|||.|... ..+....++||..|.|||++.|
T Consensus 666 ~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g 742 (772)
T KOG1152|consen 666 RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGG 742 (772)
T ss_pred ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchhhh-cCCCcceeeeeccccchhhhCC
Confidence 3445566789999999999999999999999999999998887 999999998754 4445677899999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFED 112 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~ 112 (254)
.+|-++..|||+||+++|.++....||..
T Consensus 743 ~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 743 EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999889999999999999999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-21 Score=156.90 Aligned_cols=136 Identities=22% Similarity=0.342 Sum_probs=93.4
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC---
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK--- 84 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~--- 84 (254)
.++..+..|+.+.+++||+.|+||+||+|+|+|++.+|. ++|+||+.....+..... ...+..|.+||.....
T Consensus 145 ~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~ 220 (288)
T PF14531_consen 145 AARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQF 220 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSC
T ss_pred HHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhccc
Confidence 456677799999999999999999999999999998876 999999877654332211 3445779999987432
Q ss_pred -----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCC
Q 025350 85 -----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 85 -----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
.+ +.+.|.|+||+++|.++||..||......... ...+....++|+.++.||.++|+.||.+|
T Consensus 221 ~~~~~~~-t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~----------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 221 GQNNAPY-TFATDAWQLGITLYSLWCGRLPFGLSSPEADP----------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSEEEE--HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS----------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred Cccccee-eeccCHHHHHHHHHHHHHccCCCCCCCccccc----------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 23 34489999999999999999999865332111 00222333689999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=150.12 Aligned_cols=152 Identities=27% Similarity=0.348 Sum_probs=110.1
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEe--cCCCCCcEEEecCCCcccCCCC-------CCCCCCcCCCCccc
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLH-------SQPKSTVGTPAYIA 77 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll--~~~~~~~vkl~Dfg~a~~~~~~-------~~~~~~~~~~~y~a 77 (254)
.+.+..++.|++.++.|||.+||.|||+|++|||+ +.++.+.+.|+|||+|--.... +..-..-|+...||
T Consensus 340 ~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 340 YRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred hHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 34567789999999999999999999999999998 5566678999999987532211 11112247778999
Q ss_pred chhccCCCC-----CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhch
Q 025350 78 PEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 152 (254)
Q Consensus 78 PE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 152 (254)
||+....+. +..++|.|+.|.+.||+++...||.+......-...++. .... +.+..+++.+++++..+|+
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe--~qLP--alp~~vpp~~rqlV~~lL~ 495 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE--SQLP--ALPSRVPPVARQLVFDLLK 495 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh--hhCC--CCcccCChHHHHHHHHHhc
Confidence 999864332 223489999999999999999999874321111111111 1111 2234689999999999999
Q ss_pred hCCCCCCCHh
Q 025350 153 ADPAKRISIP 162 (254)
Q Consensus 153 ~dP~~Rps~~ 162 (254)
.||++|+++.
T Consensus 496 r~pskRvsp~ 505 (598)
T KOG4158|consen 496 RDPSKRVSPN 505 (598)
T ss_pred CCccccCCcc
Confidence 9999999854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.1e-20 Score=160.34 Aligned_cols=143 Identities=34% Similarity=0.570 Sum_probs=117.5
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcch
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
....+++-++.++|+.||+|||+|++||+++.+|. +++.|||.++....... .+||..|||||++. ++.. ++
T Consensus 101 ~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~---~cgt~eymApEI~~--gh~~-a~ 172 (612)
T KOG0603|consen 101 FYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKI---ACGTYEYRAPEIIN--GHLS-AA 172 (612)
T ss_pred HHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhh---cccchhhhhhHhhh--ccCC-cc
Confidence 34566788899999999999999999999998876 99999999986544332 29999999999997 3333 48
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhHHhc
Q 025350 92 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEIRN 166 (254)
Q Consensus 92 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e~l~ 166 (254)
|.||+|+++++|++|..||.+ ...+.+.......|. .++..+++++..++..+|.+|.. +.++++
T Consensus 173 D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 173 DWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred cchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 999999999999999999987 334445554544444 47899999999999999999984 579999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
|+||..
T Consensus 243 h~f~~~ 248 (612)
T KOG0603|consen 243 HEFFQS 248 (612)
T ss_pred cchhee
Confidence 999964
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.9e-17 Score=138.28 Aligned_cols=163 Identities=31% Similarity=0.457 Sum_probs=118.7
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-------CCCCCcCCCCcccchhc
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------QPKSTVGTPAYIAPEVL 81 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-------~~~~~~~~~~y~aPE~~ 81 (254)
....++.|++.++.++|+.|++|||+||+||+++.... .++++|||.++...... ......++..|++||.+
T Consensus 102 ~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~ 180 (384)
T COG0515 102 EALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180 (384)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHh
Confidence 34567788999999999999999999999999987651 38999999987443332 23556799999999999
Q ss_pred cCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHHhccCCCCCCCCCC----CHHHHHHHHHhch
Q 025350 82 LKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PKNFRKTIHRILSVQYSIPDYVHI----SPECRHLISRIFV 152 (254)
Q Consensus 82 ~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~ 152 (254)
.+. .......|+||+|++++++++|..||..... .......+..........+..... ...+.+++.+++.
T Consensus 181 ~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (384)
T COG0515 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLA 260 (384)
T ss_pred cCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHh
Confidence 873 3444459999999999999999999877653 222222222211110111111111 2578999999999
Q ss_pred hCCCCCCCHhHHhcCccccc
Q 025350 153 ADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 153 ~dP~~Rps~~e~l~hp~~~~ 172 (254)
.+|..|.+..+...+++...
T Consensus 261 ~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 261 KDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCchhcCCHHHHhhchHhhC
Confidence 99999999999988876654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-18 Score=134.98 Aligned_cols=100 Identities=37% Similarity=0.523 Sum_probs=82.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhc-cCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVL-LKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~-~~~~~ 86 (254)
...++.+++.++.+||++|++|+||+|.||+++.++. ++|+|||.+....... ......++..|++||.+ ....+
T Consensus 100 ~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 177 (225)
T smart00221 100 ARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGY 177 (225)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCC
Confidence 3456788999999999999999999999999987754 9999999987654432 23445678889999998 55555
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCC
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFED 112 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~ 112 (254)
+. ++|+|+||+++++|++|+.||..
T Consensus 178 ~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 178 GE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred Cc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 55 59999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-18 Score=147.64 Aligned_cols=147 Identities=27% Similarity=0.347 Sum_probs=105.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-------CCCCCcCCCCcccchhcc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------QPKSTVGTPAYIAPEVLL 82 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-------~~~~~~~~~~y~aPE~~~ 82 (254)
.+.++.|++.++.| +|.+|||+||.||++..+.. +||.|||+........ .....+||..||+||.+.
T Consensus 361 ~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~ 435 (516)
T KOG1033|consen 361 MLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR 435 (516)
T ss_pred HHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHh
Confidence 34566777777777 99999999999999977765 9999999987544333 334557999999999999
Q ss_pred CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 83 KKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 83 ~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
+..|..+ +||||||++++|++. -...|... .....+....+......+ -+.-..|+.+||...|.+||++
T Consensus 436 g~~y~~k-vdIyaLGlil~EL~~~f~T~~er~-------~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 436 GQQYSEK-VDIYALGLILAELLIQFSTQFERI-------ATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hhhhhhh-cchhhHHHHHHHHHHHhccHHHHH-------HhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchH
Confidence 9999776 999999999999996 23233211 111112222221111112 2445689999999999999988
Q ss_pred hHHhcCccc
Q 025350 162 PEIRNHEWF 170 (254)
Q Consensus 162 ~e~l~hp~~ 170 (254)
.+.-.|+|.
T Consensus 507 ~~~~~~~~~ 515 (516)
T KOG1033|consen 507 IEVALHEFL 515 (516)
T ss_pred HHHhhhhhc
Confidence 887777764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.9e-18 Score=153.73 Aligned_cols=147 Identities=22% Similarity=0.311 Sum_probs=103.7
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CC----CCCcCCCCcccc
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QP----KSTVGTPAYIAP 78 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~----~~~~~~~~y~aP 78 (254)
...+..+..|++.++++.|..||+|||||.+||||++=. .+.|+||..-+..-... .. .+.....+|.||
T Consensus 119 ~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAP 196 (1431)
T KOG1240|consen 119 LIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAP 196 (1431)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCccCCCCCcccceEEEecCCceeeecCh
Confidence 344567889999999999999999999999999998643 38999998665321111 11 112244579999
Q ss_pred hhccCCC----------CCCcchhHHHHHHHHHHHHh-CCCCCCCCC-------chHHHHHHHHHHhccCCCCCCCCCCC
Q 025350 79 EVLLKKE----------YDGKIADVWSCGVTLYVMLV-GAYPFEDPE-------EPKNFRKTIHRILSVQYSIPDYVHIS 140 (254)
Q Consensus 79 E~~~~~~----------~~~~~~DiwslG~il~~ll~-g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (254)
|.+.... .-.++.||+|+||+++|+++ |++||.-.. ........+.++ -+
T Consensus 197 ERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I------------ed 264 (1431)
T KOG1240|consen 197 ERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI------------ED 264 (1431)
T ss_pred HhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC------------cC
Confidence 9875321 12355899999999999997 688885310 001111111110 14
Q ss_pred HHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 141 PECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 141 ~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
..++.||..|++.||.+|.+|++.|+.
T Consensus 265 ~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 265 VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 578999999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.5e-16 Score=133.25 Aligned_cols=161 Identities=20% Similarity=0.127 Sum_probs=113.6
Q ss_pred ccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-C--CcEEEecCCCcc--cCCCCC------C---CCCCc
Q 025350 5 AVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK--SSVLHS------Q---PKSTV 70 (254)
Q Consensus 5 ~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~--~~vkl~Dfg~a~--~~~~~~------~---~~~~~ 70 (254)
+.......+..|++.+|++||+.|++||||||.|+++.... . ..+.|.|||+|+ ...... . .....
T Consensus 119 fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~r 198 (322)
T KOG1164|consen 119 FSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFR 198 (322)
T ss_pred cCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCC
Confidence 34445566778999999999999999999999999997653 1 359999999998 321111 0 12245
Q ss_pred CCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHh
Q 025350 71 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 150 (254)
Q Consensus 71 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 150 (254)
||..|+++.+..+...... .|+||++.++.+++.|..||..........+........... ......+..+..+...+
T Consensus 199 GT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 276 (322)
T KOG1164|consen 199 GTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD-RFGDLKPEEFAKILEYI 276 (322)
T ss_pred CccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc-cccCCChHHHHHHHHHh
Confidence 9999999999988877655 899999999999999999997765433322222111111111 11222457788888877
Q ss_pred chhCCCCCCCHhHHhcC
Q 025350 151 FVADPAKRISIPEIRNH 167 (254)
Q Consensus 151 L~~dP~~Rps~~e~l~h 167 (254)
-..+...+|....+...
T Consensus 277 ~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 277 DSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccCCcCCCCHHHHHHH
Confidence 77899999987666543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.1e-17 Score=145.77 Aligned_cols=161 Identities=31% Similarity=0.487 Sum_probs=128.3
Q ss_pred cCCcHHHHHHHHHHHh-hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CC---CCCCCcC-CCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELL-PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS---QPKSTVG-TPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~---~~~~~~~-~~~y~aPE~~~~ 83 (254)
....+.|+..++.|+| ..++.||||||+|.+++.++. .++++|||+|..... .+ .....+| ++.|+|||...+
T Consensus 125 ~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 125 ASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred hhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccc
Confidence 4567889999999999 999999999999999988872 399999999976544 22 2234468 999999999988
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..+..+..|+||+|+++..+++|..|+............+.. .........+..++....+++.+++..+|..|.+.++
T Consensus 204 ~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 204 KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS-NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred hhhcCCCcccccccccccccccCCCCccccccccccceeecc-cccccccCccccCChhhhhcccccccCCchhcccccc
Confidence 777777799999999999999999999765543322111111 1122235566778999999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+..+||+..
T Consensus 283 ~~~d~~~~~ 291 (601)
T KOG0590|consen 283 LKLDNWLSS 291 (601)
T ss_pred ccccccccc
Confidence 999999987
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.1e-16 Score=133.38 Aligned_cols=153 Identities=24% Similarity=0.280 Sum_probs=109.0
Q ss_pred CcHHHHHHHHHHHhhcCc-ccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCCCC-
Q 025350 12 TLFLPTTYFWSELLPFNV-CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY- 86 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~gi-vHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~- 86 (254)
.++..+..++.|||...| .|+.+++.|++++.... +||+|||+....... .......-...|.|||.+.....
T Consensus 52 s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~ 129 (484)
T KOG1023|consen 52 SFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQ 129 (484)
T ss_pred HHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccc
Confidence 456778999999997666 99999999999998876 999999998754321 11111224457999999976321
Q ss_pred -----CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--CCCC---CCCCCHHHHHHHHHhchhCCC
Q 025350 87 -----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPD---YVHISPECRHLISRIFVADPA 156 (254)
Q Consensus 87 -----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~li~~~L~~dP~ 156 (254)
.+++.|+||+|++++++++...||..........+++..+..... ..|. ....++.+..+++.||..+|.
T Consensus 130 ~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~ 209 (484)
T KOG1023|consen 130 SLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPE 209 (484)
T ss_pred cccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChh
Confidence 245589999999999999999999874433322333333333111 1111 124566899999999999999
Q ss_pred CCCCHhHHhc
Q 025350 157 KRISIPEIRN 166 (254)
Q Consensus 157 ~Rps~~e~l~ 166 (254)
.||+++++-.
T Consensus 210 ~rPs~~~i~~ 219 (484)
T KOG1023|consen 210 KRPSIEQIRS 219 (484)
T ss_pred hCccHHHHHh
Confidence 9999988754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-14 Score=113.22 Aligned_cols=175 Identities=18% Similarity=0.142 Sum_probs=124.1
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCC--------CCCCcCCCCcccc
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAP 78 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aP 78 (254)
....++.-|+..-+.|+|.+++|||||||+|+|..-+. ..++.|+|||+|+....... .....||..|.+-
T Consensus 111 kTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASi 190 (341)
T KOG1163|consen 111 KTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASI 190 (341)
T ss_pred HhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhh
Confidence 34556778899999999999999999999999984322 13589999999986433221 1234699999988
Q ss_pred hhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC---CCCCCCHHHHHHHHHhchhCC
Q 025350 79 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 79 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP 155 (254)
-...+...+.+ -|+=|+|.++.++.-|..||.+........ ...++.......| ....+|.++.-.+.-|-..--
T Consensus 191 nAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~Q-KyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F 268 (341)
T KOG1163|consen 191 NAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQ-KYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGF 268 (341)
T ss_pred hhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHH-HHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCC
Confidence 77766655545 899999999999999999999865433222 2223333332222 234578899999998877777
Q ss_pred CCCCC---HhHHhcCccccccCCccccccCCC
Q 025350 156 AKRIS---IPEIRNHEWFLKNLPADLVVDNTT 184 (254)
Q Consensus 156 ~~Rps---~~e~l~hp~~~~~~~~~~~~~~~~ 184 (254)
.+-|. +.++.+--|+.-+...+...|+..
T Consensus 269 ~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~ 300 (341)
T KOG1163|consen 269 EEKPDYMYLRQLFRILFRTLNHQYDYIYDWTM 300 (341)
T ss_pred CCCCcHHHHHHHHHHHHhhccccCCeEeeHHH
Confidence 77775 456666667777777777776653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.2e-14 Score=111.63 Aligned_cols=145 Identities=22% Similarity=0.246 Sum_probs=107.4
Q ss_pred CCcHHHHHHHHHHHhhcC--cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC-
Q 025350 11 GTLFLPTTYFWSELLPFN--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD- 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~- 87 (254)
....+.++++++|||+.. |.---|.+..++|+.+-..++-.+|--++. .......+|.|++||.+...+.+
T Consensus 292 v~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------qe~gr~y~pawmspealqrkped~ 365 (448)
T KOG0195|consen 292 VRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDL 365 (448)
T ss_pred HHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------eccccccCcccCCHHHHhcCchhc
Confidence 345678999999999643 555678899999998876555555544332 12234567899999999876644
Q ss_pred -CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 -GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 -~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
..++|+|||++++||+.|...||...+..+.-.++. -..++...++.++..+..|++-|++.||.+||.++.++
T Consensus 366 n~raadmwsfaillwel~trevpfadlspmecgmkia----leglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 366 NIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA----LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred chhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh----hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 456899999999999999999999877655444332 22333344456899999999999999999999988765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.1e-14 Score=110.64 Aligned_cols=101 Identities=16% Similarity=0.128 Sum_probs=75.6
Q ss_pred CcHHHHHHHHHHHhhcCcccCCC-CCCcEEecCCCCCcEEEecCCCcccCCCCCCC----C----------CCcCCCCcc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----K----------STVGTPAYI 76 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdl-kp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----~----------~~~~~~~y~ 76 (254)
.++.|+..+++++|++||+|||| ||.|||++.++. ++|+|||+|......... . ....++.|+
T Consensus 95 ~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l 172 (218)
T PRK12274 95 AYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAAL 172 (218)
T ss_pred HHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 36788999999999999999999 799999987665 999999999854433311 0 112577888
Q ss_pred cchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 025350 77 APEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 114 (254)
Q Consensus 77 aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 114 (254)
+|+...-. ..+-...+.++.|+-+|.++|++.++.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 173 TPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 88764322 222233688899999999999999887643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.3e-13 Score=109.52 Aligned_cols=110 Identities=20% Similarity=0.236 Sum_probs=89.5
Q ss_pred ccccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC---CcEEEecCCCcccCCCCCC--------CCCCcCCC
Q 025350 5 AVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHSQ--------PKSTVGTP 73 (254)
Q Consensus 5 ~~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~---~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~ 73 (254)
+.-....++..|+...++++|++.+|+|||||+|+||...+. ..+.++|||+|+....... ..+..||.
T Consensus 121 FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTA 200 (449)
T KOG1165|consen 121 FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTA 200 (449)
T ss_pred ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccce
Confidence 444556788899999999999999999999999999964332 2488999999986543322 23457999
Q ss_pred CcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 025350 74 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 115 (254)
Q Consensus 74 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 115 (254)
+||+--...+...+.+ -|+=|||-++.+.+-|..||.+...
T Consensus 201 RYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 201 RYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred eeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence 9999988888777666 8999999999999999999998654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.1e-13 Score=113.00 Aligned_cols=70 Identities=19% Similarity=0.205 Sum_probs=56.5
Q ss_pred CcHHHHHHHHHHHhhcCcccCCC-CCCcEEecCCCCCcEEEecCCCcccCCCCCCC---------CCCcCCCCcccchhc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---------KSTVGTPAYIAPEVL 81 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdl-kp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---------~~~~~~~~y~aPE~~ 81 (254)
.++.+++.+|.|||++||+|||| ||+|||++.++. +||+|||+|+........ ....+++.|+|||.+
T Consensus 115 ~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 115 AWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred HHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 46788999999999999999999 999999976654 999999999865443321 233578889999988
Q ss_pred cC
Q 025350 82 LK 83 (254)
Q Consensus 82 ~~ 83 (254)
..
T Consensus 193 ~~ 194 (365)
T PRK09188 193 TP 194 (365)
T ss_pred Ch
Confidence 63
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.4e-13 Score=119.58 Aligned_cols=153 Identities=16% Similarity=0.191 Sum_probs=109.8
Q ss_pred HHHHHHHHHh-hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCC----C------CcCCCCcccchhccCC
Q 025350 16 PTTYFWSELL-PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----S------TVGTPAYIAPEVLLKK 84 (254)
Q Consensus 16 ~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~----~------~~~~~~y~aPE~~~~~ 84 (254)
++..|+.++| +.++||++|.|++|.++.++. +||+.|+++.......... . ......|.|||.+.+.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 3457789999 789999999999999998877 9999999886543322110 0 1244579999999875
Q ss_pred CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.. +.++|++|+||++|.+. .|+..+............. ............++++++++-+.++|..++..||++..
T Consensus 185 ~~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 185 TN-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred cc-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--cccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 54 44599999999999998 5555555433222211111 11111122223568999999999999999999999999
Q ss_pred HhcCcccccc
Q 025350 164 IRNHEWFLKN 173 (254)
Q Consensus 164 ~l~hp~~~~~ 173 (254)
++..|||.+.
T Consensus 262 l~~~~ff~D~ 271 (700)
T KOG2137|consen 262 LLSIPFFSDP 271 (700)
T ss_pred hhcccccCCc
Confidence 9999999764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.5e-12 Score=116.30 Aligned_cols=157 Identities=30% Similarity=0.458 Sum_probs=120.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---------------------------
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--------------------------- 63 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--------------------------- 63 (254)
+..+......+.+||...+.|||++|.|+++...+. .++++||........
T Consensus 907 Rs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l 984 (1205)
T KOG0606|consen 907 RSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQL 984 (1205)
T ss_pred cchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCcCCcccccccCcccccccccccccc
Confidence 344577888899999999999999999999987765 889998743211000
Q ss_pred -----CCCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCC-C
Q 025350 64 -----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-V 137 (254)
Q Consensus 64 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 137 (254)
.......+|+.|.+||...+...... +|+|++|+++++.++|.+||........+.. +......+|.. .
T Consensus 985 ~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n----i~~~~~~~p~g~~ 1059 (1205)
T KOG0606|consen 985 SADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAETPQQIFEN----ILNRDIPWPEGPE 1059 (1205)
T ss_pred ccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcchhhhhhc----cccCCCCCCCCcc
Confidence 00112358999999999988877655 8999999999999999999998766555543 34444444432 3
Q ss_pred CCCHHHHHHHHHhchhCCCCCCCHh---HHhcCccccccC
Q 025350 138 HISPECRHLISRIFVADPAKRISIP---EIRNHEWFLKNL 174 (254)
Q Consensus 138 ~~~~~~~~li~~~L~~dP~~Rps~~---e~l~hp~~~~~~ 174 (254)
..+...++++.++|..+|.+|..+. ++..|+||+..-
T Consensus 1060 ~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1060 EGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred ccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 4688999999999999999999877 899999997643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4e-12 Score=118.39 Aligned_cols=97 Identities=23% Similarity=0.194 Sum_probs=79.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC-----CCCCcEEEecCCCccc---CCCCCCCCCCcCCCCcccchhc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG-----SPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVL 81 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~-----~~~~~vkl~Dfg~a~~---~~~~~~~~~~~~~~~y~aPE~~ 81 (254)
...+..|+++.+.+||..||||+||||+|+||.. ....-++|+|||.+.- +..+......++|-.+-.+|..
T Consensus 796 v~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~ 875 (974)
T KOG1166|consen 796 VMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR 875 (974)
T ss_pred hhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHh
Confidence 3457789999999999999999999999999942 1223499999998853 3333344556788999999999
Q ss_pred cCCCCCCcchhHHHHHHHHHHHHhCC
Q 025350 82 LKKEYDGKIADVWSCGVTLYVMLVGA 107 (254)
Q Consensus 82 ~~~~~~~~~~DiwslG~il~~ll~g~ 107 (254)
.|.+++.. .|.|.|+.+++.|+.|+
T Consensus 876 ~grpWtYq-~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 876 EGRPWTYQ-IDYFGLAATVHVMLFGK 900 (974)
T ss_pred cCCCCchh-hhhHHHHHHHHHHHHHH
Confidence 99999777 89999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=2e-12 Score=103.07 Aligned_cols=77 Identities=13% Similarity=0.136 Sum_probs=57.4
Q ss_pred cHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcchh
Q 025350 13 LFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 92 (254)
Q Consensus 13 ~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 92 (254)
...++..+++++|..|++|||+||.||+++.++ ++|+|||.......... ....+....+.. ++|
T Consensus 140 ~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a-----------~d~~vler~y~~-~~d 204 (232)
T PRK10359 140 VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKA-----------KDRIDLERHYGI-KNE 204 (232)
T ss_pred HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhh-----------HHHHHHHhHhcc-ccc
Confidence 356899999999999999999999999998755 99999997764321111 011344455664 489
Q ss_pred HHHHHHHHHHHH
Q 025350 93 VWSCGVTLYVML 104 (254)
Q Consensus 93 iwslG~il~~ll 104 (254)
+||||+++..+.
T Consensus 205 i~~lg~~~~~~~ 216 (232)
T PRK10359 205 IKDLGYYLLIYK 216 (232)
T ss_pred ccceeEeehHHH
Confidence 999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.2e-11 Score=92.01 Aligned_cols=46 Identities=26% Similarity=0.258 Sum_probs=39.7
Q ss_pred CCcHHHHHHHHHHH-hhcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 11 GTLFLPTTYFWSEL-LPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 11 ~~~~~~~~~~l~~L-h~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
..++.|++.++.+| |+.||+||||||+|||++. + .++|+|||+|..
T Consensus 120 ~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~v~LiDFG~a~~ 166 (190)
T cd05147 120 RELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--KLYIIDVSQSVE 166 (190)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--cEEEEEcccccc
Confidence 34567899999999 7999999999999999984 3 499999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-10 Score=91.15 Aligned_cols=48 Identities=19% Similarity=0.135 Sum_probs=41.9
Q ss_pred cCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccC
Q 025350 10 RGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 60 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~ 60 (254)
...++.+++.++.+||+ +||+||||||+||+++ ++ .++|+|||++...
T Consensus 119 ~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--~~~liDFG~a~~~ 167 (190)
T cd05145 119 AEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--KPYIIDVSQAVEL 167 (190)
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--CEEEEEcccceec
Confidence 34567899999999999 9999999999999998 44 4999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-10 Score=94.77 Aligned_cols=157 Identities=15% Similarity=0.181 Sum_probs=102.3
Q ss_pred ccccCcCCcHHHHHHHHHHHhhc--CcccCCCCCCcEEecCCCCCcEEEecCCCcc--cCC---CCCCCCCCcCCCCccc
Q 025350 5 AVQRGRGTLFLPTTYFWSELLPF--NVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSV---LHSQPKSTVGTPAYIA 77 (254)
Q Consensus 5 ~~~~~~~~~~~~~~~~l~~Lh~~--givHrdlkp~NIll~~~~~~~vkl~Dfg~a~--~~~---~~~~~~~~~~~~~y~a 77 (254)
+.++....+..|++.+|.|||+. -|+|+++..+.|++..++- +|+.--.... ... .........+-++|.+
T Consensus 173 ~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a 250 (458)
T KOG1266|consen 173 LFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSA 250 (458)
T ss_pred hhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCcccc
Confidence 45556677788999999999954 5999999999999987764 5654221110 000 0011112246788999
Q ss_pred chhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCC
Q 025350 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 157 (254)
Q Consensus 78 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 157 (254)
||.-.....++. +|||++|+...+|..+..--............+..+..... ..--+.++.+||+-.|+.
T Consensus 251 ~~sg~~tn~~~a-~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le--------n~lqr~~i~kcl~~eP~~ 321 (458)
T KOG1266|consen 251 PESGTTTNTTGA-SDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE--------NGLQRGSITKCLEGEPNG 321 (458)
T ss_pred CCcCcccccccc-hhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc--------CccccCcCcccccCCCCC
Confidence 997655555555 99999999999998877543322222222222222111110 112257899999999999
Q ss_pred CCCHhHHhcCccccc
Q 025350 158 RISIPEIRNHEWFLK 172 (254)
Q Consensus 158 Rps~~e~l~hp~~~~ 172 (254)
||+++.++.||.+-+
T Consensus 322 rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 322 RPDARLLLFHPLLFE 336 (458)
T ss_pred CcchhhhhcCceeee
Confidence 999999999997643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-09 Score=92.27 Aligned_cols=146 Identities=14% Similarity=0.192 Sum_probs=100.3
Q ss_pred HHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc-----CCCCCCc
Q 025350 15 LPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-----KKEYDGK 89 (254)
Q Consensus 15 ~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~ 89 (254)
..++.+++.||..|.+-+|+.++|+|+++.+. |.|.|-..-.....+......+|.+.|++||.-. +...+..
T Consensus 124 RnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~ 201 (637)
T COG4248 124 RNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN 201 (637)
T ss_pred HHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCcc
Confidence 45788999999999999999999999987766 8888755433333344455668999999999865 2223334
Q ss_pred chhHHHHHHHHHHHHhC-CCCCCCCC----chHHHHHHH--------HH---HhccCCCCCCCCCCCHHHHHHHHHhchh
Q 025350 90 IADVWSCGVTLYVMLVG-AYPFEDPE----EPKNFRKTI--------HR---ILSVQYSIPDYVHISPECRHLISRIFVA 153 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g-~~pf~~~~----~~~~~~~~~--------~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~ 153 (254)
.|.|.||+++++++.| ++||.+-. ........+ .+ -.......+.+.-+++.+..|..+|+..
T Consensus 202 -hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~ 280 (637)
T COG4248 202 -HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTE 280 (637)
T ss_pred -ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcc
Confidence 8999999999999986 99997632 111111011 00 0111122233455789999999999965
Q ss_pred --CCCCCCCHhH
Q 025350 154 --DPAKRISIPE 163 (254)
Q Consensus 154 --dP~~Rps~~e 163 (254)
++.-|||++.
T Consensus 281 ~~~~~~RP~a~a 292 (637)
T COG4248 281 SGVATPRPTAKA 292 (637)
T ss_pred cCCCCCCCCHHH
Confidence 3568998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.7e-10 Score=98.96 Aligned_cols=151 Identities=19% Similarity=0.155 Sum_probs=109.7
Q ss_pred cHHHHHH----HHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC------CCCcCCCCcccchhcc
Q 025350 13 LFLPTTY----FWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP------KSTVGTPAYIAPEVLL 82 (254)
Q Consensus 13 ~~~~~~~----~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~------~~~~~~~~y~aPE~~~ 82 (254)
.+..... ++..+|..+++|-|+||.||+...+. ...+++|||+.......... ....|...|++||+..
T Consensus 223 ~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~ 301 (524)
T KOG0601|consen 223 SLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN 301 (524)
T ss_pred HHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc
Confidence 3445555 99999999999999999999998773 24899999988765544321 1225778899999986
Q ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC
Q 025350 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 160 (254)
Q Consensus 83 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 160 (254)
+.. +...|++++|.++.+..++..++... .......... .........+..+...+..|+..+|..|++
T Consensus 302 ~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~ 372 (524)
T KOG0601|consen 302 GLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLT 372 (524)
T ss_pred ccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------CchhhhcCcchhhhhHHHHhcCcchhhhhH
Confidence 543 34589999999999999888776543 2222211111 111122234667777999999999999999
Q ss_pred HhHHhcCcccccc
Q 025350 161 IPEIRNHEWFLKN 173 (254)
Q Consensus 161 ~~e~l~hp~~~~~ 173 (254)
++.+++|+++...
T Consensus 373 ~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 373 AQILTALNVIHSK 385 (524)
T ss_pred HHHHhccccccch
Confidence 9999999998754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-09 Score=88.20 Aligned_cols=45 Identities=22% Similarity=0.268 Sum_probs=40.2
Q ss_pred cHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 13 LFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 13 ~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
.+.+++.++.+||++||+||||||.|||++.++. ++|+|||.+..
T Consensus 147 ~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg~~~~ 191 (239)
T PRK01723 147 QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECCCccc
Confidence 3678999999999999999999999999987654 99999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.7e-09 Score=86.30 Aligned_cols=45 Identities=22% Similarity=0.180 Sum_probs=40.3
Q ss_pred CcHHHHHHHHHHHhhcC-cccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 12 TLFLPTTYFWSELLPFN-VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~g-ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
.++.|++.++++||.+| |+||||||+||+++ ++ .++|+|||.+..
T Consensus 152 ~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~--~i~LiDFg~a~~ 197 (237)
T smart00090 152 ELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG--KVVIIDVSQSVE 197 (237)
T ss_pred HHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC--CEEEEEChhhhc
Confidence 56789999999999999 99999999999998 44 499999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.9e-09 Score=82.53 Aligned_cols=47 Identities=19% Similarity=0.139 Sum_probs=41.4
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 60 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~ 60 (254)
.+..+++.++.++|+.||+||||||.||+++.++. ++|+|||.+...
T Consensus 129 ~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~--~~liDfg~~~~~ 175 (198)
T cd05144 129 EVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK--IYIIDWPQMVST 175 (198)
T ss_pred HHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc--EEEEECCccccC
Confidence 46678999999999999999999999999987655 999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.5e-09 Score=82.38 Aligned_cols=42 Identities=19% Similarity=0.086 Sum_probs=34.4
Q ss_pred HHHHHHHH-HHHhhcCcccCCCCCCcEEecCC--CCCcEEEecCC
Q 025350 14 FLPTTYFW-SELLPFNVCHRDLKLENTLLDGS--PAPRLKICDFG 55 (254)
Q Consensus 14 ~~~~~~~l-~~Lh~~givHrdlkp~NIll~~~--~~~~vkl~Dfg 55 (254)
+.+++.++ +|||+++||||||||+|||++.. +..+++|+||+
T Consensus 110 ~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 110 LRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred HHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 56777666 99999999999999999999743 22369999954
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-08 Score=78.53 Aligned_cols=48 Identities=21% Similarity=0.182 Sum_probs=41.4
Q ss_pred cCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccC
Q 025350 10 RGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 60 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~ 60 (254)
...++.+++.++.++|. .||+||||||+||+++ ++. ++|+|||.+...
T Consensus 116 ~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~--~~liDfg~a~~~ 164 (187)
T cd05119 116 PEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK--VYIIDVPQAVEI 164 (187)
T ss_pred HHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc--EEEEECcccccc
Confidence 34567889999999999 9999999999999998 444 999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.7e-08 Score=77.43 Aligned_cols=45 Identities=24% Similarity=0.369 Sum_probs=40.3
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
.++.+++.++.+||+.|++|||++|.||+++ ++ .++++|||++..
T Consensus 94 ~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence 5678899999999999999999999999998 44 499999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.4e-08 Score=77.68 Aligned_cols=46 Identities=22% Similarity=0.284 Sum_probs=40.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
..++.+++.++.+||+.|++|||++|.|||++ ++ .++|+|||.+..
T Consensus 98 ~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~~ 143 (211)
T PRK14879 98 LELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC--CEEEEECCcccC
Confidence 35677899999999999999999999999998 44 499999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.7e-08 Score=87.43 Aligned_cols=151 Identities=20% Similarity=0.145 Sum_probs=103.5
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcc--cchhccCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI--APEVLLKKEY 86 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~ 86 (254)
.+..+..|+..++.++|+..++|+|+||+||++..++ ...++.|||.+...... .....+..++. +|.......+
T Consensus 367 ~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~ 443 (524)
T KOG0601|consen 367 PRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPH 443 (524)
T ss_pred hhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccccee--cccccccccccccchhhcccccc
Confidence 3456778899999999999999999999999998754 34799999988642211 11122333334 4444444455
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
..+ .|++|||..+.+.++|...-........ +... ..+.....+..+..+.+.+...++..|+.+.++..
T Consensus 444 ~~~-~~~~sl~~~~~e~~~~~~ls~~~~~~~~-------i~~~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 444 LSK-ADIFSLGLSVDEAITGSPLSESGVQSLT-------IRSG--DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ccc-cccccccccccccccCcccCccccccee-------eecc--cccCCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 444 8999999999999988754433221111 1111 12222234578889999999999999999999999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
|.-|..
T Consensus 514 ~~~~~~ 519 (524)
T KOG0601|consen 514 HSEFYR 519 (524)
T ss_pred cchhhh
Confidence 887644
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.6e-08 Score=89.22 Aligned_cols=46 Identities=26% Similarity=0.334 Sum_probs=40.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
..++.+++.++.+||+.|++||||||+|||++ ++ .++|+|||+++.
T Consensus 431 ~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~ 476 (535)
T PRK09605 431 PELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY 476 (535)
T ss_pred HHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence 34668899999999999999999999999994 33 399999999874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.9e-07 Score=79.52 Aligned_cols=89 Identities=17% Similarity=0.194 Sum_probs=66.3
Q ss_pred cHHHHHHHHHHHh-hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCCcc
Q 025350 13 LFLPTTYFWSELL-PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 13 ~~~~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
-+.|++.||.+|| ..+++|++|.-..|+++..|. .||++|-++........ ......--.|..|+.+....+ .
T Consensus 109 Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~---s 183 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW---S 183 (690)
T ss_pred HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc---c
Confidence 4678999999997 889999999999999998887 99999988765433221 111122234666766533332 2
Q ss_pred hhHHHHHHHHHHHHhC
Q 025350 91 ADVWSCGVTLYVMLVG 106 (254)
Q Consensus 91 ~DiwslG~il~~ll~g 106 (254)
.|.|.|||++++++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.2e-07 Score=71.03 Aligned_cols=46 Identities=20% Similarity=0.213 Sum_probs=38.6
Q ss_pred CcHHHHHHHHHHH-hhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccC
Q 025350 12 TLFLPTTYFWSEL-LPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 60 (254)
Q Consensus 12 ~~~~~~~~~l~~L-h~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~ 60 (254)
.++.++..++..| |..||||+||++.||++.. + .+.|+|||.+...
T Consensus 128 ~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~--~v~iIDF~qav~~ 174 (197)
T cd05146 128 NAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-G--KVWFIDVSQSVEP 174 (197)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-C--cEEEEECCCceeC
Confidence 3467888889888 8999999999999999974 3 3999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.4e-07 Score=68.39 Aligned_cols=47 Identities=26% Similarity=0.386 Sum_probs=40.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
+..+...+-..+.-||..||||+||.++||++...+ +.++|||++..
T Consensus 94 ~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 94 RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCcccc
Confidence 455677788889999999999999999999997654 89999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.9e-07 Score=65.90 Aligned_cols=47 Identities=26% Similarity=0.381 Sum_probs=39.6
Q ss_pred CCcHHHHHHHHHHHhh---cCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 11 GTLFLPTTYFWSELLP---FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~---~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
..+..+++.++++||. .+++|+|++|.||+++..+ .++++|||.+..
T Consensus 89 ~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~~ 138 (155)
T cd05120 89 EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEecccccC
Confidence 4566778999999997 4799999999999998754 499999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-06 Score=65.98 Aligned_cols=44 Identities=30% Similarity=0.405 Sum_probs=37.9
Q ss_pred CcHHHHHHHHHHHhhcCc-----ccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 12 TLFLPTTYFWSELLPFNV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~gi-----vHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..+.+++.+++.||+.++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 87 ~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 87 ENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 456789999999998885 9999999999998 33 39999999775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.2e-06 Score=70.46 Aligned_cols=48 Identities=17% Similarity=0.195 Sum_probs=40.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC-----CCCCcEEEecCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 58 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~-----~~~~~vkl~Dfg~a~ 58 (254)
..++.+++..+..||..||+|+|+++.|||++. ++...+.|+||+.+.
T Consensus 141 ~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 141 RMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 356678999999999999999999999999975 234569999999775
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.12 E-value=3e-06 Score=67.14 Aligned_cols=50 Identities=22% Similarity=0.272 Sum_probs=42.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCccc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 59 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~ 59 (254)
+..++.+++..++.||.+||+|+|+++.|||++... ...+.|+||+.++.
T Consensus 120 ~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 120 RRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 456778899999999999999999999999998765 34599999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.5e-06 Score=74.27 Aligned_cols=40 Identities=23% Similarity=0.257 Sum_probs=35.3
Q ss_pred HHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccC
Q 025350 19 YFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 60 (254)
Q Consensus 19 ~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~ 60 (254)
.++.++|..|++|+|++|.||+++.++. ++++|||++...
T Consensus 268 ~~l~ql~~~g~~H~D~hPgNilv~~~g~--i~liDfG~~~~l 307 (437)
T TIGR01982 268 SFLNQVLRDGFFHADLHPGNIFVLKDGK--IIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHhCCceeCCCCcccEEECCCCc--EEEEeCCCeeEC
Confidence 3678999999999999999999987765 999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.2e-05 Score=62.59 Aligned_cols=46 Identities=26% Similarity=0.278 Sum_probs=33.6
Q ss_pred CCcHHHHHH-HHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 11 GTLFLPTTY-FWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 11 ~~~~~~~~~-~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
..++.++.. ...-+|..||+|+||++.||+++.+ . +.++|||.+..
T Consensus 109 ~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf~qav~ 155 (188)
T PF01163_consen 109 KELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDFGQAVD 155 (188)
T ss_dssp HHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--GTTEEE
T ss_pred HHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEecCccee
Confidence 345666666 3444689999999999999999876 3 99999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=1.9e-05 Score=60.39 Aligned_cols=48 Identities=25% Similarity=0.262 Sum_probs=39.0
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCC-cEEEecCCCccc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAP-RLKICDFGYSKS 59 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~-~vkl~Dfg~a~~ 59 (254)
.+...+-..+.-||..+|+|+||..+||++.+.+.. .+.++|||++..
T Consensus 117 ~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 117 ELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 445567788899999999999999999999766542 358999998764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.71 E-value=5.5e-05 Score=59.86 Aligned_cols=41 Identities=17% Similarity=0.113 Sum_probs=35.7
Q ss_pred HHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 15 LPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 15 ~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
-.+..++.+||+.|++|+|..|.|++++.++ ++++||+..+
T Consensus 142 ~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 142 EKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 4577889999999999999999999998654 8999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.67 E-value=3.9e-05 Score=69.00 Aligned_cols=45 Identities=24% Similarity=0.399 Sum_probs=37.0
Q ss_pred HHHHHHHHhhcCcccCCCCCCcEEecCCC--CCcEEEecCCCcccCC
Q 025350 17 TTYFWSELLPFNVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 61 (254)
Q Consensus 17 ~~~~l~~Lh~~givHrdlkp~NIll~~~~--~~~vkl~Dfg~a~~~~ 61 (254)
+...+.+++..|++|+|+||.||+++.++ .++++++|||++....
T Consensus 269 v~~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 269 VEVFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 55667888899999999999999998765 2359999999987543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=5.1e-05 Score=59.76 Aligned_cols=49 Identities=8% Similarity=0.093 Sum_probs=42.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
..++.+++..++.||..|+.|+|+-+.||+++..+...++++||--++.
T Consensus 131 ~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 131 QAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 4678889999999999999999999999999865544699999986653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.16 E-value=6.4e-05 Score=67.52 Aligned_cols=147 Identities=22% Similarity=0.213 Sum_probs=100.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
.-+....++.+++||+.-=+||| ||+..++. +|+.+|+............+..+++.++|||+.....+...
T Consensus 339 ~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~- 410 (829)
T KOG0576|consen 339 AYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGC- 410 (829)
T ss_pred hhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccccCCCCCCCCCchhhcccccccC-
Confidence 34455677788999987678988 88876644 79999999876655555667789999999999988888877
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCC---CCCCHHHH-HHHHHhchhCCCCCCCHhHHhc
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY---VHISPECR-HLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.|+|++|.--.++.-|.+|-....... . ........+.. ...++... ++...|+..-|..|+..-.++-
T Consensus 411 p~~~~~~~~~~~~ap~~pPr~~P~~~~--~-----~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacf 483 (829)
T KOG0576|consen 411 PDSGSLAVSAIQMAPGLPPRSSPPAVL--P-----MIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACF 483 (829)
T ss_pred CCccCCCcchhhcCCCCCCCCCCcccc--C-----CCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHH
Confidence 899999987777777777655421100 0 00000000000 01122222 4778899999999999999998
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
|.+|..
T Consensus 484 sKvfng 489 (829)
T KOG0576|consen 484 SKVFNG 489 (829)
T ss_pred HHHhcc
Confidence 888854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0041 Score=55.01 Aligned_cols=125 Identities=16% Similarity=0.201 Sum_probs=84.5
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcch
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 91 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 91 (254)
..+.|+..+|.+||+.|+.-+-|.|.+||++.+. +++|+..|..-...... . +.+.+. .+-
T Consensus 397 ~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~-----------~--~~le~~----Qq~ 457 (655)
T KOG3741|consen 397 SYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP-----------T--EPLESQ----QQN 457 (655)
T ss_pred HHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC-----------C--cchhHH----hhh
Confidence 4678999999999999999999999999997664 48888777654332221 1 112221 226
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 92 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 92 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
|.=.||.+++.|.||..--......... ....+ ...++.++++++.-+...+++. -++.+++.+
T Consensus 458 D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I---------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 458 DLRDLGLLLLALATGTENSNRTDSTQSS--HLTRI---------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hHHHHHHHHHHHhhcccccccccchHHH--HHHHh---------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 8889999999999996432222211111 01111 1136889999999998888886 677777754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0015 Score=62.72 Aligned_cols=142 Identities=20% Similarity=0.190 Sum_probs=91.7
Q ss_pred HHHHHHHHHHhhcCcccCCCCCCc---EEecCCCCCcEEEe--cCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC-
Q 025350 15 LPTTYFWSELLPFNVCHRDLKLEN---TLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG- 88 (254)
Q Consensus 15 ~~~~~~l~~Lh~~givHrdlkp~N---Ill~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~- 88 (254)
.++..++.++|+....|.-|.... --.+..+ .+..+ ||+..+.............+..+.+||......+..
T Consensus 293 ~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~--~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~ 370 (1351)
T KOG1035|consen 293 QKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEG--VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKS 370 (1351)
T ss_pred HHHhhhHHHHHHhccceeEEecccccccccCccc--eeecchhhhcccccCCCcccchhhcCccccccccccccccchhh
Confidence 457889999998866665554442 2222222 35555 888777665554444445566778888776554432
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
...|+|++|.....+..|..+-..... ....+... ......+++.+|+.-++++|+++.+++.|+
T Consensus 371 r~~dL~~lgll~~~~~~~~~i~~~~~~-------~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 371 RLTDLWCLGLLLLQLSQGEDISEKSAV-------PVSLLDVL--------STSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhHHHHHHHHHhhhhhcCcccccccc-------hhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 226999999999999887654322111 00011100 112678899999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
|.+..
T Consensus 436 f~~~~ 440 (1351)
T KOG1035|consen 436 FLRFP 440 (1351)
T ss_pred hcccc
Confidence 98643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.00043 Score=68.17 Aligned_cols=136 Identities=12% Similarity=0.078 Sum_probs=89.2
Q ss_pred CcccCCCCCCcEEecCCCCCcEEEecCCCcc-cCCCCCCCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhC
Q 025350 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 106 (254)
Q Consensus 28 givHrdlkp~NIll~~~~~~~vkl~Dfg~a~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 106 (254)
--+|++||+-|.+|..+.. +|++++|+.+ ............+++.|+.|++...-.++.+ +|+|..|+.+|....|
T Consensus 1360 T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSDG 1436 (2724)
T ss_pred cchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhcc
Confidence 3589999999999987766 9999999998 3333333445578888999998877777665 9999999999999888
Q ss_pred CCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccc
Q 025350 107 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 171 (254)
Q Consensus 107 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 171 (254)
..+|.. ......+......-......-.|.+.-.....+|-..-..||.-...+.-+.|.
T Consensus 1437 n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1437 NAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred cHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 877742 222222222211111111111233444455555556667888877777766663
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0039 Score=50.91 Aligned_cols=43 Identities=14% Similarity=0.056 Sum_probs=33.9
Q ss_pred HHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 14 FLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 14 ~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
+-.++.-+.-+-..||||+|+++-||+++.++. +.++||-.+.
T Consensus 208 l~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDwPQ~v 250 (304)
T COG0478 208 LDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDWPQAV 250 (304)
T ss_pred HHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeCcccc
Confidence 344455555555889999999999999998876 9999997654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.016 Score=46.80 Aligned_cols=43 Identities=19% Similarity=0.200 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 14 FLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 14 ~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
+-++...+.-|-. .|+||+||+.-|||+.. +. +.++|||.|..
T Consensus 172 ~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~-~~--p~iID~~QaV~ 215 (268)
T COG1718 172 YEDVVEYMRRLYKEAGLVHGDLSEYNILVHD-GE--PYIIDVSQAVT 215 (268)
T ss_pred HHHHHHHHHHHHHhcCcccccchhhheEEEC-Ce--EEEEECccccc
Confidence 4455555555555 99999999999999983 33 89999998764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.0081 Score=47.50 Aligned_cols=33 Identities=18% Similarity=0.313 Sum_probs=26.6
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++|+|++|.||+++.+....+.|+||+.+.
T Consensus 173 ~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 173 RPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred CcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 578999999999999987422247899999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.023 Score=47.83 Aligned_cols=31 Identities=35% Similarity=0.542 Sum_probs=26.3
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..+++|+|+.+.||+++.++. +.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 478999999999999987653 6899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.013 Score=49.48 Aligned_cols=31 Identities=32% Similarity=0.471 Sum_probs=25.3
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..|+||+|+.|.||+++.+.. .-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~--~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRL--SGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCce--EEEEeccccc
Confidence 458999999999999985432 4799999764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.027 Score=50.66 Aligned_cols=43 Identities=23% Similarity=0.258 Sum_probs=36.1
Q ss_pred HHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCC
Q 025350 17 TTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 61 (254)
Q Consensus 17 ~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 61 (254)
+...++++-..|+.|.|..|.||+++.++. +.+.|||+.....
T Consensus 274 ~~~f~~q~~~dgffHaDpHpGNi~v~~~g~--i~~lDfGi~g~l~ 316 (517)
T COG0661 274 VRAFLRQLLRDGFFHADPHPGNILVRSDGR--IVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHHHhcCccccCCCccceEEecCCc--EEEEcCcceecCC
Confidence 455667777899999999999999988865 9999999886543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.019 Score=46.30 Aligned_cols=31 Identities=29% Similarity=0.325 Sum_probs=24.9
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..+++|+|+.|.||+++.++. .-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i--~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRL--SAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCE--EEEEeCcccC
Confidence 456999999999999975432 4699999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.034 Score=46.34 Aligned_cols=30 Identities=33% Similarity=0.452 Sum_probs=25.2
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
.+++|+|+.|.||+++.++. +.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 58999999999999987543 5799998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.046 Score=45.88 Aligned_cols=30 Identities=30% Similarity=0.565 Sum_probs=25.0
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..+++|+|+.+.||+++. +. +.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 368999999999999986 33 8999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.03 Score=44.95 Aligned_cols=31 Identities=29% Similarity=0.604 Sum_probs=25.7
Q ss_pred hcCcccCCCCCCcEEecC-CCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDG-SPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~-~~~~~vkl~Dfg~a~ 58 (254)
..+++|+|+.+.|||++. ++ .+.|+||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~--~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKN--SVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCC--CEEEEEcccCC
Confidence 357999999999999986 34 39999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.028 Score=47.09 Aligned_cols=31 Identities=39% Similarity=0.655 Sum_probs=25.7
Q ss_pred hcCcccCCCCCCcEEecCC----CCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGS----PAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~----~~~~vkl~Dfg~a~ 58 (254)
..+++|+|+.|.||+++.+ +. ++++||..|.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~--i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKK--LVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCc--EEEEeeCCCC
Confidence 3468999999999999864 44 9999999774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.03 Score=44.47 Aligned_cols=32 Identities=38% Similarity=0.470 Sum_probs=20.3
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..+++|+|+.|.||+++.++. ++-|+||+.+.
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~-~i~iID~e~a~ 196 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDG-RIGIIDFEDAG 196 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTT-EEEE--GTT-E
T ss_pred CcEEEEeccccccceeeeccc-eeEEEecccce
Confidence 467999999999999983322 35799998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.04 Score=42.76 Aligned_cols=29 Identities=24% Similarity=0.392 Sum_probs=24.5
Q ss_pred CcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 28 givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
-.+|+|+.|.||+++.++ ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~---~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG---LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC---EEEEeCCcccC
Confidence 458999999999997654 89999998753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.02 Score=50.96 Aligned_cols=84 Identities=14% Similarity=0.158 Sum_probs=56.3
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC-------CCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-------DYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
+++||||+|.++.++..|...+......+....+.+ ......... ....++..+..+.++|+-..|..||..
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k-~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLK-YYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHH-hccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 359999999999999999877765433332222111 100000000 001246677889999999999999999
Q ss_pred hHHhcCcccccc
Q 025350 162 PEIRNHEWFLKN 173 (254)
Q Consensus 162 ~e~l~hp~~~~~ 173 (254)
.++.+++-|...
T Consensus 189 ~~~~k~~i~~ev 200 (725)
T KOG1093|consen 189 MELSKRCSFTEV 200 (725)
T ss_pred hHHhcCccHHHH
Confidence 999999998764
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.037 Score=46.87 Aligned_cols=49 Identities=29% Similarity=0.383 Sum_probs=31.5
Q ss_pred CCcHHHHHHHHHHH----hhcCcccCCCCCCcEEecCCCC----------------CcEEEecCCCccc
Q 025350 11 GTLFLPTTYFWSEL----LPFNVCHRDLKLENTLLDGSPA----------------PRLKICDFGYSKS 59 (254)
Q Consensus 11 ~~~~~~~~~~l~~L----h~~givHrdlkp~NIll~~~~~----------------~~vkl~Dfg~a~~ 59 (254)
+.+++|++-..--+ --.+.+|-||||+|||+-++.. .+.+|.||.+++.
T Consensus 278 kfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 278 KFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 45667766443112 1557899999999999854322 1356778877764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.044 Score=44.33 Aligned_cols=31 Identities=26% Similarity=0.266 Sum_probs=25.5
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++|+|+.|.||+++.++. +.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~--~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKF--SGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcE--EEEEEccccc
Confidence 456999999999999987543 6899998664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.89 E-value=0.073 Score=44.99 Aligned_cols=34 Identities=29% Similarity=0.369 Sum_probs=24.9
Q ss_pred CCcHHHHHHHHHHHh----hcCcccCCCCCCcEEecCC
Q 025350 11 GTLFLPTTYFWSELL----PFNVCHRDLKLENTLLDGS 44 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh----~~givHrdlkp~NIll~~~ 44 (254)
+.+++|++-..-.+- -.+.+|-||||+|||+-++
T Consensus 282 kfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 282 KFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 457788776553442 4579999999999998544
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.068 Score=41.85 Aligned_cols=33 Identities=21% Similarity=0.202 Sum_probs=25.9
Q ss_pred hcCcccCCCCCCcEEecCCCCC---cEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~---~vkl~Dfg~a~ 58 (254)
...++|||+.+.||++..++.+ .+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4578999999999999754322 48999998764
|
subfamily of choline kinases |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.054 Score=44.22 Aligned_cols=29 Identities=24% Similarity=0.397 Sum_probs=24.9
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++|+|+.|.||+++.++ +.|+||..|.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC---CEEEeccccC
Confidence 3689999999999998754 7899999775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=93.16 E-value=0.07 Score=42.84 Aligned_cols=30 Identities=20% Similarity=0.240 Sum_probs=24.7
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++|+|+.|.||+++.++ +.++||+.+.
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~---~~iIDwe~a~ 181 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG---TYWIDLGDFG 181 (226)
T ss_pred CCceEecCCCCCcEEEcCCC---cEEEechhcC
Confidence 34578999999999997654 7899999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.76 E-value=0.19 Score=42.78 Aligned_cols=29 Identities=28% Similarity=0.407 Sum_probs=24.6
Q ss_pred cccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 29 ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
+||+|+.|.||+++.... .+.++||+-|.
T Consensus 199 iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 999999999999987653 37899999764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.65 E-value=0.077 Score=41.96 Aligned_cols=31 Identities=35% Similarity=0.722 Sum_probs=19.9
Q ss_pred hcCcccCCCCCCcEEe-cCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLL-DGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll-~~~~~~~vkl~Dfg~a~ 58 (254)
...++|.|+.|.||++ +.++. ++|+||..|.
T Consensus 142 ~~v~cHnDl~~~Nil~~~~~~~--~~lIDfEya~ 173 (211)
T PF01633_consen 142 PLVFCHNDLNPGNILINNKDGE--VKLIDFEYAG 173 (211)
T ss_dssp GEEEE-S--SGGGEEETSSSSC--EEE--GTT-E
T ss_pred CceEeeccCccccEEeccCCCe--EEEecHHHHh
Confidence 3578999999999999 44444 9999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.59 E-value=0.13 Score=41.14 Aligned_cols=38 Identities=18% Similarity=0.052 Sum_probs=31.6
Q ss_pred HHHHHHHh--hcCcccCCCCCCcEEecCCCCCcEEEecCCCc
Q 025350 18 TYFWSELL--PFNVCHRDLKLENTLLDGSPAPRLKICDFGYS 57 (254)
Q Consensus 18 ~~~l~~Lh--~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a 57 (254)
...|.-.| ..+.+|+|..|+||+-++.|. +||.|-+.-
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhhh
Confidence 55666677 567999999999999998887 999998743
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.31 E-value=0.099 Score=43.34 Aligned_cols=31 Identities=23% Similarity=0.283 Sum_probs=24.5
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++|+|++|.||+++.++. ..-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 45899999999999986432 24699999775
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.17 E-value=0.27 Score=44.51 Aligned_cols=41 Identities=15% Similarity=0.228 Sum_probs=33.0
Q ss_pred HHHHHhhcCcccCCCCCCcEEecCC--CCCcEEEecCCCcccC
Q 025350 20 FWSELLPFNVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSS 60 (254)
Q Consensus 20 ~l~~Lh~~givHrdlkp~NIll~~~--~~~~vkl~Dfg~a~~~ 60 (254)
.+.+|-..|++|+|=.|.||++..+ +...+.+.|||+....
T Consensus 313 ~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 313 YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 3456668999999999999999853 3456999999988654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=92.12 E-value=0.22 Score=42.27 Aligned_cols=47 Identities=17% Similarity=0.165 Sum_probs=38.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++-.+...+--|..+|+||+|..--||++..++. ++++||-.+.
T Consensus 204 ~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--i~vIDFPQmv 250 (465)
T KOG2268|consen 204 PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK--IVVIDFPQMV 250 (465)
T ss_pred hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--EEEeechHhh
Confidence 3456666777788888999999999999999987665 9999997554
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.96 E-value=0.24 Score=40.91 Aligned_cols=29 Identities=34% Similarity=0.547 Sum_probs=25.4
Q ss_pred CcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 28 givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
-++|+|+.|.|++.++.+. ++|+||-.|.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~--l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGG--LFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCc--EEEEecccCC
Confidence 5899999999999988555 9999998775
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.89 E-value=0.14 Score=50.20 Aligned_cols=34 Identities=32% Similarity=0.493 Sum_probs=26.9
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEE-EecCCCccc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLK-ICDFGYSKS 59 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vk-l~Dfg~a~~ 59 (254)
.+++||+|+.+.|||++.+...++. |+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4689999999999999876422355 999998753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=91.83 E-value=0.32 Score=38.20 Aligned_cols=37 Identities=27% Similarity=0.334 Sum_probs=28.2
Q ss_pred HHHHHHHHhhcCcccCCCCCCcEEecCCCCC--cEEEec
Q 025350 17 TTYFWSELLPFNVCHRDLKLENTLLDGSPAP--RLKICD 53 (254)
Q Consensus 17 ~~~~l~~Lh~~givHrdlkp~NIll~~~~~~--~vkl~D 53 (254)
+-...++|-+.+|+.+||+|.||++.....+ .+.|+|
T Consensus 127 L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 127 LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 4455577889999999999999999654432 477776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.79 E-value=0.1 Score=43.95 Aligned_cols=31 Identities=19% Similarity=0.208 Sum_probs=26.3
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..+++|+|+.+.|++++.++. +.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 348999999999999987665 8999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.63 E-value=0.13 Score=44.03 Aligned_cols=32 Identities=28% Similarity=0.662 Sum_probs=25.9
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++|+|+++.||+++... ..+.++||..|.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 44789999999999997532 249999998775
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.95 E-value=0.19 Score=42.41 Aligned_cols=32 Identities=19% Similarity=0.309 Sum_probs=27.7
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
...++|+|+++.|++++..+. +-+.||+++..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRP--TGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCe--eEEEecccccc
Confidence 457899999999999988775 89999998864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=90.39 E-value=0.19 Score=39.10 Aligned_cols=50 Identities=18% Similarity=0.052 Sum_probs=40.6
Q ss_pred ccCcCCcHHHHHHHHHHHhh---cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 7 QRGRGTLFLPTTYFWSELLP---FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~---~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...|..+.++++..+.+|+. ..+.-.|++|+|+-+++++. +|++|...+.
T Consensus 58 w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 58 WEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 44566777888888888885 44888999999999987765 9999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.10 E-value=0.4 Score=41.93 Aligned_cols=30 Identities=17% Similarity=0.207 Sum_probs=25.5
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++|||+.+.||++..+. ++++||-++.
T Consensus 222 ~~~l~HgDl~~gni~~~~~~---~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEEE---TKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCCC---cEEEeccccc
Confidence 56799999999999997653 8999998664
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=89.59 E-value=0.24 Score=41.27 Aligned_cols=32 Identities=22% Similarity=0.370 Sum_probs=25.1
Q ss_pred cCcccCCCCCCcEEecCCCCC---cEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~---~vkl~Dfg~a~ 58 (254)
.-++|||+++.|||+..++.+ .+++.||-.++
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 458999999999999665432 58999997654
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.12 E-value=0.25 Score=41.98 Aligned_cols=29 Identities=17% Similarity=0.170 Sum_probs=23.9
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++||+|+.+.|||++ + . +.++||+.+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~--~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-G--PHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-C--cEEEeCCCCC
Confidence 45799999999999995 3 3 6899999764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=88.82 E-value=0.37 Score=41.07 Aligned_cols=30 Identities=30% Similarity=0.459 Sum_probs=24.4
Q ss_pred CcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 28 givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
-++|.|+.+.||+++.++ ..++++||..|.
T Consensus 183 v~CHnDl~~~NiL~~~~~-~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDE-GKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCC-CcEEEEcccccC
Confidence 379999999999997442 249999999875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=88.74 E-value=0.35 Score=42.14 Aligned_cols=30 Identities=17% Similarity=0.265 Sum_probs=25.7
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++||||.|.||+++.++ +|++|.-+|.
T Consensus 226 ~~aLlHGDlHtGSI~v~~~~---~kvIDpEFAf 255 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKNDS---TKVIDPEFAF 255 (409)
T ss_pred chhhccCcCCCCCEEecCCc---eEEEcccccc
Confidence 56799999999999998765 7999988775
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.73 E-value=0.33 Score=47.54 Aligned_cols=33 Identities=21% Similarity=0.282 Sum_probs=26.1
Q ss_pred hcCcccCCCCCCcEEecCCCCC---cEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~---~vkl~Dfg~a~ 58 (254)
..|+||+|+.+.||+++.+..+ ..-|+|||.+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 6789999999999999865311 24799999775
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=88.50 E-value=0.32 Score=41.84 Aligned_cols=30 Identities=17% Similarity=0.208 Sum_probs=25.4
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++|||+.+.||+++..+ ++++|+.++.
T Consensus 191 ~~~llHGDl~~gNi~~~~~~---~~~iD~e~~~ 220 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEHE---TKVIDPEFAF 220 (370)
T ss_pred cceeeeccCCcccEEEcCCC---CEEEcCcccc
Confidence 56799999999999997654 7899998765
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=87.57 E-value=0.81 Score=39.49 Aligned_cols=44 Identities=30% Similarity=0.465 Sum_probs=31.9
Q ss_pred cHHHHHHHHHHHh-hcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 13 LFLPTTYFWSELL-PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 13 ~~~~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
+|++.+..+.-+. ....=||++.-.||||+ +|. |.|+||.+++.
T Consensus 326 ff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfklsRl 370 (488)
T COG5072 326 FFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKLSRL 370 (488)
T ss_pred HHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeeeeec
Confidence 3444444443333 34578999999999998 555 99999999984
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=85.08 E-value=0.67 Score=44.64 Aligned_cols=33 Identities=18% Similarity=0.365 Sum_probs=25.4
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
..+||+|+++.||+++......+-|.||.++..
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 469999999999999754322357999998753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=81.51 E-value=1.3 Score=37.06 Aligned_cols=29 Identities=21% Similarity=0.288 Sum_probs=21.8
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCC
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFG 55 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg 55 (254)
..++|+|+.+.||+++..+...+.|.|..
T Consensus 193 psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 193 CVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CeeEeCCCCcccEEECCCCCceEEEECch
Confidence 46899999999999976532235677765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 254 | ||||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-107 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-106 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-106 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-105 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-97 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-94 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-28 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-24 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-21 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-20 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-20 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-19 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-19 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-19 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-19 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-19 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-19 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-19 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-19 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-19 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-18 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-15 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-15 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-15 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-15 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-15 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-15 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-15 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-15 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-04 |
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 354 bits (910), Expect = e-123
Identities = 175/227 (77%), Positives = 204/227 (89%), Gaps = 1/227 (0%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL++EYD
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
GKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+YSIPD + ISPEC HLI
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255
Query: 148 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 207
SRIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+EP+QPMQS+D IMQII+E
Sbjct: 256 SRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISE 315
Query: 208 ATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM 254
ATIPA + L+ + +LD+DD+M +D D++ ++DIDSSGEIVYA+
Sbjct: 316 ATIPAVRNRCLDDFMTDNLDLDDDM-DDFDSESEIDIDSSGEIVYAL 361
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 3e-79
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLK 83
+ HRD+K EN LLD LKI DFG + +++ GT Y+APE+L +
Sbjct: 124 IGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDYVHISPE 142
+E+ + DVWSCG+ L ML G P++ P + + + + + + I
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPWKKIDSA 237
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP----DQPMQSI 198
L+ +I V +P+ RI+IP+I+ W+ K L T+ E + +QS
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSN 297
Query: 199 DEIMQIIAEATIPAAGTQS 217
+ + + + P +G
Sbjct: 298 LDFSPVNSASRTPGSGWSK 316
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-74
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLK 83
+ HRD+K EN LLD LKI DFG + +++ GT Y+APE+L +
Sbjct: 124 IGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDYVHISPE 142
+E+ + DVWSCG+ L ML G P++ P + + + + + + I
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPWKKIDSA 237
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
L+ +I V +P+ RI+IP+I+ W+ K L
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-59
Identities = 60/152 (39%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 130 HMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
G D+WSCGV LY +L G PF+D P F+K I + IP+ +++ L
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPE--YLNRSVATL 241
Query: 147 ISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
+ + DP KR +I +IR HEWF ++LP+ L
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-59
Identities = 55/153 (35%), Positives = 77/153 (50%), Gaps = 17/153 (11%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYS-----KSSVLHSQPKSTVGTPAYIAPEVL 81
+ HRD+K N L+ +KI DFG S ++L + TVGTPA++APE L
Sbjct: 156 QKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGSDALLSN----TVGTPAFMAPESL 209
Query: 82 --LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 139
+K + GK DVW+ GVTLY + G PF D K I S PD I
Sbjct: 210 SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK----IKSQALEFPDQPDI 265
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172
+ + + LI+R+ +P RI +PEI+ H W +
Sbjct: 266 AEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 6e-59
Identities = 72/174 (41%), Positives = 91/174 (52%), Gaps = 17/174 (9%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ K Y
Sbjct: 127 HKIVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
G DVWSCG+ LYVMLVG PF+D P F+K + S Y +PD +SP + L
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPD--FLSPGAQSL 238
Query: 147 ISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 200
I R+ VADP +RI+I EIR WF NLP L + D
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFNVNLPDYL---------RPMEEVQGSYADS 283
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-59
Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 13/183 (7%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLL- 82
+ H+D+K N LL LKI G +++ + +++ G+PA+ PE+
Sbjct: 128 QGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
+ G D+WS GVTLY + G YPFE N K I Y+IP P
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPGD--CGPP 239
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV-VDNTTNNQFEEPDQPMQSIDEI 201
L+ + +PAKR SI +IR H WF K P V + ++ + M + +
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYL 299
Query: 202 MQI 204
+
Sbjct: 300 EDL 302
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-59
Identities = 58/176 (32%), Positives = 84/176 (47%), Gaps = 12/176 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ K+YD
Sbjct: 134 RIVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
G DVWS GV LY ++ G+ PF+ + + +L +Y IP Y+ S +C +L+
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFYM--STDCENLL 245
Query: 148 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 203
R V +P KR ++ +I W D + E D Q +IM
Sbjct: 246 KRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL----KPFVEPELDISDQKRIDIMV 297
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-58
Identities = 62/184 (33%), Positives = 92/184 (50%), Gaps = 8/184 (4%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 135 HMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
G D+WS GV LY +L G PF+D P F+K I + P +++P L
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQ--YLNPSVISL 246
Query: 147 ISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 206
+ + DP KR +I +IR HEWF ++LP L ++ + + D+ ++ + E +
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSE 306
Query: 207 EATI 210
E +
Sbjct: 307 EEVL 310
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-58
Identities = 44/149 (29%), Positives = 78/149 (52%), Gaps = 10/149 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 86
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ + +
Sbjct: 132 GILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
+ +DVWS G Y +L+G PF+ + T+++++ Y +P +S E + L
Sbjct: 190 GLE-SDVWSLGCMFYTLLIGRPPFDT----DTVKNTLNKVVLADYEMPS--FLSIEAKDL 242
Query: 147 ISRIFVADPAKRISIPEIRNHEWFLKNLP 175
I ++ +PA R+S+ + +H + +N
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSRNSS 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-57
Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ K +D
Sbjct: 134 KVIHRDIKPENLLMGYKG--ELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
K D+W GV Y LVG PF+ P + R+ I++V P ++ S + LI
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPFL--SDGSKDLI 243
Query: 148 SRIFVADPAKRISIPEIRNHEWFLKNLP 175
S++ P +R+ + + H W N
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSR 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-56
Identities = 62/153 (40%), Positives = 81/153 (52%), Gaps = 11/153 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 86
V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 135 RVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
+ DVWS G +Y +LVG PFE ++T RI +YSIP HI+P L
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASL 245
Query: 147 ISRIFVADPAKRISIPEIRNHEWFLKN-LPADL 178
I ++ DP R +I E+ N E+F +PA L
Sbjct: 246 IQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-56
Identities = 53/148 (35%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ + +D
Sbjct: 129 RVIHRDIKPENLLLGSAG--ELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
K D+WS GV Y LVG PFE +++T RI V+++ PD ++ R LI
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDLI 238
Query: 148 SRIFVADPAKRISIPEIRNHEWFLKNLP 175
SR+ +P++R + E+ H W N
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSS 266
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-55
Identities = 62/153 (40%), Positives = 81/153 (52%), Gaps = 11/153 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 86
V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 161 RVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
+ DVWS G +Y +LVG PFE ++T RI +YSIP HI+P L
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASL 271
Query: 147 ISRIFVADPAKRISIPEIRNHEWFLKN-LPADL 178
I ++ DP R +I E+ N E+F +PA L
Sbjct: 272 IQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-55
Identities = 53/155 (34%), Positives = 69/155 (44%), Gaps = 21/155 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVLLKK 84
V HRD+K EN L+D + LK+ DFG K +V GT Y PE +
Sbjct: 169 GVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWIRYH 223
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y G+ A VWS G+ LY M+ G PFE E I+ Q +S EC+
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--RVSSECQ 271
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLK-NLPADL 178
HLI P+ R + EI+NH W LP +
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 306
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-55
Identities = 47/155 (30%), Positives = 61/155 (39%), Gaps = 20/155 (12%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVLLKK 84
V HRD+K EN L+D K+ DFG GT Y PE + +
Sbjct: 159 GVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYTD----FDGTRVYSPPEWISRH 213
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+Y A VWS G+ LY M+ G PFE IL + P H+SP+C
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFPA--HVSPDCC 261
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 179
LI R P+ R S+ EI W +
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPL 296
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-54
Identities = 44/172 (25%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL-K 83
N+CHRD+K N L+D + R+K+ DFG S+ + + GT ++ PE +
Sbjct: 172 NICHRDVKPSNILMDKNG--RVKLSDFGESEYMVDKKIKG----SRGTYEFMPPEFFSNE 225
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV------ 137
Y+G D+WS G+ LYVM PF + + + I + P
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SLVELFNNIRTKNIEYPLDRNHFLYP 282
Query: 138 -----------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
+S E + +PA+RI+ + HEW DL
Sbjct: 283 LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 5e-52
Identities = 40/148 (27%), Positives = 65/148 (43%), Gaps = 14/148 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
++ HRD+K EN ++ +K+ DFG + + GT Y APEVL+ Y
Sbjct: 150 DIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR 207
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
G ++WS GVTLY ++ PF + EE + P V S E L+
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYLV--SKELMSLV 255
Query: 148 SRIFVADPAKRISIPEIRNHEWFLKNLP 175
S + P +R ++ ++ W + +
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQPVN 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 8e-47
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLL 82
+CHRD+K EN L + + +K+ DFG SK + + GTP ++APEVL
Sbjct: 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247
Query: 83 KKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHI 139
G D WS GV L+++L+GA PF + + +L+ + P+Y +
Sbjct: 248 TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVL 303
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173
SP R L+S + + +R H W +
Sbjct: 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-46
Identities = 44/175 (25%), Positives = 64/175 (36%), Gaps = 26/175 (14%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 68
+W +L + H DLK N L+ LK+ DFG + S
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDS 187
Query: 69 TVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 118
VGT Y+ PE + +DVWS G LY M G PF+ N
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---IN 244
Query: 119 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173
+H I+ + I + + ++ DP +RISIPE+ H +
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-46
Identities = 47/227 (20%), Positives = 78/227 (34%), Gaps = 32/227 (14%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 68
+W +L + H DLK N L+ LK+ DFG + S
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDS 168
Query: 69 TVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 118
VGT Y+ PE + +DVWS G LY M G PF+ +
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 228
Query: 119 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
+H I+ + I + + ++ DP +RISIPE+ H +
Sbjct: 229 ---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285
Query: 179 VVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS 225
+ T + + + +++ + + +I A G
Sbjct: 286 QMAKGTTEEMK------YVLGQLVGLNSPNSILKAAKTLYEHYSGGE 326
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-46
Identities = 43/202 (21%), Positives = 71/202 (35%), Gaps = 26/202 (12%)
Query: 19 YFWSELLP-------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KS 68
+W +L + H DLK N L+ LK+ DFG + + S
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDS 215
Query: 69 TVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 118
VG Y+ PE + +DVWS G LY M G PF+ +
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 119 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
+H I+ + I + + ++ DP +RISIPE+ H +
Sbjct: 276 ---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332
Query: 179 VVDNTTNNQFEEPDQPMQSIDE 200
+ T + + + ++
Sbjct: 333 QMAKGTTEEMKYVLGQLVGLNS 354
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-45
Identities = 56/152 (36%), Positives = 80/152 (52%), Gaps = 9/152 (5%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
NV HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+VL + Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY 184
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECR 144
G D WS GV +YV+L G PF P + + K I ++ D++++SP+
Sbjct: 185 -GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAE 239
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176
LI R+ P +RI+ + HEWF K L +
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-44
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+V H+DLK EN L SP +KI DFG ++ + GT Y+APEV K++
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDV 202
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRH 145
K D+WS GV +Y +L G PF + +K + + + ++P+
Sbjct: 203 TFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQAVD 257
Query: 146 LISRIFVADPAKRISIPEIRNHEWF 170
L+ ++ DP +R S ++ +HEWF
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-43
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 144
K D+W+CGV LY++LVG PF D ++ + + + I + Y P++ ++PE +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 239
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 180
LI + +P KRI+ + W +
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 34/180 (18%)
Query: 28 NVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 81
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 82 ----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS----- 132
+K+Y D+WS GVT Y G+ PF E P+ ++ +++I++ + S
Sbjct: 192 LRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 133 --------------IPDYVHISPECR----HLISRIFVADPAKRISIPEIRNHEWFLKNL 174
+P +S + +++ I AD K + + +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-42
Identities = 50/160 (31%), Positives = 71/160 (44%), Gaps = 10/160 (6%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEVL+
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 193
Query: 87 D--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYSIPDYV--HISP 141
+ D WS GV L++ L G PF + + + I S +Y+ V +S
Sbjct: 194 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYNFIPEVWAEVSE 249
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 181
+ L+ ++ V DP R + E H W D
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-42
Identities = 40/224 (17%), Positives = 79/224 (35%), Gaps = 34/224 (15%)
Query: 28 NVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 81
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 82 ----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS----- 132
+K+Y D+WS GVT Y G+ PF E P+ ++ +++I++ + S
Sbjct: 192 LRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 133 --------------IPDYVHISP----ECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174
+P +S +++ I AD K + + +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310
Query: 175 PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSL 218
V + + +++ + T + Q L
Sbjct: 311 MVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQEL 354
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-42
Identities = 52/158 (32%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N+ HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE++ D
Sbjct: 144 NIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 88 -----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHIS 140
GK D+WS GV +Y +L G+ PF ++ R I+S Y P++ S
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFGSPEWDDYS 257
Query: 141 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
+ L+SR V P KR + E H +F + + ++
Sbjct: 258 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 48/148 (32%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEVL+
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 318
Query: 87 D--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPE 142
+ D WS GV L++ L G PF + + + +I S +Y+ + +S +
Sbjct: 319 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---QITSGKYNFIPEVWAEVSEK 375
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170
L+ ++ V DP R + E H W
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWL 403
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-42
Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 7/153 (4%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 85
N+ HRD+K EN L LK+ DFG++K ++ TP Y+APEVL ++
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEK 205
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPEC 143
YD K D+WS GV +Y++L G PF RI QY P+ +S +
Sbjct: 206 YD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176
+ LI + DP +R++I + NH W +++
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-42
Identities = 51/156 (32%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 85
V HRDLK EN L D + +KI DFG+++ +QP K+ T Y APE+L +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---HRILSVQYS--IPDYVHIS 140
YD + D+WS GV LY ML G PF+ + + +I +S + ++S
Sbjct: 186 YD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 141 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176
E + LI + DP KR+ + +R +EW
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 9e-42
Identities = 50/244 (20%), Positives = 87/244 (35%), Gaps = 25/244 (10%)
Query: 28 NVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK EN +L G KI D GY+K VGT Y+APE+L +K+Y
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY 200
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR--------------ILSVQYS 132
D WS G + + G PF +P + + +
Sbjct: 201 TVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSV 259
Query: 133 IPDYVHISPECRHLISRIF----VADPAKRISIPEIRNHEWF-----LKNLPADLVVDNT 183
+P H+S + R + +R + P+ N F + +L V++
Sbjct: 260 LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMV 319
Query: 184 TNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLD 243
+ P +++ + + + T Q L Q +L+ + + + +D
Sbjct: 320 SGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLALNSAQPLTQYVIDCTVID 379
Query: 244 IDSS 247
Sbjct: 380 GRQG 383
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 19/153 (12%), Positives = 40/153 (26%), Gaps = 25/153 (16%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL------ 81
+ H L+ + +LD + + F V + + + PE+
Sbjct: 226 GLVHTYLRPVDIVLDQRG--GVFLTGFE---HLVRDGARVVSSVSRGFEPPELEARRATI 280
Query: 82 ----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 137
++ D W+ G+ +Y + P I R
Sbjct: 281 SYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW-IFR---------SCK 330
Query: 138 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+I R L+ R+ + +
Sbjct: 331 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
N+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL + Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECR 144
D K DVWS GV LY++L G PF KN + R+ + + +P + IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYG----KNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQI 204
LI ++ P+ RI+ + H W K + + + + ++ I Q
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE--------SAMTNIRQF 306
Query: 205 IAEATIPAAGTQSLNQCLNGSLDIDD--EMDEDIDTDPD 241
AE + A + L + E+ +DT+ D
Sbjct: 307 QAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNND 345
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 53/152 (34%), Positives = 79/152 (51%), Gaps = 4/152 (2%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
N+ HRD+K EN L P LK+ DFG++K + H+ + TP Y+APEVL ++Y
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPECR 144
D K D+WS GV +Y++L G PF RI QY P+ +S E +
Sbjct: 241 D-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 299
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176
LI + +P +R++I E NH W +++
Sbjct: 300 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-41
Identities = 54/149 (36%), Positives = 79/149 (53%), Gaps = 9/149 (6%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
N+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL + Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 144
D K DVWS GV LY++L G PF E ++ + + +Y+ +P + IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKN 173
LI ++ P+ RI+ + H W K
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-41
Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 144
K D+W+CGV LY++LVG PF D ++ + + + I + Y P++ ++PE +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 262
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 177
LI + +P KRI+ + W
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-41
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
N+ HRD+K EN LL + + +KI DFG S + + +GT YIAPEV LKK+Y
Sbjct: 166 NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV-LKKKY 224
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECR 144
+ K DVWSCGV +Y++L G PF +N + I ++ + D+ +IS E +
Sbjct: 225 NEK-CDVWSCGVIMYILLCGYPPFGG----QNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS--IDEIM 202
LI + D KR + E N W K N + DQ + +
Sbjct: 280 ELIKLMLTYDYNKRCTAEEALNSRWIKKY-----------ANNINKSDQKTLCGALSNMR 328
Query: 203 QIIAEATIPAAGTQSLNQCLNGSLDIDD--EMDEDIDTDPD 241
+ + A + L + + ++ + +D + D
Sbjct: 329 KFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGD 369
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 46/206 (22%), Positives = 81/206 (39%), Gaps = 9/206 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
++ H D+K EN + + A +KI DFG + K T T + APE++ ++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV- 227
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRH 145
G D+W+ GV YV+L G PF ++ +T+ + + + +SPE +
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 205
I + +P KR+++ + H W + ++ + D
Sbjct: 284 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQP 343
Query: 206 AEATIPAAGTQSLNQCLNGSLDIDDE 231
A I A SL + I D
Sbjct: 344 AIGRI--ANFSSLRKHRPQEYQIYDS 367
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-40
Identities = 42/160 (26%), Positives = 63/160 (39%), Gaps = 25/160 (15%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SVLHSQPKSTVGT 72
+ HRDLK N +D S +KI DFG +K+ S +GT
Sbjct: 136 GIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGT 193
Query: 73 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 132
Y+A EVL + + D++S G+ + M+ YPF E N K ++ SV
Sbjct: 194 AMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK---KLRSVSIE 247
Query: 133 IPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
P + + +I + DP KR + N W
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-40
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 20/219 (9%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK EN LL+ S ++I DFG S + K +GT YIAPEVL Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECR 144
D K DVWS GV LY++L G PF N + ++ + +P + +S +
Sbjct: 205 DEK-CDVWSTGVILYILLSGCPPFNG----ANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQI 204
LI ++ P+ RIS + +HEW + VD + + +I I Q
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLD---------NAILNIRQF 310
Query: 205 IAEATIPAAGTQSLNQCLNGSLDIDD--EMDEDIDTDPD 241
+ A + L + + + +D + D
Sbjct: 311 QGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGD 349
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 7/148 (4%)
Query: 28 NVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKK 84
V HRDLK N L ++ICDFG++K + T T ++APEVL ++
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPE 142
YD D+WS GV LY ML G PF + + RI S ++S+ +S
Sbjct: 196 GYD-AACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170
+ L+S++ DP +R++ + H W
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWI 281
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-40
Identities = 53/167 (31%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 85
+ HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL +K
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPEC 143
Y K D WS GV Y++L G PF + E K F K I Y P + IS
Sbjct: 184 Y-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESA 238
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 190
+ I + DP +R + + +H W N + + + Q ++
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQK 285
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 9/160 (5%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++ +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPEC 143
G AD+WS GV Y++L GA PF + + I SV Y + + H S
Sbjct: 195 L-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVSYDFDEEFFSHTSELA 249
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT 183
+ I ++ V + KR++I E H W +V
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRE 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-40
Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N+ HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+L +
Sbjct: 220 NIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDE 277
Query: 88 -----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HIS 140
GK D+W+CGV L+ +L G+ PF + R I+ QY S
Sbjct: 278 THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSPEWDDRS 333
Query: 141 PECRHLISRIFVADPAKRISIPEIRNHEWFLK 172
+ LISR+ DP R++ + H +F +
Sbjct: 334 STVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 18/152 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 84
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
K +D+W+ G +Y ++ G PF E F+K I+ ++Y P+ P+ R
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 145 HLISRIFVADPAKRISIP------EIRNHEWF 170
L+ ++ V D KR+ ++ H +F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-40
Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++ +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPEC 143
G AD+WS GV Y++L GA PF + + + +V Y D + + S
Sbjct: 194 L-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNTSALA 248
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDN 182
+ I R+ V DP KR++I + H W +K +
Sbjct: 249 KDFIRRLLVKDPKKRMTIQDSLQHPW-IKPKDTQQALSR 286
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-40
Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 8/155 (5%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
N+ H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI 210
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECR 144
D+W+ G+ Y++L PF + + + I V + + +S
Sbjct: 211 -TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVSQLAT 265
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 179
I + V +P KR + +H W + +L
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-40
Identities = 52/152 (34%), Positives = 79/152 (51%), Gaps = 9/152 (5%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
N+ HRDLK EN LL +KI DFG S + K +GT YIAPEV L+K+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKY 214
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 144
D K DVWS GV L+++L G PF + ++ + ++ +Y+ P++ ++S +
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGG----QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176
LI ++ D +RIS + H W +
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-40
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 9/160 (5%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++ +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPEC 143
G AD+WS GV Y++L GA PF + + I +V Y + + S
Sbjct: 195 L-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQTSELA 249
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT 183
+ I ++ V + KR++I E H W +V
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRE 289
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-40
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 7/165 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ H DLK EN L A ++KI DFG ++ + K GTP ++APEV+ ++
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFV 265
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRH 145
D+WS GV Y++L G PF + + IL+ ++ ++ IS E +
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN----ILACRWDLEDEEFQDISEEAKE 321
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 190
IS++ + + + RIS E H W + + N+ +
Sbjct: 322 FISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSD 366
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-39
Identities = 47/147 (31%), Positives = 75/147 (51%), Gaps = 9/147 (6%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++ +
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP 187
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPEC 143
G AD+WS GV Y++L GA PF + + I +V Y + + + S
Sbjct: 188 L-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNTSELA 242
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWF 170
+ I R+ V DP +R++I + H W
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEHSWI 269
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-39
Identities = 37/163 (22%), Positives = 64/163 (39%), Gaps = 7/163 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N+ H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV- 180
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRH 145
D+WS G +YV+L G PF + I++ +Y+ + + IS E
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMD 236
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQF 188
+ R+ V + R++ E H W + + T
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR 279
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-39
Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 34/236 (14%)
Query: 28 NVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 82
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHIS 140
K Y GK D+W+CGV LY++LVG PF D ++ + +++ I + Y P++ ++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVT 241
Query: 141 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS--I 198
PE + LI+++ +P+KRI+ E H W + +
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTV--------------ASCMHRQETV 287
Query: 199 DEIMQIIAEATIPAAGTQSLNQCLNGSL---DIDDEMDEDIDTDPDLDIDSSGEIV 251
D + + A + A + N S+ +I ++ I+ + D +S ++
Sbjct: 288 DCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDFESYTKMC 343
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-39
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 25/162 (15%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------------VGTPAY 75
+ HRDLK+EN LL +K+CDFG + + + + TP Y
Sbjct: 159 IIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMY 216
Query: 76 IAPEV--LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 133
PE+ L G+ D+W+ G LY++ +PFED RI++ +YSI
Sbjct: 217 RTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AKLRIVNGKYSI 268
Query: 134 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
P + LI + +P +R+SI E+ + +
Sbjct: 269 PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-39
Identities = 38/158 (24%), Positives = 63/158 (39%), Gaps = 17/158 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------VGTPAYIA 77
HRDLK N LL + + D G + +H + T +Y A
Sbjct: 154 GYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 78 PEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 135
PE+ + + + DVWS G LY M+ G P++ + + ++ + Q SIP
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQNQLSIPQ 268
Query: 136 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173
S L++ + DP +R IP + + L+
Sbjct: 269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-39
Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 85
N+ HRD+K LL + +K+ FG + VGTP ++APEV+ ++
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPEC 143
Y GK DVW CGV L+++L G PF +E + I+ +Y + HIS
Sbjct: 210 Y-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWSHISESA 263
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWFLKN 173
+ L+ R+ + DPA+RI++ E NH W +
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 56/166 (33%), Positives = 82/166 (49%), Gaps = 8/166 (4%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY 227
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 144
G D+WS G+ Y++L G PF D + + RIL+ +Y P + +S +
Sbjct: 228 -GPEVDMWSVGIITYILLCGFEPFYD---ERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 190
L+ ++ V DP KR++ + H W + A+ V +T + +E
Sbjct: 284 DLVRKLIVLDPKKRLTTFQALQHPW-VTGKAANFVHMDTAQKKLQE 328
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-38
Identities = 23/150 (15%), Positives = 42/150 (28%), Gaps = 10/150 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ H +N + RL + D + P AP L
Sbjct: 214 GLVHGHFTPDNLFIMPDG--RLMLGDVS---ALWKVGTRGPASSVPVTYAPREFLNASTA 268
Query: 88 --GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF---RKTIHRILSVQYSIPDYVHISPE 142
+ W G+++Y + PF R ++ + + +
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF 328
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWFLK 172
+ LI R D +R+ E FL+
Sbjct: 329 VKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-38
Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEY 86
V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y++PE + + Y
Sbjct: 136 TVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRH 145
+ K +D+WS G LY + PF + ++ +I ++ IP S E
Sbjct: 194 NEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY--RYSDELNE 246
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKNL 174
+I+R+ R S+ EI + L++
Sbjct: 247 IITRMLNLKDYHRPSVEEILENPLILEHH 275
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 12/148 (8%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ HRD+K +N LLD G + I DF + +Q + GT Y+APE+ ++
Sbjct: 135 RIIHRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 86 YDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
G D WS GVT Y +L G P+ + ++ +H + + P S E
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQEM 247
Query: 144 RHLISRIFVADPAKRI-SIPEIRNHEWF 170
L+ ++ +P +R + +++N +
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 7/148 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N H DLK EN + + LK+ DFG + K T GT + APEV K
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV- 333
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRH 145
G D+WS GV Y++L G PF +N +T+ + S +++ D + IS + +
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKN 173
I ++ +ADP R++I + H W
Sbjct: 390 FIRKLLLADPNTRMTIHQALEHPWLTPG 417
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 54/152 (35%), Positives = 86/152 (56%), Gaps = 19/152 (12%)
Query: 27 FNVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLK 83
+ +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+ +
Sbjct: 145 LGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
+ + + AD WS GV ++ ML G PF+ K+ ++T+ IL + +P + +SPE
Sbjct: 201 RGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 253
Query: 144 RHLISRIFVADPAKRI-SIP----EIRNHEWF 170
+ L+ +F +PA R+ + P EI+ H +F
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 28/175 (16%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 77
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 78 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF-----------EDPEEPKNFRKT 122
PEV+ + K D+WS GV LY++L G PF P
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 123 IHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
I +Y D+ HIS + LIS++ V D +R+S ++ H W P
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 7e-36
Identities = 45/212 (21%), Positives = 75/212 (35%), Gaps = 34/212 (16%)
Query: 28 NVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPKSTVG 71
+ HRDLK +N L+ S R+ I DFG K S + + G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 72 TPAYIAPEVLLKKEYD------GKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNFRKTIH 124
T + APE+L + + D++S G Y +L PF D
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS------RES 248
Query: 125 RILSVQYSIPDYV-----HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 179
I+ +S+ + + E LIS++ DP KR + ++ H F
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEF 308
Query: 180 VDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 211
+ ++ E P ++ ++ IP
Sbjct: 309 LLKVSDRLEIENRDPPSALLMKFDAGSDFVIP 340
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 51/154 (33%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 27 FNVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 82
+ +RD+KLEN LLD G + + DFG SK V ++ GT Y+AP+++
Sbjct: 178 LGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 83 KKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
+ K D WS GV +Y +L GA PF E + + RIL + P +S
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSA 291
Query: 142 ECRHLISRIFVADPAKRI-SIP----EIRNHEWF 170
+ LI R+ + DP KR+ P EI+ H +F
Sbjct: 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 19/152 (12%)
Query: 27 FNVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLK 83
+ +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+L++
Sbjct: 140 KGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR 195
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
+ + D WS G +Y ML GA PF +N +KTI +IL + ++P Y ++ E
Sbjct: 196 SGH-NRAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LTQEA 248
Query: 144 RHLISRIFVADPAKRI-SIP----EIRNHEWF 170
R L+ ++ + A R+ + P E++ H +F
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 56/147 (38%), Positives = 78/147 (53%), Gaps = 15/147 (10%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 84
+ +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE+LL +
Sbjct: 138 GIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 193
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+Y D WS GV LY ML+G PF +E + F I P + + E +
Sbjct: 194 KY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRW--LEKEAK 246
Query: 145 HLISRIFVADPAKRI-SIPEIRNHEWF 170
L+ ++FV +P KR+ +IR H F
Sbjct: 247 DLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-35
Identities = 33/148 (22%), Positives = 58/148 (39%), Gaps = 13/148 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ +RDLK N L + ++KI DFG S + + GT Y++PE + ++Y
Sbjct: 142 KLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYG 199
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
+ D+++ G+ L +L E F + I D + + L+
Sbjct: 200 KE-VDLYALGLILAELLHVCDT---AFETSKFFTDLRDG-----IISD--IFDKKEKTLL 248
Query: 148 SRIFVADPAKRISIPEIRNHEWFLKNLP 175
++ P R + EI K P
Sbjct: 249 QKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 7e-35
Identities = 21/157 (13%), Positives = 44/157 (28%), Gaps = 19/157 (12%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ H L+ + +LD + + F + + S P A +L +
Sbjct: 231 GLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQ 288
Query: 86 YDGKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
+ + D W+ G+ +Y + P D +I
Sbjct: 289 HHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC----------KNIPQ 338
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
R L+ R+ + + + L +L
Sbjct: 339 PVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTEL 374
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-35
Identities = 44/193 (22%), Positives = 89/193 (46%), Gaps = 17/193 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+ K Y
Sbjct: 145 KILHRDIKSQNIFLTKDG--TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRH 145
+ K +D+W+ G LY + + FE + + + +I+S + + H S + R
Sbjct: 203 NNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDLRS 255
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 205
L+S++F +P R S+ I + K + + + Q + +++ +
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRI------EKFLSPQLIAEEFCLKTFSKFGSQP 309
Query: 206 AEATIPAAGTQSL 218
A PA+G S+
Sbjct: 310 IPAKRPASGQNSI 322
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 20/151 (13%)
Query: 27 FNVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84
++ +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+ K
Sbjct: 125 KDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTK 178
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y K D WS G+ +Y ML G PF D K + K IL+ + P + + +
Sbjct: 179 PY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELRFPP--FFNEDVK 231
Query: 145 HLISRIFVADPAKRI-SIP----EIRNHEWF 170
L+SR+ D ++R+ ++ +++NH WF
Sbjct: 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 53/150 (35%), Positives = 75/150 (50%), Gaps = 18/150 (12%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 84
N+ +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APEVL K+
Sbjct: 159 NIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y + D W G LY ML G PF +N + IL+ + +I+ R
Sbjct: 215 PY-DRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKP--NITNSAR 267
Query: 145 HLISRIFVADPAKRISIP----EIRNHEWF 170
HL+ + D KR+ EI++H +F
Sbjct: 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 27 FNVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84
++ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L K
Sbjct: 160 LDLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSK 213
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y K D W+ GV +Y M G PF + + + K I+S + P H S + +
Sbjct: 214 GY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLK 266
Query: 145 HLISRIFVADPAKRI-----SIPEIRNHEWF 170
L+ + D KR + +I+NH+WF
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 46/150 (30%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
V +RDLK N LLD G ++I D G + +P ++VGT Y+APEVL K
Sbjct: 312 FVVYRDLKPANILLDEHGH----VRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
AD +S G L+ +L G PF + K+ + L++ +PD SPE R
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRS 423
Query: 146 LISRIFVADPAKRI-----SIPEIRNHEWF 170
L+ + D +R+ E++ +F
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 19/151 (12%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 84
+V +RD+KLEN +LD G +KI DFG K + T GTP Y+APEVL
Sbjct: 125 DVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+Y G+ D W GV +Y M+ G PF + + + F IL + P +SPE +
Sbjct: 181 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRT--LSPEAK 233
Query: 145 HLISRIFVADPAKRI-----SIPEIRNHEWF 170
L++ + DP +R+ E+ H +F
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 19/151 (12%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 84
+ +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE++ +
Sbjct: 141 GIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 196
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y GK D W+ GV LY ML G PFE +E + F+ I+ + P +S E
Sbjct: 197 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKEAV 249
Query: 145 HLISRIFVADPAKRI-----SIPEIRNHEWF 170
+ + P KR+ +I+ H +F
Sbjct: 250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 43/174 (24%), Positives = 67/174 (38%), Gaps = 18/174 (10%)
Query: 28 NVCHRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEV 80
N+ HRDLK N L+ + + I DFG K S+ GT +IAPE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 81 L---LKKEYDGKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNFRKTIHRILSVQYSIPDY 136
L K+ D++S G Y ++ PF + R+ + +
Sbjct: 198 LSEDCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLHP 252
Query: 137 -VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 189
H R LI ++ DP KR S + H +F +L L +++ E
Sbjct: 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF-WSLEKQLQFFQDVSDRIE 305
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 48/150 (32%), Positives = 67/150 (44%), Gaps = 16/150 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
+ +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L + Y
Sbjct: 144 GIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
G D W+ GV LY ML G PFE E F IL+ + P + + +
Sbjct: 202 -GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPT--WLHEDATGI 254
Query: 147 ISRIFVADPAKRI------SIPEIRNHEWF 170
+ +P R+ I H +F
Sbjct: 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 54/150 (36%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 85
NV +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +
Sbjct: 268 KNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y G+ D W GV +Y M+ G PF + + K F IL + P + PE +
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAKS 378
Query: 146 LISRIFVADPAKRI-SIP----EIRNHEWF 170
L+S + DP +R+ EI H +F
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ + Y
Sbjct: 306 RIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY- 362
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
D W+ G LY M+ G PF+ ++ + + V + SP+ R L
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARSLC 420
Query: 148 SRIFVADPAKRI-----SIPEIRNHEWF 170
S++ DPA+R+ S E++ H F
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 48/151 (31%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKK 84
N+ +RDLK EN LLD G ++I D G + GTP ++APE+LL +
Sbjct: 309 NIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
EY D ++ GVTLY M+ PF E ++ R+L + PD SP +
Sbjct: 365 EY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASK 421
Query: 145 HLISRIFVADPAKRI-----SIPEIRNHEWF 170
+ DP KR+ S +R H F
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 21/157 (13%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 84
+ +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE+L +
Sbjct: 130 GIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 185
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPDYVHI 139
+Y G D W+ GV ++ M+ G PF+ IL Q IP +
Sbjct: 186 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--L 242
Query: 140 SPECRHLISRIFVADPAKRI------SIPEIRNHEWF 170
S + ++ DP +R+ +I+ H +F
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 55/154 (35%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 84
HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL +
Sbjct: 187 MGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 85 EYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHI 139
D G+ D WS GV LY MLVG PF + T +I++ + PD I
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDNDI 300
Query: 140 SPECRHLISRIFVADPAKRI---SIPEIRNHEWF 170
S E ++LI F+ D R+ + EI+ H +F
Sbjct: 301 SKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 26/169 (15%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 84
+ HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 194 LHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 85 EYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYV- 137
E G D WS GV +Y ML G PF ++ +T +I++ ++ P V
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETYGKIMNHKERFQFPTQVT 307
Query: 138 HISPECRHLISRIFVADPAKRI---SIPEIRNHEWF-------LKNLPA 176
+S + LI R + R+ I + + H +F ++N A
Sbjct: 308 DVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEA 355
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-32
Identities = 50/150 (33%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 85
+ +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ +
Sbjct: 461 KGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 518
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y GK D W+ GV LY ML G PFE +E + F+ I+ + P +S E
Sbjct: 519 Y-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKEAVA 571
Query: 146 LISRIFVADPAKRI-----SIPEIRNHEWF 170
+ + P KR+ +I+ H +F
Sbjct: 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-32
Identities = 49/182 (26%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
N+ HRD+K EN L P LK+ DFG A E ++Y
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-GEKY 175
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPECR 144
D K D+WS GV +Y++L G PF RI QY P+ +S E +
Sbjct: 176 D-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 234
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQI 204
LI + +P +R++I E NH W +++ +T+ E+ ++ +E+
Sbjct: 235 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSA 294
Query: 205 IA 206
+A
Sbjct: 295 LA 296
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 21/157 (13%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 84
+ +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE+L +
Sbjct: 173 GIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-----KTIHRILSVQYSIPDYVHI 139
+Y G D W+ GV ++ M+ G PF+ N IL Q IP +
Sbjct: 229 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SL 285
Query: 140 SPECRHLISRIFVADPAKRI------SIPEIRNHEWF 170
S + ++ DP +R+ +I+ H +F
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 33/143 (23%), Positives = 55/143 (38%), Gaps = 11/143 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ H D+K N L P R K+ DFG + G P Y+APE+ L+ Y
Sbjct: 177 GLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSYG 233
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
ADV+S G+T+ + P + +++ L + +S E R ++
Sbjct: 234 TA-ADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYLPPE--FTA--GLSSELRSVL 285
Query: 148 SRIFVADPAKRISIPEIRNHEWF 170
+ DP R + +
Sbjct: 286 VMMLEPDPKLRATAEALLALPVL 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-31
Identities = 43/158 (27%), Positives = 63/158 (39%), Gaps = 21/158 (13%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 84
HRD+K +N LLD +++ DFG +S VGTP Y++PE+L
Sbjct: 181 LGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 85 EYD------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDY 136
G D W+ GV Y M G PF + +T +I+ S+P
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAETYGKIVHYKEHLSLPLV 294
Query: 137 -VHISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 170
+ E R I R + P R+ + R H +F
Sbjct: 295 DEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 8/154 (5%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEY 86
V HRD+K N + + +K+ D G + S + S VGTP Y++PE + + Y
Sbjct: 156 RVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 213
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRH 145
+ K +D+WS G LY M PF + N +I Y +P H S E R
Sbjct: 214 NFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYSEELRQ 269
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 179
L++ DP KR + + + + A +
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-29
Identities = 36/167 (21%), Positives = 65/167 (38%), Gaps = 24/167 (14%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSVLHSQPKSTVGTPA 74
+ HRDLK N +K+ DFG +++ VGT
Sbjct: 138 GLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195
Query: 75 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 134
Y++PE + Y K D++S G+ L+ +L YPF E +T+ + ++++ P
Sbjct: 196 YMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV---RTLTDVRNLKFP-P 247
Query: 135 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLVV 180
+ P ++ + P +R I + F + P V+
Sbjct: 248 LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-29
Identities = 32/156 (20%), Positives = 61/156 (39%), Gaps = 23/156 (14%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------------VGTPA 74
+ HRDLK N +K+ DFG + + ++ VGT
Sbjct: 184 GLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 75 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 134
Y++PE + Y K D++S G+ L+ +L Y F E + I + ++++
Sbjct: 242 YMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFSTQMERV---RIITDVRNLKFP-L 293
Query: 135 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ P+ ++ + P +R +I + F
Sbjct: 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-27
Identities = 43/187 (22%), Positives = 71/187 (37%), Gaps = 26/187 (13%)
Query: 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
P + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 123 PKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRILSVQYSIPDY 136
Y K DV+S G+ L+ ++ PF++ P R +
Sbjct: 180 YSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP----------LIKN 228
Query: 137 VHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTNNQFEEPDQPM 195
+ L++R + DP++R S+ EI ++ P P +
Sbjct: 229 LP--KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDG 286
Query: 196 QSIDEIM 202
+ +
Sbjct: 287 RVEPYVD 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 12/147 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKE- 85
+ HRD+K +N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ K
Sbjct: 142 QIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 86 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPE 142
Y AD+WS G T+ M G PF + EP+ + ++ + IP+ +S E
Sbjct: 201 GYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMFKVHPEIPE--SMSAE 254
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEW 169
+ I + F DP KR ++ E+
Sbjct: 255 AKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 33/164 (20%), Positives = 56/164 (34%), Gaps = 32/164 (19%)
Query: 28 NVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQPKSTV 70
++ H D+K N + S KI D G+ S P+
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSPQVEE 191
Query: 71 GTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 129
G ++A EVL + K AD+++ +T+ + ++ H I
Sbjct: 192 GDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQ-------WHEIRQG 243
Query: 130 QYS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172
+ IP +S E L+ + DP +R S + H L
Sbjct: 244 RLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 39/157 (24%), Positives = 56/157 (35%), Gaps = 11/157 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 81
+ H D+K +N LL R +CDFG++ GT ++APEV+
Sbjct: 170 RILHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
+ K D K D+WS + ML G +P+ K I IP +P
Sbjct: 229 MGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIPP--SCAP 284
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
I +P R S E+R L
Sbjct: 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 36/186 (19%), Positives = 65/186 (34%), Gaps = 38/186 (20%)
Query: 28 NVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKSTV-----GTP 73
+ H D+K +N +L + L + D G S + PK T+ T
Sbjct: 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGTIFTAKCETS 249
Query: 74 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTIHR------- 125
+ E+L K ++ +I D + T+Y ML G Y ++ R
Sbjct: 250 GFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMW 308
Query: 126 --ILSVQYSIPDYVHIS--PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 181
V +IPD H+ R + ++F +I L+N L+++
Sbjct: 309 NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRA---------LRNRLIVLLLE 359
Query: 182 NTTNNQ 187
+ +
Sbjct: 360 CKRSRK 365
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-23
Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
+ HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +++YD
Sbjct: 152 IIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY-EEKYDE 208
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYSIPDYVHISPECRHLI 147
DV++ G+ + M YP+ + + +R+ + S PE + +I
Sbjct: 209 S-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDK--VAIPEVKEII 263
Query: 148 SRIFVADPAKRISIPEIRNHEWF 170
+ +R SI ++ NH +F
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFF 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-22
Identities = 36/144 (25%), Positives = 54/144 (37%), Gaps = 16/144 (11%)
Query: 25 LPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84
L + L + ++D +I S Q + PA++APE L KK
Sbjct: 130 LEPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKK 183
Query: 85 EYDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHIS 140
D AD+WS V L+ ++ PF D + + ++ +IP IS
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFAD----LSNMEIGMKVALEGLRPTIPP--GIS 237
Query: 141 PECRHLISRIFVADPAKRISIPEI 164
P L+ DPAKR I
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDMI 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-22
Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYD 87
HR+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL + +
Sbjct: 162 HRNLKSPNLLVDKKY--TVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRH 145
K +DV+S GV L+ + P+ + N + + + IP ++ P+
Sbjct: 218 EK-SDVYSFGVILWELATLQQPWGN----LNPAQVVAAVGFKCKRLEIPRNLN--PQVAA 270
Query: 146 LISRIFVADPAKRISIPEI 164
+I + +P KR S I
Sbjct: 271 IIEGCWTNEPWKRPSFATI 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-22
Identities = 39/147 (26%), Positives = 57/147 (38%), Gaps = 16/147 (10%)
Query: 26 PFNVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 79
+ HRDLK N L+ LKI DFG ++ + S G A++APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-WHRTTKMSAAGAYAWMAPE 184
Query: 80 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYV 137
V+ + +DVWS GV L+ +L G PF + + + + IP
Sbjct: 185 VIRASMFSKG-SDVWSYGVLLWELLTGEVPFRG----IDGLAVAYGVAMNKLALPIPSTC 239
Query: 138 HISPECRHLISRIFVADPAKRISIPEI 164
L+ + DP R S I
Sbjct: 240 P--EPFAKLMEDCWNPDPHSRPSFTNI 264
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-21
Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 29 VCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--K 83
+ HRDL+ N L + K+ DFG S+ +G ++APE + +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGAEE 202
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-----SIPDYVH 138
+ Y K AD +S + LY +L G PF++ K I I ++ +IP+
Sbjct: 203 ESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRPTIPEDCP 256
Query: 139 ISPECRHLISRIFVADPAKRISIPEI 164
P R++I + DP KR I
Sbjct: 257 --PRLRNVIELCWSGDPKKRPHFSYI 280
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 7e-21
Identities = 42/193 (21%), Positives = 74/193 (38%), Gaps = 45/193 (23%)
Query: 18 TYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 77
TY + + HRD+K N L++ +K+CDFG S + S S VGT +Y++
Sbjct: 145 TYLREKH---KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMS 198
Query: 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 137
PE L Y + +D+WS G++L M VG YP P+ + ++ P
Sbjct: 199 PERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 138 HI--------------------------------------SPECRHLISRIFVADPAKRI 159
S E + +++ + +PA+R
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317
Query: 160 SIPEIRNHEWFLK 172
+ ++ H + +
Sbjct: 318 DLKQLMVHAFIKR 330
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-20
Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 12/176 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-----L 82
V HRD+K N LLD ++K+CDFG S V + G AY+APE +
Sbjct: 145 GVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISP 141
K +YD + ADVWS G++L + G +P+++ K + + ++L + +P ++ S
Sbjct: 203 KPDYDIR-ADVWSLGISLVELATGQFPYKN---CKTDFEVLTKVLQEEPPLLPGHMGFSG 258
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS 197
+ + + D KR ++ H + + ++ V + + + + P
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSG 314
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 18 TYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYI 76
+ S+L +V HRD+K N L++ ++K+CDFG S V K G Y+
Sbjct: 123 EHLHSKL---SVIHRDVKPSNVLINALG--QVKMCDFGISGYLV-DDVAKDIDAGCKPYM 176
Query: 77 APEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 132
APE + +K Y K +D+WS G+T+ + + +P++ P F+ + +++
Sbjct: 177 APERINPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP--FQ-QLKQVVEEPSP 232
Query: 133 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172
S E S+ + +R + PE+ H +F
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-19
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 20/160 (12%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 84
++ HRDLK N L +KI DFG + Q + G+ ++APEV+ +
Sbjct: 140 SIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 85 E---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
+ Y + +DV++ G+ LY ++ G P+ + N R I ++ PD +
Sbjct: 198 DSNPYSFQ-SDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKVRS 252
Query: 142 EC----RHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 177
C + L++ +R S P I ++ L +
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSFPRILAE---IEELARE 289
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-19
Identities = 50/157 (31%), Positives = 74/157 (47%), Gaps = 28/157 (17%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKK 84
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ +K
Sbjct: 136 QVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DY 136
Y K D+WS G+ M+ G P+ + E P L Y I +
Sbjct: 192 AYGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALYLIATNGTPELQNP 239
Query: 137 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173
+S R ++R D KR S E+ H+ FLK
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ-FLKI 275
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-19
Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 21/156 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----LK 83
+ HRD+K N LLD S +K+CDFG S V G Y+APE + +
Sbjct: 146 KIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIP-----DY 136
+ YD + +DVWS G+TLY + G +P+ ++ L+ V+ P +
Sbjct: 204 QGYDVR-SDVWSLGITLYELATGRFPYPKWN-------SVFDQLTQVVKGDPPQLSNSEE 255
Query: 137 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172
SP + ++ D +KR E+ H + L
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-18
Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 89
HRD+K N LL +K+ DFG + ++T VGTP ++APEV+ + YD K
Sbjct: 142 HRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199
Query: 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV------HISPEC 143
AD+WS G+T + G P + P + V + IP + S
Sbjct: 200 -ADIWSLGITAIELARGEPPHSE-LHP----------MKVLFLIPKNNPPTLEGNYSKPL 247
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWFLKN 173
+ + +P+ R + E+ H++ L+N
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKFILRN 277
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-18
Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 28/157 (17%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKK 84
V HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ +
Sbjct: 161 GVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRS 216
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DY 136
Y + D+WS G+ + M+ G P+ + P + + +
Sbjct: 217 LYATE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNS 264
Query: 137 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173
+SP R + R+ V DP +R + E+ +H FL
Sbjct: 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHP-FLLQ 300
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-18
Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 27/165 (16%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKK 84
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ +
Sbjct: 145 RKIHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DY 136
Y+ AD+WS G+T M G P+ D P + + IP
Sbjct: 201 GYNCV-ADIWSLGITAIEMAEGKPPYAD-IHP----------MRAIFMIPTNPPPTFRKP 248
Query: 137 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 181
S + + V P +R + ++ H + ++ D
Sbjct: 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 40/228 (17%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK- 83
+CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE++
Sbjct: 160 IGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPELIFGA 216
Query: 84 KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE-----------PKNFRKTIHRILS-- 128
Y I D+WS G + ++ G +P E + P R+ I +
Sbjct: 217 TNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS--REQIKTMNPNY 273
Query: 129 VQYSIPDYV----------HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKN--- 173
+++ P P+ LISR+ P+ R++ E H +F L+
Sbjct: 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333
Query: 174 -LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQ 220
+P + N EE I ++ AEA + + G N
Sbjct: 334 RMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRGIDVHNF 381
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 59/231 (25%), Positives = 90/231 (38%), Gaps = 44/231 (19%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 84
+CHRD+K +N LLD A LK+CDFG +K L + + + Y APE++
Sbjct: 176 GICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPNVSYICSRYYRAPELIFGAT 232
Query: 85 EYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE-----------PKNFRKTIHRILS--V 129
+Y I DVWS G L +L+G +P + + P R+ I +
Sbjct: 233 DYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT--REQIREMNPNYT 289
Query: 130 QYSIPDYV----------HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKN---- 173
++ P PE L SR+ P R++ E H +F L++
Sbjct: 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 349
Query: 174 LPADLVVDNTTNNQFEE----PDQPMQSIDEIMQIIAEATIPAAGTQSLNQ 220
LP N +E P I +I A A+ P T + +
Sbjct: 350 LPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDA 400
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-17
Identities = 27/170 (15%), Positives = 59/170 (34%), Gaps = 40/170 (23%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 81
+ H+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 82 ---------LKKEYDGKIADVWSCGVTLYVMLVGAYPFED--PEE-----PKNFRKTIHR 125
K + +DV++ G Y + +PF+ E + +
Sbjct: 207 RQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL-- 263
Query: 126 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
+ E ++ + + +R + ++ + L+ LP
Sbjct: 264 -------SQI--GMGKEISDILLFCWAFEQEERPTFTKLMDM---LEKLP 301
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-17
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 24/167 (14%)
Query: 31 HRDLKLENTLL--DGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLL 82
HRD+K N LL DGS ++I DFG S + K+ VGTP ++APEV+
Sbjct: 144 HRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 83 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIP 134
+ + YD K AD+WS G+T + GA P+ +N ++ + + +
Sbjct: 200 QVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLK 258
Query: 135 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 181
Y R +IS DP KR + E+ H++F K + + +
Sbjct: 259 KY---GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 36/171 (21%), Positives = 61/171 (35%), Gaps = 44/171 (25%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL- 81
+ HRDLK +N L+ + + I D G + ++ L VGT Y+APEVL
Sbjct: 133 AIAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 82 -----LKKEYDGKIADVWSCGVTLYVMLVGAY----------PFED--PEEP-------- 116
+ + D+W+ G+ L+ + PF D P +P
Sbjct: 191 ETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 117 ---KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164
R I ++ + EC + +P+ R++ I
Sbjct: 250 VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY-------QNPSARLTALRI 293
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 29/170 (17%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEY 86
NVCHRD+K N L++ + LK+CDFG +K + + + Y APE++ + Y
Sbjct: 151 NVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHY 209
Query: 87 DGKIADVWSCGVTLYVMLVGA--YPFED---------------PEE------PKNFRKTI 123
+ D+WS G M++G + ++ E P + +
Sbjct: 210 TTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDL 268
Query: 124 HRILSVQYS--IPDYV-HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ + +S D+ + E L+S + P +R+ E H +F
Sbjct: 269 YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-16
Identities = 38/198 (19%), Positives = 65/198 (32%), Gaps = 53/198 (26%)
Query: 28 NVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 83
+ H D+K EN L++ +P +KI D G + +++ T Y +PEVLL
Sbjct: 152 GIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSIQTREYRSPEVLLG 209
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--------------------PKNF---- 119
+ D+WS ++ ++ G + FE E P
Sbjct: 210 APWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 268
Query: 120 --------------------RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 159
+ +L+ +Y + E +S + DP KR
Sbjct: 269 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK--DEAKEISDFLSPMLQLDPRKRA 326
Query: 160 SIPEIRNHEWFLKNLPAD 177
+ NH W L +
Sbjct: 327 DAGGLVNHPWLKDTLGME 344
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 6e-16
Identities = 33/165 (20%), Positives = 63/165 (38%), Gaps = 30/165 (18%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL- 81
+ HRDLK +N L+ + I D G + ++ + P + VGT Y+ PEVL
Sbjct: 162 AIAHRDLKSKNILVKKNG--TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 82 -----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQY---- 131
+ AD++S G+ L+ + EE + + + S +
Sbjct: 220 ESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278
Query: 132 --------SIPDYVH---ISPECRHLISRIFVADPAKRISIPEIR 165
S P+ + L++ + +PA R++ ++
Sbjct: 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-16
Identities = 43/170 (25%), Positives = 67/170 (39%), Gaps = 32/170 (18%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLL-- 82
+ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 83 ---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP----- 134
YD K AD+WS G+TL M P + P + V I
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP----------MRVLLKIAKSDPP 240
Query: 135 ---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 181
S E R + +P R S ++ H + + +
Sbjct: 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 32/195 (16%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEY 86
+CHRD+K +N L++ LK+CDFG +K + + + + Y APE++L EY
Sbjct: 161 GICHRDIKPQNLLVNSKDN-TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEY 219
Query: 87 DGKIADVWSCGVTLYVMLVGA--YPFEDPEE-----------PKNFRKTIHRILS--VQY 131
I D+WS G +++G + E + P ++ + R+ +
Sbjct: 220 TPSI-DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT--KEQMIRMNPHYTEV 276
Query: 132 SIPDYVHIS----------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLV 179
P L+ +I +P RI+ E H +F L+N V
Sbjct: 277 RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEV 336
Query: 180 VDNTTNNQFEEPDQP 194
+N+ + P
Sbjct: 337 KNNSNFPHGVNQNIP 351
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-16
Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 32/163 (19%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKK 84
V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 149 KVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 85 E-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP----- 134
E YD K +D+WS G+T M GA P D P + + IP
Sbjct: 205 ENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD-MHP----------MRALFLIPRNPAP 252
Query: 135 --DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
S + + I V + ++R + ++ H F+++ P
Sbjct: 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQP 294
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-15
Identities = 43/187 (22%), Positives = 70/187 (37%), Gaps = 28/187 (14%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGT 72
N+ HRDL N L+ + + + DFG ++ + + VG
Sbjct: 128 NIIHRDLNSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 73 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN--FRKTIHRILSVQ 130
P ++APE++ + YD K DV+S G+ L ++ D P+ F + L
Sbjct: 186 PYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDY-LPRTMDFGLNVRGFL--D 241
Query: 131 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 190
P P + R DP KR S ++ E +L+ L L Q E+
Sbjct: 242 RYCPPNCP--PSFFPITVRCCDLDPEKRPSFVKL---EHWLETLRMHLAGHLPLGPQLEQ 296
Query: 191 PDQPMQS 197
D+
Sbjct: 297 LDRGFWE 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 27/134 (20%), Positives = 44/134 (32%), Gaps = 32/134 (23%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90
+ DLK EN +L +LK+ D G + GTP + APE++
Sbjct: 205 YNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEIVRTGPTVA-- 256
Query: 91 ADVWSCGVTLYVMLVGAYPFED------PEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
D+++ G TL + + PE+ +
Sbjct: 257 TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK------------------TYDSYG 298
Query: 145 HLISRIFVADPAKR 158
L+ R DP +R
Sbjct: 299 RLLRRAIDPDPRQR 312
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 43/215 (20%), Positives = 78/215 (36%), Gaps = 48/215 (22%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEY 86
V HRDL N LL + + ICDF ++ + V Y APE++++ K +
Sbjct: 154 GVVHRDLHPGNILLADNN--DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGF 211
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV---------------- 129
+ D+WS G + M F F +++I+ V
Sbjct: 212 TKLV-DMWSAGCVMAEMFNRKALF-----RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPS 265
Query: 130 -----QYSIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL- 174
+ S+ + P LI+++ +P +RIS + H + ++L
Sbjct: 266 ARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP-YFESLF 324
Query: 175 -PADLVVDNTTNNQFEEPDQPMQSI-----DEIMQ 203
P DL + F+E + + E+ +
Sbjct: 325 DPLDLTEGLSERFHFDESVTDVYDMHKIFTAEVER 359
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-15
Identities = 34/166 (20%), Positives = 63/166 (37%), Gaps = 30/166 (18%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 82
+ HRDLK +N L+ + I D G + + + P VGT Y+APEVL
Sbjct: 167 AIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224
Query: 83 K------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQY---- 131
E + AD+++ G+ + + E+ + + + SV+
Sbjct: 225 DSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283
Query: 132 --------SIPDYVHISPECR---HLISRIFVADPAKRISIPEIRN 166
+IP+ R ++ + A+ A R++ I+
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 48/207 (23%), Positives = 64/207 (30%), Gaps = 63/207 (30%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
++ H DLK EN LL +KI DFG SS Q + + Y +PEVLL Y
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEVLLGMPY 235
Query: 87 DGKIADVWSCGVTLYVMLVG---------------------------------------- 106
D I D+WS G L M G
Sbjct: 236 DLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEK 294
Query: 107 ----AYPFEDPEEPKN-----FRKTIHRILSVQYSIP---DYVHISPECR------HLIS 148
+ + ++ K + +H IL V+ P LI
Sbjct: 295 LPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354
Query: 149 RIFVADPAKRISIPEIRNHEWFLKNLP 175
R+ DP RI H +F K
Sbjct: 355 RMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-15
Identities = 46/202 (22%), Positives = 65/202 (32%), Gaps = 58/202 (28%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
+ H DLK EN LL +K+ DFG SS Q T + + Y APEV+L Y
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFYRAPEVILGARY 276
Query: 87 DGKIADVWSCGVTLY---------------------VMLVGAYP-------------FED 112
I D+WS G L + L+G
Sbjct: 277 GMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSS 335
Query: 113 PEEPKNFRKT----IHRILSVQYSIPDYVHISPECR---------------HLISRIFVA 153
P+ T +L+ S + PE R + +
Sbjct: 336 KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395
Query: 154 DPAKRISIPEIRNHEWFLKNLP 175
DPA R++ + H W + LP
Sbjct: 396 DPAVRMTPGQALRHPWLRRRLP 417
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-15
Identities = 43/176 (24%), Positives = 63/176 (35%), Gaps = 39/176 (22%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 83
NV HRDLK N ++ + LKI DFG ++ H K + T Y +P +LL
Sbjct: 140 NVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198
Query: 84 -KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------Q 130
Y I D+W+ G ML G F + + + IL
Sbjct: 199 PNNYTKAI-DMWAAGCIFAEMLTGKTLFAG----AHELEQMQLILESIPVVHEEDRQELL 253
Query: 131 YSIPDYV----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
IP Y+ IS E + +I P R++ E +H +
Sbjct: 254 SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-15
Identities = 45/179 (25%), Positives = 69/179 (38%), Gaps = 39/179 (21%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 147 GIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 204
Query: 88 GKIADVWSCGVTLYVMLVGA--YPFED--------------PEE---------------- 115
+ D+WS G + M+ G +P D P
Sbjct: 205 ENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 263
Query: 116 -PKNFRKTIHRILSVQYSIPDYVH---ISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
PK + ++ D H + + R L+S++ V D +KRIS+ E H +
Sbjct: 264 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-15
Identities = 42/178 (23%), Positives = 68/178 (38%), Gaps = 34/178 (19%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 85
+ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+VL+ +
Sbjct: 128 KILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 86 YDGKIADVWSCGVTLYVMLVGA--------------------YPFED--------PEEPK 117
Y I D+WSCG L M+ G P E P+
Sbjct: 186 YSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP 244
Query: 118 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
N ++ R L + + + +P R+S + +H WF
Sbjct: 245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF-AEYY 301
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-14
Identities = 35/143 (24%), Positives = 54/143 (37%), Gaps = 34/143 (23%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE +
Sbjct: 157 HRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 89 KIADVWSCGVTLYVMLVGAYPF-------------EDPEEPKNFRKTIHRILSVQYSIPD 135
+ AD+++ LY L G+ P+ + P R P
Sbjct: 215 R-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR-------------PG 260
Query: 136 YVHISPECRHLISRIFVADPAKR 158
I +I+R +P R
Sbjct: 261 ---IPVAFDAVIARGMAKNPEDR 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-14
Identities = 36/190 (18%), Positives = 61/190 (32%), Gaps = 53/190 (27%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAPEVL- 81
HR +K + L+ + + + + V+H PK +V +++PEVL
Sbjct: 151 HRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 82 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFED---------------------------- 112
+ YD K +D++S G+T + G PF+D
Sbjct: 209 QNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267
Query: 113 ------------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 160
T S P + SP H + + +P R S
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
Query: 161 IPEIRNHEWF 170
+ NH +F
Sbjct: 328 ASTLLNHSFF 337
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 47/185 (25%), Positives = 67/185 (36%), Gaps = 47/185 (25%)
Query: 28 NVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 82
HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 83 KKEYDGKIADVWSCGVTLYVML--------------------------------VGAYPF 110
+ Y + D+WS ML V A P
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270
Query: 111 EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
PK KT+ R+L + E L++ + DP KRIS H +F
Sbjct: 271 WKQSFPKFRGKTLKRVLG--------ALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322
Query: 171 LKNLP 175
+
Sbjct: 323 -SHND 326
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 45/176 (25%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 84
V HRDLK N ++ LKI DFG ++ + + T V T Y APEV+L
Sbjct: 146 GVVHRDLKPGNLAVNEDC--ELKILDFGLARHA----DAEMTGYVVTRWYRAPEVILSWM 199
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------------- 129
Y+ + D+WS G + ML G F K++ + +IL V
Sbjct: 200 HYNQTV-DIWSVGCIMAEMLTGKTLF-----KGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 130 ----QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
Y S+P + SP+ L+ ++ D KR++ + H +F
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 46/216 (21%), Positives = 82/216 (37%), Gaps = 53/216 (24%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 84
+ HRDLK N ++ LKI DFG ++ + + T V T Y APEV+L
Sbjct: 148 GIIHRDLKPGNLAVNEDC--ELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILNWM 201
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------------- 129
Y + D+WS G + M+ G F + + I+ V
Sbjct: 202 RYTQTV-DIWSVGCIMAEMITGKTLF-----KGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 130 ----QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174
Y +P+ + SP +L+ ++ V D +R++ E H + ++L
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP-YFESL 314
Query: 175 --PADLVVDNTTNNQFEEPDQPMQSI-----DEIMQ 203
D ++ F++ D+ + E++
Sbjct: 315 HDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLS 350
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 34/178 (19%), Positives = 63/178 (35%), Gaps = 39/178 (21%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 84
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+ +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPF--------------------------------ED 112
YD + D+WS G L M+ PF D
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 113 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
P + + + +SPE + ++ D R++ E H +F
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-14
Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 28 NVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--- 82
N+ HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 174 NMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILAMD 226
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-------D 135
+ +YDGK DVWS G+T + P + +S Y I
Sbjct: 227 EGQYDGK-VDVWSLGITCIELAERKPPLFN-MNA----------MSALYHIAQNESPALQ 274
Query: 136 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 181
H S R+ + P R + + H + L+ P +++D
Sbjct: 275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-14
Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 48/210 (22%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 84
++ HRDLK N ++ LKI DFG ++ + + T V T Y APE++L
Sbjct: 152 DIIHRDLKPSNLAVNEDC--ELKILDFGLARHT----ADEMTGYVATRWYRAPEIMLNWM 205
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------------- 129
Y+ + D+WS G + +L G F P + + IL +
Sbjct: 206 HYNQTV-DIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 130 ----QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174
Y S+ ++ +P L+ ++ V D KRI+ + H +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA-YFAQY 318
Query: 175 --PADLVVDNTTNNQFEEPDQPMQSIDEIM 202
P D V + + E D + +
Sbjct: 319 HDPDDEPVADPYDQSLESRDLLIDEWKSLT 348
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 42/196 (21%), Positives = 62/196 (31%), Gaps = 50/196 (25%)
Query: 28 NVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVL 81
V HRDLK N L+ G R +KI D G ++ + V T Y APE+L
Sbjct: 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207
Query: 82 L-KKEYDGKIADVWSCGVTLYVML------------------------------------ 104
L + Y I D+W+ G +L
Sbjct: 208 LGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPAD 266
Query: 105 -----VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 159
+ P R T ++Y V + HL+ ++ DP KRI
Sbjct: 267 KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326
Query: 160 SIPEIRNHEWFLKNLP 175
+ + +F P
Sbjct: 327 TSEQAMQDPYF-LEDP 341
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 5e-14
Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 40/179 (22%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 85
+ HRDLK +N L++ LK+ DFG +++ + + + V T Y AP+VL+ K+
Sbjct: 139 RILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 86 YDGKIADVWSCGVTLYVMLVGA--------------------YPFED--PE-------EP 116
Y + D+WS G M+ G P P+ +
Sbjct: 197 YSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 117 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
+ F+ + S E L+S + DP KRIS + NH +F K+L
Sbjct: 256 RTFQVFEKKPWSSIIP-----GFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-KDLD 308
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 5e-14
Identities = 42/182 (23%), Positives = 70/182 (38%), Gaps = 44/182 (24%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 85
NV HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL K
Sbjct: 121 NVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILSV-----------Q 130
Y I D+WS G + P + ++ + RI +
Sbjct: 179 YSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQ-------LKRIFRLLGTPTEEQWPSM 230
Query: 131 YSIPDYV----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174
+PDY ++ R L+ + +P +RIS E H +F +
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDF 289
Query: 175 PA 176
Sbjct: 290 CP 291
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 5e-14
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 11/96 (11%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVL---- 81
+ HRD+K +N LL + I DFG + T VGT Y+APEVL
Sbjct: 152 ISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI 209
Query: 82 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 116
+++ + D+++ G+ L+ + + P +
Sbjct: 210 NFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-14
Identities = 40/182 (21%), Positives = 69/182 (37%), Gaps = 40/182 (21%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 85
V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 86 YDGKIADVWSCGVTLYVMLVGA--------------------YPFED--------PE-EP 116
Y +I D+W G Y M G P E+ E +
Sbjct: 178 YSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 117 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176
N+ K L + + L++++ + RIS + H +F +L
Sbjct: 237 YNYPKYRAEALLSHAP-----RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF-LSLGE 290
Query: 177 DL 178
+
Sbjct: 291 RI 292
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 7e-14
Identities = 41/177 (23%), Positives = 64/177 (36%), Gaps = 46/177 (25%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 85
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ K+
Sbjct: 120 RVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 86 YDGKIADVWSCGVTLYVML--------------------------------VGAYPFEDP 113
Y I D+WS G M+ V P DP
Sbjct: 178 YSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 114 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
L + L+S++ DP +RI+ + H +F
Sbjct: 237 NFTVYEPLPWESFLK---------GLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 8e-14
Identities = 45/182 (24%), Positives = 66/182 (36%), Gaps = 45/182 (24%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
+ HRDLK N ++ LKI DFG +++ + T V T Y APEV+L
Sbjct: 184 GIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPF---------------------ED------------ 112
Y + D+WS G + M+ F E
Sbjct: 240 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 113 ----PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168
F K L S + + + R L+S++ V DPAKRIS+ + H
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNK-LKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 169 WF 170
+
Sbjct: 358 YI 359
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-13
Identities = 42/177 (23%), Positives = 60/177 (33%), Gaps = 40/177 (22%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKK 84
+ HRDLK EN L+ +K+ DFG ++ +S V T Y APEVLL+
Sbjct: 140 CIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVVTLWYRAPEVLLQS 194
Query: 85 EYDGKIADVWSCGVTLYVMLVGA--------------------YPFED--PEEPK----N 118
Y + D+WS G M P ED P +
Sbjct: 195 TYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 253
Query: 119 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
F R + + L+ + +P KRIS H + K+
Sbjct: 254 FPPRGPRPVQSVVP-----EMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-13
Identities = 42/215 (19%), Positives = 75/215 (34%), Gaps = 68/215 (31%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLLK- 83
N HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 122 NCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 84 KEYDGKIADVWSCGVTLYVMLVG------------------------------------- 106
+Y + DVW+ G +L G
Sbjct: 178 TQYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 107 -AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165
DPE+ + +IS L+ DP +R++ ++
Sbjct: 237 SGVKIPDPEDMEPLELKFP-------------NISYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 166 NHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 200
+H +F +N+ + +E D+P +++
Sbjct: 284 HHPYF-ENIRE-------IEDLAKEHDKPAENLYF 310
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 48/178 (26%), Positives = 72/178 (40%), Gaps = 43/178 (24%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 83
NV HRDLK N LL+ + LKICDFG ++ + V T Y APE++L
Sbjct: 148 NVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 84 -KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV------------ 129
K Y I D+WS G L ML F P K++ ++ IL +
Sbjct: 206 SKGYTKSI-DIWSVGCILAEMLSNRPIF-----PGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 130 ------QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
Y S+P + + + L+ ++ +P KRI + + H +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 35/146 (23%), Positives = 56/146 (38%), Gaps = 37/146 (25%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
HRD+K N ++ S +K+ DFG + S +Q + +GT Y++PE
Sbjct: 139 HRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 87 DGKIADVWSCGVTLYVMLVGAYPF--------------EDPEEPKNFRKTIHRILSVQYS 132
D + +DV+S G LY +L G PF EDP P
Sbjct: 197 DAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------------ 243
Query: 133 IPDYVHISPECRHLISRIFVADPAKR 158
+S + ++ + +P R
Sbjct: 244 -EG---LSADLDAVVLKALAKNPENR 265
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-13
Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 85
N+ HRD+K EN L+ S +K+CDFG++++ + V T Y APE+L+ +
Sbjct: 144 NIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRIL-----SVQ---YSIPDY 136
Y + DVW+ G + M +G F D + + + I L Q P +
Sbjct: 202 YGKAV-DVWAIGCLVTEMFMGEPLFPGDSDIDQLYH--IMMCLGNLIPRHQELFNKNPVF 258
Query: 137 V------------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 177
+S L + DP KR E+ +H++F + A+
Sbjct: 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE 317
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 33/83 (39%), Positives = 44/83 (53%), Gaps = 5/83 (6%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE + D
Sbjct: 134 HRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 89 KIADVWSCGVTLYVMLVGAYPFE 111
D++S G+ LY MLVG PF
Sbjct: 192 C-TDIYSIGIVLYEMLVGEPPFN 213
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 4e-13
Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 39/176 (22%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
V HRDLK +N L+ S ++K+ DFG ++ Q T V T Y APEVLL+
Sbjct: 140 RVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 86 YDGKIADVWSCGVTLYVMLVGA--------------------YPFED--PEE---PK-NF 119
Y + D+WS G M P E+ P + P+ F
Sbjct: 196 YATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 254
Query: 120 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
+ + + I + L+ + +PAKRIS +H +F ++L
Sbjct: 255 HSKSAQPIEKFVT-----DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDLE 304
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-13
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 64/230 (27%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-------VGTPAYI 76
NV HRDLK N L++ + LK+CDFG +S+ +S+P V T Y
Sbjct: 132 NVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 77 APEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV----- 129
APEV+L +Y + DVWSCG L + + F P +++R + I +
Sbjct: 190 APEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIF-----PGRDYRHQLLLIFGIIGTPH 243
Query: 130 --------------QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEI 164
+Y S+P + ++P+ L+ R+ V DPAKRI+ E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 165 RNHEWFLKNL-------PADLVVDNTTNNQFEEPDQPMQSI-----DEIM 202
H +L+ + + + + + + +EI
Sbjct: 304 LEHP-YLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-13
Identities = 46/187 (24%), Positives = 72/187 (38%), Gaps = 42/187 (22%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQP-KSTVGTPAYIAPEVLL 82
+ HRD+K N L+ LK+ DFG +S + + V T Y PE+LL
Sbjct: 144 KILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 201
Query: 83 -KKEYDGKIADVWSCGVTLYVMLVGA--------------------YPFED--PE----- 114
+++Y I D+W G + M + + P
Sbjct: 202 GERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260
Query: 115 --EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172
E K R + + YV P LI ++ V DPA+RI + NH++F
Sbjct: 261 LYEKLELVKGQKRKVKDRL--KAYV-RDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317
Query: 173 N-LPADL 178
+ +P+DL
Sbjct: 318 DPMPSDL 324
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 49/182 (26%), Positives = 74/182 (40%), Gaps = 48/182 (26%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 83
+ HRDLK N LLD G LK+ DFG +KS ++ + V T Y APE+L
Sbjct: 132 WILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 187
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILSV---------- 129
+ Y + D+W+ G L +L+ PF D ++ + RI
Sbjct: 188 RMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLDQ-------LTRIFETLGTPTEEQWP 238
Query: 130 -QYSIPDYV---------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173
S+PDYV + LI +F+ +P RI+ + ++F N
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SN 297
Query: 174 LP 175
P
Sbjct: 298 RP 299
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 41/214 (19%), Positives = 67/214 (31%), Gaps = 60/214 (28%)
Query: 28 NVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQPKST- 69
+ H DLK EN L S +++ DFG S+ + +T
Sbjct: 143 QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEHHTTI 199
Query: 70 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--YPFED--------------- 112
V T Y PEV+L+ + DVWS G L+ G + +
Sbjct: 200 VATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 113 ---------------------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 151
E + R ++ + + L+ R+
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318
Query: 152 VADPAKRISIPEIRNHEWFLKNLPADLVVDNTTN 185
DPA+RI++ E H +F P + + N
Sbjct: 319 EFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 5e-12
Identities = 36/190 (18%), Positives = 58/190 (30%), Gaps = 37/190 (19%)
Query: 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SS 60
RG +L T + + HRDL N L+ I DFG S
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPG 179
Query: 61 VLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVML---VGAYPFE 111
+ S VGT Y+APEVL E K D+++ G+ + + +P E
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 112 DPEE---------PKNFRKTIHRILSVQY----SIPDYVHISPECRHLISRIFV----AD 154
E + ++L + P+ + + D
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 155 PAKRISIPEI 164
R++
Sbjct: 300 AEARLTAQXA 309
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-12
Identities = 46/199 (23%), Positives = 63/199 (31%), Gaps = 60/199 (30%)
Query: 28 NVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQPKST- 69
+ H DLK EN L S P +K+ DFG S+ + ST
Sbjct: 138 KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDEHHSTL 194
Query: 70 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY---------------------VMLVGAY 108
V T Y APEV+L + DVWS G L ++G
Sbjct: 195 VSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 109 P------------FED-----PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 151
P F E R ++ + LI ++
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 152 VADPAKRISIPEIRNHEWF 170
DPAKRI++ E H +F
Sbjct: 314 EYDPAKRITLREALKHPFF 332
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 42/207 (20%), Positives = 66/207 (31%), Gaps = 67/207 (32%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------------------ 69
+ HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 129 GLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 70 ----VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG------------------ 106
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 107 -----------------------AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
+ + N R + ++ I + E
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWF 170
L+ ++ +P KRIS + H +
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 39/212 (18%), Positives = 59/212 (27%), Gaps = 78/212 (36%)
Query: 28 NVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSSVLHS 64
++ H DLK EN LLD +K+ DFG + S
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CATFKS 213
Query: 65 QPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG----------------- 106
+ + T Y APEV+L +D D+WS G L + G
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272
Query: 107 ----------------------------AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 138
+ + N K + + L + I
Sbjct: 273 SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH--- 329
Query: 139 ISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ I DP R S E+ H++
Sbjct: 330 --ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 40/220 (18%), Positives = 67/220 (30%), Gaps = 80/220 (36%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------------- 74
+ HRDLK N LL+ +K+CDFG +++
Sbjct: 149 GIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 75 ----------YIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG----------------- 106
Y APE++L + Y I D+WS G +L
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265
Query: 107 -------AYPFEDPEEPKNFRKTIHRILSV------------------QY--SIPD---- 135
K+ R ++ I ++ +Y P
Sbjct: 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPI 325
Query: 136 -----YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
Y IS + +L+ + +P KRI+I + +H +
Sbjct: 326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 32/166 (19%), Positives = 52/166 (31%), Gaps = 45/166 (27%)
Query: 47 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 106
++KI D G + +H + T Y + EVL+ Y+ AD+WS + + G
Sbjct: 233 LKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATG 289
Query: 107 AYPFE--DPEE------------------PKNF----------------RKTIHRI--LS 128
Y FE EE P+ K I ++
Sbjct: 290 DYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349
Query: 129 VQYSIPDYVHISPE----CRHLISRIFVADPAKRISIPEIRNHEWF 170
+ + + S E + + P KR + E H W
Sbjct: 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 43/228 (18%), Positives = 70/228 (30%), Gaps = 88/228 (38%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------------- 74
+ HRDLK N L++ +K+CDFG +++ S +
Sbjct: 176 GILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 75 ---------------YIAPEVLL-KKEYDGKIADVWSCGVTLYVML-------------- 104
Y APE++L ++ Y I DVWS G +L
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFAELLNMIKENVAYHADRG 292
Query: 105 ----------VGAYPFEDPEEPKNFRKTIH---RILSV------------------QY-- 131
+ + + R I ++ +Y
Sbjct: 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIR 352
Query: 132 SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
P + S + HL+ R+ V +P KRI+I E H +F
Sbjct: 353 IFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 6e-08
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 15/95 (15%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYIAPEVLLKKEY- 86
HRD+K N LLD + KI DFG ++ S ++ VGT AY+AP E
Sbjct: 156 HRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYMAP------EAL 207
Query: 87 DGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKN 118
G+I +D++S GV L ++ G ++ EP+
Sbjct: 208 RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 18/132 (13%), Positives = 32/132 (24%), Gaps = 32/132 (24%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88
V + S + + PA +
Sbjct: 150 VALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA--------N 180
Query: 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--ISPECRHL 146
D+ G +LY +LV +P + R + Q P + I + +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 147 ISRIFVADPAKR 158
+R D R
Sbjct: 240 AARSVQGDGGIR 251
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 35/86 (40%), Positives = 43/86 (50%), Gaps = 16/86 (18%)
Query: 29 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYIAPE-----V 80
+ HRD+K N LLD + P KI DFG SK Q STV GT YI PE
Sbjct: 160 IIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR 217
Query: 81 LLKKEYDGKIADVWSCGVTLYVMLVG 106
L +K +DV+S GV L+ +L
Sbjct: 218 LTEK------SDVYSFGVVLFEVLCA 237
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 3e-06
Identities = 26/80 (32%), Positives = 33/80 (41%), Gaps = 21/80 (26%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYIAPE-----V 80
HRD+K N LLD + DFG +K L + V GT +IAPE
Sbjct: 157 HRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211
Query: 81 LLKKEYDGKIADVWSCGVTL 100
+K DV+ GV L
Sbjct: 212 SSEK------TDVFGYGVML 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-06
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 11/104 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 82
HRDL N LL +KICDFG ++ ++ P A + APE +
Sbjct: 213 KCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKGDARLPLKWMAPETIF 268
Query: 83 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHR 125
+ Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 269 DRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 8e-06
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 7/86 (8%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLKKEYD 87
HRDL N L+ +P +KI DFG +K + G P ++A E +L + Y
Sbjct: 140 HRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 88 GKIADVWSCGVTLY-VMLVGAYPFED 112
+ +DVWS GVT++ +M G+ P++
Sbjct: 198 HQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 30/107 (28%), Positives = 41/107 (38%), Gaps = 12/107 (11%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI-----APEVLLKK 84
HRDL N L+ S A +KI DFG +K +L V P APE L
Sbjct: 150 HRDLAARNILV-ESEA-HVKIADFGLAK--LLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 130
+ + +DVWS GV LY + E + ++
Sbjct: 206 IFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 27/76 (35%), Positives = 37/76 (48%), Gaps = 9/76 (11%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKE 85
HRDL N L+ + R+KI DFG +K + + V P APE L + +
Sbjct: 137 HRDLATRNILV-ENEN-RVKIGDFGLTKV-LPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 86 YDGKIADVWSCGVTLY 101
+ +DVWS GV LY
Sbjct: 194 FSVA-SDVWSFGVVLY 208
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 6/88 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 85
N HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 86 YDGKIADVWSCGVTLY-VMLVGAYPFED 112
+ K +DVWS G+ L + G P+
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 25/89 (28%), Positives = 34/89 (38%), Gaps = 12/89 (13%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLKK 84
HRDL N LL + +KI DFG + L APE L +
Sbjct: 144 HRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
+ +D W GVTL+ + G P+
Sbjct: 200 TFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 27/76 (35%), Positives = 37/76 (48%), Gaps = 9/76 (11%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKE 85
HRDL N L+ + R+KI DFG +K + + V P APE L + +
Sbjct: 168 HRDLATRNILV-ENEN-RVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 86 YDGKIADVWSCGVTLY 101
+ +DVWS GV LY
Sbjct: 225 FSVA-SDVWSFGVVLY 239
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 6/88 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 85
N HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 86 YDGKIADVWSCGVTLY-VMLVGAYPFED 112
+ K +DVWS G+ L + G P+
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 24/88 (27%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 85
N HR+L N L+ + +K+ DFG S+ + APE L +
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 86 YDGKIADVWSCGVTLY-VMLVGAYPFED 112
+ K +DVW+ GV L+ + G P+
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 30/92 (32%), Positives = 41/92 (44%), Gaps = 12/92 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVL 81
N HRDL N LL + KI DFG SK L + K+ P + APE +
Sbjct: 137 NFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 82 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 112
++ K +DVWS GV ++ G P+
Sbjct: 193 NYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 19/153 (12%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 82
HRDL N L+ LKI DFG S+ + G + APE L
Sbjct: 233 CCIHRDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 83 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
Y + +DVWS G+ L+ +GA P+ + + ++T + +P
Sbjct: 289 YGRYSSE-SDVWSFGILLWETFSLGASPYPN----LSNQQTREFVEK-GGRLPCPELCPD 342
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174
L+ + + +P +R S I L+++
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTIY---QELQSI 372
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 39/186 (20%), Positives = 74/186 (39%), Gaps = 29/186 (15%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKE 85
HR+L N LL SP+ ++++ DFG + +L K + + A A E + +
Sbjct: 138 HRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 86 YDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRI-----LSVQYSIPDYVH- 138
Y + +DVWS GVT++ +M GA P+ + + L+ V+
Sbjct: 194 YTHQ-SDVWSYGVTVWELMTFGAEPYAG----LRLAEVPDLLEKGERLAQPQICTIDVYM 248
Query: 139 ISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTNNQFEEPDQPMQS 197
+ +C D R + E+ N ++ P LV+ + +P
Sbjct: 249 VMVKCWM-------IDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGL 301
Query: 198 IDEIMQ 203
++ ++
Sbjct: 302 TNKKLE 307
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 12/89 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 84
N HRDL N L+ K+ DFG +K + + + APE L +K
Sbjct: 309 NFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 361
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
++ K +DVWS G+ L+ + G P+
Sbjct: 362 KFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 12/92 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVL 81
N HRDL N LL + KI DFG SK L + + P + APE +
Sbjct: 130 NFVHRDLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 82 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 112
+++ + +DVWS GVT++ + G P++
Sbjct: 186 NFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-05
Identities = 31/89 (34%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 84
HRDL N L+D +K+ DFG ++ VL Q S+VGT + APEV
Sbjct: 124 QFIHRDLAARNCLVDRDLC--VKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
+Y K +DVW+ G+ ++ V +G P++
Sbjct: 181 KYSSK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-05
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 12/89 (13%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLKK 84
HR+L N LL + KI DFG SK L + + + APE + +
Sbjct: 459 HRNLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
++ + +DVWS GVT++ + G P++
Sbjct: 515 KFSSR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 7e-05
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 84
V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 124 CVIHRDLAARNCLVGENQV--IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
Y K +DVWS GV ++ V G P+E+
Sbjct: 181 RYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-05
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 7/86 (8%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLKKEYD 87
HRDL N L+ +P +KI DFG +K + G P ++A E +L + Y
Sbjct: 140 HRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 88 GKIADVWSCGVTLY-VMLVGAYPFED 112
+ +DVWS GVT++ +M G+ P++
Sbjct: 198 HQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-05
Identities = 28/76 (36%), Positives = 36/76 (47%), Gaps = 9/76 (11%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKE 85
HRDL N LL + +KI DFG +K+ V V APE L + +
Sbjct: 157 HRDLAARNVLL-DNDR-LVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 86 YDGKIADVWSCGVTLY 101
+ +DVWS GVTLY
Sbjct: 214 FYYA-SDVWSFGVTLY 228
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 9e-05
Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 8/90 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLK 83
HRDL N L+D + K+ DFG S+ +T G I APE +
Sbjct: 171 GYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 84 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 112
+ + +DVWS GV ++ V+ G P+ +
Sbjct: 229 RTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 9e-05
Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 21/153 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 82
HRDL N L+ + +KI DFG ++ +++ T + APE L
Sbjct: 223 KCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 278
Query: 83 KKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 139
+ Y + +DVWS GV ++ + +G YP EE K HR+ P +
Sbjct: 279 DRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM-----DKPA--NC 330
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNH-EWFL 171
+ E ++ + A P++R + ++ + L
Sbjct: 331 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 8/89 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 84
N HRDL+ N L+ S KI DFG ++ + ++ + G I APE +
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
+ K +DVWS G+ L ++ G P+
Sbjct: 361 SFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 8/89 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLKK 84
N HRDL N L+ + +K+ DFG S+ + + G P + APE L
Sbjct: 131 NFIHRDLAARNCLVGENHL--VKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
++ K +DVW+ GV L+ + G P+
Sbjct: 188 KFSIK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 35/176 (19%), Positives = 66/176 (37%), Gaps = 21/176 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 82
HRDL N ++ + +KI DFG ++ ++ G + +PE L
Sbjct: 158 KFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESLK 213
Query: 83 KKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 139
+ +DVWS GV L+ + + Y E+ F + PD +
Sbjct: 214 DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL-----DKPD--NC 265
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTNNQFEEPDQP 194
L+ + +P R S EI + + ++ ++ + N+ EP++
Sbjct: 266 PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEEL 321
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 1e-04
Identities = 45/292 (15%), Positives = 83/292 (28%), Gaps = 98/292 (33%)
Query: 20 FWSELLPFNVCHRD---LKLENTLL-----------DGSPAPRLKICDFGYSKSSVLHSQ 65
FW L C+ L++ LL D S +L+I +L S+
Sbjct: 185 FW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 66 PKSTVGTPAYIAPEVLLKKEYDGKI-ADVWS----------C---------GVTLYVMLV 105
P Y LL + +V + C VT ++
Sbjct: 242 P--------Y--ENCLL-------VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 106 GAY---------PFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISP--------ECRHLI 147
E K + Q +P V +P R +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLD--CRPQ-DLPREVLTTNPRRLSIIAESIRDGL 341
Query: 148 SRIFVADPAKRISIPEIRNH-EWFLKNL-PADLVVDNTTNNQFEE----PDQ---PMQSI 198
+ D K ++ ++ E L L PA+ F+ P P
Sbjct: 342 ATW---DNWKHVNCDKLTTIIESSLNVLEPAEY------RKMFDRLSVFPPSAHIPTI-- 390
Query: 199 DEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEI 250
++ +I I + +N+ SL ++ + E + P + ++ ++
Sbjct: 391 --LLSLIWFDVIKSDVMVVVNKLHKYSL-VEKQPKESTISIPSIYLELKVKL 439
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 37/179 (20%), Positives = 66/179 (36%), Gaps = 25/179 (13%)
Query: 31 HRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKK 84
HRD+ N LL R+ KI DFG ++ ++ G A + PE ++
Sbjct: 204 HRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKWMPPEAFMEG 261
Query: 85 EYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
+ K D WS GV L+ + +G YP + +E F + R+ P +
Sbjct: 262 IFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-----DPPK--NCPG 313
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 200
++++ + P R + I ++ D + N P+ +E
Sbjct: 314 PVYRIMTQCWQHQPEDRPNFAIIL---ERIEYCTQD---PDVINTALPIEYGPLVEEEE 366
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 10/90 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 81
+ HRD+ N LL R+ KI DFG ++ ++ G A + PE
Sbjct: 160 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 82 LKKEYDGKIADVWSCGVTLY-VMLVGAYPF 110
++ + K D WS GV L+ + +G P+
Sbjct: 218 MEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 12/92 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVL 81
HRDL N L++ + K+ DFG + VL P +T G I +PE +
Sbjct: 167 GYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 82 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 112
+++ +DVWS G+ L+ VM G P+ +
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 21/166 (12%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 82
N HRDL N +L + + DFG S+ ++S G + + A E L
Sbjct: 157 NFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYYRQGCASKLPVKWLALESLA 212
Query: 83 KKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 139
Y +DVW+ GVT++ +M G Y + E N+ +R+ P
Sbjct: 213 DNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL-----KQPPEC-- 264
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTT 184
E L+ + + ADP +R S +R E L +L +
Sbjct: 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 27/77 (35%), Positives = 40/77 (51%), Gaps = 11/77 (14%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI-----APEVLLKK 84
HRDL N L+ S ++KI DFG +K + + + TV APE L++
Sbjct: 149 HRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 85 EYDGKIADVWSCGVTLY 101
++ +DVWS GVTL+
Sbjct: 205 KFYIA-SDVWSFGVTLH 220
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 31 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLKKEY 86
HRDL N L++ + K+ DFG S+ + +T G I APE + +++
Sbjct: 170 HRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 87 DGKIADVWSCGVTLY-VMLVGAYPFED 112
+DVWS G+ ++ VM G P+ +
Sbjct: 228 TSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 27/89 (30%), Positives = 41/89 (46%), Gaps = 12/89 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 84
N HRDL N L+ S K+ DFG +K + + + APE L +K
Sbjct: 137 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 189
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
++ K +DVWS G+ L+ + G P+
Sbjct: 190 KFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 8/89 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 84
N HRDL+ N L+ + + KI DFG ++ + ++ + G I APE +
Sbjct: 129 NYIHRDLRAANILVSDTLS--CKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
+ K +DVWS G+ L ++ G P+
Sbjct: 186 TFTIK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 42/157 (26%), Positives = 65/157 (41%), Gaps = 21/157 (13%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 82
N HRDL N +L + + DFG SK ++S G A + A E L
Sbjct: 167 NFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLA 222
Query: 83 KKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 139
+ Y K +DVW+ GVT++ + G YP E ++ HR+ P+
Sbjct: 223 DRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL-----KQPE--DC 274
Query: 140 SPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLP 175
E ++ + DP R + +R E L++LP
Sbjct: 275 LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 2e-04
Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 8/89 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 84
HRDL N L++ +K+ DFG S+ VL + S+VG+ + PEVL+
Sbjct: 140 QFLHRDLAARNCLVNDQGV--VKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 85 EYDGKIADVWSCGVTLY-VMLVGAYPFED 112
++ K +D+W+ GV ++ + +G P+E
Sbjct: 197 KFSSK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 5e-04
Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 11/88 (12%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 82
N HRD+ N LL + KI DFG ++ + + V A + APE +
Sbjct: 184 NCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMNDSNYIVKGNARLPVKWMAPESIF 239
Query: 83 KKEYDGKIADVWSCGVTLY-VMLVGAYP 109
Y + +DVWS G+ L+ + +G P
Sbjct: 240 DCVYTVQ-SDVWSYGILLWEIFSLGLNP 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 9e-04
Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 11/88 (12%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 82
N HRDL N LL KICDFG ++ + + V A + APE +
Sbjct: 165 NCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKNDSNYVVKGNARLPVKWMAPESIF 220
Query: 83 KKEYDGKIADVWSCGVTLY-VMLVGAYP 109
Y + +DVWS G+ L+ + +G+ P
Sbjct: 221 NCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 254 | |||
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.98 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.98 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.83 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.61 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.36 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.08 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.66 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.51 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.2 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.45 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 95.05 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.67 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.03 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 93.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.38 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 93.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 93.0 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 92.72 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 92.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.58 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 89.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 89.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.14 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 87.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.07 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.5 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 80.52 |
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=333.80 Aligned_cols=245 Identities=73% Similarity=1.184 Sum_probs=150.4
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....++.|++.+|+|||++||+||||||+|||++.++.+++||+|||+++...........+||+.|+|||++.+..+++
T Consensus 117 ~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 196 (361)
T 3uc3_A 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196 (361)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCH
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCC
Confidence 34567889999999999999999999999999987766679999999997554444455668999999999998888877
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+++|||||||++|+|++|+.||.+..........+..+.......+....+++.+++||.+||..||.+|||+.++++||
T Consensus 197 ~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 76899999999999999999999876666666677777777777777777899999999999999999999999999999
Q ss_pred cccccCCccccccCCCCCCCCCCCCCCCCHHHHHHHHHHhCCCCCCCCchhhhhcCCCCCcccccccCCCCCCCCCCCCC
Q 025350 169 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSG 248 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~d~d~~g 248 (254)
||++.++............+..+.++.++.+.+++.+.+..++........+......+.||+++ +++++++.|.|++|
T Consensus 277 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~~~-~~d~~~~~d~d~~g 355 (361)
T 3uc3_A 277 WFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMD-DFDSESEIDIDSSG 355 (361)
T ss_dssp HHHTTCCCC------------------CCHHHHHHHHHHHTCC-------------------------------------
T ss_pred chhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCcccccccchhccccccccccccc-cccchhhhccCCCC
Confidence 99999888776666666677778888999999999999999988766665555555445444333 34555677999999
Q ss_pred ceeecC
Q 025350 249 EIVYAM 254 (254)
Q Consensus 249 ~~~~~~ 254 (254)
+|+|||
T Consensus 356 ~~~~~~ 361 (361)
T 3uc3_A 356 EIVYAL 361 (361)
T ss_dssp ------
T ss_pred cEEecC
Confidence 999997
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=303.13 Aligned_cols=160 Identities=39% Similarity=0.645 Sum_probs=125.6
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+.........+.+||+.|+|||++.+..+++
T Consensus 113 ~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~ 190 (275)
T 3hyh_A 113 EARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190 (275)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------------CTTSCHHHHSSSSCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCC
Confidence 34567899999999999999999999999999988776 9999999998765555556778999999999999888876
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
.++|||||||++|+|++|+.||.+.+... ....+......+|. .+|+++++||.+||+.||++|||++|+++||
T Consensus 191 ~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 191 PEVDVWSCGVILYVMLCRRLPFDDESIPV----LFKNISNGVYTLPK--FLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred ChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 66999999999999999999998755433 33334444444443 5899999999999999999999999999999
Q ss_pred cccccCCc
Q 025350 169 WFLKNLPA 176 (254)
Q Consensus 169 ~~~~~~~~ 176 (254)
||+..+|.
T Consensus 265 w~k~~~p~ 272 (275)
T 3hyh_A 265 WFKVDLPE 272 (275)
T ss_dssp HHHTTCCG
T ss_pred ccccCCCh
Confidence 99877654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=301.26 Aligned_cols=163 Identities=27% Similarity=0.474 Sum_probs=134.8
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
.....++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++.+..|
T Consensus 170 ~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y 247 (346)
T 4fih_A 170 EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY 247 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCC
Confidence 334567899999999999999999999999999988776 999999999865443 33456789999999999998888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|||||||++|+|++|++||.+.+....+..+.. ......+.+..+|+++++||.+||.+||++|||+.|+|+
T Consensus 248 ~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 248 GPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 665 9999999999999999999988665444433221 122334445568999999999999999999999999999
Q ss_pred CccccccCCc
Q 025350 167 HEWFLKNLPA 176 (254)
Q Consensus 167 hp~~~~~~~~ 176 (254)
||||++..++
T Consensus 324 Hp~~~~~~~p 333 (346)
T 4fih_A 324 HPFLAKAGPP 333 (346)
T ss_dssp CGGGGGCCCG
T ss_pred CHhhcCCCCC
Confidence 9999876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=301.63 Aligned_cols=162 Identities=27% Similarity=0.476 Sum_probs=134.6
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.|++.||+|||++|||||||||+||||+.++. +||+|||+|+..... ....+.+||+.|||||++.+..|+
T Consensus 248 ~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~ 325 (423)
T 4fie_A 248 QIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 325 (423)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCC
Confidence 34567899999999999999999999999999988776 999999999865433 334567899999999999988887
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
.+ +|||||||++|+|++|++||.+......+..+.. ......+.+..+|+++++||.+||.+||.+|||+.|+|+|
T Consensus 326 ~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 326 PE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 65 9999999999999999999988665444433221 2223344556789999999999999999999999999999
Q ss_pred ccccccCCc
Q 025350 168 EWFLKNLPA 176 (254)
Q Consensus 168 p~~~~~~~~ 176 (254)
|||++..++
T Consensus 402 p~~~~~~~p 410 (423)
T 4fie_A 402 PFLAKAGPP 410 (423)
T ss_dssp GGGGGCCCG
T ss_pred HHhcCCCCC
Confidence 999875543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=294.47 Aligned_cols=156 Identities=29% Similarity=0.504 Sum_probs=130.2
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~ 84 (254)
.....++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++.+.
T Consensus 132 ~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~ 209 (311)
T 4aw0_A 132 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS
T ss_pred HHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC
Confidence 334567899999999999999999999999999988776 999999999865332 234566899999999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH-
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE- 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e- 163 (254)
.|+.+ +|||||||++|+|++|++||.+.+.... ..++....+.+|. .+|+++++||.+||.+||.+|||++|
T Consensus 210 ~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 210 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEGLI----FAKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp CBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred CCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 88655 9999999999999999999988655433 3334455555554 58999999999999999999999988
Q ss_pred -----HhcCccccc
Q 025350 164 -----IRNHEWFLK 172 (254)
Q Consensus 164 -----~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 283 ~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 283 EGYGPLKAHPFFES 296 (311)
T ss_dssp TCHHHHHTSGGGTT
T ss_pred cCCHHHHCCCCcCC
Confidence 589999965
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=290.36 Aligned_cols=155 Identities=25% Similarity=0.406 Sum_probs=124.1
Q ss_pred cCCcHHHHHHHHHHHhhcC--cccCCCCCCcEEecC-CCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFN--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.||+|||++| ||||||||+|||++. ++. +||+|||+|+... .....+.+||+.|||||++.+ .|
T Consensus 131 ~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~-~y 206 (290)
T 3fpq_A 131 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KY 206 (290)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CC
T ss_pred HHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeCC-CCccCCcccCccccCHHHcCC-CC
Confidence 3457889999999999999 999999999999974 444 9999999997532 333456689999999999865 57
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|||||||++|+|+||+.||.+......... .+............+++++++||.+||..||.+|||++++|+
T Consensus 207 ~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 207 DES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH---HHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 655 9999999999999999999987655443332 233332222223457899999999999999999999999999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
||||++
T Consensus 283 Hp~~~~ 288 (290)
T 3fpq_A 283 HAFFQE 288 (290)
T ss_dssp SGGGC-
T ss_pred CccccC
Confidence 999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=291.42 Aligned_cols=155 Identities=34% Similarity=0.581 Sum_probs=128.7
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++.+..|+
T Consensus 127 ~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 204 (304)
T 3ubd_A 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCccccccccCcccCCHHHhccCCCC
Confidence 34567889999999999999999999999999988776 999999999864332 334567899999999999988887
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----Hh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IP 162 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~ 162 (254)
.+ +|||||||++|+|++|+.||.+.+...... .+.......| ..+|+++++||++||++||++||| ++
T Consensus 205 ~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~ 277 (304)
T 3ubd_A 205 QS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMT----MILKAKLGMP--QFLSPEAQSLLRMLFKRNPANRLGAGPDGVE 277 (304)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHH
T ss_pred CC-CcccchHHHHHHHHhCCCCCCCcCHHHHHH----HHHcCCCCCC--CcCCHHHHHHHHHHcccCHHHCCCCCcCCHH
Confidence 65 999999999999999999999866544333 3444444444 358999999999999999999998 47
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
|+++||||+.
T Consensus 278 eil~Hp~f~~ 287 (304)
T 3ubd_A 278 EIKRHSFFST 287 (304)
T ss_dssp HHHTSGGGTT
T ss_pred HHHcCccccC
Confidence 9999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=299.73 Aligned_cols=157 Identities=26% Similarity=0.448 Sum_probs=130.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+...... ...+.+||+.|||||++.+..|+.+
T Consensus 128 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~ 205 (350)
T 4b9d_A 128 LDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK 205 (350)
T ss_dssp HHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHH
T ss_pred HHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcH
Confidence 457889999999999999999999999999988776 9999999998654322 1234579999999999998888765
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+|||||||++|+|++|+.||.+.+....+.+ +....+ .+.+..+|+++++||.+||.+||.+|||+.|+|+|||
T Consensus 206 -~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 206 -SDIWALGCVLYELCTLKHAFEAGSMKNLVLK----IISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp -HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred -HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 9999999999999999999998665444333 333332 2334568999999999999999999999999999999
Q ss_pred ccccCC
Q 025350 170 FLKNLP 175 (254)
Q Consensus 170 ~~~~~~ 175 (254)
|++...
T Consensus 280 ~~~~~~ 285 (350)
T 4b9d_A 280 IAKRIE 285 (350)
T ss_dssp HHTTGG
T ss_pred hhcCCC
Confidence 987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=292.28 Aligned_cols=165 Identities=23% Similarity=0.279 Sum_probs=132.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-----CCCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~~~~~y~aPE~~~~~ 84 (254)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|+|||++.+.
T Consensus 160 ~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~ 237 (398)
T 4b99_A 160 VRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 237 (398)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecccCccccccccccceeChHhcCHHHhcCC
Confidence 4567899999999999999999999999999988776 999999999864322 234466899999999999887
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC----------------CCC---------CCCC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS----------------IPD---------YVHI 139 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------~~~---------~~~~ 139 (254)
.+.+.++||||+||++|+|++|++||.+.+....+..+.......... .+. +..+
T Consensus 238 ~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
T 4b99_A 238 HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGA 317 (398)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTC
T ss_pred CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCC
Confidence 665666999999999999999999999887766665554432211100 010 2347
Q ss_pred CHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 140 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
++++++||.+||.+||.+|||+.|+|+||||++...+
T Consensus 318 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 318 DRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 8999999999999999999999999999999876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=290.85 Aligned_cols=162 Identities=25% Similarity=0.433 Sum_probs=121.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC--------------------------
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------------------------- 63 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-------------------------- 63 (254)
...++.|++.||+|||++|||||||||+|||++.+. +.+||+|||+|+.....
T Consensus 119 ~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (361)
T 4f9c_A 119 VREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGGGGGC------------------
T ss_pred HHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccccccccccccccccccccccccc
Confidence 456788999999999999999999999999998653 35999999999743221
Q ss_pred ---CCCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHH--------------
Q 025350 64 ---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHR-------------- 125 (254)
Q Consensus 64 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~-------------- 125 (254)
....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||....+... +..+...
T Consensus 198 ~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~ 277 (361)
T 4f9c_A 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFG 277 (361)
T ss_dssp --------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred cccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcc
Confidence 1123457999999999998876555669999999999999999999976543322 2221110
Q ss_pred --------------------Hhcc--------------CCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccc
Q 025350 126 --------------------ILSV--------------QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 171 (254)
Q Consensus 126 --------------------~~~~--------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 171 (254)
.... ......+..+|+++++||++||.+||++|+|++|+|+||||+
T Consensus 278 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~ 357 (361)
T 4f9c_A 278 KSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFK 357 (361)
T ss_dssp EEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred ccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 0000 011123456899999999999999999999999999999997
Q ss_pred c
Q 025350 172 K 172 (254)
Q Consensus 172 ~ 172 (254)
+
T Consensus 358 ~ 358 (361)
T 4f9c_A 358 D 358 (361)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=285.82 Aligned_cols=159 Identities=23% Similarity=0.250 Sum_probs=125.9
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC------CCCCcCCCCcccchhcc
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ------PKSTVGTPAYIAPEVLL 82 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~------~~~~~~~~~y~aPE~~~ 82 (254)
....++.|++.||+|||++|||||||||+|||++.++. ++||+|||+|+....... ....+||+.|||||++.
T Consensus 151 ~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 229 (336)
T 4g3f_A 151 RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229 (336)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC------------CCCCCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC
Confidence 34567899999999999999999999999999987652 499999999986543221 23357999999999999
Q ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC-CCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-PDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 83 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
+..|+.+ +|||||||++|+|++|++||.+........++.. ..... ..+..+|+.+++||.+||.+||.+|||+
T Consensus 230 ~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa 304 (336)
T 4g3f_A 230 GKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASA 304 (336)
T ss_dssp TCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCH
Confidence 9888766 9999999999999999999988665444443332 22111 2234689999999999999999999999
Q ss_pred hHH-------------hcCcccccc
Q 025350 162 PEI-------------RNHEWFLKN 173 (254)
Q Consensus 162 ~e~-------------l~hp~~~~~ 173 (254)
.|+ ++|||+.+.
T Consensus 305 ~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 305 MELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHHHHHhhhhhccCCCcCCC
Confidence 997 578998653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=275.39 Aligned_cols=151 Identities=23% Similarity=0.384 Sum_probs=112.6
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-------------CCCCCcCCCCcccc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYIAP 78 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~~~~y~aP 78 (254)
.++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+...... ...+.+||+.||||
T Consensus 122 ~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP 199 (299)
T 4g31_A 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199 (299)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCCCC--------------------------CCCTTSCH
T ss_pred HHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCccceecCCCccccccccccccccccCCcccCccccCH
Confidence 47789999999999999999999999999988776 9999999998643321 12335799999999
Q ss_pred hhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCC
Q 025350 79 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 79 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
|++.+..|+.+ +|||||||++|+|++ ||.+.. .....+..+..... .+.+...++.+++||++||+.||.+|
T Consensus 200 E~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~---~~~~~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~R 271 (299)
T 4g31_A 200 EQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQM---ERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMER 271 (299)
T ss_dssp HHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHH---HHHHHHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGS
T ss_pred HHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCcc---HHHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHC
Confidence 99998888765 999999999999996 776421 11222222222221 11222356778999999999999999
Q ss_pred CCHhHHhcCccccc
Q 025350 159 ISIPEIRNHEWFLK 172 (254)
Q Consensus 159 ps~~e~l~hp~~~~ 172 (254)
||+.++++||||++
T Consensus 272 ps~~eil~h~~~~~ 285 (299)
T 4g31_A 272 PEAINIIENAVFED 285 (299)
T ss_dssp CCHHHHHTSGGGCC
T ss_pred cCHHHHhcCHhhCC
Confidence 99999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=295.69 Aligned_cols=158 Identities=28% Similarity=0.416 Sum_probs=129.5
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC-CC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EY 86 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~ 86 (254)
.....++.|++.||+|||++|||||||||+||||+.++. +||+|||+|+.... ....+.+||+.|||||++.++ .|
T Consensus 292 ~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~-~~~~t~~GTp~YmAPEvl~~~~~y 368 (689)
T 3v5w_A 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAY 368 (689)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-CCCCSCCSCGGGCCHHHHSTTCCC
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC-CCCCCccCCcCccCHHHHhCCCCC
Confidence 344567899999999999999999999999999998876 99999999986543 345677999999999999754 55
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----H
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----I 161 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~ 161 (254)
+. ++|+|||||++|+|++|.+||.+..... ...+...+.......| ..+|+++++||.+||.+||.+|++ +
T Consensus 369 ~~-~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p--~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga 444 (689)
T 3v5w_A 369 DS-SADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGA 444 (689)
T ss_dssp CT-HHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSCGGGCTTCSSSTH
T ss_pred Cc-HHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCC--ccCCHHHHHHHHHHccCCHhHCCCCCCCCH
Confidence 54 5999999999999999999997643322 2233444445555444 358999999999999999999998 7
Q ss_pred hHHhcCccccc
Q 025350 162 PEIRNHEWFLK 172 (254)
Q Consensus 162 ~e~l~hp~~~~ 172 (254)
++|++||||+.
T Consensus 445 ~ei~~HpfF~~ 455 (689)
T 3v5w_A 445 QEVKESPFFRS 455 (689)
T ss_dssp HHHTTSGGGTT
T ss_pred HHHhcCccccC
Confidence 99999999974
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=270.58 Aligned_cols=156 Identities=22% Similarity=0.289 Sum_probs=118.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCC--
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKK-- 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~-- 84 (254)
+..++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... ......+||+.|||||++.+.
T Consensus 134 ~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~ 211 (307)
T 3omv_A 134 LIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC------------CCCCTTSCCHHHHHCCSS
T ss_pred HHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCcceeecccccCCCccCHHHhhccCC
Confidence 4567889999999999999999999999999998775 999999999854322 223456899999999998643
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 -EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 -~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
+|+. ++|||||||++|||+||+.||.+..........+............+..+|+.+++||.+||+.||.+|||+.+
T Consensus 212 ~~y~~-ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 290 (307)
T 3omv_A 212 NPFSF-QSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQ 290 (307)
T ss_dssp CCCCH-HHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHH
T ss_pred CCCCc-HHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 3544 49999999999999999999988766544443332211111111223468999999999999999999999998
Q ss_pred HhcCc
Q 025350 164 IRNHE 168 (254)
Q Consensus 164 ~l~hp 168 (254)
++++.
T Consensus 291 i~~~L 295 (307)
T 3omv_A 291 ILSSI 295 (307)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 86553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.07 Aligned_cols=160 Identities=27% Similarity=0.447 Sum_probs=134.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.||+|||++||+||||||+|||++.+..+.+||+|||+|+.........+.+||+.|+|||++.+..|+.+
T Consensus 257 ~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~ 336 (573)
T 3uto_A 257 AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336 (573)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHH
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcH
Confidence 45678999999999999999999999999999866445699999999987655555556789999999999999888655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC--CCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|||||||++|+|++|.+||.+......+.. +......+ +.+..+|+++++||++||..||.+|||+.|+|+|
T Consensus 337 -~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 337 -TDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999998765444333 33333333 3345789999999999999999999999999999
Q ss_pred ccccccC
Q 025350 168 EWFLKNL 174 (254)
Q Consensus 168 p~~~~~~ 174 (254)
|||+...
T Consensus 412 pw~~~~~ 418 (573)
T 3uto_A 412 PWLTPGN 418 (573)
T ss_dssp TTTSCCC
T ss_pred cCcCCCC
Confidence 9998643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=269.68 Aligned_cols=150 Identities=23% Similarity=0.387 Sum_probs=123.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.|++|||+++||||||||+|||++.++. +||+|||+|+....... ....+||+.|||||++.+..|+
T Consensus 188 ~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~ 265 (353)
T 4ase_A 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 265 (353)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence 456789999999999999999999999999988776 99999999986543322 2344689999999999988887
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|||+| |+.||.+......+...+.. ....+.+..+++++++||.+||+.||.+|||+.+|++
T Consensus 266 ~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~----g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~ 340 (353)
T 4ase_A 266 IQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 340 (353)
T ss_dssp HH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc----CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 65 999999999999998 99999887654444443332 2233444568999999999999999999999999998
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
|
T Consensus 341 ~ 341 (353)
T 4ase_A 341 H 341 (353)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=262.87 Aligned_cols=158 Identities=34% Similarity=0.583 Sum_probs=133.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||++............+||+.|+|||++.+..+.+.
T Consensus 116 ~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 193 (328)
T 3fe3_A 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193 (328)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSH
T ss_pred HHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCc
Confidence 3467889999999999999999999999999988776 99999999986655555566789999999999998888767
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|||||||++|+|++|+.||.+...... ...+.......|. .+++.+.+||++||..||.+|||++++++|||
T Consensus 194 ~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 194 EVDVWSLGVILYTLVSGSLPFDGQNLKEL----RERVLRGKYRIPF--YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred hhhhhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 79999999999999999999988654333 3334444555554 47999999999999999999999999999999
Q ss_pred ccccCC
Q 025350 170 FLKNLP 175 (254)
Q Consensus 170 ~~~~~~ 175 (254)
|+....
T Consensus 268 ~~~~~~ 273 (328)
T 3fe3_A 268 INAGHE 273 (328)
T ss_dssp TTTTCT
T ss_pred hcCCCc
Confidence 987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=263.19 Aligned_cols=150 Identities=22% Similarity=0.329 Sum_probs=116.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+..++.|++.|++|||+++||||||||+|||++.++. +||+|||+|+...... .....+||+.|||||++.+..+
T Consensus 160 ~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~ 237 (329)
T 4aoj_A 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237 (329)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC----------------CCCCGGGCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EEEcccccceeccCCCcceecCcccccccccChhhhcCCCC
Confidence 4567899999999999999999999999999998775 9999999998643322 2234579999999999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|||+| |+.||.+.+....... +... ...+.+..+|+++.+|+.+||+.||++|||+.+|+
T Consensus 238 ~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----i~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 311 (329)
T 4aoj_A 238 TTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC----ITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVH 311 (329)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH----HHHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred Ccc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHH----HHcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 765 999999999999999 8999998765443332 2222 23344456899999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
++
T Consensus 312 ~~ 313 (329)
T 4aoj_A 312 AR 313 (329)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=261.94 Aligned_cols=149 Identities=19% Similarity=0.276 Sum_probs=122.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.|++|||+++||||||||+|||++.++. +||+|||+|+...... .....+||+.|||||++.+..++
T Consensus 148 ~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s 225 (308)
T 4gt4_A 148 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS 225 (308)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC
Confidence 457889999999999999999999999999988776 9999999998543322 23445799999999999988887
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|||+| |..||.+.+...... .+.. ....|.+..+|+.+.+|+.+||+.||.+|||+.+|++
T Consensus 226 ~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~----~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 226 ID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE----MIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp HH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH----HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 65 999999999999998 899999876543332 2222 2334455678999999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 300 ~ 300 (308)
T 4gt4_A 300 R 300 (308)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=265.26 Aligned_cols=164 Identities=26% Similarity=0.289 Sum_probs=126.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC----------------------CCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL----------------------HSQPKS 68 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~----------------------~~~~~~ 68 (254)
..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+.... ......
T Consensus 112 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (388)
T 3oz6_A 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189 (388)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCCCCCCCGGGCCC---------------
T ss_pred HHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccccccccccccccccccccccccccccC
Confidence 456789999999999999999999999999988776 99999999975422 111233
Q ss_pred CcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-----------------
Q 025350 69 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----------------- 131 (254)
Q Consensus 69 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------- 131 (254)
.+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..+.........
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~ 269 (388)
T 3oz6_A 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES 269 (388)
T ss_dssp CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHH
T ss_pred CcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh
Confidence 579999999999987444445599999999999999999999987766655554422111000
Q ss_pred ------------------------CCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 132 ------------------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 132 ------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
.......+++.+.+||.+||..||.+|||+.++|+||||+.....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 270 LKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338 (388)
T ss_dssp HHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCG
T ss_pred CcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCC
Confidence 000112578999999999999999999999999999999875543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=262.85 Aligned_cols=154 Identities=21% Similarity=0.280 Sum_probs=123.8
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 85 (254)
.+..++.|++.|++|||+++||||||||+|||++.++. +||+|||+|+....... .....||+.|||||++.+..
T Consensus 129 ~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~ 206 (299)
T 4asz_A 129 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 206 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC
Confidence 34568899999999999999999999999999988776 99999999975433221 22346899999999999888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
|+.+ +|||||||++|||+| |+.||.+.+....... +.... ..+.+..+|+++.+||.+||+.||++|||+.++
T Consensus 207 ~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 207 FTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC----ITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8765 999999999999998 8999998765443332 22222 233445689999999999999999999999999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
+ +|+++
T Consensus 281 ~--~~L~~ 286 (299)
T 4asz_A 281 H--TLLQN 286 (299)
T ss_dssp H--HHHHH
T ss_pred H--HHHHH
Confidence 4 56643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=269.77 Aligned_cols=164 Identities=27% Similarity=0.381 Sum_probs=125.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+...........+||+.|+|||++.+..++.+
T Consensus 166 ~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 243 (464)
T 3ttj_A 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243 (464)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHH
Confidence 3457889999999999999999999999999988776 99999999987655545566789999999999998888765
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC---------------CCCCCCCC----------------
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSIPDYVH---------------- 138 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~---------------- 138 (254)
+|||||||++|+|++|+.||.+.+....+..++....... ...+....
T Consensus 244 -~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (464)
T 3ttj_A 244 -VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS 322 (464)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSS
T ss_pred -HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccc
Confidence 9999999999999999999998776665555443221110 00010000
Q ss_pred -----CCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 139 -----ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 139 -----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
.++.+++||.+||..||.+|||++|+|+||||+....+
T Consensus 323 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 323 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred ccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 14678999999999999999999999999999876544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=252.12 Aligned_cols=161 Identities=26% Similarity=0.304 Sum_probs=130.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++............||+.|+|||++.+..++.+
T Consensus 122 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 199 (308)
T 3g33_A 122 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP 199 (308)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeCccccccCCCcccCCccccccccCchHHcCCCCCch
Confidence 4557899999999999999999999999999987775 99999999987655555556689999999999988888665
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-CCC--------------------CCCCCCHHHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIP--------------------DYVHISPECRHLIS 148 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--------------------~~~~~~~~~~~li~ 148 (254)
+|||||||++|+|++|+.||.+................... .++ ....+++.+.+||.
T Consensus 200 -~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (308)
T 3g33_A 200 -VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL 278 (308)
T ss_dssp -HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHH
T ss_pred -HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHH
Confidence 99999999999999999999987766665555443221110 000 01357899999999
Q ss_pred HhchhCCCCCCCHhHHhcCcccccc
Q 025350 149 RIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 149 ~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+||..||.+|||+.++|+||||++.
T Consensus 279 ~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 279 EMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHhcCCCccCCCHHHHhcCccccCC
Confidence 9999999999999999999999763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=258.09 Aligned_cols=159 Identities=43% Similarity=0.686 Sum_probs=131.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||++............+||+.|+|||++.+..+.+.
T Consensus 110 ~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 187 (336)
T 3h4j_B 110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCH
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCC
Confidence 4567889999999999999999999999999988765 99999999987666555667789999999999988877666
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|||||||++|+|++|+.||.+....... ..+....... +..+++.+++||++||..||.+|||+.++++|||
T Consensus 188 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNSCVYVM--PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCSSCCCC--CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred ccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCCCC--cccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 699999999999999999999875432211 1111222222 3357999999999999999999999999999999
Q ss_pred ccccCCc
Q 025350 170 FLKNLPA 176 (254)
Q Consensus 170 ~~~~~~~ 176 (254)
|+...+.
T Consensus 262 ~~~~~~~ 268 (336)
T 3h4j_B 262 FNVNLPD 268 (336)
T ss_dssp HHTTCCG
T ss_pred hccCCcc
Confidence 9876654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=250.11 Aligned_cols=161 Identities=25% Similarity=0.330 Sum_probs=126.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+....+
T Consensus 121 ~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 198 (311)
T 3niz_A 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCC
Confidence 3456889999999999999999999999999988776 9999999997654322 234457899999999997754444
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC-CC-----------------------CCCCCCHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IP-----------------------DYVHISPECR 144 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-----------------------~~~~~~~~~~ 144 (254)
.++|||||||++|+|++|+.||.+.................... ++ ....++++++
T Consensus 199 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (311)
T 3niz_A 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGI 278 (311)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHH
T ss_pred chHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHH
Confidence 55999999999999999999998877666555544332211100 00 0124678999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
+||.+||..||.+|||+.++++||||++
T Consensus 279 ~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 279 DLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 9999999999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=252.48 Aligned_cols=154 Identities=33% Similarity=0.573 Sum_probs=127.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 107 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 184 (337)
T 1o6l_A 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCc
Confidence 3456789999999999999999999999999988776 99999999985332 23345567999999999998888765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e 163 (254)
+ +|+|||||++|+|++|..||.+....... ..+......+|. .+++++++||.+||..||.+|| ++.+
T Consensus 185 ~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~e 257 (337)
T 1o6l_A 185 A-VDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257 (337)
T ss_dssp T-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred h-hhcccchhHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHH
Confidence 5 99999999999999999999876543333 233334444443 5899999999999999999999 8999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 258 i~~h~~f~~ 266 (337)
T 1o6l_A 258 VMEHRFFLS 266 (337)
T ss_dssp HHTSGGGTT
T ss_pred HHcCCCcCC
Confidence 999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=257.80 Aligned_cols=158 Identities=28% Similarity=0.461 Sum_probs=130.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC--CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|.|||++||+||||||+|||++.++. ..+||+|||++............+||+.|+|||++.+..++
T Consensus 117 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (361)
T 2yab_A 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG 196 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCC
Confidence 4457889999999999999999999999999976652 25999999999876555555667899999999999887776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|..||.+......... +......++ .+..+++.+++||.+||..||.+|||+.+++
T Consensus 197 ~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 197 LE-ADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp TH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 55 9999999999999999999988655443332 333333332 2356899999999999999999999999999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 272 ~hp~~~~ 278 (361)
T 2yab_A 272 RHPWITP 278 (361)
T ss_dssp TSTTTSC
T ss_pred cCcCcCC
Confidence 9999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=246.44 Aligned_cols=164 Identities=21% Similarity=0.306 Sum_probs=124.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+....+
T Consensus 103 ~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 180 (292)
T 3o0g_A 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180 (292)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCccccccCCccccCCcChHHHcCCCCcC
Confidence 3457889999999999999999999999999988776 999999999765432 2334457899999999998776445
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHHhccCCC-----------------------CCCCCCCCHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRILSVQYS-----------------------IPDYVHISPECR 144 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~ 144 (254)
.++|||||||++|+|++|..||....... ............... ......+++.++
T Consensus 181 ~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (292)
T 3o0g_A 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260 (292)
T ss_dssp THHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHH
T ss_pred chHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHH
Confidence 55999999999999999888865444333 333332221111000 011124789999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
+||.+||..||.+|||++++++||||++..+
T Consensus 261 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 261 DLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred HHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=247.59 Aligned_cols=161 Identities=23% Similarity=0.324 Sum_probs=123.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++...... .......+|+.|+|||++.+....+
T Consensus 102 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 179 (288)
T 1ob3_A 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCC
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCccccccccccccccccCchheeCCCCCC
Confidence 3457789999999999999999999999999988776 999999998754322 2233457899999999997655334
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-C-------------CC---------CCCCCCHHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S-------------IP---------DYVHISPECRH 145 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-------------~~---------~~~~~~~~~~~ 145 (254)
.++|||||||++|+|++|..||.+................... . .+ ....+++.+++
T Consensus 180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (288)
T 1ob3_A 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259 (288)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHH
Confidence 5599999999999999999999987765555544433211100 0 00 11347899999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
||.+||..||.+|||+.++++||||++
T Consensus 260 li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 260 LLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 999999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=257.68 Aligned_cols=158 Identities=28% Similarity=0.470 Sum_probs=127.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCC-CCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+|+... ......+.+||+.|+|||++.+..++.
T Consensus 155 ~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~ 232 (396)
T 4dc2_A 155 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232 (396)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCCccccccCCcccCCchhhcCCCCCh
Confidence 4457789999999999999999999999999988776 9999999998532 333445668999999999999888865
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH--
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPK-----NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-- 161 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-- 161 (254)
+ +|||||||++|+|++|+.||....... ........+.......|. .+++.+++||++||..||.+||++
T Consensus 233 ~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~ 309 (396)
T 4dc2_A 233 S-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHP 309 (396)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCST
T ss_pred H-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCC
Confidence 5 999999999999999999997533211 112233334444545544 589999999999999999999985
Q ss_pred ----hHHhcCccccc
Q 025350 162 ----PEIRNHEWFLK 172 (254)
Q Consensus 162 ----~e~l~hp~~~~ 172 (254)
.++++||||+.
T Consensus 310 ~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 310 QTGFADIQGHPFFRN 324 (396)
T ss_dssp TTHHHHHHHSTTTTT
T ss_pred CCCHHHHhcCccccC
Confidence 79999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=257.49 Aligned_cols=154 Identities=31% Similarity=0.472 Sum_probs=124.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+|+.... .....+.+||+.|+|||++.+..++.
T Consensus 126 ~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 203 (353)
T 3txo_A 126 ARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCC
Confidence 3457789999999999999999999999999988776 99999999985332 22344567999999999998887765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH------h
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI------P 162 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~------~ 162 (254)
+ +|||||||++|+|++|..||.+.+...... .+.......|. .+++.+++||++||..||.+||++ .
T Consensus 204 ~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~ 276 (353)
T 3txo_A 204 A-VDWWAMGVLLYEMLCGHAPFEAENEDDLFE----AILNDEVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEH 276 (353)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTH
T ss_pred c-cCCCcchHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHH
Confidence 5 999999999999999999998866544333 34444444444 489999999999999999999998 8
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++||||+.
T Consensus 277 ~il~hp~f~~ 286 (353)
T 3txo_A 277 AILRHPFFKE 286 (353)
T ss_dssp HHHTSGGGTT
T ss_pred HHhhCCcccC
Confidence 9999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=258.39 Aligned_cols=164 Identities=28% Similarity=0.366 Sum_probs=117.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-------------------------
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------------------------- 64 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~------------------------- 64 (254)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+......
T Consensus 158 ~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (458)
T 3rp9_A 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN 235 (458)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSCTTCCCCCC------------------
T ss_pred HHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccCccccccccccCcccccccccccccccc
Confidence 4557889999999999999999999999999988776 9999999998643211
Q ss_pred ---CCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHh-----------CCCCCCCCCc---------------
Q 025350 65 ---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-----------GAYPFEDPEE--------------- 115 (254)
Q Consensus 65 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-----------g~~pf~~~~~--------------- 115 (254)
.....+||+.|+|||++......+.++|||||||++|+|++ |+++|.+...
T Consensus 236 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~ 315 (458)
T 3rp9_A 236 LKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKF 315 (458)
T ss_dssp ---------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC-------------------
T ss_pred ccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccc
Confidence 12344789999999987544433455999999999999998 7777766431
Q ss_pred -----hHHHHHHHHHHhccC-----------------CC---------CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 116 -----PKNFRKTIHRILSVQ-----------------YS---------IPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 116 -----~~~~~~~~~~~~~~~-----------------~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
...+..+. .+.... .. ...+..+++.+.+||++||..||.+|||++|+
T Consensus 316 ~~~~~~~~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~ 394 (458)
T 3rp9_A 316 HTRGNRDQLNVIF-NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINEC 394 (458)
T ss_dssp -CHHHHHHHHHHH-HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cccCCHHHHHHHH-HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHH
Confidence 11111111 111000 00 01123568999999999999999999999999
Q ss_pred hcCccccccCCc
Q 025350 165 RNHEWFLKNLPA 176 (254)
Q Consensus 165 l~hp~~~~~~~~ 176 (254)
|+||||+.....
T Consensus 395 L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 395 LAHPFFKEVRIA 406 (458)
T ss_dssp HHSGGGTTTCCG
T ss_pred hcCHhhhhcCCC
Confidence 999999875443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=270.94 Aligned_cols=239 Identities=28% Similarity=0.425 Sum_probs=165.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++..+ ...+||+|||++............+||+.|+|||++.+ .++.
T Consensus 138 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~ 216 (494)
T 3lij_A 138 AAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDE 216 (494)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCT
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCC
Confidence 345788999999999999999999999999997643 24599999999987655555566789999999999864 4655
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|||||||++|+|++|..||.+............. ......+.+..+++.+++||++||..||.+|||+.++|+||
T Consensus 217 ~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 217 K-CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG--KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred c-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 4 99999999999999999999987654443332221 12223344567899999999999999999999999999999
Q ss_pred cccccCCccc-----c-ccCCC--CCCCCCCC--------------CCCCCHHHHHHHHHHhCCCCCCCCchhhhhcCCC
Q 025350 169 WFLKNLPADL-----V-VDNTT--NNQFEEPD--------------QPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSL 226 (254)
Q Consensus 169 ~~~~~~~~~~-----~-~~~~~--~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (254)
||++...... . ..... ...+.... .......++.+.+.....+..|..+..+....-.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~ 373 (494)
T 3lij_A 294 WIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYS 373 (494)
T ss_dssp HHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHTTH
T ss_pred ccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHHHH
Confidence 9976422110 0 00000 00111111 0123355677778888888888888777654432
Q ss_pred CC----------cccccccCCCCCCCCCCCCCceee
Q 025350 227 DI----------DDEMDEDIDTDPDLDIDSSGEIVY 252 (254)
Q Consensus 227 ~~----------~d~~~~~~~~~~~~d~d~~g~~~~ 252 (254)
.. ...+++-.......|.|.+|.|+|
T Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~ 409 (494)
T 3lij_A 374 KLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDY 409 (494)
T ss_dssp HHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEH
T ss_pred HhcccccccccccccHHHHHHHHHHhCCCCCCcCcH
Confidence 11 000111122233457788888876
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=247.00 Aligned_cols=158 Identities=25% Similarity=0.385 Sum_probs=129.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......||+.|+|||++.+..++.
T Consensus 118 ~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 195 (297)
T 3fxz_A 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195 (297)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCT
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCc
Confidence 3457789999999999999999999999999988776 9999999987654332 234457999999999998888866
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|||||||++|+|++|..||.+............ ...........+++.+++||.+||..||.+|||+.++++||
T Consensus 196 ~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred H-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 5 9999999999999999999988665444333222 22223333446899999999999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
||+..
T Consensus 272 ~~~~~ 276 (297)
T 3fxz_A 272 FLKIA 276 (297)
T ss_dssp GGGGC
T ss_pred hhccc
Confidence 99764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=248.49 Aligned_cols=157 Identities=34% Similarity=0.516 Sum_probs=127.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCC--
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY-- 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-- 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+...
T Consensus 139 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 216 (298)
T 2zv2_A 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIF 216 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCE
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCC
Confidence 3456789999999999999999999999999988775 9999999997654322 2234579999999999976543
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+.++|||||||++|+|++|..||........ ...+.......+....+++.+++||.+||..||.+|||+.++++
T Consensus 217 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 217 SGKALDVWAMGVTLYCFVFGQCPFMDERIMCL----HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCCCccHHHH----HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 34558999999999999999999987543322 22333444455555678999999999999999999999999999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
||||++
T Consensus 293 hp~~~~ 298 (298)
T 2zv2_A 293 HPWVTR 298 (298)
T ss_dssp CHHHHC
T ss_pred CccccC
Confidence 999963
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=248.95 Aligned_cols=164 Identities=22% Similarity=0.314 Sum_probs=127.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... .......+|+.|+|||++.+....+.
T Consensus 111 ~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 188 (317)
T 2pmi_A 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYST 188 (317)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCT
T ss_pred HHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCc
Confidence 445679999999999999999999999999988776 999999999765432 22345578999999999976543345
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC-------C---------------------CCCCCCCH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-------I---------------------PDYVHISP 141 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~---------------------~~~~~~~~ 141 (254)
++|||||||++|+|++|+.||.+.........+.......... . .....+++
T Consensus 189 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (317)
T 2pmi_A 189 SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDG 268 (317)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCH
Confidence 5999999999999999999999877655554444322111000 0 01124788
Q ss_pred HHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 142 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
.+++||.+||..||.+|||+.++++||||++....
T Consensus 269 ~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 269 NLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred HHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 99999999999999999999999999999876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=255.33 Aligned_cols=164 Identities=27% Similarity=0.398 Sum_probs=118.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++............||+.|+|||++.+..++.+
T Consensus 130 ~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~- 206 (371)
T 2xrw_A 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN- 206 (371)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC----------------CTTCCHHHHTTCCCCTT-
T ss_pred HHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccccccccCCceecCCccCHHHhcCCCCCch-
Confidence 457889999999999999999999999999988775 99999999986544444455679999999999988877665
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC---------------CCCCCCC------------------
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSIPDYV------------------ 137 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~------------------ 137 (254)
+|||||||++|+|++|+.||.+......+........... ...+...
T Consensus 207 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (371)
T 2xrw_A 207 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSE 286 (371)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSH
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccc
Confidence 9999999999999999999998765554443322110000 0000000
Q ss_pred ---CCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCcc
Q 025350 138 ---HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 177 (254)
Q Consensus 138 ---~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~ 177 (254)
..++.+++||++||..||.+|||++++++||||+......
T Consensus 287 ~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 329 (371)
T 2xrw_A 287 HNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 329 (371)
T ss_dssp HHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHH
T ss_pred ccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCcc
Confidence 0146789999999999999999999999999998766543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=259.04 Aligned_cols=162 Identities=24% Similarity=0.349 Sum_probs=129.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEec-CCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++ .++ .+||+|||+|+............+|+.|+|||++.+....+.
T Consensus 144 ~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 221 (394)
T 4e7w_A 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTT 221 (394)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCT
T ss_pred HHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCc
Confidence 45678999999999999999999999999998 455 499999999987655555566789999999999977654445
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------------CCCCCC----------CCCCCHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------QYSIPD----------YVHISPECRHL 146 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~~~~~~~l 146 (254)
++|||||||++|+|++|+.||.+......+..++...... ....+. ...+++++++|
T Consensus 222 ~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (394)
T 4e7w_A 222 NIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDL 301 (394)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHH
Confidence 5999999999999999999999887666655554421110 011111 12478999999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
|.+||..||.+|||+.++++||||+...
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 302 ISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 9999999999999999999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=255.03 Aligned_cols=158 Identities=30% Similarity=0.546 Sum_probs=129.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC-CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++..+. ..+||+|||++.............||+.|+|||++.+..++.
T Consensus 130 ~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 209 (362)
T 2bdw_A 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCc
Confidence 3456789999999999999999999999999976532 459999999998765544455668999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC--CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++|+|++|..||.+......... +...... .+.+..+++.+++||.+||..||.+|||+.++++
T Consensus 210 ~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 210 P-VDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred h-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 5 9999999999999999999988654433332 3333332 3334568999999999999999999999999999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
||||+.
T Consensus 285 hp~~~~ 290 (362)
T 2bdw_A 285 VPWICN 290 (362)
T ss_dssp SHHHHT
T ss_pred CcccCC
Confidence 999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=256.04 Aligned_cols=160 Identities=23% Similarity=0.415 Sum_probs=129.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+|||++......+||+|||++.............||+.|+|||++.+..++.+
T Consensus 104 ~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 183 (321)
T 1tki_A 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183 (321)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHH
T ss_pred HHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCch
Confidence 45578899999999999999999999999999874344699999999986654444445579999999999988766554
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|||||||++|+|++|..||.+......... +.......+ .+..+++++++||.+||..||.+|||+.++++|
T Consensus 184 -~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 184 -TDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999999988665443333 333333322 234689999999999999999999999999999
Q ss_pred ccccccC
Q 025350 168 EWFLKNL 174 (254)
Q Consensus 168 p~~~~~~ 174 (254)
|||++..
T Consensus 259 p~~~~~~ 265 (321)
T 1tki_A 259 PWLKQKI 265 (321)
T ss_dssp HHHHSCG
T ss_pred hhhccCc
Confidence 9998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=260.80 Aligned_cols=164 Identities=32% Similarity=0.547 Sum_probs=122.8
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.|++.+|.|||++||+||||||+|||++... .+.+||+|||+++...........+||+.|+|||++.+..++
T Consensus 162 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 241 (400)
T 1nxk_A 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 241 (400)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSS
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCC
Confidence 3456789999999999999999999999999998632 245999999999865544445567899999999999888776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--CCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|..||.+.............+....+ ..+.+..+++++++||++||..||.+|||+.+++
T Consensus 242 ~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil 320 (400)
T 1nxk_A 242 KS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 320 (400)
T ss_dssp SH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred Cc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 55 99999999999999999999865432211111112222222 3344567899999999999999999999999999
Q ss_pred cCcccccc
Q 025350 166 NHEWFLKN 173 (254)
Q Consensus 166 ~hp~~~~~ 173 (254)
+||||.+.
T Consensus 321 ~hp~~~~~ 328 (400)
T 1nxk_A 321 NHPWIMQS 328 (400)
T ss_dssp HSHHHHTT
T ss_pred cCccccCC
Confidence 99999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=258.25 Aligned_cols=160 Identities=30% Similarity=0.560 Sum_probs=128.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-CCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||++||+||||||+|||++.. ..+.+||+|||++....... ......||+.|+|||++.+..++
T Consensus 112 ~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 191 (444)
T 3soa_A 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 191 (444)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCC
Confidence 34578899999999999999999999999999743 22459999999997654332 23456799999999999888776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
.+ +|||||||++|+|++|.+||.+.........+... ......+.+..+++.+++||.+||..||.+|||+.++|+|
T Consensus 192 ~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 192 KP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG--AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Cc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 55 99999999999999999999886654443332221 2223334556789999999999999999999999999999
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||+.
T Consensus 269 p~~~~ 273 (444)
T 3soa_A 269 PWISH 273 (444)
T ss_dssp CTTHH
T ss_pred ccccC
Confidence 99975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=256.78 Aligned_cols=163 Identities=28% Similarity=0.409 Sum_probs=129.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|+|||++||+||||||+|||++.++. .+||+|||+++...........++|+.|+|||++.+....+.+
T Consensus 159 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 237 (420)
T 1j1b_A 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 237 (420)
T ss_dssp HHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTH
T ss_pred HHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCch
Confidence 346789999999999999999999999999986542 4899999999866555445567899999999999765433455
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc----------c---CCCCCC----------CCCCCHHHHHHH
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------V---QYSIPD----------YVHISPECRHLI 147 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------~---~~~~~~----------~~~~~~~~~~li 147 (254)
+|||||||++|+|++|+.||.+......+.+++..... . .+.++. ...+++++++||
T Consensus 238 ~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li 317 (420)
T 1j1b_A 238 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 317 (420)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHH
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHH
Confidence 99999999999999999999987766666555442211 0 111111 124689999999
Q ss_pred HHhchhCCCCCCCHhHHhcCccccccC
Q 025350 148 SRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 148 ~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
.+||..||.+|||+.++++||||....
T Consensus 318 ~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 318 SRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhccCChhHCCCHHHHhCCHhhcccc
Confidence 999999999999999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=260.95 Aligned_cols=164 Identities=24% Similarity=0.313 Sum_probs=126.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.++...+||+|||++.... ......+||+.|+|||++.+..++.+
T Consensus 202 ~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~ 279 (429)
T 3kvw_A 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMP 279 (429)
T ss_dssp HHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTH
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--CcccccCCCCCccChHHHhCCCCCch
Confidence 3457889999999999999999999999999988765569999999997532 23455689999999999998888655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC----------------CCC-------------------
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----------------SIP------------------- 134 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------~~~------------------- 134 (254)
+|||||||++|+|++|.+||.+......+..+......... ..|
T Consensus 280 -~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (429)
T 3kvw_A 280 -IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR 358 (429)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEE
T ss_pred -HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccc
Confidence 99999999999999999999987766555444332110000 000
Q ss_pred ----------C--------CCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 135 ----------D--------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 135 ----------~--------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
. ....++.+++||++||..||.+|||+.|+|+||||++..+.
T Consensus 359 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418 (429)
T ss_dssp CTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-----
T ss_pred cchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCC
Confidence 0 01237889999999999999999999999999999886644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.05 Aligned_cols=163 Identities=21% Similarity=0.306 Sum_probs=122.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......+|+.|+|||++.+....+
T Consensus 102 ~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 179 (324)
T 3mtl_A 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179 (324)
T ss_dssp HHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC------------CGGGCCHHHHTTCCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccccccCcccccChhhhcCCCCCC
Confidence 3456789999999999999999999999999988775 9999999987543322 233457899999999997754444
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-CCC-----------------------CCCCCCHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIP-----------------------DYVHISPECR 144 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-----------------------~~~~~~~~~~ 144 (254)
.++|||||||++|+|++|+.||.+................... .++ ....+++.++
T Consensus 180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (324)
T 3mtl_A 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259 (324)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHH
Confidence 5599999999999999999999987765555444332211110 000 1124688999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
+||.+||..||.+|||++|+++||||.+..
T Consensus 260 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 260 DLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred HHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999997643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.58 Aligned_cols=154 Identities=36% Similarity=0.600 Sum_probs=127.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 120 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 197 (345)
T 1xjd_A 120 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 197 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCC
Confidence 3456789999999999999999999999999988775 99999999975432 22345568999999999998888765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh-HHhcC
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP-EIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~-e~l~h 167 (254)
+ +|+|||||++|+|++|..||.+.+...... .+.......|. .+++.+++||.+||..||.+||++. ++++|
T Consensus 198 ~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 198 S-VDWWSFGVLLYEMLIGQSPFHGQDEEELFH----SIRMDNPFYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred h-hhhHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHhCCCCCCc--ccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 5 999999999999999999998865543333 33334444443 4899999999999999999999998 99999
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||+.
T Consensus 271 p~f~~ 275 (345)
T 1xjd_A 271 PLFRE 275 (345)
T ss_dssp GGGTT
T ss_pred ccccC
Confidence 99975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=251.25 Aligned_cols=154 Identities=32% Similarity=0.516 Sum_probs=127.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 123 ~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 200 (353)
T 2i0e_A 123 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBST
T ss_pred HHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCC
Confidence 3457789999999999999999999999999988776 99999999985332 22345568999999999998888765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e 163 (254)
+ +|+|||||++|+|++|+.||.+....... ..+.......| ..+++++++||++||..||.+||+ +++
T Consensus 201 ~-~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 273 (353)
T 2i0e_A 201 S-VDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273 (353)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHH
T ss_pred c-ccccchHHHHHHHHcCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH
Confidence 5 99999999999999999999886554333 33344444444 358999999999999999999995 699
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 274 i~~h~~f~~ 282 (353)
T 2i0e_A 274 IKEHAFFRY 282 (353)
T ss_dssp HHTSGGGTT
T ss_pred HhcCccccC
Confidence 999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=253.54 Aligned_cols=159 Identities=23% Similarity=0.428 Sum_probs=129.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.+....+||+|||+++............||+.|+|||++.+..++.+
T Consensus 151 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 230 (387)
T 1kob_A 151 VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 230 (387)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCc
Confidence 45578899999999999999999999999999865445699999999986654444445579999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--CCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|||||||++|+|++|..||.+......... +..... ....+..+++.+++||.+||..||.+|||+.++++|
T Consensus 231 -~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 231 -TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 9999999999999999999988665443333 222222 223345689999999999999999999999999999
Q ss_pred cccccc
Q 025350 168 EWFLKN 173 (254)
Q Consensus 168 p~~~~~ 173 (254)
|||+..
T Consensus 306 p~~~~~ 311 (387)
T 1kob_A 306 PWLKGD 311 (387)
T ss_dssp TTTSSC
T ss_pred ccccCC
Confidence 999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=250.38 Aligned_cols=158 Identities=30% Similarity=0.509 Sum_probs=128.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC--CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|.|||++||+||||||+|||++.++ ...+||+|||+++............||+.|+|||++.+..++
T Consensus 116 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 195 (326)
T 2y0a_A 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCC
Confidence 445788999999999999999999999999998765 125999999999876555555566899999999999887776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|..||.+.......... .......+ .+..+++.+++||.+||..||.+|||+.+++
T Consensus 196 ~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 270 (326)
T 2y0a_A 196 LE-ADMWSIGVITYILLSGASPFLGDTKQETLANV----SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270 (326)
T ss_dssp TH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----HhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 55 99999999999999999999876554433332 22222222 2245799999999999999999999999999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 271 ~hp~~~~ 277 (326)
T 2y0a_A 271 QHPWIKP 277 (326)
T ss_dssp HSTTTSC
T ss_pred cCCCccC
Confidence 9999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=260.77 Aligned_cols=159 Identities=37% Similarity=0.625 Sum_probs=133.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||++..........+.+||+.|+|||++.+..+.+.
T Consensus 118 ~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 195 (476)
T 2y94_A 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 195 (476)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSH
T ss_pred HHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCC
Confidence 4457889999999999999999999999999988776 99999999987655555566789999999999988877666
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|||||||++|+|++|..||.+........ .+.......| ..+++.+++||++||..||.+|||+.++++|||
T Consensus 196 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 196 EVDIWSSGVILYALLCGTLPFDDDHVPTLFK----KICDGIFYTP--QYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----HHHTTCCCCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred cceehhhHHHHHHHhhCCCCCCCCCHHHHHH----HHhcCCcCCC--ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 7999999999999999999998766544333 3333333333 357999999999999999999999999999999
Q ss_pred ccccCCc
Q 025350 170 FLKNLPA 176 (254)
Q Consensus 170 ~~~~~~~ 176 (254)
|++..+.
T Consensus 270 ~~~~~~~ 276 (476)
T 2y94_A 270 FKQDLPK 276 (476)
T ss_dssp HHTTCCT
T ss_pred hhhcCcc
Confidence 9876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=246.65 Aligned_cols=151 Identities=34% Similarity=0.585 Sum_probs=127.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... ...+.+||+.|+|||++.+..++.+
T Consensus 109 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~- 183 (318)
T 1fot_A 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKS- 183 (318)
T ss_dssp HHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTT-
T ss_pred HHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--ccccccCCccccCHhHhcCCCCCcc-
Confidence 456789999999999999999999999999988775 99999999986432 2345689999999999988887665
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l 165 (254)
+|+|||||++|+|++|..||.+......... +.......| ..+++++++||.+||..||.+|| ++++++
T Consensus 184 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHCCCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred cchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCC--CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 9999999999999999999988655443333 334444444 35899999999999999999999 899999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 258 ~hp~f~~ 264 (318)
T 1fot_A 258 NHPWFKE 264 (318)
T ss_dssp TSGGGSS
T ss_pred cCccccC
Confidence 9999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=270.28 Aligned_cols=161 Identities=32% Similarity=0.529 Sum_probs=127.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|.|||++||+||||||+|||++..+ ...+||+|||+++...........+||+.|+|||++.+ .++.
T Consensus 123 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 201 (486)
T 3mwu_A 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDE 201 (486)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCH
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCc
Confidence 445788999999999999999999999999996432 23599999999986655555556789999999999975 4544
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
++|||||||++|+|++|.+||.+............ .......+.+..+|+.+++||.+||..||.+|||+.++|+||
T Consensus 202 -~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 202 -KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp -HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred -hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 59999999999999999999988765444333222 122233455567899999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||++..
T Consensus 279 ~~~~~~ 284 (486)
T 3mwu_A 279 WIQKYS 284 (486)
T ss_dssp HHHHTC
T ss_pred hhccCc
Confidence 998644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=249.33 Aligned_cols=158 Identities=28% Similarity=0.471 Sum_probs=126.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 112 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 189 (345)
T 3a8x_A 112 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCCCcccccCCCccccCccccCCCCCCh
Confidence 3456789999999999999999999999999988775 99999999975332 23344568999999999998888765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH--
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-- 161 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-- 161 (254)
+ +|+|||||++|+|++|+.||...... .........+......+|. .+++.+++||++||..||.+||++
T Consensus 190 ~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~ 266 (345)
T 3a8x_A 190 S-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHP 266 (345)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCT
T ss_pred H-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCC
Confidence 5 99999999999999999999753211 1112223334444444443 589999999999999999999995
Q ss_pred ----hHHhcCccccc
Q 025350 162 ----PEIRNHEWFLK 172 (254)
Q Consensus 162 ----~e~l~hp~~~~ 172 (254)
.++++||||+.
T Consensus 267 ~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 267 QTGFADIQGHPFFRN 281 (345)
T ss_dssp TTHHHHHHTSGGGTT
T ss_pred cCCHHHHhcCCccCC
Confidence 79999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=248.58 Aligned_cols=161 Identities=24% Similarity=0.336 Sum_probs=127.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC-CCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .....++|+.|+|||++.+ ..++
T Consensus 130 ~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~- 204 (367)
T 1cm8_A 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYT- 204 (367)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCC-
T ss_pred HHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCC-
Confidence 3457789999999999999999999999999988776 99999999986432 3445678999999999987 4454
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-------------------CCC------CCCCCCCHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------------------YSI------PDYVHISPEC 143 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~------~~~~~~~~~~ 143 (254)
.++|||||||++|+|++|+.||.+......+..+........ ... ..+..+++.+
T Consensus 205 ~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (367)
T 1cm8_A 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 284 (367)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHH
T ss_pred hhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 459999999999999999999998776555544433211100 000 1123578999
Q ss_pred HHHHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 144 RHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
.+||.+||..||.+|||+.++|+||||+....
T Consensus 285 ~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 285 VNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 99999999999999999999999999987543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=253.89 Aligned_cols=165 Identities=26% Similarity=0.325 Sum_probs=117.6
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----------------------C
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----------------------Q 65 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----------------------~ 65 (254)
....++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+...... .
T Consensus 130 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (432)
T 3n9x_A 130 HIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207 (432)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC----------------------------
T ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCcccccccccccccccccccccccccccchhcc
Confidence 34567889999999999999999999999999988776 9999999998643321 1
Q ss_pred CCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhC-----------CCCCCCCCc-----------------hH
Q 025350 66 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-----------AYPFEDPEE-----------------PK 117 (254)
Q Consensus 66 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-----------~~pf~~~~~-----------------~~ 117 (254)
....+||+.|+|||++......+.++|||||||++|+|++| .++|.+... ..
T Consensus 208 ~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ 287 (432)
T 3n9x_A 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287 (432)
T ss_dssp ---CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHH
T ss_pred ccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHH
Confidence 24567999999999975444344559999999999999984 444444321 11
Q ss_pred HHHHHHHH--------------------HhccCCCCC-----CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 118 NFRKTIHR--------------------ILSVQYSIP-----DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 118 ~~~~~~~~--------------------~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
.+..+... +.......+ .+..+++.+.+||++||..||.+|||++++|+||||+.
T Consensus 288 ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 288 QLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 11111110 000001111 12357999999999999999999999999999999987
Q ss_pred cCC
Q 025350 173 NLP 175 (254)
Q Consensus 173 ~~~ 175 (254)
...
T Consensus 368 ~~~ 370 (432)
T 3n9x_A 368 VRK 370 (432)
T ss_dssp TCC
T ss_pred ccC
Confidence 543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=247.86 Aligned_cols=163 Identities=24% Similarity=0.317 Sum_probs=125.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-----CCCCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... ........||+.|+|||++.+.
T Consensus 126 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (351)
T 3mi9_A 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 203 (351)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhcccccccccccccccCCcccccCccCchhhcCC
Confidence 4567889999999999999999999999999988775 99999999975432 1223445789999999999775
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC-CCCCC-------------------------C
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYV-------------------------H 138 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~-------------------------~ 138 (254)
...+.++|||||||++|+|++|..||.+.................... .+... .
T Consensus 204 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
T 3mi9_A 204 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV 283 (351)
T ss_dssp CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHH
T ss_pred CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhcc
Confidence 544455999999999999999999999876655544433322111111 01100 0
Q ss_pred CCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 139 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 139 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
.++.+++||.+||..||.+|||+.++++||||+...
T Consensus 284 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 284 RDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred CChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 267899999999999999999999999999997643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=246.96 Aligned_cols=162 Identities=31% Similarity=0.537 Sum_probs=130.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++...... ......+||+.|+|||++.+..+
T Consensus 107 ~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 184 (323)
T 3tki_A 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184 (323)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred HHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCC
Confidence 4557889999999999999999999999999988775 999999999754322 22335679999999999988777
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+.++|||||||++|+|++|+.||........... .........+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 185 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 56669999999999999999999987654322222 122233334445568999999999999999999999999999
Q ss_pred CccccccCCc
Q 025350 167 HEWFLKNLPA 176 (254)
Q Consensus 167 hp~~~~~~~~ 176 (254)
||||++....
T Consensus 262 h~~~~~~~~~ 271 (323)
T 3tki_A 262 DRWYNKPLKK 271 (323)
T ss_dssp CTTTTCCCCC
T ss_pred Chhhcccccc
Confidence 9999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=254.47 Aligned_cols=158 Identities=27% Similarity=0.460 Sum_probs=128.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||+..+....+||+|||+++...........+||+.|+|||++.+..++.+
T Consensus 189 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 268 (373)
T 2x4f_A 189 TILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFP 268 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHH
T ss_pred HHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcH
Confidence 34567899999999999999999999999999543334599999999987655544555679999999999987776554
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC--CCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|||||||++|+|++|..||.+.........+. ...... ..+..+++++++||.+||..||.+|||+.++++|
T Consensus 269 -~DiwslG~il~elltg~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 269 -TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL----ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999999999999999999876554444333 222222 2235689999999999999999999999999999
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||++
T Consensus 344 p~~~~ 348 (373)
T 2x4f_A 344 PWLSD 348 (373)
T ss_dssp HHHHC
T ss_pred cCcCC
Confidence 99975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=256.08 Aligned_cols=159 Identities=32% Similarity=0.480 Sum_probs=129.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCC-
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEY- 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~- 86 (254)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+...... ...+.+||+.|+|||++.+...
T Consensus 170 ~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 247 (410)
T 3v8s_A 170 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247 (410)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTT
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCC
Confidence 4457789999999999999999999999999988776 9999999997654332 2346689999999999976551
Q ss_pred --CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCC--CCCHh
Q 025350 87 --DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK--RISIP 162 (254)
Q Consensus 87 --~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rps~~ 162 (254)
.+.++|||||||++|+|++|+.||.+.+......++..... ....|....+++++++||++||..+|.+ |++++
T Consensus 248 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ 325 (410)
T 3v8s_A 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVE 325 (410)
T ss_dssp CEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHH
T ss_pred cCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--cccCCCcccccHHHHHHHHHHccChhhhCCCCCHH
Confidence 23459999999999999999999998766555544433221 2344555578999999999999999988 99999
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
+|++||||+.
T Consensus 326 ei~~Hp~f~~ 335 (410)
T 3v8s_A 326 EIKRHLFFKN 335 (410)
T ss_dssp HHHTSGGGCC
T ss_pred HHhcCccccC
Confidence 9999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=248.14 Aligned_cols=192 Identities=23% Similarity=0.299 Sum_probs=135.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... ......||+.|+|||++.+....+.
T Consensus 146 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 221 (371)
T 4exu_A 146 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQ 221 (371)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCT
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCc
Confidence 4457889999999999999999999999999988776 99999999975432 2345678999999999987333344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------------------CCCCC------CCCCCCHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------------QYSIP------DYVHISPECR 144 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~~~------~~~~~~~~~~ 144 (254)
++|||||||++|+|++|+.||.+................. ....+ .+..+++.++
T Consensus 222 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (371)
T 4exu_A 222 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAA 301 (371)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHH
T ss_pred HHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHH
Confidence 5999999999999999999999876655544443321110 00000 1234689999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccCCccccccCCCCCCCCCC-CCCCCCHHHHHHHHHH
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP-DQPMQSIDEIMQIIAE 207 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 207 (254)
+||.+||..||.+|||+.++++||||+....+..... ....+... .....+++++.+.+.+
T Consensus 302 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (371)
T 4exu_A 302 DLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETE--AQQPFDDSLEHEKLTVDEWKQHIYK 363 (371)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCC--CSSCCCCTTSSCCCCHHHHHHHHHH
T ss_pred HHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccc--cccCcCcchhhcccchHHHHHHHHH
Confidence 9999999999999999999999999987544332211 11122221 2233456676665543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=247.03 Aligned_cols=152 Identities=21% Similarity=0.229 Sum_probs=118.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
+..++.|++.+|+|||++||+||||||+|||++.++. +||+|||++.............||+.|+|||++.+ .++.
T Consensus 159 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~- 234 (311)
T 3p1a_A 159 VWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGT- 234 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCST-
T ss_pred HHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCc-
Confidence 4457889999999999999999999999999987775 99999999987655544555679999999999876 5554
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|||||||++|+|++|..||.+.. ... .+............+++.+.+||.+||..||.+|||+.++++|||
T Consensus 235 ~~DiwslG~il~el~~g~~~~~~~~---~~~----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 235 AADVFSLGLTILEVACNMELPHGGE---GWQ----QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp HHHHHHHHHHHHHHHHTCCCCSSHH---HHH----HHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCcc---HHH----HHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 4999999999999999977765421 111 122221111122357999999999999999999999999999999
Q ss_pred ccc
Q 025350 170 FLK 172 (254)
Q Consensus 170 ~~~ 172 (254)
|++
T Consensus 308 ~~~ 310 (311)
T 3p1a_A 308 LRQ 310 (311)
T ss_dssp GSC
T ss_pred ccC
Confidence 975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=248.64 Aligned_cols=166 Identities=25% Similarity=0.343 Sum_probs=129.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... .....+||+.|+|||++.+..
T Consensus 130 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 207 (364)
T 3qyz_A 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207 (364)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCC
Confidence 3457889999999999999999999999999988776 9999999997543322 123457999999999876655
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC----------------CCCC---------CCCCCC
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------------YSIP---------DYVHIS 140 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~~~~---------~~~~~~ 140 (254)
..+.++|||||||++|+|++|+.||.+.........+........ ...+ ....++
T Consensus 208 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (364)
T 3qyz_A 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD 287 (364)
T ss_dssp SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC
T ss_pred CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCC
Confidence 444559999999999999999999998776555554432211100 0000 013478
Q ss_pred HHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCcc
Q 025350 141 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 177 (254)
Q Consensus 141 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~ 177 (254)
+.+.+||.+||..||.+|||+.++++||||++...+.
T Consensus 288 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~ 324 (364)
T 3qyz_A 288 SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence 9999999999999999999999999999999876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=245.56 Aligned_cols=163 Identities=25% Similarity=0.324 Sum_probs=129.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+....+
T Consensus 114 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 191 (346)
T 1ua2_A 114 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 191 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCC
T ss_pred HHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCCcccCCcccccccccCchHhhCCCCCC
Confidence 4567889999999999999999999999999988775 9999999998654322 334557999999999997655445
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-CCCC---------------------CCCCCHHHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPD---------------------YVHISPECRHL 146 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~---------------------~~~~~~~~~~l 146 (254)
.++|||||||++|+|++|.+||.+......+............ .++. +..+++.+++|
T Consensus 192 ~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 271 (346)
T 1ua2_A 192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 271 (346)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHH
T ss_pred chhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHH
Confidence 5699999999999999999999987766665555443221110 0000 13467899999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
|.+||..||.+|||+.|+++||||++..
T Consensus 272 i~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 272 IQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 9999999999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=238.52 Aligned_cols=161 Identities=29% Similarity=0.519 Sum_probs=130.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC-CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+++|||++||+||||||+||+++.++. ..+||+|||++.............|++.|+|||++.+..++.+
T Consensus 108 ~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 187 (284)
T 3kk8_A 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187 (284)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcc
Confidence 456789999999999999999999999999975442 3599999999976655544455679999999999988877655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+||||||+++|+|++|+.||.+............ .......+.+..+++.+.+||.+||..||.+|||+.++++|||
T Consensus 188 -~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 188 -VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred -cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh--ccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 9999999999999999999988655443333221 1222333444578999999999999999999999999999999
Q ss_pred ccccC
Q 025350 170 FLKNL 174 (254)
Q Consensus 170 ~~~~~ 174 (254)
|++..
T Consensus 265 ~~~~~ 269 (284)
T 3kk8_A 265 ICNRE 269 (284)
T ss_dssp HHSCC
T ss_pred ccCCh
Confidence 97643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=250.42 Aligned_cols=157 Identities=25% Similarity=0.403 Sum_probs=127.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC---CCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK---KEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~ 86 (254)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...........+||+.|+|||++.+ ..+
T Consensus 117 ~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 194 (384)
T 4fr4_A 117 VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194 (384)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCB
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCC
Confidence 3457789999999999999999999999999988776 99999999987655555567789999999999864 335
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-HhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-IPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-~~e~l 165 (254)
+.+ +|||||||++|+|++|..||....... .......+.......| ..+++.+.+||.+||..||.+||+ +++++
T Consensus 195 ~~~-~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 195 SFA-VDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CTT-HHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred Ccc-ceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCC--CcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 444 999999999999999999997644322 2223333333333333 358999999999999999999998 89999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||..
T Consensus 271 ~hp~f~~ 277 (384)
T 4fr4_A 271 NFPYMND 277 (384)
T ss_dssp TSGGGTT
T ss_pred cChhhhc
Confidence 9999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.34 Aligned_cols=163 Identities=23% Similarity=0.358 Sum_probs=119.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .....+||+.|+|||++.+....+.
T Consensus 134 ~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 209 (367)
T 2fst_X 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQ 209 (367)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC-----------------CCCTTCCHHHHTTCCSCCT
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCc
Confidence 3457889999999999999999999999999988776 99999999976432 2345679999999999987433344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------------------CCCCCC------CCCCCHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------------QYSIPD------YVHISPECR 144 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~~~~------~~~~~~~~~ 144 (254)
++|||||||++|+|++|+.||.+......+..+....... ....+. +..+++.++
T Consensus 210 ~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (367)
T 2fst_X 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 289 (367)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHH
Confidence 5999999999999999999999877655554443321110 000110 134688999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
+||.+||..||.+|||+.++|+||||+....+
T Consensus 290 dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 290 DLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 99999999999999999999999999876544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=247.96 Aligned_cols=152 Identities=30% Similarity=0.539 Sum_probs=127.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .....+||+.|+|||++.+..++.+
T Consensus 143 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 218 (350)
T 1rdq_E 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKA 218 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--CcccccCCccccCHHHhcCCCCCCc
Confidence 3457889999999999999999999999999988776 99999999986533 2345689999999999988887655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e~ 164 (254)
+|||||||++|+|++|..||.+........ .+......+| ..+++.+++||.+||..||.+||+ ++++
T Consensus 219 -~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei 291 (350)
T 1rdq_E 219 -VDWWALGVLIYEMAAGYPPFFADQPIQIYE----KIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291 (350)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH
T ss_pred -CCEecccHhHhHHhhCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHH
Confidence 999999999999999999998765443333 3334444444 358999999999999999999998 9999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||+.
T Consensus 292 ~~h~~f~~ 299 (350)
T 1rdq_E 292 KNHKWFAT 299 (350)
T ss_dssp HTSGGGTT
T ss_pred HhCcCcCC
Confidence 99999964
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=250.87 Aligned_cols=160 Identities=22% Similarity=0.338 Sum_probs=128.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC-CCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++. ++ .+||+|||+|+............+|+.|+|||++.+....+.
T Consensus 144 ~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 221 (383)
T 3eb0_A 144 SIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTP 221 (383)
T ss_dssp HHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTT--EEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCT
T ss_pred HHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCC--cEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCc
Confidence 456789999999999999999999999999974 44 499999999987655555566789999999999887653345
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------------CCCCC----------CCCCCCHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------QYSIP----------DYVHISPECRHL 146 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~----------~~~~~~~~~~~l 146 (254)
++||||+||++|+|++|+.||.+.........++...... ....+ ....+++.+++|
T Consensus 222 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 222 SIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred chhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence 5999999999999999999999877766665554322111 00111 122478899999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccccc
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
|.+||..||.+|||+.++++||||+.
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHHHccCChhhCCCHHHHhcCHHHHH
Confidence 99999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=267.29 Aligned_cols=159 Identities=35% Similarity=0.549 Sum_probs=129.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC-CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. ..+||+|||++............+||+.|+|||++.+ .++.
T Consensus 148 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 226 (504)
T 3q5i_A 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNE 226 (504)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCT
T ss_pred HHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCc
Confidence 4567889999999999999999999999999987653 2599999999987655555566789999999999864 4655
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC--CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++|+|++|..||.+......... +...... .+.+..+|+.+++||++||..||.+|||+.++|+
T Consensus 227 ~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 227 K-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKK----VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred h-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 4 9999999999999999999998665443333 3333322 2334568999999999999999999999999999
Q ss_pred CccccccC
Q 025350 167 HEWFLKNL 174 (254)
Q Consensus 167 hp~~~~~~ 174 (254)
||||++..
T Consensus 302 h~~~~~~~ 309 (504)
T 3q5i_A 302 SRWIKKYA 309 (504)
T ss_dssp SHHHHHTC
T ss_pred CHhhhhch
Confidence 99998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=255.03 Aligned_cols=154 Identities=35% Similarity=0.563 Sum_probs=125.9
Q ss_pred cCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||+ +||+||||||+|||++.++. +||+|||+|+.... .......+||+.|+|||++.+..++
T Consensus 250 ~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 327 (446)
T 4ejn_A 250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCC
T ss_pred HHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCC
Confidence 34567899999999998 99999999999999988775 99999999975332 2334556899999999999888886
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIP 162 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~ 162 (254)
.+ +|||||||++|+|++|+.||.+........ .+.......| ..+++.+++||.+||..||.+|| |+.
T Consensus 328 ~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ 400 (446)
T 4ejn_A 328 RA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFP--RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 400 (446)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHH
T ss_pred Cc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHH----HHHhCCCCCC--ccCCHHHHHHHHHHcccCHHHhCCCCCCCHH
Confidence 55 999999999999999999998765443332 2333344444 35899999999999999999999 999
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++||||+.
T Consensus 401 ell~hp~f~~ 410 (446)
T 4ejn_A 401 EIMQHRFFAG 410 (446)
T ss_dssp HHHTSGGGTT
T ss_pred HHHhCccccC
Confidence 9999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=246.58 Aligned_cols=167 Identities=22% Similarity=0.303 Sum_probs=121.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++.............+|+.|+|||++.+....+.
T Consensus 136 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 213 (362)
T 3pg1_A 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTK 213 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCTTC---------------CGGGCCHHHHTTCTTCCT
T ss_pred HHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEecCcccccccccccceecccceecCcHHhcCCCCCCc
Confidence 4457889999999999999999999999999987765 99999999976554444555679999999999987443445
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC--------------------CCCC------CCCCCCHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------------YSIP------DYVHISPEC 143 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------~~~~------~~~~~~~~~ 143 (254)
++|||||||++|+|++|+.||.+.................. ...+ ....+++.+
T Consensus 214 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (362)
T 3pg1_A 214 LVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVA 293 (362)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHH
T ss_pred HhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHH
Confidence 59999999999999999999998766555444433211100 0001 113468899
Q ss_pred HHHHHHhchhCCCCCCCHhHHhcCccccccCCccc
Q 025350 144 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~ 178 (254)
.+||.+||..||.+|||+.++++||||+....+..
T Consensus 294 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 328 (362)
T 3pg1_A 294 LDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD 328 (362)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence 99999999999999999999999999988665433
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=247.48 Aligned_cols=163 Identities=22% Similarity=0.337 Sum_probs=128.5
Q ss_pred CCcHHHHHHHHHHHh--hcCcccCCCCCCcEEecC-CCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELL--PFNVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh--~~givHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.++.||| ++||+||||||+|||++. ++ .+||+|||+++............||+.|+|||++.+....
T Consensus 132 ~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 209 (360)
T 3e3p_A 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHY 209 (360)
T ss_dssp HHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSC
T ss_pred HHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCC
Confidence 346789999999999 999999999999999986 44 4999999999876555555566799999999999776644
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-----------C--C-------------CCCCCCCCH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-----------Y--S-------------IPDYVHISP 141 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----------~--~-------------~~~~~~~~~ 141 (254)
+.++|||||||++|+|++|+.||.+.................. . . .......++
T Consensus 210 ~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (360)
T 3e3p_A 210 TTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK 289 (360)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHH
T ss_pred CcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccH
Confidence 4559999999999999999999998776555555443211100 0 0 001112568
Q ss_pred HHHHHHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 142 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
.+++||.+||..||.+|||+.++++||||++...
T Consensus 290 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 290 EAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 8999999999999999999999999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=258.57 Aligned_cols=156 Identities=14% Similarity=0.145 Sum_probs=121.6
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC--CCCCCc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGK 89 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~ 89 (254)
.++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... .....+|+.|+|||++.+ ..++ .
T Consensus 198 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~-~ 272 (371)
T 3q60_A 198 ILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR--LMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFT-H 272 (371)
T ss_dssp HHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSC--EEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECC-H
T ss_pred HHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCC--EEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcC-c
Confidence 44589999999999999999999999999988775 999999999864322 224567799999999976 5565 4
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHH--HH-HHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNF--RK-TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
++|||||||++|+|++|+.||.+....... .. ............+....+++.+++||.+||..||.+|||+.++++
T Consensus 273 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 273 ALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 599999999999999999999875321100 00 000011123334444578999999999999999999999999999
Q ss_pred Cccccc
Q 025350 167 HEWFLK 172 (254)
Q Consensus 167 hp~~~~ 172 (254)
||||++
T Consensus 353 hp~f~~ 358 (371)
T 3q60_A 353 TPEFLQ 358 (371)
T ss_dssp SHHHHH
T ss_pred CHHHHH
Confidence 999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=245.64 Aligned_cols=161 Identities=26% Similarity=0.413 Sum_probs=125.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++... .+.+||+|||+++............||+.|+|||++.+..++.
T Consensus 133 ~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 212 (327)
T 3lm5_A 133 VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCc
Confidence 445788999999999999999999999999998621 2349999999998765544445567999999999998887765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|||||||++|+|++|..||.+............ .......+.+..+++.+++||.+||..||.+|||++++++||
T Consensus 213 ~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 213 A-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh--cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 5 9999999999999999999988665444333222 122333344456899999999999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
||++.
T Consensus 290 ~~~~~ 294 (327)
T 3lm5_A 290 WLQQW 294 (327)
T ss_dssp GGCCC
T ss_pred hhccc
Confidence 99763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=251.27 Aligned_cols=165 Identities=25% Similarity=0.302 Sum_probs=116.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC--CCCcEEEecCCCcccCCCC----CCCCCCcCCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~--~~~~vkl~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~ 83 (254)
...++.|++.||+|||++||+||||||+|||+... ..+.+||+|||+++..... ......+||+.|+|||++.+
T Consensus 130 ~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 45678899999999999999999999999999321 2235999999999764332 22334578999999999987
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch---------HHHHHHHHHHhccCCC-C--------------------
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRILSVQYS-I-------------------- 133 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~~~~~~~~~~~-~-------------------- 133 (254)
....+.++|||||||++|+|++|..||.+.... ..+..+.......... +
T Consensus 210 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (405)
T 3rgf_A 210 ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNT 289 (405)
T ss_dssp CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGG
T ss_pred CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccC
Confidence 654456699999999999999999999765431 2222222211100000 0
Q ss_pred -----------CCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 134 -----------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 134 -----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
......++.+.+||.+||..||.+|||++++|+||||++..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 290 YTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp GTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred CCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 00112377899999999999999999999999999998743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.85 Aligned_cols=153 Identities=33% Similarity=0.533 Sum_probs=126.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 142 ~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 219 (373)
T 2r5t_A 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT 219 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTH
T ss_pred HHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCch
Confidence 346789999999999999999999999999988776 99999999975322 334456689999999999988887655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH----hHHh
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI----PEIR 165 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~----~e~l 165 (254)
+|+|||||++|+|++|..||.+......... +.......+ ..++..+++||++||..||.+||++ .+++
T Consensus 220 -~DiwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~~~~~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 220 -VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH----HHHSCCCCC--SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred -hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhcccCCC--CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 9999999999999999999988655443333 333333333 3589999999999999999999986 6999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 293 ~h~~f~~ 299 (373)
T 2r5t_A 293 SHVFFSL 299 (373)
T ss_dssp TSGGGTT
T ss_pred CCccccC
Confidence 9999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=246.89 Aligned_cols=151 Identities=27% Similarity=0.414 Sum_probs=126.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++.............||+.|+|||++.+..+.+.
T Consensus 132 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 209 (335)
T 3dls_A 132 ASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP 209 (335)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSH
T ss_pred HHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCC
Confidence 3457889999999999999999999999999988765 99999999987655544455679999999999988887666
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|||||||++|+|++|..||..... .... .......+++.+++||.+||..||.+|||+.++++|||
T Consensus 210 ~~DiwslG~il~el~~g~~pf~~~~~----------~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 210 ELEMWSLGVTLYTLVFEENPFCELEE----------TVEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred cccchhHHHHHHHHHhCCCchhhHHH----------HHhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 69999999999999999999976321 1111 12223357999999999999999999999999999999
Q ss_pred ccccC
Q 025350 170 FLKNL 174 (254)
Q Consensus 170 ~~~~~ 174 (254)
|++..
T Consensus 278 ~~~~~ 282 (335)
T 3dls_A 278 VTQPV 282 (335)
T ss_dssp TTCCC
T ss_pred ccCCc
Confidence 98754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=244.89 Aligned_cols=163 Identities=18% Similarity=0.283 Sum_probs=124.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.++. .+||+|||+++............+++.|+|||++.+....+.
T Consensus 132 ~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 210 (330)
T 3nsz_A 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210 (330)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCT
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCc
Confidence 3457789999999999999999999999999986652 599999999986655555566789999999999987444445
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHH---------HhccCCC----------------------CCCCC
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHR---------ILSVQYS----------------------IPDYV 137 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~---------~~~~~~~----------------------~~~~~ 137 (254)
++|||||||++|+|++|..||........ ....... +...... .....
T Consensus 211 ~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (330)
T 3nsz_A 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH 290 (330)
T ss_dssp HHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGG
T ss_pred hhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccc
Confidence 59999999999999999999965443222 2211110 0000000 01112
Q ss_pred CCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 138 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 138 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
.+++.+++||.+||..||.+|||++++|+||||+..
T Consensus 291 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 291 LVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp GCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 268999999999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=243.37 Aligned_cols=153 Identities=29% Similarity=0.514 Sum_probs=122.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 124 ~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 201 (327)
T 3a62_A 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA 201 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTH
T ss_pred HHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCc
Confidence 446789999999999999999999999999988765 999999998753322 23345679999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~ 164 (254)
+|||||||++|+|++|..||.+......... +.......| ..+++.+++||.+||..||.+|| ++.++
T Consensus 202 -~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~~p--~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~ 274 (327)
T 3a62_A 202 -VDWWSLGALMYDMLTGAPPFTGENRKKTIDK----ILKCKLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEV 274 (327)
T ss_dssp -HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCCCCC--TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHH
T ss_pred -ccchhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCC--CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHH
Confidence 9999999999999999999988665443333 333333443 35799999999999999999999 88999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||+.
T Consensus 275 l~hp~f~~ 282 (327)
T 3a62_A 275 QAHPFFRH 282 (327)
T ss_dssp HHSGGGSS
T ss_pred HcCCcccC
Confidence 99999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=247.07 Aligned_cols=160 Identities=33% Similarity=0.513 Sum_probs=118.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC-CCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|.|||++||+||||||+|||++. +....+||+|||+++............||+.|+|||++.+..++.
T Consensus 150 ~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 229 (349)
T 2w4o_A 150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGP 229 (349)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCc
Confidence 3457789999999999999999999999999975 223459999999998654444445567999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC--CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++|+|++|..||.......... ..+...... .+.+..++..+++||++||..||.+|||+.++++
T Consensus 230 ~-~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 230 E-VDMWSVGIITYILLCGFEPFYDERGDQFMF---RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTCCTTCHHHHH---HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-cchHHHHHHHHHHHhCCCCCCCCcccHHHH---HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 5 999999999999999999998765543222 222333222 2334568999999999999999999999999999
Q ss_pred Ccccccc
Q 025350 167 HEWFLKN 173 (254)
Q Consensus 167 hp~~~~~ 173 (254)
||||+..
T Consensus 306 hp~~~~~ 312 (349)
T 2w4o_A 306 HPWVTGK 312 (349)
T ss_dssp STTTTST
T ss_pred CcccCCC
Confidence 9999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=262.59 Aligned_cols=158 Identities=30% Similarity=0.432 Sum_probs=129.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...........+||+.|+|||++.+..++.+
T Consensus 288 ~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~ 365 (576)
T 2acx_A 288 AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365 (576)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSH
T ss_pred HHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccCccccccCCCccccCHHHHcCCCCCcc
Confidence 3456789999999999999999999999999988775 99999999987654444455689999999999988877655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~ 164 (254)
+|||||||++|+|++|..||.+.............+......++ ..+++.+++||++||..||.+|| ++.++
T Consensus 366 -~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~ei 442 (576)
T 2acx_A 366 -PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442 (576)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHH
T ss_pred -chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHH
Confidence 99999999999999999999876432222333333333333333 45899999999999999999999 78999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||+.
T Consensus 443 l~HpfF~~ 450 (576)
T 2acx_A 443 KEHPLFKK 450 (576)
T ss_dssp HTSGGGTT
T ss_pred HhChhhcc
Confidence 99999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=246.26 Aligned_cols=163 Identities=26% Similarity=0.308 Sum_probs=120.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC---CCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~---~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++ ...+||+|||+++..... .......+|+.|+|||++.+..
T Consensus 134 ~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 213 (329)
T 3gbz_A 134 IKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSR 213 (329)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCC
Confidence 345788999999999999999999999999995322 235999999999754322 2234456899999999998765
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-CC------CCC-----------------CCCCH
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI------PDY-----------------VHISP 141 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~------~~~-----------------~~~~~ 141 (254)
..+.++|||||||++|+|++|..||.+................... .. +.+ ..+++
T Consensus 214 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (329)
T 3gbz_A 214 HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDD 293 (329)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCH
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCH
Confidence 4445599999999999999999999987766655554443211110 00 000 01678
Q ss_pred HHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 142 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
++++||.+||..||.+|||+.++++||||++
T Consensus 294 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 294 EGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 9999999999999999999999999999976
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=241.36 Aligned_cols=159 Identities=27% Similarity=0.449 Sum_probs=127.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......||+.|+|||++.+..++.
T Consensus 143 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 220 (321)
T 2c30_A 143 IATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220 (321)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCc
Confidence 4557889999999999999999999999999987765 9999999987654332 234557999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|||||||++|+|++|+.||............. . ...........+++.+++||.+||..||.+|||+.++++||
T Consensus 221 ~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 221 E-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-D--SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-H--SSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-c--CCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 5 999999999999999999998765443332221 1 11122223345789999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||++..
T Consensus 297 ~~~~~~ 302 (321)
T 2c30_A 297 FLLQTG 302 (321)
T ss_dssp GGGGCC
T ss_pred hhccCC
Confidence 997643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=239.53 Aligned_cols=192 Identities=22% Similarity=0.294 Sum_probs=134.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||+++.... ......+|+.|+|||++.+....+.
T Consensus 128 ~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 203 (353)
T 3coi_A 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQ 203 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCT
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCc
Confidence 3457889999999999999999999999999988765 99999999975432 2344578999999999887333344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc------------------------CCCC-CCCCCCCHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------------------QYSI-PDYVHISPECR 144 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------------------~~~~-~~~~~~~~~~~ 144 (254)
++|||||||++|+|++|..||.+................. ...+ .....+++.++
T Consensus 204 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
T 3coi_A 204 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAA 283 (353)
T ss_dssp THHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHH
Confidence 5999999999999999999999876554444333211000 0000 11235789999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCccccccCCccccccCCCCCCCCCC-CCCCCCHHHHHHHHHH
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP-DQPMQSIDEIMQIIAE 207 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 207 (254)
+||.+||..||.+|||+.++++||||+....+...... ...+... .....+.+++++.+.+
T Consensus 284 ~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 345 (353)
T 3coi_A 284 DLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEA--QQPFDDSLEHEKLTVDEWKQHIYK 345 (353)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCC--SSCCCCTTTTCCCCHHHHHHHHHH
T ss_pred HHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccC--CCCCccchhhccCCHHHHHHHHHH
Confidence 99999999999999999999999999875443321111 1122221 2234456777666543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=249.50 Aligned_cols=161 Identities=27% Similarity=0.295 Sum_probs=124.2
Q ss_pred cCCcHHHHHHHHHHHh--hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELL--PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh--~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|.||| +.||+||||||+|||++.+....+||+|||+++.... ......||+.|+|||++.+..++
T Consensus 159 ~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~ 236 (382)
T 2vx3_A 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYD 236 (382)
T ss_dssp HHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCC
Confidence 3467889999999999 5799999999999999654445699999999976532 34456899999999999988876
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC---------------------------------CCC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------------------------------SIP 134 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~ 134 (254)
.+ +|||||||++|+|++|+.||.+.........+......... ..+
T Consensus 237 ~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (382)
T 2vx3_A 237 LA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315 (382)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCT
T ss_pred cH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCc
Confidence 55 99999999999999999999987766555554432111000 000
Q ss_pred CCCC-------------------------CCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 135 DYVH-------------------------ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 135 ~~~~-------------------------~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
.... .++.+++||.+||..||.+|||+.++|+||||++.
T Consensus 316 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 316 GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred chhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 0000 01378999999999999999999999999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=240.08 Aligned_cols=161 Identities=24% Similarity=0.364 Sum_probs=120.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++....... ......+|+.|+|||++.+....+
T Consensus 104 ~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (311)
T 4agu_A 104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC------------GGGCCHHHHHTCSCCC
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCC
Confidence 3456789999999999999999999999999987765 9999999997654322 234457899999999997644434
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cCCCCCC----------CCCCCHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIPD----------YVHISPEC 143 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~----------~~~~~~~~ 143 (254)
.++|||||||++|+|++|..||.+................ .....+. ...+++.+
T Consensus 182 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (311)
T 4agu_A 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPA 261 (311)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHH
T ss_pred cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHH
Confidence 5599999999999999999999887665544433322111 0001111 13578899
Q ss_pred HHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 144 RHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
.+||.+||..||.+|||++++++||||++
T Consensus 262 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 262 LGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 99999999999999999999999999976
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=245.78 Aligned_cols=160 Identities=28% Similarity=0.503 Sum_probs=124.8
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcccchhccC--C
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLK--K 84 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~ 84 (254)
.++.|++.+|+|||++||+||||||+|||++.++...+||+|||++....... ......||+.|+|||++.+ .
T Consensus 172 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 47889999999999999999999999999987764469999999997543211 1234579999999999875 4
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.++ .++|||||||++|+|++|+.||.+............. ......+.+..+++.+++||.+||..||.+|||+.++
T Consensus 252 ~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 252 SYG-PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK--KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCC-cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc--ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 444 4599999999999999999999887665544443321 1122223334579999999999999999999999999
Q ss_pred hcCccccccC
Q 025350 165 RNHEWFLKNL 174 (254)
Q Consensus 165 l~hp~~~~~~ 174 (254)
++||||++..
T Consensus 329 l~hp~~~~~~ 338 (345)
T 3hko_A 329 LQHPWISQFS 338 (345)
T ss_dssp HHSHHHHTTS
T ss_pred hcChhhccCh
Confidence 9999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=258.49 Aligned_cols=158 Identities=30% Similarity=0.446 Sum_probs=129.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|.|||++||+||||||+|||++.++. +||+|||+++....... ....+||+.|+|||++.+..++.
T Consensus 291 ~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 368 (543)
T 3c4z_A 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368 (543)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCCCcccccccCCccccChhhhcCCCCCh
Confidence 3456789999999999999999999999999988776 99999999986544332 23458999999999999888865
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e 163 (254)
+ +|||||||++|+|++|..||.+.............+.......| ..+++.+++||++||..||.+||+ +++
T Consensus 369 ~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~e 445 (543)
T 3c4z_A 369 S-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDG 445 (543)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHH
T ss_pred H-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHHH
Confidence 5 99999999999999999999876433233334444444444444 458999999999999999999996 589
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 446 i~~Hpff~~ 454 (543)
T 3c4z_A 446 LRTHPLFRD 454 (543)
T ss_dssp HHTSGGGTT
T ss_pred HHcCccccC
Confidence 999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=264.03 Aligned_cols=154 Identities=31% Similarity=0.511 Sum_probs=129.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.||.|||++|||||||||+|||++.++. +||+|||+|+.... .....+.+||+.|+|||++.+..++.
T Consensus 444 ~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 521 (674)
T 3pfq_A 444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521 (674)
T ss_dssp HHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBST
T ss_pred HHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCc
Confidence 4457889999999999999999999999999988776 99999999985332 23345568999999999998888865
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH-----hH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-----PE 163 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e 163 (254)
+ +|||||||++|+|++|..||.+.+.... ...+......+|. .+++++++||++||..||.+||++ ++
T Consensus 522 ~-~DvwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~e 594 (674)
T 3pfq_A 522 S-VDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERD 594 (674)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHSSCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHH
T ss_pred c-ceEechHHHHHHHHcCCCCCCCCCHHHH----HHHHHhCCCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHH
Confidence 5 9999999999999999999998655433 3344455555554 589999999999999999999997 99
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
|++||||+.
T Consensus 595 i~~h~ff~~ 603 (674)
T 3pfq_A 595 IKEHAFFRY 603 (674)
T ss_dssp HHSSGGGSS
T ss_pred HhcCccccC
Confidence 999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.23 Aligned_cols=156 Identities=33% Similarity=0.559 Sum_probs=126.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC-----
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK----- 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~----- 84 (254)
...++.|++.+|.|||+.||+||||||+|||++.++. +||+|||++.............||+.|+|||++.+.
T Consensus 202 ~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 279 (365)
T 2y7j_A 202 TRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH 279 (365)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTS
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccCCCcccccCCCCCCccChhhccccccccC
Confidence 4457789999999999999999999999999988775 999999999876555455567899999999998632
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC--CCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 85 -EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 85 -~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
.++. ++|||||||++|+|++|..||........... +...... .+.+..++..+.+||.+||..||.+|||+
T Consensus 280 ~~~~~-~~Di~slG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 354 (365)
T 2y7j_A 280 PGYGK-EVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTA 354 (365)
T ss_dssp CCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred cCCCc-hhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 3444 49999999999999999999987654333322 2222222 22334678999999999999999999999
Q ss_pred hHHhcCccccc
Q 025350 162 PEIRNHEWFLK 172 (254)
Q Consensus 162 ~e~l~hp~~~~ 172 (254)
.++++||||++
T Consensus 355 ~ell~hp~f~r 365 (365)
T 2y7j_A 355 EQALQHPFFER 365 (365)
T ss_dssp HHHHHSGGGCC
T ss_pred HHHhcCcccCC
Confidence 99999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=240.04 Aligned_cols=161 Identities=27% Similarity=0.323 Sum_probs=129.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||++.............+++.|+|||++.+..++.+
T Consensus 122 ~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 199 (326)
T 1blx_A 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 199 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcc
Confidence 3457889999999999999999999999999988775 99999999986544444455678999999999988877655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-CCC--------------------CCCCCCCHHHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSI--------------------PDYVHISPECRHLIS 148 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~--------------------~~~~~~~~~~~~li~ 148 (254)
+|||||||++|+|++|..||.+.................. ..+ .....+++.+++||.
T Consensus 200 -~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (326)
T 1blx_A 200 -VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 278 (326)
T ss_dssp -HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred -hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHH
Confidence 9999999999999999999998776555555443321110 000 012357899999999
Q ss_pred HhchhCCCCCCCHhHHhcCcccccc
Q 025350 149 RIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 149 ~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+||..||.+|||+.++++||||++.
T Consensus 279 ~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 279 KCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHcCCCcccCCCHHHHhcCcccccc
Confidence 9999999999999999999999763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=247.53 Aligned_cols=161 Identities=30% Similarity=0.541 Sum_probs=126.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC--CcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||+..... ..+||+|||+++..... ......+||+.|+|||++.+..+
T Consensus 118 ~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 197 (342)
T 2qr7_A 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCC
Confidence 3457889999999999999999999999999854321 35999999999865433 23345679999999999987766
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
+.+ +|||||||++|+|++|..||.+... .........+.......+ .+..+++.+++||++||..||.+|||+.++
T Consensus 198 ~~~-~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~i 275 (342)
T 2qr7_A 198 DAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275 (342)
T ss_dssp HHH-HHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCc-cCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 554 9999999999999999999986432 122233333444443332 345689999999999999999999999999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||.+
T Consensus 276 l~hp~~~~ 283 (342)
T 2qr7_A 276 LRHPWIVH 283 (342)
T ss_dssp TTSHHHHT
T ss_pred hcCCeecC
Confidence 99999965
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=245.39 Aligned_cols=157 Identities=30% Similarity=0.556 Sum_probs=125.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||++||+||||||+|||++.++ ...+||+|||++........ ....+||+.|+|||++.+..++
T Consensus 132 ~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 211 (351)
T 3c0i_A 132 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 211 (351)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCC
Confidence 345778999999999999999999999999997643 23599999999976544332 3456799999999999888776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|..||.+... .....+.......+ .+..+++.+++||.+||..||.+|||+.+++
T Consensus 212 ~~-~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 285 (351)
T 3c0i_A 212 KP-VDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285 (351)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCSSHH-----HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ch-HhhHHHHHHHHHHHHCCCCCCCcHH-----HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 55 9999999999999999999987421 12222333332222 2346899999999999999999999999999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 286 ~hp~~~~ 292 (351)
T 3c0i_A 286 NHPWLKE 292 (351)
T ss_dssp TSHHHHT
T ss_pred cChhhcC
Confidence 9999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=245.43 Aligned_cols=158 Identities=25% Similarity=0.350 Sum_probs=121.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-----------------------CCCcEEEecCCCcccCCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-----------------------PAPRLKICDFGYSKSSVLHSQP 66 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-----------------------~~~~vkl~Dfg~a~~~~~~~~~ 66 (254)
...++.|++.+|+|||++||+||||||+|||++.. ....+||+|||++..... ..
T Consensus 139 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~ 216 (360)
T 3llt_A 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YH 216 (360)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CC
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CC
Confidence 34578899999999999999999999999999751 134599999999975332 33
Q ss_pred CCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC----------------
Q 025350 67 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------- 130 (254)
Q Consensus 67 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 130 (254)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+............ .....
T Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~ 294 (360)
T 3llt_A 217 GSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMES-IIQPIPKNMLYEATKTNGSKY 294 (360)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HTCCCCHHHHHHHTTSGGGGG
T ss_pred cCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH-hcCCCCHHHHhhhhhccCccc
Confidence 45679999999999998888765 9999999999999999999988665444333222 11100
Q ss_pred -------CCCCCC------------------CCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccc
Q 025350 131 -------YSIPDY------------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 171 (254)
Q Consensus 131 -------~~~~~~------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 171 (254)
..+|.. ...++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 295 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 295 VNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp EETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 000100 01237788999999999999999999999999995
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=240.19 Aligned_cols=157 Identities=25% Similarity=0.399 Sum_probs=114.1
Q ss_pred cCCcHHHHHHHHHHHhhc-CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhc----cCC
Q 025350 10 RGTLFLPTTYFWSELLPF-NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----LKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~-givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~----~~~ 84 (254)
...++.|++.+++|||++ ||+||||||+||+++.++. +||+|||++.............||+.|+|||++ .+.
T Consensus 111 ~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 188 (290)
T 3fme_A 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC---------------CCCCCCSCHHHHSCCTTC-
T ss_pred HHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccccccccccccCCCccccChhhcChhhcCc
Confidence 345788999999999998 9999999999999987765 999999999866554444555799999999996 334
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.++ .++|||||||++|+|++|..||........... ..............+++.+.+||.+||..||.+|||+.++
T Consensus 189 ~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~ 264 (290)
T 3fme_A 189 GYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLK---QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264 (290)
T ss_dssp -CC-HHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH---HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCC-cHHHHHHHHHHHHHHHHCCCCccccCchHHHHH---HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 444 459999999999999999999986443322221 1222222222234589999999999999999999999999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||+.
T Consensus 265 l~hp~f~~ 272 (290)
T 3fme_A 265 MQHPFFTL 272 (290)
T ss_dssp TTSHHHHH
T ss_pred HhCccccc
Confidence 99999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=238.10 Aligned_cols=157 Identities=27% Similarity=0.503 Sum_probs=117.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-CCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+||+++.. ....+||+|||++.............|++.|+|||++.+ .++
T Consensus 126 ~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~- 203 (285)
T 3is5_A 126 VAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVT- 203 (285)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-CCC-
T ss_pred HHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-CCC-
Confidence 44678899999999999999999999999999542 224599999999986555444556679999999999864 454
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC-CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
.++|||||||++|+|++|+.||.+......... ....... ......+++.+.+||.+||..||.+|||+.++++|
T Consensus 204 ~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 204 FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh----hccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 459999999999999999999987654333222 1111111 12223478999999999999999999999999999
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||++
T Consensus 280 p~f~~ 284 (285)
T 3is5_A 280 EWFKQ 284 (285)
T ss_dssp GGGGC
T ss_pred HHhhc
Confidence 99975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=238.36 Aligned_cols=158 Identities=34% Similarity=0.595 Sum_probs=127.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEe---cCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll---~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+++|||++||+||||||+||++ +.++ .+||+|||++.............||+.|+|||++.+. +
T Consensus 108 ~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~ 184 (277)
T 3f3z_A 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y 184 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-B
T ss_pred HHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCccchhccCCCCCccChHHhccc-C
Confidence 44578899999999999999999999999999 4444 4999999999866555555566799999999998654 5
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC--CCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
+.+ +||||||+++|+|++|..||........... +.......+. +..+++.+.+||.+||..||.+|||+.++
T Consensus 185 ~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~ 259 (277)
T 3f3z_A 185 GPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259 (277)
T ss_dssp CTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred Cch-hhehhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 444 9999999999999999999988665443333 2233333322 23579999999999999999999999999
Q ss_pred hcCccccccCC
Q 025350 165 RNHEWFLKNLP 175 (254)
Q Consensus 165 l~hp~~~~~~~ 175 (254)
++||||++...
T Consensus 260 l~h~~~~~~~~ 270 (277)
T 3f3z_A 260 LEHEWFEKQLS 270 (277)
T ss_dssp TTSHHHHHHHC
T ss_pred hcCHHHhcccc
Confidence 99999987553
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=245.05 Aligned_cols=158 Identities=27% Similarity=0.392 Sum_probs=119.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccC---
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK--- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~--- 83 (254)
+..++.|++.+|+|||++||+||||||+|||++. + .+||+|||+++....... ....+||+.|+|||++.+
T Consensus 110 ~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 186 (343)
T 3dbq_A 110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186 (343)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccc
Confidence 3457889999999999999999999999999974 3 499999999976543221 234579999999999864
Q ss_pred --------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 84 --------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 84 --------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
..++ .++|||||||++|+|++|+.||........ ..................+..+.+||.+||..||
T Consensus 187 ~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp 262 (343)
T 3dbq_A 187 SRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 262 (343)
T ss_dssp ----------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred cccccccccCCC-chhhHHHHHHHHHHHHhCCCcchhhhhHHH---HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCCh
Confidence 3444 459999999999999999999986543221 1222333333333334567899999999999999
Q ss_pred CCCCCHhHHhcCccccccC
Q 025350 156 AKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 156 ~~Rps~~e~l~hp~~~~~~ 174 (254)
.+|||+.++++||||+...
T Consensus 263 ~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 263 KQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp TTSCCHHHHHTSHHHHSCC
T ss_pred hHCCCHHHHHhCccccccC
Confidence 9999999999999997644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=237.29 Aligned_cols=159 Identities=38% Similarity=0.643 Sum_probs=121.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++.............+++.|+|||++.+..+.+.
T Consensus 113 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 190 (276)
T 2h6d_A 113 ARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC-------------CCTGGGTTSCCCHH
T ss_pred HHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCc
Confidence 3457889999999999999999999999999987765 99999999986654444455678999999999987776556
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++||||||+++|+|++|..||......... ..+.......| ..++..+.++|.+||..||.+|||+.++++|||
T Consensus 191 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLF----KKIRGGVFYIP--EYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred cchHHHHHHHHHHHHhCCCCCCCCcHHHHH----HHhhcCcccCc--hhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 699999999999999999999875543322 22223333333 347899999999999999999999999999999
Q ss_pred ccccCCc
Q 025350 170 FLKNLPA 176 (254)
Q Consensus 170 ~~~~~~~ 176 (254)
|++.++.
T Consensus 265 ~~~~~~~ 271 (276)
T 2h6d_A 265 FKQDLPS 271 (276)
T ss_dssp HHTTCCG
T ss_pred hccCchh
Confidence 9887654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=248.57 Aligned_cols=158 Identities=26% Similarity=0.384 Sum_probs=121.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccC---
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLK--- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~--- 83 (254)
+..++.|++.+|.|||++||+||||||+|||++. + .+||+|||+++...... .....+||+.|+|||++.+
T Consensus 157 ~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 233 (390)
T 2zmd_A 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233 (390)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S--CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC--
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C--eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccc
Confidence 3457789999999999999999999999999964 3 49999999998654322 1245579999999999865
Q ss_pred --------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 84 --------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 84 --------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
..+ +.++|||||||++|+|++|..||........ .+..+.......+.....+..+++||.+||..||
T Consensus 234 ~~~~~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 309 (390)
T 2zmd_A 234 SRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 309 (390)
T ss_dssp ----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred cccccccccCC-CChhhHHHHHHHHHHHHHCCCcchhhhHHHH---HHHHHhCccccCCCCccchHHHHHHHHHHcccCh
Confidence 234 4459999999999999999999987543221 2223333333333334468899999999999999
Q ss_pred CCCCCHhHHhcCccccccC
Q 025350 156 AKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 156 ~~Rps~~e~l~hp~~~~~~ 174 (254)
.+|||+.++++||||+...
T Consensus 310 ~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 310 KQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp TTSCCHHHHHTSHHHHSCC
T ss_pred hhCCCHHHHhhCcCccccC
Confidence 9999999999999997643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=252.44 Aligned_cols=158 Identities=26% Similarity=0.480 Sum_probs=126.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhcc-----
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLL----- 82 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~----- 82 (254)
...++.|++.||.|||++|||||||||+|||++.++. +||+|||+|+....... ....+||+.|+|||++.
T Consensus 177 ~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 254 (437)
T 4aw2_A 177 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254 (437)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccC
Confidence 3457889999999999999999999999999988776 99999999975543322 23457999999999987
Q ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC-CCCCCHHHHHHHHHhchhCCCC--CC
Q 025350 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLISRIFVADPAK--RI 159 (254)
Q Consensus 83 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~--Rp 159 (254)
...++. ++|||||||++|+|++|+.||.+.+......++...... ...|. ...+++++++||++||..+|++ |+
T Consensus 255 ~~~~~~-~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~ 331 (437)
T 4aw2_A 255 KGRYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--FQFPTQVTDVSENAKDLIRRLICSREHRLGQN 331 (437)
T ss_dssp CCEECT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTT
T ss_pred CCCCCC-cCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc--ccCCcccccCCHHHHHHHHHHhcccccccCCC
Confidence 344544 599999999999999999999987765555554432211 22332 2458999999999999988888 99
Q ss_pred CHhHHhcCccccc
Q 025350 160 SIPEIRNHEWFLK 172 (254)
Q Consensus 160 s~~e~l~hp~~~~ 172 (254)
+++++++||||+.
T Consensus 332 ~~~eil~Hpff~~ 344 (437)
T 4aw2_A 332 GIEDFKKHPFFSG 344 (437)
T ss_dssp TTHHHHTSGGGTT
T ss_pred CHHHHhCCCccCC
Confidence 9999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=241.28 Aligned_cols=158 Identities=29% Similarity=0.489 Sum_probs=128.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC--CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||++||+||||||+||+++.++. ..+||+|||++.............||+.|+|||++.+..++
T Consensus 117 ~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (321)
T 2a2a_A 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG 196 (321)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCC
Confidence 4457889999999999999999999999999987652 15999999999876555445566799999999999887776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC--CCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|..||.+......... +.......+. +..+++.+++||.+||..||.+|||+.+++
T Consensus 197 ~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 271 (321)
T 2a2a_A 197 LE-ADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEAL 271 (321)
T ss_dssp TH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHH
T ss_pred Cc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 55 9999999999999999999987655433332 2233222221 245789999999999999999999999999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 272 ~hp~~~~ 278 (321)
T 2a2a_A 272 RHPWITP 278 (321)
T ss_dssp HSTTTSC
T ss_pred cCccccC
Confidence 9999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=248.73 Aligned_cols=161 Identities=21% Similarity=0.342 Sum_probs=120.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC--------CCCCCCcCCCCcccchhc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--------SQPKSTVGTPAYIAPEVL 81 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--------~~~~~~~~~~~y~aPE~~ 81 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||.+...... ......+||+.|+|||++
T Consensus 130 ~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (389)
T 3gni_B 130 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207 (389)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccccceeeccccccccccccccccccccccccCHHHH
Confidence 4457889999999999999999999999999987775 999999987533211 122334789999999999
Q ss_pred cC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc------------------------------
Q 025350 82 LK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------------------------ 129 (254)
Q Consensus 82 ~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------------------------ 129 (254)
.+ ..++. ++|||||||++|+|++|+.||.+.................
T Consensus 208 ~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (389)
T 3gni_B 208 QQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLT 286 (389)
T ss_dssp STTSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------
T ss_pred hccCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccc
Confidence 87 45555 4999999999999999999998765544433322111000
Q ss_pred ----------CCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 130 ----------QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 130 ----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
....+....+++.+++||.+||..||.+|||+.++|+||||++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 287 TSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp -------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 00111234578999999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=259.91 Aligned_cols=162 Identities=31% Similarity=0.530 Sum_probs=129.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-CCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++.. ....+||+|||++............+||+.|+|||++.+ .++.
T Consensus 128 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 206 (484)
T 3nyv_A 128 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDE 206 (484)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCT
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCC
Confidence 34578899999999999999999999999999532 223599999999976544444445579999999999876 4554
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
++|||||||++|+|++|.+||.+.........+... ......+.+..+|+.+++||++||..||.+|||+.++|+||
T Consensus 207 -~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 207 -KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG--KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp -HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred -cceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 499999999999999999999987654443332221 12233445567899999999999999999999999999999
Q ss_pred cccccCC
Q 025350 169 WFLKNLP 175 (254)
Q Consensus 169 ~~~~~~~ 175 (254)
||+....
T Consensus 284 ~~~~~~~ 290 (484)
T 3nyv_A 284 WIQTYTK 290 (484)
T ss_dssp HHHHHTC
T ss_pred hhccccc
Confidence 9986543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=236.42 Aligned_cols=155 Identities=34% Similarity=0.550 Sum_probs=123.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++..... .......|++.|+|||++.+..++.+
T Consensus 111 ~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 187 (279)
T 3fdn_A 111 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMIEGRMHDEK 187 (279)
T ss_dssp HHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-ccccccCCCCCccCHhHhccCCCCcc
Confidence 3457789999999999999999999999999988776 99999998865432 22345578999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+||||||+++|+|++|..||.......... .+.......+ ..+++.+++||.+||..||.+|||+.++++|||
T Consensus 188 -~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 188 -VDLWSLGVLCYEFLVGKPPFEANTYQETYK----RISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCCC--TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred -chhHhHHHHHHHHHHCCCCCCCCcHHHHHH----HHHhCCCCCC--CcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 999999999999999999998765433332 2233333333 347999999999999999999999999999999
Q ss_pred ccccC
Q 025350 170 FLKNL 174 (254)
Q Consensus 170 ~~~~~ 174 (254)
|+...
T Consensus 261 ~~~~~ 265 (279)
T 3fdn_A 261 ITANS 265 (279)
T ss_dssp HHHHC
T ss_pred ccCCc
Confidence 98744
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=248.55 Aligned_cols=157 Identities=27% Similarity=0.460 Sum_probs=124.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccC----
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLK---- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~---- 83 (254)
...++.|++.+|.|||++||+||||||+|||++.++. +||+|||+++....... ....+||+.|+|||++..
T Consensus 164 ~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~ 241 (412)
T 2vd5_A 164 ARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241 (412)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccC
Confidence 3456789999999999999999999999999988776 99999999976543322 234589999999999872
Q ss_pred ---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC-CCCCCHHHHHHHHHhchhCCCCC-
Q 025350 84 ---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLISRIFVADPAKR- 158 (254)
Q Consensus 84 ---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R- 158 (254)
..++. ++|||||||++|+|++|+.||.+.+......++...... ...|. ...+|+++++||++||. +|.+|
T Consensus 242 ~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~s~~~~dli~~lL~-~p~~Rl 317 (412)
T 2vd5_A 242 PGTGSYGP-ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH--LSLPLVDEGVPEEARDFIQRLLC-PPETRL 317 (412)
T ss_dssp TTCSEECT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCC----CCCHHHHHHHHTTSS-CGGGCT
T ss_pred cCCCCCCh-HHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--cCCCccccCCCHHHHHHHHHHcC-ChhhcC
Confidence 34544 499999999999999999999987665555444332111 22232 24589999999999999 99998
Q ss_pred --CCHhHHhcCccccc
Q 025350 159 --ISIPEIRNHEWFLK 172 (254)
Q Consensus 159 --ps~~e~l~hp~~~~ 172 (254)
++++++++||||+.
T Consensus 318 gr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 318 GRGGAGDFRTHPFFFG 333 (412)
T ss_dssp TTTTHHHHHTSGGGTT
T ss_pred CCCCHHHHhcCCCcCC
Confidence 59999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=243.64 Aligned_cols=155 Identities=26% Similarity=0.352 Sum_probs=125.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc---CCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++..... .....||+.|+|||++. ...+
T Consensus 156 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~ 230 (348)
T 1u5q_A 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQY 230 (348)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCB
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCC
Confidence 3457789999999999999999999999999987765 99999999976432 23457999999999985 3455
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|||||||++|+|++|..||.+.......... ............+++.+++||.+||..||.+|||+.++++
T Consensus 231 ~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 231 DGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 544 99999999999999999999876654433322 2222222233467999999999999999999999999999
Q ss_pred CccccccC
Q 025350 167 HEWFLKNL 174 (254)
Q Consensus 167 hp~~~~~~ 174 (254)
||||.+..
T Consensus 306 h~~~~~~~ 313 (348)
T 1u5q_A 306 HRFVLRER 313 (348)
T ss_dssp CHHHHSCC
T ss_pred ChhhhccC
Confidence 99997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=234.00 Aligned_cols=160 Identities=31% Similarity=0.547 Sum_probs=127.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||++...... .......|++.|+|||++.+..+
T Consensus 107 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (276)
T 2yex_A 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184 (276)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSB
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCC
Confidence 3457889999999999999999999999999987765 999999998754322 12334578999999999987776
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+.++||||||+++|+|++|..||............ ........+.+..+++.+++||.+||..||.+|||+.++++
T Consensus 185 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 556699999999999999999999876543222221 22222233344568999999999999999999999999999
Q ss_pred CccccccC
Q 025350 167 HEWFLKNL 174 (254)
Q Consensus 167 hp~~~~~~ 174 (254)
||||++..
T Consensus 262 ~~~~~~~~ 269 (276)
T 2yex_A 262 DRWYNKPL 269 (276)
T ss_dssp CTTTTCCC
T ss_pred CccccChh
Confidence 99998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=251.57 Aligned_cols=159 Identities=32% Similarity=0.522 Sum_probs=117.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC---CC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK---KE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++ ...+||+|||+++...........+||+.|+|||++.+ ..
T Consensus 241 ~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 320 (419)
T 3i6u_A 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAG 320 (419)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CT
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCC
Confidence 345778999999999999999999999999997543 23599999999987655555556789999999999864 33
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC--CCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
+ +.++|||||||++|+|++|..||............+. ...... ..+..+++.+++||.+||..||.+|||+.+
T Consensus 321 ~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 396 (419)
T 3i6u_A 321 Y-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396 (419)
T ss_dssp T-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred C-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHH
Confidence 3 3459999999999999999999987554333333222 222221 122457999999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||++
T Consensus 397 ~l~hp~~~~ 405 (419)
T 3i6u_A 397 ALRHPWLQD 405 (419)
T ss_dssp HHHSGGGCC
T ss_pred HhCCcccCC
Confidence 999999965
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=240.45 Aligned_cols=159 Identities=28% Similarity=0.343 Sum_probs=123.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-----------------CCcEEEecCCCcccCCCCCCCCCCcCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-----------------APRLKICDFGYSKSSVLHSQPKSTVGT 72 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-----------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 72 (254)
...++.|++.+|+|||++||+||||||+|||++..+ ...+||+|||++.... .......||
T Consensus 120 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt 197 (339)
T 1z57_A 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD--EHHSTLVST 197 (339)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETT--SCCCSSCSC
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCc--cccccccCC
Confidence 345788999999999999999999999999998643 3359999999997543 233456799
Q ss_pred CCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC------------------C--
Q 025350 73 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------------------S-- 132 (254)
Q Consensus 73 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------~-- 132 (254)
+.|+|||++.+..++.+ +|||||||++|+|++|..||............. ....... .
T Consensus 198 ~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 275 (339)
T 1z57_A 198 RHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME-RILGPLPKHMIQKTRKRKYFHHDRLDWD 275 (339)
T ss_dssp GGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH-HHHCSCCHHHHHHCSCGGGEETTEECCC
T ss_pred ccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCCCCHHHHhhccchhHHhhcccccc
Confidence 99999999988877655 999999999999999999998866544333222 1111000 0
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 133 -------------------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 133 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
.......++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 276 EHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp TTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred ccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 0001123467899999999999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=243.80 Aligned_cols=156 Identities=22% Similarity=0.260 Sum_probs=109.4
Q ss_pred cCCcHHHHHHHHHHHhhc--------CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcc
Q 025350 10 RGTLFLPTTYFWSELLPF--------NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYI 76 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~--------givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~ 76 (254)
+..++.|++.|++|||++ |||||||||+|||++.++. +||+|||+|+...... .....+||+.||
T Consensus 102 ~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ym 179 (303)
T 3hmm_A 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179 (303)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEESCC-----CCGGGC
T ss_pred HHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCccccCCCCceeeeccccccccccc
Confidence 345788999999999977 9999999999999988876 9999999997543322 123457999999
Q ss_pred cchhccCCCC-----CCcchhHHHHHHHHHHHHhCCCCCCCCCc----------h-HHHHHHHHHHhccCCC--CCCC--
Q 025350 77 APEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEE----------P-KNFRKTIHRILSVQYS--IPDY-- 136 (254)
Q Consensus 77 aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~----------~-~~~~~~~~~~~~~~~~--~~~~-- 136 (254)
|||++.+... .+.++|||||||++|||+||.+||..... . .........+...... .|..
T Consensus 180 APE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~ 259 (303)
T 3hmm_A 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 259 (303)
T ss_dssp CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred CHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCcccc
Confidence 9999976421 13459999999999999999876643211 0 1112222222222222 1111
Q ss_pred -CCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 137 -VHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 137 -~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
...+..+.+|+.+||..||.+|||+.++++.
T Consensus 260 ~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 260 SCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1123468899999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=243.12 Aligned_cols=163 Identities=30% Similarity=0.526 Sum_probs=109.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||++||+||||||+|||++.++ ...+||+|||+++...... .....+||+.|+|||++.+..++
T Consensus 108 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 187 (325)
T 3kn6_A 108 ASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD 187 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCC
T ss_pred HHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCC
Confidence 445788999999999999999999999999997654 2259999999997543322 23455789999999999888776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhccCCCCCC--CCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
.+ +|||||||++|+|++|..||.+.... .........+.......+. +..+++++++||.+||..||.+|||+.
T Consensus 188 ~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 266 (325)
T 3kn6_A 188 ES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266 (325)
T ss_dssp HH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTT
T ss_pred Cc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHH
Confidence 55 99999999999999999999864421 1122334444444433322 235799999999999999999999999
Q ss_pred HHhcCcccccc
Q 025350 163 EIRNHEWFLKN 173 (254)
Q Consensus 163 e~l~hp~~~~~ 173 (254)
++++||||++.
T Consensus 267 ell~h~w~~~~ 277 (325)
T 3kn6_A 267 GLRYNEWLQDG 277 (325)
T ss_dssp TSTTCGGGCTT
T ss_pred HHhcChhhccC
Confidence 99999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=250.72 Aligned_cols=147 Identities=15% Similarity=0.207 Sum_probs=117.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC-----
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK----- 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~----- 84 (254)
+..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++.... .....+| +.|+|||++.+.
T Consensus 208 ~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~ 282 (377)
T 3byv_A 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISY 282 (377)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHH
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEechhheecCC--cccCCCC-cCccChhhhcccccccc
Confidence 4457899999999999999999999999999987765 99999999985322 2334567 999999999877
Q ss_pred ------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCC
Q 025350 85 ------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 85 ------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
.++. ++|||||||++|+|++|+.||.+....... .........+++.+++||.+||..||.+|
T Consensus 283 ~~~~~~~~~~-~~DvwSlG~il~elltg~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 283 HRDRRTLMTF-SFDAWALGLVIYWIWCADLPITKDAALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHCCEEECCH-HHHHHHHHHHHHHHHHSSCCC------CCS----------GGGGSSCCCCCHHHHHHHHHHTCSSGGGC
T ss_pred cccccccCCh-hhhHHHHHHHHHHHHHCCCCCcccccccch----------hhhhhhccCCCHHHHHHHHHHcCCCchhC
Confidence 6654 499999999999999999999764322111 11112234689999999999999999999
Q ss_pred CCHhHHhcCccccc
Q 025350 159 ISIPEIRNHEWFLK 172 (254)
Q Consensus 159 ps~~e~l~hp~~~~ 172 (254)
||+.++++||||+.
T Consensus 352 pt~~e~l~hp~f~~ 365 (377)
T 3byv_A 352 LLPLQAMETPEYEQ 365 (377)
T ss_dssp CCHHHHHTSHHHHH
T ss_pred CCHHHHhhChHHHH
Confidence 99999999999965
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=240.08 Aligned_cols=164 Identities=29% Similarity=0.381 Sum_probs=124.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-----------CCCCcCCCCcccc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----------PKSTVGTPAYIAP 78 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-----------~~~~~~~~~y~aP 78 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++........ .....||+.|+||
T Consensus 114 ~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (353)
T 2b9h_A 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC----------------CCCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccccccccccCccccccchhhccccccccCC
Confidence 3457789999999999999999999999999988765 99999999975432211 1234689999999
Q ss_pred hhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC--------------------CCCC----
Q 025350 79 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------------YSIP---- 134 (254)
Q Consensus 79 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------~~~~---- 134 (254)
|++.+....+.++|||||||++|+|++|..||.+.................. ...+
T Consensus 192 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
T 2b9h_A 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL 271 (353)
T ss_dssp HHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCH
T ss_pred eeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcch
Confidence 9886644445569999999999999999999998765444433322111100 0000
Q ss_pred --CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 135 --DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 135 --~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
.+..+++.+++||.+||..||.+|||+.++++||||+....
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 272 EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 01357899999999999999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=242.47 Aligned_cols=160 Identities=25% Similarity=0.317 Sum_probs=122.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-----------------CCCcEEEecCCCcccCCCCCCCCCCcCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQPKSTVGT 72 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-----------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 72 (254)
...++.|++.+|+|||++||+||||||+|||++.. ....+||+|||+++... .......||
T Consensus 125 ~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt 202 (355)
T 2eu9_A 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVAT 202 (355)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccc--ccccCCcCC
Confidence 44578899999999999999999999999999432 12359999999997533 233456799
Q ss_pred CCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC------------------C--
Q 025350 73 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------------------S-- 132 (254)
Q Consensus 73 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------~-- 132 (254)
+.|+|||++.+..++.+ +|||||||++|+|++|..||.............. ...... .
T Consensus 203 ~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~ 280 (355)
T 2eu9_A 203 RHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK-ILGPIPSHMIHRTRKQKYFYKGGLVWD 280 (355)
T ss_dssp GGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCCHHHHHHCSCGGGEETTEECCC
T ss_pred CcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HcCCCcHHHhhhccchhhhcccccccc
Confidence 99999999988887665 9999999999999999999988765444333222 111100 0
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 133 -------------------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 133 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
.......+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 281 ENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred cccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 00011124578899999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=243.50 Aligned_cols=158 Identities=32% Similarity=0.501 Sum_probs=124.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCC-CC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKE-YD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~ 87 (254)
..++.|++.+|.|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+.. ..
T Consensus 162 ~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 239 (355)
T 1vzo_A 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239 (355)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCC
Confidence 456779999999999999999999999999988775 9999999997543221 223457999999999997532 22
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIP 162 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~ 162 (254)
+.++|||||||++|+|++|+.||...............+.......+ ..++..+++||.+||..||.+|| |+.
T Consensus 240 ~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ 317 (355)
T 1vzo_A 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 317 (355)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHH
T ss_pred CchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--cccCHHHHHHHHHHhhhCHHHhcCCCCCCHH
Confidence 44599999999999999999999865433333334444444333333 45899999999999999999999 999
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++||||++
T Consensus 318 ell~h~~f~~ 327 (355)
T 1vzo_A 318 EIKEHLFFQK 327 (355)
T ss_dssp HHHTSGGGTT
T ss_pred HHHcCcchhc
Confidence 9999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.73 Aligned_cols=161 Identities=25% Similarity=0.397 Sum_probs=122.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||++...... .......+++.|+|||++.+....+
T Consensus 126 ~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 203 (331)
T 4aaa_A 126 VQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203 (331)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC------------CCCCCTTCCHHHHTTCTTCC
T ss_pred HHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcc
Confidence 3457889999999999999999999999999988775 999999999754332 2234457899999999998764444
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cCCCCCC----------CCCCCHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIPD----------YVHISPEC 143 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~----------~~~~~~~~ 143 (254)
.++|||||||++|+|++|+.||.+................ .....+. ...+++.+
T Consensus 204 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 283 (331)
T 4aaa_A 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV 283 (331)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHH
T ss_pred hHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHH
Confidence 5599999999999999999999987765554443322110 0011111 12578999
Q ss_pred HHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 144 RHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
.+||.+||..||.+|||+.++|+||||+.
T Consensus 284 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 284 IDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred HHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 99999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=239.11 Aligned_cols=163 Identities=31% Similarity=0.519 Sum_probs=119.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC-CcEEEecCCCcccCCCCC--------CCCCCcCCCCcccchh
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEV 80 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~ 80 (254)
...++.|++.+|+|||++||+||||||+|||++.++. ..+||+|||++....... .....+||+.|+|||+
T Consensus 113 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 192 (316)
T 2ac3_A 113 ASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHH
Confidence 3457889999999999999999999999999986543 349999999987543211 1223469999999999
Q ss_pred ccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchH-----------HHHHHHHHHhccCCCCCC--CCCCCHH
Q 025350 81 LLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----------NFRKTIHRILSVQYSIPD--YVHISPE 142 (254)
Q Consensus 81 ~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~--~~~~~~~ 142 (254)
+.+ ..++.+ +|||||||++|+|++|+.||.+..... ........+.......+. +..+++.
T Consensus 193 ~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (316)
T 2ac3_A 193 VEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCA 271 (316)
T ss_dssp HHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred hhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHH
Confidence 864 345444 999999999999999999998754211 112223333334333332 2457999
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+++||.+||..||.+|||+.++++||||+..
T Consensus 272 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 272 AKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 9999999999999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=234.43 Aligned_cols=160 Identities=31% Similarity=0.544 Sum_probs=127.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc------C
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL------K 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~------~ 83 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||++.............+++.|+|||++. .
T Consensus 126 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (298)
T 1phk_A 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 203 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTS
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhhcCCCcccccccCCccccCHHHhcccccccc
Confidence 4457889999999999999999999999999988776 9999999998665544445567999999999985 2
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++ .++||||||+++|+|++|..||............... ......+.+..++..+.+||.+||..||.+|||+.+
T Consensus 204 ~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (298)
T 1phk_A 204 PGYG-KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280 (298)
T ss_dssp CCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ccCC-cccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC--CcccCcccccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 3344 4599999999999999999999876544333322211 112222334568999999999999999999999999
Q ss_pred HhcCccccccC
Q 025350 164 IRNHEWFLKNL 174 (254)
Q Consensus 164 ~l~hp~~~~~~ 174 (254)
+++||||++..
T Consensus 281 ll~h~~~~~~~ 291 (298)
T 1phk_A 281 ALAHPFFQQYV 291 (298)
T ss_dssp HTTSGGGCTTC
T ss_pred HHhChHhhhcc
Confidence 99999998644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=247.76 Aligned_cols=159 Identities=23% Similarity=0.296 Sum_probs=120.2
Q ss_pred cCCcHHHHHHHHHHHhhc-CcccCCCCCCcEEecCCC-------------------------------------------
Q 025350 10 RGTLFLPTTYFWSELLPF-NVCHRDLKLENTLLDGSP------------------------------------------- 45 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~-givHrdlkp~NIll~~~~------------------------------------------- 45 (254)
...++.|++.||+|||++ ||+||||||+|||++.++
T Consensus 148 ~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (397)
T 1wak_A 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEP 227 (397)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSG
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccc
Confidence 455788999999999998 999999999999998653
Q ss_pred ----CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-----
Q 025350 46 ----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----- 116 (254)
Q Consensus 46 ----~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----- 116 (254)
...+||+|||++..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......
T Consensus 228 ~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~ 304 (397)
T 1wak_A 228 KNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRD 304 (397)
T ss_dssp GGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHH
T ss_pred ccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCcH-HHHHHHHHHHHHHhhCCCCCCCCcccccCch
Confidence 02599999999976433 2345679999999999998887665 99999999999999999999865421
Q ss_pred -HHHHHHHHHHhccC---------CC----------------------------CCCCCCCCHHHHHHHHHhchhCCCCC
Q 025350 117 -KNFRKTIHRILSVQ---------YS----------------------------IPDYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 117 -~~~~~~~~~~~~~~---------~~----------------------------~~~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
..... +....... .. .......++.+++||.+||..||.+|
T Consensus 305 ~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 383 (397)
T 1wak_A 305 EDHIAL-IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383 (397)
T ss_dssp HHHHHH-HHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGS
T ss_pred HHHHHH-HHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhc
Confidence 11111 11111110 00 00011124678899999999999999
Q ss_pred CCHhHHhcCccccc
Q 025350 159 ISIPEIRNHEWFLK 172 (254)
Q Consensus 159 ps~~e~l~hp~~~~ 172 (254)
||+.++|+||||++
T Consensus 384 pt~~e~l~hp~~~~ 397 (397)
T 1wak_A 384 ATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHTSGGGGC
T ss_pred CCHHHHhhCccccC
Confidence 99999999999963
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=232.49 Aligned_cols=154 Identities=32% Similarity=0.544 Sum_probs=126.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.++.|||++||+||||||+||+++.++. +||+|||++..... .......|++.|+|||++.+..++.+
T Consensus 116 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 192 (284)
T 2vgo_A 116 SATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LRRRTMCGTLDYLPPEMIEGKTHDEK 192 (284)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SCBCCCCSCGGGCCHHHHTTCCBCTT
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-cccccccCCCCcCCHHHhccCCCCcc
Confidence 3457789999999999999999999999999987775 99999999875432 22345578999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+||||||+++|+|++|..||.......... .+.......+ ..++..+++||.+||..||.+|||+.++++|||
T Consensus 193 -~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 193 -VDLWCAGVLCYEFLVGMPPFDSPSHTETHR----RIVNVDLKFP--PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHTTCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred -cchhhHHHHHHHHHHCCCCCCCCCHhHHHH----HHhccccCCC--CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 999999999999999999998765443322 2333333333 357999999999999999999999999999999
Q ss_pred cccc
Q 025350 170 FLKN 173 (254)
Q Consensus 170 ~~~~ 173 (254)
|+..
T Consensus 266 ~~~~ 269 (284)
T 2vgo_A 266 VKAN 269 (284)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 9764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=232.80 Aligned_cols=154 Identities=24% Similarity=0.380 Sum_probs=121.0
Q ss_pred CCcHHHHHHHHHHHhhcC--cccCCCCCCcEEec-CCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFN--VCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++| |+||||||+|||++ .++. +||+|||++..... .......|++.|+|||++.+ .++
T Consensus 132 ~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~ 207 (290)
T 1t4h_A 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYD 207 (290)
T ss_dssp HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCC
T ss_pred HHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCcccccc-cccccccCCcCcCCHHHHhc-cCC
Confidence 456789999999999999 99999999999997 4544 99999999865322 22344579999999998864 454
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
. ++|||||||++|+|++|+.||............ ..............++.+.+||.+||..||.+|||+.++++|
T Consensus 208 ~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 208 E-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp T-HHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-cchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH---HhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 4 499999999999999999999876554443322 222222222233467899999999999999999999999999
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||++
T Consensus 284 ~~f~~ 288 (290)
T 1t4h_A 284 AFFQE 288 (290)
T ss_dssp GGGC-
T ss_pred ccccc
Confidence 99975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=249.05 Aligned_cols=147 Identities=16% Similarity=0.208 Sum_probs=119.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhc--------
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-------- 81 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~-------- 81 (254)
+..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... ....+| +.|+|||++
T Consensus 213 ~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~ 287 (413)
T 3dzo_A 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFG 287 (413)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTG
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccc
Confidence 3455689999999999999999999999999998876 999999998764333 345567 999999999
Q ss_pred --cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC
Q 025350 82 --LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 159 (254)
Q Consensus 82 --~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 159 (254)
.+..++. ++|||||||++|+|++|+.||.......... ..+.....+|+.+++||.+||..||.+||
T Consensus 288 ~~~~~~~~~-~~DvwSlGvil~elltg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 288 QHHPTLMTF-AFDTWTLGLAIYWIWCADLPNTDDAALGGSE----------WIFRSCKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp GGCCEEECH-HHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------GGGSSCCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred cccCcCCCc-hhhHHHHHHHHHHHHHCCCCCCCcchhhhHH----------HHHhhcccCCHHHHHHHHHHccCChhhCc
Confidence 4444544 4999999999999999999998754322111 11222345799999999999999999999
Q ss_pred CHhHHhcCccccc
Q 025350 160 SIPEIRNHEWFLK 172 (254)
Q Consensus 160 s~~e~l~hp~~~~ 172 (254)
|+.++++||||+.
T Consensus 357 t~~~~l~~~~~~~ 369 (413)
T 3dzo_A 357 LPLQAMETPEYEQ 369 (413)
T ss_dssp CHHHHTTSHHHHH
T ss_pred CHHHHHhCHHHHH
Confidence 9999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=234.18 Aligned_cols=156 Identities=33% Similarity=0.525 Sum_probs=124.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEe---cCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll---~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.++.|||++||+||||||+||++ +.++ .+||+|||++..... .......|++.|+|||++.+..+
T Consensus 108 ~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 184 (304)
T 2jam_A 108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS--KIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPY 184 (304)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC--CEEBCSCSTTCCCCC-BTTHHHHSCCCBCCTTTBSSCSC
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC--CEEEccCCcceecCC-CccccccCCCCccChHHhccCCC
Confidence 34577899999999999999999999999999 4444 499999999875432 22334469999999999988777
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--CCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
+.+ +|||||||++|+|++|..||........... +..... ..+.+..+++.+++||.+||..||.+|||+.++
T Consensus 185 ~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 259 (304)
T 2jam_A 185 SKA-VDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259 (304)
T ss_dssp CHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred Cch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 654 9999999999999999999987665443333 222222 223345689999999999999999999999999
Q ss_pred hcCcccccc
Q 025350 165 RNHEWFLKN 173 (254)
Q Consensus 165 l~hp~~~~~ 173 (254)
++||||...
T Consensus 260 l~h~~~~~~ 268 (304)
T 2jam_A 260 LSHPWIDGN 268 (304)
T ss_dssp HTSHHHHSS
T ss_pred hcCccccCC
Confidence 999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=231.73 Aligned_cols=155 Identities=27% Similarity=0.505 Sum_probs=103.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++....... ......|++.|+|||++.+..++.
T Consensus 114 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 191 (278)
T 3cok_A 114 ARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191 (278)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC----------------------------
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCc
Confidence 3457889999999999999999999999999987765 9999999997643222 223456899999999998777755
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +||||||+++|+|++|+.||.......... ......... ...++..+++||.+||..||.+|||+.++++||
T Consensus 192 ~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 192 E-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVLADYEM--PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCChhHHHHHH----HHhhcccCC--ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 5 999999999999999999998755432221 122222222 335799999999999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
||.+.
T Consensus 265 ~~~~~ 269 (278)
T 3cok_A 265 FMSRN 269 (278)
T ss_dssp TTC--
T ss_pred cccCC
Confidence 99763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=242.07 Aligned_cols=164 Identities=29% Similarity=0.522 Sum_probs=105.8
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.|++.+|+|||++||+||||||+|||++.++ ...+||+|||++..... .......+|+.|+|||++.+..++
T Consensus 129 ~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~ 207 (336)
T 3fhr_A 129 EAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYD 207 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-cccccCCCCcCccChhhhCCCCCC
Confidence 3456789999999999999999999999999997633 34599999999975432 233456789999999999777775
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc--cCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|..||...............+.. .....+.+..+++.+++||.+||..||.+|||+.+++
T Consensus 208 ~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 286 (336)
T 3fhr_A 208 KS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286 (336)
T ss_dssp HH-HHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 54 99999999999999999999775543322221222222 2223344457899999999999999999999999999
Q ss_pred cCccccccC
Q 025350 166 NHEWFLKNL 174 (254)
Q Consensus 166 ~hp~~~~~~ 174 (254)
+||||++..
T Consensus 287 ~hp~~~~~~ 295 (336)
T 3fhr_A 287 NHPWINQSM 295 (336)
T ss_dssp HSHHHHTGG
T ss_pred cCccccccc
Confidence 999998743
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=239.20 Aligned_cols=152 Identities=20% Similarity=0.338 Sum_probs=117.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-------------CCCCCcCCCCccc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYIA 77 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~~~~y~a 77 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|
T Consensus 167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 457889999999999999999999999999987765 9999999997654331 2234569999999
Q ss_pred chhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCC
Q 025350 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 157 (254)
Q Consensus 78 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 157 (254)
||++.+..++.+ +|||||||++|+|++|..|+.. .............. ......++.+++||.+||..||.+
T Consensus 245 PE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 245 PEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp HHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred hHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCCc
Confidence 999988877655 9999999999999998776531 12222222222111 111235688899999999999999
Q ss_pred CCCHhHHhcCccccc
Q 025350 158 RISIPEIRNHEWFLK 172 (254)
Q Consensus 158 Rps~~e~l~hp~~~~ 172 (254)
|||+.++++||||++
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=233.54 Aligned_cols=158 Identities=27% Similarity=0.436 Sum_probs=116.4
Q ss_pred cCCcHHHHHHHHHHHhhc-CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc-----C
Q 025350 10 RGTLFLPTTYFWSELLPF-NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-----K 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~-givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-----~ 83 (254)
...++.|++.+|.|||++ ||+||||||+||+++.++. +||+|||++.............+++.|+|||++. .
T Consensus 126 ~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (318)
T 2dyl_A 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC--------------CCTTCCHHHHC------
T ss_pred HHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCccccccCCCccccChhhcccccccc
Confidence 346788999999999995 9999999999999987765 9999999997654444444567999999999985 3
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++ .++|||||||++|+|++|+.||............. ........+....+++.+.+||.+||..||.+|||+.+
T Consensus 204 ~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (318)
T 2dyl_A 204 PDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280 (318)
T ss_dssp --CC-THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH--HHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCc-cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH--hccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 3444 45999999999999999999998754433222222 12222334444568999999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||++
T Consensus 281 ll~h~~~~~ 289 (318)
T 2dyl_A 281 LLEHSFIKR 289 (318)
T ss_dssp HTTSHHHHH
T ss_pred HhhCHHHHh
Confidence 999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=235.02 Aligned_cols=156 Identities=37% Similarity=0.558 Sum_probs=127.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|.|||++||+||||||+|||++.++. +||+|||++....... ......|++.|+|||++.+..++.
T Consensus 143 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 220 (335)
T 2owb_A 143 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220 (335)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcccccccCCCccccCHHHhccCCCCc
Confidence 4457889999999999999999999999999988765 9999999997654322 234457999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|||||||++|+|++|..||........... +.......+ ..+++.+.+||.+||..||.+|||+.++++||
T Consensus 221 ~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 221 E-VDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IKKNEYSIP--KHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred h-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HhcCCCCCC--ccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 5 9999999999999999999987654333322 223333333 35799999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||+...
T Consensus 294 ~~~~~~ 299 (335)
T 2owb_A 294 FFTSGY 299 (335)
T ss_dssp HHHTSC
T ss_pred cccCCC
Confidence 998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=240.14 Aligned_cols=161 Identities=26% Similarity=0.431 Sum_probs=122.8
Q ss_pred cCCcHHHHHHHHHHHhhc-CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPF-NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~-givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.+++.+++|||++ ||+||||||+|||++.++. +||+|||++..... .......||+.|+|||++.+..++.
T Consensus 133 ~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 209 (360)
T 3eqc_A 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSV 209 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC----CCCCTTCCHHHHTTCCCSH
T ss_pred HHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-ccccCCCCCCCeECHHHHcCCCCCc
Confidence 345788999999999986 9999999999999988776 99999999864322 2234557999999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHH--------------------------------------HHHHHHhccC
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR--------------------------------------KTIHRILSVQ 130 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------------------------------------~~~~~~~~~~ 130 (254)
+ +|||||||++|+|++|+.||.......... .....+....
T Consensus 210 ~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
T 3eqc_A 210 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288 (360)
T ss_dssp H-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSC
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC
Confidence 5 999999999999999999998755322211 1111112222
Q ss_pred CCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 131 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 131 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
........++..+++||.+||..||.+|||+.++++||||+...
T Consensus 289 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 289 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 22222234789999999999999999999999999999998643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=240.31 Aligned_cols=164 Identities=22% Similarity=0.307 Sum_probs=119.6
Q ss_pred cCCcHHHHHHHHHHHhhc-CcccCCCCCCcEEecCCC----CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPF-NVCHRDLKLENTLLDGSP----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~-givHrdlkp~NIll~~~~----~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
...++.|++.+|+|||++ ||+||||||+|||++..+ ...+||+|||++..... ......||+.|+|||++.+.
T Consensus 133 ~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~ 210 (373)
T 1q8y_A 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA 210 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCC
Confidence 345788999999999998 999999999999995322 22599999999976432 23455799999999999888
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHHHHHhccC----------------------------
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE------PKNFRKTIHRILSVQ---------------------------- 130 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~---------------------------- 130 (254)
.++.+ +|||||||++|+|++|..||.+... ...............
T Consensus 211 ~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (373)
T 1q8y_A 211 PWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 289 (373)
T ss_dssp CCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB
T ss_pred CCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccc
Confidence 87655 9999999999999999999986542 111222111110000
Q ss_pred --------CCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 131 --------YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 131 --------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
........+++.+++||.+||..||.+|||+.++++||||++....
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 290 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp CCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred cchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCc
Confidence 0000111245788999999999999999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=234.26 Aligned_cols=158 Identities=29% Similarity=0.499 Sum_probs=123.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC--CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|.|||++||+||||||+||+++.++ ...+||+|||++.............+++.|+|||++.+..++
T Consensus 110 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 189 (283)
T 3bhy_A 110 ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLG 189 (283)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCC
Confidence 446788999999999999999999999999998765 225999999999865544444556799999999999887776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +||||||+++|+|++|..||.+......... +.......+ .+..+++.+++||.+||..||.+|||+.+++
T Consensus 190 ~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 264 (283)
T 3bhy_A 190 LE-ADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264 (283)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHHH----hHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 55 9999999999999999999988654433322 222222221 1245789999999999999999999999999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 265 ~h~~~~~ 271 (283)
T 3bhy_A 265 EHSWIKA 271 (283)
T ss_dssp HCHHHHH
T ss_pred hCHHHHH
Confidence 9999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=230.73 Aligned_cols=156 Identities=38% Similarity=0.562 Sum_probs=127.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++....... ......|++.|+|||++.+..++.
T Consensus 117 ~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (294)
T 2rku_A 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194 (294)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCccccccccCCCCcCCcchhccCCCCc
Confidence 4457889999999999999999999999999988765 9999999997654322 233456899999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +||||||+++|+|++|..||.......... .+.......+ ..+++.+.++|.+||..||.+|||+.++++||
T Consensus 195 ~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 195 E-VDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIKKNEYSIP--KHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHTTCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhhccCCCc--cccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 5 999999999999999999998765443322 2333333333 35799999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||++..
T Consensus 268 ~~~~~~ 273 (294)
T 2rku_A 268 FFTSGY 273 (294)
T ss_dssp HHHTSC
T ss_pred heecCC
Confidence 998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=234.83 Aligned_cols=156 Identities=26% Similarity=0.342 Sum_probs=117.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhcc-----C
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLL-----K 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~-----~ 83 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......|++.|+|||++. +
T Consensus 131 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 208 (326)
T 2x7f_A 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC-------------CCGGGCCHHHHC------
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCcCccccccccCCccccChhhhccccccC
Confidence 3457789999999999999999999999999987765 9999999987543321 233457899999999986 3
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++.+ +|||||||++|+|++|..||........... +............++..+++||.+||..||.+|||+.+
T Consensus 209 ~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 283 (326)
T 2x7f_A 209 ATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283 (326)
T ss_dssp --CCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cCCCcc-chHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHH
Confidence 445444 9999999999999999999987654433322 22222222223457999999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||++
T Consensus 284 ll~hp~~~~ 292 (326)
T 2x7f_A 284 LMKHPFIRD 292 (326)
T ss_dssp HHTSHHHHC
T ss_pred HhhChHHhh
Confidence 999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=232.63 Aligned_cols=158 Identities=33% Similarity=0.562 Sum_probs=126.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|.|||++||+||||||+||+++.++ ...+||+|||++.............+++.|+|||++.+. ++.
T Consensus 123 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~ 201 (287)
T 2wei_A 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDE 201 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCT
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCC-CCC
Confidence 445788999999999999999999999999997643 235999999999865544444455689999999998754 544
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC--CCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
++||||||+++|+|++|..||.+......... +.... ...+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 202 -~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 202 -KCDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -chhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 49999999999999999999988654433222 22222 233444568999999999999999999999999999
Q ss_pred Ccccccc
Q 025350 167 HEWFLKN 173 (254)
Q Consensus 167 hp~~~~~ 173 (254)
||||++.
T Consensus 277 hp~~~~~ 283 (287)
T 2wei_A 277 HPWIQKY 283 (287)
T ss_dssp SHHHHHH
T ss_pred CHHHhcc
Confidence 9999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=232.28 Aligned_cols=157 Identities=33% Similarity=0.524 Sum_probs=125.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCCCC-
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY- 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~- 86 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||++...... .......|++.|+|||++.+...
T Consensus 112 ~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 189 (305)
T 2wtk_C 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189 (305)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCE
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccCccccccccccCCCCCCCcChhhccCcccC
Confidence 457789999999999999999999999999987765 999999999754321 11234468999999999876432
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+.++||||||+++|+|++|..||.+....... ..+.......+ ..+++.+.+||.+||..||.+|||+.++++
T Consensus 190 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~i~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 190 SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF----ENIGKGSYAIP--GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHCCCCCC--SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----HHHhcCCCCCC--CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 244599999999999999999999875543332 22333333333 357999999999999999999999999999
Q ss_pred CccccccCC
Q 025350 167 HEWFLKNLP 175 (254)
Q Consensus 167 hp~~~~~~~ 175 (254)
||||++..+
T Consensus 264 ~~~~~~~~~ 272 (305)
T 2wtk_C 264 HSWFRKKHP 272 (305)
T ss_dssp SHHHHSCCC
T ss_pred CcccccCCC
Confidence 999987554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=236.43 Aligned_cols=150 Identities=34% Similarity=0.501 Sum_probs=122.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEec-CCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
..++.|++.+|+|||++||+||||||+|||++ .++ .+||+|||++..... .......||+.|+|||++.+..+.+.
T Consensus 152 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (320)
T 3a99_A 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGR 228 (320)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHH
T ss_pred HHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCcccccccc-ccccCCCCCccCCChHHhccCCCCCc
Confidence 45778999999999999999999999999998 444 499999999976543 22344579999999999987777666
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|||||||++|+|++|+.||.... . ....... ....+++.+.+||.+||..||.+|||+.++++|||
T Consensus 229 ~~Di~slG~il~el~~g~~pf~~~~------~----~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 229 SAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQVF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred cchHHhHHHHHHHHHHCCCCCCChh------h----hhccccc--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 6899999999999999999997521 1 1112222 22358999999999999999999999999999999
Q ss_pred ccccCC
Q 025350 170 FLKNLP 175 (254)
Q Consensus 170 ~~~~~~ 175 (254)
|++...
T Consensus 297 ~~~~~~ 302 (320)
T 3a99_A 297 MQDVLL 302 (320)
T ss_dssp GSSCCC
T ss_pred hcCccC
Confidence 987553
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=235.78 Aligned_cols=157 Identities=28% Similarity=0.471 Sum_probs=126.0
Q ss_pred cCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC-CCC
Q 025350 10 RGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~ 87 (254)
...++.|++.+++|||+ +||+||||||+||+++.++. +||+|||++...... ......|++.|+|||++.+. .++
T Consensus 153 ~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 229 (348)
T 2pml_X 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYN 229 (348)
T ss_dssp HHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEE
T ss_pred HHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCC
Confidence 34578899999999999 99999999999999987775 999999999764332 33455789999999999877 454
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCC-----------------CCCCHHHHHHHHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-----------------VHISPECRHLISRI 150 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~ 150 (254)
..++|||||||++|+|++|..||......... ...+.......+.. ..+++.+.+||.+|
T Consensus 230 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 306 (348)
T 2pml_X 230 GAKVDIWSLGICLYVMFYNVVPFSLKISLVEL---FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF 306 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH---HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHH
T ss_pred cchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHH
Confidence 53699999999999999999999876653222 22233333333321 45899999999999
Q ss_pred chhCCCCCCCHhHHhcCccccc
Q 025350 151 FVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 151 L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
|..||.+|||+.++++||||+.
T Consensus 307 L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 307 LRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp CCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccCChhhCCCHHHHhcCccccC
Confidence 9999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=236.78 Aligned_cols=158 Identities=32% Similarity=0.529 Sum_probs=121.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc---CCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~ 86 (254)
..++.|++.+|+|||++||+||||||+|||++.++ ...+||+|||++.............||+.|+|||++. ...+
T Consensus 117 ~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 196 (322)
T 2ycf_A 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 196 (322)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTC
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCC
Confidence 45678999999999999999999999999997654 2359999999997654332223446899999999974 3344
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC--CCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
+ .++|||||||++|+|++|..||............+.. ..... ..+..+++.+.+||.+||..||.+|||+.++
T Consensus 197 ~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~ 272 (322)
T 2ycf_A 197 N-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272 (322)
T ss_dssp T-THHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred C-chhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 4 4599999999999999999999875543333332221 11111 1124578999999999999999999999999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||+.
T Consensus 273 l~h~~~~~ 280 (322)
T 2ycf_A 273 LRHPWLQD 280 (322)
T ss_dssp HTSGGGCC
T ss_pred hhCcCcCC
Confidence 99999965
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=239.65 Aligned_cols=157 Identities=29% Similarity=0.476 Sum_probs=103.1
Q ss_pred cCCcHHHHHHHHHHHhhc-CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc----CC
Q 025350 10 RGTLFLPTTYFWSELLPF-NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----KK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~-givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~----~~ 84 (254)
...++.|++.++.|||++ ||+||||||+|||++.++. +||+|||+++............|++.|+|||++. +.
T Consensus 127 ~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 204 (327)
T 3aln_A 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC-----------------------------
T ss_pred HHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCceecccccccccCCCCccccCceeeccccCcC
Confidence 346788999999999998 9999999999999987765 9999999998654444444457999999999983 44
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC---CCCCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---YSIPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
.++. ++|||||||++|+|++|..||........ ......... ........+++.+.+||.+||..||.+|||+
T Consensus 205 ~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 280 (327)
T 3aln_A 205 GYDV-RSDVWSLGITLYELATGRFPYPKWNSVFD---QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY 280 (327)
T ss_dssp -CCS-HHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCc-hhhHHHHHHHHHHHHHCCCCCCCcchHHH---HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH
Confidence 4554 49999999999999999999986432111 111111111 1111223579999999999999999999999
Q ss_pred hHHhcCccccc
Q 025350 162 PEIRNHEWFLK 172 (254)
Q Consensus 162 ~e~l~hp~~~~ 172 (254)
.++++||||..
T Consensus 281 ~ell~hp~~~~ 291 (327)
T 3aln_A 281 KELLKHPFILM 291 (327)
T ss_dssp HHHTTSHHHHH
T ss_pred HHHHhChHHHH
Confidence 99999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=234.38 Aligned_cols=162 Identities=24% Similarity=0.314 Sum_probs=122.3
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC----CCCCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.+|+|||++||+||||||+|||++..+ ..+||+|||+++..... .......+++.|+|||++.+...
T Consensus 123 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (320)
T 2i6l_A 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNN 201 (320)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTC
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCccccccCCCcccccccccccccccccCcHHhcCccc
Confidence 45678999999999999999999999999997443 25999999999764321 12234467999999999876443
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc------------------cCCCCC------CCCCCCHH
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------------VQYSIP------DYVHISPE 142 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~~~~------~~~~~~~~ 142 (254)
.+.++|||||||++|+|++|+.||.+................ .....+ ....++..
T Consensus 202 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (320)
T 2i6l_A 202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE 281 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHH
T ss_pred CCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHH
Confidence 455599999999999999999999987655444433321100 000000 12357999
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+++||++||..||.+|||+.++++||||+..
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 282 AVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 9999999999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=234.17 Aligned_cols=162 Identities=29% Similarity=0.361 Sum_probs=118.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC------CCCCCcCCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~~~~~y~aPE~~~~ 83 (254)
...++.|++.+|.|||++||+||||||+||+++.++. +||+|||++....... ......||+.|+|||++.+
T Consensus 123 ~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHHHCC---------------CCCTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence 4457789999999999999999999999999987765 9999999986543221 1234468999999999875
Q ss_pred C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC----CCCCCCCCCCHHHHHHHHHhchhCCCCC
Q 025350 84 K-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----YSIPDYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 84 ~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
. .++ .++|||||||++|+|++|..||.................... ........+++.+++||.+||..||.+|
T Consensus 201 ~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 279 (303)
T 2vwi_A 201 VRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279 (303)
T ss_dssp HHCCC-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGS
T ss_pred ccCCC-chhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhC
Confidence 3 344 459999999999999999999988665444332221110000 0011224578999999999999999999
Q ss_pred CCHhHHhcCccccccC
Q 025350 159 ISIPEIRNHEWFLKNL 174 (254)
Q Consensus 159 ps~~e~l~hp~~~~~~ 174 (254)
||+.++++||||++..
T Consensus 280 ps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 280 PTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCHHHHHTSTTC----
T ss_pred cCHHHHhhChhhhcCC
Confidence 9999999999997643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=229.13 Aligned_cols=153 Identities=19% Similarity=0.209 Sum_probs=117.7
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-----------------CCcEEEecCCCcccCCCCCCCCCCcC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-----------------APRLKICDFGYSKSSVLHSQPKSTVG 71 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-----------------~~~vkl~Dfg~a~~~~~~~~~~~~~~ 71 (254)
....++.|++.+|+|||++||+||||||+|||++.++ ...+||+|||.+..... .....|
T Consensus 116 ~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~g 192 (289)
T 1x8b_A 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS---PQVEEG 192 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC---SCCCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC---ccccCC
Confidence 3456789999999999999999999999999997442 23599999999876433 234468
Q ss_pred CCCcccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhc
Q 025350 72 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 151 (254)
Q Consensus 72 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 151 (254)
|+.|+|||++.+....+.++|||||||++|+|++|.+++.... .... +..... ......+++.+++||.+||
T Consensus 193 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~----~~~~~~-~~~~~~~~~~~~~li~~~l 264 (289)
T 1x8b_A 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE----IRQGRL-PRIPQVLSQEFTELLKVMI 264 (289)
T ss_dssp CGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH----HHTTCC-CCCSSCCCHHHHHHHHHHT
T ss_pred CccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH----HHcCCC-CCCCcccCHHHHHHHHHHh
Confidence 9999999999876444456999999999999999998775432 1111 112111 1223458999999999999
Q ss_pred hhCCCCCCCHhHHhcCccccc
Q 025350 152 VADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 152 ~~dP~~Rps~~e~l~hp~~~~ 172 (254)
..||.+|||+.++++||||++
T Consensus 265 ~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 265 HPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp CSSGGGSCCHHHHHTCTTC--
T ss_pred CCCcccCCCHHHHhhChHhhh
Confidence 999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=229.22 Aligned_cols=159 Identities=23% Similarity=0.325 Sum_probs=126.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.+++.++.|||++||+||||||+||+++.++. +||+|||++....... ......|++.|+|||++.+..++.
T Consensus 127 ~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 204 (314)
T 3com_A 127 IATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204 (314)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred HHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCc
Confidence 3457889999999999999999999999999987765 9999999997543322 233457899999999998887766
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +||||||+++|+|++|..||............ .............++..+.+||.+||..||.+|||+.++++||
T Consensus 205 ~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 205 V-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp T-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred c-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 5 99999999999999999999876543332221 1112222223345789999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||+...
T Consensus 281 ~~~~~~ 286 (314)
T 3com_A 281 FVRSAK 286 (314)
T ss_dssp HHHTCC
T ss_pred HHhcCC
Confidence 997643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=242.89 Aligned_cols=157 Identities=27% Similarity=0.413 Sum_probs=114.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC---CCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~---~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~ 83 (254)
..++.|++.||+|||++||+||||||+|||++. .+..++||+|||+|+...... .....+||+.|+|||++.+
T Consensus 121 ~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 121 ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSC
T ss_pred HHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhc
Confidence 457889999999999999999999999999953 333458999999997654321 2334579999999999974
Q ss_pred ---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCC-CCCCCCCCHHHHHHHHHhchhCCCCC
Q 025350 84 ---KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 84 ---~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
..+ +.++|||||||++|+|++ |..||........ .. . ....... .......+..+++||.+||..||.+|
T Consensus 201 ~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~-~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 275 (432)
T 3p23_A 201 DCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NI-L--LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR 275 (432)
T ss_dssp C---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HH-H--TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGS
T ss_pred ccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HH-H--hccCCccccCccccccHHHHHHHHHHHhCCHhhC
Confidence 333 345999999999999999 9999965433221 11 1 1111111 11112235668999999999999999
Q ss_pred CCHhHHhcCccccc
Q 025350 159 ISIPEIRNHEWFLK 172 (254)
Q Consensus 159 ps~~e~l~hp~~~~ 172 (254)
||+.++++||||..
T Consensus 276 ps~~evl~hp~f~~ 289 (432)
T 3p23_A 276 PSAKHVLKHPFFWS 289 (432)
T ss_dssp CCHHHHHTSTTTCC
T ss_pred CCHHHHHhCccccC
Confidence 99999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=228.51 Aligned_cols=156 Identities=26% Similarity=0.362 Sum_probs=125.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.++.|||++||+||||||+||+++.++. +||+|||++....... ......|++.|+|||++.+..++.
T Consensus 121 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 198 (303)
T 3a7i_A 121 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198 (303)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCc
Confidence 3457889999999999999999999999999987765 9999999997654332 233457899999999998887766
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +||||||+++|+|++|..||........... +.... .......++..+.+||.+||..||.+|||+.++++||
T Consensus 199 ~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 199 K-ADIWSLGITAIELARGEPPHSELHPMKVLFL----IPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSC-CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred h-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----hhcCC-CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 5 9999999999999999999987654333222 11111 1122345799999999999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
||.+.
T Consensus 273 ~~~~~ 277 (303)
T 3a7i_A 273 FILRN 277 (303)
T ss_dssp HHHHH
T ss_pred hhhcC
Confidence 99764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=230.22 Aligned_cols=157 Identities=27% Similarity=0.397 Sum_probs=118.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccC---
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK--- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~--- 83 (254)
...++.|++.+|+|||++||+||||||+|||++. + .+||+|||++........ .....|++.|+|||++.+
T Consensus 129 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (313)
T 3cek_A 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205 (313)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC--------------CCGGGCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccc
Confidence 3456789999999999999999999999999964 3 499999999976433221 234468999999999875
Q ss_pred --------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 84 --------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 84 --------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
..+ +.++|||||||++|+|++|..||........ ..................+..+.+||.+||..||
T Consensus 206 ~~~~~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 281 (313)
T 3cek_A 206 SRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 281 (313)
T ss_dssp ---------CC-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred ccccccccccC-CchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhcccccCCcccchHHHHHHHHHHccCCc
Confidence 234 4459999999999999999999987543322 1222333333333334568999999999999999
Q ss_pred CCCCCHhHHhcCcccccc
Q 025350 156 AKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 156 ~~Rps~~e~l~hp~~~~~ 173 (254)
.+|||+.++++||||+..
T Consensus 282 ~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 282 KQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp TTSCCHHHHHTSHHHHCC
T ss_pred ccCcCHHHHhcCccccCC
Confidence 999999999999999764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=239.27 Aligned_cols=154 Identities=27% Similarity=0.418 Sum_probs=115.0
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-----------CCcEEEecCCCcccCCCCCC-----CCCCcCCCCc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-----------APRLKICDFGYSKSSVLHSQ-----PKSTVGTPAY 75 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-----------~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~y 75 (254)
.++.|++.||+|||++||+||||||+|||++..+ ...+||+|||+++....... .....||+.|
T Consensus 119 ~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y 198 (434)
T 2rio_A 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198 (434)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTT
T ss_pred HHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCc
Confidence 4789999999999999999999999999997542 34699999999986543221 2345799999
Q ss_pred ccchhccC-------CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCC-----CCCCHH
Q 025350 76 IAPEVLLK-------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-----VHISPE 142 (254)
Q Consensus 76 ~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 142 (254)
+|||++.+ ..+ +.++|||||||++|+|++ |..||....... ... .......+.. ..++++
T Consensus 199 ~aPE~~~~~~~~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i----~~~~~~~~~~~~~~~~~~~~~ 271 (434)
T 2rio_A 199 RAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNI----IRGIFSLDEMKCLHDRSLIAE 271 (434)
T ss_dssp SCHHHHSCCCTTSCCCCC-CTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHH----HHTCCCCCCCTTCCCHHHHHH
T ss_pred cCHHHhccccccccccCc-chhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHH----hcCCCCcccccccccccchHH
Confidence 99999975 334 455999999999999999 999997654322 111 1222222211 124578
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
+++||.+||..||.+|||+.++++||||..
T Consensus 272 ~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 272 ATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 999999999999999999999999999964
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=231.32 Aligned_cols=157 Identities=24% Similarity=0.350 Sum_probs=120.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEe----cCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc---
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--- 82 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll----~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~--- 82 (254)
...++.|++.+|+|||++||+||||||+|||+ +..+ .+||+|||+++............||+.|+|||++.
T Consensus 114 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 191 (319)
T 4euu_A 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191 (319)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCceecCCCCceeecccCCCccCHHHhhhcc
Confidence 44578899999999999999999999999998 4443 49999999998765555555667999999999986
Q ss_pred -----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-------------------CCCCCC-
Q 025350 83 -----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------------------SIPDYV- 137 (254)
Q Consensus 83 -----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~- 137 (254)
+..++.+ +|||||||++|+|++|..||............+..+..... ..+...
T Consensus 192 ~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (319)
T 4euu_A 192 LRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270 (319)
T ss_dssp SCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCS
T ss_pred ccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccc
Confidence 3455544 99999999999999999999765544433344433332221 111111
Q ss_pred ---CCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 138 ---HISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 138 ---~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
.++..+.+||++||..||.+|||++|+++||-
T Consensus 271 ~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 271 LSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp SCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 23467889999999999999999999999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=226.97 Aligned_cols=157 Identities=31% Similarity=0.374 Sum_probs=120.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC-CCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCC-CC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKE-YD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~ 87 (254)
..++.|++.+++|||++||+||||||+||+++. ++ .+||+|||++....... ......|++.|+|||++.+.. ..
T Consensus 125 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 202 (295)
T 2clq_A 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202 (295)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC--CEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGC
T ss_pred HHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC--CEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCC
Confidence 346789999999999999999999999999986 44 49999999997643322 234457899999999987543 12
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+.++||||||+++|+|++|..||............ ........ .....+++.+.+||.+||..||.+|||+.++++|
T Consensus 203 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHP--EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp SHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCC--CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hccccccc--cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 44599999999999999999999765433221111 11112222 2234589999999999999999999999999999
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||+.
T Consensus 280 ~~~~~ 284 (295)
T 2clq_A 280 EFLKV 284 (295)
T ss_dssp GGGCC
T ss_pred hhhhh
Confidence 99975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-33 Score=230.65 Aligned_cols=157 Identities=25% Similarity=0.342 Sum_probs=120.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhcc-----C
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLL-----K 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~-----~ 83 (254)
...++.|++.++.|||++||+||||||+||+++.++. +||+|||++..... ........|++.|+|||++. +
T Consensus 119 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (302)
T 2j7t_A 119 IQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196 (302)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTS
T ss_pred HHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccccccccCChhhcCCeeeccccCCC
Confidence 3457789999999999999999999999999987765 99999998753211 11223457899999999984 4
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++ .++||||||+++|+|++|..||.............. ...........++..+.+||.+||..||.+|||+.+
T Consensus 197 ~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 272 (302)
T 2j7t_A 197 TPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272 (302)
T ss_dssp TTTT-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCCc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHH
Confidence 4454 459999999999999999999987665443332221 112222233457899999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 273 ll~h~~~~~ 281 (302)
T 2j7t_A 273 LLEHPFVSS 281 (302)
T ss_dssp HTTSTTTTT
T ss_pred HhcChHHhh
Confidence 999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=225.70 Aligned_cols=154 Identities=27% Similarity=0.364 Sum_probs=112.9
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---------------CCCCCCcCCCCcc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---------------SQPKSTVGTPAYI 76 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---------------~~~~~~~~~~~y~ 76 (254)
.++.|++.+++|||++||+||||||+|||++.++. +||+|||++...... .......|++.|+
T Consensus 120 ~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 197 (303)
T 1zy4_A 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYV 197 (303)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCCSCTTC-------------------------CTTS
T ss_pred HHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcchhhcccccchhccccccccccccccccCCCccccc
Confidence 46789999999999999999999999999987775 999999998754321 1123446899999
Q ss_pred cchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhC
Q 025350 77 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 77 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~d 154 (254)
|||++.+....+.++|||||||++|+|++ ||..... .......+.......| .....++.+++||.+||..|
T Consensus 198 aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 271 (303)
T 1zy4_A 198 ATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271 (303)
T ss_dssp CHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSS
T ss_pred CcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---HHHHHHhccccccccCccccccchHHHHHHHHHHHhcC
Confidence 99999865433455999999999999998 5543222 2222333333332222 22356788999999999999
Q ss_pred CCCCCCHhHHhcCcccccc
Q 025350 155 PAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 155 P~~Rps~~e~l~hp~~~~~ 173 (254)
|.+|||+.++++||||+..
T Consensus 272 p~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 272 PNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp GGGSCCHHHHHHSSCSCCC
T ss_pred cccCcCHHHHhCCCCcCCC
Confidence 9999999999999999653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-33 Score=232.37 Aligned_cols=156 Identities=19% Similarity=0.288 Sum_probs=118.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......||+.|+|||++.+..
T Consensus 118 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 195 (311)
T 3ork_A 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC------------------CCTTCCHHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCC
Confidence 3457889999999999999999999999999988776 9999999997543322 123346899999999998887
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC--CCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
++.+ +|||||||++|+|++|+.||.+............ ..... .....+++.+.+||.+||..||.+||++.+
T Consensus 196 ~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 196 VDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR----EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp CCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----CCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred CCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc----CCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 7655 9999999999999999999988665443332221 11111 112457999999999999999999999999
Q ss_pred HhcCccccc
Q 025350 164 IRNHEWFLK 172 (254)
Q Consensus 164 ~l~hp~~~~ 172 (254)
++.|+|++.
T Consensus 271 ~l~~~l~~~ 279 (311)
T 3ork_A 271 EMRADLVRV 279 (311)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=229.14 Aligned_cols=159 Identities=23% Similarity=0.301 Sum_probs=114.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..+
T Consensus 139 ~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 216 (323)
T 3qup_A 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY 216 (323)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--EEEeeccccccccccccccccccccCcccccCchhhcCCCC
Confidence 4567889999999999999999999999999988765 99999999975433222 123346778999999988777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS----- 160 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----- 160 (254)
+.+ +|||||||++|+|++ |..||.+........... . ....+....+++.+.+||.+||..||.+|||
T Consensus 217 ~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 290 (323)
T 3qup_A 217 TVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI----G-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR 290 (323)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----T-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred CCc-cchhhHHHHHHHHHhCCCCCccccChHHHHHHHh----c-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 655 999999999999999 999998876654433322 1 2223334568999999999999999999999
Q ss_pred --HhHHhcCccccccCCc
Q 025350 161 --IPEIRNHEWFLKNLPA 176 (254)
Q Consensus 161 --~~e~l~hp~~~~~~~~ 176 (254)
++++++|||+......
T Consensus 291 ~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 291 MELENILGHLSVLSTSQD 308 (323)
T ss_dssp HHHHHHHHC---------
T ss_pred HHHHHHHHHhhhcCCCCC
Confidence 7788999999775443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=227.31 Aligned_cols=149 Identities=32% Similarity=0.503 Sum_probs=121.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEec-CCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+||+++ .++ .+||+|||++...... ......|++.|+|||++.+..+.+
T Consensus 141 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 217 (312)
T 2iwi_A 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHA 217 (312)
T ss_dssp HHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCH
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCC
Confidence 345788999999999999999999999999998 454 4999999999765432 334557899999999998777766
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
.++|||||||++|+|++|+.||.... . ........+ ..++..+++||.+||..||.+|||+.++++||
T Consensus 218 ~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 218 LPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHFP--AHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCCC--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCCc--ccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 56999999999999999999997521 1 112222222 45799999999999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
||+..
T Consensus 286 ~~~~~ 290 (312)
T 2iwi_A 286 WMQTP 290 (312)
T ss_dssp TTCC-
T ss_pred hhcCc
Confidence 99763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=227.34 Aligned_cols=156 Identities=26% Similarity=0.364 Sum_probs=115.6
Q ss_pred cCCcHHHHHHHHHHHhhcC--cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFN--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++| |+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..+
T Consensus 139 ~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (309)
T 3p86_A 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS 216 (309)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-----------------CCTTSCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCccccccccccccCCCCccccChhhhcCCCC
Confidence 3457789999999999999 999999999999988765 9999999997543322 2334579999999999988877
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|||||||++|+|++|+.||........... +.......+....+++.+.+||.+||..||.+|||+.++++
T Consensus 217 ~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 217 NEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAA----VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp CTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 655 9999999999999999999987655433322 22222233334568999999999999999999999999987
Q ss_pred --Cccccc
Q 025350 167 --HEWFLK 172 (254)
Q Consensus 167 --hp~~~~ 172 (254)
+++++.
T Consensus 292 ~L~~~~~~ 299 (309)
T 3p86_A 292 LLRPLIKS 299 (309)
T ss_dssp HHHHHHC-
T ss_pred HHHHHHHh
Confidence 455544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=221.70 Aligned_cols=153 Identities=22% Similarity=0.305 Sum_probs=111.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC---CCCCCCCcCCCCcccchhcc---CC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLL---KK 84 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~---~~~~~~~~~~~~y~aPE~~~---~~ 84 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||++..... ........||+.|+|||++. +.
T Consensus 123 ~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (289)
T 3og7_A 123 IDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200 (289)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC------------------CCCTTCCHHHHC----C
T ss_pred HHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceeccccccccccccccccCCCccccCchhhcccCCC
Confidence 457889999999999999999999999999988765 99999999875432 12223456899999999986 34
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.++ .++|||||||++|+|++|+.||............................+++.+++||.+||..||.+|||+.++
T Consensus 201 ~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 279 (289)
T 3og7_A 201 PYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279 (289)
T ss_dssp CSC-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCC-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 444 4599999999999999999999887665555444433211111111224578999999999999999999999999
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 280 l~ 281 (289)
T 3og7_A 280 LA 281 (289)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=221.20 Aligned_cols=156 Identities=14% Similarity=0.119 Sum_probs=117.9
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC---CcEEEecCCCcccCCCCCC--------CCCCcCCCCccc
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIA 77 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~---~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~a 77 (254)
....++.|++.+|+|||++||+||||||+|||++.++. ..+||+|||+++....... .....||+.|+|
T Consensus 107 ~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 186 (298)
T 1csn_A 107 TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCC
Confidence 34567899999999999999999999999999976432 3499999999975443221 234569999999
Q ss_pred chhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhC
Q 025350 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 78 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 154 (254)
||++.+..++.+ +|||||||++|+|++|+.||.+.... .............. .......+++.+.+|+.+||..|
T Consensus 187 PE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~d 264 (298)
T 1csn_A 187 INTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LRELCAGFPEEFYKYMHYARNLA 264 (298)
T ss_dssp HHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHHCC
T ss_pred chhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-HHHHHhhCcHHHHHHHHHHhcCC
Confidence 999988777554 99999999999999999999875422 22222211111111 11112357999999999999999
Q ss_pred CCCCCCHhHHhc
Q 025350 155 PAKRISIPEIRN 166 (254)
Q Consensus 155 P~~Rps~~e~l~ 166 (254)
|.+|||+.++++
T Consensus 265 p~~RP~~~~l~~ 276 (298)
T 1csn_A 265 FDATPDYDYLQG 276 (298)
T ss_dssp TTCCCCHHHHHH
T ss_pred cccCCCHHHHHH
Confidence 999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=228.91 Aligned_cols=148 Identities=20% Similarity=0.327 Sum_probs=118.4
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCCC
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..++.
T Consensus 207 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 284 (370)
T 2psq_A 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284 (370)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH
T ss_pred HHHHHHHHHHHHHHhCCeeccccchhhEEECCCCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc
Confidence 46789999999999999999999999999988775 9999999997543322 122345778999999998887765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|||||||++|+|++ |..||.+......... +. .....+....++..+.+||.+||..||.+|||+.+++++
T Consensus 285 ~-~DvwslG~il~ellt~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 285 Q-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL----LK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----HH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5 999999999999999 9999987655433322 11 122233344689999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=228.38 Aligned_cols=156 Identities=14% Similarity=0.151 Sum_probs=116.9
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCcccchh
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEV 80 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~ 80 (254)
.+..++.|++.+|+|||++||+||||||+|||++.+....+||+|||+++....... .....||+.|+|||+
T Consensus 153 ~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 232 (364)
T 3op5_A 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDA 232 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHH
Confidence 345678999999999999999999999999999833334599999999975433221 123459999999999
Q ss_pred ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC------CCCCCCCCCCHHHHHHHHHhchhC
Q 025350 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------YSIPDYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 81 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~d 154 (254)
+.+..++.+ +|||||||++|+|++|+.||.+.................. ..+ ....+++++.+++..||..|
T Consensus 233 ~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~ 310 (364)
T 3op5_A 233 HNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLD 310 (364)
T ss_dssp HTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCC
T ss_pred hCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCC
Confidence 988877655 9999999999999999999986433222221111110000 001 11357999999999999999
Q ss_pred CCCCCCHhHHhc
Q 025350 155 PAKRISIPEIRN 166 (254)
Q Consensus 155 P~~Rps~~e~l~ 166 (254)
|.+||++.++++
T Consensus 311 p~~RP~~~~l~~ 322 (364)
T 3op5_A 311 YTEKPLYENLRD 322 (364)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=229.02 Aligned_cols=157 Identities=15% Similarity=0.131 Sum_probs=118.2
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCcccchh
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEV 80 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~ 80 (254)
....++.|++.+|+|||++||+||||||+|||++.++...+||+|||+++....... .....||+.|+|||+
T Consensus 152 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 231 (345)
T 2v62_A 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDA 231 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHH
Confidence 345678899999999999999999999999999877644699999999975432211 134469999999999
Q ss_pred ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHHhccCCC----CCCCCCCCHHHHHHHHHhchhCC
Q 025350 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-EPKNFRKTIHRILSVQYS----IPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 81 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP 155 (254)
+.+..++.+ +|||||||++|+|++|+.||.... .................. ......+++.++++|.+||..||
T Consensus 232 ~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 310 (345)
T 2v62_A 232 HKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAY 310 (345)
T ss_dssp HHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCT
T ss_pred hcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCc
Confidence 988777555 999999999999999999996532 222222222211111100 01112579999999999999999
Q ss_pred CCCCCHhHHhc
Q 025350 156 AKRISIPEIRN 166 (254)
Q Consensus 156 ~~Rps~~e~l~ 166 (254)
.+|||+.++++
T Consensus 311 ~~Rps~~~l~~ 321 (345)
T 2v62_A 311 DEKPNYQALKK 321 (345)
T ss_dssp TCCCCHHHHHH
T ss_pred ccCCCHHHHHH
Confidence 99999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=224.67 Aligned_cols=150 Identities=18% Similarity=0.233 Sum_probs=117.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..+
T Consensus 117 ~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (325)
T 3kex_A 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccCcccccccccCCCCcccccChHHhccCCC
Confidence 4557789999999999999999999999999987765 99999999986543322 233457789999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+......... + . .....+....++..+.++|.+||..||.+|||+.+++
T Consensus 195 ~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~---~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~ 268 (325)
T 3kex_A 195 THQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-L---E-KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELA 268 (325)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-H---H-TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHH
T ss_pred Chh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-H---H-cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 655 999999999999999 9999987654333222 1 1 1222333345788999999999999999999999999
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
+|
T Consensus 269 ~~ 270 (325)
T 3kex_A 269 NE 270 (325)
T ss_dssp HH
T ss_pred HH
Confidence 87
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=221.52 Aligned_cols=154 Identities=18% Similarity=0.159 Sum_probs=117.2
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEe---cCCCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCccc
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIA 77 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll---~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~a 77 (254)
....++.|++.+|+|||++||+||||||+|||+ +.++. +||+|||+++....... .....||+.|+|
T Consensus 106 ~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a 183 (296)
T 4hgt_A 106 TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcccCccCCCCcccccCCCccccc
Confidence 345678899999999999999999999999999 55554 99999999975443221 234579999999
Q ss_pred chhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhC
Q 025350 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 78 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 154 (254)
||++.+..++.+ +|||||||++|+|++|+.||.+.... ............... ......+++.+.+||.+||+.|
T Consensus 184 PE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~ 261 (296)
T 4hgt_A 184 INTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EVLCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp HHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HHHTTTSCHHHHHHHHHHHTSC
T ss_pred hHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-hhhhccCCHHHHHHHHHHHhcC
Confidence 999988877554 99999999999999999999875432 222222222111110 0111347899999999999999
Q ss_pred CCCCCCHhHHhc
Q 025350 155 PAKRISIPEIRN 166 (254)
Q Consensus 155 P~~Rps~~e~l~ 166 (254)
|.+|||+.++++
T Consensus 262 p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 262 FDDKPDYSYLRQ 273 (296)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999999885
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=228.98 Aligned_cols=150 Identities=23% Similarity=0.388 Sum_probs=120.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+..++
T Consensus 196 ~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 273 (359)
T 3vhe_A 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 273 (359)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCC
Confidence 347889999999999999999999999999987765 9999999997543322 12334688899999999887776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+..........+.. ....+....+++++.++|.+||..||.+|||+.++++
T Consensus 274 ~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 348 (359)
T 3vhe_A 274 IQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348 (359)
T ss_dssp HH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55 999999999999998 99999887655544443332 2222333458999999999999999999999999997
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
|
T Consensus 349 ~ 349 (359)
T 3vhe_A 349 H 349 (359)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=221.22 Aligned_cols=157 Identities=29% Similarity=0.388 Sum_probs=122.2
Q ss_pred cCCcHHHHHHHHHHHhhcC-----cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-CCCCcCCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELLPFN-----VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~g-----ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~ 83 (254)
...++.|++.+|+|||++| |+||||||+||+++.++. +||+|||++........ .....|++.|+|||++.+
T Consensus 113 ~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (279)
T 2w5a_A 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC
T ss_pred HHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCchheeeccccccccccCCCccccChHHhcc
Confidence 4567889999999999999 999999999999987765 99999999875432211 123468999999999988
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++.+ +||||||+++|+|++|..||........... +..... .+....+++.+.++|.+||..||.+|||+.+
T Consensus 191 ~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 264 (279)
T 2w5a_A 191 MSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGK----IREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEE 264 (279)
T ss_dssp C-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHHHHH----Hhhccc-ccCCcccCHHHHHHHHHHcCCCcccCCCHHH
Confidence 777654 9999999999999999999987654332222 222222 1223357999999999999999999999999
Q ss_pred HhcCccccccC
Q 025350 164 IRNHEWFLKNL 174 (254)
Q Consensus 164 ~l~hp~~~~~~ 174 (254)
+++|+|+....
T Consensus 265 ll~~~~~~~~~ 275 (279)
T 2w5a_A 265 ILENPLILEHH 275 (279)
T ss_dssp HHTSTTCCGGG
T ss_pred HHhChhhhhhc
Confidence 99999997643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=220.99 Aligned_cols=153 Identities=18% Similarity=0.156 Sum_probs=116.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEec---CCCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCcccc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAP 78 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~---~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aP 78 (254)
...++.|++.+++|||++||+||||||+|||++ .++ .+||+|||++........ .....||+.|+||
T Consensus 107 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 3uzp_A 107 VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCcccccccccccccccccccccccccccCCh
Confidence 456788999999999999999999999999994 444 499999999976443322 2345799999999
Q ss_pred hhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 79 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 79 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
|++.+..++.+ +|||||||++|+|++|+.||.+... ................ ......+++.+.+|+.+||+.||
T Consensus 185 E~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp 262 (296)
T 3uzp_A 185 NTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HHHTTTSCHHHHHHHHHHHTSCT
T ss_pred hhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-HHHHhhCCHHHHHHHHHHHhcCc
Confidence 99988777654 9999999999999999999986432 1222222222111110 00113478999999999999999
Q ss_pred CCCCCHhHHhc
Q 025350 156 AKRISIPEIRN 166 (254)
Q Consensus 156 ~~Rps~~e~l~ 166 (254)
.+|||+.++++
T Consensus 263 ~~Rps~~~l~~ 273 (296)
T 3uzp_A 263 DDKPDYSYLRQ 273 (296)
T ss_dssp TCCCCHHHHHH
T ss_pred CcCCCHHHHHH
Confidence 99999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=230.17 Aligned_cols=156 Identities=17% Similarity=0.236 Sum_probs=122.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCC---CCCCCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.+|+|||++||+||||||+|||++.++ ...+||+|||+++.... ........+|+.|+|||++.+..+
T Consensus 184 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 263 (367)
T 3l9p_A 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF 263 (367)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCC
Confidence 34788999999999999999999999999998543 23499999999974321 122334568899999999988777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||........... +... ...+....++..+.+||.+||..||.+|||+.+++
T Consensus 264 ~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~~----i~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil 337 (367)
T 3l9p_A 264 TSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF----VTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337 (367)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcC-CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 655 999999999999998 9999988655433322 2222 22333446899999999999999999999999999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+|.++..
T Consensus 338 ~~l~~~~ 344 (367)
T 3l9p_A 338 ERIEYCT 344 (367)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=226.79 Aligned_cols=150 Identities=21% Similarity=0.294 Sum_probs=118.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+..+
T Consensus 119 ~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3poz_A 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCCcccccccCCCccccccChHHhccCCC
Confidence 3457789999999999999999999999999988765 99999999975433222 123346789999999988777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+....... .. .......+....++..+.+++.+||..||.+|||+.+++
T Consensus 197 ~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 270 (327)
T 3poz_A 197 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI----LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270 (327)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HH----HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred Cch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HH----HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 655 999999999999999 99999876554322 22 222233344456899999999999999999999999999
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
++
T Consensus 271 ~~ 272 (327)
T 3poz_A 271 IE 272 (327)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=224.86 Aligned_cols=157 Identities=11% Similarity=0.156 Sum_probs=121.0
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCcccchh
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEV 80 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~ 80 (254)
....++.|++.+|+|||++||+||||||+|||++.++...+||+|||+++....... .....||+.|+|||+
T Consensus 160 ~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 239 (352)
T 2jii_A 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL 239 (352)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH
Confidence 345678999999999999999999999999999887623599999999975433221 133479999999999
Q ss_pred ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHHhccCCCCC----CCCCCCHHHHHHHHHhchhCC
Q 025350 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-EPKNFRKTIHRILSVQYSIP----DYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 81 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP 155 (254)
+.+..++.+ +|||||||++|+|++|+.||.... ...................+ .+..+++.+.+||.+||..||
T Consensus 240 ~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 240 HKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp HTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCT
T ss_pred HccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCCh
Confidence 988777555 999999999999999999998764 33333333332222222211 123578999999999999999
Q ss_pred CCCCCHhHHhc
Q 025350 156 AKRISIPEIRN 166 (254)
Q Consensus 156 ~~Rps~~e~l~ 166 (254)
.+|||+.++++
T Consensus 319 ~~Rps~~~l~~ 329 (352)
T 2jii_A 319 EEKPPYAMLRN 329 (352)
T ss_dssp TCCCCHHHHHH
T ss_pred hhCCCHHHHHH
Confidence 99999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=226.52 Aligned_cols=151 Identities=21% Similarity=0.312 Sum_probs=120.5
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 85 (254)
....++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+..
T Consensus 192 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 269 (382)
T 3tt0_A 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC
Confidence 34567889999999999999999999999999988765 9999999998654322 223345778899999998877
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |..||.+........ .+. ..........+++.+.+||.+||..||.+|||+.++
T Consensus 270 ~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 343 (382)
T 3tt0_A 270 YTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFK----LLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343 (382)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7655 999999999999999 999998765433222 222 222333345689999999999999999999999999
Q ss_pred hcC
Q 025350 165 RNH 167 (254)
Q Consensus 165 l~h 167 (254)
+++
T Consensus 344 l~~ 346 (382)
T 3tt0_A 344 VED 346 (382)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=216.89 Aligned_cols=152 Identities=26% Similarity=0.333 Sum_probs=114.8
Q ss_pred cCCcHHHHHHHHHHHhhcC---cccCCCCCCcEEecCC------CCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchh
Q 025350 10 RGTLFLPTTYFWSELLPFN---VCHRDLKLENTLLDGS------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 80 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~g---ivHrdlkp~NIll~~~------~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~ 80 (254)
...++.|++.+++|||++| |+||||||+|||++.. ..+.+||+|||++...... ......|++.|+|||+
T Consensus 107 ~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~ 185 (271)
T 3dtc_A 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPEV 185 (271)
T ss_dssp HHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHH
T ss_pred HHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc-cccCCCCccceeCHHH
Confidence 3456789999999999999 8999999999999752 1235999999999754332 2334578999999999
Q ss_pred ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC
Q 025350 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 160 (254)
Q Consensus 81 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 160 (254)
+.+..++.+ +||||||+++|+|++|+.||.+........ .........+....+++.+.++|.+||..||.+|||
T Consensus 186 ~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 260 (271)
T 3dtc_A 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAY----GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPS 260 (271)
T ss_dssp HHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcC
Confidence 987777554 999999999999999999998765443322 233334444445678999999999999999999999
Q ss_pred HhHHhcC
Q 025350 161 IPEIRNH 167 (254)
Q Consensus 161 ~~e~l~h 167 (254)
+.++++|
T Consensus 261 ~~e~l~~ 267 (271)
T 3dtc_A 261 FTNILDQ 267 (271)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=223.90 Aligned_cols=150 Identities=21% Similarity=0.292 Sum_probs=114.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..+
T Consensus 119 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3lzb_A 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC----------------CCCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCC
Confidence 3457789999999999999999999999999987765 99999999976433222 223346778999999988777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+......... .......+....++..+.+||.+||..||.+|||+.+++
T Consensus 197 ~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 270 (327)
T 3lzb_A 197 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 270 (327)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 655 999999999999999 9999987665433222 222333444456899999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
+.
T Consensus 271 ~~ 272 (327)
T 3lzb_A 271 IE 272 (327)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=225.75 Aligned_cols=152 Identities=25% Similarity=0.355 Sum_probs=122.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||++........ .....+|+.|+|||++.+..++
T Consensus 175 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 252 (344)
T 1rjb_A 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252 (344)
T ss_dssp HHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC
Confidence 347889999999999999999999999999987765 99999999975433222 1233578899999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+..........+. .....+....+++.+.+||.+||..||.+|||+.++++
T Consensus 253 ~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 253 IK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp HH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hh-HhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHh----cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55 999999999999998 9999988765444443332 22333344467999999999999999999999999998
Q ss_pred Ccc
Q 025350 167 HEW 169 (254)
Q Consensus 167 hp~ 169 (254)
|..
T Consensus 328 ~l~ 330 (344)
T 1rjb_A 328 FLG 330 (344)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=218.70 Aligned_cols=149 Identities=20% Similarity=0.341 Sum_probs=109.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..++.
T Consensus 119 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (281)
T 1mp8_A 119 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196 (281)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------------------CCGGGCCHHHHHHCCCSH
T ss_pred HHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccCcccccccccCCCcccccChhhcccCCCCC
Confidence 456789999999999999999999999999987765 99999999976533222 22334678899999998777755
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|||||||++|+|++ |..||.+.......... .. ....+....+++.+.++|.+||..||.+|||+.+++++
T Consensus 197 ~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 197 A-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----Hc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4 999999999999996 99999886654433322 12 12233445689999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=223.16 Aligned_cols=155 Identities=23% Similarity=0.317 Sum_probs=113.8
Q ss_pred cCCcHHHHHHHHHHHh--------hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-----CCCCcCCCCcc
Q 025350 10 RGTLFLPTTYFWSELL--------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYI 76 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh--------~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~y~ 76 (254)
...++.|++.+|+||| ++||+||||||+|||++.++. +||+|||+++....... .....||+.|+
T Consensus 107 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 184 (301)
T 3q4u_A 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184 (301)
T ss_dssp HHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEEECCCCCCCCCGGGC
T ss_pred HHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCCeeeccccccccccccccccccccee
Confidence 3457889999999999 999999999999999987765 99999999864332221 23347999999
Q ss_pred cchhccCCCCC-----CcchhHHHHHHHHHHHHhC----------CCCCCCCCchHHHHHHHHHHhccCCCCCCC-----
Q 025350 77 APEVLLKKEYD-----GKIADVWSCGVTLYVMLVG----------AYPFEDPEEPKNFRKTIHRILSVQYSIPDY----- 136 (254)
Q Consensus 77 aPE~~~~~~~~-----~~~~DiwslG~il~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 136 (254)
|||++.+.... +.++|||||||++|+|++| ..||.......................+..
T Consensus 185 aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (301)
T 3q4u_A 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWF 264 (301)
T ss_dssp CHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred ChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhc
Confidence 99999776322 1459999999999999999 888865432222122222222222111211
Q ss_pred -CCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 137 -VHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 137 -~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
..+++.+.+||.+||..||.+|||+.++++
T Consensus 265 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 265 SDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 124477999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=219.75 Aligned_cols=151 Identities=26% Similarity=0.373 Sum_probs=121.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||++........ .....+++.|+|||++.+..+
T Consensus 147 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence 3457789999999999999999999999999987765 99999999976543322 223457788999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+............. ....+....+++.+.++|.+||..||.+|||+.+++
T Consensus 225 ~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 299 (313)
T 1t46_A 225 TFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (313)
T ss_dssp CHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ChH-HHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 654 999999999999998 99999887654444443332 222333346899999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
++
T Consensus 300 ~~ 301 (313)
T 1t46_A 300 QL 301 (313)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=220.76 Aligned_cols=155 Identities=26% Similarity=0.296 Sum_probs=115.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......||+.|+|||++.+..++
T Consensus 113 ~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (294)
T 4eqm_A 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190 (294)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-------------CCSSCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccccccCccccCccccCHhHhcCCCCC
Confidence 3456789999999999999999999999999988775 9999999997654332 22335699999999999888776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC--CCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|+.||.+........... ...... ......+++.+.++|.+||..||.+||+..+.+
T Consensus 191 ~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l 266 (294)
T 4eqm_A 191 EC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI---QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266 (294)
T ss_dssp TT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH---SSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHH
T ss_pred ch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh---hccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHH
Confidence 55 999999999999999999998866543332222 111111 112345799999999999999999999666666
Q ss_pred cCccc
Q 025350 166 NHEWF 170 (254)
Q Consensus 166 ~hp~~ 170 (254)
.+.|.
T Consensus 267 ~~~l~ 271 (294)
T 4eqm_A 267 KDDLS 271 (294)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 66654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=222.95 Aligned_cols=151 Identities=22% Similarity=0.271 Sum_probs=118.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++............+++.|+|||++.+..++.+
T Consensus 144 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 221 (327)
T 1fvr_A 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 221 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCch
Confidence 4567889999999999999999999999999987765 99999999975443333344567889999999987776654
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 90 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 90 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+|||||||++|+|++ |..||.+....... ..+. .....+....+++.+++||.+||..||.+|||+.+++++-
T Consensus 222 -~Di~slG~il~ellt~g~~pf~~~~~~~~~----~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 222 -SDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp -HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -hcchHHHHHHHHHHcCCCCCCCCCcHHHHH----HHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999999999999998 99999876543322 2222 2223334456899999999999999999999999999763
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=221.72 Aligned_cols=149 Identities=21% Similarity=0.312 Sum_probs=117.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+..
T Consensus 153 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 230 (325)
T 3kul_A 153 LVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC
Confidence 3457789999999999999999999999999987765 99999999986533221 12234577899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |..||.+......... +. .....+....+++.+.+||.+||..||.+|||+.++
T Consensus 231 ~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ei 304 (325)
T 3kul_A 231 FSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VE-EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQI 304 (325)
T ss_dssp ECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HH-cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence 7655 999999999999999 9999987655433322 22 223444455789999999999999999999999999
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 305 l~ 306 (325)
T 3kul_A 305 VS 306 (325)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=216.52 Aligned_cols=150 Identities=21% Similarity=0.338 Sum_probs=119.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+..++
T Consensus 108 ~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 185 (269)
T 4hcu_A 108 LLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185 (269)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEeccccccccccccccccccCcccccccCCHHHhcCCCCC
Confidence 3456789999999999999999999999999987765 9999999997543221 22344567889999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +||||||+++|+|++ |..||........... +.. .........+++.+.+++.+||..||.+|||+.++++
T Consensus 186 ~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 259 (269)
T 4hcu_A 186 SK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----IST-GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 259 (269)
T ss_dssp HH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----Hhc-CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 55 999999999999999 9999987655433322 222 2223333457999999999999999999999999997
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
|
T Consensus 260 ~ 260 (269)
T 4hcu_A 260 Q 260 (269)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=215.98 Aligned_cols=150 Identities=22% Similarity=0.250 Sum_probs=121.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|.|||++||+||||||+||+++.++. +||+|||++.............+++.|+|||++.+..++.+
T Consensus 124 ~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (284)
T 2a19_B 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE 201 (284)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred HHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECcchhheeccccccccccCCcccccChhhhccCCCcch
Confidence 3457789999999999999999999999999987765 99999999987655544556679999999999988777655
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
+||||||+++|+|++|..||... ........... . ...++..+++||.+||..||.+|||+.++++|++
T Consensus 202 -~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~~--~--~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 202 -VDLYALGLILAELLHVCDTAFET------SKFFTDLRDGI--I--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp -HHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTTC--C--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -hhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhccc--c--cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999887531 11122222211 1 2347899999999999999999999999999998
Q ss_pred ccc
Q 025350 170 FLK 172 (254)
Q Consensus 170 ~~~ 172 (254)
...
T Consensus 271 ~~~ 273 (284)
T 2a19_B 271 VWK 273 (284)
T ss_dssp HHT
T ss_pred HHh
Confidence 754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=219.45 Aligned_cols=150 Identities=23% Similarity=0.334 Sum_probs=119.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......+++.|+|||++.+..+
T Consensus 152 ~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 152 LISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence 3457889999999999999999999999999987765 9999999997543322 1233457788999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+......... + ......+....+++.+.++|.+||..||.+|||+.+++
T Consensus 230 ~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~ 303 (314)
T 2ivs_A 230 TTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL-L----KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303 (314)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-H----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-h----hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 655 999999999999999 9999987665433222 1 12222333456899999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
++
T Consensus 304 ~~ 305 (314)
T 2ivs_A 304 KD 305 (314)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=222.24 Aligned_cols=156 Identities=22% Similarity=0.362 Sum_probs=113.5
Q ss_pred cCCcHHHHHHHHHHHhhc--------CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-----CCCCcCCCCcc
Q 025350 10 RGTLFLPTTYFWSELLPF--------NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYI 76 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~--------givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~y~ 76 (254)
...++.|++.+|+|||++ ||+||||||+|||++.++. +||+|||+++....... .....||+.|+
T Consensus 136 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 213 (337)
T 3mdy_A 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213 (337)
T ss_dssp HHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEECC---------CCSSCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCceeeccccccccCCCCCCccCccee
Confidence 345778999999999998 9999999999999987765 99999999975433222 12457999999
Q ss_pred cchhccCCCCCCc-----chhHHHHHHHHHHHHhC----------CCCCCCCCchHHHHHHHHHHhcc-CCC--CCC---
Q 025350 77 APEVLLKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDPEEPKNFRKTIHRILSV-QYS--IPD--- 135 (254)
Q Consensus 77 aPE~~~~~~~~~~-----~~DiwslG~il~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~-~~~--~~~--- 135 (254)
|||++.+..+... ++|||||||++|+|++| ..||................... ... .+.
T Consensus 214 aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (337)
T 3mdy_A 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293 (337)
T ss_dssp CHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred ChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccch
Confidence 9999987665443 38999999999999999 67776533222111112222111 111 111
Q ss_pred CCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 136 YVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 136 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
...+++.+.+||.+||..||.+|||+.++++|
T Consensus 294 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 294 SDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 11345779999999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=220.97 Aligned_cols=155 Identities=19% Similarity=0.202 Sum_probs=115.5
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC---CcEEEecCCCcccCCCCCC--------CCCCcCCCCccc
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIA 77 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~---~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~a 77 (254)
....++.|++.+|+|||++||+||||||+|||++.++. ..+||+|||+++....... .....||+.|+|
T Consensus 106 ~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a 185 (330)
T 2izr_A 106 TVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccC
Confidence 34567889999999999999999999999999976542 2399999999985433221 235579999999
Q ss_pred chhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC---CCCCCHHHHHHHHHhchhC
Q 025350 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD---YVHISPECRHLISRIFVAD 154 (254)
Q Consensus 78 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~d 154 (254)
||++.+..++.+ +|||||||++|+|++|..||.+...... ...+..+.......+. ...++ ++.+++.+||..|
T Consensus 186 PE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~ 262 (330)
T 2izr_A 186 INTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLD 262 (330)
T ss_dssp HHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCC
T ss_pred hHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCC
Confidence 999988877654 9999999999999999999987543221 1111111111111110 11234 9999999999999
Q ss_pred CCCCCCHhHHhc
Q 025350 155 PAKRISIPEIRN 166 (254)
Q Consensus 155 P~~Rps~~e~l~ 166 (254)
|.+||++.++++
T Consensus 263 p~~RP~~~~l~~ 274 (330)
T 2izr_A 263 FFEKPDYDYLRK 274 (330)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999988775
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=216.90 Aligned_cols=154 Identities=20% Similarity=0.223 Sum_probs=115.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||++........ .....++..|+|||++.+..
T Consensus 116 ~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 193 (295)
T 3ugc_A 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-------------CTTCGGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC
Confidence 3457789999999999999999999999999987765 99999999976533221 22334677899999998887
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCch-----------HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhC
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 154 (254)
++.+ +||||||+++|+|++|..||...... .................+....+++.+.+||.+||..|
T Consensus 194 ~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 272 (295)
T 3ugc_A 194 FSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN 272 (295)
T ss_dssp CCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred CChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCC
Confidence 7655 99999999999999999998653211 00111112222333344555678999999999999999
Q ss_pred CCCCCCHhHHhc
Q 025350 155 PAKRISIPEIRN 166 (254)
Q Consensus 155 P~~Rps~~e~l~ 166 (254)
|.+|||+.++++
T Consensus 273 p~~Rps~~el~~ 284 (295)
T 3ugc_A 273 VNQRPSFRDLAL 284 (295)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHHH
Confidence 999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-31 Score=214.21 Aligned_cols=151 Identities=20% Similarity=0.259 Sum_probs=119.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+..++
T Consensus 106 ~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 183 (268)
T 3sxs_A 106 LLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183 (268)
T ss_dssp HHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEE
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCc
Confidence 4467889999999999999999999999999988775 9999999997543322 12233467789999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +||||||+++|+|++ |..||........... +... ........+++.+.+++.+||..||.+|||+.++++
T Consensus 184 ~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 184 SK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQG-HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp TT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTT-CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHcC-CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55 999999999999999 9999987665433322 2222 222233457899999999999999999999999998
Q ss_pred Cc
Q 025350 167 HE 168 (254)
Q Consensus 167 hp 168 (254)
+-
T Consensus 258 ~L 259 (268)
T 3sxs_A 258 SI 259 (268)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=213.23 Aligned_cols=152 Identities=27% Similarity=0.339 Sum_probs=117.3
Q ss_pred cCCcHHHHHHHHHHHhhcC--cccCCCCCCcEEecCCCC---CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC-
Q 025350 10 RGTLFLPTTYFWSELLPFN--VCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~~~~~---~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~- 83 (254)
...++.|++.+++|||++| |+||||||+|||++.++. ..+||+|||+++.... ......||+.|+|||++.+
T Consensus 124 ~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~ 201 (287)
T 4f0f_A 124 KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAE 201 (287)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCS
T ss_pred HHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccC
Confidence 3457889999999999999 999999999999976442 2489999999975332 2344679999999999843
Q ss_pred -CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 84 -KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 84 -~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..+ +.++|||||||++|+|++|+.||.......... ................+++.+.+||.+||..||.+|||+.
T Consensus 202 ~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 278 (287)
T 4f0f_A 202 EESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFS 278 (287)
T ss_dssp SCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHH
Confidence 333 345999999999999999999998765433211 1222223333334456899999999999999999999999
Q ss_pred HHhc
Q 025350 163 EIRN 166 (254)
Q Consensus 163 e~l~ 166 (254)
++++
T Consensus 279 ~ll~ 282 (287)
T 4f0f_A 279 YIVK 282 (287)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=219.50 Aligned_cols=152 Identities=23% Similarity=0.371 Sum_probs=120.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||+++....... .....+|+.|+|||++.+..+
T Consensus 150 ~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 3457789999999999999999999999999987765 99999999975433221 123457889999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+..........+.. ....+....+++.+.++|.+||..||.+|||+.+++
T Consensus 228 ~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 302 (316)
T 2xir_A 228 TIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302 (316)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cch-hHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhcc----CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 654 999999999999998 99999876654444333322 112223345799999999999999999999999999
Q ss_pred cCc
Q 025350 166 NHE 168 (254)
Q Consensus 166 ~hp 168 (254)
+|.
T Consensus 303 ~~L 305 (316)
T 2xir_A 303 EHL 305 (316)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=216.32 Aligned_cols=150 Identities=22% Similarity=0.289 Sum_probs=116.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++........ .....+++.|+|||++.+..++
T Consensus 115 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 192 (281)
T 3cc6_A 115 LVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192 (281)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccccccccccccCCCCcceeCchhhccCCCC
Confidence 3456789999999999999999999999999987765 99999999976443221 2234567889999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +||||||+++|+|++ |+.||............ .. ....+....+++.+.++|.+||..||.+|||+.++++
T Consensus 193 ~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 193 TA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EK----GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp HH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-HH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-hc----CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 54 999999999999998 99999876554433222 11 1223334468999999999999999999999999987
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 267 ~ 267 (281)
T 3cc6_A 267 S 267 (281)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=221.04 Aligned_cols=150 Identities=25% Similarity=0.321 Sum_probs=114.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC---------------CCCcCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---------------KSTVGTPA 74 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---------------~~~~~~~~ 74 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++........ ....||+.
T Consensus 110 ~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 187 (310)
T 3s95_A 110 RVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187 (310)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC--------------------CCCCSCGG
T ss_pred HHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccccccccccccccccccccccCCCcc
Confidence 3457889999999999999999999999999988776 999999999754322211 14579999
Q ss_pred cccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchh
Q 025350 75 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 153 (254)
Q Consensus 75 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 153 (254)
|+|||++.+..++.+ +|||||||++|+|++|..||........ ........... .....+++.+.++|.+||..
T Consensus 188 y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~ 262 (310)
T 3s95_A 188 WMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDL 262 (310)
T ss_dssp GCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHHHHHHTCS
T ss_pred eeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----cCCCCCCHHHHHHHHHHccC
Confidence 999999988877665 9999999999999999999875332111 00000001111 11235789999999999999
Q ss_pred CCCCCCCHhHHhc
Q 025350 154 DPAKRISIPEIRN 166 (254)
Q Consensus 154 dP~~Rps~~e~l~ 166 (254)
||.+|||+.++++
T Consensus 263 dP~~Rps~~~l~~ 275 (310)
T 3s95_A 263 DPEKRPSFVKLEH 275 (310)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=235.88 Aligned_cols=163 Identities=26% Similarity=0.342 Sum_probs=121.7
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC-CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.+++.+++|||++||+||||||+||+++.++. ..+||+|||++.............|++.|+|||++.+..++
T Consensus 122 ~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s 201 (676)
T 3qa8_A 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYT 201 (676)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCS
T ss_pred HHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCC
Confidence 34567889999999999999999999999999986543 24899999999876555555566899999999999888876
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH-----HHH-----hccCC----CCCCC----CCCCHHHHHHHHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-----HRI-----LSVQY----SIPDY----VHISPECRHLISR 149 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~-----~~~~~----~~~~~----~~~~~~~~~li~~ 149 (254)
.+ +|||||||++|+|++|..||.+......+.... ... ..... ..+.. ..+++.+.+||.+
T Consensus 202 ~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~ 280 (676)
T 3qa8_A 202 VT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC 280 (676)
T ss_dssp TT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHH
T ss_pred ch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHH
Confidence 65 999999999999999999997653322110000 000 00000 11111 1256889999999
Q ss_pred hchhCCCCCCCHhHHhcCccccc
Q 025350 150 IFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 150 ~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
||..||.+|||+.++++||||+.
T Consensus 281 mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 281 MLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp HSCSSCC---CCTTCCCCTTHHH
T ss_pred HccCCHhhCcCHHHHhcCHHHHH
Confidence 99999999999999999999965
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=229.07 Aligned_cols=148 Identities=23% Similarity=0.316 Sum_probs=119.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++....++.
T Consensus 287 ~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 364 (454)
T 1qcf_A 287 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364 (454)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCc
Confidence 346789999999999999999999999999988765 9999999997643221 122334678899999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++|+|++ |+.||.+.........+. .....+....+++.+.+||.+||..||.+|||+.++++
T Consensus 365 ~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 365 K-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-----RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 5 999999999999999 999998866544333221 22344455678999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=217.54 Aligned_cols=150 Identities=22% Similarity=0.305 Sum_probs=114.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......+++.|+|||++.+..+
T Consensus 149 ~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 226 (313)
T 3brb_A 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 226 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECSCSCC----------------CCGGGSCHHHHHSSCC
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEeecCcceecccccccCcccccCCCccccCchhhcCCCc
Confidence 3457789999999999999999999999999988765 9999999997543322 1223357789999999988777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+........... . ....+....+++.+.++|.+||..||.+|||+.+++
T Consensus 227 ~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 300 (313)
T 3brb_A 227 TSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL----H-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLR 300 (313)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----T-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred cch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH----c-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 655 999999999999999 899998766544333221 1 122333456899999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
++
T Consensus 301 ~~ 302 (313)
T 3brb_A 301 LQ 302 (313)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=217.14 Aligned_cols=150 Identities=22% Similarity=0.318 Sum_probs=118.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||++........ .....+++.|+|||++.+..
T Consensus 123 ~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (291)
T 1u46_A 123 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200 (291)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEccccccccccccccchhhhccCCCCceeeCchhhcCCC
Confidence 3457789999999999999999999999999987765 99999999876533221 22345778899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++. ++||||||+++|+|++ |..||.+....... ..+.......+....++..+.++|.+||..||.+|||+.++
T Consensus 201 ~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 275 (291)
T 1u46_A 201 FSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275 (291)
T ss_dssp EEH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCc-hhhHHHHHHHHHHHHhCCCCCcccCCHHHHH----HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHH
Confidence 654 4999999999999999 99999876544332 33333444445556789999999999999999999999999
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 276 ~~ 277 (291)
T 1u46_A 276 RD 277 (291)
T ss_dssp HH
T ss_pred HH
Confidence 96
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=214.70 Aligned_cols=151 Identities=18% Similarity=0.266 Sum_probs=119.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+..++
T Consensus 122 ~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 199 (283)
T 3gen_A 122 LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199 (283)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCS
T ss_pred HHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccccccccCCccCcccCCHHHhccCCCC
Confidence 4467889999999999999999999999999987765 9999999997543221 22334567889999999877775
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +||||||+++|+|++ |+.||........... +.. .........+++.+.++|.+||..||.+|||+.++++
T Consensus 200 ~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 273 (283)
T 3gen_A 200 SK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 273 (283)
T ss_dssp HH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHH----Hhc-ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 54 999999999999998 9999987665433332 222 2222333457899999999999999999999999997
Q ss_pred Cc
Q 025350 167 HE 168 (254)
Q Consensus 167 hp 168 (254)
|-
T Consensus 274 ~L 275 (283)
T 3gen_A 274 NI 275 (283)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=215.80 Aligned_cols=152 Identities=24% Similarity=0.303 Sum_probs=120.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|.|||++||+||||||+||+++.++. +||+|||++........ .....+++.|+|||++.+..
T Consensus 112 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (287)
T 1u59_A 112 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeeccCcceeeccccccccccccCHHHhccCC
Confidence 3457889999999999999999999999999987765 99999999976533221 22335688999999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |..||........... +.. ....+....+++.+.++|.+||..||.+|||+.++
T Consensus 190 ~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 263 (287)
T 1u59_A 190 FSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 263 (287)
T ss_dssp ECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----HHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred CCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----Hhc-CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7655 999999999999998 9999987665433322 212 12223334689999999999999999999999999
Q ss_pred hcCcc
Q 025350 165 RNHEW 169 (254)
Q Consensus 165 l~hp~ 169 (254)
++|.+
T Consensus 264 ~~~l~ 268 (287)
T 1u59_A 264 EQRMR 268 (287)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=212.99 Aligned_cols=149 Identities=23% Similarity=0.295 Sum_probs=115.7
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-----CCCCCCcCCCCcccchhccCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 85 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... .......+++.|+|||.+.+..
T Consensus 127 ~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 204 (298)
T 3pls_A 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCC
Confidence 456789999999999999999999999999987765 999999999754322 1223345788999999998877
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
++.+ +|||||||++|+|++|..|+............+. .....+....+++.+.+|+.+||..||.+|||+.+++
T Consensus 205 ~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 279 (298)
T 3pls_A 205 FTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279 (298)
T ss_dssp CCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHH
Confidence 7655 9999999999999996555544433333333222 2223344456899999999999999999999999988
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 280 ~ 280 (298)
T 3pls_A 280 G 280 (298)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=227.08 Aligned_cols=147 Identities=23% Similarity=0.332 Sum_probs=117.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||+++..... .....+++.|+|||++.+..++.+
T Consensus 291 ~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 366 (450)
T 1k9a_A 291 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTK 366 (450)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHH
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCCcH
Confidence 3457789999999999999999999999999987765 999999999754322 223367889999999988887655
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 90 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 90 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+|||||||++|+|++ |..||.+......... +. .....+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 367 -sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 367 -SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VE-KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH----HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999998 9999987655443322 21 22334445568999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=218.10 Aligned_cols=149 Identities=19% Similarity=0.229 Sum_probs=118.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||+++....... .....+++.|+|||++.+..++
T Consensus 141 ~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 218 (322)
T 1p4o_A 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218 (322)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEECcCccccccccccccccccCCCCCCCccChhhhccCCCC
Confidence 446789999999999999999999999999988765 99999999975433221 1233568899999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+......... +.... ..+....++..+.+||.+||..||.+|||+.++++
T Consensus 219 ~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~ 292 (322)
T 1p4o_A 219 TY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292 (322)
T ss_dssp HH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hhHHHHHHHHHHHHhcCCCccccCCHHHHHHH----HHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 54 999999999999999 8999987654333222 22222 22333468999999999999999999999999998
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
|
T Consensus 293 ~ 293 (322)
T 1p4o_A 293 S 293 (322)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=209.73 Aligned_cols=148 Identities=24% Similarity=0.249 Sum_probs=117.8
Q ss_pred CcCCcHHHHHHHHHHHhhcC--cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFN--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
....++.|++.+|+|||++| |+||||||+||+++.++. ++|+|||++... ......+|+.|+|||++.+..+
T Consensus 112 ~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~ 185 (271)
T 3kmu_A 112 QAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPE 185 (271)
T ss_dssp HHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTT----SCTTCBSCGGGSCHHHHHSCGG
T ss_pred HHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceeee----cccCccCCccccChhhhccCCC
Confidence 34567889999999999999 999999999999988776 888888776532 2234578999999999987655
Q ss_pred CC--cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 87 DG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 87 ~~--~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.. .++|||||||++|+|++|+.||.+......... ........+....+++.+.++|.+||..||.+|||+.++
T Consensus 186 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (271)
T 3kmu_A 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMI 261 (271)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 44 259999999999999999999987665443332 222333333445689999999999999999999999999
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 262 l~ 263 (271)
T 3kmu_A 262 VP 263 (271)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=221.58 Aligned_cols=151 Identities=21% Similarity=0.327 Sum_probs=119.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++........ .....+++.|+|||++.+..+
T Consensus 166 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 243 (333)
T 2i1m_A 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243 (333)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE--EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe--EEECccccccccccccceeecCCCCCCccccCHHHhccCCC
Confidence 3456789999999999999999999999999987765 99999999975433221 223456788999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+............. ....+....+++.+.+||.+||..||.+|||+.+++
T Consensus 244 ~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 318 (333)
T 2i1m_A 244 TVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318 (333)
T ss_dssp CHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 654 999999999999998 99999876655444443332 223333345789999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
++
T Consensus 319 ~~ 320 (333)
T 2i1m_A 319 SF 320 (333)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-31 Score=224.76 Aligned_cols=149 Identities=23% Similarity=0.269 Sum_probs=117.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.|++|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..+
T Consensus 215 ~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 292 (377)
T 3cbl_A 215 LLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292 (377)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCC
Confidence 3457789999999999999999999999999987765 99999999975432211 112235678999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.+......... .......+.+..+++.+.+||.+||..||.+|||+.+++
T Consensus 293 ~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 366 (377)
T 3cbl_A 293 SSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREF-----VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366 (377)
T ss_dssp EHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 555 999999999999998 9999987654332221 122333444556899999999999999999999999997
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 367 ~ 367 (377)
T 3cbl_A 367 Q 367 (377)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=219.49 Aligned_cols=150 Identities=28% Similarity=0.445 Sum_probs=101.8
Q ss_pred cCCcHHHHHHHHHHHhhcC--cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC-------------CCCcCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFN--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-------------KSTVGTPA 74 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~-------------~~~~~~~~ 74 (254)
...++.|++.+|+|||++| |+||||||+|||++.++. +||+|||++......... ....+|+.
T Consensus 138 ~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~ 215 (337)
T 3ll6_A 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM 215 (337)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTTCBCCSSCC-----------------------
T ss_pred HHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCccceeccccCcccccccccccchhhccccCCCC
Confidence 4567889999999999999 999999999999988765 999999999765432211 13458999
Q ss_pred cccchhc---cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhc
Q 025350 75 YIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 151 (254)
Q Consensus 75 y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 151 (254)
|+|||++ .+..++ .++|||||||++|+|++|..||....... ........+.....+..+.+||.+||
T Consensus 216 y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l 286 (337)
T 3ll6_A 216 YRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCFRQHPFEDGAKLR--------IVNGKYSIPPHDTQYTVFHSLIRAML 286 (337)
T ss_dssp --------CCTTSCSS-HHHHHHHHHHHHHHHHHSSCCC--------------------CCCCTTCCSSGGGHHHHHHHS
T ss_pred cCChhhhhccccCCCC-hHHhHHHHHHHHHHHHhCCCCCcchhHHH--------hhcCcccCCcccccchHHHHHHHHHc
Confidence 9999998 344444 45999999999999999999997643221 12223334444567889999999999
Q ss_pred hhCCCCCCCHhHHhcCccc
Q 025350 152 VADPAKRISIPEIRNHEWF 170 (254)
Q Consensus 152 ~~dP~~Rps~~e~l~hp~~ 170 (254)
..||.+|||+.++++|.+-
T Consensus 287 ~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 287 QVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp CSSGGGSCCHHHHHHHHHH
T ss_pred cCChhhCcCHHHHHHHHHH
Confidence 9999999999999988643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=220.69 Aligned_cols=149 Identities=21% Similarity=0.260 Sum_probs=116.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++..... .......+++.|+|||++.+..++
T Consensus 177 ~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 254 (343)
T 1luf_A 177 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 254 (343)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC
Confidence 347889999999999999999999999999987765 999999998753222 122344678899999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+......... +.... ..+....+++.+.+||.+||..||.+|||+.++++
T Consensus 255 ~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 255 TE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY----VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp HH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc-cccHHHHHHHHHHHhcCCCcCCCCChHHHHHH----HhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55 999999999999999 9999987654333222 22222 12233468999999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 329 ~ 329 (343)
T 1luf_A 329 I 329 (343)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-31 Score=220.69 Aligned_cols=154 Identities=19% Similarity=0.195 Sum_probs=112.1
Q ss_pred cCCcHHHHHHHHHHHhhc----------CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcc
Q 025350 10 RGTLFLPTTYFWSELLPF----------NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYI 76 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~----------givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~ 76 (254)
...++.|++.+++|||++ ||+||||||+|||++.++. +||+|||+++...... ......||+.|+
T Consensus 123 ~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~ 200 (322)
T 3soc_A 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200 (322)
T ss_dssp HHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTCEEECTTSCCCCCTTCCCCGGGC
T ss_pred HHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEccCCcccccccccCccccccCccCcccc
Confidence 345788999999999999 9999999999999987765 9999999997543322 223357999999
Q ss_pred cchhccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCchH------------HHHHHHHHHhccCCCCCCCC---
Q 025350 77 APEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK------------NFRKTIHRILSVQYSIPDYV--- 137 (254)
Q Consensus 77 aPE~~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~~--- 137 (254)
|||++.+... .+.++|||||||++|+|++|+.||.+..... ............. ..+...
T Consensus 201 aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 279 (322)
T 3soc_A 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK-KRPVLRDYW 279 (322)
T ss_dssp CHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCGGG
T ss_pred CHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhccc-CCCCccccc
Confidence 9999976322 1234899999999999999999997643211 1111111111111 111111
Q ss_pred ---CCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 138 ---HISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 138 ---~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
..++.+.+||.+||..||.+|||+.++++
T Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 280 QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12345999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=211.35 Aligned_cols=147 Identities=24% Similarity=0.330 Sum_probs=112.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+++|||++||+||||||+||+++.++. +||+|||++...... .....+++.|+|||++.+..++.+
T Consensus 119 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 194 (278)
T 1byg_A 119 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTK 194 (278)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------------CCTTTSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc--ccCCCccccccCHHHhCCCCCCch
Confidence 3457789999999999999999999999999987765 999999998754322 233467889999999987777655
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 90 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 90 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+||||||+++|+|++ |..||........... +. .....+....+++.+.++|.+||..||.+|||+.++++
T Consensus 195 -~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 195 -SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HT-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----Hh-cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999999999998 9999987654333222 21 22233344568999999999999999999999999885
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-30 Score=214.29 Aligned_cols=150 Identities=28% Similarity=0.401 Sum_probs=111.6
Q ss_pred CCcHHHHHHHHHHHhh---cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLP---FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~---~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+++|||+ +||+||||||+|||++.++. .+||+|||++..... ......||+.|+|||++.+..++
T Consensus 105 ~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 181 (307)
T 2eva_A 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYS 181 (307)
T ss_dssp HHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC--------------CCTTSSCHHHHTCCCCC
T ss_pred HHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc--ccccCCCCCceEChhhhCCCCCC
Confidence 3456799999999999 89999999999999987653 379999999875432 22345689999999999887776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
.+ +|||||||++|+|++|+.||........ ....... .....+....+++.+.++|.+||..||.+|||+.+++++
T Consensus 182 ~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 182 EK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH-NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH-TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh-cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 55 9999999999999999999986543221 1111111 122233445689999999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-31 Score=222.99 Aligned_cols=156 Identities=22% Similarity=0.192 Sum_probs=115.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||+++...... ......||+.|+|||++.+..++
T Consensus 142 ~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 219 (321)
T 2qkw_B 142 LEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219 (321)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCC
T ss_pred HHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccccccccccccccCCCccccCHHHhcCCCCC
Confidence 457889999999999999999999999999987765 9999999997543221 12234589999999999877776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHH-HHHHhccCC--------CCCCCCCCCHHHHHHHHHhchhCCC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN--FRKT-IHRILSVQY--------SIPDYVHISPECRHLISRIFVADPA 156 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~ 156 (254)
.+ +|||||||++|+|++|+.||........ .... ......... .......++..+.+++.+||..||.
T Consensus 220 ~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 298 (321)
T 2qkw_B 220 EK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298 (321)
T ss_dssp TH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGG
T ss_pred cc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcc
Confidence 55 9999999999999999999976443211 1111 011111110 0001112356789999999999999
Q ss_pred CCCCHhHHhcCcc
Q 025350 157 KRISIPEIRNHEW 169 (254)
Q Consensus 157 ~Rps~~e~l~hp~ 169 (254)
+|||+.++++|..
T Consensus 299 ~Rps~~ell~~L~ 311 (321)
T 2qkw_B 299 DRPSMGDVLWKLE 311 (321)
T ss_dssp GSCCHHHHHHHHH
T ss_pred cCcCHHHHHHHHH
Confidence 9999999998764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=227.66 Aligned_cols=154 Identities=18% Similarity=0.154 Sum_probs=116.7
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEec---CCCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCccc
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIA 77 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~---~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~a 77 (254)
....++.|++.+|.|||++|||||||||+||||+ ..+ .+||+|||+++....... .....||+.|+|
T Consensus 104 ~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 181 (483)
T 3sv0_A 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181 (483)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCccccccccccccccCCCccccC
Confidence 3456788999999999999999999999999993 444 499999999976543322 125579999999
Q ss_pred chhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhC
Q 025350 78 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 78 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 154 (254)
||++.+..++.+ +|||||||++|+|++|+.||.+..... .+........... .......++.++.+||.+||..+
T Consensus 182 PE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~l~~~~p~~l~~li~~cl~~d 259 (483)
T 3sv0_A 182 VNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS-IEALCRGYPTEFASYFHYCRSLR 259 (483)
T ss_dssp HHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-HHHHHTTSCHHHHHHHHHHHTCC
T ss_pred HHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-HHHHhcCCcHHHHHHHHHHhcCC
Confidence 999988887655 999999999999999999998754322 2222221111111 00111347899999999999999
Q ss_pred CCCCCCHhHHhc
Q 025350 155 PAKRISIPEIRN 166 (254)
Q Consensus 155 P~~Rps~~e~l~ 166 (254)
|.+||++.+|++
T Consensus 260 P~~RPs~~el~~ 271 (483)
T 3sv0_A 260 FDDKPDYSYLKR 271 (483)
T ss_dssp TTCCCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999988764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=222.03 Aligned_cols=149 Identities=21% Similarity=0.261 Sum_probs=108.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcccchhccCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~ 85 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..
T Consensus 195 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 272 (373)
T 3c1x_A 195 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------------------CCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeeccccccccccccccccccCCCCCcccccChHHhcCCC
Confidence 346689999999999999999999999999987765 9999999997543221 112335778899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |.+||........... +... ...+....++..+.++|.+||..||.+|||+.++
T Consensus 273 ~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~----~~~~-~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 273 FTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH----HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH----HHcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7655 999999999999999 7788876554333222 1121 1223334589999999999999999999999999
Q ss_pred hcC
Q 025350 165 RNH 167 (254)
Q Consensus 165 l~h 167 (254)
+++
T Consensus 347 l~~ 349 (373)
T 3c1x_A 347 VSR 349 (373)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=215.19 Aligned_cols=153 Identities=22% Similarity=0.278 Sum_probs=118.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......+|..|+|||++.+..
T Consensus 128 ~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 205 (302)
T 4e5w_A 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205 (302)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC
Confidence 3457789999999999999999999999999987765 9999999997654332 223446788899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCC-----------chHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhC
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPE-----------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 154 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 154 (254)
++.+ +|||||||++|+|++|..|+.... ......... .........+....+++.+.+||.+||..|
T Consensus 206 ~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 283 (302)
T 4e5w_A 206 FYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ 283 (302)
T ss_dssp EEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred CCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH-HHHhccCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 7644 999999999999999998864321 111112222 222333344455678999999999999999
Q ss_pred CCCCCCHhHHhc
Q 025350 155 PAKRISIPEIRN 166 (254)
Q Consensus 155 P~~Rps~~e~l~ 166 (254)
|.+|||+.++++
T Consensus 284 p~~Rps~~~ll~ 295 (302)
T 4e5w_A 284 PSNRTSFQNLIE 295 (302)
T ss_dssp GGGSCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=210.51 Aligned_cols=149 Identities=21% Similarity=0.284 Sum_probs=118.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+..++
T Consensus 111 ~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 188 (279)
T 1qpc_A 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188 (279)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcccccccCCCCccCccChhhhccCCCC
Confidence 3467889999999999999999999999999987765 9999999997653322 12234567889999999877765
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +||||||+++|+|++ |..||.+......... +.. .........+++.+.+++.+||..||.+|||+.++++
T Consensus 189 ~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 189 IK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----Hhc-ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 54 999999999999999 9999987655433222 211 2223334568999999999999999999999999885
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=215.83 Aligned_cols=150 Identities=19% Similarity=0.332 Sum_probs=113.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..
T Consensus 149 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 226 (333)
T 1mqb_A 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226 (333)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhhccccccccccCCCCccccccCchhcccCC
Confidence 4457889999999999999999999999999987765 99999999976433221 11224577899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |..||.......... .+.. ....+....+++.+.++|.+||..||.+||++.++
T Consensus 227 ~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 300 (333)
T 1mqb_A 227 FTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMK----AIND-GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 300 (333)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHT-TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHHC-CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7655 999999999999998 999998765433322 2222 22334445689999999999999999999999999
Q ss_pred hcC
Q 025350 165 RNH 167 (254)
Q Consensus 165 l~h 167 (254)
+++
T Consensus 301 ~~~ 303 (333)
T 1mqb_A 301 VSI 303 (333)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-30 Score=214.04 Aligned_cols=153 Identities=26% Similarity=0.388 Sum_probs=109.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|.|||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+..++.
T Consensus 138 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (310)
T 2wqm_A 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 215 (310)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC------------------CCSSCCHHHHTTCCCCH
T ss_pred HHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCc
Confidence 3457789999999999999999999999999987765 9999999987543322 223456899999999998877765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +||||||+++|+|++|..||.+.... .......+............+++.+++||.+||..||.+|||+.+++++
T Consensus 216 ~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 216 K-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred h-hhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 5 99999999999999999999764321 1122223333333322234689999999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=219.64 Aligned_cols=155 Identities=22% Similarity=0.253 Sum_probs=119.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......+++.|+|||++.+..
T Consensus 129 ~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (327)
T 3lxl_A 129 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceecccCCccceeeccCCccccccCHHHhccCC
Confidence 4557789999999999999999999999999987765 9999999997543322 223345788899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHH----------HHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN----------FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
++.+ +|||||||++|+|++|+.||........ ...............+....+++.+.+||.+||..||
T Consensus 207 ~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 285 (327)
T 3lxl_A 207 FSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSP 285 (327)
T ss_dssp EEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCCh
Confidence 6544 9999999999999999999865322100 0011122223333444556789999999999999999
Q ss_pred CCCCCHhHHhcC
Q 025350 156 AKRISIPEIRNH 167 (254)
Q Consensus 156 ~~Rps~~e~l~h 167 (254)
.+|||+.+++++
T Consensus 286 ~~Rps~~ell~~ 297 (327)
T 3lxl_A 286 QDRPSFSALGPQ 297 (327)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=217.23 Aligned_cols=149 Identities=20% Similarity=0.328 Sum_probs=118.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......+++.|+|||++.+..++
T Consensus 160 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 237 (334)
T 2pvf_A 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237 (334)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcC
Confidence 456789999999999999999999999999987765 9999999997543322 12334567889999999877775
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+......... +. . ....+....++..+.++|.+||..||.+|||+.++++
T Consensus 238 ~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~---~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 238 HQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-LK---E-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp HH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HH---H-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hH-HHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH-Hh---c-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 55 999999999999999 9999987654332222 21 1 1122333468999999999999999999999999987
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 312 ~ 312 (334)
T 2pvf_A 312 D 312 (334)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=217.88 Aligned_cols=157 Identities=17% Similarity=0.239 Sum_probs=121.5
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.+|.|||++||+||||||+|||++.++ ...+||+|||++...... .......+++.|+|||++.+..+
T Consensus 143 ~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 222 (327)
T 2yfx_A 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 222 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC
Confidence 45778999999999999999999999999998433 235999999998643221 12234467889999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |..||.......... .+... ...+....+++.+.++|.+||..||.+|||+.+++
T Consensus 223 ~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 296 (327)
T 2yfx_A 223 TSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----FVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296 (327)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH----HHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 654 999999999999998 999998765433222 22222 22233346899999999999999999999999999
Q ss_pred cCcccccc
Q 025350 166 NHEWFLKN 173 (254)
Q Consensus 166 ~hp~~~~~ 173 (254)
+|.|+...
T Consensus 297 ~~l~~~~~ 304 (327)
T 2yfx_A 297 ERIEYCTQ 304 (327)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhc
Confidence 99987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=220.84 Aligned_cols=149 Identities=18% Similarity=0.323 Sum_probs=108.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC----CCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++........ ....+++.|+|||++.+..
T Consensus 149 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 226 (373)
T 2qol_A 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC----------------------CTTSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccCCccceeccCCCcCCCccChhhhccCC
Confidence 3457889999999999999999999999999988765 999999999765332211 1223567899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |..||........... + ......+....++..+.+||.+||..||.+||++.++
T Consensus 227 ~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i 300 (373)
T 2qol_A 227 FTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA----V-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300 (373)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH----H-HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHH
Confidence 7655 999999999999998 9999987654333222 2 2223344445689999999999999999999999998
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 301 ~~ 302 (373)
T 2qol_A 301 VS 302 (373)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=219.63 Aligned_cols=161 Identities=21% Similarity=0.253 Sum_probs=111.1
Q ss_pred CCcHHHHHHHHHHHhhc---------CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---------CCCCCcCC
Q 025350 11 GTLFLPTTYFWSELLPF---------NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QPKSTVGT 72 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~---------givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---------~~~~~~~~ 72 (254)
..++.|++.+|+|||++ ||+||||||+|||++.++. +||+|||+++...... ......||
T Consensus 114 ~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt 191 (336)
T 3g2f_A 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191 (336)
T ss_dssp HHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCCTTCEECSSSSCC---------CCTTSC
T ss_pred HHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEeeccceeecccccccCccccccccccCCCc
Confidence 34678999999999999 9999999999999987765 9999999997543221 12244699
Q ss_pred CCcccchhccCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHH-------------HHHHHHHhccC--
Q 025350 73 PAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF-------------RKTIHRILSVQ-- 130 (254)
Q Consensus 73 ~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------------~~~~~~~~~~~-- 130 (254)
+.|+|||++.+. .+ +.++|||||||++|+|++|..||......... ...........
T Consensus 192 ~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (336)
T 3g2f_A 192 IRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ 270 (336)
T ss_dssp GGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC
T ss_pred cceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhccccc
Confidence 999999999763 23 24589999999999999997766432211000 00111111111
Q ss_pred -CCCCC----CCCCCHHHHHHHHHhchhCCCCCCCHhHHhc------CccccccC
Q 025350 131 -YSIPD----YVHISPECRHLISRIFVADPAKRISIPEIRN------HEWFLKNL 174 (254)
Q Consensus 131 -~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~~~~ 174 (254)
...+. ...+++.+.+||.+||..||++|||+.++++ ++|-+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 271 RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 11111 1113457999999999999999999999954 66665543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=212.37 Aligned_cols=149 Identities=22% Similarity=0.237 Sum_probs=116.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+||+++.++. +||+|||++........ .....+++.|+|||++.+..
T Consensus 119 ~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 196 (291)
T 1xbb_A 119 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196 (291)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC
Confidence 3457889999999999999999999999999987765 99999999975433221 12234678899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +||||||+++|+|++ |..||.+......... +.. ....+....+++.+.++|.+||..||.+|||+.++
T Consensus 197 ~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 270 (291)
T 1xbb_A 197 FSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----LEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 270 (291)
T ss_dssp EEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 6544 999999999999999 9999987654332221 212 22223334689999999999999999999999998
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 271 ~~ 272 (291)
T 1xbb_A 271 EL 272 (291)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=212.20 Aligned_cols=148 Identities=22% Similarity=0.311 Sum_probs=118.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||++........ .....+++.|+|||++.+..++.
T Consensus 114 ~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 191 (288)
T 3kfa_A 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCccccccCCccccCcCChhhhccCCCCc
Confidence 456789999999999999999999999999987765 99999999976543221 12234678899999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +||||||+++|+|++ |..||........... + ......+....+++.+.+||.+||..||.+|||+.++++
T Consensus 192 ~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 192 K-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-L----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-H----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H----hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 5 999999999999999 9999987665433222 1 222333444568999999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=209.82 Aligned_cols=150 Identities=21% Similarity=0.321 Sum_probs=117.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.++++||++||+||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+..++
T Consensus 106 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 183 (267)
T 3t9t_A 106 LLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183 (267)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEcccccccccccccccccccccccccccChhhhcCCCcc
Confidence 3456789999999999999999999999999987765 9999999987543211 22334577889999999877775
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
. ++||||||+++|+|++ |..||........... +... ........+++.+.+++.+||..||.+|||+.++++
T Consensus 184 ~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 184 S-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTG-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp H-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-hhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH----HhcC-CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 4 4999999999999999 8999987654333322 2222 222233457999999999999999999999999986
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
+
T Consensus 258 ~ 258 (267)
T 3t9t_A 258 Q 258 (267)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=212.34 Aligned_cols=150 Identities=17% Similarity=0.208 Sum_probs=112.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC------CCCCCCCcCCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL------HSQPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~------~~~~~~~~~~~~y~aPE~~~~ 83 (254)
...++.|++.+++|||++||+||||||+|||++. + .+||+|||++..... ........|++.|+|||++.+
T Consensus 132 ~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~-~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 132 TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-G--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred HHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC-C--CEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence 4457899999999999999999999999999973 3 499999999864321 112233458899999999875
Q ss_pred C--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 84 K--------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 84 ~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
. ...+.++|||||||++|+|++|..||........... +............++..+.++|.+||..||
T Consensus 209 ~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ----MGTGMKPNLSQIGMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp BSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH----HHTTCCCCCCCSSCCTTHHHHHHHHHCSST
T ss_pred ccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hccCCCCCCCcCCCCHHHHHHHHHHhcCCh
Confidence 2 1224459999999999999999999987654333222 222222222223578999999999999999
Q ss_pred CCCCCHhHHhc
Q 025350 156 AKRISIPEIRN 166 (254)
Q Consensus 156 ~~Rps~~e~l~ 166 (254)
.+|||+.++++
T Consensus 285 ~~Rpt~~~l~~ 295 (319)
T 2y4i_B 285 EERPTFTKLMD 295 (319)
T ss_dssp TTSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=225.17 Aligned_cols=149 Identities=19% Similarity=0.288 Sum_probs=115.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..++
T Consensus 282 ~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 359 (452)
T 1fmk_A 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359 (452)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------------CCGGGSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCceecccCCcccccccCHhHHhcCCCC
Confidence 3457789999999999999999999999999987765 99999999976433221 1233467889999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+......... + ......+....+++.+.+||.+||..||.+|||+.++++
T Consensus 360 ~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 360 IK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 55 999999999999999 9999987665433322 2 223344445578999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=213.75 Aligned_cols=149 Identities=17% Similarity=0.157 Sum_probs=111.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCC------cEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~------~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~ 83 (254)
+..++.|++.+|+|||++||+||||||+|||++.++.. .+||+|||++..... .....+++.|+|||++.+
T Consensus 115 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIEN 191 (289)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHC
T ss_pred HHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC---ccccCCcCcccCHHHhCC
Confidence 34578899999999999999999999999999766531 299999999864322 223458889999999987
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
....+.++|||||||++|+|++|..|+............. ......+ ...++.+.+||.+||..||.+|||+.+
T Consensus 192 ~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~----~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ 265 (289)
T 4fvq_A 192 PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----EDRHQLP--APKAAELANLINNCMDYEPDHRPSFRA 265 (289)
T ss_dssp GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTTCCCC--CCSSCTTHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----hccCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 3434555999999999999999655544433333222211 1222222 235888999999999999999999999
Q ss_pred HhcC
Q 025350 164 IRNH 167 (254)
Q Consensus 164 ~l~h 167 (254)
+++|
T Consensus 266 ll~~ 269 (289)
T 4fvq_A 266 IIRD 269 (289)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=226.92 Aligned_cols=148 Identities=22% Similarity=0.311 Sum_probs=118.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..++.
T Consensus 321 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 398 (495)
T 1opk_A 321 LYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398 (495)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCc
Confidence 356789999999999999999999999999987765 9999999998643222 122334677899999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++|+|++ |..||.+......... .......+....+++.+.+||.+||..||.+|||+.++++
T Consensus 399 ~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 399 K-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 5 999999999999999 9999988665433222 2223344445578999999999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=211.25 Aligned_cols=148 Identities=22% Similarity=0.263 Sum_probs=113.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcccchhccCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~ 85 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||+++...... ......+|+.|+|||++.+..
T Consensus 131 ~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (298)
T 3f66_A 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccccccccchhccccccCCCCCccccChHHhcCCC
Confidence 446789999999999999999999999999987765 9999999997543322 122345778899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +||||||+++|+|++ |.+||............ .... .......+++.+.+++.+||..||.+|||+.++
T Consensus 209 ~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 282 (298)
T 3f66_A 209 FTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 282 (298)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7655 999999999999999 56667665443332221 1111 222234579999999999999999999999999
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 283 l~ 284 (298)
T 3f66_A 283 VS 284 (298)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=214.61 Aligned_cols=154 Identities=23% Similarity=0.265 Sum_probs=118.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++....... ......+++.|+|||++.+..
T Consensus 136 ~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 213 (318)
T 3lxp_A 136 LLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213 (318)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCccccccccccccccccccCCCCCceeeChHHhcCCC
Confidence 3457789999999999999999999999999988765 9999999997654332 123345788899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCch----------HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
++.+ +|||||||++|+|++|..||...... .................+....+++.+.+||++||..||
T Consensus 214 ~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 292 (318)
T 3lxp_A 214 FYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEA 292 (318)
T ss_dssp EEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCc
Confidence 7644 99999999999999999999753211 011111222233334445556789999999999999999
Q ss_pred CCCCCHhHHhc
Q 025350 156 AKRISIPEIRN 166 (254)
Q Consensus 156 ~~Rps~~e~l~ 166 (254)
.+|||+.++++
T Consensus 293 ~~Rps~~ell~ 303 (318)
T 3lxp_A 293 SFRPTFENLIP 303 (318)
T ss_dssp GGSCCHHHHHH
T ss_pred ccCcCHHHHHH
Confidence 99999999984
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=223.48 Aligned_cols=155 Identities=24% Similarity=0.361 Sum_probs=116.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEe----cCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC--
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-- 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll----~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-- 83 (254)
...++.|++.+|+|||++||+||||||+|||+ +..+ .+||+|||+++............||+.|+|||++.+
T Consensus 114 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 191 (396)
T 4eut_A 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191 (396)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE--EEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce--eEEEecCCCceEccCCCccccccCCccccCHHHhhccc
Confidence 45578899999999999999999999999998 4433 499999999987655555556679999999999864
Q ss_pred ------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-------------------CCCCCC-
Q 025350 84 ------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------------------SIPDYV- 137 (254)
Q Consensus 84 ------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~- 137 (254)
..++ .++|||||||++|+|++|+.||............+..+..... ..+...
T Consensus 192 ~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (396)
T 4eut_A 192 LRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270 (396)
T ss_dssp C--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCS
T ss_pred cccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccc
Confidence 3333 4599999999999999999999764433333333333332221 111111
Q ss_pred ---CCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 138 ---HISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 138 ---~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
.++..+.++|++||..||.+|||+.+++++
T Consensus 271 l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 271 LSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 234678899999999999999999998654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=215.59 Aligned_cols=143 Identities=31% Similarity=0.555 Sum_probs=103.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.+|+|||++||+||||||+|||++... ...+||+|||++.... +..++
T Consensus 119 ~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~- 176 (299)
T 3m2w_A 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYD- 176 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGG-
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCC-
Confidence 456789999999999999999999999999998732 2359999999886432 12233
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.++|||||||++|+|++|..||.......................+ .+..+++.+++||.+||..||.+|||+.++++
T Consensus 177 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 177 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 3499999999999999999999764332211100000111111111 11457999999999999999999999999999
Q ss_pred CccccccC
Q 025350 167 HEWFLKNL 174 (254)
Q Consensus 167 hp~~~~~~ 174 (254)
||||++..
T Consensus 257 hp~~~~~~ 264 (299)
T 3m2w_A 257 HPWIMQST 264 (299)
T ss_dssp SHHHHTGG
T ss_pred Chhhcccc
Confidence 99997643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=212.86 Aligned_cols=153 Identities=25% Similarity=0.298 Sum_probs=114.2
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.+|+|||++||+||||||+||+++.++. +||+|||++........ .....|++.|+|||++.+. ++
T Consensus 136 ~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~ 212 (307)
T 2nru_A 136 CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-IT 212 (307)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-EC
T ss_pred HHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccccccccccccCCCcCcCChHHhcCC-CC
Confidence 456789999999999999999999999999987765 99999999875433221 2345689999999998654 44
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--------CC-CCCCCCCHHHHHHHHHhchhCCCCC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------SI-PDYVHISPECRHLISRIFVADPAKR 158 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~~li~~~L~~dP~~R 158 (254)
. ++||||||+++|+|++|..||..................... .. ......+..+.+++.+||..||.+|
T Consensus 213 ~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 291 (307)
T 2nru_A 213 P-KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291 (307)
T ss_dssp T-HHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTS
T ss_pred c-cchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccC
Confidence 4 499999999999999999999875543322222222111110 00 1111235678999999999999999
Q ss_pred CCHhHHhcC
Q 025350 159 ISIPEIRNH 167 (254)
Q Consensus 159 ps~~e~l~h 167 (254)
||+.+++++
T Consensus 292 ps~~~l~~~ 300 (307)
T 2nru_A 292 PDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=218.26 Aligned_cols=157 Identities=22% Similarity=0.222 Sum_probs=114.9
Q ss_pred cCCcHHHHHHHHHHHhhc---CcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPF---NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~---givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 84 (254)
+..++.|++.+|+|||++ ||+||||||+|||++.++. +||+|||++........ .....||+.|+|||++.+.
T Consensus 133 ~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 210 (326)
T 3uim_A 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 210 (326)
T ss_dssp HHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS
T ss_pred HHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccccCcccccccccccCCcCccCHHHhccC
Confidence 345788999999999999 9999999999999988765 99999999975433222 2334599999999999877
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCC----CchHHHHHHHHHHhccCC---------CCCCCCCCCHHHHHHHHHhc
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPKNFRKTIHRILSVQY---------SIPDYVHISPECRHLISRIF 151 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L 151 (254)
.++.+ +|||||||++|+|++|..||... .................. ........+..+.+++.+||
T Consensus 211 ~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 289 (326)
T 3uim_A 211 KSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCT 289 (326)
T ss_dssp EECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHT
T ss_pred CCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHh
Confidence 77554 99999999999999999999521 111111111111111100 00001112367899999999
Q ss_pred hhCCCCCCCHhHHhcCcc
Q 025350 152 VADPAKRISIPEIRNHEW 169 (254)
Q Consensus 152 ~~dP~~Rps~~e~l~hp~ 169 (254)
..||.+|||+.++++|..
T Consensus 290 ~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 290 QSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CSCGGGSCCHHHHHHHHH
T ss_pred CcCCccCCCHHHHHHHhc
Confidence 999999999999998865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=229.39 Aligned_cols=149 Identities=24% Similarity=0.310 Sum_probs=115.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..
T Consensus 438 ~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~ 515 (613)
T 2ozo_A 438 VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515 (613)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC--------------CCTTSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCC
Confidence 3457789999999999999999999999999987765 99999999986533221 11224568899999998777
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |+.||.+......... +.. ....+....+++.+.+||.+||..||.+|||+.++
T Consensus 516 ~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 516 FSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH----HHT-TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred CCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 7655 999999999999998 9999998766443322 222 22334445689999999999999999999999997
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 590 ~~ 591 (613)
T 2ozo_A 590 EQ 591 (613)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=215.49 Aligned_cols=156 Identities=22% Similarity=0.259 Sum_probs=114.7
Q ss_pred cCCcHHHHHHHHHHHh--------hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcc
Q 025350 10 RGTLFLPTTYFWSELL--------PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYI 76 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh--------~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~ 76 (254)
...++.|++.+++||| ++||+||||||+|||++.++. +||+|||++....... ......||+.|+
T Consensus 141 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~ 218 (342)
T 1b6c_B 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218 (342)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTCEEEETTTTEEEECCCSCCCCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCceeccccccccccccccCCcCcccC
Confidence 3457889999999999 999999999999999988775 9999999997543332 234457999999
Q ss_pred cchhccCCCCCC-----cchhHHHHHHHHHHHHhC----------CCCCCCCCchH-HHHHHHHHHhccCCCCCCC----
Q 025350 77 APEVLLKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPEEPK-NFRKTIHRILSVQYSIPDY---- 136 (254)
Q Consensus 77 aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g----------~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~---- 136 (254)
|||++.+..... .++|||||||++|+|++| ..||....... ........+..........
T Consensus 219 aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (342)
T 1b6c_B 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 298 (342)
T ss_dssp CHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred CHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCccccc
Confidence 999997653221 459999999999999999 78887643211 1122222222222211111
Q ss_pred -CCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 137 -VHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 137 -~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
..++..+.+||.+||..||.+|||+.++++|
T Consensus 299 ~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 299 SCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1234578999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=211.96 Aligned_cols=150 Identities=21% Similarity=0.266 Sum_probs=107.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+++|||++||+||||||+|||++.++. +||+|||++....... ......+++.|+|||++.+..++
T Consensus 136 ~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 213 (309)
T 2h34_A 136 AVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213 (309)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC----------------CCGGGCCGGGTCC----
T ss_pred HHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCccccccccccccccCCCcCccCHHHHcCCCCC
Confidence 3467889999999999999999999999999987765 9999999987543322 22345689999999999887776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-CCCCCCCCCHHHHHHHHHhchhCCCCCC-CHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKRI-SIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rp-s~~e~l 165 (254)
.+ +||||||+++|+|++|..||.+.... ..... +..... .......+++.+.++|.+||..||.+|| |+++++
T Consensus 214 ~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 214 YR-ADIYALTCVLYECLTGSPPYQGDQLS-VMGAH---INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS 288 (309)
T ss_dssp CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHH---HHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHHHH---hccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence 55 99999999999999999999875432 11111 111111 1122346899999999999999999999 788877
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 289 ~ 289 (309)
T 2h34_A 289 A 289 (309)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=212.39 Aligned_cols=153 Identities=20% Similarity=0.230 Sum_probs=116.6
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 86 (254)
..++.|++.+|++||++||+||||||+||+++.++. +||+|||++........ .....++..|+|||++.+..+
T Consensus 148 ~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 225 (326)
T 2w1i_A 148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225 (326)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhccccccccccccCCCCceeEECchhhcCCCC
Confidence 456789999999999999999999999999987765 99999999976543321 223356778999999987776
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCch-----------HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
+.+ +|||||||++|+|++|..||...... ......+..........+....+++.+.+||.+||..||
T Consensus 226 ~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 304 (326)
T 2w1i_A 226 SVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 304 (326)
T ss_dssp EHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSG
T ss_pred Cch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCCh
Confidence 544 99999999999999999998642110 111111112222233344455789999999999999999
Q ss_pred CCCCCHhHHhc
Q 025350 156 AKRISIPEIRN 166 (254)
Q Consensus 156 ~~Rps~~e~l~ 166 (254)
.+|||+.++++
T Consensus 305 ~~Rps~~el~~ 315 (326)
T 2w1i_A 305 NQRPSFRDLAL 315 (326)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=215.63 Aligned_cols=152 Identities=26% Similarity=0.356 Sum_probs=114.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC----------CCCcCCCCcccch
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----------KSTVGTPAYIAPE 79 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~~~~~y~aPE 79 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||++......... ....||+.|+|||
T Consensus 136 ~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 213 (317)
T 2buj_A 136 ILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213 (317)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGG
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhcccccccccccccccccccccCCcccCCHh
Confidence 3457889999999999999999999999999987765 999999988754221110 1234799999999
Q ss_pred hccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 80 VLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 80 ~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
++.+.. ++ .++|||||||++|+|++|+.||...... ..... ........+....+++.+.+||.+||..||
T Consensus 214 ~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 288 (317)
T 2buj_A 214 LFSVQSHCVID-ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----AVQNQLSIPQSPRHSSALWQLLNSMMTVDP 288 (317)
T ss_dssp GSSCCSEEEEC-THHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----HHHCC--CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred HhccCCCcCCC-chhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----HhhccCCCCccccCCHHHHHHHHHHhhcCh
Confidence 987544 34 4599999999999999999999531100 01111 112233445555689999999999999999
Q ss_pred CCCCCHhHHhcCc
Q 025350 156 AKRISIPEIRNHE 168 (254)
Q Consensus 156 ~~Rps~~e~l~hp 168 (254)
.+|||+.+++++-
T Consensus 289 ~~Rps~~~ll~~L 301 (317)
T 2buj_A 289 HQRPHIPLLLSQL 301 (317)
T ss_dssp GGSCCHHHHHHHH
T ss_pred hhCCCHHHHHHHh
Confidence 9999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=230.52 Aligned_cols=149 Identities=22% Similarity=0.233 Sum_probs=116.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..
T Consensus 471 ~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~ 548 (635)
T 4fl3_A 471 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548 (635)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC-------------CGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCC
Confidence 3567889999999999999999999999999987765 99999999975433221 12234678899999998877
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |+.||.+......... +. .....+....+++++.+||.+||..||.+|||+.++
T Consensus 549 ~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 622 (635)
T 4fl3_A 549 FSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----LE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 622 (635)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 7655 999999999999998 9999988665433222 22 222333445689999999999999999999999998
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 623 ~~ 624 (635)
T 4fl3_A 623 EL 624 (635)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=225.07 Aligned_cols=149 Identities=19% Similarity=0.292 Sum_probs=119.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.+|+|||++||+||||||+|||++.++. +||+|||+++...... ......++..|+|||++.+..++
T Consensus 365 ~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 442 (535)
T 2h8h_A 365 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442 (535)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCceecccCCcCcccccCHHHhccCCCC
Confidence 3457789999999999999999999999999987765 9999999997643211 12234567889999999877776
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++ |..||.+......... + ......+....++..+.+||.+||..||.+|||+.+|++
T Consensus 443 ~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 443 IK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55 999999999999999 9999987655433322 2 223344445578999999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=216.20 Aligned_cols=145 Identities=16% Similarity=0.201 Sum_probs=110.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecC-----------CCCCcEEEecCCCcccCC---CCCCCCCCcCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDG-----------SPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAY 75 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~-----------~~~~~vkl~Dfg~a~~~~---~~~~~~~~~~~~~y 75 (254)
...++.|++.||+|||++|||||||||+|||++. ++ .+||+|||+|+... ........+||+.|
T Consensus 174 ~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 251 (365)
T 3e7e_A 174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA--GLALIDLGQSIDMKLFPKGTIFTAKCETSGF 251 (365)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT--TEEECCCTTCEEGGGSCTTEEECCSSCTTSC
T ss_pred HHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC--CEEEeeCchhhhhhccCCCceeeeecCCCCC
Confidence 4567899999999999999999999999999976 44 49999999996432 22233456799999
Q ss_pred ccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCC
Q 025350 76 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 155 (254)
Q Consensus 76 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 155 (254)
+|||++.+..++.+ +|||||||++|+|++|+.||....... .......+.. ..++.+.+++.+||+.+|
T Consensus 252 ~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~---------~~~~~~~~~~-~~~~~~~~~~~~~l~~~p 320 (365)
T 3e7e_A 252 QCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGE---------CKPEGLFRRL-PHLDMWNEFFHVMLNIPD 320 (365)
T ss_dssp CCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTE---------EEECSCCTTC-SSHHHHHHHHHHHHCCCC
T ss_pred CChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCc---------eeechhcccc-CcHHHHHHHHHHHcCCCC
Confidence 99999998887655 999999999999999999996532210 0111111111 246788999999999999
Q ss_pred CCCCCHhHHhcC
Q 025350 156 AKRISIPEIRNH 167 (254)
Q Consensus 156 ~~Rps~~e~l~h 167 (254)
.+|++..+.+.+
T Consensus 321 ~~r~~~~~~l~~ 332 (365)
T 3e7e_A 321 CHHLPSLDLLRQ 332 (365)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCcchHHHHHHH
Confidence 999765544443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=227.18 Aligned_cols=149 Identities=20% Similarity=0.341 Sum_probs=115.8
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..++.
T Consensus 494 ~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 571 (656)
T 2j0j_A 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571 (656)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCc
Confidence 356789999999999999999999999999987765 99999999986533322 12234678999999998777765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|||||||++|+|++ |..||.+.......... .. ....+....+++.+.+||.+||..||.+|||+.++++.
T Consensus 572 ~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i----~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 572 A-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred h-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----Hc-CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4 999999999999997 99999886654433322 11 12233345689999999999999999999999999853
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=213.05 Aligned_cols=149 Identities=13% Similarity=0.110 Sum_probs=110.3
Q ss_pred CcCCcHHHHHHHHHHHh-hcCcccCCCCCCcEEecCCCC------------------CcEEEecCCCcccCCCCCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELL-PFNVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKST 69 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~------------------~~vkl~Dfg~a~~~~~~~~~~~~ 69 (254)
....++.|++.||+||| ++||+||||||+|||++.++. ..+||+|||+|+.... ...
T Consensus 162 ~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~ 237 (336)
T 2vuw_A 162 TAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIV 237 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEE
T ss_pred HHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcE
Confidence 34567899999999999 999999999999999987651 1599999999986432 245
Q ss_pred cCCCCcccchhccCCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCchHHHHHHHHHHhcc-CCCCC----CCCCCCHHH
Q 025350 70 VGTPAYIAPEVLLKKEYDGKIADVWSCGVT-LYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIP----DYVHISPEC 143 (254)
Q Consensus 70 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~ 143 (254)
+||+.|+|||++.+.. ..++||||+|++ .+++++|..||..... .......+... ..... .+..+++++
T Consensus 238 ~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp ECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred EEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhccCcccchhhhhhcCHHH
Confidence 7999999999998765 455999998777 7778889999853110 01111122211 11111 122467899
Q ss_pred HHHHHHhchhCCCCCCCHhHHh-cCcccc
Q 025350 144 RHLISRIFVADPAKRISIPEIR-NHEWFL 171 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l-~hp~~~ 171 (254)
++||++||.+| |+.++| +||||+
T Consensus 313 ~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 99999999976 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-28 Score=220.73 Aligned_cols=142 Identities=20% Similarity=0.195 Sum_probs=112.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.+|.|||++|||||||||+|||++.+ .+||+|||+++..... ....||+.|+|||++.+.. +.
T Consensus 184 ~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~--~~ 255 (681)
T 2pzi_A 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGP--TV 255 (681)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCS--CH
T ss_pred HHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC---CccCCCccccCHHHHcCCC--CC
Confidence 34578999999999999999999999999999864 4999999999864332 4567999999999987654 45
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcc
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 169 (254)
++|||||||++|+|++|..||.+..... ..........++.+.+||.+||..||.+||+..+.+.|+|
T Consensus 256 ~sDi~slG~~l~~l~~g~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 256 ATDIYTVGRTLAALTLDLPTRNGRYVDG------------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp HHHHHHHHHHHHHHHSCCCEETTEECSS------------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred ceehhhhHHHHHHHHhCCCCCccccccc------------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 5999999999999999999887521100 0000000123678999999999999999999999999998
Q ss_pred cc
Q 025350 170 FL 171 (254)
Q Consensus 170 ~~ 171 (254)
+.
T Consensus 324 ~~ 325 (681)
T 2pzi_A 324 TG 325 (681)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-25 Score=181.19 Aligned_cols=126 Identities=12% Similarity=0.007 Sum_probs=93.1
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.+|+|||++||+||||||+|||++.++. +||+++|. ++| + +.+
T Consensus 132 ~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~~-------------------~~~-------~-~~~ 182 (286)
T 3uqc_A 132 IRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPAT-------------------MPD-------A-NPQ 182 (286)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCCC-------------------CTT-------C-CHH
T ss_pred HHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEeccc-------------------cCC-------C-Cch
Confidence 346889999999999999999999999999998776 89885442 222 3 345
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC--CCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|||||||++|+|++|+.||.+............ ........ .....+++.+++||.+||..||.+| |+.++++.
T Consensus 183 ~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred hHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999999999987554221100000 00000000 0123579999999999999999999 99999863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-22 Score=181.85 Aligned_cols=92 Identities=14% Similarity=0.087 Sum_probs=62.2
Q ss_pred CcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCCcc
Q 025350 12 TLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 12 ~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
.++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+...... ...+.+||+.|+|||++.+.. .. +
T Consensus 343 ~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~-~~-~ 418 (569)
T 4azs_A 343 KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENK-SW-N 418 (569)
T ss_dssp HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CCSHHHHHHHHHHHHHHC---------
T ss_pred HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCccccCceechhhccHHHhCCCC-CC-c
Confidence 37899999999999999999999999999988776 9999999998654332 334557999999999997653 33 4
Q ss_pred hhHHHHHHHHHHHHhCC
Q 025350 91 ADVWSCGVTLYVMLVGA 107 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~ 107 (254)
+|+||+|++++.+.++.
T Consensus 419 ~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 419 GFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ----------CCCCTTH
T ss_pred ccccccccchhhhcccc
Confidence 89999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3.3e-17 Score=146.53 Aligned_cols=97 Identities=23% Similarity=0.239 Sum_probs=78.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--------CCCCcCCCCcccchhc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVL 81 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~ 81 (254)
...++.|++.+|+|||++||+||||||+|||++. ++||+|||+++....... .....||+.|+|||++
T Consensus 433 ~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~ 508 (540)
T 3en9_A 433 NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIW 508 (540)
T ss_dssp CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHH
Confidence 4577899999999999999999999999999987 499999999986543211 1245799999999999
Q ss_pred cC--CCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 025350 82 LK--KEYDGKIADVWSCGVTLYVMLVGAYPFE 111 (254)
Q Consensus 82 ~~--~~~~~~~~DiwslG~il~~ll~g~~pf~ 111 (254)
.. ..|... +|+||..+-..+-+.++.+|.
T Consensus 509 ~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 509 ERFLEGYKSV-YDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred HHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence 76 455444 799999988888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.4e-13 Score=111.85 Aligned_cols=57 Identities=19% Similarity=0.084 Sum_probs=48.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 82 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~ 82 (254)
..++.|++.+++|||++||+||||||+|||++ ++ .+||+|||+|+. +..+.|||.+.
T Consensus 196 ~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 196 DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEECCCCeE------------CCCCCHHHHHH
Confidence 35789999999999999999999999999999 55 499999999863 33568999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=9.4e-11 Score=94.99 Aligned_cols=47 Identities=17% Similarity=0.170 Sum_probs=41.9
Q ss_pred CcCCcHHHHHHHHHHHh-hcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 9 GRGTLFLPTTYFWSELL-PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
....++.|++.++.+|| ++||+||||||+|||++. .++|+|||+|..
T Consensus 171 ~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~----~~~liDFG~a~~ 218 (258)
T 1zth_A 171 DVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID----KVYFIDMGQAVT 218 (258)
T ss_dssp CHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS----SEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC----cEEEEECccccc
Confidence 34567889999999999 999999999999999986 399999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.66 E-value=1.4e-08 Score=86.56 Aligned_cols=48 Identities=17% Similarity=0.144 Sum_probs=40.9
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCC--------cEEEecCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAP--------RLKICDFGYSK 58 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~--------~vkl~Dfg~a~ 58 (254)
..++.|++.++.+||++|||||||||.|||++.++.+ .+.|+||+.+.
T Consensus 208 ~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 208 ASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 3578899999999999999999999999999766532 37899999765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.54 E-value=2.4e-05 Score=64.40 Aligned_cols=82 Identities=22% Similarity=0.180 Sum_probs=48.3
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccc----------------hhccCCCCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP----------------EVLLKKEYDGKI 90 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aP----------------E~~~~~~~~~~~ 90 (254)
..++|+|++|.||+++.+....+.|+||+.+.................-..| +...... -.
T Consensus 191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~--~~- 267 (304)
T 3sg8_A 191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYR--MK- 267 (304)
T ss_dssp CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHH--HH-
T ss_pred ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHH--HH-
Confidence 4689999999999998742223789999987642111000000000000122 2221111 11
Q ss_pred hhHHHHHHHHHHHHhCCCCCC
Q 025350 91 ADVWSCGVTLYVMLVGAYPFE 111 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~ 111 (254)
.+.|++|.++|.+.+|..+|.
T Consensus 268 ~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 268 EKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHHHHcCCHHHH
Confidence 589999999999999987764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=5.8e-05 Score=60.12 Aligned_cols=29 Identities=24% Similarity=0.224 Sum_probs=23.8
Q ss_pred CcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 28 givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
+++|+|++|.||+++.++ .+.|+||+.+.
T Consensus 185 ~l~HgDl~~~Nil~~~~~--~~~liD~~~a~ 213 (264)
T 1nd4_A 185 VVTHGDACLPNIMVENGR--FSGFIDCGRLG 213 (264)
T ss_dssp EEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred EEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence 399999999999997653 25699999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00011 Score=58.79 Aligned_cols=30 Identities=23% Similarity=0.263 Sum_probs=24.2
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
.+++|+|++|.||+++.++ .+.|+||+.+.
T Consensus 183 ~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~ 212 (263)
T 3tm0_A 183 LVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG 212 (263)
T ss_dssp EEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred ceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence 5699999999999997643 25799998663
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00022 Score=59.91 Aligned_cols=33 Identities=21% Similarity=0.388 Sum_probs=26.8
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
.+++|+|++|.||+++.++...+.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 479999999999999866533358999998863
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.20 E-value=0.0042 Score=51.36 Aligned_cols=31 Identities=29% Similarity=0.451 Sum_probs=25.9
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..+++|+|+++.||+++.++. +.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~--~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQ--IWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGC--EEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCc--EEEEehhhcc
Confidence 368999999999999975554 8999999664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.93 E-value=0.084 Score=40.99 Aligned_cols=101 Identities=14% Similarity=0.066 Sum_probs=54.0
Q ss_pred HHHHHHHHHHHh-hcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcchh
Q 025350 14 FLPTTYFWSELL-PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 92 (254)
Q Consensus 14 ~~~~~~~l~~Lh-~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 92 (254)
..|.+..|+.+- .+.-..+=+.|..|++..+|. |-+.+ +.+. .....+.|||... .. .+.+.-
T Consensus 55 c~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~~~~~~~~pe~~~-~~-~te~~~ 118 (229)
T 2yle_A 55 CYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-----------AGEPPPVAGKLGY-SQ-CMETEV 118 (229)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C-----------------------CCSS-SS-SCHHHH
T ss_pred HHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-----------ccccCCCChhhcc-cc-chHHHH
Confidence 345555555542 112123344568899988876 55543 1110 1123456788763 22 233478
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchh
Q 025350 93 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 153 (254)
Q Consensus 93 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 153 (254)
|||||+++|..+--..|=. ....+|+.+..||..|..-
T Consensus 119 IysLG~tLY~ALDygL~e~-----------------------eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 119 IESLGIIIYKALDYGLKEN-----------------------EERELSPPLEQLIDHMANT 156 (229)
T ss_dssp HHHHHHHHHHHHTTTCCTT-----------------------EEECCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhhcCCCcc-----------------------cchhhCHHHHHHHHHHHhc
Confidence 9999999998874332211 1124799999999999766
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.01 Score=50.92 Aligned_cols=32 Identities=16% Similarity=0.188 Sum_probs=27.5
Q ss_pred hhcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 25 LPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 25 h~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
+...++|+|++|.||+++.++ ++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCccccc
Confidence 578899999999999997654 89999998763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.67 E-value=0.016 Score=47.56 Aligned_cols=31 Identities=29% Similarity=0.417 Sum_probs=25.1
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..+++|+|+.+.||+++.++. +.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 358999999999999986532 4799998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.03 E-value=0.032 Score=46.06 Aligned_cols=34 Identities=26% Similarity=0.329 Sum_probs=26.9
Q ss_pred hcCcccCCCCCCcEEecCCC--CCcEEEecCCCccc
Q 025350 26 PFNVCHRDLKLENTLLDGSP--APRLKICDFGYSKS 59 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~--~~~vkl~Dfg~a~~ 59 (254)
...++|+|+.+.||+++.+. ...+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 56899999999999997631 12489999998763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=93.95 E-value=0.024 Score=45.11 Aligned_cols=30 Identities=27% Similarity=0.370 Sum_probs=24.2
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++|+|+.+.||+++..+. +-|+||+.+.
T Consensus 193 ~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 193 SVVTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp EEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred cEEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 35899999999999986542 5699999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.38 E-value=0.066 Score=43.90 Aligned_cols=29 Identities=17% Similarity=0.132 Sum_probs=24.6
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++|+|+++.||+++ + .+.|+||+.+.
T Consensus 194 ~~~l~HgD~~~~Nil~~-~---~~~lIDfe~a~ 222 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D---GPMFVDLDDAR 222 (328)
T ss_dssp CCEECCSSCSGGGEEES-S---SEEECCCTTCC
T ss_pred CeeeeeCCCCcccEeEc-C---CCEEEECCCCC
Confidence 45789999999999998 3 38999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=93.17 E-value=0.036 Score=45.34 Aligned_cols=33 Identities=24% Similarity=0.247 Sum_probs=25.7
Q ss_pred hcCcccCCCCCCcEEecC---CCCCcEEEecCCCccc
Q 025350 26 PFNVCHRDLKLENTLLDG---SPAPRLKICDFGYSKS 59 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~---~~~~~vkl~Dfg~a~~ 59 (254)
...++|+|++|.||+++. ++. .+.|+||+.+..
T Consensus 189 ~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~~ 224 (306)
T 3tdw_A 189 TPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAAI 224 (306)
T ss_dssp CCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCEE
T ss_pred CCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcCC
Confidence 457899999999999986 232 248999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.97 E-value=0.081 Score=44.31 Aligned_cols=29 Identities=34% Similarity=0.616 Sum_probs=24.1
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
.+++|+|+.+.|||++.++ +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~---~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC---LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C---EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc---EEEEEecCCC
Confidence 5799999999999997543 8999998775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=92.72 E-value=0.028 Score=46.85 Aligned_cols=31 Identities=13% Similarity=0.129 Sum_probs=25.1
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++|+|++|.||+++... .+.|+||+.+.
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~--~~~vIDwe~a~ 251 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQ--PVAVLDWEMVA 251 (357)
T ss_dssp CCEEECSSCSGGGEEEETTE--EEEECCGGGCE
T ss_pred CceEEeCCCCCCeEEEeCCc--EEEEEcccccc
Confidence 45799999999999998432 36899998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.32 E-value=0.078 Score=44.02 Aligned_cols=32 Identities=22% Similarity=0.466 Sum_probs=26.5
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCccc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 59 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~ 59 (254)
..+++|+|+.+.||+++.++. +.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEES--IYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGC--EEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCe--EEEEECCCCee
Confidence 457999999999999976544 89999987753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=92.17 E-value=0.067 Score=45.27 Aligned_cols=30 Identities=17% Similarity=0.189 Sum_probs=25.4
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
...++|+|+.|.||+++.++ ++++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~---~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE---TKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC---EEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCCC---eEEEeCcccc
Confidence 56899999999999997643 8999998664
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.58 E-value=0.098 Score=45.01 Aligned_cols=19 Identities=42% Similarity=0.758 Sum_probs=15.8
Q ss_pred hcCcccCCCCCCcEEecCC
Q 025350 26 PFNVCHRDLKLENTLLDGS 44 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~ 44 (254)
...++|+|+.+.|||++.+
T Consensus 248 ~~v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 248 PVTFCHNDLQEGNILLPKA 266 (429)
T ss_dssp CEEEECSCCCGGGEEEEC-
T ss_pred CeEEEeCCCCCCeEEeeCC
Confidence 3468999999999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=89.90 E-value=0.15 Score=41.31 Aligned_cols=29 Identities=34% Similarity=0.462 Sum_probs=23.6
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++|+|+.|.||+.+ ++. +.|+||..+.
T Consensus 173 ~~l~HgDl~~~Nil~~-~~~--~~lID~e~a~ 201 (301)
T 3dxq_A 173 LAACHCDPLCENFLDT-GER--MWIVDWEYSG 201 (301)
T ss_dssp CEEECSCCCGGGEEEC-SSC--EEECCCTTCE
T ss_pred ceeeccCCCcCCEEEC-CCC--EEEEeccccc
Confidence 4589999999999953 443 8999999775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=89.55 E-value=0.18 Score=43.79 Aligned_cols=16 Identities=31% Similarity=0.492 Sum_probs=14.8
Q ss_pred cCcccCCCCCCcEEec
Q 025350 27 FNVCHRDLKLENTLLD 42 (254)
Q Consensus 27 ~givHrdlkp~NIll~ 42 (254)
..++|+|+.+.|||++
T Consensus 290 ~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 290 IVLCHCDLLSSNIINT 305 (458)
T ss_dssp EEEECSCCCGGGEEEC
T ss_pred eeEEecCCCCCcEEee
Confidence 4789999999999997
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.14 E-value=0.19 Score=42.42 Aligned_cols=33 Identities=39% Similarity=0.643 Sum_probs=25.9
Q ss_pred hcCcccCCCCCCcEEecCC--CCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~--~~~~vkl~Dfg~a~ 58 (254)
...++|+|+.+.||+++.+ ....+.|+||..|.
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3579999999999999765 11248999999775
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.07 E-value=0.49 Score=40.15 Aligned_cols=31 Identities=39% Similarity=0.563 Sum_probs=24.1
Q ss_pred CcccCCCCCCcEEecC----CCCCcEEEecCCCcc
Q 025350 28 NVCHRDLKLENTLLDG----SPAPRLKICDFGYSK 58 (254)
Q Consensus 28 givHrdlkp~NIll~~----~~~~~vkl~Dfg~a~ 58 (254)
.++|+|+.+.||++.. +....++++||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 4689999999999943 122359999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.50 E-value=0.61 Score=40.00 Aligned_cols=29 Identities=28% Similarity=0.527 Sum_probs=24.0
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++|+|+.+.||+ +.++. +.|+||..|.
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~--~~~IDwe~a~ 290 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNN--IRMIDYEYSA 290 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSC--EEECCCTTCE
T ss_pred ceEECCCCCcccee-cCCCc--EEEEecccCC
Confidence 46899999999999 44444 9999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=80.52 E-value=0.61 Score=37.35 Aligned_cols=25 Identities=24% Similarity=0.085 Sum_probs=20.5
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecC
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDF 54 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Df 54 (254)
..+||+|+.+.||+++.++ ..+.|-
T Consensus 188 p~LvHGDlw~gNvl~~~~g---~~~iDp 212 (288)
T 3f7w_A 188 PARIHGDLWNGNVLWQDDG---AVVIDP 212 (288)
T ss_dssp CEEECSCCSGGGEEEETTE---EEECSC
T ss_pred CeeeecCCCCCcEEEcCCC---eEEEec
Confidence 4799999999999998776 456664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 254 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-34 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-25 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-24 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-22 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-22 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-22 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-22 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-22 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-22 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-18 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-18 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-42
Identities = 53/146 (36%), Positives = 79/146 (54%), Gaps = 10/146 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ + +D
Sbjct: 126 RVIHRDIKPENLLLGSAG--ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
K D+WS GV Y LVG PFE +++T RI V+++ PD ++ R LI
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDLI 235
Query: 148 SRIFVADPAKRISIPEIRNHEWFLKN 173
SR+ +P++R + E+ H W N
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-41
Identities = 48/151 (31%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 84
+ HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L ++
Sbjct: 123 GITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
E+ + DVWSCG+ L ML G P++ P + + + + + I
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
L+ +I V +P+ RI+IP+I+ W+ K L
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 9e-38
Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 7/150 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N+ H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRH 145
D+WS G +YV+L G PF + ++ I I++ +Y+ + + IS E
Sbjct: 182 TA-TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLKNLP 175
+ R+ V + R++ E H W + +
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-37
Identities = 56/183 (30%), Positives = 91/183 (49%), Gaps = 4/183 (2%)
Query: 28 NVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
N+ HRD+K EN L P LK+ DFG++K + H+ + TP Y+APEVL ++Y
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECR 144
D D+WS GV +Y++L G PF RI QY P+ + +S E +
Sbjct: 191 DKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 249
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQI 204
LI + +P +R++I E NH W +++ +T+ E+ ++ +E+
Sbjct: 250 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSA 309
Query: 205 IAE 207
+A
Sbjct: 310 LAT 312
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 132 bits (332), Expect = 3e-37
Identities = 46/209 (22%), Positives = 87/209 (41%), Gaps = 15/209 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
++ H D+K EN + + A +KI DFG + K T T + APE++ ++
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRH 145
D+W+ GV YV+L G PF ++ +T+ + + + + +SPE +
Sbjct: 207 -FYTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 146 LISRIFVADPAKRISIPEIRNHEWF---LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIM 202
I + +P KR+++ + H W NL + + ++++ + Q ++
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI-----PSSRYNKIRQKIKEKYADW 316
Query: 203 QIIAEATIPAAGTQSLNQCLNGSLDIDDE 231
A A SL + I D
Sbjct: 317 PAPQPAIGRIANFSSLRKHRPQEYQIYDS 345
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 8e-37
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +++YD
Sbjct: 134 PIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY-EEKYD 190
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
DV++ G+ + M YP+ + +N + R+ S PE + +I
Sbjct: 191 ES-VDVYAFGMCMLEMATSEYPYSEC---QNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 148 SRIFVADPAKRISIPEIRNHEWF 170
+ +R SI ++ NH +F
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 129 bits (325), Expect = 3e-36
Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 17/186 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N H DLK EN + + LK+ DFG + K T GT + APEV K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRH 145
D+WS GV Y++L G PF +N +T+ + S +++ D + IS + +
Sbjct: 204 YY-TDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 146 LISRIFVADPAKRISIPEIRNHEWFLK-NLPADLV---------VDNTTNNQFEEPDQPM 195
I ++ +ADP R++I + H W N P + ++ +++ +P+
Sbjct: 259 FIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPL 318
Query: 196 QSIDEI 201
+ I
Sbjct: 319 PPLGRI 324
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 126 bits (318), Expect = 8e-36
Identities = 50/148 (33%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N+ HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE++ D
Sbjct: 130 NIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 187
Query: 88 -----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
GK D+WS GV +Y +L G+ PF ++ R + + Q+ P++ S
Sbjct: 188 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDT 245
Query: 143 CRHLISRIFVADPAKRISIPEIRNHEWF 170
+ L+SR V P KR + E H +F
Sbjct: 246 VKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 7e-35
Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 18/177 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KK 84
N+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L +
Sbjct: 135 NMIHRDVKAGNILLSEPG--LVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEG 189
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+YDGK DVWS G+T + P + N ++ I + H S R
Sbjct: 190 QYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYFR 244
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEI 201
+ + P R + + H + L+ P +++D + ++ +D +
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD-----LIQRTKDAVRELDNL 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 7e-35
Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 9/143 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYIAPEVLLKKEY 86
V HRDLK N LDG +K+ DFG ++ + TP Y++PE + + Y
Sbjct: 134 TVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY 191
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
+ K +D+WS G LY + PF + ++ +I ++ Y S E +
Sbjct: 192 NEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY-RYSDELNEI 245
Query: 147 ISRIFVADPAKRISIPEIRNHEW 169
I+R+ R S+ EI +
Sbjct: 246 ITRMLNLKDYHRPSVEEILENPL 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-34
Identities = 50/143 (34%), Positives = 66/143 (46%), Gaps = 14/143 (9%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
V HRD+K EN L+D + LK+ DFG + + GT Y PE + Y
Sbjct: 130 GVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
G+ A VWS G+ LY M+ G PFE EE I+ Q +S EC+HLI
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSECQHLI 235
Query: 148 SRIFVADPAKRISIPEIRNHEWF 170
P+ R + EI+NH W
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-34
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 7/149 (4%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
V HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 136 QVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
K D+WS G+ M+ G P+ + + + + + +S R
Sbjct: 194 GPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDF 249
Query: 147 ISRIFVADPAKRISIPEIRNHEWFLKNLP 175
++R D KR S E+ H++ P
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-34
Identities = 49/147 (33%), Positives = 76/147 (51%), Gaps = 9/147 (6%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++ +
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 192
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPEC 143
AD+WS GV Y++L GA PF ++T+ + +V Y D + + S
Sbjct: 193 LG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNTSALA 247
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWF 170
+ I R+ V DP KR++I + H W
Sbjct: 248 KDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-34
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 84
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 128 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+D+W+ G +Y ++ G PF N +I+ ++Y P+ P+ R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKAR 238
Query: 145 HLISRIFVADPAKRISIPEIRNHEWFLK 172
L+ ++ V D KR+ E+ +
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (308), Expect = 4e-34
Identities = 55/170 (32%), Positives = 77/170 (45%), Gaps = 8/170 (4%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 82
L + HRDLK EN L ++ I DFG SK S + GTP Y+APEVL
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHIS 140
+K Y D WS GV Y++L G PF D +N K +IL +Y P + IS
Sbjct: 183 QKPYSKA-VDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 141 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 190
+ I + DP KR + + H W + D + + + Q ++
Sbjct: 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 287
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 6e-34
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 12/157 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++ +
Sbjct: 130 KIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 87 DGKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISP 141
+ ADVWS G+TL M P + N + + +I + ++ S
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHE----LNPMRVLLKIAKSEPPTLAQPSRWSS 243
Query: 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
+ + + + R + ++ H + + +
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-32
Identities = 41/184 (22%), Positives = 75/184 (40%), Gaps = 42/184 (22%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEE-------------------------------- 115
+ +D+WS G++L M VG YP P+
Sbjct: 182 VQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 116 ------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 169
P + + I++ S E + +++ + +PA+R + ++ H +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 170 FLKN 173
++
Sbjct: 301 IKRS 304
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (296), Expect = 2e-32
Identities = 52/148 (35%), Positives = 79/148 (53%), Gaps = 16/148 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
++ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ K Y+
Sbjct: 124 DIIYRDLKPENILLDKNG--HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
D WS G+ +Y ML G PF D N KT +IL+ + P + + + L+
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPP--FFNEDVKDLL 232
Query: 148 SRIFVADPAKRI-----SIPEIRNHEWF 170
SR+ D ++R+ +++NH WF
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-31
Identities = 34/158 (21%), Positives = 63/158 (39%), Gaps = 8/158 (5%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEV 80
L ++ HRDLK N L +KI DFG + Q + G+ ++APEV
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 81 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 138
+ ++ + +DV++ G+ LY ++ G P+ + + R +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 139 ISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLP 175
+ L++ +R P+I E ++LP
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-30
Identities = 55/150 (36%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 23 ELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 81
L + +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+L
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
L ++Y+ D WS GV LY ML+G PF ++ + H I P +
Sbjct: 176 LGQKYNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPR--WLEK 228
Query: 142 ECRHLISRIFVADPAKRISIP-EIRNHEWF 170
E + L+ ++FV +P KR+ + +IR H F
Sbjct: 229 EAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 113 bits (284), Expect = 3e-30
Identities = 53/198 (26%), Positives = 82/198 (41%), Gaps = 28/198 (14%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 127 FVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAY 183
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
AD +S G L+ +L G PF + K+ + L++ +PD SPE R L+
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLL 240
Query: 148 SRIFVADPAKRISIP-----EIRNHEWF---------LKNLPADLV--------VDNTTN 185
+ D +R+ E++ +F L+ P L+ D
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDI 300
Query: 186 NQFEEPDQPMQSIDEIMQ 203
F+E D + + Q
Sbjct: 301 GSFDEEDTKGIKLLDSDQ 318
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-29
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 15/149 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 86
+V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL +Y
Sbjct: 125 DVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
D W GV +Y M+ G PF + ++ + IL + P +SPE + L
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPR--TLSPEAKSL 235
Query: 147 ISRIFVADPAKRIS-----IPEIRNHEWF 170
++ + DP +R+ E+ H +F
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-29
Identities = 44/164 (26%), Positives = 61/164 (37%), Gaps = 24/164 (14%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
V HRDLK +N L+ S ++K+ DFG ++ S V T Y APEVLL+ Y
Sbjct: 136 RVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 193
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------------------- 127
D+WS G M F + K + I
Sbjct: 194 TP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 252
Query: 128 -SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
S Q I + L+ + +PAKRIS +H +F
Sbjct: 253 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 7e-29
Identities = 50/203 (24%), Positives = 74/203 (36%), Gaps = 26/203 (12%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+CHRD+K +N LLD A K+CDFG +K V S + + Y APE++
Sbjct: 142 GICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEE-----------------------PKNFRKTIH 124
DVWS G L +L+G F P
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 260
Query: 125 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLVVDN 182
+I + ++ PE L SR+ P R++ E H +F L++ L
Sbjct: 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGR 320
Query: 183 TTNNQFEEPDQPMQSIDEIMQII 205
T F Q + S + I+
Sbjct: 321 DTPALFNFTTQELSSNPPLATIL 343
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 5e-28
Identities = 42/188 (22%), Positives = 70/188 (37%), Gaps = 42/188 (22%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL 81
+ HRD+K N L+ LK+ DFG ++ + ++ + V T Y PE+L
Sbjct: 136 NKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--- 138
L + G D+W G + M + + + + I + SI V
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALISQLCGSITPEVWPNV 249
Query: 139 ---------------------------ISPECRHLISRIFVADPAKRISIPEIRNHEWFL 171
P LI ++ V DPA+RI + NH++F
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
Query: 172 KN-LPADL 178
+ +P+DL
Sbjct: 310 SDPMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-27
Identities = 49/210 (23%), Positives = 79/210 (37%), Gaps = 41/210 (19%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLK 83
NV HRDLK N LL+ + LKICDFG ++ V T Y APE++L
Sbjct: 129 NVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-------- 135
+ K D+WS G L ML F K++ ++ IL + S
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPG----KHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 136 ---------------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174
+ + + L+ ++ +P KRI + + H + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
Query: 175 -PADLVVDNTTNN-QFEEPDQPMQSIDEIM 202
P+D + E D P + + E++
Sbjct: 303 DPSDEPIAEAPFKFDMELDDLPKEKLKELI 332
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 8e-27
Identities = 43/172 (25%), Positives = 66/172 (38%), Gaps = 26/172 (15%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEY 86
+ HRDLK N LLD + LK+ DFG +KS + V T Y APE+L
Sbjct: 120 WILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------QYSIPDYV-- 137
G D+W+ G L +L+ + + + + S+PDYV
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 138 -------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176
+ LI +F+ +P RI+ + ++F N P
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPG 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 9e-27
Identities = 43/174 (24%), Positives = 68/174 (39%), Gaps = 26/174 (14%)
Query: 21 WSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 79
+ V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 80 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------RILSVQYS 132
+LL +Y D+WS G M+ F E + + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 133 IPDYV----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+PDY + + R L+S++ DP KRIS H +F
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (257), Expect = 2e-26
Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 30/195 (15%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
++ +RDLK EN L+D +++ DFG++K + + GTP +APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQG--YIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
D W+ GV +Y M G PF + +I+S + P H S + + L+
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPS--HFSSDLKDLL 269
Query: 148 SRIFVADPAKRI-----SIPEIRNHEWF---------LKNLPADLV-----VDNTTNNQF 188
+ D KR + +I+NH+WF + + A + +T+N
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329
Query: 189 EEPDQPMQSIDEIMQ 203
E ++ SI+E
Sbjct: 330 YEEEEIRVSINEKCG 344
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-26
Identities = 30/156 (19%), Positives = 58/156 (37%), Gaps = 11/156 (7%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVL 81
+ N HRDL+ N L+ + K+ DFG ++ ++ + + APE
Sbjct: 129 VERMNYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 141
L + K +DVWS G+ L + + + R Y +P
Sbjct: 187 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPE 241
Query: 142 ECRHLISRIFVADPAKRISIPEIRN--HEWFLKNLP 175
L+ + + +P +R + ++ ++F P
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-26
Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEY 86
+ +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 149 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 208
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 146
K D WS GV +Y +L GA PF E + + RIL + P +S + L
Sbjct: 209 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALAKDL 266
Query: 147 ISRIFVADPAKRIS-----IPEIRNHEWF 170
I R+ + DP KR+ EI+ H +F
Sbjct: 267 IQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-25
Identities = 35/175 (20%), Positives = 63/175 (36%), Gaps = 11/175 (6%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEV 80
L + HRDL N L+ +KI DFG +K + + ++A E
Sbjct: 127 LEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 140
+L + Y + +DVWS GVT++ ++ D I IL +P +
Sbjct: 185 ILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQPPICT 239
Query: 141 PECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTNNQFEEPDQP 194
+ ++ + ++ D R E+ ++ LV+ P
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (246), Expect = 2e-25
Identities = 34/140 (24%), Positives = 55/140 (39%), Gaps = 9/140 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
N HRDL N L+ K+ DFG +K S + + APE L +K++
Sbjct: 123 NFVHRDLAARNVLVSEDN--VAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFS 178
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
K +DVWS G+ L+ + K+ + + + PD P ++
Sbjct: 179 TK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--GYKMDAPD--GCPPAVYEVM 233
Query: 148 SRIFVADPAKRISIPEIRNH 167
+ D A R S ++R
Sbjct: 234 KNCWHLDAAMRPSFLQLREQ 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 98.7 bits (245), Expect = 3e-25
Identities = 27/144 (18%), Positives = 55/144 (38%), Gaps = 5/144 (3%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ HRD+K N ++ + A ++ + S +Q + +GT Y++PE
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
D + +DV+S G LY +L G PF + + + + +S +
Sbjct: 191 VDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--GLSADLDA 247
Query: 146 LISRIFVADPAKRISIPEIRNHEW 169
++ + +P R +
Sbjct: 248 VVLKALAKNPENRYQTAAEMRADL 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (245), Expect = 3e-25
Identities = 42/178 (23%), Positives = 68/178 (38%), Gaps = 27/178 (15%)
Query: 23 ELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 81
NV HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 82 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------SVQYSI 133
+ D+WS G + P + + K I R+L +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 134 PDYV----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175
PDY ++ R L+ + +P +RIS E H +F P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 6e-25
Identities = 33/144 (22%), Positives = 62/144 (43%), Gaps = 11/144 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 84
+ HRDL N L+ +KICDFG ++ S + + ++APE L +
Sbjct: 184 SCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 85 EYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
Y K +DVWS G+ L+ + +G P+ ++++ + + + + E
Sbjct: 242 IYTIK-SDVWSYGILLWEIFSLGVNPYPG----IPVDANFYKLIQNGFKMDQPFYATEEI 296
Query: 144 RHLISRIFVADPAKRISIPEIRNH 167
++ + D KR S P + +
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 7e-25
Identities = 40/201 (19%), Positives = 75/201 (37%), Gaps = 30/201 (14%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
+ HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 141 GIIHRDLKPGNLAVNEDC--ELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRY 196
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV---------- 137
+ D+WS G + M+ G F+ + ++ + + +
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256
Query: 138 ---------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLVVD 181
+ SP +L+ ++ V D +R++ E H +F + D
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV 316
Query: 182 NTTNNQFEEPDQPMQSIDEIM 202
++ F++ D+ + +
Sbjct: 317 QKYDDSFDDVDRTLDEWKRVT 337
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 1e-24
Identities = 31/140 (22%), Positives = 54/140 (38%), Gaps = 7/140 (5%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
HRDL N L+ + KI DFG S+ ++ + ++A E L Y
Sbjct: 147 QFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 204
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 147
+DVWS GV L+ ++ P + ++ Y + ++ E L+
Sbjct: 205 TN-SDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLM 259
Query: 148 SRIFVADPAKRISIPEIRNH 167
+ + P +R S +I
Sbjct: 260 RQCWREKPYERPSFAQILVS 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 97.3 bits (241), Expect = 1e-24
Identities = 37/167 (22%), Positives = 63/167 (37%), Gaps = 26/167 (15%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 86
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 120 RVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--------- 137
D+WS G M+ G F E + + + V
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 138 --------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 170
+ L+S++ DP +RI+ + H +F
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 1e-24
Identities = 41/201 (20%), Positives = 76/201 (37%), Gaps = 30/201 (14%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87
++ HRDLK N ++ LKI DFG ++ + V T Y APE++L +
Sbjct: 141 DIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD------------ 135
+ D+WS G + +L G F + + + + + +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 136 -------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLVVD 181
++ +P L+ ++ V D KRI+ + H +F + + P D V
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 316
Query: 182 NTTNNQFEEPDQPMQSIDEIM 202
+ + FE D + +
Sbjct: 317 DPYDQSFESRDLLIDEWKSLT 337
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 97.6 bits (242), Expect = 2e-24
Identities = 31/182 (17%), Positives = 62/182 (34%), Gaps = 33/182 (18%)
Query: 21 WSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 80
+ HRD+K N ++D +L++ D+G ++ + V + + PE+
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200
Query: 81 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------- 131
L+ + D+WS G L M+ PF + + I ++L +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 132 -----------------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168
+ +SPE + ++ D R++ E H
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
Query: 169 WF 170
+F
Sbjct: 321 YF 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 5e-24
Identities = 33/145 (22%), Positives = 57/145 (39%), Gaps = 12/145 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLK 83
HRDL N LL +KI DFG + + + + A+ APE L
Sbjct: 131 RFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 84 KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
+ + +D W GVTL+ M G P+ N + +H+I +P +
Sbjct: 189 RTFSHA-SDTWMFGVTLWEMFTYGQEPWIG----LNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 143 CRHLISRIFVADPAKRISIPEIRNH 167
+++ + + P R + +R+
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 1e-23
Identities = 26/145 (17%), Positives = 51/145 (35%), Gaps = 12/145 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 82
HRDL N +LD +K+ DFG ++ ++A E L
Sbjct: 150 KFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 142
+++ K +DVWS GV L+ ++ P + + + + +
Sbjct: 208 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GRRLLQPEYCPDP 262
Query: 143 CRHLISRIFVADPAKRISIPEIRNH 167
++ + + R S E+ +
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.4 bits (231), Expect = 4e-23
Identities = 32/142 (22%), Positives = 56/142 (39%), Gaps = 12/142 (8%)
Query: 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 83
HRDL N L+ + +KI DFG S+ S+ + + ++ PE +
Sbjct: 159 RKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPE 142
Y + +DVW+ GV L+ + P + I+ + + P+ + E
Sbjct: 217 NRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGMAHEEVIYYVRDGNILACPE--NCPLE 270
Query: 143 CRHLISRIFVADPAKRISIPEI 164
+L+ + PA R S I
Sbjct: 271 LYNLMRLCWSKLPADRPSFCSI 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 6e-23
Identities = 31/142 (21%), Positives = 63/142 (44%), Gaps = 9/142 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
HRD+ N L+ + +K+ DFG S+ + K++ ++APE + +
Sbjct: 128 RFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
+ +DVW GV ++ +L+ P + I RI + + +P + P
Sbjct: 186 FTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPPTLYS 240
Query: 146 LISRIFVADPAKRISIPEIRNH 167
L+++ + DP++R E++
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 6e-23
Identities = 29/142 (20%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 85
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV
Sbjct: 121 CVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
Y K +DVWS GV ++ + P E ++ + + I + + + S
Sbjct: 179 YSSK-SDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST-GFRLYKPRLASTHVYQ 233
Query: 146 LISRIFVADPAKRISIPEIRNH 167
+++ + P R + +
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.6 bits (229), Expect = 7e-23
Identities = 36/169 (21%), Positives = 62/169 (36%), Gaps = 17/169 (10%)
Query: 28 NVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAP 78
N HRD+K +N L+ G + I DFG +K + + + K+ GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 79 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV- 137
L E + D+ S G L +G+ P++ + +K RI + S P V
Sbjct: 183 NTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMSTPIEVL 240
Query: 138 --HISPECRHLISRIFVADPAKRISIPEIRN---HEWFLKNLPADLVVD 181
E ++ + +R + + + D V D
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 92.2 bits (228), Expect = 1e-22
Identities = 27/153 (17%), Positives = 55/153 (35%), Gaps = 16/153 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPR---LKICDFGYSK--------SSVLHSQPKSTVGTPAYI 76
++ +RD+K +N L+ + + + DFG K + + + K+ GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 77 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 136
+ L +E + D+ + G L G+ P++ + N +K RI + S P
Sbjct: 181 SINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPLR 238
Query: 137 V---HISPECRHLISRIFVADPAKRISIPEIRN 166
E + ++
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.4 bits (228), Expect = 2e-22
Identities = 36/194 (18%), Positives = 66/194 (34%), Gaps = 45/194 (23%)
Query: 28 NVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 85
+ H D+K EN L++ SP ++I + +++ T Y +PEVLL
Sbjct: 146 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAP 205
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQYSIPDYV------ 137
+ AD+WS ++ ++ G + F ++ I +I+ + +P Y+
Sbjct: 206 WGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY 264
Query: 138 ----------------------------------HISPECRHLISRIFVADPAKRISIPE 163
+ E +S + DP KR
Sbjct: 265 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324
Query: 164 IRNHEWFLKNLPAD 177
+ NH W L +
Sbjct: 325 LVNHPWLKDTLGME 338
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 2e-22
Identities = 30/155 (19%), Positives = 57/155 (36%), Gaps = 11/155 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLK 83
N HRDL N L++ + K+ DFG S+ + APE +
Sbjct: 130 NYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 143
+++ +DVWS G+ ++ ++ K I+ + +P +
Sbjct: 188 RKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCPSAI 242
Query: 144 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 178
L+ + + + A+R +I + L P L
Sbjct: 243 YQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 91.4 bits (226), Expect = 2e-22
Identities = 34/154 (22%), Positives = 63/154 (40%), Gaps = 16/154 (10%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 81
N HRDL N L++ + K+ DFG S+ S ++ + APE +
Sbjct: 148 NYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 82 LKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 140
+++ +DVWS G+ ++ ++ G P+ D + I+ I Y +P +
Sbjct: 206 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD----MTNQDVINAIEQ-DYRLPPPMDCP 259
Query: 141 PECRHLISRIFVADPAKRISIPEIRNH-EWFLKN 173
L+ + D R +I N + ++N
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.9 bits (225), Expect = 3e-22
Identities = 34/152 (22%), Positives = 58/152 (38%), Gaps = 18/152 (11%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLK 83
N HRDL N LL + I DFG SK ++ + + APE +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 84 KEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISP 141
+++ + +DVWS GVT++ L G P++ + + I + P P
Sbjct: 187 RKFSSR-SDVWSYGVTMWEALSYGQKPYKK----MKGPEVMAFIEQGKRMECPP--ECPP 239
Query: 142 ECRHLISRIFVADPAKRISIPEIR---NHEWF 170
E L+S ++ R + ++
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 4e-22
Identities = 26/143 (18%), Positives = 55/143 (38%), Gaps = 11/143 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
HRDL N L++ +K+ DFG S+ + S + PEVL+ +
Sbjct: 120 QFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 86 YDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
+ K +D+W+ GV ++ + +G P+E + + S +
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKVY 231
Query: 145 HLISRIFVADPAKRISIPEIRNH 167
++ + +R + + ++
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 5e-22
Identities = 33/160 (20%), Positives = 53/160 (33%), Gaps = 17/160 (10%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 79
L N HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 80 VLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYV 137
+ ++ K +DVWS GV ++ G P+ + + + P
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG----MKGSEVTAMLEKGERMGCPA-- 233
Query: 138 HISPECRHLISRIFVADPAKRISIPEIRN--HEWFLKNLP 175
E L++ + D R + ++ +
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.7 bits (222), Expect = 5e-22
Identities = 30/147 (20%), Positives = 53/147 (36%), Gaps = 11/147 (7%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 85
N HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
+ K +DVWS G+ L ++ + + R Y + + E
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQ 241
Query: 146 LISRIFVADPAKRISIPEIRN--HEWF 170
L+ + P R + +R+ ++F
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 89.0 bits (220), Expect = 1e-21
Identities = 31/140 (22%), Positives = 56/140 (40%), Gaps = 9/140 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 85
N HRDL N L+ + +K+ DFG S+ + ++ + APE L +
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
+ K +DVW+ GV L+ + + ++ +L Y + +
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDYRMERPEGCPEKVYE 247
Query: 146 LISRIFVADPAKRISIPEIR 165
L+ + +P+ R S EI
Sbjct: 248 LMRACWQWNPSDRPSFAEIH 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 5e-21
Identities = 33/143 (23%), Positives = 57/143 (39%), Gaps = 9/143 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 84
HRDL N LL +KICDFG ++ + + ++APE + +
Sbjct: 154 KCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 211
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y + +DVWS GV L+ + P + R L + + +PE
Sbjct: 212 VYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 267
Query: 145 HLISRIFVADPAKRISIPEIRNH 167
+ + +P++R + E+ H
Sbjct: 268 QTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 2e-19
Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 39/218 (17%)
Query: 24 LLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 83
L + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPD 135
Y + D+WS G + M+ F + + K I ++ + +Q ++ +
Sbjct: 193 MGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 136 YVH----------------------------ISPECRHLISRIFVADPAKRISIPEIRNH 167
YV + + R L+S++ V DPAKRIS+ + H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 168 EWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 205
+ V ++ D+ +I+E ++I
Sbjct: 312 PYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 2e-18
Identities = 25/139 (17%), Positives = 56/139 (40%), Gaps = 8/139 (5%)
Query: 28 NVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86
HRDL N L+ ++ + + + ++APE L + Y
Sbjct: 155 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 214
Query: 87 DGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 145
+ +DVWS GV L+ + +G P+ + + ++L + + + + E
Sbjct: 215 THQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-----EELFKLLKEGHRMDKPSNCTNELYM 268
Query: 146 LISRIFVADPAKRISIPEI 164
++ + A P++R + ++
Sbjct: 269 MMRDCWHAVPSQRPTFKQL 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 2e-18
Identities = 36/187 (19%), Positives = 64/187 (34%), Gaps = 29/187 (15%)
Query: 5 AVQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKS 59
A+ G L ++ P + HRDLK +N L+ + I D G S +
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSAT 162
Query: 60 SVLHSQPKSTVGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 114
+ P VGT Y+APEVL +K K AD+++ G+ + + E
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 115 EPKNFRKTIHRILSVQYSIPDYV----------------HISPECRHLISRIFVADPAKR 158
+ + + + V ++ + A+ A R
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
Query: 159 ISIPEIR 165
++ I+
Sbjct: 283 LTALRIK 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 3e-18
Identities = 30/144 (20%), Positives = 56/144 (38%), Gaps = 12/144 (8%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 84
HRDL N ++ +KI DFG ++ + + + + +++PE L
Sbjct: 153 KFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 210
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPEC 143
+ DVWS GV L+ + A P + + + + ++ PD +
Sbjct: 211 VFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEGGLLDKPD--NCPDML 264
Query: 144 RHLISRIFVADPAKRISIPEIRNH 167
L+ + +P R S EI +
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 5e-18
Identities = 33/140 (23%), Positives = 54/140 (38%), Gaps = 9/140 (6%)
Query: 28 NVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 84
N HRDL N LL KICDFG ++ S ++APE +
Sbjct: 165 NCIHRDLAARNILLTHG--RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222
Query: 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 144
Y + +DVWS G+ L+ + ++++ + + H E
Sbjct: 223 VYTFE-SDVWSYGIFLWELFSLGSSPYPGM---PVDSKFYKMIKEGFRMLSPEHAPAEMY 278
Query: 145 HLISRIFVADPAKRISIPEI 164
++ + ADP KR + +I
Sbjct: 279 DIMKTCWDADPLKRPTFKQI 298
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 254 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.98 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.42 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 93.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 93.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.54 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 92.3 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=288.59 Aligned_cols=162 Identities=31% Similarity=0.539 Sum_probs=132.4
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC---CCCCCCcCCCCcccchhccCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~ 85 (254)
....++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+..... ......+||+.|+|||++.+..
T Consensus 104 ~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~ 181 (271)
T d1nvra_ 104 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSS
T ss_pred HHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCccccccceeeCcCccCHhHhcCCC
Confidence 34568899999999999999999999999999988765 999999999865322 2234567999999999999888
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+++.++|||||||++|+|++|+.||............ ........+.+..+|+++++||.+||+.||++|||++|++
T Consensus 182 ~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 8767799999999999999999999876543332222 2223333344556899999999999999999999999999
Q ss_pred cCccccccCC
Q 025350 166 NHEWFLKNLP 175 (254)
Q Consensus 166 ~hp~~~~~~~ 175 (254)
+||||++.++
T Consensus 259 ~hpwf~~~l~ 268 (271)
T d1nvra_ 259 KDRWYNKPLK 268 (271)
T ss_dssp TCTTTTCCCC
T ss_pred cCHhhCcCCC
Confidence 9999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=284.35 Aligned_cols=155 Identities=35% Similarity=0.554 Sum_probs=130.2
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+.... ......+||+.|+|||++.+..++.
T Consensus 107 ~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~~~~~Gt~~Y~APE~~~~~~~~~ 183 (263)
T d2j4za1 107 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMHDE 183 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCCEETTEEGGGCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-CcccccCCCCcccCHHHHcCCCCCc
Confidence 34567899999999999999999999999999988776 99999999976533 3345567999999999999888865
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
+ +|||||||++|+|++|+.||.+.+.... ...+.......|. .+|+++++||.+||+.||.+|||++|+|+||
T Consensus 184 ~-~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 184 K-VDLWSLGVLCYEFLVGKPPFEANTYQET----YKRISRVEFTFPD--FVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp T-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred h-hhhhhHhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence 5 9999999999999999999987654333 3334444544443 5899999999999999999999999999999
Q ss_pred ccccc
Q 025350 169 WFLKN 173 (254)
Q Consensus 169 ~~~~~ 173 (254)
||+.+
T Consensus 257 ~~~~~ 261 (263)
T d2j4za1 257 WITAN 261 (263)
T ss_dssp HHHHH
T ss_pred CcCCc
Confidence 99753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=283.26 Aligned_cols=158 Identities=25% Similarity=0.381 Sum_probs=131.3
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+...... .....+||+.|+|||++.+..++
T Consensus 117 ~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 194 (293)
T d1yhwa1 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBC
T ss_pred HHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--EeeccchhheeeccccccccccccCCCccChhhhcCCCCC
Confidence 34567899999999999999999999999999988765 9999999998654332 34456799999999999988887
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
.+ +|||||||++|+|++|+.||.+............ ......+.+..+|+.+++||.+||..||.+|||+.|+|+|
T Consensus 195 ~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 195 PK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 65 9999999999999999999988665544433322 2233344445689999999999999999999999999999
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||+.
T Consensus 271 p~~~~ 275 (293)
T d1yhwa1 271 QFLKI 275 (293)
T ss_dssp GGGGG
T ss_pred HhhCC
Confidence 99975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=282.08 Aligned_cols=159 Identities=34% Similarity=0.560 Sum_probs=118.2
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC-CCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.|++.||+|||++||+||||||+|||+... ..+.+||+|||+|+.........+.+||+.|+|||++.+..++
T Consensus 108 ~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~ 187 (307)
T d1a06a_ 108 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCC
Confidence 345678999999999999999999999999999642 2245999999999876555555667899999999999988887
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--CCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|+.||.+......... +..... ..+.+..+|+++++||.+||.+||.+|||++|++
T Consensus 188 ~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 188 KA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQ----ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 65 9999999999999999999988655443333 333333 3344567899999999999999999999999999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 263 ~hp~~~~ 269 (307)
T d1a06a_ 263 QHPWIAG 269 (307)
T ss_dssp HSTTTTS
T ss_pred cCHhhCC
Confidence 9999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=274.79 Aligned_cols=153 Identities=25% Similarity=0.414 Sum_probs=122.9
Q ss_pred CCcHHHHHHHHHHHhhcC--cccCCCCCCcEEecC-CCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 11 GTLFLPTTYFWSELLPFN--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~g--ivHrdlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
..++.|++.||+|||++| |+||||||+|||++. ++. +||+|||+|+... .....+.+||+.|+|||++.+ .++
T Consensus 115 ~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~-~~~ 190 (270)
T d1t4ha_ 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYD 190 (270)
T ss_dssp HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCC
T ss_pred HHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcceecc-CCccCCcccCccccCHHHhCC-CCC
Confidence 457889999999999999 999999999999964 444 9999999997532 233345689999999999865 465
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
.+ +|||||||++|+|++|+.||.+........+ .+............+++++++||.+||..||++|||++|+|+|
T Consensus 191 ~~-~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 191 ES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Cc-CchhhHHHHHHHHHHCCCCCCCcccHHHHHH---HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 54 9999999999999999999987655444333 2333222222234578999999999999999999999999999
Q ss_pred cccc
Q 025350 168 EWFL 171 (254)
Q Consensus 168 p~~~ 171 (254)
|||+
T Consensus 267 p~fk 270 (270)
T d1t4ha_ 267 AFFQ 270 (270)
T ss_dssp GGGC
T ss_pred cccC
Confidence 9995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-41 Score=285.95 Aligned_cols=161 Identities=27% Similarity=0.446 Sum_probs=132.9
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
.....++.|++.||+|||++|||||||||+|||++.+..+.+||+|||+|+.........+..||+.|+|||++.+..++
T Consensus 124 ~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~ 203 (350)
T d1koaa2 124 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBC
T ss_pred HHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCC
Confidence 33456789999999999999999999999999997654456999999999876555555567899999999999988886
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|+.||.+.+....+.. +.......+ .+..+|+++++||.+||..||++|||++|+|
T Consensus 204 ~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 278 (350)
T d1koaa2 204 YY-TDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278 (350)
T ss_dssp HH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred hh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 55 9999999999999999999987665444433 333333322 2346899999999999999999999999999
Q ss_pred cCcccccc
Q 025350 166 NHEWFLKN 173 (254)
Q Consensus 166 ~hp~~~~~ 173 (254)
+||||+..
T Consensus 279 ~hp~~~~~ 286 (350)
T d1koaa2 279 EHPWLTPG 286 (350)
T ss_dssp HSTTTSCT
T ss_pred cCcccCCC
Confidence 99999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.9e-41 Score=282.08 Aligned_cols=160 Identities=23% Similarity=0.430 Sum_probs=133.4
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....++.|++.||+|||++|||||||||+|||++....+++||+|||+|+.........+..||+.|+|||++.+..++.
T Consensus 128 ~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (352)
T d1koba_ 128 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207 (352)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCH
T ss_pred HHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCC
Confidence 34557899999999999999999999999999985544569999999998766555555668999999999999888866
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCC--CCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++|+|++|+.||.+......+.. +....... +.+..+|+++++||.+||..||.+|||+.|+|+
T Consensus 208 ~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 208 Y-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp H-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred c-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 5 9999999999999999999988665444333 33333332 334578999999999999999999999999999
Q ss_pred Ccccccc
Q 025350 167 HEWFLKN 173 (254)
Q Consensus 167 hp~~~~~ 173 (254)
||||+..
T Consensus 283 Hp~~~~~ 289 (352)
T d1koba_ 283 HPWLKGD 289 (352)
T ss_dssp STTTSSC
T ss_pred CHhhCCC
Confidence 9999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-41 Score=278.02 Aligned_cols=160 Identities=27% Similarity=0.330 Sum_probs=132.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.||+|||++|||||||||+|||++..+. +||+|||+++...........+||+.|+|||++.+..++.+
T Consensus 118 ~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~ 195 (305)
T d1blxa_ 118 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 195 (305)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred HHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChh
Confidence 3457899999999999999999999999999988776 99999999987655555567789999999999999888766
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC-C--------------------CCCCCCCCHHHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S--------------------IPDYVHISPECRHLIS 148 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~--------------------~~~~~~~~~~~~~li~ 148 (254)
+||||+||++|+|++|++||.+.+....+..+......... . ......+++.+++||.
T Consensus 196 -~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 274 (305)
T d1blxa_ 196 -VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 274 (305)
T ss_dssp -HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred -ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHH
Confidence 99999999999999999999987766665554443211100 0 0112357899999999
Q ss_pred HhchhCCCCCCCHhHHhcCccccc
Q 025350 149 RIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 149 ~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
+||.+||.+|||+.|+|+||||++
T Consensus 275 ~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 275 KCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHCcCChhHCcCHHHHhcChhhcC
Confidence 999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=278.08 Aligned_cols=158 Identities=25% Similarity=0.339 Sum_probs=127.5
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhcc-----
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLL----- 82 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~----- 82 (254)
....++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+..... ....+.+||+.|+|||++.
T Consensus 111 ~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 188 (288)
T d2jfla1 111 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTT
T ss_pred HHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccccccccccCCHHHHhhcccC
Confidence 34668899999999999999999999999999988776 999999999754322 1234567999999999984
Q ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 83 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 83 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
+..|+. ++|||||||++|+|++|+.||.+.+....+.++.. ......+.+..+|+++++||++||+.||.+|||+.
T Consensus 189 ~~~y~~-k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ 264 (288)
T d2jfla1 189 DRPYDY-KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTS 264 (288)
T ss_dssp TSSTTT-HHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH---SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCh-hhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 334444 59999999999999999999998776555444332 12223333456899999999999999999999999
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
|+++||||+.
T Consensus 265 ell~hp~~~~ 274 (288)
T d2jfla1 265 QLLQHPFVTV 274 (288)
T ss_dssp HHTTSGGGCC
T ss_pred HHhcCcccCC
Confidence 9999999965
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=283.48 Aligned_cols=162 Identities=26% Similarity=0.432 Sum_probs=123.6
Q ss_pred cCcCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCC
Q 025350 8 RGRGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
.....++.|++.||+|||+ +||+||||||+|||++.++. +||+|||+|+.... ....+.+||+.|+|||++.+..|
T Consensus 104 ~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~~~~~GT~~Y~APEvl~~~~y 180 (322)
T d1s9ja_ 104 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY 180 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC---CCSSCCCCHHHHHCSCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-CccccccCCccccCchHHcCCCC
Confidence 3345678899999999997 59999999999999988776 99999999985432 23456789999999999999888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHH--------------------------------------HHHHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK--------------------------------------TIHRILS 128 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------------------------------------~~~~~~~ 128 (254)
+.+ +||||+||++|+|++|+.||.+.+....... .......
T Consensus 181 ~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T d1s9ja_ 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN 259 (322)
T ss_dssp CTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHT
T ss_pred CcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhc
Confidence 766 9999999999999999999987543221110 0001111
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 129 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 129 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
..........+|.++++||.+||..||.+|||++|+|+||||++.
T Consensus 260 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 260 EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp SCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 111111112368899999999999999999999999999999763
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-41 Score=279.14 Aligned_cols=155 Identities=27% Similarity=0.358 Sum_probs=127.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccC---CCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK---KEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~ 86 (254)
...++.|++.||.|||++|||||||||+|||++.++. +||+|||+|+.... ....+||+.|+|||++.+ ..|
T Consensus 117 ~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y 191 (309)
T d1u5ra_ 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQY 191 (309)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCB
T ss_pred HHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CCccccCccccCHHHHhccCCCCc
Confidence 4567899999999999999999999999999988765 99999999986433 345679999999999864 345
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|||||||++|+|++|..||.+......... +............+|+.+++||.+||+.||.+|||++++|+
T Consensus 192 ~~~-~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 192 DGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Cch-hhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 544 9999999999999999999988665443333 33333333334568999999999999999999999999999
Q ss_pred CccccccC
Q 025350 167 HEWFLKNL 174 (254)
Q Consensus 167 hp~~~~~~ 174 (254)
||||++..
T Consensus 267 Hp~~~~~~ 274 (309)
T d1u5ra_ 267 HRFVLRER 274 (309)
T ss_dssp CHHHHSCC
T ss_pred CHHhcCCC
Confidence 99997643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=278.29 Aligned_cols=155 Identities=33% Similarity=0.563 Sum_probs=130.2
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-CCCCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+.... .......+||+.|+|||++.+..|+
T Consensus 106 ~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~ 183 (337)
T d1o6la_ 106 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBC
T ss_pred HHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCcccccceeCHHHhhhhhccCCCCC
Confidence 34567789999999999999999999999999988776 99999999986543 3334567899999999999999887
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----Hh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IP 162 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~ 162 (254)
.+ +|||||||++|+|++|++||.+.+..... ..+......+| ..+|+++++||++||++||.+|++ +.
T Consensus 184 ~~-~DiwSlGvilyeml~G~~pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~ 256 (337)
T d1o6la_ 184 RA-VDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256 (337)
T ss_dssp TT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHH
T ss_pred hh-hcccchhhHHHHHHHCCCCCCCcCHHHHH----HHHhcCCCCCC--ccCCHHHHHHHHhhccCCchhhcccccccHH
Confidence 65 99999999999999999999986654333 33444444444 458999999999999999999994 89
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
++++||||++
T Consensus 257 eil~Hp~f~~ 266 (337)
T d1o6la_ 257 EVMEHRFFLS 266 (337)
T ss_dssp HHHTSGGGTT
T ss_pred HHHcCccccc
Confidence 9999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=271.28 Aligned_cols=164 Identities=24% Similarity=0.314 Sum_probs=130.9
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
.....++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+...... .....+||+.|+|||++.+...
T Consensus 100 ~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 177 (299)
T d1ua2a_ 100 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177 (299)
T ss_dssp SHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSC
T ss_pred HHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccceecChhhccHHHHccCCC
Confidence 345567889999999999999999999999999988776 9999999997654332 3345679999999999876655
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC-C---------------CC------CCCCCHHHH
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-I---------------PD------YVHISPECR 144 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~---------------~~------~~~~~~~~~ 144 (254)
.+.++|||||||++|+|++|.+||.+......+..+.......... . +. ...++++++
T Consensus 178 ~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 257 (299)
T d1ua2a_ 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 257 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHH
T ss_pred CChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHH
Confidence 5566999999999999999999999887766655554432211100 0 00 124688999
Q ss_pred HHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 145 HLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 145 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
+||++||..||++|||++|+|+||||++.
T Consensus 258 dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 258 DLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 99999999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-40 Score=275.64 Aligned_cols=151 Identities=34% Similarity=0.584 Sum_probs=128.0
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCcc
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 90 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 90 (254)
..++.|++.|++|||++||+||||||+|||++.++. +||+|||+|+.... ...+.+||+.|+|||++.+..++.+
T Consensus 107 ~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~~y~~~- 181 (316)
T d1fota_ 107 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKS- 181 (316)
T ss_dssp HHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTT-
T ss_pred HHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--ccccccCcccccCHHHHcCCCCCch-
Confidence 456789999999999999999999999999988776 99999999986533 3346789999999999998888765
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHHh
Q 025350 91 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIR 165 (254)
Q Consensus 91 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l 165 (254)
+|||||||++|+|++|+.||.+.+..... .++.......| ..+|++++++|.+||.+||.+|+ |+++++
T Consensus 182 ~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il 255 (316)
T d1fota_ 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255 (316)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred hhccccchhHHHHHhCCCCCCCcCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHH
Confidence 99999999999999999999886554433 33444444444 35899999999999999999996 899999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||++
T Consensus 256 ~Hp~f~~ 262 (316)
T d1fota_ 256 NHPWFKE 262 (316)
T ss_dssp TSGGGSS
T ss_pred cCccccc
Confidence 9999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-41 Score=275.31 Aligned_cols=154 Identities=30% Similarity=0.509 Sum_probs=125.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+...... ...+.+||+.|+|||++.+..+
T Consensus 110 ~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 187 (288)
T d1uu3a_ 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC----------CCCCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCcccccccccCCccccCceeeccCCC
Confidence 4567889999999999999999999999999988776 9999999998654322 2345679999999999998888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH---
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE--- 163 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e--- 163 (254)
+.+ +|||||||++|+|++|+.||.+.+.... ..++....+.+| ..+++++++||++||+.||.+|||++|
T Consensus 188 ~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 188 CKS-SDLWALGCIIYQLVAGLPPFRAGNEYLI----FQKIIKLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHTTCCCCC--TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred Ccc-cceehhhHHHHHHhhCCCCCCCcCHHHH----HHHHHcCCCCCC--ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 655 9999999999999999999988654433 333444454444 358999999999999999999999988
Q ss_pred ---HhcCccccc
Q 025350 164 ---IRNHEWFLK 172 (254)
Q Consensus 164 ---~l~hp~~~~ 172 (254)
+++||||+.
T Consensus 261 ~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 261 YGPLKAHPFFES 272 (288)
T ss_dssp HHHHHTSGGGTT
T ss_pred CHHHHcCCccCC
Confidence 578999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=282.38 Aligned_cols=168 Identities=32% Similarity=0.550 Sum_probs=133.3
Q ss_pred cccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC
Q 025350 6 VQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
.+.....++.|++.||+|||++||+||||||+|||++... .+.+||+|||+|+...........+||+.|+|||++.+.
T Consensus 109 ~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 188 (335)
T d2ozaa1 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188 (335)
T ss_dssp EHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGG
T ss_pred CHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCC
Confidence 3344567889999999999999999999999999997633 346999999999876666666677899999999999888
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCC--CCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
.|+.+ +|||||||++|+|+||+.||.+.............+......+|. +..+|+++++||++||..||++|||+.
T Consensus 189 ~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 267 (335)
T d2ozaa1 189 KYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 267 (335)
T ss_dssp GGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 88655 999999999999999999998765544444333333333333332 235799999999999999999999999
Q ss_pred HHhcCccccccC
Q 025350 163 EIRNHEWFLKNL 174 (254)
Q Consensus 163 e~l~hp~~~~~~ 174 (254)
|+++||||++..
T Consensus 268 eil~hp~~~~~~ 279 (335)
T d2ozaa1 268 EFMNHPWIMQST 279 (335)
T ss_dssp HHHHSHHHHTTT
T ss_pred HHHcCHHhhCCC
Confidence 999999997643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-40 Score=279.72 Aligned_cols=157 Identities=27% Similarity=0.349 Sum_probs=126.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... .....+||+.|+|||++......+.
T Consensus 109 ~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~ 185 (364)
T d1omwa3 109 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDS 185 (364)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCc
Confidence 4457789999999999999999999999999988776 999999999865433 3456689999999999975543344
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCC-----HhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-----~~e~ 164 (254)
++|||||||++|+|++|+.||.+...... ............ +.+..+|+++++||.+||..||.+||| ++++
T Consensus 186 ~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei 262 (364)
T d1omwa3 186 SADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAV--ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262 (364)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCCC--CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH
T ss_pred ccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCC--CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH
Confidence 59999999999999999999987553222 223333333333 333468999999999999999999999 7999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||+.
T Consensus 263 l~Hp~f~~ 270 (364)
T d1omwa3 263 KESPFFRS 270 (364)
T ss_dssp HTSGGGTT
T ss_pred HcCccccC
Confidence 99999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-40 Score=279.03 Aligned_cols=152 Identities=30% Similarity=0.539 Sum_probs=128.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.||.|||++|||||||||+|||++.++. +||+|||+|+.... ...+.+||+.|+|||++.+..++.+
T Consensus 143 ~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~ 218 (350)
T d1rdqe_ 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKA 218 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--ccccccCccccCCHHHHcCCCCCcc
Confidence 4567899999999999999999999999999988775 99999999986533 3346689999999999998888755
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHhHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEI 164 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~ 164 (254)
+|||||||++|+|++|+.||.+.+..... ..+.......| ..+++++.+||++||..||.+|+ |++++
T Consensus 219 -~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~el 291 (350)
T d1rdqe_ 219 -VDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291 (350)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH
T ss_pred -ccccchhHHHHHHHhCCCCCCCcCHHHHH----HHHhcCCCCCC--ccCCHHHHHHHHHHhhhCHHhccccccccHHHH
Confidence 99999999999999999999886544333 33344444433 46899999999999999999995 89999
Q ss_pred hcCccccc
Q 025350 165 RNHEWFLK 172 (254)
Q Consensus 165 l~hp~~~~ 172 (254)
++||||+.
T Consensus 292 l~Hp~f~~ 299 (350)
T d1rdqe_ 292 KNHKWFAT 299 (350)
T ss_dssp HTSGGGTT
T ss_pred HcCccccC
Confidence 99999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=271.68 Aligned_cols=152 Identities=34% Similarity=0.490 Sum_probs=125.9
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....++.|++.||+|||++||+||||||+|||++.+. +.+||+|||+|+.... ....+..||+.|+|||++.+..+.+
T Consensus 111 ~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~ 188 (273)
T d1xwsa_ 111 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHG 188 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCH
T ss_pred HHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCC
Confidence 3456789999999999999999999999999998553 2499999999975433 3345668999999999998877777
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 168 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 168 (254)
.++|||||||++|+|++|+.||.+.. .+.......+ ..+|+++++||++||..||++|||++|+++||
T Consensus 189 ~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~--~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 189 RSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred cccccccceeeehhHhhCCCCCCCch----------HHhhcccCCC--CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 76899999999999999999997521 1222333333 35899999999999999999999999999999
Q ss_pred cccccC
Q 025350 169 WFLKNL 174 (254)
Q Consensus 169 ~~~~~~ 174 (254)
||++..
T Consensus 257 ~~~~~~ 262 (273)
T d1xwsa_ 257 WMQDVL 262 (273)
T ss_dssp GGSSCC
T ss_pred hhCCCC
Confidence 998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-40 Score=269.45 Aligned_cols=163 Identities=31% Similarity=0.516 Sum_probs=131.9
Q ss_pred ccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC--
Q 025350 7 QRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-- 84 (254)
Q Consensus 7 ~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-- 84 (254)
......++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...........+||+.|+|||.+.+.
T Consensus 109 e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~ 186 (277)
T d1phka_ 109 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 186 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEccCCCceeeeeccCCCCCHHHhhcccc
Confidence 3345567899999999999999999999999999987776 999999999876655555667899999999998632
Q ss_pred ---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCH
Q 025350 85 ---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 161 (254)
Q Consensus 85 ---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 161 (254)
...+.++||||+||++|+|++|+.||.+.........+... ......+....+|+++++||.+||+.||.+|||+
T Consensus 187 ~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~ 264 (277)
T d1phka_ 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264 (277)
T ss_dssp TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred ccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--CCCCCCcccccCCHHHHHHHHHHccCChhHCcCH
Confidence 12244599999999999999999999987654443333221 1223344455789999999999999999999999
Q ss_pred hHHhcCcccccc
Q 025350 162 PEIRNHEWFLKN 173 (254)
Q Consensus 162 ~e~l~hp~~~~~ 173 (254)
+|+|+||||++.
T Consensus 265 ~eil~h~~~~~~ 276 (277)
T d1phka_ 265 EEALAHPFFQQY 276 (277)
T ss_dssp HHHTTSGGGCTT
T ss_pred HHHHcCHHHHHh
Confidence 999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=271.58 Aligned_cols=153 Identities=28% Similarity=0.385 Sum_probs=116.4
Q ss_pred cCCcHHHHHHHHHHHhhcC-----cccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELLPFN-----VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~g-----ivHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~ 83 (254)
...++.|++.||+|||++| ||||||||+|||++.++. +||+|||+|+...... .....+||+.|+|||++.+
T Consensus 111 ~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~ 188 (269)
T d2java1 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHHHHHC-----------CCCSCCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccceeecccCCCccccCCCCcccCCHHHHcC
Confidence 4567899999999999876 999999999999988776 9999999998654332 3345679999999999988
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 84 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
..++.+ +|||||||++|+|++|+.||.+.+...... .+...... +.+..+|+++++||.+||..||.+|||+.|
T Consensus 189 ~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~~~~----~i~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~e 262 (269)
T d2java1 189 MSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEE 262 (269)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHHHHH----HHHcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 888655 999999999999999999998765543332 23333322 223468999999999999999999999999
Q ss_pred HhcCccc
Q 025350 164 IRNHEWF 170 (254)
Q Consensus 164 ~l~hp~~ 170 (254)
+++|||+
T Consensus 263 ll~hp~i 269 (269)
T d2java1 263 ILENPLI 269 (269)
T ss_dssp HHTSTTC
T ss_pred HHhCCcC
Confidence 9999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=273.41 Aligned_cols=158 Identities=30% Similarity=0.517 Sum_probs=131.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCC--CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
...++.|++.||+|||++||+||||||+|||++.++. ..+||+|||+|..........+..||+.|+|||++.+..++
T Consensus 115 ~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~ 194 (293)
T d1jksa_ 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG 194 (293)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCC
Confidence 4567899999999999999999999999999976653 35999999999876655556667899999999999888776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
.+ +|||||||++|+|++|+.||.+.+....... +.......+ .+..+|+.+++||++||..||.+|||+++++
T Consensus 195 ~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 195 LE-ADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred Cc-ccchhhhHHHHHHHcCCCCCCCCCHHHHHHH----HHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 55 9999999999999999999998665443333 333333322 2346899999999999999999999999999
Q ss_pred cCccccc
Q 025350 166 NHEWFLK 172 (254)
Q Consensus 166 ~hp~~~~ 172 (254)
+||||+.
T Consensus 270 ~hp~~~~ 276 (293)
T d1jksa_ 270 QHPWIKP 276 (293)
T ss_dssp HSTTTCC
T ss_pred cCcccCC
Confidence 9999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=268.36 Aligned_cols=165 Identities=25% Similarity=0.327 Sum_probs=131.9
Q ss_pred cccCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC-CCCCCCcCCCCcccchhccCC
Q 025350 6 VQRGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 84 (254)
.......++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... .......||+.|+|||++...
T Consensus 100 ~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~ 177 (298)
T d1gz8a_ 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177 (298)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTC
T ss_pred CHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccceeecccceeeehhhhccc
Confidence 33445678899999999999999999999999999987765 999999999754332 334456799999999998888
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC--------------CCCC---------CCCCCH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------SIPD---------YVHISP 141 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~~~~---------~~~~~~ 141 (254)
.+.+.++|||||||++|+|++|+.||.+.+......+.......... ..+. ...+++
T Consensus 178 ~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 257 (298)
T d1gz8a_ 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDE 257 (298)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCH
T ss_pred cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCH
Confidence 77677799999999999999999999987766555554433211110 0000 124678
Q ss_pred HHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 142 ECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 142 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
++++||++||..||++|||+.|+++||||++
T Consensus 258 ~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 258 DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 9999999999999999999999999999965
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=269.31 Aligned_cols=154 Identities=36% Similarity=0.591 Sum_probs=128.6
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+...... .....+||+.|+|||++.+..++.
T Consensus 105 ~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (320)
T d1xjda_ 105 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182 (320)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCc
Confidence 4567889999999999999999999999999988776 9999999998654333 334457999999999999988876
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh-HHhcC
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP-EIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~-e~l~h 167 (254)
+ +|||||||++|+|++|+.||.+.+...... .+....+..| ..+|+++++||++||..||.+|||+. ++++|
T Consensus 183 ~-~DiwSlGvilyemltG~~PF~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 183 S-VDWWSFGVLLYEMLIGQSPFHGQDEEELFH----SIRMDNPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred h-hhhhhhhHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCC--ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 5 999999999999999999998866543333 3334444444 35899999999999999999999996 89999
Q ss_pred ccccc
Q 025350 168 EWFLK 172 (254)
Q Consensus 168 p~~~~ 172 (254)
|||++
T Consensus 256 pff~~ 260 (320)
T d1xjda_ 256 PLFRE 260 (320)
T ss_dssp GGGTT
T ss_pred chhcc
Confidence 99975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=274.88 Aligned_cols=161 Identities=23% Similarity=0.411 Sum_probs=133.1
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....++.|++.|++|||++||+||||||+|||++.++..++||+|||+++............+|+.|+|||.+.+..++.
T Consensus 103 ~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~ 182 (321)
T d1tkia_ 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECH
T ss_pred HHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCc
Confidence 34567899999999999999999999999999987665679999999998765544445567999999999998888765
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC--CCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+ +|||||||++|+|++|..||.+......+.. +......++ .+..+|+++++||.+||..||.+|||+.|+++
T Consensus 183 ~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 183 A-TDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h-hhcccHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 5 9999999999999999999998665444333 333333332 23468999999999999999999999999999
Q ss_pred CccccccC
Q 025350 167 HEWFLKNL 174 (254)
Q Consensus 167 hp~~~~~~ 174 (254)
||||++..
T Consensus 258 hp~~~~~~ 265 (321)
T d1tkia_ 258 HPWLKQKI 265 (321)
T ss_dssp SHHHHSCG
T ss_pred CHhhccCc
Confidence 99998643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=268.29 Aligned_cols=164 Identities=27% Similarity=0.391 Sum_probs=131.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
...++.|++.||+|||++||+||||||+|||++.++. .+||+|||+++.........+.+|++.|+|||.+.+....+.
T Consensus 124 ~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (350)
T d1q5ka_ 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 202 (350)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred HHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCCcccccccccccccChHHhhcccCCCc
Confidence 3467889999999999999999999999999987652 499999999987666666667789999999999876554455
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------------CCCCC----------CCCCCCHHHHHH
Q 025350 90 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------QYSIP----------DYVHISPECRHL 146 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~----------~~~~~~~~~~~l 146 (254)
++||||+||++|+|++|..||........+..+....... ....+ ....+++++.+|
T Consensus 203 ~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 282 (350)
T d1q5ka_ 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282 (350)
T ss_dssp HHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHH
T ss_pred ceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHH
Confidence 5999999999999999999998877655554443211100 00111 123478999999
Q ss_pred HHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 147 ISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 147 i~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
|.+||..||.+|||+.|+|+||||++..
T Consensus 283 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 283 CSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 9999999999999999999999997643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.7e-39 Score=262.78 Aligned_cols=161 Identities=23% Similarity=0.314 Sum_probs=125.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||.|....... ......+++.|+|||.+.+..+.+
T Consensus 102 ~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 179 (286)
T d1ob3a_ 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179 (286)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCC
T ss_pred hHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccceecccchhhhHHHHhCCCCCC
Confidence 4467889999999999999999999999999988776 9999999997643322 234456899999999998776666
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCC-----------------------CCCCCCCCHHHHH
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-----------------------IPDYVHISPECRH 145 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~ 145 (254)
.++|||||||++|+|++|+.||.+.+......+........... ......+++.+++
T Consensus 180 ~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 259 (286)
T d1ob3a_ 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259 (286)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred cceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHH
Confidence 66999999999999999999999877655555544322111000 0012346889999
Q ss_pred HHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 146 LISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 146 li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
||++||..||++|||++|+|+||||++
T Consensus 260 li~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 260 LLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCc
Confidence 999999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-39 Score=261.78 Aligned_cols=156 Identities=22% Similarity=0.273 Sum_probs=119.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCC--
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKK-- 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~-- 84 (254)
+..++.|++.|++|||++|||||||||+|||++.++. +||+|||+|+...... ...+..||+.|+|||++.+.
T Consensus 106 ~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 183 (276)
T d1uwha_ 106 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183 (276)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC------------CCCCGGGCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCCcccccccccCcccCCHHHHhcccC
Confidence 4557889999999999999999999999999988776 9999999997643322 23445799999999998643
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 -EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 -~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.++ .++|||||||++|+|+||+.||.+..........+.+.............+|+.+++||.+||..||.+|||+++
T Consensus 184 ~~~~-~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~ 262 (276)
T d1uwha_ 184 NPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQ 262 (276)
T ss_dssp CCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCC-chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 344 459999999999999999999998766555544443321111111223468999999999999999999999999
Q ss_pred HhcCc
Q 025350 164 IRNHE 168 (254)
Q Consensus 164 ~l~hp 168 (254)
++++-
T Consensus 263 il~~L 267 (276)
T d1uwha_ 263 ILASI 267 (276)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-38 Score=263.49 Aligned_cols=163 Identities=23% Similarity=0.306 Sum_probs=129.7
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
.....++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+... .......||+.|+|||++.+..+.
T Consensus 121 ~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~ 196 (346)
T d1cm8a_ 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRY 196 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC--CccccccccccccCHHHHcCCCCC
Confidence 345567899999999999999999999999999988876 9999999998643 334567899999999999876665
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------------CCC----CCCCCCCCHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------------QYS----IPDYVHISPE 142 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------------~~~----~~~~~~~~~~ 142 (254)
+.++||||+||++|+|++|++||.+.+....+.......... ... ......+++.
T Consensus 197 ~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 276 (346)
T d1cm8a_ 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 276 (346)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHH
T ss_pred CccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHH
Confidence 566999999999999999999998876555443332211100 000 0112357899
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
+++||.+||..||.+|||+.|+|+||||+...
T Consensus 277 ~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 277 AVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 99999999999999999999999999998643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-38 Score=263.84 Aligned_cols=166 Identities=25% Similarity=0.339 Sum_probs=128.9
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 84 (254)
....++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+...... .....+||+.|+|||++...
T Consensus 110 ~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 187 (345)
T d1pmea_ 110 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTB
T ss_pred HHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCCCccceeeccccccceechHHHhhcC
Confidence 34568899999999999999999999999999988765 9999999997543322 23455799999999998666
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC----------------CCCC---------CCCCC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------------YSIP---------DYVHI 139 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~~~~---------~~~~~ 139 (254)
...+.++||||+||++|+|++|+.||.+.................. ...+ ....+
T Consensus 188 ~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (345)
T d1pmea_ 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 267 (345)
T ss_dssp CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS
T ss_pred CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCC
Confidence 5556669999999999999999999987665444333222110000 0000 12357
Q ss_pred CHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCCc
Q 025350 140 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 176 (254)
Q Consensus 140 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 176 (254)
++++++||.+||..||.+|||+.++|+||||+....+
T Consensus 268 s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 268 DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 8899999999999999999999999999999876554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-38 Score=261.13 Aligned_cols=162 Identities=23% Similarity=0.311 Sum_probs=124.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCC-----CCCCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
...++.|++.|+.|||++||+||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+.
T Consensus 119 ~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeeecccccccccccccceecCHHHhhHHHHcCC
Confidence 3467889999999999999999999999999988776 99999999975432 1223445799999999999876
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCC-CC-------------------------CC
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DY-------------------------VH 138 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~-------------------------~~ 138 (254)
...+.++||||+||++|+|++|+.||.+...................... .. ..
T Consensus 197 ~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (318)
T d3blha1 197 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV 276 (318)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHH
T ss_pred CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhcccc
Confidence 54445699999999999999999999887655544443332211111000 00 01
Q ss_pred CCHHHHHHHHHhchhCCCCCCCHhHHhcCcccccc
Q 025350 139 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 173 (254)
Q Consensus 139 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 173 (254)
.++.+++||.+||..||++|||++|+|+||||+..
T Consensus 277 ~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 277 RDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 36778899999999999999999999999999753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-38 Score=265.76 Aligned_cols=164 Identities=19% Similarity=0.294 Sum_probs=128.6
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
.....++.|++.||.|||++|||||||||+|||++.++. .+||+|||+|+...........++|+.|+|||.+.+....
T Consensus 129 ~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 207 (328)
T d3bqca1 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcccccccCccccCcccccCCCCC
Confidence 344568899999999999999999999999999986542 4899999999876655566677899999999998876654
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc----------cC----------------------CCCCC
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------VQ----------------------YSIPD 135 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------~~----------------------~~~~~ 135 (254)
+.++||||+||++|+|++|+.||............+..... .. ...+.
T Consensus 208 ~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (328)
T d3bqca1 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 287 (328)
T ss_dssp CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTT
T ss_pred CcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccc
Confidence 55699999999999999999999876544332222211111 00 00111
Q ss_pred CCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccc
Q 025350 136 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 172 (254)
Q Consensus 136 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 172 (254)
...+++++++||++||.+||.+|||++|+|+||||+.
T Consensus 288 ~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 288 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp GGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 2246889999999999999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-38 Score=266.05 Aligned_cols=164 Identities=26% Similarity=0.348 Sum_probs=120.9
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
....++.|++.||+|||++||+||||||+|||++.++. +|++|||+++...........++|+.|+|||++.+..++.
T Consensus 120 ~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~ 197 (355)
T d2b1pa1 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC---------------CCTTCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccccccccccccccccccChhhhcCCCCCC
Confidence 34568899999999999999999999999999988776 9999999988766655666678999999999999888766
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc------------------cCCCCCC---------------
Q 025350 89 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------------VQYSIPD--------------- 135 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~~~~~--------------- 135 (254)
+ +||||+||++|+|++|+.||.+.+.............. .......
T Consensus 198 ~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (355)
T d2b1pa1 198 N-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPAD 276 (355)
T ss_dssp T-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCS
T ss_pred C-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccccccc
Confidence 5 99999999999999999999987665554444322211 0000000
Q ss_pred ---CCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 136 ---YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 136 ---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
....++++++||++||..||++||||+|+|+||||+....
T Consensus 277 ~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 277 SEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp SHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred ccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 0013567899999999999999999999999999998654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-37 Score=253.44 Aligned_cols=165 Identities=23% Similarity=0.312 Sum_probs=127.5
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-CCCCCcCCCCcccchhccCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
....++.|++.||+|||++|||||||||+|||++.++. +||+|||.|+...... ......+++.|+|||++.+..+.
T Consensus 102 ~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 179 (292)
T d1unla_ 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCC
T ss_pred HHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccceeeccccchhhhhHhccCCCC
Confidence 34567899999999999999999999999999987765 9999999998654433 23344578899999999877765
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCC------------------------CCCCCCCCCHHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------------------------SIPDYVHISPEC 143 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~ 143 (254)
+.++|||||||++|+|++|+.||....+.......+........ .......+++.+
T Consensus 180 ~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 259 (292)
T d1unla_ 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259 (292)
T ss_dssp CTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHH
T ss_pred CchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHH
Confidence 66699999999999999999997655544433333322221110 001123468899
Q ss_pred HHHHHHhchhCCCCCCCHhHHhcCccccccCC
Q 025350 144 RHLISRIFVADPAKRISIPEIRNHEWFLKNLP 175 (254)
Q Consensus 144 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 175 (254)
++||++||+.||++|||++|+|+||||++..+
T Consensus 260 ~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 260 RDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 99999999999999999999999999987554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=263.75 Aligned_cols=151 Identities=25% Similarity=0.365 Sum_probs=124.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+..++.|++.|++|||++|||||||||+|||++.++. +||+|||+|+....... ..+..||+.|+|||++.+..+
T Consensus 166 ~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 166 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC
Confidence 3447889999999999999999999999999988765 99999999976443322 123468999999999988888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|+| |..||.+......+.+.+ ......+.+..+|+++++||.+||+.||++|||++||+
T Consensus 244 ~~~-~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 244 TIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp CHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Ccc-eeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHH----hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 655 999999999999997 899998876555444433 33344455567899999999999999999999999999
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-37 Score=257.59 Aligned_cols=158 Identities=32% Similarity=0.501 Sum_probs=128.4
Q ss_pred CCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCC--CCCCCCcCCCCcccchhccCCC-CC
Q 025350 11 GTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLKKE-YD 87 (254)
Q Consensus 11 ~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~ 87 (254)
..++.|++.|++|||++|||||||||+|||++.++. +||+|||+|+..... ....+..|++.|+|||.+.+.. +.
T Consensus 132 ~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~ 209 (322)
T d1vzoa_ 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 209 (322)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---
T ss_pred HHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhcccccccccccccccccchhHHhhcCCcCC
Confidence 446789999999999999999999999999988775 999999999754332 2234567999999999997654 23
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCC-----CHh
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIP 162 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~ 162 (254)
+.++|||||||++|+|++|..||.+.....................| ..+|+++++||++||.+||.+|| |++
T Consensus 210 ~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~ 287 (322)
T d1vzoa_ 210 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287 (322)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHH
T ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc--ccCCHHHHHHHHHHcccCHHHcCCCCcccHH
Confidence 44599999999999999999999887665555555555444444433 36899999999999999999999 589
Q ss_pred HHhcCccccc
Q 025350 163 EIRNHEWFLK 172 (254)
Q Consensus 163 e~l~hp~~~~ 172 (254)
|+++||||++
T Consensus 288 eil~Hpff~~ 297 (322)
T d1vzoa_ 288 EIKEHLFFQK 297 (322)
T ss_dssp HHHTSGGGTT
T ss_pred HHHcCHhhcC
Confidence 9999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-37 Score=252.09 Aligned_cols=156 Identities=19% Similarity=0.204 Sum_probs=123.2
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
.+..++.|++.|++|||++||+||||||+|||++.++. +||+|||+|+...... ......||+.|+|||++.+..+
T Consensus 110 ~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 187 (272)
T d1qpca_ 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187 (272)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCccccccccCCcccccChHHHhCCCC
Confidence 34567899999999999999999999999999988776 9999999998654332 2334568999999999988777
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 87 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
+.+ +|||||||++|+|+||..|+........... .+.. ....+.+..+++++++||.+||+.||++|||++++++
T Consensus 188 ~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~---~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 188 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp CHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH---HHHh-cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 655 9999999999999996555444333332222 2222 2333444578999999999999999999999999998
Q ss_pred --Ccccc
Q 025350 167 --HEWFL 171 (254)
Q Consensus 167 --hp~~~ 171 (254)
|+||+
T Consensus 263 ~L~~~ft 269 (272)
T d1qpca_ 263 VLEDFFT 269 (272)
T ss_dssp HHHHHHH
T ss_pred Hhhhhhh
Confidence 78885
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-37 Score=255.41 Aligned_cols=151 Identities=23% Similarity=0.356 Sum_probs=116.7
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+..++.|++.|++|||++|||||||||+|||++.++. +||+|||+|+...... ......||+.|+|||++.+..+
T Consensus 136 ~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 136 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence 4457889999999999999999999999999987775 9999999997543322 2234579999999999988887
Q ss_pred CCcchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++| .+||.+......+...+.. ....+.+..+++++++||.+||..||.+|||+++++
T Consensus 214 ~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil 288 (299)
T d1ywna1 214 TIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288 (299)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Ccc-cceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 655 9999999999999986 5678776655544443332 223334456899999999999999999999999999
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
+|
T Consensus 289 ~~ 290 (299)
T d1ywna1 289 EH 290 (299)
T ss_dssp HH
T ss_pred HH
Confidence 87
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=261.33 Aligned_cols=163 Identities=23% Similarity=0.352 Sum_probs=126.7
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
.....++.|++.||+|||++||+||||||+|||++.++. +|++|||++.... ....+..|++.|+|||++.+..+.
T Consensus 121 ~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~ 196 (348)
T d2gfsa1 121 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHY 196 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC--cccccccccccccCchhhcCCccC
Confidence 344567899999999999999999999999999988876 9999999987543 234556789999999998877766
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccC-------------------CCCC------CCCCCCHH
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------------------YSIP------DYVHISPE 142 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~------~~~~~~~~ 142 (254)
+.++|||||||++|+|++|++||.+.+.......+........ ...+ ....+++.
T Consensus 197 ~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 276 (348)
T d2gfsa1 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 276 (348)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHH
T ss_pred CcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHH
Confidence 6669999999999999999999998776555444433221110 0011 02357899
Q ss_pred HHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 143 CRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 143 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
+++||++||..||.+|||+.|+|+||||++..
T Consensus 277 ~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 277 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 99999999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=253.12 Aligned_cols=154 Identities=21% Similarity=0.246 Sum_probs=121.3
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 84 (254)
.+..++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+...... ......||+.|+|||++.+.
T Consensus 108 ~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 108 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccccCCCceecCchhhcCC
Confidence 34567889999999999999999999999999988775 9999999997543322 12234689999999999888
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.++.+ +|||||||++|+|+| |+.||.+........ .+.. ....+.+..+|+++++||.+||+.||.+|||+++
T Consensus 186 ~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~----~i~~-~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~ 259 (277)
T d1xbba_ 186 KFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 259 (277)
T ss_dssp EEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 77655 999999999999998 899998866533222 2222 2233444578999999999999999999999999
Q ss_pred H---hcCccc
Q 025350 164 I---RNHEWF 170 (254)
Q Consensus 164 ~---l~hp~~ 170 (254)
+ |+|+|+
T Consensus 260 i~~~L~~~~~ 269 (277)
T d1xbba_ 260 VELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHhhCHHh
Confidence 8 456654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-36 Score=250.61 Aligned_cols=150 Identities=21% Similarity=0.319 Sum_probs=113.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCC------CCCcCCCCcccchhccC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP------KSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~------~~~~~~~~y~aPE~~~~ 83 (254)
+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+........ ....||+.|+|||++.+
T Consensus 130 ~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (299)
T d1jpaa_ 130 LVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------------------CGGGSCHHHHHS
T ss_pred HHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc
Confidence 4567889999999999999999999999999988776 999999999865432221 12347889999999988
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 84 KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..++.+ +|||||||++|||+| |..||.+........ .+. .....+.+..+++.+.+||.+||+.||.+|||+.
T Consensus 208 ~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~----~i~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 281 (299)
T d1jpaa_ 208 RKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVIN----AIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281 (299)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHH
Confidence 888655 999999999999998 899998866543322 222 2334455567899999999999999999999999
Q ss_pred HHhcC
Q 025350 163 EIRNH 167 (254)
Q Consensus 163 e~l~h 167 (254)
+++++
T Consensus 282 ei~~~ 286 (299)
T d1jpaa_ 282 QIVNT 286 (299)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-37 Score=251.15 Aligned_cols=155 Identities=24% Similarity=0.305 Sum_probs=124.5
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 84 (254)
.+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+...... ......||+.|+|||++.+.
T Consensus 110 ~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (285)
T d1u59a_ 110 NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhcccccccccccccccccCccccChHHHhCC
Confidence 34567899999999999999999999999999988765 9999999998654322 12344688999999999888
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhH
Q 025350 85 EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 163 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 163 (254)
.++.+ +|||||||++|||+| |+.||.+......... +.. ....+.+..+|+++.+||.+||..||++|||+.+
T Consensus 188 ~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~----i~~-~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~ 261 (285)
T d1u59a_ 188 KFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLT 261 (285)
T ss_dssp EECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----HHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 87655 999999999999998 8999988765433222 222 2233444568999999999999999999999988
Q ss_pred H---hcCcccc
Q 025350 164 I---RNHEWFL 171 (254)
Q Consensus 164 ~---l~hp~~~ 171 (254)
+ |+|+|+.
T Consensus 262 i~~~L~~~~~~ 272 (285)
T d1u59a_ 262 VEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 7 6788874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-36 Score=249.11 Aligned_cols=150 Identities=21% Similarity=0.231 Sum_probs=120.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+....... .....|++.|+|||++.+..++
T Consensus 117 ~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 194 (287)
T d1opja_ 117 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCS
T ss_pred HHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCceeeccccccccccChHHHcCCCCC
Confidence 4456789999999999999999999999999988775 99999999986543322 1223588999999999888886
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|++|..||..........+.+ ......+.+..+|+.+++||.+||..||.+|||++++++
T Consensus 195 ~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 195 IK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 55 999999999999999777765554444433332 223444555578999999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-36 Score=245.19 Aligned_cols=150 Identities=21% Similarity=0.322 Sum_probs=110.2
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+....... .....||+.|+|||++.+..++
T Consensus 103 ~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 180 (263)
T d1sm2a_ 103 LLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180 (263)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------------CTTSCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceeecceecCcccCChHHhcCCCCC
Confidence 4557899999999999999999999999999998776 99999999976543322 2335689999999999988887
Q ss_pred CcchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|+|+ .+||..... ......+. . ....+.+..+++++.+||.+||..||++|||++++++
T Consensus 181 ~k-~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~---~-~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 254 (263)
T d1sm2a_ 181 SK-SDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDIS---T-GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254 (263)
T ss_dssp HH-HHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHH---H-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHH---h-cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 55 9999999999999995 555555433 22222222 2 2223334467999999999999999999999999997
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
|
T Consensus 255 ~ 255 (263)
T d1sm2a_ 255 Q 255 (263)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-36 Score=245.98 Aligned_cols=150 Identities=19% Similarity=0.260 Sum_probs=113.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 85 (254)
+..++.|++.|++|||++||+||||||+|||++.++. +||+|||+|+....... .....||+.|+|||++.+..
T Consensus 112 ~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 189 (283)
T d1mqba_ 112 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189 (283)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC
Confidence 3467889999999999999999999999999998776 99999999986433221 12235889999999998888
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
++.+ +|||||||++|+|++|..||............ + ......+.+..++..+++||.+||..||++|||+.+|+
T Consensus 190 ~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~---i-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil 264 (283)
T d1mqba_ 190 FTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---I-NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264 (283)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---H-HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHH---H-hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHH
Confidence 8765 99999999999999976665544433333222 2 22334455567899999999999999999999999998
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 265 ~ 265 (283)
T d1mqba_ 265 S 265 (283)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-36 Score=242.94 Aligned_cols=150 Identities=18% Similarity=0.269 Sum_probs=122.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC--CCCCcCCCCcccchhccCCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYD 87 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 87 (254)
+..+..|++.|++|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+..++
T Consensus 102 ~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 179 (258)
T d1k2pa_ 102 LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179 (258)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCC
Confidence 4457789999999999999999999999999988765 99999999975443322 2235689999999999988886
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhc
Q 025350 88 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 166 (254)
Q Consensus 88 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 166 (254)
.+ +|||||||++|+|+| |+.||.+.+...... .+.. ....+.+..+++++++||++||+.||++|||++++++
T Consensus 180 ~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~----~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 253 (258)
T d1k2pa_ 180 SK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 253 (258)
T ss_dssp HH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH----HHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cc-eeecccchhhHhHHhcCCCCCCCCCHHHHHH----HHHh-CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 55 999999999999998 899998876544332 2322 2334455678999999999999999999999999998
Q ss_pred C
Q 025350 167 H 167 (254)
Q Consensus 167 h 167 (254)
|
T Consensus 254 ~ 254 (258)
T d1k2pa_ 254 N 254 (258)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-36 Score=248.24 Aligned_cols=159 Identities=18% Similarity=0.231 Sum_probs=121.0
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 85 (254)
..+..++.+++.|++|||++||+||||||+||||+.++. +||+|||+|+...... ......||+.|+|||++....
T Consensus 113 ~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 190 (285)
T d1fmka3 113 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------------CCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCceeeccccccccccChHHHhCCC
Confidence 345678899999999999999999999999999988765 9999999997643222 223356899999999998888
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
++.+ +|||||||++|+|++|..||............+ .. ....+....+++++++||.+||+.||++|||+++|+
T Consensus 191 ~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i---~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 265 (285)
T d1fmka3 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265 (285)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hh-cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 8655 999999999999999766655444433332222 22 233445567899999999999999999999999998
Q ss_pred c--Ccccccc
Q 025350 166 N--HEWFLKN 173 (254)
Q Consensus 166 ~--hp~~~~~ 173 (254)
+ |+||...
T Consensus 266 ~~L~~~~~~~ 275 (285)
T d1fmka3 266 AFLEDYFTST 275 (285)
T ss_dssp HHHHTTTSCS
T ss_pred HHHhhhhcCC
Confidence 7 7888653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-36 Score=246.24 Aligned_cols=151 Identities=20% Similarity=0.340 Sum_probs=113.7
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC--CCCCCcCCCCcccchhccCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
....++.|++.|++|||++||+||||||+||+++.++. +||+|||+|+...... ......||+.|+|||++.+..+
T Consensus 109 ~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~ 186 (273)
T d1mp8a_ 109 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcceeccceecCcccchhhHhccCCC
Confidence 34566889999999999999999999999999988775 9999999998654322 2233468899999999988887
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++ |.+||.+.........+ .. ....+.+..+|+.+++||.+||..||.+|||+.+|+
T Consensus 187 ~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~ 260 (273)
T d1mp8a_ 187 TSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 260 (273)
T ss_dssp SHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 655 999999999999998 89999887665443332 22 223345567899999999999999999999999998
Q ss_pred cC
Q 025350 166 NH 167 (254)
Q Consensus 166 ~h 167 (254)
+|
T Consensus 261 ~~ 262 (273)
T d1mp8a_ 261 AQ 262 (273)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.4e-36 Score=246.36 Aligned_cols=156 Identities=19% Similarity=0.299 Sum_probs=115.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC----CCCCCcCCCCcccchhccCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 85 (254)
...++.|++.||+|||++|||||||||+|||++.++. ++|+|||.+....... .....+||+.|+|||++.+..
T Consensus 113 ~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 190 (277)
T d1o6ya_ 113 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC----------------TTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCC
Confidence 4567899999999999999999999999999988776 9999999886443222 234457999999999998888
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 86 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
++.+ +|||||||++|+|+||++||.+.+......+.+.. ...........+|+.+++||.+||..||.+||+..+.+
T Consensus 191 ~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l 267 (277)
T d1o6ya_ 191 VDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 267 (277)
T ss_dssp CCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred CCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc--CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH
Confidence 7655 99999999999999999999886654444333221 11111223456899999999999999999999544444
Q ss_pred cCccc
Q 025350 166 NHEWF 170 (254)
Q Consensus 166 ~hp~~ 170 (254)
.|+|.
T Consensus 268 ~~~l~ 272 (277)
T d1o6ya_ 268 RADLV 272 (277)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 56665
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-36 Score=250.44 Aligned_cols=152 Identities=20% Similarity=0.288 Sum_probs=120.8
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+..++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+....... .....||+.|+|||++.+..+
T Consensus 113 ~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 190 (317)
T d1xkka_ 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190 (317)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecccccccccccccccCccccChHHHhcCCC
Confidence 4457889999999999999999999999999988775 99999999986543222 223358999999999988887
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|+| |.+||.+...... ...+.. ....+.+..+++.+.+||.+||..||.+|||+.+++
T Consensus 191 ~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil 264 (317)
T d1xkka_ 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEK----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264 (317)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHH----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Chh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHc----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHH
Confidence 655 999999999999998 7889887655433 222222 233344456899999999999999999999999999
Q ss_pred cCcc
Q 025350 166 NHEW 169 (254)
Q Consensus 166 ~hp~ 169 (254)
+|..
T Consensus 265 ~~l~ 268 (317)
T d1xkka_ 265 IEFS 268 (317)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9853
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-36 Score=244.06 Aligned_cols=152 Identities=22% Similarity=0.310 Sum_probs=122.3
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC----CCCCcCCCCcccchhccC
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLK 83 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~ 83 (254)
..+..++.|++.|++|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+
T Consensus 111 ~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 188 (273)
T d1u46a_ 111 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC
Confidence 344577899999999999999999999999999988765 99999999986533322 223357889999999988
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHh
Q 025350 84 KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 162 (254)
Q Consensus 84 ~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 162 (254)
..++.+ +|||||||++|+|+| |..||.+.+..... ..+.......+....+|+.+++||.+||..||++|||+.
T Consensus 189 ~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 263 (273)
T d1u46a_ 189 RTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263 (273)
T ss_dssp CEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHHH----HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHH
Confidence 777655 999999999999998 89999886654433 334445555566677899999999999999999999999
Q ss_pred HHhc
Q 025350 163 EIRN 166 (254)
Q Consensus 163 e~l~ 166 (254)
+|++
T Consensus 264 ei~~ 267 (273)
T d1u46a_ 264 ALRD 267 (273)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-35 Score=244.96 Aligned_cols=171 Identities=18% Similarity=0.129 Sum_probs=125.0
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCC-CCcEEEecCCCcccCCCCC--------CCCCCcCCCCcccch
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPE 79 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE 79 (254)
....++.|++.+|+|||++|||||||||+|||++..+ ...+||+|||+|+...... .....+||+.|+|||
T Consensus 104 ~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 183 (299)
T d1ckia_ 104 TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHH
Confidence 3456778999999999999999999999999986432 2359999999998653322 123457999999999
Q ss_pred hccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH---HhccCCCCCCCCCCCHHHHHHHHHhchhCCC
Q 025350 80 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR---ILSVQYSIPDYVHISPECRHLISRIFVADPA 156 (254)
Q Consensus 80 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 156 (254)
++.+..++.+ +|||||||++|+|++|..||............... ...... ......+|+++.+||.+||..+|.
T Consensus 184 ~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~li~~cl~~~p~ 261 (299)
T d1ckia_ 184 THLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EVLCKGYPSEFATYLNFCRSLRFD 261 (299)
T ss_dssp HHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-HHHTTTSCHHHHHHHHHHHHSCTT
T ss_pred HHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-hHhccCCCHHHHHHHHHHccCChh
Confidence 9998887655 99999999999999999999876543332222111 111110 011235799999999999999999
Q ss_pred CCCCHh---HHhcCccccccCCcccccc
Q 025350 157 KRISIP---EIRNHEWFLKNLPADLVVD 181 (254)
Q Consensus 157 ~Rps~~---e~l~hp~~~~~~~~~~~~~ 181 (254)
+||++. ++|+|+|.+.++..+..+|
T Consensus 262 ~RP~~~~i~~~l~~~~~~~~~~~~~~~D 289 (299)
T d1ckia_ 262 DKPDYSYLRQLFRNLFHRQGFSYDYVFD 289 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHTCCCSCCCH
T ss_pred HCcCHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999986 5678988877666554433
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-35 Score=241.15 Aligned_cols=150 Identities=21% Similarity=0.321 Sum_probs=121.8
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKE 85 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 85 (254)
.+..++.|++.|++|||++|||||||||+|||++.++. +||+|||+++...... ......+++.|+|||.+.+..
T Consensus 136 ~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~ 213 (299)
T d1fgka_ 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCC
Confidence 34678899999999999999999999999999988876 9999999998654332 233456889999999998888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 86 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 86 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
++.+ +|||||||++|+|++ |.+||.+....... .. + ......+.+..+++.+++||.+||+.||++|||+.+|
T Consensus 214 y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-~~---i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~ei 287 (299)
T d1fgka_ 214 YTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF-KL---L-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287 (299)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HH---H-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCch-hhhHHhHHHHHHhccCCCCCCCCCCHHHHH-HH---H-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence 8755 999999999999998 78888775543322 22 2 2233444455789999999999999999999999999
Q ss_pred hc
Q 025350 165 RN 166 (254)
Q Consensus 165 l~ 166 (254)
++
T Consensus 288 l~ 289 (299)
T d1fgka_ 288 VE 289 (299)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-35 Score=240.59 Aligned_cols=149 Identities=20% Similarity=0.250 Sum_probs=117.9
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC---CCCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+..++.|++.|++|||++|||||||||+|||++.++. +||+|||+|+...... ...+..+++.|+|||.+.+..+
T Consensus 142 ~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 219 (301)
T d1lufa_ 142 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219 (301)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC
Confidence 4557889999999999999999999999999988765 9999999997443222 2234568899999999998888
Q ss_pred CCcchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|++|. +||.+....+.... +.... ..+.+..+++++.+||.+||+.||++|||+.+|+
T Consensus 220 t~k-sDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~----v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 220 TTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY----VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp CHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Chh-hhhccchhhHHHHHccCCCCCCCCCHHHHHHH----HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 755 99999999999999985 67777655443332 22222 2334456899999999999999999999999996
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 294 ~ 294 (301)
T d1lufa_ 294 R 294 (301)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=240.54 Aligned_cols=150 Identities=21% Similarity=0.246 Sum_probs=120.1
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCCc
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 89 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 89 (254)
+..++.|++.|+.|||++||+||||||+|||++.++. +||+|||+|+............||..|+|||.+.+..++.+
T Consensus 129 ~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 206 (309)
T d1fvra_ 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 206 (309)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--eEEccccccccccccccccceecCCcccchHHhccCCCCcc
Confidence 3456889999999999999999999999999988775 99999999986655555556679999999999988888655
Q ss_pred chhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 90 IADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 90 ~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+|||||||++|+|++|. +||.+.+.... ...+.. ....+.+..+++++++||.+||+.||++|||+.+|++|
T Consensus 207 -sDvwSfGvil~ell~~~~~p~~~~~~~~~----~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 207 -SDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -HHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -ceeehhHHHHHHHHhcCCCCCCCCCHHHH----HHHHHh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999975 56766544332 222322 23344455789999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-34 Score=237.70 Aligned_cols=149 Identities=20% Similarity=0.214 Sum_probs=120.0
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+..++.+++.|++|||+++|+||||||+|||++.++. +||+|||+|+....... .....+|+.|+|||.+.+..+
T Consensus 135 ~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~ 212 (308)
T d1p4oa_ 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 212 (308)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeecccceeccCCcceeeccceecccccCCHHHHccCCC
Confidence 4557899999999999999999999999999988776 99999999975433222 233468999999999988887
Q ss_pred CCcchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|+||. +||.+.+....... +... ...+....+++.+.+||.+||+.||.+|||+.+++
T Consensus 213 ~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~----i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il 286 (308)
T d1p4oa_ 213 TTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286 (308)
T ss_dssp CHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Ccc-cccccHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 655 99999999999999984 77876555443332 2222 23334456899999999999999999999999999
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 287 ~ 287 (308)
T d1p4oa_ 287 S 287 (308)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-34 Score=230.90 Aligned_cols=149 Identities=23% Similarity=0.325 Sum_probs=114.6
Q ss_pred CcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCCCCCC
Q 025350 9 GRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 88 (254)
Q Consensus 9 ~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 88 (254)
.+..++.|++.|+.|||+++|+||||||+|||++.++. +||+|||+++.... ......+++.|+|||++.+..++.
T Consensus 104 ~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~--~~~~~~~~~~y~aPE~l~~~~~t~ 179 (262)
T d1byga_ 104 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQDTGKLPVKWTAPEALREKKFST 179 (262)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------------CCTTTSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--CCccccccccCCChHHHhCCCCCh
Confidence 34567899999999999999999999999999998876 99999999986432 234456889999999998887765
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 89 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 89 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
+ +|||||||++|+|+| |++||........... +. .....+....+++++++||++||..||.+|||+.+++++
T Consensus 180 ~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~----i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 180 K-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HT-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH----HH-cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 4 999999999999998 7888877654433322 22 223334445689999999999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-34 Score=242.22 Aligned_cols=161 Identities=24% Similarity=0.351 Sum_probs=118.7
Q ss_pred cCCcHHHHHHHHHHHhh-cCcccCCCCCCcEEecCCCC----CcEEEecCCCcccCCCCCCCCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLP-FNVCHRDLKLENTLLDGSPA----PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~-~givHrdlkp~NIll~~~~~----~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~ 84 (254)
...++.|++.|++|||+ .||+||||||+|||++..+. ..++++|||.+..... .....+||+.|+|||++.+.
T Consensus 127 i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhcccc
Confidence 35678999999999997 99999999999999975442 2489999999875432 34566899999999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHHHHhcc---------------------CCCC----
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK------NFRKTIHRILSV---------------------QYSI---- 133 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~---------------------~~~~---- 133 (254)
.++.+ +|+||+||++++|++|+.||....... .....+. .... ....
T Consensus 205 ~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
T d1q8ya_ 205 PWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 282 (362)
T ss_dssp CCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred CCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH-HhCCCCHHHhhcccccccccccchhhhcccccc
Confidence 88765 999999999999999999997543211 1111111 0000 0000
Q ss_pred ------------CCCCCCCHHHHHHHHHhchhCCCCCCCHhHHhcCccccccC
Q 025350 134 ------------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 174 (254)
Q Consensus 134 ------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 174 (254)
......++.+++||.+||.+||.+|||++|+|+||||++..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 283 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp BCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred CCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 00112357899999999999999999999999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-34 Score=236.28 Aligned_cols=151 Identities=19% Similarity=0.208 Sum_probs=117.5
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC-----CCCCcCCCCcccchhccCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKK 84 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 84 (254)
+..++.|++.|+.|||+.||+||||||+|||++.++. +||+|||+++....... .....||+.|+|||.+.+.
T Consensus 132 ~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 209 (311)
T d1r0pa_ 132 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccceecccccccccccChHHHhcC
Confidence 3467889999999999999999999999999988765 99999999986543322 1224589999999999888
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHH
Q 025350 85 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 164 (254)
Q Consensus 85 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 164 (254)
.++.+ +||||||+++|+|+||..||........... .+... ...+.+..+++.+.+||.+||..||++|||+.||
T Consensus 210 ~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~g-~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei 284 (311)
T d1r0pa_ 210 KFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284 (311)
T ss_dssp CCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHH---HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcC-CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 87655 9999999999999998888766443322222 22222 2333445689999999999999999999999999
Q ss_pred hcC
Q 025350 165 RNH 167 (254)
Q Consensus 165 l~h 167 (254)
++|
T Consensus 285 ~~~ 287 (311)
T d1r0pa_ 285 VSR 287 (311)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-33 Score=233.88 Aligned_cols=150 Identities=26% Similarity=0.380 Sum_probs=120.4
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCCC---CCCCcCCCCcccchhccCCCC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 86 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 86 (254)
+..++.|++.|++|||++|||||||||+||+++.++. +||+|||+++....... ....+||+.|+|||++.+..+
T Consensus 147 ~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 224 (311)
T d1t46a_ 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccccccccccccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC
Confidence 4457899999999999999999999999999988765 99999999986543322 233468999999999987777
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchhCCCCCCCHhHHh
Q 025350 87 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 165 (254)
Q Consensus 87 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 165 (254)
+.+ +|||||||++|+|+| |.+||.+......+.+.+.. .........+++.+.+||.+||+.||.+|||+.+|+
T Consensus 225 ~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il 299 (311)
T d1t46a_ 225 TFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (311)
T ss_dssp CHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCc-ccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 655 999999999999998 56666665554444444332 333344456899999999999999999999999998
Q ss_pred c
Q 025350 166 N 166 (254)
Q Consensus 166 ~ 166 (254)
+
T Consensus 300 ~ 300 (311)
T d1t46a_ 300 Q 300 (311)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.98 E-value=1.1e-32 Score=226.99 Aligned_cols=157 Identities=15% Similarity=0.116 Sum_probs=116.7
Q ss_pred cCcCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCC---CCCcEEEecCCCcccCCCCC--------CCCCCcCCCCcc
Q 025350 8 RGRGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYI 76 (254)
Q Consensus 8 ~~~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~---~~~~vkl~Dfg~a~~~~~~~--------~~~~~~~~~~y~ 76 (254)
.....++.|++.+|+|||++||+||||||+|||++.. ..+.+||+|||+|+...... .....+||+.|+
T Consensus 101 ~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~ 180 (293)
T d1csna_ 101 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhc
Confidence 3445688999999999999999999999999999752 22459999999997543221 223457999999
Q ss_pred cchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHHHHHHhccCCCCCCCCCCCHHHHHHHHHhchh
Q 025350 77 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF---RKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 153 (254)
Q Consensus 77 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 153 (254)
|||++.+..++.+ +|||||||++|+|++|..||.+....... ........... .......+|+++.+++..|+..
T Consensus 181 aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~l~~~~p~~l~~ii~~~~~~ 258 (293)
T d1csna_ 181 SINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LRELCAGFPEEFYKYMHYARNL 258 (293)
T ss_dssp CHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHHC
T ss_pred CHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC-hHHhcCCCCHHHHHHHHHHhcC
Confidence 9999998887655 99999999999999999999865432221 11111111110 0011235789999999999999
Q ss_pred CCCCCCCHhHHhc
Q 025350 154 DPAKRISIPEIRN 166 (254)
Q Consensus 154 dP~~Rps~~e~l~ 166 (254)
+|.+||+.+.+.+
T Consensus 259 ~~~~rP~y~~l~~ 271 (293)
T d1csna_ 259 AFDATPDYDYLQG 271 (293)
T ss_dssp CTTCCCCHHHHHH
T ss_pred CcccCcCHHHHHH
Confidence 9999998776643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-32 Score=224.99 Aligned_cols=156 Identities=21% Similarity=0.200 Sum_probs=109.7
Q ss_pred cCCcHHHHHHHHHHHhh--------cCcccCCCCCCcEEecCCCCCcEEEecCCCcccCCCCC-----CCCCCcCCCCcc
Q 025350 10 RGTLFLPTTYFWSELLP--------FNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYI 76 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~--------~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~ 76 (254)
+..+..+++.+++|||+ +|||||||||+||||+.++. +||+|||+++...... ......||+.|+
T Consensus 102 ~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~ 179 (303)
T d1vjya_ 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179 (303)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEECC----CCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCccccccCCCcceeccccceecccCcC
Confidence 34678899999999995 69999999999999988775 9999999997543322 223457999999
Q ss_pred cchhccCCCC-----CCcchhHHHHHHHHHHHHhCCCCCCCCCch-----------HHHHHHHHHHhccCCCCCCCC---
Q 025350 77 APEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTIHRILSVQYSIPDYV--- 137 (254)
Q Consensus 77 aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~--- 137 (254)
|||++.+... .+.++|||||||++|+|+||..||...... .................+...
T Consensus 180 aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 259 (303)
T d1vjya_ 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 259 (303)
T ss_dssp CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred ChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccC
Confidence 9999875432 134589999999999999998877432210 111122222222222111111
Q ss_pred --CCCHHHHHHHHHhchhCCCCCCCHhHHhcC
Q 025350 138 --HISPECRHLISRIFVADPAKRISIPEIRNH 167 (254)
Q Consensus 138 --~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 167 (254)
..+..+.+|+.+||..||++|||+.||+++
T Consensus 260 ~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 260 SCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122458899999999999999999999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.42 E-value=3.4e-14 Score=108.32 Aligned_cols=48 Identities=19% Similarity=0.117 Sum_probs=42.3
Q ss_pred cCCcHHHHHHHHHHHhhcCcccCCCCCCcEEecCCCCCcEEEecCCCcccC
Q 025350 10 RGTLFLPTTYFWSELLPFNVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 60 (254)
Q Consensus 10 ~~~~~~~~~~~l~~Lh~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~~~ 60 (254)
...++.|++.+++|||++||+||||||+|||++.++ ++|+|||.|+..
T Consensus 105 ~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~~ 152 (191)
T d1zara2 105 PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVEV 152 (191)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEECCCcccC
Confidence 345788999999999999999999999999998654 899999998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.55 E-value=0.0047 Score=48.73 Aligned_cols=31 Identities=29% Similarity=0.417 Sum_probs=26.2
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..|+||+|+.++||+++.+.. .-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccc--eeEecccccc
Confidence 678999999999999986643 5799999764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=93.74 E-value=0.012 Score=44.66 Aligned_cols=30 Identities=23% Similarity=0.286 Sum_probs=24.1
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++|+|+.|.||+++.++. +.|+||+.+.
T Consensus 183 ~~l~HgD~~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T d1j7la_ 183 LVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp EEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred cEEEEeeccCcceeecCCce--EEEeechhcc
Confidence 45899999999999986542 4699998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=93.34 E-value=0.013 Score=44.41 Aligned_cols=30 Identities=23% Similarity=0.248 Sum_probs=24.3
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++|+|+.|.||+++.+.. +-|+||+.+.
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~--~~iID~~~~~ 204 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRF--SGFIDCGRLG 204 (255)
T ss_dssp EEEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ceEEeCCCCCcceEEeCCce--EEEEEchhcc
Confidence 45899999999999986543 6799998664
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.54 E-value=0.027 Score=44.51 Aligned_cols=29 Identities=17% Similarity=0.121 Sum_probs=23.8
Q ss_pred hcCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 26 PFNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 26 ~~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++||+|+.|.|||++. + ..++||+-|.
T Consensus 191 p~~liHgDlh~~NvL~~~-~---~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G---PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S---EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeC-C---ceEEechhcc
Confidence 468999999999999963 2 4589999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=92.30 E-value=0.032 Score=45.42 Aligned_cols=29 Identities=17% Similarity=0.192 Sum_probs=24.9
Q ss_pred cCcccCCCCCCcEEecCCCCCcEEEecCCCcc
Q 025350 27 FNVCHRDLKLENTLLDGSPAPRLKICDFGYSK 58 (254)
Q Consensus 27 ~givHrdlkp~NIll~~~~~~~vkl~Dfg~a~ 58 (254)
..++|+|+.|.|||++.++ ++|+||..|.
T Consensus 223 ~~LiHGDl~~gNIlv~~~~---~~vID~E~a~ 251 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE---TKVIDPEFAF 251 (392)
T ss_dssp CEEECSCCCGGGEEECSSC---EEECCCTTCE
T ss_pred cceeccCCcCCceeEcCCc---eEEechhhcc
Confidence 4699999999999998654 8999998775
|